<SEC-DOCUMENT>0001140361-22-029251.txt : 20220811
<SEC-HEADER>0001140361-22-029251.hdr.sgml : 20220811
<ACCEPTANCE-DATETIME>20220811161612
ACCESSION NUMBER:		0001140361-22-029251
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		80
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220811
DATE AS OF CHANGE:		20220811

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brooklyn ImmunoTherapeutics, Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		221156087

	BUSINESS ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALROY INDUSTRIES INC
		DATE OF NAME CHANGE:	19850411
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>brhc10040603_10q.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:btx="http://brooklynitx.com/20220630" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="background-color: #ffffff; color: #000000;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_ddfc7c74924d4f309d4a59ace6576e34" contextRef="c20220101to20220630" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="Fact_23826375958c4306acc8c76fc630b1b9" contextRef="c20220101to20220630" format="ixt:datemonthday">12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" id="Fact_38b6890574564b3db35d76aba54b2111" contextRef="c20220101to20220630">2022</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" id="Fact_ef1da885a61849f8b43548134172c53c" contextRef="c20220101to20220630">Q2</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_6bf80679b32d4f7fa28276ba2126de6f" contextRef="c20220101to20220630">0000748592</ix:nonNumeric><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_816a5bfe7554457abf9cb7a46a5bdc57" contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">P5Y6M</ix:nonNumeric><ix:nonNumeric name="btx:AggregateCalendarDays" id="Fact_79f909b8446d493ba4844bbccec3c0e8" contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember">P15D</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="btx-20220630.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220101to20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-08-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-26</xbrli:startDate><xbrli:endDate>2021-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_AssetAcquisitionAxis_NovellusIncMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AssetAcquisitionAxis_NovellusIncMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_AssetAcquisitionAxis_NovellusIncMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">btx:CitiusPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-16</xbrli:startDate><xbrli:endDate>2021-07-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220524to20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-24</xbrli:startDate><xbrli:endDate>2022-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220524_AwardTypeAxis_MilestoneOptionsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:MilestoneOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220524to20220524_AwardTypeAxis_MilestoneOptionsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:MilestoneOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-24</xbrli:startDate><xbrli:endDate>2022-05-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220630_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_RestructuringCostAndReserveAxis_EmployeeSeveranceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:DheshGovenderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-15</xbrli:startDate><xbrli:endDate>2021-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211215to20211215_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:DheshGovenderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-15</xbrli:startDate><xbrli:endDate>2021-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210205to20210205_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220805to20220805_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-05</xbrli:startDate><xbrli:endDate>2022-08-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_LegalEntityAxis_UniversityOfSouthFloridaMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">btx:UniversityOfSouthFloridaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-13</xbrli:startDate><xbrli:endDate>2021-04-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-30</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210415to20210415_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-15</xbrli:startDate><xbrli:endDate>2021-04-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210426_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember_StatementScenarioAxis_ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220630_RelatedPartyTransactionsByRelatedPartyAxis_NoveCiteMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NoveCiteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:InvestorRoyaltyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-22</xbrli:startDate><xbrli:endDate>2021-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180622to20180622_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:CollaboratorRoyaltyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-22</xbrli:startDate><xbrli:endDate>2018-06-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20120501to20120501_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:InvestorRoyaltyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-05-01</xbrli:startDate><xbrli:endDate>2012-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210301to20210331_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210430_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210430_AwardTypeAxis_TimeBasedStockOptionGrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedStockOptionGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210430_AwardTypeAxis_PerformanceBasedStockOptionGrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:PerformanceBasedStockOptionGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_AwardTypeAxis_TimeBasedStockOptionGrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedStockOptionGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_AwardTypeAxis_TimeBasedStockOptionGrantMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedStockOptionGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220301to20220331_AwardTypeAxis_PerformanceBasedStockOptionGrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:PerformanceBasedStockOptionGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220301to20220331_AwardTypeAxis_TimeBasedStockOptionGrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedStockOptionGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220630_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">btx:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_EmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">btx:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">btx:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220630_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220630_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220630_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_InvestmentTypeAxis_PIPEInvestorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325_StatementClassOfStockAxis_CommonClassCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210325to20210325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-25</xbrli:startDate><xbrli:endDate>2021-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-12</xbrli:startDate><xbrli:endDate>2022-07-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220714_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220712_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U001"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U002"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U003"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U004"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U005"><xbrli:measure>btx:BoardMember</xbrli:measure></xbrli:unit><xbrli:unit id="U006"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U007"><xbrli:measure>btx:Installment</xbrli:measure></xbrli:unit><xbrli:unit id="U008"><xbrli:measure>btx:Goals</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div style="text-align: center; font-weight: bold;">
          <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" />
          <div style="color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">UNITED STATES SECURITIES AND EXCHANGE COMMISSION<br />
          </div>

          <div style="font-size: 12pt; font-weight: bold;">Washington, D.C. 20549<br />
          </div>

          <div>&#160;</div>

          <div style="font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_65a5bd1dc56e4e9fa76fe4c159364cb1" contextRef="c20220101to20220630">10-Q</ix:nonNumeric></div>

          <div>&#160;</div>

          <div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: normal;">(Mark One)</div>

          </div>

          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:DocumentQuarterlyReport" id="Fact_f5695269fd9849b1ad3e287311e756db" contextRef="c20220101to20220630" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric><br />
                </td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
                </td>

  </tr>


</table>
          <div>
            <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;"> <br />
            </div>

            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">For the quarterly period ended <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_1a5e02a723a44803911ce76215333228" contextRef="c20220101to20220630" format="ixt:datemonthdayyearen">June 30, 2022</ix:nonNumeric></div>

          </div>

          <div>
            <div style="color: rgb(0, 0, 0);">or</div>

          </div>

          <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:DocumentTransitionReport" id="Fact_8f0bb10d72d14a57a69b5a993fd689db" contextRef="c20220101to20220630" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                </td>

    <td style="width: auto; vertical-align: top;">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
                </td>

  </tr>


</table>
          <div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> <br />
            </div>

            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">For the transition period from _________ to _____________</div>

          </div>

          <div>&#160;</div>

          <div style="font-weight: bold;">Commission file number: <ix:nonNumeric name="dei:EntityFileNumber" id="Fact_90945eedff1d43ccb6b9f2cf10eb4255" contextRef="c20220101to20220630">001-11460</ix:nonNumeric></div>

          <div>&#160; <br />
          </div>

          <div><img src="logo01.jpg" alt="graphic" /></div>

          <div style="font-weight: bold;"> <br />
          </div>

          <div style="font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_667a4cb77c0e4f97a5f98867d5da68f7" contextRef="c20220101to20220630">Brooklyn ImmunoTherapeutics, Inc.</ix:nonNumeric><br />
          </div>

          <div style="font-style: italic; font-weight: normal;">(Exact name of registrant as specified in its charter)</div>

          <div>&#160;</div>

          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_365d4ddc9f38423e9711b8d4963edc92" contextRef="c20220101to20220630" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_97b5b2e4b47d404f9034ad5fbfd3ff25" contextRef="c20220101to20220630">31-1103425</ix:nonNumeric><br />
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-style: italic;">(State of incorporation)</div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-style: italic;">(I.R.S. Employer Identification No.)</div>
                </td>

  </tr>


</table>
          <div><br />
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_24198666a6e1424db0ed06e7967ad2a3" contextRef="c20220101to20220630">10355 Science Center Drive, Suite 150</ix:nonNumeric></div>
                  <div style="text-align: center; font-weight: bold;"> <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_7ddd7994e15149029c9b495d3f55e217" contextRef="c20220101to20220630">San Diego</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_d6a7dfe18d2540d191c1187b4d1f1189" contextRef="c20220101to20220630" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; text-align: center;">
                  <div style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_0e555dd5288741d7b9cd4cb57dbe1c83" contextRef="c20220101to20220630">92121</ix:nonNumeric><br />
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-style: italic;">(Address of principal executive offices)</div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top;">
                  <div style="text-align: center; font-style: italic;">(Zip Code)</div>
                </td>

  </tr>


</table>
          <div style="font-weight: bold;"> <br />
          </div>

          <div style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_aec6d7905fe745589eba585f16b05baa" contextRef="c20220101to20220630">212</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_3140b70708c34c3b9a68858bc300e443" contextRef="c20220101to20220630">582-1199</ix:nonNumeric></div>

          <div style="font-style: italic; font-weight: normal;">(Registrant&#8217;s telephone number, including area code)</div>

          <div><br />
          </div>

          <div style="color: rgb(0, 0, 0); font-weight: normal;">Securities registered pursuant to Section 12(b) of the Act:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; color: rgb(0, 0, 0);">Title of each class</div>
                  </div>
                </td>

    <td style="width: 2%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; color: rgb(0, 0, 0);">Trading symbol</div>
                  </div>
                </td>

    <td style="width: 2%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td style="width: 32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>
                    <div style="text-align: center; color: rgb(0, 0, 0);">Name of each exchange on which registered</div>
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 32%; vertical-align: top;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_784fd6f68af849e29a263038edce410e" contextRef="c20220101to20220630">Common stock, $0.005 par value per share</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_e013b520c9f44ff789c9f63b9dd0b8af" contextRef="c20220101to20220630">BTX</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>

    <td style="width: 32%; vertical-align: top;">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_62cb464167ec4dbf90e91b7d4085fc8e" contextRef="c20220101to20220630" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br />
                  </div>
                </td>

  </tr>


</table>
          <div style="text-align: justify; font-weight: normal;"> <br />
          </div>

          <div style="text-align: justify; font-weight: normal;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
            for such shorter period that the registrant <span style="color: rgb(0, 0, 0);">was required to file </span>such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric name="dei:EntityCurrentReportingStatus" id="Fact_76afc7460ee64ea68778bff5cb3053c1" contextRef="c20220101to20220630">Yes</ix:nonNumeric> &#9746; No &#9744;</div>

          <div style="font-weight: normal;">&#160;</div>

          <div style="text-align: justify;"><span style="color: rgb(0, 0, 0); font-weight: normal;">Indicate by check mark whether the registrant has submitted electronically every interactive data file required to be submitted pursuant to Rule 405 of
              Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric name="dei:EntityInteractiveDataCurrent" id="Fact_bd444aff6e7b4585aa924e220d53ef0e" contextRef="c20220101to20220630">Yes</ix:nonNumeric> </span><span style="font-weight: normal;">&#9746;</span><span style="color: rgb(0, 0, 0); font-weight: normal;">&#160; No &#9744;</span></div>

          <div style="font-weight: normal;">&#160;</div>

          <div style="text-align: justify; font-weight: normal;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See
            definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 20%; vertical-align: top; font-weight: normal;">
                  <div style="text-align: justify;">Large accelerated filer</div>
                </td>

    <td style="width: 45%; vertical-align: bottom; font-weight: normal;">&#9744;</td>

    <td style="width: 20%; vertical-align: bottom; font-weight: normal;">
                  <div style="text-align: justify;">Accelerated filer</div>
                </td>

    <td style="width: 5%; vertical-align: bottom; font-weight: normal;">
                  <div style="text-align: justify;">&#9744;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 20%; vertical-align: top; font-weight: normal;">
                  <div style="text-align: justify;"><ix:nonNumeric name="dei:EntityFilerCategory" id="Fact_6ad38af2f2c743f7a2915bc8443fc032" contextRef="c20220101to20220630" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric><br />
                  </div>
                </td>

    <td style="width: 45%; vertical-align: bottom; font-weight: normal;">&#9746;</td>

    <td style="width: 20%; vertical-align: bottom; font-weight: normal;">
                  <div style="text-align: justify;">Smaller reporting company</div>
                </td>

    <td style="width: 5%; vertical-align: bottom; font-weight: normal;"><ix:nonNumeric name="dei:EntitySmallBusiness" id="Fact_ccf1d8e8266345448d6fdca3a5cd7b08" contextRef="c20220101to20220630" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric><br />
                </td>

  </tr>

  <tr>

    <td style="width: 20%; vertical-align: top; font-weight: normal;">&#160;</td>

    <td style="width: 45%; vertical-align: bottom; font-weight: normal;">&#160;</td>

    <td style="width: 20%; vertical-align: bottom; font-weight: normal;">
                  <div style="text-align: justify;">Emerging growth company</div>
                </td>

    <td style="width: 5%; vertical-align: bottom; font-weight: normal;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_b9f91141568345a09bf6e35e6d05b327" contextRef="c20220101to20220630" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
                </td>

  </tr>


</table>
          <div style="text-align: justify; font-weight: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
            standards provided <span style="color: rgb(0, 0, 0);">pursuant to </span>Section 13(a) of the Exchange Act. &#9744;</div>

          <div style="font-weight: normal;">&#160;</div>

          <div style="text-align: justify; font-weight: normal;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <ix:nonNumeric name="dei:EntityShellCompany" id="Fact_95af04fbd2c948c29a2cb7458163301a" contextRef="c20220101to20220630" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric>&#160; No &#9746;</div>

          <div style="font-weight: normal; text-align: left;">&#160; <br />
          </div>

          <div style="text-align: justify; font-weight: normal;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">As of August 10, 2022, the registrant had outstanding <ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" id="Fact_bc957f6268e2465a826577b07f033e50" contextRef="c20220810" unitRef="U001" decimals="INF" scale="0" format="ixt:numdotdecimal">58,825,739</ix:nonFraction> shares of common stock, $0.005 par value per share.</div>

          </div>

          <div style="text-align: justify;">
            <p style="font: 10pt 'Times New Roman'; margin: 0px; text-indent: 24.5pt;">&#160;</p>
          </div>

          <div style="text-align: justify;">
            <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /> </div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="page-break-after:always;" class="DSPFPageBreak">
              <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          </div>

          <!--PROfilePageNumberReset%LCR%1%%%--> </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <a id="TABLEOFCONTENTS"><!--Anchor--></a>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TABLE OF CONTENTS</div>

    <div>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-weight: bold;">
<div><br /></div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 9pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160; <br />
                </div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><span style="text-decoration: underline;"> <span style="font-weight: bold;">Page</span></span></div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;" colspan="2">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">PART I &#8211; FINANCIAL INFORMATION</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 9%; font-weight: normal;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Item 1.</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Financial Statements (unaudited)</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 9%; font-weight: normal;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#CONDENSEDCONSOLIDATEDBALA">Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">1</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#CONDENSEDCONSOLIDATEDSTAT">Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2022 and 2021</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">2</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#RSANDMEMBERSEQUITY">Condensed Consolidated Statements of Changes in Stockholders&#8217; and Members&#8217; Equity for the three and six
                    months ended June 30, 2022 and 2021</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">3</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#CASHFLOWS">Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2022 and 2021</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">5<br />
                </div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#NOTESTOCONDENSEDCONSOLIDA">Notes to Condensed Consolidated Financial Statements</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">6<br />
                </div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Item 2.</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#ManagementsDiscussionandA">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">26</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Item 3.</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#QuantitativeandQualitativ">Quantitative and Qualitative Disclosures About Market Risk</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">36</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Item 4.</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#ControlsandProcedures.">Controls and Procedures</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">36</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">&#160;</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;" colspan="2">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">PART II &#8211; OTHER INFORMATION</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Item 1.</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#LegalProceedings.">Legal Proceedings</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">37</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Item 1A.</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#RiskFactors.">Risk Factors</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">37</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Item 2.</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%; background-color: rgb(204, 238, 255);">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#UnregisteredSalesofEquity">Unregistered Sales of Equity Securities and Use of Proceeds</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">37</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Item 3.</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#DefaultsUponSeniorSecurit">Defaults Upon Senior Securities</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">38</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Item 4.</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#MineSafetyDisclosures.">Mine Safety Disclosures</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">38</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Item 5.</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#OtherInformation.">Other Information</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">38</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Item 6.</div>
              </td>

    <td valign="bottom" style="vertical-align: top; width: 82%; background-color: rgb(204, 238, 255);">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#Exhibits.">Exhibits</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">38</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;" colspan="2">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><a href="#SIGNATURE">Signatures</a></div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">39</div>
              </td>

  </tr>


</table>
      </div>

      <div><br /></div>

    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">i</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
          </a></div>

      </div>

    </div>

    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

    <div style="text-align: center;"><br />
    </div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">This Quarterly Report on Form 10-Q contains &#8220;forward-looking statements&#8221; as that term is defined under the Private Securities Litigation Reform Act
      of 1995 (&#8220;PSLRA&#8221;), Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Forward-looking statements include statements related to future
      events, results, performance, prospects and opportunities, including statements related to our strategic plans and targets, revenue generation, product availability and offerings, capital needs, capital expenditures, industry trends and our financial
      position. Forward-looking statements are based on information currently available to us, on our current expectations, estimates, forecasts, and projections about the industries in which we operate and on the beliefs and assumptions of management.
      Forward looking statements often contain words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;could,&#8221; &#8220;targets,&#8221; &#8220;projects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and similar expressions. In addition, any statements that
      refer to projections of our future financial performance, our anticipated growth and trends in our business, and other characterizations of future events or circumstances, are forward-looking statements. Forward-looking statements by their nature
      address matters that are, to different degrees, subject to risks and uncertainties that could cause actual results to differ materially and adversely from those expressed in any forward-looking statements. For us, particular factors that might cause
      or contribute to such differences include those risks and uncertainties described in Part I, Item 1A &#8220;Risk Factors&#8221; of our Annual Report on Form 10-K/A for the year ended December 31, 2021 and described in other documents we file from time to time
      with the Securities and Exchange Commission, or SEC.</div>

    <div style="text-align: left;"><br />
    </div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Readers are urged not to place undue reliance on the forward-looking statements in this Quarterly Report on Form 10-Q, which speak only as of the
      date of this Quarterly Report on Form 10-Q. We are including this cautionary note to make applicable, and take advantage of, the safe harbor provisions of the PSLRA. Except as required by law, we do not undertake, and expressly disclaim any
      obligation, to disseminate, after the date hereof, any updates or revisions to any such forward-looking statements to reflect any change in expectations or events, conditions or circumstances on which any such statements are based.</div>

    <div style="text-align: left;"><br />
    </div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">We believe that the expectations reflected in forward-looking statements in this Quarterly Report on Form 10-Q are based upon reasonable assumptions
      at the time made. However, given the risks and uncertainties, you should not rely on any forward- looking statements as a prediction of actual results, developments or other outcomes. You should read these forward-looking statements with the
      understanding that we may be unable to achieve projected results, developments or other outcomes and that actual results, developments or other outcomes may be materially different from what we expect.</div>

    <div><br />
    </div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Unless stated otherwise or the context otherwise requires, all references in this Quarterly Report on Form 10-Q to &#8220;Brooklyn&#8221; refer to Brooklyn
      ImmunoTherapeutics, Inc., references to &#8220;Brooklyn LLC&#8221; refer to Brooklyn ImmunoTherapeutics LLC, a wholly owned subsidiary of Brooklyn, and references to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; refer to Brooklyn. and its subsidiaries, including Brooklyn
      LLC, Novellus, Inc. and Novellus Therapeutics Limited.</div>

    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">ii</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
          </a></div>

      </div>

    </div>

    <!--PROfilePageNumberReset%Num%1%%%--> </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div style="text-align: center; font-weight: bold;">
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">PART I. FINANCIAL
            INFORMATION</div>

          <div><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

          <div><span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
            </span> </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Item












                  1.</td>

    <td style="width: auto; vertical-align: top;">
                  <div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Financial Statements</div>
                </td>

  </tr>


</table>
        </div>

        <div style="text-align: center; font-weight: bold;"> <br />
        </div>

        <div style="text-align: center; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>

        <a id="CONDENSEDCONSOLIDATEDBALA"><!--Anchor--></a>
        <div style="text-align: center; font-weight: bold;">&#160;<!--Anchor-->CONDENSED CONSOLIDATED
          <!--Anchor--><!--Anchor-->BALANCE SHEETS<!--Anchor--></div>

        <div style="text-align: center; font-weight: bold;"> (In thousands, except par value amount)<br />
        </div>

        <div style="text-align: center; font-weight: bold;"> <span style="font-weight: bold;">(unaudited)</span></div>

        <div style="text-align: center; font-weight: bold;"><span style="font-weight: bold;"> <br />
          </span></div>

        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; font-family: &#38;amp; padding-bottom: 2px;" colspan="1"><br />
              </td>

    <td valign="bottom" style="font-family: &#38;amp; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;" colspan="2">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">June 30,</div>
                <div style="color: rgb(0, 0, 0); font-weight: bold;">2022<br />
                </div>
              </td>

    <td style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;" colspan="1">&#160;</td>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;" colspan="2">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
                <div style="color: rgb(0, 0, 0); font-weight: bold;">2021<br />
                </div>
              </td>

    <td style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;">
                <div style="color: rgb(0, 0, 0); font-weight: bold; text-indent: -9pt; margin-left: 9pt;">ASSETS<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; text-align: center;" colspan="2"><br />
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Current assets:</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Cash</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Cash" id="Fact_95dda23c92d847678e06bd2488a77e2c" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">19,407</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Cash" id="Fact_00fbac43fe3841daa4f9f17da38d8a8c" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">16,985</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Other receivable</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" id="Fact_eb3475879c984b229da0795b69991627" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">694</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" id="Fact_ee182beb80e7427a8e44921a96eb5c21" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">684</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Prepaid expenses and other current assets</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_924d072972a64dd2b93231a29a239d7a" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,824</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_633ad162eaa44dc4a84145c32d193f57" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,097</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total current assets</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_b1a7b6ef9531485da0a1aaaacd639959" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">21,925</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_5ad64840ea984061bb9d10cc8681d789" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">18,766</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Property and equipment, net</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_95132a85f15144539816df2bb02a1d59" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">424</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_616e4d8489d14af6aed2f9d5c53fce4f" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">670</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Right-of-use assets - operating leases<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_2d6c8bfbafe64faeb5325d376d987e88" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,943</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_d3cbf3d126324979a3925bafe52a7e54" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,567</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Goodwill</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_8c5567a64f284563936e2406a212f5be" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,044</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_a91021e738a643ea81d1a3e80a79f3b8" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,044</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">In-process research and development<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_2563293303b0443184d81479b5fd26fe" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_305c31e3e34e447498e6f4e82b5a4c36" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,990</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%;">
                <div style="margin-left: 9pt">Investment in non-controlling interest<br />
                </div>
              </td>

    <td valign="bottom" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1"><ix:nonFraction name="us-gaap:EquityMethodInvestments" id="Fact_f765a194746c48209deb2d7ac37174bf" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">89</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1"><ix:nonFraction name="us-gaap:EquityMethodInvestments" id="Fact_e1f3e4ff044e4d9596113337af2cbe4a" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Security deposits and other assets</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DepositAssets" id="Fact_61ebf41ddf65449da4bbbaf14da5eec2" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">477</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DepositAssets" id="Fact_c031daa388624efd81b9d901e8502cfd" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">488</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total assets</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Assets" id="Fact_c7903c4571694ce9b1482fe730890507" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">26,902</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Assets" id="Fact_ee512d5e84194a08af027857dfe049d1" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">31,525</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); font-weight: bold; text-indent: -9pt; margin-left: 9pt;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Current liabilities:</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Accounts payable</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_ddf230f2796345b395bd34589bc38b79" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,478</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_33a32138c0854027ad3522b61cc19cfa" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,755</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Accrued expenses</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_b61db524492d4b58bfb731f1120e6aff" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,821</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_d831c2cccf664f6d8fc457e89d5ba8c0" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,249</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Operating lease liabilities, current<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_b94f6793cab6457eb78f7e1832ba896a" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">390</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_ef94ba6be7944a3c824a289d1e306ede" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">426</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: 9pt; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" rowspan="1">Other current liabilities</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" id="Fact_8dd64977a66549d6920b51ec5a568387" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,429</ix:nonFraction><br />
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" id="Fact_f9fd8dad044942f499343933f2acd4fb" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">247</ix:nonFraction><br />
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total current liabilities</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_6be829a26ca64ba286ba625da0ea7b54" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7,118</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_9b27efcee29f42e691e5c5ab0193ece9" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,677</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Warrant liabilities<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" id="Fact_81c39921f8f1494584e9b0e0df2f3e0d" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,524</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" id="Fact_3d35589e2cd049a4b429279cfc9bb764" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Operating lease liabilities, non-current<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_abf2a7f4593748bdb9998514f383eb09" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,433</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_b71b9a9e7c01476da652aa1645264aa9" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,297</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Other liabilities</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_993b24efd49d450d9d4bd629f60f4d81" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">48</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_12693b77fb904038aee287c909bdd16b" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">48</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total liabilities</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_47d0c88d67d143fd882dbfd3c41ba003" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,123</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_c4685ad725a0456896a4daaea179f7cc" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,022</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Stockholders&#8217; equity:<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="text-indent: -9pt; margin-left: 18pt;">Preferred stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_c0ea5613ea6d40f0b9dffe14abd1edc5" contextRef="c20220630" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_bcd8709d033f428e8173ed7775036d5c" contextRef="c20211231" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal">0.005</ix:nonFraction></ix:nonFraction></span> par value, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_4ac7253f1c734f6ea97099ac1ba020da" contextRef="c20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_4a03470ef4d44c388f86bc6c1a210cb6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></ix:nonFraction></span> shares authorized, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_f02586de8d224caaadf31d214af57aa9" contextRef="c20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_cf2c9722e4d248b3800a3c6265700290" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_9249699cab6b4d61b305f727f21d5fb3" contextRef="c20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_62790db89ed1415c8007a230ba3678a0" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span>
                  designated, issued and outstanding of Series A convertible preferred stock at <span style="text-indent: 0pt;">June 30</span>, <span style="text-indent: 0pt;">2022</span> and <span style="text-indent: 0pt;">December 31</span>, <span style="text-indent: 0pt;">2021</span>, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" id="Fact_ebb9e8aebf25456688cf39b98102f735" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" id="Fact_6d87828446cb4966bfa8abfdc0b31371" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></ix:nonFraction></span> liquidation
                  preference<br />
                </div>
              </td>

    <td valign="bottom" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_bf15d0c11c1f4cf69948bff8bdbae6bb" contextRef="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_45395650bc8540d6bb8258ab24654d4f" contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Common stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_bff4899c7a4c455b8db15fdbcecbf908" contextRef="c20220630" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_257c1ec62cdd4252b18550449dd232ac" contextRef="c20211231" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal">0.005</ix:nonFraction></ix:nonFraction></span> par value, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_7119e67f1a7d414fbf6f3bffc85e9a59" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_3e6a98d480254a9d85432242ebb4f684" contextRef="c20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">100,000</ix:nonFraction></ix:nonFraction></span> shares authorized at June 30, 2022 and December 31, 2021; <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_f601d269d9c04248b625a64786b12601" contextRef="c20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_2e2aaa0c1032417d9bb0449e4aa7a77f" contextRef="c20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,469</ix:nonFraction></ix:nonFraction></span> and <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_7915b2a904804cc7a5afe329e97d0616" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_697836017c014cf592042b99e699dc22" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,021</ix:nonFraction></ix:nonFraction></span> issued and outstanding at <span style="text-indent: 0pt;">June 30</span>, <span style="text-indent: 0pt;">2022</span> and <span style="text-indent: 0pt;">December 31</span>, <span style="text-indent: 0pt;">2021</span>,
                  respectively</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_2b231a38168d4d269f9df29f7d542e8a" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">287</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_ca85d9de920342b1b645849103698793" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">260</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Additional paid-in capital</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_67dbf3fddadd48278c72fff99da58c09" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">167,974</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_0f4c94f4fa8e4d368768b6209f607800" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">165,944</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 18pt;">Accumulated deficit</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_1e9c34acc7db4ab88c524eb84650e8ca" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">153,483</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_05e0332d63fc428795de517bc62f82c3" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">140,702</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total stockholders&#8217; equity<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_25a6999c8d124f7399563b7bb55bef01" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,779</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_7598124631174cfd8973ed650ad791d0" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">25,503</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div style="color: rgb(0, 0, 0);"></div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 27pt;">Total liabilities and stockholders&#8217;&#160; equity<br />
                </div>
              </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_cf6023ac81b54e04b6ab6b340a1e0533" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">26,902</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_9ffeeb1208514f12a9d7a2f5890fbd93" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">31,525</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
        <div><br />
        </div>

        <div style="text-align: center;">The accompanying notes are an integral part of these condensed consolidated financial statements.</div>

        <div style="text-align: center;"><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">1</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>

        <!--PROfilePageNumberReset%Num%1%%%--> </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>

      <a id="CONDENSEDCONSOLIDATEDSTAT"><!--Anchor--></a>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CONDENSED CONSOLIDATED
        <!--Anchor--><!--Anchor-->STATEMENTS OF OPERATIONS</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> (In thousands, except per share amounts)<br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
<div>(unaudited)
        </div>
<div><br />
        </div>

      </div>

    </div>

    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;" rowspan="1" colspan="6"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Three months ended <span style="text-indent: 0pt;">June 30</span>,</span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;" rowspan="1" colspan="6"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Six months ended <span style="text-indent: 0pt;">June 30</span>,</span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2"><span style="font-weight: bold;">2022</span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">2021</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">2022</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">2021</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Operating expenses:</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Research and development</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" id="Fact_fcb8f0cde1114c07b550fe04507d8d18" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,685</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" id="Fact_4baba3fedfaa46a5b44db1c0124b5198" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,432</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" id="Fact_840636f9220643929a58cb20b249e345" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,467</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" id="Fact_efa411487c7443d29e55f55e87d5d015" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,965</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">General and administrative</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" id="Fact_382a802f7726496388367cc0debdf509" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,205</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" id="Fact_9b0a112c6c794a4e93e1d33ce49087b0" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">4,581</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" id="Fact_9ad72ade040a4b049b70fbb4d86b37e5" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,719</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" id="Fact_71bc332108c244b9b954c382194c95fd" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,204</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255); text-indent: -9pt; margin-left: 9pt;" rowspan="1">
              <div style="margin: 0px 0px 0px 9pt; text-indent: -9pt;">Impairment of in-process research and development<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_a52d436b986e479da3662e6dc4297aa6" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,990</ix:nonFraction><br />
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_f8204a263ca04f61a729589f0d936e76" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction><br />
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_fd15a7fd2684495fb7d50e75cdb9117d" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,990</ix:nonFraction><br />
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_7645bfe81afb45acad87078dec96eafc" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction><br />
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Transaction costs</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_14386ef69dd1497dbb51a88bb6d0c53d" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_f8a575a4b02e43fdbd4ba3d9b3546157" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_d881b244f47947a8b160e83a1efa1174" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_5f4f246c7004423686bd87e095dbd87c" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,765</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Total operating expenses</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_48719b92a24c4ac5b2752149e44e1201" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">13,880</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_4a0f638652f34b16ba1639fb8bbc6055" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,013</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_39c253dbb5124f45971363183669fe36" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">20,176</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_24377a5b3c9b43b1848b682ef0a833b2" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">18,934</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Loss from operations</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_2d897a233ebb4ad0be4ade512ee55fa6" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">13,880</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_f179c2fd71e547b0aa066aa61e5535d0" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,013</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_1418c70c8e0f435f865efb9432688699" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">20,176</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_6efb307c97c54042bf83014798879f7d" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">18,934</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255); text-indent: -9pt; margin-left: 9pt;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Other income (expense), net:</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Loss on sale of NTN assets</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_30173ad10791464cb91b3418ca4a142f" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_6a74ee0f9a064b45b437a3a4273a4417" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">50</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_6855e694e42144c7b1e331b1e40854b9" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_3ce596e5f1b14ed8bb5ffe5706ac2a4c" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,648</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; text-indent: -9pt; margin-left: 9pt;" rowspan="1">
              <div style="margin: 0px 0px 0px 9pt; text-indent: -9pt;">Change in fair value of warrant liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="btx:WarrantLiabilitiesExpense" id="Fact_09993d5225204b7caa6ca7d4f40c6c92" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,792</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="btx:WarrantLiabilitiesExpense" id="Fact_e7b4de36b2c3466b8050a0a431426175" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="btx:WarrantLiabilitiesExpense" id="Fact_950d79fa9d0449eea6c47ce7e73aa85e" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,470</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="btx:WarrantLiabilitiesExpense" id="Fact_457867c777044514a66cfe9c09fc092e" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255); text-indent: -9pt; margin-left: 9pt;" rowspan="1">
              <div style="margin: 0px 0px 0px 9pt; text-indent: -9pt;">Loss on non-controlling investment</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">(<ix:nonFraction name="btx:LossOnNonControllingInvestment" id="Fact_3f038166563149a4b083bd752f644e9c" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">296</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="btx:LossOnNonControllingInvestment" id="Fact_ff416c1f37d94c02887a46fab3796636" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">(<ix:nonFraction name="btx:LossOnNonControllingInvestment" id="Fact_1e724508381b4cb58c9bf82a1a02ef1d" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">911</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="btx:LossOnNonControllingInvestment" id="Fact_f739b0840a1947a89a84d0ff18a851e8" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Other expense, net</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_ee661a9bed9d491b9df675ac429fb866" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">14</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_199635d1118e4377867adddf06737e38" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">22</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_ac6ed153c95941a09af234023c7d9448" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,156</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_dbe81c3a14c2421aabf1a11d26ed5c98" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">25</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Total other income (expense), net<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_a59c4e37d799493a8bb5aedd6001fd20" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,482</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_7c0d2eab914c4a1487c58810e0911177" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">72</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_8823257c2d30437c9572d21385e75ab6" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7,403</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_cf4114f4f3c84db8bb9c94125102779c" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,673</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Net loss</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_68213818e5ac47a097dfde7f03c1e393" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,398</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_438c5c00826b4c08836c403e9cade373" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,085</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_cd0915f19365455195d370c781cc246b" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">12,773</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a97d3e8b54b34845b74ae6c11feb13f2" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">28,607</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px; text-indent: -9pt; margin-left: 9pt; background-color: rgb(204, 238, 255);" rowspan="1">
              <div style="margin: 0px 0px 0px 9pt; text-indent: -9pt;">Series A preferred stock dividend<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PreferredStockDividendsAndOtherAdjustments" id="Fact_05c6e75ae7bb463ba96c2871b7032d49" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PreferredStockDividendsAndOtherAdjustments" id="Fact_0305675da2e5442589390b4539a1aafb" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PreferredStockDividendsAndOtherAdjustments" id="Fact_bd5dc0b6c5b54b8caa9510ca37735228" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PreferredStockDividendsAndOtherAdjustments" id="Fact_9a99306c5734409895f7d86828cfb424" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 4px; text-indent: -9pt; margin-left: 9pt;" rowspan="1">
              <div style="margin: 0px 0px 0px 9pt; text-indent: -9pt;">Net loss attributable to common stockholders<br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" id="Fact_4e1e088824dd44ad923a8e25ceb358b6" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,406</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" id="Fact_f2597401e7e44824a30433ffe906adfe" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,093</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" id="Fact_4b0ff00d58bd4918b7bb38e7b1fb271e" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">12,781</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" id="Fact_22922fe6a31b430cbd66cbf73ae129dc" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">28,615</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; background-color: rgb(204, 238, 255);" rowspan="1"><br />
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Net loss per common share - basic and diluted</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_433df7f7277f4b94946da8bad192474e" contextRef="c20220401to20220630" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_34e303eedf6d4022a679cd466dff4c2d" contextRef="c20220401to20220630" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal">0.06</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_1c308bf4448f4774b40f898bb89aae72" contextRef="c20210401to20210630" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_0cef766e9b09437393e9a0d493fc9b6c" contextRef="c20210401to20210630" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal">0.24</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_e9f58143840a447f9b4067028d43e66e" contextRef="c20220101to20220630" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_cc5a8df7b9b1487a9cfd802b3997d0c2" contextRef="c20220101to20220630" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal">0.23</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_7d74759038d44725b24221fed9ba6b8f" contextRef="c20210101to20210630" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_18faedef211946f2b18e747aeb2aa275" contextRef="c20210101to20210630" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal">0.81</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Weighted average shares outstanding - basic and diluted</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_81ee7bb08d264453a916fcb311c108d6" contextRef="c20220401to20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_4f9541bb27cc4aa086bff8336f667a4d" contextRef="c20220401to20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">58,805</ix:nonFraction></ix:nonFraction><br />
              </div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_dbe8c3fc5a704a71977e6e252771729f" contextRef="c20210401to20210630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_453bc034a8e241cca5854de8eef0bfe3" contextRef="c20210401to20210630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">42,448</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_9c2e2607e7e3449bb03e99107b4c46e2" contextRef="c20220101to20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_0ee05e117a8e4df5a41747e7d6f2d59e" contextRef="c20220101to20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">56,230</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_c77751be56f0491fb9fe96fca6793fe4" contextRef="c20210101to20210630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_b198cc0dac9646a59e6c1831bdc2c158" contextRef="c20210101to20210630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,187</ix:nonFraction></ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      <div><br />
      </div>

      <div>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: center;">The accompanying notes are an integral part of these condensed consolidated financial statements.<br />
        </div>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: center;"> <br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">2</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div style="text-align: center; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>

        <div style="text-align: center; font-weight: bold;">
          <div>CONDENSED <a id="RSANDMEMBERSEQUITY"><!--Anchor--></a><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: center; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; AND <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: center; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">MEMBERS&#8217; </span>EQUITY </span></div>

          <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; orphans: 2; text-align: center; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">For the three and six months ended June 30, 2022 and 2021 </span>(unaudited)</div>

          <div> (in thousands)<br />
          </div>

          <div> <br />
          </div>

          <div>
            <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common Stock</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Series A Preferred </div>
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; font-weight: bold;">
                    <div> Additional</div>
                    <div>Paid-in </div>
                  </td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center;">Accumulated </td>

    <td valign="bottom" colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Capital</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Deficit</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total<br />
                    </div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; font-weight: bold; text-indent: -9pt; margin-left: 9pt; width: 16%; background-color: #CCEEFF;">
                    <div style="margin-left: 9pt;">Balances at April 1, 2022</div>
                  </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_2927047dbd66486b928aef2bc88a4f7c" contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,452</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_4ed684404e144f029c5e555d8a6c896f" contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">287</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_b7bf02e4a2ca4ce99a83cf5944517eb6" contextRef="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_7f7790cc22fb4be28ceca3072560f3d7" contextRef="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_a6a53515702e4892ab396f4944c39c74" contextRef="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">167,100</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_26f44a86d6fa4ce0a539302374f9d95d" contextRef="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">150,077</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_71b76e2d64644c0d93b4bc506d8e7227" contextRef="c20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">17,311</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 16%;">
                    <div style="margin-left: 9pt; font-weight: normal;">Issuance of common stock from vested restricted stock units</div>
                  </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_eeac8b25cee44defb66cded41b7552ef" contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_b0b46c3263174a7b8663a3280b0a60b0" contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_a4d56b1c7e7140f1ba512744f0861d20" contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_5bb6c2541f3f41ac8edfc4847a0803af" contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_b789a021df3f4b41948661867a548400" contextRef="c20220401to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_c10d0b63258b4938bf3c8843a6389df3" contextRef="c20220401to20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_89f9751828694414bed3aaa6f1ceeb72" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 16%; background-color: #CCEEFF;">
                    <div style="margin-left: 9pt; font-weight: normal;">Stock-based compensation</div>
                  </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_eeadcda726a2458a9d0c259a4d2b4b9c" contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_2d9a9629dee44d539c83b6f2c87c0136" contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_18ebf2c7324141ab9b3385efe5e37d2e" contextRef="c20220401to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">879</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_ba62822c15f742708f3f41b0ec4e9b2f" contextRef="c20220401to20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_cd23086422654defb2bf9b91d2322b2f" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">879</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 16%;">
                    <div style="margin-left: 9pt; font-weight: normal;">Cash dividends to Series A preferred stockholders</div>
                  </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;"><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_b2be19fe658a45b3aae7f51d8b882551" contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_40e8ea7cc2944082aac409135d92018c" contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;"><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_183dd9909ae444259868266a841e9e04" contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_16d57614b47e4a3fa852da59648fc1f2" contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_77ff6685be574eb6a3fccf4fc389eed0" contextRef="c20220401to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;">(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_a0db434726c34227a40cfc27b981b220" contextRef="c20220401to20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; font-weight: normal;">(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_8f01dfdb28d546fab09680587e9f4da8" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 16%; padding-bottom: 2px; background-color: #CCEEFF;">
                    <div style="margin-left: 9pt; font-weight: normal;">Net loss</div>
                  </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_b3a37c6aa1aa4412923407dc5e92d4aa" contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">-</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_f245953ec5554fc19308bb23db07d173" contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_599cca97ebd94dc9b6dbeafc52ffe2ef" contextRef="c20220401to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_e1b5d5991a874625a6ba5e790208a3f9" contextRef="c20220401to20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,398</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-weight: normal;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_bae3ac3fb230434b8bfaf17b0feaea8a" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,398</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; font-weight: bold; text-indent: -9pt; margin-left: 9pt; width: 16%; padding-bottom: 4px;">
                    <div style="margin-left: 9pt;">Balances at June 30, 2022</div>
                  </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_81802789831f455581589c991284c342" contextRef="c20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,469</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_5a089da664cf4998889c9ee38f5a56ec" contextRef="c20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">287</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_27327000c0914b28a9333dbf579b46fe" contextRef="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_45ea070f38a846208cfc46abdcd8209d" contextRef="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_99803db7b17042c394e21f489f5d1609" contextRef="c20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">167,974</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_04ea6894f8fd476d90d9ef3bc4b0989f" contextRef="c20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">153,483</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">$</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_d53b7733c0784ef99d84ec0f9f18cf7f" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,779</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 16%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 16%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balances at January 1, 2022</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_20d1759c466545e2a69833926142ed9a" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,021</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_dc7eaea9d4ac4b41ad5cd57510ff240e" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">260</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_682c18f0b1d34c47964bd492338fd7bd" contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_02146ade7f874076934a94f0ba89044a" contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_7a08d647999b42dea61b9c1d739c7258" contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">165,944</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_859ec9af8ed24a46bb7b32cb692167ba" contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">140,702</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_b12cffe1962e4bcebed8951d7e63c86f" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">25,503</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 16%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Issuance of common stock in connection with private offering</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesPrivateOffering" id="Fact_ccb3bc29200f40628fceb5a834529327" contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,500</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_2d4073f4cc4146ff8a4efc6d18076222" contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">27</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesPrivateOffering" id="Fact_24ba3d25af5c4c72986198ce9e36bba6" contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_cd481066e8494d7d8db99da8bd4bcc86" contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_bedbe0879a6d465aa7be11cdfe770277" contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">27</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_528208fbeff142abac5e1504584aa34a" contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValuePrivateOffering" id="Fact_239aa2b79d39452aaeb9f4c06f364144" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 16%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Forfeiture of unvested restricted stock</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_4ce1b1b5ccc145fe80369c41d964b0f3" contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">78</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_a7e4033825c045b0ac97bdf9c1d0516e" contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_cb8c7f010d5a4d3b830df07dac16f776" contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_2791c6b9bc1e4bccbe459976e855980e" contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_1b1f53aafa6c46c5aec27af7774f41f5" contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_3f9a416561f94d559f9dbbe8048c8437" contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_42d78f8a4b5f412596ac52ccb3ccb074" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; width: 16%; background-color: #CCEEFF;">
                    <div style="margin: 0px 0px 0px 7.2px; text-indent: -7.2px; font-weight: normal;">Issuance of common stock from vested restricted stock units</div>
                  </td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_97514c041ce547c4a675e0e9eaa9e761" contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_4f7f6ba2953f49fc883e1dcaaec0d19d" contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_e511a048cec34c4cbdec4328cdb16703" contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_b0b9a1d0d765455baca0edea120ae06e" contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_e6218a3942e74af7b91b163bfadcfe4f" contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_91e4f32b25c148eaa1e72aeb75a276e3" contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_406d3c01c5ad4bcfaf9c12c6851052b6" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 16%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Stock-based compensation</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_d82465f53d1e4381ab202c02c323ff99" contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_d19d8f75261a4744805664ca458a67ea" contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_a40235c78baf4546b554cc114ff3c593" contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,062</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_73bf769e6451493888db2757d587a08e" contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_cee29d1609bd47c8a4bd97aacecb2446" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,062</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 16%; background-color: #CCEEFF;">
                    <div style="margin-left: 9pt; font-weight: normal;">Cash dividends to Series A preferred stockholders</div>
                  </td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_0979c7f5e6f64b019158ee17a5efc439" contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_dc64e7e9126b4bdd95f4623b3273fc10" contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:PreferredStockDividendsShares" id="Fact_92100f5c01a94d12975e7146fcb9e670" contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_ef9e69d6809d473381775ba8b46e505f" contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;"><ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_3806d8949b414f83b97cb1e6f53b14d1" contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;">(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_6b575100798748f38b95b27cf7d912b3" contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">)</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: normal;">(<ix:nonFraction name="us-gaap:DividendsPreferredStockCash" id="Fact_f7e41e10705a4be28c4130b4ad6c9f68" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 16%; padding-bottom: 2px;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Net loss</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_e0d30a68239c4017ae0be6637ad1d61d" contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_af6c1e883c86414ead8db7f45955191c" contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_5f42513181414895b8c36a4eb8d29b36" contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_8239d7fbf5cd402d85b4605c5096a60d" contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">12,773</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_a80fa073fee44f90b63058a13dc2628e" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">12,773</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 16%; padding-bottom: 4px; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balances at June 30, 2022</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_1fbfa1544418481ab3bfd8a17f7b8cfd" contextRef="c20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,469</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_3b2e7f0e82884ece82954f9043c5327c" contextRef="c20220630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">287</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_9fe49c0267b4405fba2f690be6eb4f64" contextRef="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_d1b3bcf315504f95b583211d43d22e65" contextRef="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_3e33a3e246e24862919ff6a9c26b0468" contextRef="c20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">167,974</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_d3b95fe2b0034979b5ffa88359a95779" contextRef="c20220630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">153,483</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_28d510b195f84ba8a56f04ab935d39f5" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,779</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
            <div><span style="font-weight: normal;"><br />
              </span> </div>

            <div><span style="font-weight: normal;">The accompanying notes are an integral part of these condensed consolidated financial statements.</span> </div>

            <div><span style="font-weight: normal;"> <br />
              </span></div>

            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
              <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-weight: normal; font-style: normal; font-family: 'Times New Roman'; font-size: 8pt;" class="DSPFPageNumber">3</span></div>

              <div style="page-break-after: always;" class="DSPFPageBreak">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

              <div style="width: 100%;" class="DSPFPageHeader">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
                  </a></div>

              </div>

            </div>

            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="14">Membership Equity</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="6">Common Stock</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="6">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center;">Series A Preferred </div>
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center;">Stock</div>
                  </td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; font-weight: bold;" rowspan="1" colspan="2">
                    <div style="text-align: center;"> Additional</div>
                    <div style="text-align: center;">Paid-in </div>
                  </td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold;" rowspan="1" colspan="2">Accumulated</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom;" rowspan="1" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">Class A</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2"><span style="font-weight: bold;">Class B</span><br />
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2"><span style="font-weight: bold;">Class C</span><br />
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2"><span style="font-weight: bold;">Common</span></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">Shares</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">Amount</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">Shares</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">Amount</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">Capital</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">Deficit</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; font-weight: bold; vertical-align: bottom; padding-bottom: 2px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px;" rowspan="1" colspan="2">Total</td>

    <td valign="bottom" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; font-weight: bold; text-indent: -9pt; margin-left: 9pt; width: 12%; background-color: #CCEEFF;" rowspan="1">
                    <div style="margin-left: 9pt;">Balances at April 1, 2021</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_a38781f8641c4637897254358d5c2fa0" contextRef="c20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_fc662eab0ce04070a86dfa6c05a27a0c" contextRef="c20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_e035b0d742db43829615afac04e6a2e3" contextRef="c20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_ce8838e139394033a0f8de4efc6d1e9a" contextRef="c20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_ac3efd219a854b7eae01cdf977458098" contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">41,506</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_56956a8fdf104af7bdc350e0fe877135" contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">208</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_fd0ea072fb34497e9252051878bbc05f" contextRef="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_62e3f3386c9a4554834f1826e0201dc8" contextRef="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_c42f3a96d12147dbb4c95a21aaba70f9" contextRef="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">50,453</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_9b6aa464c6d242b7bf74af8b53428907" contextRef="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">36,663</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_fa2d43944326401d85536c2b4b58a6dd" contextRef="c20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">13,999</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 12%;" rowspan="1">
                    <div style="margin-left: 9pt; font-weight: normal;">Common stock to be retained by NTN stockholders<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:CommonStockToBeRetainedByNTNValueStockholders" id="Fact_0d506b9e6c8145f59d10285002450a5e" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:CommonStockToBeRetainedByNTNValueStockholders" id="Fact_705fe6aa6e7f48c3bff3a803a5adf99d" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:CommonStockToBeRetainedByNTNValueStockholders" id="Fact_88cfa77e5c0a4ba3bd63ac078fc6b2ed" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:CommonStockToBeRetainedByNTNValueStockholders" id="Fact_bcddca0c303747478ee38f1091ae4ce1" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:CommonStockToBeRetainedByNTNSharesStockholders" id="Fact_c8be14a7cdbd4d3096a9a267c6f37da3" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:CommonStockToBeRetainedByNTNValueStockholders" id="Fact_dc02cb479a36466fa23e59fde65f64ad" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:CommonStockToBeRetainedByNTNSharesStockholders" id="Fact_27bc4d74d0874195a6e90e5136c368cb" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:CommonStockToBeRetainedByNTNValueStockholders" id="Fact_82d0a3cb74624359901ddf44d62acca3" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:CommonStockToBeRetainedByNTNValueStockholders" id="Fact_ec7b54084994457981cd29f9f22f3110" contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:CommonStockToBeRetainedByNTNValueStockholders" id="Fact_c26ec4cc7a6f46159a5fcbf1731ac8c9" contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:CommonStockToBeRetainedByNTNValueStockholders" id="Fact_397bf0fa09024ef5a0ad1d9f71aafcbc" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 12%; background-color: #CCEEFF;" rowspan="1">
                    <div style="margin-left: 9pt; font-weight: normal;">Issuance of common stock from the exercise of stock options<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_32f8e8019cd74a8c88114273d63e362c" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_e520cccf475240739b0e02484fea5c7f" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_10ccef4696cb46349c6ae8d0a663f54c" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_382737801dd544d4815fdbf3527edbed" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_245bbf5e895c44c8b9608d5f7cfdf436" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_ef4ef35cf2a74bfb982964ec50736c29" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_f89d7c9348ec4bd793ba1626aa5d65dc" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_7ffc73a29ccf49759b4b54edcf2199ec" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_2b7bc2f48dfb476c90553012f50aeeef" contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_478a2ce0326c46be914a739cbe063a51" contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_bea6db3c005544dfbc4119b994d2e012" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 12%;" rowspan="1">
                    <div style="margin-left: 9pt; font-weight: normal;">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_c168d8d49dbb48f48f48c4f71584a6c2" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_dc3ec7d22ed245b6a5df7bd0d08843c8" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_d6e535fcbf8b496a88a798866e80b47c" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_8ab4c893fa6c40f39d1c02f23b66e803" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement" id="Fact_616ed77ec7cb4da88ac54c03eae4e086" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,212</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_faab698eecf34e18b3c2f35fb0b55253" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">16</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement" id="Fact_4d02d5f864f94eadbe0ce622425038d5" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_577e94e8336c41d494e58a805b66dc61" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_e480a6a005e3459fb6ca469bd2ce038b" contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">48,509</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_8e03cdbc6f224f51b511facc206f2ae9" contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_137f445205154b19b829382f9f1e2b3c" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">48,525</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 12%; background-color: #CCEEFF;" rowspan="1">
                    <div style="margin-left: 9pt; font-weight: normal;">Issuance of common stock in lieu of cash dividend to Series A preferred stockholders<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_23297e50db564baf809a17b13a829fd1" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_8bb37397ff40435ba83fad1cb8c54099" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_c5e725329aef49629056a4eb9b06f180" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_b0960e52b9ef437db1aa1db8291b7a82" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesInLieuOfDividends" id="Fact_85bbbccb62fc4ca9be1ac2ea030e8851" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_41970b1e94d74942afa458444fadb117" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesInLieuOfDividends" id="Fact_56ac3737a2544d908fb07e16b8e6c1ae" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_253359f3a65b4fd0b1551db0c9cfb75c" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_058a4668a37b425ca341aa64b6ec6843" contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">(<ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_855f8000150546a0b8162180f55a95f3" contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_78d44e428f1a46c1b1b1b304ec0e191e" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 12%;" rowspan="1">
                    <div style="margin-left: 9pt; font-weight: normal;">Forfeiture of unvested restricted stock<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_ade19aecd8fe45abb1fe8984f6e827cd" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_113b8c1236114647a0be751165a68092" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_7bb49b0594264faa810b886be3313927" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_24e03e9642444125bb32c9d11adc8caa" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1">(<ix:nonFraction name="btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_b7f3260987b94623b1904dbde2a35317" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_983cd797bff6409da63d75b6ebef30c3" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_cccc2822a1774a5093add1075ccd183a" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_d28551077da44cc28b00c29f33759293" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_d388a5db1ad54ba5b5854f0f2bb659cf" contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_122a811599014c6280cbf3cfff442965" contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_61727658da324883a1844501c9667c1e" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 12%; background-color: #CCEEFF;" rowspan="1">
                    <div style="margin-left: 9pt; font-weight: normal;">Stock-based compensation<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_9b8be60598d34fda9a2c6b6db21938b5" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_f66fbfb6482e45b4a1b6ed096845a76c" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_675ae60c4ef648a69e1719ae089d6ad7" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_3be59dbef7d64dc5b214f5da34798ca2" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">-</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_532e5945aebf4e03970fefd69cd3b2e3" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">-</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_97d7200164d648089559ec74fd6d3825" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_aad34114114743faadbfbc5c3de893f4" contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,154</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_8e3ba9be246e48f7b1e85b1c4ad3c0fa" contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_cbb8be64880d42e195e6b827577c5131" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,154</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 12%; padding-bottom: 2px;" rowspan="1">
                    <div style="margin-left: 9pt; font-weight: normal;">Net loss<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_c509871061884ede9ee4050eb013b24e" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_13d6493ee257425191f4d91bcacace1a" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_02e0f14b275341cbbb5a54dee9d3dde6" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_e1df1f5a91e54878a68fe01367dadea0" contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">-</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_9c5a285d118446f9b5f3e5728b74fc3e" contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">-</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_98a60516fc644d1e94c53fa6e001111c" contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_86776e265cc54797a2485ed5d9f2ba8b" contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_e53039cf0a1a4f28ba45797537c2163b" contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,085</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: 2px solid rgb(0, 0, 0); font-weight: normal;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_f16d3d8633f6492ba1c1b2c8153252fd" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,085</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; font-weight: bold; text-indent: -9pt; margin-left: 9pt; width: 12%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1">
                    <div style="margin-left: 9pt;">Balances at June 30, 2021</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_2e19747bd2a04a3893fe099ea9a4e14e" contextRef="c20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_569301a6dabc45ba84f2662b470beda5" contextRef="c20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_4ce622d6aa464810b9d2bf9581a1851f" contextRef="c20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_092a4bc6f7974439b95e5f2b734e2773" contextRef="c20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_7d93d75b38984883912d3a2c1045afb0" contextRef="c20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">44,707</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_375bc21550074535a00df4ba76d99597" contextRef="c20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">224</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_adc2cd3894804f2f9578ed622295cc61" contextRef="c20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_12d62ecd1bd8402c8ad200d55d5b8b2e" contextRef="c20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_f49357a7547241a687659a1db161027b" contextRef="c20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">100,134</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_e1e9caff6449489680c2411f5bcf5005" contextRef="c20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">46,756</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_bed76d6ce1274b02aeacf26b18ac3306" contextRef="c20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">53,603</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%;" rowspan="1"><br />
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balances at January 1, 2021</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_92065f596efd4002901e733675b73c58" contextRef="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">23,202</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_fc9be794287749618eaaba82c2a90969" contextRef="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,400</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_65124b00db6749d29eff99734d19ae66" contextRef="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_ceb4546f317c4933a1d96935f44663bb" contextRef="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">198</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_bd4fe68c92c045fb9a9ae2b4838b3379" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_5fe0c6acf14a402ca5bb9a28e03f89ad" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_599c95aa5f834b5fb158d0a1ef26f255" contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_51d35c04137f4f1fa443682867464e9e" contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_44c88183e07b400d98b60f729649cc59" contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_613e3ef7b72d4993988610703705a016" contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">18,141</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_99cb915e67c942448b8c8dcd5a7cf7b0" contextRef="c20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7,659</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Brooklyn rights offerings membership units</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_0d719e63621e43eb9244ad9b5325af16" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,500</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_ee2314b0c660495595e9853774427721" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_03b8ce97ec344c99844f20ab920d7cff" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_59200f765e1c44bfa3557dcadd771553" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_2a08739825bb4307925d30fe7e70c295" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_1f1059783ff748dc86ca2c6f9a1b36c7" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_e510c8a8df9e451f87e24c16dea43857" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_d0f2b943e9c74ac2aa57167d2a1df760" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="Fact_789d7208e543428db81794652b0df319" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,500</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Elimination of Brooklyn&#8217;s historical members&#8217; equity</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_96ee3d34fa44430ab5985f52fed93bc6" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">33,702</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_2e934b2248d0473792caf60f20124754" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,400</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_ed6443e6e5e14a45ad554a254bf5244c" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,000</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_887313fb354040f1b54b9a6a7bc36678" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">198</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_a6db80f6ba9445368a3bfb54d85c535a" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_7638da1b206245848315ef0821f94a10" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_2c330382aefe4eb881a4f355888f387e" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">36,300</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_c885e8f3f768431abdf1158796c97a18" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="Fact_89398ad132b54fc085f764b56bfb4dee" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Issuance of common stock for business combination</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_f70c014f6ebf439ba1aea8b821f2beb8" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_bf8dc8d180a741268a141023cd147724" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_f9e0c560138947789db3cccd7d430581" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_3e6062c7a56843a4a9b0a74b1f621cd0" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesAcquisitions1" id="Fact_7e69451602394ce9b0a347af17b3033b" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,514</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_b92d36f40ab04de08dc0a1fdb749412f" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesAcquisitions1" id="Fact_00ab12d4e02f466b8dc2fdc3035274af" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_62ddd51867034e70b1b60eca13ea72c3" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_e7ba3bdb3b4940a1a3a8e661fe0be6b5" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,170</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_ae7a7a8b1563401d9832ba9122605234" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueAcquisitions1" id="Fact_f4a0b2ef123f4341b75ebab5ca51967e" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,178</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Series A preferred stock retained in business combination</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_d43fe073ecce4327bfadc3cabcb935db" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_46a18667e29440d0a75ff0f88d5f5356" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_1285dd92b97247b0a5baec8f2a932e30" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_99d3340edff7444182baf72b382df546" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_3b9e709f14a74441819908ae1bb3381d" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_5699292090db43e5ad090c26158316d3" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_38e1b7cf700d47ce8416ada048fb5c9f" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_cf17dcbb0d5c4a4b9e66302781a32607" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_a809237b76f14202b2cb4133a0b0bc10" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_8b4aa62479634041a98760c5cac6b012" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="Fact_15f13f0b016646c8a8a3fc2ff79893c0" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Issuance of common stock to Brooklyn members</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_42f41f4535b14611be5e287b64ce5bad" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_92fb790948e24fcc82ce0586d7e47e93" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_13c613295a8e46dbb76d0a61900e1bb5" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_d078499d8199446dab50e8c09680fafa" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountUnitsAcquisitions" id="Fact_7766b03fe63f454fb40d38b5288e2f50" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">38,924</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_a8e77e89498d4b5cad1d9ec151f20587" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">195</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountUnitsAcquisitions" id="Fact_b6e73ace1ee6469f80a38a0d846e527f" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_2c299b215eda4503965ccadd832119f5" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_b2ed32593f2c4b428787062ef2bae704" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">195</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_bd6fe6ac3c6b4503b3a221f87cf188f8" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:PartnersCapitalAccountAcquisitions" id="Fact_f309ef64ee4b44ab9a06da488e22fcff" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Issuance of common stock to Financial Advisor upon consummation of merger</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_a40da98b8a394b1eb6cdc58f5c61697e" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_76bfb07500c543d89c8b2b6d37b3781e" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_71d74f97e72c4813872bc035c08f0d45" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_bf0ff3f1c96245e597472f99c73a9740" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_b3c7f8f8fe634e49b07953bc7f944c2f" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,068</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_fe4fcf721831464f8a18bfc2dbc74a7b" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_0ca48c39d8d246f4abbdf6f3e5f4a2bf" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_43661a9017134c80b1157275d3a26318" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_d2b18a1fcae04237bdfa20a49cbd0b98" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,760</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_c78ad53c83694d6796029e1e9c0867e3" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_c0f9d99253894d4a8fed5342b2b9beed" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,765</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 12%;" rowspan="1">
                    <div style="margin-left: 9pt; font-weight: normal;">Issuance of common stock from the exercise of stock options<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_ea2a91666cd640dcb67fe088031e9835" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_6ffcc78911924490b27cb380d15bef78" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_e1582f6cfd6a45669de00ac03eff9ca3" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_7be5ca5065d24044b3671aef5c72f5bc" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_8deded6f76a94b45bcd523b14bf6db55" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_0fee8f29731046b5a892b180fd83fbbf" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_a5f414c26ec3438494a6401af9598e1f" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_84150ce237c24b07b096840ebb9cb45d" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_174165280edc45ccba05be1b8e4907ac" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_cfa72e12d1284e3dbe7337afb22b0a95" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_f3fd016c1b70488fa5ea99e5980dd132" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 12%; background-color: #CCEEFF;" rowspan="1">
                    <div style="margin-left: 9pt; font-weight: normal;">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_460242143a20455384559f60d5f02a9c" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_1e8cff897874422eabc482382f3ccebe" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_d14fabf39fbb4830b9afb4c3ceeb5f55" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_f04ebdd7638e4b319c927a0d2ad93ec7" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement" id="Fact_ccefeeb088704cce86bd471d9135b281" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,212</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_47ddc6f227c443e2b7ab999728f59f93" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">16</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement" id="Fact_1ba4f2d179594d788b8da83350950ef5" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_d38acc474be8437d8f070d382bf85a5d" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_61fc80bec91346158a160defa49618ff" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">48,509</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_c380f23d47844b13843903ddeab8c182" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueStockPurchaseAgreement" id="Fact_3122c57c124743eca8e41dec83d36125" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">48,525</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 12%;" rowspan="1">
                    <div style="margin-left: 9pt; font-weight: normal;">Issuance of common stock in lieu of cash dividend to Series A preferred stockholders<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_37fb7291e9934a42b9d483e4c26e5301" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_7eca9abdf5b34bc5a37336c7bd1ae569" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_0278c90ab2bf40d0b49c96b85d5d197f" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_f933a458fa664a2287b229340d255920" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesInLieuOfDividends" id="Fact_08b6bbbe18b044de9f5f1c06eff2eb61" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_603d0ab4c9474e788bcd2d30c8b187a0" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodSharesInLieuOfDividends" id="Fact_fabe86001039413fae2c9169110c428c" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_9285eaa544b74a4997ea629dd91f2a3d" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_6cfd51648b0743b7a5cbf5e57be6bb26" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1">(<ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_ce35dfe5166a40edbd5ebf0ae5dda143" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueInLieuOfDividends" id="Fact_8767798641204b45b3a437beaf5a7037" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 12%; background-color: #CCEEFF;" rowspan="1">
                    <div style="margin-left: 9pt; font-weight: normal;">Forfeiture of unvested restricted stock<br />
                    </div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_4d6dad37538e48f39bb06d4aba3748f3" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_63854de944df4dad912a4be63c9a6d15" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_711edb9eb1cb4fa397430e9602b9c805" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_b2ade8e34a504673b0a4032c9432c259" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">(<ix:nonFraction name="btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_c8ac2b6fedce4852a4f28871f98f38b8" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_437b05c2259b47d8ae4c4f053c1e1096" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="Fact_09d3213a995d49df82fc3bf59fcb0119" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_d5e1177121a6498d978e5a139e7dbeec" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_30736d8f953b46078c2071d8e2a78264" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_397038a9bef34fd881f1c16905c1d54f" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; background-color: rgb(204, 238, 255); font-weight: normal;" rowspan="1" colspan="1"><ix:nonFraction name="btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="Fact_9eaaee313547428a83dec432e41e2ee6" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-weight: normal; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Stock-based compensation</div>
                  </td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%;" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_d787739df4fe4c29b212387188718835" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%;" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_be3959f719c2401891917c20abb4ddcc" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%;" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_734ca259d2fe4517b1b216a5271c9f66" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%;" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_38023937562f40fa81aeb482d0e8c730" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%;" colspan="1">-</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%;" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_83875bf80c4d46208b25fb2c25bdcd79" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%;" colspan="1">-</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%;" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_eb7de405869445739622dbc315de6f6a" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%;" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_dfdd0c942ccc45ec99d93ff1e3023ffa" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,573</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%;" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_4236253babe04c0b87f6ddb138631b59" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%;" colspan="1"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_5097ac416ac940abaed857d4d179a5c0" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,573</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; padding-bottom: 2px; background-color: #CCEEFF;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">Net loss</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_54e71aed16cf4b9096a1f9e6f9e9d608" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_f0a99b7e3271497f99672a3b9af06015" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_3195539896b340aca8e2a0b81350dbf3" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_7cd00254abcf48d3b753ccf76f974fee" contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_d91b2cf5ac7e498fa30a5e68c6a2ab71" contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">-</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_53e4a86fc91a4cebac132dbdf0e0a6ec" contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_98cd330bb65a4694a81931bcb7752310" contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_bdbfc4f04451465e9e23dff6bb021b0a" contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">28,607</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_82e6500d91764a4584c81f86cf68f29f" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">28,607</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 12%; padding-bottom: 4px;">
                    <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balances at June 30, 2021</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_cd289149c6dd4e398d76aa443c1223b6" contextRef="c20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_2acbfda4237c495abd4659a47245871d" contextRef="c20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_a1856189ed22433d9f2ef71a24545764" contextRef="c20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_bd3228d47d134bf18f6e5e57fcc19315" contextRef="c20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_e512fa1307d9407d9ef4a64312a4a0cf" contextRef="c20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">44,707</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_79f62becc156412fafdc23c0f2cb1e19" contextRef="c20210630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">224</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_7b8a50a145cf49f097d04df1ecf22420" contextRef="c20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">156</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_b7b11b04f51d4be4bf23fa7901bb33ab" contextRef="c20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_57a83bc89fd742deba87386b505798be" contextRef="c20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">100,134</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_664993b436ec4faabba99d7ff13803f2" contextRef="c20210630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">46,756</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 5%; border-bottom: #000000 double 4px;" colspan="1">
                    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_462114da01854e87bcb88af97a7f89bf" contextRef="c20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">53,603</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
          </div>

        </div>

        <div><br />
        </div>

        <div style="text-align: center;"><span style="font-weight: normal;">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div>

        <div><br /></div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-weight: normal; font-style: normal; font-family: 'Times New Roman'; font-size: 8pt;" class="DSPFPageNumber">4</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div style="text-align: center; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>

        <div><span style="font-weight: bold;"> </span></div>

        <div style="text-align: center; font-weight: bold;">CONDENSED CONSOLIDATED STATEMENTS OF
          <!--Anchor--><!--Anchor--><!--Anchor--><!--Anchor-->CASH FLOWS<a id="CASHFLOWS"><!--Anchor--></a></div>

        <div style="text-align: center; font-weight: bold;">(in thousands) </div>

        <div style="text-align: center; font-weight: bold; text-indent: -81pt; margin-left: 81pt;"> (unaudited)<br />
        </div>

        <div><br />
        </div>

        <div style="text-align: center;">
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="6">
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">For the six months ended</div>
                  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">June 30,<br />
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">2022<br />
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: center; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: center; border-bottom: #000000 solid 2px;" colspan="2">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;">2021<br />
                  </div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Cash flows used in operating activities:</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Net loss</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_6f4f0938e705409e94ac1b73bb1e3782" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">12,773</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_6f3b8843d08e4ee9a23065b21d921a11" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">28,607</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Adjustments to reconcile net loss to net cash used in operating activities:</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Depreciation and amortization</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_52c3a375a4bc4ef3a35ebac43a7a055b" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">104</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_46233d7668a1445c909bce61aa877bfe" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">63</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Stock-based compensation</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_6fb1e37bcaff4d3ea366570481288ecb" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,062</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_e9daee9d9c134e3ba876a7acdd3e7f0d" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,573</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Amortization of right-of-use asset</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_e8a57958dfa64ad9af1fda481bbc817a" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">186</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_846320f5f364420baaedabc15565c637" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">149</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%;" rowspan="1">
                  <div style="margin-left: 9pt;">
                    <div style="margin-left: 9pt;">
                      <div style="margin-left: 9pt;">Impairment of right-of-use asset<br />
                      </div>
                    </div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_7d6e1951ffab441fa30136c75211d561" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">772</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_c3f5998dca1f4449a63a37f0b621834e" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF;" rowspan="1">
                  <div style="margin-left: 9pt;">
                    <div style="margin-left: 9pt;">
                      <div style="margin-left: 9pt;">Impairment of in-process research and development<br />
                      </div>
                    </div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_a9cbbd3606314678adf463b4ed119cbd" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,990</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_4d4895a83d2a484bb975e46c5a9d5516" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Transaction costs - shares to Financial Advisor</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_845d862a50614f16816355c3df31707e" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:NoncashMergerRelatedCosts" id="Fact_ea2dfa78201241efa117efa36c4e983e" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5,765</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Loss on sale of NTN assets</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_fd03224a48344f47b38694ef12fd9665" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" id="Fact_c92af19678294878b3796383c06fbc0d" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,648</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">
                  <div style="margin-left: 18pt;">Loss on disposal of fixed assets<br />
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="btx:GainLossOnDisposalOfFixedAssets" id="Fact_66db2d7e57854ec887f6e58344ea87ec" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">274</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="btx:GainLossOnDisposalOfFixedAssets" id="Fact_457e8979737d4828a06529ce29be430c" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" rowspan="1">
                  <div style="margin-left: 18pt;">Gain on lease termination<br />
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">(<ix:nonFraction name="btx:GainOnTerminationOfLease" id="Fact_d5112a306f0e42298775a537de0108f0" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">85</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="btx:GainOnTerminationOfLease" id="Fact_2aa8db5a59a44247bb110873cb5dfef2" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;" rowspan="1">
                  <div style="margin-left: 18pt;">Gain on warrant liabilities<br />
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">(<ix:nonFraction name="btx:WarrantLiabilitiesExpense" id="Fact_3b7eea33734148619b2f90453f98759e" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,470</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="btx:WarrantLiabilitiesExpense" id="Fact_c0a2ab30569d4c15b138ec2457bdbe58" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="margin-left: 18pt;"> Loss on non-controlling investment<br />
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="btx:LossOnNonControllingInvestment" id="Fact_4b1f3da2cc1944009396c13fa39c4ba3" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">911</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: bold;"><ix:nonFraction name="btx:LossOnNonControllingInvestment" id="Fact_68a861101a8c4077a800bd61258f50fa" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Changes in operating assets and liabilities:</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="margin-left: 27pt;"> Other receivable<br />
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherReceivables" id="Fact_321c1973cc5047a891af6441bdf24fb0" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherReceivables" id="Fact_c6ef839db990450f8b728fa2ddfbf06e" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 27pt;">Prepaid expenses and other current assets</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_520f5afb31b34c90ae1ef28e60bb64af" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">727</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_e64fdf9e0a804db3a0b4c84741503972" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,508</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); margin-left: 27pt;">Security deposits and other non-current assets</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" id="Fact_bf8dd294cc0b412bb83aa8debd6020d3" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">11</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" id="Fact_cf7683086b6848e5a5e5b5a2bf36f095" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">27</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 27pt;">Accounts payable and accrued expenses</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_3d86258584294221bc4a8f1779bf05d1" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,295</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_1017090743054a8b989bdcf7f1f92067" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,862</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); margin-left: 27pt;">Operating lease liability</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="btx:IncreaseDecreaseInOperatingLeaseLiabilities" id="Fact_ab893a212ace4afd9248c9af7adde3b7" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">153</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">(<ix:nonFraction name="btx:IncreaseDecreaseInOperatingLeaseLiabilities" id="Fact_ec6073fc08e24ab08f7ec95a1eaa1167" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">139</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); margin-left: 27pt;">Other liabilities</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" id="Fact_6388b59ba02b4c47b13572a9b8368eec" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,183</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" id="Fact_6464b7360e484717bcde3755511ad950" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">982</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; margin-left: 27pt;">Net cash used in operating activities</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_6afe89da9d5e4371852a35cd6bcf978a" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,425</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_0d27849903f54936966c012f234980eb" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,234</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Cash flows (used in) provided by investing activities:</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Purchase of property and equipment</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" id="Fact_907da751a9484053bd82995235768cfe" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">233</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" id="Fact_345be2badee34621acc0609312969b97" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%;" rowspan="1">
                  <div style="margin-left: 9pt;">
                    <div style="margin-left: 9pt;">Proceeds from the sales of fixed assets<br />
                    </div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" id="Fact_4e447ab2f13b4cb1b5a9e8876cd4c63c" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">100</ix:nonFraction><br />
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" id="Fact_80ce915fc2a0443bb431089b2edcb2e2" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction><br />
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Purchase of NTN, net of cash acquired</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromSalesOfAssetsInvestingActivities" id="Fact_8738013835e34e668a0b8d2e26358450" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:ProceedsFromSalesOfAssetsInvestingActivities" id="Fact_5c08b6ebac864f6aa134d216b4f43f95" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">147</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Proceeds from the sale of NTN assets, net of cash disposed</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_8481d30f6c17452cbc0f049374130a54" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_4d634b1023414ddbb6c7b5e13d186617" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">119</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; margin-left: 27pt;">Net cash (used in) provided by investing activities<br />
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_86c765326cbf4488a9d5ef8f728cac04" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">133</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_dd20e0dd75b346f6a76968736b843588" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">266</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Cash flows provided by financing activities:</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; font-weight: normal; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;" rowspan="1">
                  <div style="margin-left: 9pt;"> Proceeds from issuance of common stock and warrants in connection with private offering<br />
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_8f7ade7b2c2d4d62b6a51617dbace42f" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,993</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; font-weight: normal; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_f2fe506cce404ab4bf920a520b6a4b28" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%;" rowspan="1">
                  <div style="margin-left: 9pt;">
                    <div style="margin-left: 9pt;">Payroll tax remitted on net share settlement of equity awards<br />
                    </div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" id="Fact_f1e98fc89dd24b2092775070c109ff70" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">5</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; font-weight: normal; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" id="Fact_8d18602ab28a439582665c4340208d05" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF;" rowspan="1">
                  <div style="margin-left: 9pt;">
                    <div style="margin-left: 9pt;">Dividends paid to Series A preferred stockholders<br />
                    </div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" id="Fact_2c5e2f636e9f480580f5a893f53b46ed" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

    <td valign="bottom" style="text-align: right; font-weight: normal; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" id="Fact_d4181d37f2dd40838e89408f34444526" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%;" rowspan="1">
                  <div style="margin-left: 9pt;">
                    <div style="margin-left: 9pt;">Proceeds from issuance of common stock to Lincoln Park<br />
                    </div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="btx:ProceedsFromIssuanceOfCommonStockToLincolnPark" id="Fact_6ce04020486c479b8ad2e96bd5a000f3" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; font-weight: normal; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%;" rowspan="1" colspan="1"><ix:nonFraction name="btx:ProceedsFromIssuanceOfCommonStockToLincolnPark" id="Fact_f73da412b2e04317aa4d6e064ebd4e72" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">50,497</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF;" rowspan="1">
                  <div style="margin-left: 9pt;">
                    <div style="margin-left: 9pt;">Fees incurred in connection with the common stock issued to Lincoln Park<br />
                    </div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="btx:FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" id="Fact_8e4cc7acdd7e4685808343e0ec186918" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; font-weight: normal; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="font-weight: normal; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1">(<ix:nonFraction name="btx:FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" id="Fact_effb9da0837d42a3a1898e6569447588" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,972</ix:nonFraction></td>

    <td valign="bottom" style="font-weight: normal; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Proceeds from sale of members&#8217; equity</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" id="Fact_81e0f700f7b24b9da524e4208f788c87" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" id="Fact_9ab7998575c94e0091fea177541ae6c4" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,500</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%; background-color: #CCEEFF;" rowspan="1">
                  <div style="margin-left: 9pt;">
                    <div style="margin-left: 9pt;">Proceeds from the exercise of stock options<br />
                    </div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" id="Fact_2b77964f2c20484facd57a4d73fa6684" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction><br />
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" id="Fact_5ad45aa45f484cadbf65e6ec4aed9d88" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction><br />
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Repayment of NTN&#8217;s PPP loan</div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="btx:PaymentsOfPaycheckProtectionProgramLoan" id="Fact_bb728a9e854a4dfc85c9053211f0c4fe" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="btx:PaymentsOfPaycheckProtectionProgramLoan" id="Fact_58b3dad94bc641a8b91d06894aa1f4bb" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">532</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">)</div>
                </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal; margin-left: 27pt;">Net cash provided by financing activities</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_7ee8c29eaf5d4137bd1dade481e9fe87" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">11,980</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_a3c0168a36be4dc9b4e6aedd42e190c2" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">58,503</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">Net increase in cash and cash equivalents<br />
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" id="Fact_a7ca9048f87f4fd2a35d9628a1157dbf" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,422</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" id="Fact_d342d4143f6d43069d907c90637f390c" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">48,535</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Cash and cash equivalents at beginning of period</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_68ddc76da6d24c3ca6d775ad07700aa7" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">16,985</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_21e1369ba44b4e44af787746f2cb5a06" contextRef="c20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,630</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Cash and cash equivalents at end of period</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_4e6af96bfd13497f9ce3100a1be4038f" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">19,407</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_f3250412451646d5979ec858937827e3" contextRef="c20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">50,165</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div>&#160;</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Supplemental disclosures of cash flow information:</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Cash paid during the period for:</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                  <div style="color: rgb(0, 0, 0); margin-left: 18pt;">Interest</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_bc7be38cf8dc49669a94ff5a0b1da0a8" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_ab19eca704eb470ca2f10673d71b420b" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; text-indent: -9pt; margin-left: 9pt; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1">
                  <div style="margin-left: 9pt;">
                    <div style="margin-left: 9pt;">
                      <div style="margin-left: 9pt;">Income taxes<br />
                      </div>
                    </div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_011a88eee4e94cf1b2cd0165df3665a9" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction><br />
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_ed12edf98566485f87fecac4405cebab" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction><br />
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                  <div>&#160;</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                  <div style="color: rgb(0, 0, 0); font-weight: normal;">Supplemental disclosure of non-cash investing and financing activities:</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                  <div style="color: rgb(0, 0, 0); margin-left: 9pt;">Issuance of common stock for business combination</div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:StockIssued1" id="Fact_b605189355444d24a4142fd3e8fad3c5" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);">$</div>
                </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" colspan="1">
                  <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:StockIssued1" id="Fact_eefa35ba47fd41208551e33ee8ef2db6" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,177</ix:nonFraction></div>
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1">
                  <div style="margin-left: 9pt;">Series A preferred stock retained in business combination<br />
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" id="Fact_f4c255ac08514813bafeb28c359e9af5" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" id="Fact_6125f9343898419088c1928f1d5288aa" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;" rowspan="1">
                  <div>
                    <div>
                      <div style="text-indent: -9pt; margin-left: 18pt;">Initial measurement of ROU assets and liabilities<br />
                      </div>
                    </div>
                  </div>
                </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1"><ix:nonFraction name="btx:InitialMeasurementOfRightOfUseAssetsAndLiabilities" id="Fact_7d564310af0e485d8b60800f6518fbd1" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,706</ix:nonFraction><br />
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" rowspan="1" colspan="1"><ix:nonFraction name="btx:InitialMeasurementOfRightOfUseAssetsAndLiabilities" id="Fact_5add340712bc4e5bbaf034afc3e70e55" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">874</ix:nonFraction><br />
                </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>


</table>
        </div>

        <div style="text-align: center;"> <br />
        </div>

        <div style="text-align: center;">
          <div>The accompanying notes are an integral part of these condensed consolidated financial statements.</div>

        </div>

        <div><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 8pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">5</span></div>

          <div style="page-break-after:always;" class="DSPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span>  <span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div style="text-align: center; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>

        <div style="text-align: center; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><a id="NOTESTOCONDENSEDCONSOLIDA"><!--Anchor--></a><!--Anchor--><!--Anchor--><!--Anchor--><!--Anchor-->NOTES TO CONDENSED CONSOLIDATED FINANCIAL
          STATEMENTS</div>

        <div style="text-align: center; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(Unaudited) </div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
<ix:nonNumeric name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="Text_c159c89179e84bc69ae87d8760bbfc7e" contextRef="c20220101to20220630" escape="true" continuedAt="Text_3dfed097a71542579b76c976f70a4a391">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
         </div>
</ix:nonNumeric>
        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a391" continuedAt="Text_3dfed097a71542579b76c976f70a4a392">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></div>
              </td>

  </tr>


</table>
</ix:continuation>
        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a392" continuedAt="Text_3dfed097a71542579b76c976f70a4a393">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a393" continuedAt="Text_3dfed097a71542579b76c976f70a4a394">
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a394" continuedAt="Text_3dfed097a71542579b76c976f70a4a395">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Description of Business</div>
</ix:continuation>
        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a395" continuedAt="Text_3dfed097a71542579b76c976f70a4a396">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </span> </div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">
          <div>
            <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a396" continuedAt="Text_3dfed097a71542579b76c976f70a4a397">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Brooklyn ImmunoTherapeutics Inc., a Delaware corporation (&#8220;Brooklyn&#8221; or the &#8220;Company&#8221;), together with its subsidiaries including Brooklyn
              ImmunoTherapeutics LLC (&#8220;Brooklyn LLC&#8221;), Novellus, Inc. (&#8220;Novellus&#8221;) and Novellus Therapeutics, Ltd. (&#8220;Novellus, Ltd.&#8221;), is a biopharmaceutical company utilizing its mRNA technology platform, including mRNA-based cell reprogramming and gene
              editing technologies, to create next generation mRNA, gene editing and cell therapies, including iPSC therapies for multiple therapeutic indications. As used herein, the &#8220;Company&#8221; refers collectively to Brooklyn and its subsidiaries.</div>
</ix:continuation>
          </div>

        </div>

        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a397" continuedAt="Text_3dfed097a71542579b76c976f70a4a398">
<div><br /></div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><ix:continuation id="Text_3dfed097a71542579b76c976f70a4a398" continuedAt="Text_3dfed097a71542579b76c976f70a4a399">
<div><span style="font-family: 'Times New Roman';"> </span></div>
</ix:continuation>
          <div><ix:continuation id="Text_3dfed097a71542579b76c976f70a4a399" continuedAt="Text_3dfed097a71542579b76c976f70a4a3910">
<div><span style="font-family: 'Times New Roman';"> </span></div>
</ix:continuation>
            <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3910" continuedAt="Text_3dfed097a71542579b76c976f70a4a3911">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On August 12, 2020, Brooklyn (then known as &#8220;NTN Buzztime, Inc.&#8221;), Brooklyn LLC and BIT Merger Sub, Inc., a wholly owned subsidiary of
              Brooklyn (the &#8220;Merger Sub&#8221;), entered into an agreement and plan of merger and reorganization (the &#8220;Merger Agreement&#8221;) pursuant to which, among other matters, Merger Sub merged with and into Brooklyn LLC, with Brooklyn LLC continuing as a
              wholly owned subsidiary of Brooklyn and as the surviving company of the merger (the &#8220;Merger&#8221;). The Merger closed on March 25, 2021. After the Merger, Brooklyn changed its name from &#8220;NTN Buzztime, Inc.&#8221; to &#8220;Brooklyn ImmunoTherapeutics, Inc.&#8221;
              The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes.</div>
</ix:continuation>
            <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3911" continuedAt="Text_3dfed097a71542579b76c976f70a4a3912">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3912" continuedAt="Text_3dfed097a71542579b76c976f70a4a3913">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 26, 2021, Brooklyn sold (the &#8220;Disposition&#8221;) its rights, title and interest in and to the assets relating to the business operated
              under the name &#8220;NTN Buzztime, Inc.&#8221; prior to the Merger to eGames.com Holdings LLC (&#8220;eGames.com&#8221;) in accordance with the terms of an asset purchase agreement dated September 18, 2020, as amended, between Brooklyn and eGames.com (the &#8220;Asset
              Purchase Agreement&#8221;). </div>
</ix:continuation>
          </div>

        </div>

        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3913" continuedAt="Text_3dfed097a71542579b76c976f70a4a3914">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </span> </div>
</ix:continuation>
        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3914" continuedAt="Text_3dfed097a71542579b76c976f70a4a3915">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On July 16, 2021, Brooklyn and its newly formed, wholly owned subsidiary Brooklyn Acquisition Sub, Inc. entered into an
          agreement and plan of acquisition (the &#8220;Acquisition Agreement&#8221;) with (a) Novellus LLC, (b) Novellus (the sole equity holder of Novellus, Ltd. and, prior to the closing under the Acquisition Agreement, a subsidiary of Novellus, LLC), and (c) a
          seller representative (the &#8220;Acquisition&#8221;), pursuant to which Brooklyn acquired Novellus and its subsidiary, Novellus, Ltd. As part of the Acquisition, Brooklyn also acquired <ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact_f567853a4cee441eaed79f3734f9a8cd" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U004" decimals="3" scale="-2" format="ixt:numdotdecimal">25.0</ix:nonFraction>% of the total outstanding equity interests of NoveCite, Inc. (&#8220;NoveCite&#8221;), a corporation focused on developing an allogeneic mesenchymal stem cell product for patients with acute
          respiratory distress syndrome, including from COVID-19. </div>
</ix:continuation>
        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3915" continuedAt="Text_3dfed097a71542579b76c976f70a4a3916">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><br />
        </div>
</ix:continuation>

        <ix:nonNumeric name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="Text_981de089ea644818a2ff1997672bf5df" contextRef="c20220101to20220630" escape="true" continuedAt="Text_5e71b3c51611452fab27feed5575b6691"><ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3916" continuedAt="Text_3dfed097a71542579b76c976f70a4a3917">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Basis of Presentation</div>
</ix:continuation></ix:nonNumeric>
        <ix:continuation id="Text_5e71b3c51611452fab27feed5575b6691" continuedAt="Text_5e71b3c51611452fab27feed5575b6692"><ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3917" continuedAt="Text_3dfed097a71542579b76c976f70a4a3918">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </span> </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_5e71b3c51611452fab27feed5575b6692" continuedAt="Text_5e71b3c51611452fab27feed5575b6693"><ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3918" continuedAt="Text_3dfed097a71542579b76c976f70a4a3919">
<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_5e71b3c51611452fab27feed5575b6693" continuedAt="Text_5e71b3c51611452fab27feed5575b6694"><ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3919" continuedAt="Text_3dfed097a71542579b76c976f70a4a3920">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The














          accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial statements and with the instructions to
          Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the unaudited financial statements include all the
          normal recurring adjustments that are necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.<br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_5e71b3c51611452fab27feed5575b6694" continuedAt="Text_5e71b3c51611452fab27feed5575b6695"><ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3920" continuedAt="Text_3dfed097a71542579b76c976f70a4a3921">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_5e71b3c51611452fab27feed5575b6695"><ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3921" continuedAt="Text_3dfed097a71542579b76c976f70a4a3922">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">These
































          condensed consolidated financial statements should be read together with the audited consolidated financial statements and notes thereto contained in Brooklyn&#8217;s Annual Report on Form 10-K/A for the year ended December 31, 2021 filed with the
          Securities and Exchange Commission (the &#8220;SEC&#8221;) on June 30, 2022 (the &#8220;10-K/A&#8221;). The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements contained in the 10-K/A but does
          not include all of the information and footnotes required by GAAP for complete financial statements. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be anticipated for
          the entire year ending December 31, 2022, or any other period.</div>
</ix:continuation></ix:continuation>

        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3922" continuedAt="Text_3dfed097a71542579b76c976f70a4a3923">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">6</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>
<ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3923" continuedAt="Text_3dfed097a71542579b76c976f70a4a3924"><ix:nonNumeric name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="Text_71c8f622b17c4c8e9d9a5535cd70cf24" contextRef="c20220101to20220630" escape="true" continuedAt="Text_d379c4a2e62941e88dacf2633aca2e731">
<div>
         <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>
</ix:nonNumeric></ix:continuation>
        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3924" continuedAt="Text_3dfed097a71542579b76c976f70a4a3925"><ix:continuation id="Text_d379c4a2e62941e88dacf2633aca2e731" continuedAt="Text_d379c4a2e62941e88dacf2633aca2e732">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-style: italic;">Reclassifications</span><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3925" continuedAt="Text_3dfed097a71542579b76c976f70a4a3926"><ix:continuation id="Text_d379c4a2e62941e88dacf2633aca2e732" continuedAt="Text_d379c4a2e62941e88dacf2633aca2e733">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_3dfed097a71542579b76c976f70a4a3926"><ix:continuation id="Text_d379c4a2e62941e88dacf2633aca2e733">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Certain reclassifications have been made
          to Brooklyn&#8217;s prior years&#8217; financial statements to conform to the current year presentation. These reclassifications had no effect on Brooklyn&#8217;s previously reported results of operations or accumulated deficit.</div>
</ix:continuation></ix:continuation>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; margin-right: 57.55pt; margin-left: 24pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160; <span style="width: 9pt; font-size: 1px; display: inline-block;" class="HorizontalTab">&#160;</span> </div>

      </div>

      <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</div>

    <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> <span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> <span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

      <div><ix:nonNumeric name="btx:LiquidityAndCapitalResourcesTextBlock" id="Text_b6fb6892a9904282bc9f5185ebebb1c1" contextRef="c20220101to20220630" escape="true" continuedAt="Text_8ef455f0fb374607ac0a69977df8a9541">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>
</ix:nonNumeric>
        <ix:continuation id="Text_8ef455f0fb374607ac0a69977df8a9541" continuedAt="Text_8ef455f0fb374607ac0a69977df8a9542">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">LIQUIDITY AND CAPITAL RESOURCES</div>
              </td>

  </tr>


</table>
</ix:continuation>
        <ix:continuation id="Text_8ef455f0fb374607ac0a69977df8a9542" continuedAt="Text_8ef455f0fb374607ac0a69977df8a9543">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_8ef455f0fb374607ac0a69977df8a9543" continuedAt="Text_8ef455f0fb374607ac0a69977df8a9544">
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">
          <ix:continuation id="Text_8ef455f0fb374607ac0a69977df8a9544" continuedAt="Text_8ef455f0fb374607ac0a69977df8a9545">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has incurred significant operating losses and has an accumulated deficit as a result of ongoing efforts to develop product candidates, including conducting clinical trials and providing general and
              administrative support for operations. As of June 30, 2022, the Company had a cash balance of approximately $<ix:nonFraction name="us-gaap:Cash" id="Fact_621be4f751bf43a1b1d6bc5295adf4a9" contextRef="c20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">19.4</ix:nonFraction> million and an
              accumulated deficit of approximately $<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_086fa4a396e9443eae26a1ca9138a1ad" contextRef="c20220630" unitRef="U002" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">153.5</ix:nonFraction> million. For the three and six months ended June 30, 2022, the Company incurred a net
              loss of $<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_22c0e4497b264a628decf3dbb3591584" contextRef="c20220401to20220630" unitRef="U002" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">3.4</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_4fa14d548fa6445ca77ea79f48506a31" contextRef="c20220101to20220630" unitRef="U002" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">12.8</ix:nonFraction>
              million, respectively, and the Company used cash in operating activities of $<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_a808fc8258594a6383b7797381499e42" contextRef="c20220101to20220630" unitRef="U002" decimals="-5" scale="6" sign="-" format="ixt:numdotdecimal">9.4</ix:nonFraction></span><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> million.</span><br />
            </span> </div>
</ix:continuation>
          <div style="text-indent: 27pt;">
            <ix:continuation id="Text_8ef455f0fb374607ac0a69977df8a9545" continuedAt="Text_8ef455f0fb374607ac0a69977df8a9546">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160; <br />
              </span></div>
</ix:continuation>
            <ix:continuation id="Text_8ef455f0fb374607ac0a69977df8a9546" continuedAt="Text_8ef455f0fb374607ac0a69977df8a9547">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">In connection with preparing the accompanying condensed consolidated financial statements as of and for the three months ended June 30, 2022, the Company&#8217;s management concluded that there is substantial doubt regarding the Company&#8217;s
              ability to continue as a going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these financial statements. The Company
              will need to raise additional capital, which could be through the remaining availability under an equity line purchase agreement with Lincoln Park Capital Fund, LLC (the &#8220;Second Purchase Agreement&#8221;) (to the extent the Company is permitted to
              use such agreement) (see Note 11), public or private equity offerings, debt financings, corporate collaborations or other means. The Company may also seek governmental grants to support its clinical trials and preclinical trials. The Company
              currently has no arrangements for such capital and no assurances can be given that it will be able to raise such capital when needed, on acceptable terms, or at all.</div>
</ix:continuation>
            <ix:continuation id="Text_8ef455f0fb374607ac0a69977df8a9547" continuedAt="Text_8ef455f0fb374607ac0a69977df8a9548">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_8ef455f0fb374607ac0a69977df8a9548">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The accompanying condensed
                consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying condensed consolidated
                financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the
                Company&#8217;s ability to continue as a going concern</span>.</div>
</ix:continuation>

            <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br />
            </div>

          </div>

        </div>

        <!--PROfilePageNumberReset%Num%6%%%--> </div>

    </div>

    <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <div>
          <ix:nonNumeric name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="Text_fbcb17304ce04aa5b619ffb95c920909" contextRef="c20220101to20220630" escape="true" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b541">
<div>
            <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">3)</div>
                  </td>

    <td style="align: left; vertical-align: top; width: auto;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</div>
                  </td>

  </tr>


</table>
          </div>
</ix:nonNumeric>
        </div>

        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b541" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b542">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b542" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b543">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 27pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Merger</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b543" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b544">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b544" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b545">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On August 12, 2020, Brooklyn, Brooklyn LLC and the Merger Sub
          entered into the Merger Agreement, and the Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes. Brooklyn LLC, as the accounting
          acquirer, recorded the assets acquired and liabilities assumed of Brooklyn in the Merger at their fair values as of the acquisition date.</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b545" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b546">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b546" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b547">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Brooklyn LLC was determined to be the accounting acquirer
          based upon the terms of the Merger and other factors including that (i) Brooklyn LLC members, received common stock in the Merger that represented <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_473e5e62563b4a449402541d32e94007" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">96.35</ix:nonFraction>%
          of Brooklyn&#8217;s outstanding common stock on a fully diluted basis, (ii) all of the directors of Brooklyn immediately after the Merger were designated by Brooklyn LLC under the terms of the Merger Agreement and (iii) existing members of Brooklyn
          LLC&#8217;s management became the management of Brooklyn immediately after the Merger.</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b547" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b548">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b548" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b549">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">At the closing of the Merger, all the outstanding membership
          interests of Brooklyn LLC converted into the right to receive an aggregate of approximately <ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" id="Fact_c078d6e413f444228084595d269b2b40" contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">39,992,000</ix:nonFraction> shares of common stock, of
          which <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="Fact_9f994df8ddb2422db68561292acae0d6" contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,068,000</ix:nonFraction> shares were issued as compensation to Maxim Group LLC, Brooklyn LLC&#8217;s financial advisor (the &#8220;Financial Advisor&#8221;) for
          its services to Brooklyn LLC in connection with the Merger.</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b549" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5410">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">7</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>

        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5410" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5411">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The purchase price of $<ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" id="Fact_9bac632d28684df99b4d7ccd3b861e5c" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">8.2</ix:nonFraction> million, which represents the consideration transferred in the Merger to stockholders of Brooklyn immediately before the Merger, was calculated
          based on the closing price of $<ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" id="Fact_b8cb777b335843f195a3706d195f8328" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">5.40</ix:nonFraction> per share for approximately <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_c03dc294afee4c7fbbfba83f045f302c" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,514,000</ix:nonFraction> shares common stock that those stockholders owned on March 25, 2021 immediately prior to the Merger because that represented a more reliable measure of the fair value of
          consideration transferred in the Merger.</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5411" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5412">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5412" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5413">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Under the acquisition method of accounting, the total
          purchase price has been allocated to the acquired tangible and intangible assets and assumed liabilities of Brooklyn based on their estimated fair values as of March 25, 2021, the Merger closing date. Because the consideration paid by Brooklyn
          LLC in the Merger is more than the estimated fair values of Brooklyn&#8217;s net assets deemed to be acquired, goodwill is equal to the difference of approximately $<ix:nonFraction name="us-gaap:Goodwill" id="Fact_60d0c60bf5c04beebfbac6cc24d229e7" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">8.6</ix:nonFraction> million, which has been calculated using the fair values of the net assets of Brooklyn as of March 25, 2021.</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5413" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5414">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>

        <ix:nonNumeric name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="Text_c4998b5fcb854dbda6d5d8398d1e26e9" contextRef="c20220101to20220630" escape="true" continuedAt="Text_86cc8996ba33403b848cbd38f01d0c911"><ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5414" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5415">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The allocation of the purchase price to the tangible and
          intangible assets acquired and liabilities deemed to be assumed from Brooklyn, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):</div>
</ix:continuation></ix:nonNumeric>
        <ix:continuation id="Text_86cc8996ba33403b848cbd38f01d0c911" continuedAt="Text_86cc8996ba33403b848cbd38f01d0c912"><ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5415" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5416">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_86cc8996ba33403b848cbd38f01d0c912"><ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5416" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5417">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Historical</div>
                <div style="text-align: center; font-weight: bold;">Balance</div>
                <div style="text-align: center; font-weight: bold;">Sheet of</div>
                <div style="text-align: center; font-weight: bold;">Brooklyn at</div>
                <div style="text-align: center; font-weight: bold;">March 25, 2021</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Fair Value</div>
                <div style="text-align: center; font-weight: bold;">Adjustment</div>
                <div style="text-align: center; font-weight: bold;">to Brooklyn</div>
                <div style="text-align: center; font-weight: bold;">Pre-Merger</div>
                <div style="text-align: center; font-weight: bold;">Assets</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; white-space: nowrap;" colspan="2">
                <div style="font-weight: bold;">
                  <div><span style="font-weight: bold;">Purchase</span></div>
                </div>
                <div><span style="font-weight: bold;">Price</span></div>
                <div><span style="font-weight: bold;">Allocation</span></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" id="Fact_9cd5872f359548e2b420f2788bb923a0" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">148</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" id="Fact_46476bc58f464358b9d0b054c78e6ca7" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" id="Fact_cc8f1d409e2c40a4bde0302c7ea26bcb" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">148</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_707b862ef5b545a88b26d6594b92cb3d" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">103</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_d701ae65f2a04284aa46d1c67170aeac" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_1e4e5dfc37fc43768cc254a2a1d51fcf" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">103</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;">
                <div style="text-align: left;">Prepaid expense and other current assets</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" id="Fact_273c0949aa7a49e08e24dcd4b8e821f4" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">329</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" id="Fact_b3ff1cb97a95486c9e02055f438fdc2a" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" id="Fact_9a58be55268240e18cf960871579f792" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">329</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" id="Fact_7b6a52dd71fc4d33bba85560c4260a82" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,015</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" id="Fact_d25c389ae84144f3a25ce222a1209b0e" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" id="Fact_7a7ef84cfd584bcb923e7b0ba4ceae93" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,015</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="Fact_9d199f0a33544fbd93e068c2624e0f82" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,296</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div>(<ix:nonFraction name="btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="Fact_dcf0044d9ad54f8a9fffd01e89e4727b" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">368</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="Fact_6a6e93053cab4ceca240bf184463d12c" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">928</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;">
                <div style="text-align: left;">Customers</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_4307e51d59214de78a60893d6822a5a7" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_e672d0652a1949d397747dd78dc0ff62" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">548</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_1365b3ef20c749e58c1899380e07a56b" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">548</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_412e9bc8e670401d956b00aff1b38b62" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_f1549ecca9a5453cacf73ac1d7bb92b0" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">299</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" id="Fact_506c3cd91e9f4c708e87b83752254a05" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">299</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;">
                <div style="text-align: left;">Accounts payable, accrued liabilities and other current</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;">
                <div style="text-align: left;">liabilities</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_98064196059548a1b6eca21c3efdfc50" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,781</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_e65c44db68e041f395db01fc11730355" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" id="Fact_de533c9dc7a8438fa40e9caa89913f9f" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,781</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_3ceb1fe3e9194f51aadcd89680163c71" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">890</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_3b3d6310974b4b3c8968b3b66238aca8" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">479</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_2a0990040b434a88b974e718d8740617" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">411</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;">
                <div style="text-align: left;">Total consideration</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" id="Fact_f3f30ae77cfb4d818676da5b898c91ca" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,178</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_47cd18c8d2844cdd95595343af31bc44" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">411</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div><ix:nonFraction name="us-gaap:Goodwill" id="Fact_7e313a7e40dc45c98d991744da8fbd23" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,589</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5417" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5418">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5418" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5419">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Brooklyn LLC was obligated under the Merger Agreement to have
          $<ix:nonFraction name="btx:ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" id="Fact_8c65be17ff8a4c7ea9da364aa259abc7" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">10.0</ix:nonFraction> million in cash and cash equivalents on its balance sheet at the effective time of the Merger. To ensure Brooklyn LLC had the
          required funds, certain beneficial holders of Brooklyn LLC&#8217;s Class A membership interests entered into contractual commitments to invest $<ix:nonFraction name="btx:BeneficialHoldersContractualCommitmentsToInvest" id="Fact_781feb6f148e44eb9a71041e1f81396e" contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">10.0</ix:nonFraction>
          million into Brooklyn LLC immediately prior to the closing of the Merger. During March 2021, Brooklyn offered its Class A unit holders an additional <ix:nonFraction name="btx:PercentageOfAdditionalRightsOffering" id="Fact_64ae455798ea4194961d178f613a95e1" contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">5</ix:nonFraction>%
          rights offering for an additional $<ix:nonFraction name="btx:ProceedsFromSaleOfRights" id="Fact_1574f1243d73418e9d0785568d71672d" contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million to be raised by a rights offering. Brooklyn received funds from the rights offering
          between February 17, 2021 and April 5, 2021.</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5419" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5420">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">8</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>

        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5420" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5421">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-indent: 36pt;">Disposition</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5421" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5422">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>

        <ix:nonNumeric name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="Text_a08043633ac149379ad703bbb3529414" contextRef="c20220101to20220630" escape="true" continuedAt="Text_bbc2cd3590194a86b1df39746e4bc3f51"><ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5422" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5423">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On March 26, 2021, Brooklyn sold its rights, title and
          interest in and to the assets relating to the business it operated (under the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $<ix:nonFraction name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" id="Fact_e5c11d3678774d8f834119ba17ceb45d" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction> million and assumption of specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of the
          Disposition are as follows (in thousands):</div>
</ix:continuation></ix:nonNumeric>
        <ix:continuation id="Text_bbc2cd3590194a86b1df39746e4bc3f51" continuedAt="Text_bbc2cd3590194a86b1df39746e4bc3f52"><ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5423" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5424">
<div><br /></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_bbc2cd3590194a86b1df39746e4bc3f52"><ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5424" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5425">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" rowspan="1">
                <div style="text-align: left; font-weight: bold;">Proceeds from sale:</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" rowspan="1" colspan="2">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" rowspan="1">Cash</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" rowspan="1" colspan="1"><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" id="Fact_76c17021385c473e9c6c9ae7fd4ec462" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">132</ix:nonFraction></td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Escrow</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" id="Fact_2fccb37d6ff147299c5dc9514e53b00e" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">50</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;">
                <div style="text-align: left;">Assume advance/loans</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" id="Fact_ab2d0cde21f24ff595921deade35d3c6" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,700</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Interest on advance/loans</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" id="Fact_f4c4e1b752ae41ff814510cf45bd4477" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">68</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left; font-weight: bold;">Carrying value of assets sold:</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" id="Fact_ce5617a2b672423a8d2beff942423e16" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" id="Fact_0dd2545f78904def87dd7d8b194a5a7d" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">75</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Prepaids and other current assets</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" id="Fact_3ecd39e4fea140cc933f41e252b99e39" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">124</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" id="Fact_86df970d3c8e4316beb9891cadf3064d" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,014</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div>(<ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" id="Fact_fafc3dfe87b242ada7a7d25ad333c226" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">927</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Customers</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" id="Fact_4c9b0f9bb28340bc9c41f0658f16be35" contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">548</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" id="Fact_ccda067df4864b6c838722ad175ef526" contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">299</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1" id="Fact_1574d315e1a24d33b1797f373595ba1d" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,589</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Other assets</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" id="Fact_ecdd4316c4434fc39dd40789f57f6cfb" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">103</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-weight: bold;">Liabilities transferred upon sale:</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Accounts payable and accrued expenses</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" id="Fact_52bc316c630442f29925062d24c40acc" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">113</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Obligations under finance leases</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" id="Fact_d7d23107488a4d7f9854ddceb546ff1a" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">17</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Lease liability</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationLeaseLiability" id="Fact_680a8b5844ff44e980590b7678833aa4" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">26</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Deferred revenue</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1">
                <div><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" id="Fact_c0b80053f0a546cea08367845906807d" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">55</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Other current liabilities</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" id="Fact_d8e95392449d4aecb68a68efbece12bc" contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">149</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Transaction costs</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div>(<ix:nonFraction name="btx:DisposalGroupIncludingDiscontinuedOperationTransactionCosts" id="Fact_f09fa2b23a8a407a9b7a3cb94d3bf35c" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">265</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" rowspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" rowspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px;">
                <div style="text-align: left; font-weight: bold;">Total loss on sale of assets</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="font-weight: bold;">$</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1">
                <div style="font-weight: bold;">(<ix:nonFraction name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" id="Fact_4d153c5b252d42968661431f6ba52d2b" contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9,648</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                <div style="font-weight: bold;">)</div>
              </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5425" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5426">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5426" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5427">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 36pt; font-variant: normal; text-transform: none;">Acquisition</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5427" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5428">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5428" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5429">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On July 16, 2021, Brooklyn and Brooklyn Acquisition Sub, Inc.
          entered into the Acquisition Agreement. The Acquisition closed contemporaneously with the execution and delivery of the Acquisition Agreement. At the closing:</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5429" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5430">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <div>
          <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5430" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5431">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: left;">&#8226;</div>
                </td>

    <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: justify;">Brooklyn acquired all of the outstanding equity interests of Novellus, Inc. as the result of the merger of Brooklyn Acquisition Sub, Inc. with and into Novellus, Inc., following which, Novellus, Inc., as
                    the surviving corporation, became Brooklyn&#8217;s wholly owned subsidiary and Novellus Ltd. became Brooklyn&#8217;s indirectly owned subsidiary; and</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5431" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5432">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5432" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5433">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: left;">&#8226;</div>
                </td>

    <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: justify;">Brooklyn acquired <ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact_a5b136cbcd174f68a75241d2eed778a2" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U004" decimals="3" scale="-2" format="ixt:numdotdecimal">25.0</ix:nonFraction>% of the total outstanding equity interests of NoveCite.</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5433" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5434">
<div> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
            </span></div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5434" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5435">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As consideration for the Acquisition, Brooklyn paid $<ix:nonFraction name="us-gaap:PaymentsToAcquireOtherProductiveAssets" id="Fact_24ef348347ca4bf0a2b3906467380cda" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">22.9</ix:nonFraction> million in cash and delivered approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" id="Fact_f7f3e49b34f94e6dacd71bfcc4fe9cd2" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">7,022,000</ix:nonFraction>
          shares of common stock, which under the terms of the Acquisition Agreement, were valued at a total of $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" id="Fact_52d8fc0526da4e3aa9c5bf541e3ce97c" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">102.0</ix:nonFraction> million based on an agreed
          upon price of $<ix:nonFraction name="btx:AssetAcquisitionSharePrice" id="Fact_0e5db743fce948fdbfe6d4ae5d8e88d6" contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U003" decimals="4" scale="0" format="ixt:numdotdecimal">14.5253</ix:nonFraction> per share. At the date of issuance, the fair value of the shares was approximately $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_80137ea0a902423990e42bcac63ca67c" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">58.6</ix:nonFraction> million.</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5435" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5436">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5436" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5437">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Acquisition Agreement contained customary
          representations, warranties and certain indemnification provisions. Approximately <ix:nonFraction name="btx:EscrowShares" id="Fact_71609d787ba44f1a96605a60f67dbe27" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">741,000</ix:nonFraction> of the shares issued as consideration were
          placed in escrow for a period of up to <ix:nonNumeric name="btx:EscrowPeriod" id="Fact_1b01036813c1446688022a4898b389bb" contextRef="c20220101to20220630_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember" format="ixt-sec:durmonth">12</ix:nonNumeric> months in order to secure indemnification obligations to Brooklyn under the Acquisition
          Agreement. The Acquisition Agreement also contains certain non-competition and non-solicitation provisions pursuant to which Novellus LLC agreed not to engage in certain competitive activities for a period of <ix:nonNumeric name="btx:AcquisitionAgreementNonCompetitivePeriod" id="Fact_30c2a22ae4fb4448b5185b899a904cbf" contextRef="c20220101to20220630_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric> following the closing, including customary restrictions relating to employees. No employees of Novellus Ltd. or Novellus, Inc. prior to the
          Acquisition continued their employment, or were otherwise engaged by Brooklyn, following the Acquisition.</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5437" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5438">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5438" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5439">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In connection with the Acquisition, the co-founders of
          Novellus, Inc. entered into lock-up agreements with respect to approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" id="Fact_7e805f2bddb547c1931d92618404e5e1" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusIncMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,378,000</ix:nonFraction> of the shares of common stock received in the
          Acquisition, and Brooklyn&#8217;s Chairman of the Board of Directors (the &#8220;Board&#8221;) and its former Chief Executive Officer and President entered into identical lock-up agreements with respect to their current holdings of Brooklyn stock. Each lock-up
          agreement extends for a period of <ix:nonNumeric name="btx:EachLockUpAgreementExtendsTerm" id="Fact_691d8e990f064bd8bd12daff876ddc12" contextRef="c20220101to20220630_AssetAcquisitionAxis_NovellusIncMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric>, provided that up to <ix:nonFraction name="btx:PercentageOfCommonStockSubjectToLockUpAgreement" id="Fact_4d1ccd02e0e846d691efe4b10b49939d" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusIncMember_RangeAxis_MaximumMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock on the Nasdaq exceeds specified
          thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period. </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5439" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5440">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">9</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>

        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5440" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5441">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company expects the Acquisition will advance its
          evolution into a platform company with a pipeline of next generation mRNA cellular and gene editing programs. In addition, the acquisition of Novellus, Ltd. builds on the License Agreement. (See Note 9). The completion of the acquisition of
          Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor Bioscience
          Limited (&#8220;Factor&#8221;) under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene editing and cell therapy products, remained unchanged.</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5441" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5442">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5442" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5443">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Although Brooklyn acquired all of the outstanding equity
          interests of Novellus, Inc., the Company accounted for the Acquisition as an asset acquisition (as the assets acquired did not constitute a business as defined in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 805,&#160;<span style="font-style: italic;">Business Combinations</span>),&#160;and was measured by the amount of cash paid and by the fair value of the shares of common stock issued. As a result, substantially all of the value acquired was attributed to in-process research and
          development (IPR&amp;D), with the exception of the cash paid for the investment in NoveCite, which is being accounted for as an investment in equity securities, as discussed further below.</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5443" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5444">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5444" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5445">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Brooklyn paid $<ix:nonFraction name="btx:PaymentsToAcquireProductiveAssetsNet" id="Fact_c7f8153cf5da49548ae0562a54b8de65" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">22.9</ix:nonFraction> million in cash, net of cash acquired, as part of the consideration for the Acquisition, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" id="Fact_bf42a554f2ce408b9895e7eb9a4fcb2e" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million was paid in cash for the investment in NoveCite. Brooklyn also issued approximately 7,022,000 shares of the Company&#8217;s common stock, of which approximately <ix:nonFraction name="btx:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" id="Fact_918be23fd1c34f4a82edc895c58d3dbd" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,644,000</ix:nonFraction> shares are unrestricted and <ix:nonFraction name="btx:StockIssuedDuringPeriodRestrictedSharesAcquisitions" id="Fact_0a5d9c7ffc2b44aa83d371f6bb030d11" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,378,000</ix:nonFraction>
          shares are subject to the <ix:nonNumeric name="btx:LockUpPeriodForRestrictedShares" id="Fact_59d733d860824ddf9b8117fa67de0bba" contextRef="c20220101to20220630_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" format="ixt-sec:durwordsen">three-year</ix:nonNumeric> lockup. The unrestricted shares were valued at $<ix:nonFraction name="btx:AssetAcquisitionUnrestrictedSharesSharePrice" id="Fact_5c15b3bb367846d0a35aee6463c8ab32" contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">10.05</ix:nonFraction> per share, which was the closing price of Brooklyn&#8217;s common stock on July 16, 2021. The fair value of the restricted shares was discounted by approximately <ix:nonFraction name="btx:PercentageOfDiscountOnFairValueOfRestrictedShares" id="Fact_b311a6f2556445e8b6addeadc5a1fb38" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">35</ix:nonFraction>% to $<ix:nonFraction name="btx:AssetAcquisitionRestrictedSharesSharePrice" id="Fact_00c7e5526f004330bb7fad536b1f1dd1" contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">6.53</ix:nonFraction> per restricted share,
          which was derived from the average discount rate between the Black Scholes and Finnerty valuation models. <ix:nonNumeric name="us-gaap:AssetAcquisitionTableTextBlock" id="Text_3ac8744c64734e319bb6f2f33b766498" contextRef="c20220101to20220630" escape="true" continuedAt="Text_56e88f7ae9f440649ae244abad5728031"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal;">The resulting fair value of the asset acquired is as follows (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5445" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5446"><ix:continuation id="Text_56e88f7ae9f440649ae244abad5728031" continuedAt="Text_56e88f7ae9f440649ae244abad5728032">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5446" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5447"><ix:continuation id="Text_56e88f7ae9f440649ae244abad5728032">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" colspan="2">
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Fair Value of</div>
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Consideration</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;">
                <div style="text-align: left;">Cash paid</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_7198331b474647189e0f6ec357ed4a6f" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">22,882</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;">
                <div style="text-align: left;">Cash acquired</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" id="Fact_1a454a8e5c44448cb75e4abf70976a3c" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">28</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;">
                <div style="text-align: left;">Unrestricted shares</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="btx:StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" id="Fact_2519d12930fb49ccab2fa9cdd24a1a95" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">36,628</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;">
                <div style="text-align: left;">Restricted shares</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1">
                <div><ix:nonFraction name="btx:StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" id="Fact_60c1dae0529644f7b7429b12658e72d9" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">22,056</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;">
                <div style="text-align: left;">Total fair value of consideration paid</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="btx:AssetAcquisitionFairValueOfConsiderationPaid" id="Fact_b4c6cd3aa7d04bd9986d718def299eca" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">81,538</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;">
                <div style="text-align: left;">Less amount of cash paid for NoveCite investment</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1">
                <div>(<ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" id="Fact_d4073769b28c46dcb32f1e05af75a002" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,000</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;">
                <div style="text-align: left;">Fair value of IPR&amp;D acquired</div>
              </td>

    <td valign="bottom" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1">&#160;</td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1">
                <div><ix:nonFraction name="btx:ResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_1534ad4545b1411c8bbf76ae06213e00" contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">80,538</ix:nonFraction></div>
              </td>

    <td valign="bottom" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5447" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5448">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5448" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5449">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">IPR&amp;D that is acquired through an asset purchase that has
          no alternative future uses and no separate economic values from its original intended purpose is expensed in the period the cost is incurred. Accordingly, the Company expensed the fair value of the IPR&amp;D during the third quarter of 2021 in
          the amount of $<ix:nonFraction name="btx:ResearchAndDevelopmentInProcessAssetAcquisition" id="Fact_2dcc688c6d224beba3a96db4b4fc14b7" contextRef="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="1" scale="0" format="ixt:numdotdecimal">80.5</ix:nonFraction> million.</div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5449" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5450">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5450" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5451">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Investment in NoveCite</span></div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5451" continuedAt="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5452">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_0f6a9d28ccf244c6b7f0749d5b8f9b5452">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">As a result of the Acquisition,&#160; Brooklyn acquired and
          currently owns <ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" id="Fact_b799c943a6244edb8739537efff37bc5" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction>% of NoveCite and Citius Pharmaceuticals, Inc. (&#8220;Citius&#8221;) owns the remaining <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" id="Fact_13fb0dfeb4cb41c7b378ef632d6f6b0d" contextRef="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%. A member of the Company&#8217;s management holds one of <ix:nonFraction name="btx:NumberOfBoardSeats" id="Fact_47a2741b162a468a9455d28c49c0ed71" contextRef="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U005" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction>
          board seats on NoveCite&#8217;s board of directors. Citius&#8217; s officers and directors hold the other two board seats. The Company is accounting for its interest in NoveCite under ASC Topic 323,&#160;<span style="font-style: italic;">Investments&#160;&#8211;&#160;Equity
            Method and Joint&#160;Ventures</span>.&#160;The investment was recorded at cost, which was $<ix:nonFraction name="us-gaap:EquityMethodInvestments" id="Fact_74641c58e631420cad665b6263d769c6" contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million&#160;and is adjusted for the Company&#8217;s share
          of&#160;NoveCite&#8217;s earnings or losses, which are reflected in the accompanying condensed consolidated statement of operations. The investment may also reflect an equity loss in the event that circumstances indicate an other-than-temporary impairment.
          For the three and six months ended June 30, 2022, the Company recorded $<ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" id="Fact_b415804e18544dbda288e301877d08b1" contextRef="c20220401to20220630_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" id="Fact_796dc73b15e94e20afda85d0e77f7cfb" contextRef="c20220101to20220630_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction> million, respectively, in losses from its investment in NoveCite, and of the $<ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" id="Fact_e53013eb5c6842809755e36960307b9d" contextRef="c20220101to20220630_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction>
          million loss for the six months ended June 30, 2022, $<ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" id="Fact_6478090ecc51477c969b08131f025362" contextRef="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million related to NoveCite&#8217;s year ended December 31, 2021.</div>
</ix:continuation>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">10</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>

      </div>

    </div>

    <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <ix:nonNumeric name="us-gaap:FairValueDisclosuresTextBlock" id="Text_e7c69bb7250f40eca795c907e47ea32c" contextRef="c20220101to20220630" escape="true" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec1">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold;">4)<br />
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">FAIR VALUE OF FINANCIAL INSTRUMENTS</div>
              </td>

  </tr>


</table>
</ix:nonNumeric>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec1" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec2">
<div>&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec2" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec3">
<div style="display:none;"><br /></div>
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Fair












          value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest
          priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:</div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec3" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec4">
<div>&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec4" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec5">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <div>
          <div>
            <div>
              <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec5" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec6">
<div>
                <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8226;</span></div>
                      </td>

    <td style="align: left; vertical-align: top; width: auto;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Level
                          1 Inputs &#8211; Valued based on quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</div>
                      </td>

  </tr>


</table>
              </div>
</ix:continuation>
            </div>

          </div>

        </div>

        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec6" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec7">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec7" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec8">
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec8" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec9">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <div>
          <div>
            <div>
              <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec9" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec10">
<div>
                <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8226;</span></div>
                      </td>

    <td style="align: left; vertical-align: top; width: auto;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Level
                          2 Inputs &#8211; Valued based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in
                          active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities,
                          prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.</div>
                      </td>

  </tr>


</table>
              </div>
</ix:continuation>
            </div>

          </div>

        </div>

        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec10" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec11">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec11" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec12">
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec12" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec13">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <div>
          <div>
            <div>
              <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec13" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec14">
<div>
                <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8226;</span></div>
                      </td>

    <td style="align: left; vertical-align: top; width: auto;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Level
                          3 Inputs &#8211; Valued based on inputs for which there is little or no market value, which require the reporting entity to develop its own assumptions.</div>
                      </td>

  </tr>


</table>
              </div>
</ix:continuation>
            </div>

          </div>

        </div>

        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec14" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec15">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec15" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec16">
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation><ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec16" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec17"><ix:nonNumeric name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="Text_4d476c48d31d495f848d9bf273e04d58" contextRef="c20220101to20220630" escape="true" continuedAt="Text_f00a267b55c84fd6874d934bfe1ac24f1">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
        <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:nonNumeric></ix:continuation>
        <div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec17" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec18"><ix:continuation id="Text_f00a267b55c84fd6874d934bfe1ac24f1" continuedAt="Text_f00a267b55c84fd6874d934bfe1ac24f2">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
          <div><ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec18" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec19"><ix:continuation id="Text_f00a267b55c84fd6874d934bfe1ac24f2" continuedAt="Text_f00a267b55c84fd6874d934bfe1ac24f3">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
            <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec19" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec20"><ix:continuation id="Text_f00a267b55c84fd6874d934bfe1ac24f3" continuedAt="Text_f00a267b55c84fd6874d934bfe1ac24f4">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The following tables summarize the liabilities that are measured at fair value as of June 30, 2022 (in thousands).&#160; There were <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_501cb0cfd94e42a8963661fd718f52b1" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> liabilities measured at fair value as of Decem</span>ber 31, 2021:</div>
</ix:continuation></ix:continuation>
          </div>

          <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec20" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec21"><ix:continuation id="Text_f00a267b55c84fd6874d934bfe1ac24f4" continuedAt="Text_f00a267b55c84fd6874d934bfe1ac24f5">
<div> <br />
          </div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec21" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec22"><ix:continuation id="Text_f00a267b55c84fd6874d934bfe1ac24f5">
<div>
            <table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of June 30,
                      2022</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 1</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 2</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 3</div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Liabilities:</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Pre-Funded Warrants</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_609ad91924bb456795b685924b336513" contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_2d13b34a57884436a6604125e37c65f1" contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">702</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_2ac917cdec6f4537a5cc31f7fa2416a6" contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Common Warrants</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_24f22669017f40e8b44c094370d8c1dc" contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_adbd83dc423d41678ee952017406046a" contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_848ffac4d850460fb1cd57e990c03f2e" contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,822</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_76bdb1afa5664cc7926066f0aff0f4b7" contextRef="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_80baf7ca33a546b6947400cab5a2bef8" contextRef="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">702</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" id="Fact_a6f41fe3bb5748e2829acbe49655f138" contextRef="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,822</ix:nonFraction></div>
                  </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>


</table>
          </div>
</ix:continuation></ix:continuation>
        </div>

        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec22" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec23">
<div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">  <br /></div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec23" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec24">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec24" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec25">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">On
          March 9, 2022, the Company issued pre-funded warrants exercisable for approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_6e10902d6cb14e89b08f292e04096575" contextRef="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,357,000</ix:nonFraction> shares of common stock (the &#8220;Pre-Funded
          Warrants&#8221;) and warrants exercisable for approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_aa04d20afe4f43c4817b4ab29eeb6877" contextRef="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">6,857,000</ix:nonFraction> shares of common stock (the &#8220;Common Warrants&#8221;) in connection with the
          PIPE Transaction (as defined below).&#160; See Note 11 for more information related to the PIPE Transaction. </div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec25" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec26">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
        </div>
</ix:continuation>
        <div style="text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">
            <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec26" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec27">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Common Warrants and Pre-Funded Warrants were accounted for as liabilities under ASC
              815-40,&#160;Derivatives and Hedging, Contracts in Entity&#8217;s Own Equity&#160;(&#8220;ASC 815-40&#8221;), as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant
              liabilities were measured at fair value at inception and are then subsequently measured on a recurring basis, with changes in fair value presented within the Company&#8217;s statement of operations.</div>
</ix:continuation>
            <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec27" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec28">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec28" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec29">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Company uses a Black-Scholes option pricing model to estimate the fair value of the Common
              Warrants, which is considered a Level 3 fair value measurement.&#160; Certain inputs used in this Black-Scholes pricing model may fluctuate in future periods based upon factors that are outside of the Company&#8217;s control.&#160; A significant change in
              one or more of these inputs used in the calculation of the fair value may cause a significant change to the fair value of the Company&#8217;s warrant liabilities, which could also result in material non-cash gains or losses being reported in the
              Company&#8217;s consolidated statement of operations.</div>
</ix:continuation>
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">
              <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec29" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec30">
<div><br />
              </div>
</ix:continuation>
              <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec30" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec31">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The estimated fair value of the Pre-Funded Warrants was deemed a Level 2 measurement as of June 30, 2022, as all significant inputs to the valuation model used to estimate the fair value of the Pre-Funded Warrants
                  were directly observable from the Company&#8217;s publicly-traded common stock.</span> </div>
</ix:continuation>
            </div>

          </div>

          <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec31" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec32">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec32" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec33">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_aa3003dcdfad459f92f8f86faeea3f70" contextRef="c20220101to20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.6</ix:nonFraction> million in the aggregate, which was $<ix:nonFraction name="btx:OverSubscriptionAmountReceived" id="Fact_d1d319dbf1484ec9953fe00a762116b4" contextRef="c20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million more
            than the $<ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" id="Fact_3d1fb5cb97fc47b3bef1350c3a9ef2c6" contextRef="c20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction> million proceeds received in the PIPE Transaction.&#160; The excess $<ix:nonFraction name="btx:OverSubscriptionAmountReceived" id="Fact_39dfebd2c8ef460385f91d5c0fc4a54b" contextRef="c20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million represents an inducement to the purchaser to enter into the PIPE Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of
            operations.&#160; Given the Company&#8217;s capital requirements and market conditions, the Company consummated this financing on market terms available at the time of the transaction. </div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec33" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec34">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec34" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec35">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br />
        </div>
</ix:continuation>
        <div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">11</span></div>

            <div style="page-break-after: always;" class="DSPFPageBreak">
              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

            <div style="width: 100%;" class="DSPFPageHeader">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
                </a></div>

            </div>

          </div>

          <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec35" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec36">
<div><br /></div>
</ix:continuation>
        </div>

        <div style="clear: both;">
          <ix:nonNumeric name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="Text_55fe4c73466947d584f99fad7ef80692" contextRef="c20220101to20220630" escape="true" continuedAt="Text_6c28f0bfa9714780b26e0b5cab2552421"><ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec36" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec37">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company remeasured the fair value of the warrant liabilities as of June 30, 2022, and the following table presents the changes in the
            warrant liabilities from the issuance date (in thousands): </div>
</ix:continuation></ix:nonNumeric>
          <ix:continuation id="Text_6c28f0bfa9714780b26e0b5cab2552421" continuedAt="Text_6c28f0bfa9714780b26e0b5cab2552422"><ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec37" continuedAt="Text_09a0f2ac852a4aa2adf6e101098343ec38">
<div>&#160;</div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_09a0f2ac852a4aa2adf6e101098343ec38"><ix:continuation id="Text_6c28f0bfa9714780b26e0b5cab2552422">
<div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pre-Funded <span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
                      </span></div>
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Warrants<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
                      </span></div>
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 2)</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common</div>
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Warrants<br />
                      </span>(Level 3)</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Warrant<span style="font-size: 10pt; font-family: 'Times New Roman';"><br />
                      </span>Liabilities</div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at January 1, 2022</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_d3184432696b42a9a3311fe132cec361" contextRef="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_3bb72ec5f2284be4a934cdfb1cb01cac" contextRef="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_e6c78bb63fed4235bc5efeec0644a200" contextRef="c20211231" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 9, 2022 (issuance date)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_2d9de2de7db44df68cdb0db6e61ac5cf" contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,646</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_ecc54ca567684fca96395092999f4972" contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">9,943</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_64b48933a0524840b86514d5ca061722" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,589</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in fair value of warrant liabilities</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" id="Fact_29f2d7a567f4407eb6e189f0004b62fa" contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,944</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" id="Fact_782617855baf44cfb11d5b48989866f4" contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,121</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LiabilitiesFairValueAdjustment" id="Fact_09c0954b58ae42ff84c40f4a478beeed" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,065</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at June 30, 2022</div>
                  </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_496ea452386446ccb643f4fdb25095c1" contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">702</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_88f1d3e86e7749cf8848ac3c3d37eab1" contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,822</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" id="Fact_e94cad12047846d7ab9d9d3cf56d1906" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,524</ix:nonFraction></div>
                  </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
            </div>
</ix:continuation></ix:continuation>
        </div>

        <div style="clear: both;">
        </div>

        <div style="font-family: 'Times New Roman';">&#160; </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
      <ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" id="Text_20195ec403ad458d849948633e03ae63" contextRef="c20220101to20220630" escape="true" continuedAt="Text_50bdfcd0329044ea863abbff1f4982281">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">5)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">LEASES</div>
            </td>

  </tr>


</table>
</ix:nonNumeric>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f4982281" continuedAt="Text_50bdfcd0329044ea863abbff1f4982282">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f4982282" continuedAt="Text_50bdfcd0329044ea863abbff1f4982283">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The Company has operating leases for office and laboratory space in the borough of
        Manhattan in New York, New York and in Cambridge, Massachusetts, which expire in 2026 and 2028, respectively. On March 31, 2022, the Company entered into the Torrey Pines Science Center Lease in San Diego, California (the &#8220;San Diego Lease&#8221;) with<span style="font-family: 'Times New Roman'; font-size: 10pt;"> Torrey Pines Science Center Limited Partnership for approximately <ix:nonFraction name="btx:OperatingLeaseArea" id="Fact_5bc439b04d0c42f7b5532dde69a21b7b" contextRef="c20220630" unitRef="U006" decimals="0" scale="0" format="ixt:numdotdecimal">5,200</ix:nonFraction>
          square feet of lab and office space. The term of the San Diego Lease is <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Fact_921af385ba544713bcf0dafba021b788" contextRef="c20220630" format="ixt-sec:durmonth">62</ix:nonNumeric> months and the lease commencement date was April 19, 2022.
          The San Diego Lease will expire in June</span> 2027.</div>
</ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f4982283" continuedAt="Text_50bdfcd0329044ea863abbff1f4982284">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br />
      </div>
</ix:continuation>
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">
        <ix:continuation id="Text_50bdfcd0329044ea863abbff1f4982284" continuedAt="Text_50bdfcd0329044ea863abbff1f4982285">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Base rent for the San Diego Lease is $<ix:nonFraction name="btx:BaseRentPerSquareFoot" id="Fact_e874ba262af84d179a9c4577b276aa69" contextRef="c20220101to20220630" unitRef="U006" decimals="2" scale="0" format="ixt:numdotdecimal">6.35</ix:nonFraction>
          per square foot in the first year of the San Diego Lease, with a rent abatement for the second and third full months of the first year. The base rent will increase by approximately <ix:nonFraction name="btx:PercentageBaseRentIncreaseOnEachAnniversary" id="Fact_6a02786f56824702a0d20f9279867dd1" contextRef="c20220630" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">3</ix:nonFraction>% on each anniversary of the lease commencement date. The Company is also required to pay its share of operating expenses and property taxes. The San Diego Lease provides for a one-time
          option to extend the lease term for an additional <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="Fact_22a8780a1e234b809bdb5ce1ea54b1ec" contextRef="c20220630" format="ixt-sec:durwordsen">five years</ix:nonNumeric> at the then fair rental value. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Company recorded a $<ix:nonFraction name="btx:InitialMeasurementOfOperatingLeaseROUAssets" id="Fact_6304ca30afda4ff9881ccc1274408a0f" contextRef="c20220101to20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction> million right-of-use (&#8220;ROU&#8221;) asset and $<ix:nonFraction name="btx:InitialMeasurementOfOperatingLeaseLiabilities" id="Fact_33fea9ac140b403a95dc633a6a94b729" contextRef="c20220101to20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.7</ix:nonFraction> million lease liabilities
            for the San Diego Lease.</span></div>
</ix:continuation>
        <ix:continuation id="Text_50bdfcd0329044ea863abbff1f4982285" continuedAt="Text_50bdfcd0329044ea863abbff1f4982286">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br />
          </span></div>
</ix:continuation>
        <ix:continuation id="Text_50bdfcd0329044ea863abbff1f4982286" continuedAt="Text_50bdfcd0329044ea863abbff1f4982287">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">During the second quarter of 2022, the Company made the decision to consolidate its research and
            development efforts in Cambridge, Massachusetts, and the Company intends to sublease the San Diego lab and office space.&#160; As a result, the Company recognized an impairment charge of approximately $<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_60af938f2ca34ea696d12656dfe89e6c" contextRef="c20220101to20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.8</ix:nonFraction> million on the San Diego Lease ROU asset.</span> </div>
</ix:continuation>
        <ix:continuation id="Text_50bdfcd0329044ea863abbff1f4982287" continuedAt="Text_50bdfcd0329044ea863abbff1f4982288">
<div><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_50bdfcd0329044ea863abbff1f4982288" continuedAt="Text_50bdfcd0329044ea863abbff1f4982289">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On March 5, 2022, the Company entered into an Agreement to Assign Space Lease with Regen Lab USA LLC (&#8220;Regen&#8221;) pursuant to which the Company
          agreed to assign its Brooklyn, New York lease (the &#8220;Brooklyn Lease&#8221;) to Regen. The effective date of the assignment was contingent upon, among other things, a consent from BioBat, Inc. (the &#8220;Landlord&#8221;) to assign the Brooklyn Lease.&#160; Additionally,
          Regen agreed to purchase certain equipment from the Company for $<ix:nonFraction name="btx:LesseeCommitmentToPurchaseProperty" id="Fact_5bc52a3de41847039c2e6d034b3a548f" contextRef="c20220305" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">50,000</ix:nonFraction>, partly reimburse the Company $<ix:nonFraction name="btx:UnamortizedLeaseholdImprovements" id="Fact_96f0ef2896344bcc8a5b874530bcc06d" contextRef="c20220305" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">50,000</ix:nonFraction> toward certain existing unamortized leasehold improvements, and to reimburse the Company for the existing security deposit the Company had
          under the Brooklyn Lease of approximately $<ix:nonFraction name="us-gaap:DepositAssets" id="Fact_bbce9293d85c43a1b9063e6b5930c764" contextRef="c20220305" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">63,000</ix:nonFraction>.</div>
</ix:continuation>
      </div>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 27pt;">
        <ix:continuation id="Text_50bdfcd0329044ea863abbff1f4982289" continuedAt="Text_50bdfcd0329044ea863abbff1f49822810">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 27pt;"> <br />
        </div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 27pt;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">
            <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822810" continuedAt="Text_50bdfcd0329044ea863abbff1f49822811">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On March 25, 2022, the Company entered into an Assignment and Assumption of Lease Agreement (the
              &#8220;Assignment Agreement&#8221;) with Regen, the consent of which was provided by the Landlord in the Assignment Agreement. The effective date of the assignment was March 28, 2022.&#160; Under the Assignment Agreement, Regen (i) accepts the assignment of
              the Brooklyn Lease; (ii) assumes all of the obligations, liabilities, covenants and conditions of the Company&#8217;s as tenant under the Brooklyn Lease; (iii) assumes and agrees to perform and observe all of the obligations, terms, requirements,
              covenants and conditions to be performed or observed by the Company under the Brooklyn Lease; and (iv) makes all of the representations and warranties binding under the Brooklyn Lease with the same force and effect as if Regens had executed
              the Brooklyn Lease originally as the tenant.</div>
</ix:continuation>
            <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822811" continuedAt="Text_50bdfcd0329044ea863abbff1f49822812">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822812" continuedAt="Text_50bdfcd0329044ea863abbff1f49822813">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Notwithstanding the above assumptions by Regen, the Company shall be and remain liable and
              responsible for the due keeping, and full performance and observance, of all the provisions of the Brooklyn Lease on the part of the tenant to be kept, performed and observed.&#160; As a result of the Assignment Agreement, the Company wrote off
              the remaining ROU asset balance and the corresponding lease liability.</div>
</ix:continuation>
          </div>

        </div>

        <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822813" continuedAt="Text_50bdfcd0329044ea863abbff1f49822814">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 27pt;"> <br />
        </div>
</ix:continuation>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">12</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822814" continuedAt="Text_50bdfcd0329044ea863abbff1f49822815">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Company accounts for leases under ASC 842,</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-style: normal;">&#160;Leases</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">. Operating leases are included in
          &#8220;Right-of use assets - operating leases&#8221; within the Company&#8217;s balance sheets and represent the Company&#8217;s right to use an underlying asset for the lease term. The Company&#8217;s related obligation to make lease payments are included in &#8220;Operating lease
          liabilities, non-current&#8221; and &#8220;Operating lease liabilities, current&#8221; within the Company&#8217;s balance sheets. ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Because the
          rate implicit in the lease is not readily determinable, the Company uses its incremental borrowing rates based on the information available at the lease commencement date in determining the present value of lease payments. Lease expense for lease
          payments is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet and are recognized as lease expense on a straight-line basis over the lease term.</span></div>
</ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822815" continuedAt="Text_50bdfcd0329044ea863abbff1f49822816">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822816" continuedAt="Text_50bdfcd0329044ea863abbff1f49822817">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Some leasing arrangements require variable payments that are dependent on usage or may vary for other reasons, such as
        payments for insurance, tax payments and other miscellaneous costs. The variable portion of lease payments is not included in the ROU assets or lease liabilities. Rather, variable payments, other than those dependent upon an index or rate, are
        expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease contract are accounted for as lease expenses.</div>
</ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822817" continuedAt="Text_50bdfcd0329044ea863abbff1f49822818">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822818" continuedAt="Text_50bdfcd0329044ea863abbff1f49822819"><ix:nonNumeric name="us-gaap:LeaseCostTableTextBlock" id="Text_61c9f6b734834163875eb001b9438a4f" contextRef="c20220101to20220630" escape="true" continuedAt="Text_1835bcdeaf434ac1b5bb2c8fd5ab22d51">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2022 and 2021, the net operating lease expenses were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822819" continuedAt="Text_50bdfcd0329044ea863abbff1f49822820"><ix:continuation id="Text_1835bcdeaf434ac1b5bb2c8fd5ab22d51" continuedAt="Text_1835bcdeaf434ac1b5bb2c8fd5ab22d52">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822820" continuedAt="Text_50bdfcd0329044ea863abbff1f49822821"><ix:continuation id="Text_1835bcdeaf434ac1b5bb2c8fd5ab22d52" continuedAt="Text_1835bcdeaf434ac1b5bb2c8fd5ab22d53">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" colspan="6"><span style="font-weight: bold;">Three months ended June 30,</span><br />
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br />
              </div>
            </td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" colspan="2"><span style="font-weight: bold;">2021</span> <br />
            </td>

    <td valign="bottom" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating lease expense</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_0a46fa5d1df74ee09c182630b3c47a3a" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">146</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_63be4e2bf72947afa38d04df9ecdfee8" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">164</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Sublease income</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:SubleaseIncome" id="Fact_3f1a9d67c94e4029ad5062b1a5111bfc" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">21</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:SubleaseIncome" id="Fact_78f2864e78124f178fb4528937ceefba" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">21</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Variable lease expense</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_e3e935bb0ba5428ca347803255ba2270" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">51</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_219feced751b49a6adad91a9ac5a4b42" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total lease expense</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_a729aeb6a19c4dac8fe578f66764409f" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">176</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_cf7b8b08d64e4386b3deb8be5f4b07ad" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">144</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822821" continuedAt="Text_50bdfcd0329044ea863abbff1f49822822"><ix:continuation id="Text_1835bcdeaf434ac1b5bb2c8fd5ab22d53" continuedAt="Text_1835bcdeaf434ac1b5bb2c8fd5ab22d54">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822822" continuedAt="Text_50bdfcd0329044ea863abbff1f49822823"><ix:continuation id="Text_1835bcdeaf434ac1b5bb2c8fd5ab22d54">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="6" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;"><span style="font-weight: bold;">Six months ended June 30,</span></td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; font-weight: bold; white-space: nowrap;">2022</td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" rowspan="1" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;"><span style="font-weight: bold;">2021<br />
                </span></td>

    <td valign="bottom" rowspan="1" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating lease expense</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_e7f7e8a2a70d46b7a889d4be7046964a" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">333</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_a256afee48d4471aa27b9ebc51dc9914" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">315</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Sublease income</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:SubleaseIncome" id="Fact_2e9aec5b776c495e942058373948137d" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">42</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">(<ix:nonFraction name="us-gaap:SubleaseIncome" id="Fact_918695d03caa47389f9ad81687735341" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">42</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Variable lease expense</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_0ec678514c894531a376940348f645e2" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">53</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_24d8090bf7934291b8542e40505f54ec" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total lease expense</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_87c061cca6494f1b9b7010f27b41f070" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">344</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;">
                <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_b61247b276f044fbac6770146eb8aec4" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">283</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
         </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822823" continuedAt="Text_50bdfcd0329044ea863abbff1f49822824">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation>

      <div>
        <ix:nonNumeric name="btx:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" id="Text_0117423f6c5d4e8889085a4954592f89" contextRef="c20220101to20220630" escape="true" continuedAt="Text_bd3d805ba2dd49c2acee2a842f6fa0ea1"><ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822824" continuedAt="Text_50bdfcd0329044ea863abbff1f49822825">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">The tables below show the beginning
          balances of the operating ROU assets and lease liabilities as of January 1, 2022 and the ending balances as of June 30, 2022, including the changes during the period (in thousands).</div>
</ix:continuation></ix:nonNumeric>
        <ix:continuation id="Text_bd3d805ba2dd49c2acee2a842f6fa0ea1" continuedAt="Text_bd3d805ba2dd49c2acee2a842f6fa0ea2"><ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822825" continuedAt="Text_50bdfcd0329044ea863abbff1f49822826">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_bd3d805ba2dd49c2acee2a842f6fa0ea2" continuedAt="Text_bd3d805ba2dd49c2acee2a842f6fa0ea3"><ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822826" continuedAt="Text_50bdfcd0329044ea863abbff1f49822827">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 36pt; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br />
          </span></div>
</ix:continuation></ix:continuation>
      </div>

      <ix:continuation id="Text_bd3d805ba2dd49c2acee2a842f6fa0ea3" continuedAt="Text_bd3d805ba2dd49c2acee2a842f6fa0ea4"><ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822827" continuedAt="Text_50bdfcd0329044ea863abbff1f49822828">
<table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating Lease</div>
              <span style="font-weight: bold;"> </span>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">ROU Assets</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease ROU assets at
                January 1, 2022</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_af33c76e923e44a6a079cbcabc999bc6" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,567</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Initial measurement of operating lease ROU assets</span></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><ix:nonFraction name="btx:InitialMeasurementOfOperatingLeaseROUAssets" id="Fact_39eacce730fb4c1da2352b814a4609a5" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,706</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Amortization of operating lease
                ROU assets</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" id="Fact_003991c6f0ff4d919391035a8bf9cd78" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">186</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Impairment of ROU assets</span></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">(<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" id="Fact_56358d44a03e4690bc13ff1e3868c218" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">772</ix:nonFraction></td>

    <td valign="bottom" colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Write off of ROU asset due to lease termination</span></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(<ix:nonFraction name="btx:WriteOffOfOperatingLeaseRightOfUseAsset" id="Fact_c646e04a668d4fad83d81c4ebaa81a4c" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,372</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease ROU assets at
                June 30, 2022</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_e56329d893094854adfce357e4efd7f6" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,943</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_bd3d805ba2dd49c2acee2a842f6fa0ea4" continuedAt="Text_bd3d805ba2dd49c2acee2a842f6fa0ea5"><ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822828" continuedAt="Text_50bdfcd0329044ea863abbff1f49822829">
<div style="display:none;"><br /></div>
<div style="letter-spacing: normal; white-space: normal; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-weight: 400; text-align: left; text-indent: 0px; text-transform: none;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_bd3d805ba2dd49c2acee2a842f6fa0ea5"><ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822829" continuedAt="Text_50bdfcd0329044ea863abbff1f49822830">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating Lease</div>
              <span style="font-weight: bold;"> </span>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Liabilities</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease liabilities at
                January 1, 2022</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_a12c1036abb0463bb9061375663172d6" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,723</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" rowspan="1"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Initial measurement of operating lease liabilities</span></td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="btx:InitialMeasurementOfOperatingLeaseLiabilities" id="Fact_cf2cb8d48d6e4b548838de220e75b117" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,706</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Principal payments on operating
                lease liabilities</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(<ix:nonFraction name="btx:PrincipalPaymentsOnOperatingLeaseLiabilities" id="Fact_31d367b8e3934f5c81b3857f261bc1d7" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">153</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Write off of operating lease liability due to lease termination</span></div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(<ix:nonFraction name="btx:WriteOffOfOperatingLeaseLiability" id="Fact_1aeb0087dee346f3893e7d04d2eaf805" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,453</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease liabilities at
                June 30, 2022</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_64bf693a396f4d959d6531352ef217fa" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,823</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Less non-current portion</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_979b27d8b82047bda15e80881ea2ae52" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,433</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Current portion at June 30, 2022</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_1b33db281ebb47abbd04f4a66844f874" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">390</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822830" continuedAt="Text_50bdfcd0329044ea863abbff1f49822831">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">13</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>

      </div>

      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822831" continuedAt="Text_50bdfcd0329044ea863abbff1f49822832">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 36pt;">As of June 30, 2022, the Company&#8217;s operating leases had a weighted-average remaining
        life of <ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_a9874613fea041d0a33110223f1e9099" contextRef="c20220630" format="ixt-sec:duryear">5.2</ix:nonNumeric> years with a weighted-average discount rate of <ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_ca437531d7594f29a104957ae64ca0d8" contextRef="c20220630" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">8.97</ix:nonFraction>%.&#160; <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Text_e2b159b4095a42d88f56aa812e76c0ed" contextRef="c20220101to20220630" escape="true" continuedAt="Text_c94bd6fb6e9f41aebbed8063c132402d1"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-weight: 400; font-variant: normal;">The maturities of the operating lease liabilities are as follows (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822832" continuedAt="Text_50bdfcd0329044ea863abbff1f49822833"><ix:continuation id="Text_c94bd6fb6e9f41aebbed8063c132402d1" continuedAt="Text_c94bd6fb6e9f41aebbed8063c132402d2">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_50bdfcd0329044ea863abbff1f49822833"><ix:continuation id="Text_c94bd6fb6e9f41aebbed8063c132402d2">
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="2">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">June 30, 2022</div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2022</span><br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" id="Fact_2ca15c1b294041f39ec1b7f601fd3263" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">299</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2023</span><br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" id="Fact_df16cca7502f4b02978d976c11289b1b" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">673</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2024</span><br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" id="Fact_74e4bf78f25544c9a11bfc66617bf753" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">688</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2025</span><br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" id="Fact_a9c9134d115f4397a9b06548eb9928ab" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">703</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2026</span><br />
              </div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" id="Fact_26db5a8660934f8a84bcb0613a454f90" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">708</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Thereafter</div>
            </td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="btx:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" id="Fact_5d82b9978a3e4fb4ae8930475d9f694a" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">470</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;">Total payments</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1"> <br />
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" id="Fact_cd046b47ad724898a1c182d9a2bfcbd9" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,541</ix:nonFraction></div>
            </td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" rowspan="1">Less imputed interest</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" rowspan="1" colspan="1">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" id="Fact_8460800d0965475d92dff2f395de585c" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">718</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" rowspan="1" colspan="1">)</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1">Total operating lease liabilities</td>

    <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_018fa72479764b13b5bf3bbbe3dde4c6" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,823</ix:nonFraction></td>

    <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" rowspan="1" colspan="1">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <div><br />
      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="Text_958859c10cee45918dfcea8c45a4d142" contextRef="c20220101to20220630" escape="true" continuedAt="Text_65a3eb3de62f4c3498fed46303ded92c1">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">6)<br />
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL<br />
                </div>
              </td>

  </tr>


</table>
</ix:nonNumeric>
        <ix:continuation id="Text_65a3eb3de62f4c3498fed46303ded92c1" continuedAt="Text_65a3eb3de62f4c3498fed46303ded92c2">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_65a3eb3de62f4c3498fed46303ded92c2" continuedAt="Text_65a3eb3de62f4c3498fed46303ded92c3">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In 2018, the Company acquired IRX Therapeutics (&#8220;IRX&#8221;), which was accounted for as a business combination. The Company recorded IPR&amp;D in the
          amount of $<ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_9a8b565be318474480556f2abc655975" contextRef="c20181231" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">6.0</ix:nonFraction> million, which represents the fair value assigned to technologies that were acquired in connection with the IRX
          acquisition and which have not reached technological feasibility and have no alternative future use. IPR&amp;D assets acquired in a business combination are considered to be indefinite lived until the completion or abandonment of the associated
          research and development projects. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize products associated with the IPR&amp;D assets, these assets are then deemed
          definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a full or partial impairment charge related to the IPR&amp;D assets,
          calculated as the excess of carrying value of the IPR&amp;D assets over fair value</div>
</ix:continuation>
        <ix:continuation id="Text_65a3eb3de62f4c3498fed46303ded92c3" continuedAt="Text_65a3eb3de62f4c3498fed46303ded92c4">
<div><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_65a3eb3de62f4c3498fed46303ded92c4" continuedAt="Text_65a3eb3de62f4c3498fed46303ded92c5">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company also recorded goodwill in the amount of $<ix:nonFraction name="us-gaap:Goodwill" id="Fact_325eaf3fabb44ad5bfb58384d3bbeeb3" contextRef="c20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction>
          million related to the IRX acquisition. Goodwill and indefinite-lived IPR&amp;D assets are not amortized but are tested for impairment annually, or more frequently if the Company becomes aware of any events occurring or changes in circumstances
          that indicate that the fair value of the entity is less than its carrying values.</div>
</ix:continuation>
        <ix:continuation id="Text_65a3eb3de62f4c3498fed46303ded92c5" continuedAt="Text_65a3eb3de62f4c3498fed46303ded92c6">
<div><br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_65a3eb3de62f4c3498fed46303ded92c6" continuedAt="Text_65a3eb3de62f4c3498fed46303ded92c7">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As of June 30, 2022, the Company performed a qualitative assessment to determine whether it is more likely than not that the fair value of the
          entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and other relevant events.<br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_65a3eb3de62f4c3498fed46303ded92c7" continuedAt="Text_65a3eb3de62f4c3498fed46303ded92c8">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_65a3eb3de62f4c3498fed46303ded92c8" continuedAt="Text_65a3eb3de62f4c3498fed46303ded92c9">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">In June 2022, the Company received results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnosed stage II, III or IVA squamous cell carcinoma of the oral
            cavity. The IRX-2 multi-cytokine biologic immunotherapy represents substantially all the fair value assigned to the technologies of IRX that the Company acquired. Despite outcomes that favored IRX-2 in certain predefined subgroups, the INSPIRE
            trial did not meet the primary endpoint of Event-Free Survival (at two years of follow up. Significant additional clinical development work would be required to advance IRX-2 in the form of additional Phase 2 and 3 studies to further evaluate
            the treatment effect of IRX-2 in patient subgroups and in combination with checkpoint inhibitor therapies.&#160; The INSPIRE trial is the only Company-sponsored study of IRX-2.&#160; IRX-2 has been studied externally in other clinical settings outside of
            head and neck cancer in the form of investigator sponsored trials, which have either ended or are not currently active. Based on the totality of available information, the Company currently does not have plans to further develop the IRX-2
            product candidate. As such, the Company determined that the carrying value of the IPR&amp;D asset was impaired and recognized a non-cash impairment charge of approximately $<ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_6a72cf387e50467ab7d249b064cf05c0" contextRef="c20220101to20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:ImpairmentOfOngoingProject" id="Fact_b7f1abd9333648408ed6422350e7a55b" contextRef="c20220401to20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">6.0</ix:nonFraction></ix:nonFraction> million on the condensed consolidated statement of operations for the three and six months ended June 30, 2022, which reduced the value of the asset to <ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" id="Fact_091899da149849fda23af4d9c8d7f5c0" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt-sec:numwordsen">zero</ix:nonFraction>.</span> </div>
</ix:continuation>
        <ix:continuation id="Text_65a3eb3de62f4c3498fed46303ded92c9" continuedAt="Text_65a3eb3de62f4c3498fed46303ded92c10">
<div><br />
        </div>
</ix:continuation>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">14</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>

        <ix:continuation id="Text_65a3eb3de62f4c3498fed46303ded92c10">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Company also determined that there were qualitative indications of a goodwill impairment, namely the Company&#8217;s stock price declined from $<ix:nonFraction name="us-gaap:SharePrice" id="Fact_dcad6a88818c49778f7a53af5b3e6b0a" contextRef="c20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.05</ix:nonFraction> per share as of March 31, 2022 to $<ix:nonFraction name="us-gaap:SharePrice" id="Fact_d972dc4a2c7246d98eca73659dd66a21" contextRef="c20220630" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.52</ix:nonFraction> per share as of June 30,
            2022.&#160; Accordingly, the Company proceeded to the first step in the quantitative assessment of impairment and determined that the fair value of the reporting unit exceeded the carrying amount of the reporting unit, and therefore, the goodwill
            was <ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_5fa9c00661f347db9e4abc34a65e2340" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction>t impaired as of June 30, 2022</span>.</div>
</ix:continuation>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);"> <div><span style="font-size: 10pt;"> </span></div>

    <div>
      <div>
        <ix:nonNumeric name="btx:ChiefExecutiveOfficerSeparationAgreementTextBlock" id="Text_6ceabdf972514268a0aae5473fc3ec3b" contextRef="c20220101to20220630" escape="true" continuedAt="Text_ff349b3b871f453e888102355834a1801">
<div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                  <div style="font-weight: bold;">7)</div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="font-weight: bold;">CEO SEPARATION AGREEMENT</div>
                </td>

  </tr>


</table>
        </div>
</ix:nonNumeric>
      </div>

      <ix:continuation id="Text_ff349b3b871f453e888102355834a1801" continuedAt="Text_ff349b3b871f453e888102355834a1802">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a1802" continuedAt="Text_ff349b3b871f453e888102355834a1803">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On May 24, 2022, Dr. Howard J. Federoff resigned as the Company&#8217;s Chief Executive
        Officer and President effective May 26, 2022.&#160; In connection with Dr. Federoff&#8217;s resignation, the Company entered into a&#160;<span style="color: rgb(0, 0, 0);">Separation Agreement and General Release with Dr. Federoff (the &#8220;Separation Agreement&#8221;),
          pursuant to which Dr. Federoff resigned from his positions as Chief Executive Officer and as an officer, director and employee of the Company and all subsidiaries.&#160; Dr. Federoff&#8217;s resignation from the Board was not due to any disagreement with
          the Company on any matter relating to the Company&#8217;s operations, policies or practices. In consideration for Dr. Federoff&#8217;s execution of the Separation Agreement and non-revocation of a waiver and release of claims relating thereto, Dr. Federoff
          will receive following benefits under the Separation Agreement:</span></div>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a1803" continuedAt="Text_ff349b3b871f453e888102355834a1804">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a1804" continuedAt="Text_ff349b3b871f453e888102355834a1805">
<table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">a lump sum cash severance benefit in the amount of $<ix:nonFraction name="us-gaap:PaymentsForPostemploymentBenefits" id="Fact_a78e5340a5724b008dfcf41894dfdf10" contextRef="c20220524to20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million, representing Dr. Federoff&#8217;s
                target bonus for 2022;</div>
            </td>

  </tr>


</table>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a1805" continuedAt="Text_ff349b3b871f453e888102355834a1806">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a1806" continuedAt="Text_ff349b3b871f453e888102355834a1807">
<table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">payment of Dr. Federoff&#8217;s annual base salary for a period of twelve months after the expiration of the applicable revocation period (the &#8220;Separation Period&#8221;), for a total gross amount equal to $<ix:nonFraction name="btx:PaymentToOfficerBaseSalary" id="Fact_ceadef75d8924c9d85668441b0d9b24f" contextRef="c20220524to20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million;</div>
            </td>

  </tr>


</table>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a1807" continuedAt="Text_ff349b3b871f453e888102355834a1808">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a1808" continuedAt="Text_ff349b3b871f453e888102355834a1809">
<table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">payment of Dr. Federoff&#8217;s premiums for continued health benefits provided under COBRA for the Separation Period;</div>
            </td>

  </tr>


</table>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a1809" continuedAt="Text_ff349b3b871f453e888102355834a18010">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a18010" continuedAt="Text_ff349b3b871f453e888102355834a18011">
<table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">full acceleration of the vesting of all outstanding options (with the exception of the Milestone Grant (as defined below) options) that would have vested during the Separation Period, and such options,
                together with outstanding options that vested prior to the separation date, representing collectively approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_9c4531a411584c68ad46b4980616e9d6" contextRef="c20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,523,000</ix:nonFraction>
                shares of common stock, may be exercised for a period of <ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="Fact_a216ec68b86945c98d676d850026a7aa" contextRef="c20220524to20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" format="ixt-sec:durwordsen">thirty-six months</ix:nonNumeric> after the separation date.&#160; (See Note 10 for
                modification accounting impact);</div>
            </td>

  </tr>


</table>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a18011" continuedAt="Text_ff349b3b871f453e888102355834a18012">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a18012" continuedAt="Text_ff349b3b871f453e888102355834a18013">
<table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><span style="color: rgb(0, 0, 0); font-size: 10pt;">acceleration and vesting of 25/36</span><span style="font-size: 10pt;"><sup style="color: rgb(0, 0, 0); vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup><span style="color: rgb(0, 0, 0);">&#160;of the Milestone Grant options, representing collectively approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_4d153ee6d5454a0f9ee5434b16670cf4" contextRef="c20220524_AwardTypeAxis_MilestoneOptionsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">415,000</ix:nonFraction> shares of
                    common stock, may be exercised for a period of <ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="Fact_09d8226bc3c1427e8eb159bccb04a5da" contextRef="c20220524to20220524_AwardTypeAxis_MilestoneOptionsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" format="ixt-sec:durwordsen">thirty-six months</ix:nonNumeric> after the separation date.&#160; (See Note 10 for modification
                    accounting impact); and</span></span></div>
            </td>

  </tr>


</table>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a18013" continuedAt="Text_ff349b3b871f453e888102355834a18014">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a18014" continuedAt="Text_ff349b3b871f453e888102355834a18015">
<table cellspacing="0" cellpadding="0" border="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">a lump sum cash severance benefit in the amount of $<ix:nonFraction name="btx:SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" id="Fact_bfe791cc745f4b8eb6a9556ba085aafd" contextRef="c20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million, representing the value Dr.
                Federoff would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period, assuming the performance metrics were waived and
                assuming a per share value of $<ix:nonFraction name="us-gaap:SharePrice" id="Fact_2205ab382f7440c88ca0097ca61134c5" contextRef="c20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.81</ix:nonFraction>.</div>
            </td>

  </tr>


</table>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a18015" continuedAt="Text_ff349b3b871f453e888102355834a18016">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation>
      <ix:continuation id="Text_ff349b3b871f453e888102355834a18016">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Separation Agreement also includes certain other customary representations,
        warranties and covenants of Dr. Federoff, and provides for reimbursement of certain expenses incurred by Dr Federoff. The Separation Agreement supersedes all other agreements or arrangements between Dr. Federoff and the Company regarding the
        subject matter of the agreement, including those with respect to severance payments and benefits.</div>
</ix:continuation>

      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">15</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

    </div>

    <div><span style="font-size: 10pt;"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <ix:nonNumeric name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Text_11b1ef32b2cd47caa90778a9d86a8757" contextRef="c20220101to20220630" escape="true" continuedAt="Text_3461879276c243e3a0f4af4336c684da1">
<div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: left;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">8)</span>
                  </div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: bold;">ACCRUED EXPENSES</span></div>
                </td>

  </tr>


</table>
        </div>
</ix:nonNumeric>
        <ix:continuation id="Text_3461879276c243e3a0f4af4336c684da1" continuedAt="Text_3461879276c243e3a0f4af4336c684da2">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>

        <ix:nonNumeric name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Text_be17dfdfa79a4b779d61a265c3966534" contextRef="c20220101to20220630" escape="true" continuedAt="Text_9d64edae36df46208a9d6585ff82c3be1"><ix:continuation id="Text_3461879276c243e3a0f4af4336c684da2" continuedAt="Text_3461879276c243e3a0f4af4336c684da3">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued expenses consisted of the following (in thousands):</div>
</ix:continuation></ix:nonNumeric>
        <ix:continuation id="Text_9d64edae36df46208a9d6585ff82c3be1" continuedAt="Text_9d64edae36df46208a9d6585ff82c3be2"><ix:continuation id="Text_3461879276c243e3a0f4af4336c684da3" continuedAt="Text_3461879276c243e3a0f4af4336c684da4">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_9d64edae36df46208a9d6585ff82c3be2"><ix:continuation id="Text_3461879276c243e3a0f4af4336c684da4" continuedAt="Text_3461879276c243e3a0f4af4336c684da5">
<table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">June 30,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
                    </span></span></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
                    </span></span></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued compensation<br />
                </div>
              </td>

    <td valign="bottom" colspan="1" style="font-family: &#38;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: &#38;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="font-family: &#38;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_d27fee4487544377a923b8025bb91517" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,613</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="font-family: &#38; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: &#38;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-family: &#38;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="font-family: &#38;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_3e7742ed41af424ca35b49aa0587cc72" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">656</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="font-family: &#38; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued research and development expenses</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="btx:AccruedResearchAndDevelopmentExpenses" id="Fact_7dd0dbc7e70d4574ac9a92a5b2313e89" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">388</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="btx:AccruedResearchAndDevelopmentExpenses" id="Fact_9d548722ca3947dda8811e8936375b42" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">222</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued general and administrative expenses</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="btx:AccruedGeneralAndAdministrativeExpenses" id="Fact_ec0a50ba10c24509962d906fce4ac28a" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,820</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="btx:AccruedGeneralAndAdministrativeExpenses" id="Fact_71ca1d797b3e4243bbc016d59437f3d1" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">371</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Total accrued expenses</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_b9b5f25b1033458c8405888a6c2e3b1a" contextRef="c20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">3,821</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_8b0e06feeb9641aa9b38c71137230a6f" contextRef="c20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,249</ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

        <ix:continuation id="Text_3461879276c243e3a0f4af4336c684da5" continuedAt="Text_3461879276c243e3a0f4af4336c684da6">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
          </span> </div>
</ix:continuation>
        <ix:continuation id="Text_3461879276c243e3a0f4af4336c684da6" continuedAt="Text_3461879276c243e3a0f4af4336c684da7">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_3461879276c243e3a0f4af4336c684da7">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued compensation includes $<ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_a6d72e6bdfdc4ceea06915cd6e6ae505" contextRef="c20220630_RestructuringCostAndReserveAxis_EmployeeSeveranceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million of severance, of which, approximately $<ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_a0750be0bea24cbca5e1e0beb441b200" contextRef="c20220630_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction>
                million relates to severance for Dr. Federoff pursuant to the Separation Agreement discussed above.</span> </span>Accrued general and administration expenses includes $<ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" id="Fact_4193ceb1e676424f8287f91cebaf1ac2" contextRef="c20220630" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction> million for legal-related matters.</span><br />
        </div>
</ix:continuation>

        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div>
        <ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Text_4cf1c0a45d11426480401321d6af121c" contextRef="c20220101to20220630" escape="true" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea01">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">9)<br />
                </span> </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">COMMITMENTS AND CONTINGENCIES</div>
              </td>

  </tr>


</table>
</ix:nonNumeric>
        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea01" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea02">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea02" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea03">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Legal Matters<br />
        </div>
</ix:continuation>
        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea03" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea04">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
</ix:continuation>
        <div style="text-align: justify; text-indent: 28.9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea04" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea05">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs
            associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the
            amount can be reasonably estimated.</div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea05" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea06">
<div><br /></div>
</ix:continuation>
        <div style="text-align: justify;">
          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea06" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea07">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); text-indent: 36pt;"><span style="text-decoration: underline;"><span style="font-style: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Dhesh Govender v. Brooklyn
                Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)</span></span></div>
</ix:continuation>
          <div style="text-align: justify;"> <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea07" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea08">
<div><br /></div>
</ix:continuation>
            <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea08" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea09">
<div style="display:none;"><br /></div>
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">On or about February 5, 2021, Dhesh Govender, a former short-term consultant of Brooklyn LLC, filed a complaint against Brooklyn LLC and certain individuals that plaintiff alleges were directors of Brooklyn LLC. The complaint is
              captioned, Dhesh Govender v. Brooklyn Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021). Plaintiff alleges that Brooklyn LLC and certain of its officers and directors (&#8220;defendants&#8221;) engaged in unlawful and
              discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserts various breach of contract, fraud and quantum meruit claims based on an alleged oral agreement pursuant to which he alleges Brooklyn
              LLC agreed to hire him as an executive once the Merger was completed. In particular, plaintiff alleges that, in exchange for transferring an opportunity to obtain an agreement to acquire a license from Novellus for its mRNA-based gene editing
              and cell reprogramming technology to Brooklyn LLC, he was promised a $<ix:nonFraction name="btx:LossContingencyDamagesSoughtExpectedSalary" id="Fact_b7fbef9f035f48579990240c9cd4ab53" contextRef="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million salary and <ix:nonFraction name="btx:LossContingencyDamagesSoughtExpectedEquityPercentage" id="Fact_cdd41b3e8ea6480b94ec8418b77864bc" contextRef="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">7</ix:nonFraction>% of the equity of Brooklyn LLC. Based on these and other allegations, plaintiff seeks damages of not less than $<ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" id="Fact_15baee9e0525492b8a38605a6ee8c637" contextRef="c20210205to20210205_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction> million<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">. By Order dated November 10,&#160;2021, the Court granted defendants&#8217; motion to compel Govender to arbitrate all of his claims against them, based on the arbitration clause
                of his consulting agreement with Brooklyn LLC.&#160; Govender thereafter filed his Statement of Claim (the &#8220;Demand&#8221;) with the American Arbitration Association (&#8220;AAA&#8221;), Case No. 01-21-0017-9417, on December 15,&#160;2021 against the same defendants,
                and served it on defendants&#8217; counsel on February 3,&#160;2022. In his Demand, Govender continues to assert statutory discrimination claims against all defendants, claims against Brooklyn LLC premised on the breach of an alleged oral promise to
                issue Govender <ix:nonFraction name="btx:LossContingencyDamagesSoughtExpectedEquityPercentage" id="Fact_c23a6c006e3541238b77066c0cd2deef" contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">7</ix:nonFraction>% of the equity of Brooklyn LLC and to employ Govender at a $<ix:nonFraction name="btx:LossContingencyDamagesSoughtExpectedSalary" id="Fact_82f5579ffcd84240a9840f4b7f699392" contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million annual salary in exchange for allegedly arranging and negotiating the Novellus license, common law fraud claims against Brooklyn LLC and Cherington based on
                the breach of these same promises and a claim for quantum meruit against the Brooklyn LLC. In his Demand, Govender now claims that the fair and reasonable value of his services on the quantum meruit claim exceeded $<ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" id="Fact_0e61b4edf3604ddcade881b64824b3f6" contextRef="c20211215to20211215_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember" unitRef="U002" decimals="-6" scale="6" format="ixt:numdotdecimal">100</ix:nonFraction> million and is seeking damages in an amount to be determined at the hearing. Defendants filed an answering statement to the Demand on
                February 28,&#160;2022 and the parties have selected a <ix:nonFraction name="btx:LossContingencyNumberOfArbitrationPanel" id="Fact_5d22711d052f49e7a7c54dfab3b3a24a" contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember" unitRef="U005" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">-member arbitration panel. The
                  arbitration is scheduled to begin December 5, 2022. Defendants intend to vigorously defend themselv</span>es against these claims.</span> At this stage in the litigation, the Company is not able to predict the probability of a favorable
              or unfavorable outcome. </div>
</ix:continuation>
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: justify;">
                  <div>
                    <div style="font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea09" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea010">
<div><br /></div>
</ix:continuation>
                      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
                        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea010" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea011">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; text-indent: 36pt;"><span style="text-decoration: underline;">Emerald Private Equity Fund, LLC Matter</span></div>
</ix:continuation>
                        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea011" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea012">
<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
                          </span> </div>
</ix:continuation>
                        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
                          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea012" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea013">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#8220;Emerald&#8221;), a stockholder of Brooklyn, made a demand pursuant
                            to 8 Del. C. 220 to inspect certain books and records of Brooklyn. The stated purpose of the demand was to investigate possible wrongdoing by persons responsible for the implementation of the Merger and the issuance of paper
                            stock certificates, including investigating whether: (i) Brooklyn&#8217;s stock certificates were issued in accordance with the Merger Agreement; (ii)&#160;certain restrictions on the sale of Brooklyn common stock following the Merger were
                            proper and applied without favor; (iii) anyone received priority in post-Merger issuances of Brooklyn&#8217;s stock certificates that allowed them to benefit from an increase in the trading price of Brooklyn&#8217;s common stock; and (iv)
                            it<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> should pursue
                              remedial measures and/or report alleged misconduct to the SEC. Brooklyn responded to the demand letter and produced certain information to Emerald in connection with the demand, which is subject to the terms of a
                              confidentiality agreement entered into among the parties, including certain additional stockholders who subsequently joined as parties to such agreement. In October 2021, Emerald requested that Brooklyn produce additional
                              information related to the authority, purpose and justification for the restriction imposed on the sale of Brooklyn common stock following the Merger and the timing of share delivery to Brooklyn stockholders, following which
                              request Brooklyn agreed to produce certain additional information and emails relating to these topics.</span></div>
</ix:continuation>
                          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea013" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea014">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
                            </span></div>
</ix:continuation>
                          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea014" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea015">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
                          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
                            <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">16</span></div>

                            <div style="page-break-after: always;" class="DSPFPageBreak">
                              <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

                            <div style="width: 100%;" class="DSPFPageHeader">
                              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
                                </a></div>

                            </div>

                          </div>

                          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">
                            <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea015" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea016">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On March 30,&#160;2022, counsel to Emerald advised the Company that it was prepared to file suit against the Company, certain current and former directors of the
                                Company, and the Company&#8217;s financial advisor in connection with the Merger, on behalf of Emerald and a class of similarly situated stockholders with respect to some or all of the foregoing matters, alleging claims for breach
                                of fiduciary duty, conversion and aiding and abetting breach of fiduciary duty. Emerald&#8217;s counsel expressed a willingness to engage in private pre-suit early resolution discussions with the Company and its financial advisor
                                on behalf of individual stockholders whom counsel represents in addition to Emerald (collectively, the &#8220;Emerald Plaintiffs&#8221;); and the Company engaged in such discussions in lieu of incurring the legal costs anticipated in
                                respect of litigating </span>the Emerald Plaintiffs&#8217; claims, all of which the Company disputes.&#160; Following such discussions, with no admission of wrongdoing, the Company and the Emerald Plaintiffs entered into a
                              confidential settlement agreement, pursuant to which the Company agreed to pay $<ix:nonFraction name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" id="Fact_f53e1eac4eb84eca8bc18b2e3002c816" contextRef="c20220805to20220805_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction> million in full settlement of
                              all of the Emerald Plaintiffs&#8217; purported claims, including a release by the Emerald Plaintiffs in favor of the Company in respect of any and all such claims<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">. The Company
                                  subsequently made such payment.</span><br />
                              </span></div>
</ix:continuation>
                          </div>

                          <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea016" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea017">
<div><br /></div>
</ix:continuation>
                            <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea017" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea018">
<div style="display:none;"><br /></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="text-decoration: underline;">John Westman v. Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949
                                (Middlesex County (Massachusetts) Superior Court)</span></div>
</ix:continuation>
                            <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea018" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea019">
<div><br />
                            </div>
</ix:continuation>
                            <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea019" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea020">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> or about September 7, 2021, John Westman, a former employee of Novellus, Inc. filed a Complaint in Middlesex
                                County (Massachusetts) Superior Court against Novellus, Inc. and the company&#8217;s founders and former executives, Dr. Christopher Rohde and Dr. Matthew Angel (collectively, &#8220;Defendants&#8221;). The case includes allegations that
                                Novellus, Inc. violated the Massachusetts Wage Act.. Brooklyn acquired Novellus, Inc. on July 16,&#160;2021. Mr. Westman&#8217;s claims relate to alleged conduct that took place before Brooklyn acquired Novellus, Inc. Defense and
                                liability in association with any Wage Act claims have been assumed by Dr. Rohde and Dr. Angel. On December 24,&#160;2021, Westman dismissed the case without prejudice so the parties could mediate the matter. The parties&#8217;
                                February 2022 mediation was unsuccessful and the dispute is currently pending in arbitration.</span></div>
</ix:continuation>
                            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea020" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea021">
<div><span style="font-style: italic;"><br />
                              </span></div>
</ix:continuation>
                              <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea021" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea022">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-left: 36pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;"><span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; font-style: normal;">Novellus, Inc</span><span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">. <span style="font-style: normal;">v. Sowyrda et al</span></span><span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; font-style: normal;">., C.A. No.
                                    2184CV02436-BLS2</span></span></div>
</ix:continuation>
                              <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea022" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea023">
<div><span style="font-style: normal;"> </span></div>
</ix:continuation>
                              <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea023" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea024">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; background-color: rgb(255, 255, 255);"><br />
                              </div>
</ix:continuation>
                              <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea024" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea025">
<div style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);">On October 25, 2021 Novellus, Inc. filed a complaint in the Superior Court of
                                Massachusetts, Suffolk County, against former Novellus, Inc. employees Paul Sowyrda and John Westman and certain other former investors in Novellus LLC (Novellus, Inc.&#8217;s former parent company prior to the Company&#8217;s
                                acquisition of Novellus, Inc.), alleging breach of fiduciary duty, breach of contract and civil conspiracy. Brooklyn acquired Novellus, Inc. on July 16, 2021. On May 27, 2022 Novellus, Inc. amended the complaint to withdraw
                                all claims against all defendants except Paul Sowyrda and John Westman. On July 1, 2022, Westman filed a motion to compel arbitration or in the alternative, to stay the litigation pending the disposition of certain
                                litigations in the Court of Chancery for the State of Delaware filed by Mr. Sowyrda against Novellus LLC, Dr. Christopher Rohde, Dr. Matthew Angel, Leonard Mazur and Factor Bioscience, Inc. captioned&#160;<span style="font-style: italic;">Zelickson et al., v. Angel et al.,</span>&#160;C.A. 2021-1014-JRS and by Westman against Novellus LLC captioned&#160;<span style="font-style: italic;">Westman v. Novellus LLC</span>, C.A. No. 2021-0882-NAC (the &#8220;Delaware
                                Actions&#8221;). On July 1, 2022, Sowyrda answered the complaint and asserted counterclaims against Novellus, Inc, and third-party defendants Dr. Matthew Angel and Dr. Christopher Rohde alleging violations of the Massachusetts
                                Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, breach of contract, unjust enrichment and quantum meruit. Sowyrda also joined in Westman&#8217;s motion to stay the case pending the Delaware Actions.
                                Novellus, Inc.&#8217;s claims and Mr. Sowyrda&#8217;s counterclaims relate to alleged conduct that took place before Brooklyn acquired Novellus, Inc. Defense and liability in association with any Wage Act claims have been assumed by Dr.
                                Rohde and Dr. Angel. The Company believes that the plaintiffs<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8217; claims in the foregoing matters are without merit, and the Company intends to defend against them vigorously</span>.</div>
</ix:continuation>
                              <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea025" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea026">
<div style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);"> <br />
                              </div>
</ix:continuation>
                              <div style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);">
                                <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea026" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea027">
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Under applicable Delaware law and Novellus Inc.&#8217;s organizational documents, the Company may be required to advance or reimburse certain legal
                                  expenses incurred by former officers and directors of Novellus, Inc. in connection with the foregoing Westman and Sowyrda matters.</div>
</ix:continuation>
                              </div>

                            </div>

                            <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea027" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea028">
<div><br /></div>
</ix:continuation>
                          </div>

                        </div>

                      </div>

                    </div>

                  </div>

                </div>

              </div>

              <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
                <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">17</span></div>

                <div style="page-break-after: always;" class="DSPFPageBreak">
                  <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

                <div style="width: 100%;" class="DSPFPageHeader">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
                    </a></div>

                </div>

              </div>

              <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea028" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea029">
<div style="display:none;"><br /></div>
<div style="font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Licensing Agreements</div>
</ix:continuation>
                <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea029" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea030">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
</ix:continuation>
                <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea030" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea031">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">USF</span></div>
</ix:continuation>
                <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea031" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea032">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
</ix:continuation>
                <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea032" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea033">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Brooklyn LLC has license agreements with University
                  of South Florida Research Association, Inc. (&#8220;USF&#8221;), granting Brooklyn LLC the right to sell, market, and distribute IRX-2, subject to a <ix:nonFraction name="btx:LossContingencyPercentageOfRoyaltyPayable" id="Fact_add3e0fa9ab84ee29723690c14284c4a" contextRef="c20220101to20220630_LegalEntityAxis_UniversityOfSouthFloridaMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">7</ix:nonFraction>%
                  royalty payable to USF based on a percentage of gross product sales. Under the license agreement with USF, Brooklyn LLC is obligated to repay patent prosecution expenses incurred by USF. To date, Brooklyn LLC has not recorded any product
                  sales, or obligations related to USF patent prosecution expenses. The license agreement terminates upon the expiration of the IRX-2 patents.</div>
</ix:continuation>
                <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea033" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea034">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
</ix:continuation>
                <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea034" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea035">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Novellus, Ltd. and Factor <br />
                  </span></div>
</ix:continuation>
                <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea035" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea036">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
</ix:continuation>
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal;">
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea036" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea037">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In December 2020, Brooklyn LLC entered into option agreements (the
                    &#8220;Option Agreements&#8221;) with Novellus, Ltd. and Factor (together, the &#8220;Licensors&#8221;) to obtain the right to exclusively license the Licensors&#8217; intellectual property and mRNA cell reprogramming and gene editing technology for use in the
                    development of certain cell-based therapies to be evaluated and developed for treating human diseases, including certain types of cancer, sickle cell disease, and beta thalassemia (the &#8220;Licensed Technology&#8221;). The option was exercisable
                    before February 28, 2021 (or April 30, 2021 if the Merger had not closed by that date) and required Brooklyn LLC to pay a non-refundable option fee of $<ix:nonFraction name="btx:LossContingencyNonRefundableOptionFee" id="Fact_a92731ee50e841d09d34000385026567" contextRef="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million and then an initial license fee of $<ix:nonFraction name="btx:InitialLicenseFees" id="Fact_3ae9e333b02645c68f652e4c9aeac1ec" contextRef="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction> million <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">(including the non-refundable fee of $<ix:nonFraction name="btx:LossContingencyNonRefundableOptionFee" id="Fact_8764dacfc6ab443c95c4f2fea53d6fed" contextRef="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million) in order to exercise the option.</span></div>
</ix:continuation>
                </div>

                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea037" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea038">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <br />
                  </div>
</ix:continuation>
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea038" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea039">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"> In April 2021, Brooklyn LLC and the Licensors amended the Option Agreements to extend the exercise period to May 21, 2021 and to require Brooklyn, LLC to pay a
                    total $<ix:nonFraction name="btx:AdditionalFeesObligatedToPay" id="Fact_4535bfdcd81745d8b41264c588a382ef" contextRef="c20210415to20210415_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million of the $<ix:nonFraction name="btx:InitialLicenseFees" id="Fact_0e4da9725f9945f3875cbe5f3751d763" contextRef="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction>
                    million initial license fees to the Licensors by April 15, 2021.</div>
</ix:continuation>
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea039" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea040">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br />
                    </span></div>
</ix:continuation>
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea040" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea041">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">In April 2021, Brooklyn LLC and the Licensors entered into an exclusive license agreement (the &#8220;License Agreement&#8221;) pursuant to which Brooklyn LLC acquired an exclusive worldwide license to the Licensed Technology <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">for
                        use in the development of certain mRNA, gene-editing, and cellular therapies to be evaluated and developed for treating human diseases, including certain types of cancer, sickle cell disease, and beta thalassemia. </span>Under the
                      terms of the License Agreement, Brooklyn LLC is obligated to pay the Licensors a total of $<ix:nonFraction name="btx:AmountRequireToPayInitialLicenseFees" id="Fact_b79e180459734a338224bad1b0f97002" contextRef="c20210426_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction> million in connection with
                      the execution of the License Agreement, all of which was paid as of June 2021.</span></div>
</ix:continuation>
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea041" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea042">
<div><br /></div>
</ix:continuation>
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea042" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea043">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The completion of the acquisition of Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical
                        development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene
                        editing and cell therapy products, remained unchanged. Accordingly, Brooklyn LLC is obligated to pay to Factor a fee</span> of $<ix:nonFraction name="btx:AmountObligatedToPayInYearTwo" id="Fact_b86821fecc404d949c7b0da6d4916019" contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember_StatementScenarioAxis_ScenarioForecastMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">3.5</ix:nonFraction>
                      million in October 2022, which will be in addition to a fee of $<ix:nonFraction name="btx:AmountObligatedToPayInYearOne" id="Fact_cf4243431dc241d58a0206d62a76f05e" contextRef="c20211031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">2.5</ix:nonFraction> million paid to Factor in October 2021.</span> </div>
</ix:continuation>
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea043" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea044">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"><br />
                  </div>
</ix:continuation>
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea044" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea045">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Brooklyn



                      LLC is also required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization milestones. In general, upon its
                      achievement of these milestones, Brooklyn LLC will be obligated to pay, in the case of development and regulatory milestones, milestone payments to the Licensors in specified amounts and, in the case of commercialization milestones,
                      specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers. In the event Brooklyn LLC fails to timely achieve certain delineated milestones, the Licensors will have the right to terminate
                      Brooklyn LLC&#8217;s rights under provisions of the License Agreement relating to those milestones.</span> </div>
</ix:continuation>
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea045" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea046">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>
</ix:continuation>
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea046" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea047">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">Novellus, Ltd. also has a license agreement with Factor, which was entered into in February 2015, amended in June 2018 and March 2020, and then amended and restated
                    in November 2020. This license agreement provides for Novellus, Ltd. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">to use certain technology owned by Factor for the development of certain cellular therapies to be evaluation and developed for treating diseases.</span></div>
</ix:continuation>
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea047" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea048">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>
</ix:continuation>
                  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
                    <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">18</span></div>

                    <div style="page-break-after: always;" class="DSPFPageBreak">
                      <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

                    <div style="width: 100%;" class="DSPFPageHeader">
                      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
                        </a></div>

                    </div>

                  </div>

                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea048" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea049">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">Novellus, Ltd. is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory
                    milestones and specified commercialization milestones. In general, upon its achievement of these milestones, Novellus, Ltd. will be obligated, in the case of development and regulatory milestones, to make milestone payments of up to $<ix:nonFraction name="btx:MilestonePayments" id="Fact_021890fa77444f8db2a2f15ed5404403" contextRef="c20220101to20220630_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">51.0</ix:nonFraction> million in aggregate to Factor and, in the case of commercialization milestones, specified royalties with respect to product sales,
                    sublicense fees or sales of pediatric review vouchers. In the event Novellus, Ltd. fails to timely achieve certain delineated milestones, Factor may have the right to terminate Novellus, Ltd.&#8217;s rights under provisions of the License
                    Agreement relating to those milestones.</div>
</ix:continuation>
                  <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea049" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea050">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;">&#160;</div>
</ix:continuation>
                </div>

              </div>

            </div>

          </div>

        </div>

        <div style="text-align: justify; text-indent: 27pt;">
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
            <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                    <div style="text-align: justify;">
                      <div>
                        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea050" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea051">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></div>
</ix:continuation>
                          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea051" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea052">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">NoveCite</span></div>
</ix:continuation>
                          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea052" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea053">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;"> <br />
                            </span></div>
</ix:continuation>
                          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea053" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea054">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;"> </span>In October 2020, Novellus, Ltd. (as
                            sublicensor) and NoveCite (as sublicensee) entered into an exclusive license agreement (the &#8220;Sublicense&#8221;) to license novel cellular therapy for acute respiratory distress syndrome, which NoveCite is licensing from Factor. Under
                            the sublicense agreement, NoveCite is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization
                            milestones. In general, upon its achievement of these milestones, NoveCite will be obligated, in the case of development and regulatory milestones, to make milestone payments to the Novellus, Ltd. in specified amounts and, in
                            the case of commercialization milestones, specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers.</div>
</ix:continuation>
                          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea054" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea055">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;"><br />
                            </span></div>
</ix:continuation>
                          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea055" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea056">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Under the terms of the Sublicense, in the
                            event that Novellus, Ltd. receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd. shall remit to NoveCite <ix:nonFraction name="btx:PercentageOfRevenue" id="Fact_e25da5b0eeb443ecb15b1574a47afb85" contextRef="c20220630_RelatedPartyTransactionsByRelatedPartyAxis_NoveCiteMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>% of such revenue.<span style="text-decoration: underline;"><br />
                            </span></div>
</ix:continuation>
                          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea056" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea057">
<div><br /></div>
</ix:continuation>
                        </div>

                      </div>

                    </div>

                  </div>

                </div>

              </div>

            </div>

          </div>

        </div>

        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea057" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea058">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Royalty Agreements</div>
</ix:continuation>
        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea058" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea059">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea059" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea060">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Collaborator Royalty Agreement</span></div>
</ix:continuation>
        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea060" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea061">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea061" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea062">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Effective June 22, 2018, IRX terminated its Research,
          Development and Option Facilitation Agreement and its Options Agreement (the &#8220;RDO and Options Agreements&#8221;) with a collaborative partner (the &#8220;Collaborator&#8221;), pursuant to a termination agreement (the &#8220;Termination Agreement&#8221;). <span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Termination Agreement was assigned to Brooklyn, LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. </span>In
          connection with the Termination Agreement, all of the rights granted to the Collaborator under the RDO and Options Agreements were terminated, and Brooklyn LLC has no obligation to refund any payments received from the Collaborator. As
          consideration for entering into the Termination Agreement, the Collaborator will receive a royalty equal to <ix:nonFraction name="btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" id="Fact_9d3aa5977dd641fc84aaeecebc993109" contextRef="c20180622to20180622_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">6</ix:nonFraction>% of revenues from the
          sale of IRX-2, for the period of time beginning with the first sale of IRX-2 through the later of (i) the twelfth anniversary of the first sale of IRX-2 or (ii) the expiration of the last IRX patent, or other exclusivity of IRX-2.</div>
</ix:continuation>
        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea062" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea063">
<div><br /></div>
</ix:continuation>
        <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-indent: 36pt; text-transform: none;">
          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea063" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea064">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"> <span style="text-decoration: underline;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Royalty Agreement with certain former IRX Therapeutics Investors</span></span> </div>
</ix:continuation>
          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea064" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea065">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"> <br />
          </div>
</ix:continuation>
          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea065" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea066">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">On May 1, 2012, IRX Therapeutics entered into a royalty agreement (the &#8220;IRX Investor Royalty Agreement<span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">&#8221;</span>)
              with certain investors who participated in a financing transaction. The IRX Investor Royalty Agreement was assigned to Brooklyn LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. Pursuant to the IRX Investor Royalty Agreement,
              when Brooklyn LLC becomes obligated to pay royalties to USF under the agreement described above under &#8220;Licensing Agreements-USF,&#8221; it will pay an additional royalty of <ix:nonFraction name="btx:PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" id="Fact_8969005e0e8a4c24926ff931f9f51b1d" contextRef="c20120501to20120501_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% of gross sales to an entity organized by the investors who participated in such financing transaction. There are no termination provisions in the IRX Investor Royalty
              Agreement. Brooklyn LLC has not recognized any revenues to date, and no royalties are due pursuant to any of the above-mentioned royalty agreements.</span> </div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea066" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea067">
<div><span style="text-decoration: underline;"> <br />
        </span></div>
</ix:continuation>
        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea067" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea068">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Investor Royalty Agreement</span></div>
</ix:continuation>
        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea068" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea069">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
        <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea069" continuedAt="Text_d0e9c422e44a44a5aa53ff6853224ea070">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <div style="text-align: justify; text-indent: 28.9pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal;">
          <ix:continuation id="Text_d0e9c422e44a44a5aa53ff6853224ea070">
<div style="display:none;"><br /></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-indent: 36pt;">On




            March 22, 2021, Brooklyn LLC restated its royalty agreement with certain beneficial holders of Brooklyn ImmunoTherapeutics Investors GP LLC and Brooklyn ImmunoTherapeutics Investors LP, whereby such beneficial holders will continue to receive,
            on an annual basis, royalties in an aggregate amount equal to <ix:nonFraction name="btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" id="Fact_93c877398e7442ccad48fa6caba9543f" contextRef="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">4</ix:nonFraction>% of the net revenues of IRX-2, a cytokine-based therapy being
            developed by Brooklyn LLC to treat patients with cancer.</div>
</ix:continuation>
<div>
           <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</div>
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
         <br /></div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">19</span></div>

        <div style="page-break-after: always;" class="DSPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <div> <br />
      </div>

    </div>

    <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="font-family: 'Times New Roman';"> <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>

    <ix:nonNumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Text_70a2bde5640b4c6fbfb4f07f8c2ae6f1" contextRef="c20220101to20220630" escape="true" continuedAt="Text_eda783120e194d01aed9005d4512a8e91">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">10)<br />
              </span> </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;">STOCK-BASED COMPENSATION</div>
              </div>
            </td>

  </tr>


</table>
    </div>
</ix:nonNumeric><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e91" continuedAt="Text_eda783120e194d01aed9005d4512a8e92">
<div><span style="font-family: 'Times New Roman';">&#160; <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span>
     <br /></div>
</ix:continuation>
    <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none;">
      <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e92" continuedAt="Text_eda783120e194d01aed9005d4512a8e93">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Stock Options</span></div>
</ix:continuation>
      <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e93" continuedAt="Text_eda783120e194d01aed9005d4512a8e94">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>

      <ix:nonNumeric name="btx:ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" id="Text_a42af0f817d24c2ebcb0d6af991c7f03" contextRef="c20220101to20220630" escape="true" continuedAt="Text_08823473239d47688a53aea2a3f7d37b1"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e94" continuedAt="Text_eda783120e194d01aed9005d4512a8e95">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2022 and 2021, the Company granted the
        following stock options (in thousands):</div>
</ix:continuation></ix:nonNumeric>
      <ix:continuation id="Text_08823473239d47688a53aea2a3f7d37b1" continuedAt="Text_08823473239d47688a53aea2a3f7d37b2"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e95" continuedAt="Text_eda783120e194d01aed9005d4512a8e96">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
      </div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_08823473239d47688a53aea2a3f7d37b2"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e96" continuedAt="Text_eda783120e194d01aed9005d4512a8e97">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended June 30,</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Six months ended June 30,</div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2022<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br />
              </div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Stock options granted</div>
            </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_0bcc0bfdad094afc8b258e8de5817223" contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">723</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_b889dd1fb7c14c5e92f0d01aad7186b2" contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,366</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_146d5f9a492443298cd07ecbcf83a69c" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,981</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">
              <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_4cf2e7062c8849999f1a63a28a0f7d01" contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,366</ix:nonFraction></div>
            </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

      <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e97" continuedAt="Text_eda783120e194d01aed9005d4512a8e98">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"> <br />
      </div>
</ix:continuation>

      <ix:nonNumeric name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="Text_5cceeba9c96e484bac4dec338d0cbe9f" contextRef="c20220101to20220630" escape="true" continuedAt="Text_38e2f734d7784b9a8e09eb4041ce3df21"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e98" continuedAt="Text_eda783120e194d01aed9005d4512a8e99">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The following weighted-average assumptions were used for stock options granted during the three and six months ended June
        30, 2022 and 2021:</div>
</ix:continuation></ix:nonNumeric>
      <ix:continuation id="Text_38e2f734d7784b9a8e09eb4041ce3df21" continuedAt="Text_38e2f734d7784b9a8e09eb4041ce3df22"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e99" continuedAt="Text_eda783120e194d01aed9005d4512a8e910">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
        </span></div>
</ix:continuation></ix:continuation>
      <ix:continuation id="Text_38e2f734d7784b9a8e09eb4041ce3df22" continuedAt="Text_38e2f734d7784b9a8e09eb4041ce3df23"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e910" continuedAt="Text_eda783120e194d01aed9005d4512a8e911">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation></div>

    <ix:continuation id="Text_38e2f734d7784b9a8e09eb4041ce3df23" continuedAt="Text_38e2f734d7784b9a8e09eb4041ce3df24"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e911" continuedAt="Text_eda783120e194d01aed9005d4512a8e912">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_38e2f734d7784b9a8e09eb4041ce3df24" continuedAt="Text_38e2f734d7784b9a8e09eb4041ce3df25"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e912" continuedAt="Text_eda783120e194d01aed9005d4512a8e913">
<table cellspacing="0" cellpadding="0" border="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" rowspan="1" style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">&#160;</td>

    <td valign="bottom" colspan="6" rowspan="1" style="vertical-align: bottom; font-size: 10pt; font-weight: bold; text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">Three months ended June 30,</td>

    <td valign="bottom" colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: center; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; text-align: right; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-weight: bold; text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average risk-free rate</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact_751e130eb76f412ebe759cf4879853f0" contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">2.74</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact_2479f84f934a46cbbe2720ac3e38492d" contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">1.06</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><br />
            </div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average volatility</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact_e7b950bc09dd414c88b8237764699cd6" contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">92.74</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact_e19f7fbb0862459093bb7c01cbd3e83c" contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">134.30</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><br />
            </div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Dividend yield</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" id="Fact_b0c0b225e5434a948277dced0d22ecee" contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"> <br />
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" id="Fact_4e05088d9de348c0bf5fa1c4a57d9c5f" contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><br />
            </div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Expected term</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_cf4670b12e4a45919280648cdcb93657" contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">4.15</ix:nonNumeric> years</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_80440035599f40ef93ca34bf269a56fd" contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">6.08</ix:nonNumeric> years</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_38e2f734d7784b9a8e09eb4041ce3df25" continuedAt="Text_38e2f734d7784b9a8e09eb4041ce3df26"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e913" continuedAt="Text_eda783120e194d01aed9005d4512a8e914">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_38e2f734d7784b9a8e09eb4041ce3df26" continuedAt="Text_38e2f734d7784b9a8e09eb4041ce3df27"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e914" continuedAt="Text_eda783120e194d01aed9005d4512a8e915">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br />
      </span> </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_38e2f734d7784b9a8e09eb4041ce3df27" continuedAt="Text_38e2f734d7784b9a8e09eb4041ce3df28"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e915" continuedAt="Text_eda783120e194d01aed9005d4512a8e916">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_38e2f734d7784b9a8e09eb4041ce3df28"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e916" continuedAt="Text_eda783120e194d01aed9005d4512a8e917">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Six months ended June 30,</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average risk-free rate</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact_41b67031538e438a8aa140eeabddffac" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">2.42</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" id="Fact_07eeab3e830c4a7689f740735edbd5ae" contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">1.06</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><br />
            </div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average volatility</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact_3da0567a3ba94276ac1e949f50882a78" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">92.85</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" id="Fact_b7bcf66763a44cbaaa6779dae08136a2" contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">134.30</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><br />
            </div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Dividend yield</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" id="Fact_6c23acf616464e739d08960c35aa4994" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" id="Fact_2da000f2171941ed87c618be4eeb2761" contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">0</ix:nonFraction>%</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><br />
            </div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Expected term</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_0189abd6b87f48e8abe725b33e51ec3a" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">4.79</ix:nonNumeric> years</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_4b82022aabba47009918edd2f48471f1" contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">6.08</ix:nonNumeric> years</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e917" continuedAt="Text_eda783120e194d01aed9005d4512a8e918">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">  </span></div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e918" continuedAt="Text_eda783120e194d01aed9005d4512a8e919">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e919" continuedAt="Text_eda783120e194d01aed9005d4512a8e920">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Of the <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_9534622bddd2465d90d48be3adf5fd7c" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,981</ix:nonFraction>,000 stock options granted during the six months ended June 30, 2022, approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_46e26e2a076b45de8720acc4a96527fa" contextRef="c20210301to20210331_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">414,000</ix:nonFraction> stock
      options were granted in March 2022 to Dr. Howard J. Federoff, who served as the Company&#8217;s Chief Executive Officer and President until May 26, 2022 (the &#8220;March 2022 Stock Option Grant&#8221;).&#160; The March 2022 Stock Option Grant vests in <ix:nonFraction name="btx:ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" id="Fact_dd22790d33a04e4aa3added2ca1acff8" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">36</ix:nonFraction> substantially equal monthly installments from the grant date and had an exercise price equal to the closing price of the Company&#8217;s common stock on the
      grant date.</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e920" continuedAt="Text_eda783120e194d01aed9005d4512a8e921">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e921" continuedAt="Text_eda783120e194d01aed9005d4512a8e922">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Of the <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_4706c2db18d7476b864fd43eba70e1ec" contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,366</ix:nonFraction>,000 stock options granted during the six months ended June 30, 2021, approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_e829e2b453cd41ccbe762fa0e1cfb88e" contextRef="c20210401to20210430_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,225,000</ix:nonFraction> stock
      options were granted to Dr. Federoff upon his appointment as Chief Executive Officer and President in April 2021. <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_45d5edb624f945298a7415ce66c51610" contextRef="c20210401to20210430_AwardTypeAxis_TimeBasedStockOptionGrantMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">2,628,000</ix:nonFraction> stock options
      were under a time-based grant (the &#8220;Time-Based Grant&#8221;) and <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_09ad4eb411ff4096b1ce60c1bb52328e" contextRef="c20210401to20210430_AwardTypeAxis_PerformanceBasedStockOptionGrantMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">597,000</ix:nonFraction> were under a performance-based grant (the &#8220;Milestone Grant&#8221;).&#160; The
      Time-Based Grant vests over <ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact_60e137675ca34d6e936f611f0203a883" contextRef="c20210101to20210630_AwardTypeAxis_TimeBasedStockOptionGrantMember" format="ixt-sec:durwordsen">four years</ix:nonNumeric>, with <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" id="Fact_51a4099125024d61abd0831290a3be92" contextRef="c20210101to20210630_AwardTypeAxis_TimeBasedStockOptionGrantMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">25</ix:nonFraction>%
      vesting on the one-year anniversary of the grant date and the remaining options vesting in <ix:nonFraction name="btx:ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" id="Fact_29b52e2246c74a6d85853c379eddbe4a" contextRef="c20210101to20210630_AwardTypeAxis_TimeBasedStockOptionGrantMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">36</ix:nonFraction> substantially equal monthly installments
      thereafter.&#160; The Milestone Grant vests upon the first concurrence by the U.S. Food and Drug Administration that a proposed investigation may proceed following review of a Company filed investigational new drug application in connection with that the
      License Agreement. Both the Time-Based Grant and the Milestone Grant had an exercise price equal to the closing price of the Company&#8217;s common stock on the grant date.</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e922" continuedAt="Text_eda783120e194d01aed9005d4512a8e923">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e923" continuedAt="Text_eda783120e194d01aed9005d4512a8e924">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Vesting of all stock options grants is subject to continuous service with the Company
      through such vesting dates.</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e924" continuedAt="Text_eda783120e194d01aed9005d4512a8e925">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e925" continuedAt="Text_eda783120e194d01aed9005d4512a8e926">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">As discussed above, pursuant to the Separation Agreement that the Company entered into
      with Dr. Federoff, the Company&#160;<span style="color: rgb(0, 0, 0);">accelerated the vesting of approximately <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" id="Fact_3cba46c2b5124000b362160cc8cb5cfe" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">138,000</ix:nonFraction> stock options under the
        March 2022 Stock Option Grant and approximately <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" id="Fact_056ee95d2b4642d0aee4f68fd887bf3e" contextRef="c20220301to20220331_AwardTypeAxis_TimeBasedStockOptionGrantMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">657,000</ix:nonFraction> stock options under the Time-Based Grant.&#160; The Company also waived the
        performance condition under the Milestone Grant and accelerated the vesting of approximately <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" id="Fact_2377f5a8d22546b1a5c0644a6d22fe91" contextRef="c20220301to20220331_AwardTypeAxis_PerformanceBasedStockOptionGrantMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">415,000</ix:nonFraction> stock options under the Milestone
        Grant.&#160; Lastly, the Company extended the post-termination exercise period from <ix:nonNumeric name="btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" id="Fact_888bbb0e306143cbbfe0dc7ef367e931" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember" format="ixt-sec:durwordsen">90 days</ix:nonNumeric> to <ix:nonNumeric name="btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" id="Fact_19cdd0622f55494b85bddcb832939a84" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">36 months</ix:nonNumeric> immediately following the Separation Date for all options that were vested after such accelerations.</span></div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e926" continuedAt="Text_eda783120e194d01aed9005d4512a8e927">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">20</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
          </a></div>

      </div>

    </div>

    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e927" continuedAt="Text_eda783120e194d01aed9005d4512a8e928">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-size: 10pt;">The above modifications to Dr. Federoff&#8217;s stock options grants resulted in modification accounting under ASC 718,&#160;</span><span style="font-style: italic; color: rgb(0, 0, 0); font-size: 10pt;">Compensation &#8211; Stock Compensation.&#160;</span><span style="color: rgb(0, 0, 0); font-size: 10pt;">As a result, the Company immediately recognized approximately $<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" id="Fact_8afcb4b4321c4948bb38f60818d757d7" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million for the incremental fair value of stock options that were vested prior to the modification by calculating the difference&#160;</span><span style="font-size: 10pt;">between
        the fair value of the modified award and the fair value of the original award immediately before it was modified.&#160; For stock options that were not vested prior to the modification but then vested as a result of the acceleration, the Company
        reversed any stock compensation expense previously recognized, remeasured the fair value of the modified award and immediately recognized approximately $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_46b54861a8294ae4acc0b83257a1ddd2" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction>
        million of stock compensation expense in full since there was no future service period required to be provided.</span></div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e928" continuedAt="Text_eda783120e194d01aed9005d4512a8e929">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e929" continuedAt="Text_eda783120e194d01aed9005d4512a8e930">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2021, there were <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_d19e65488b19475abd1459c83969a7ad" contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_39d6f9861d0c4bc3862d567f4b161eae" contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,300</ix:nonFraction></ix:nonFraction> options exercised for total cash proceeds of $<ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" id="Fact_6fae267c83444352b88784f66c30bfda" contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" id="Fact_261258ee708942898c6ff4d32ff241d8" contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">10,202</ix:nonFraction></ix:nonFraction>.&#160;























      The options exercised had a total intrinsic value of $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" id="Fact_f77b6ed7ca5644448faccbc25805a6bf" contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" id="Fact_6bdb4fb05c7144359545788308d00aa9" contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">57,212</ix:nonFraction></ix:nonFraction>.&#160; There were <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_f1d88ebdf2f04e0a8bf84677f967ef36" contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_beec668f577443feb7bb844bd42827ae" contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> options exercised during the three and six months ended June 30, 2022.</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e930" continuedAt="Text_eda783120e194d01aed9005d4512a8e931">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e931" continuedAt="Text_eda783120e194d01aed9005d4512a8e932">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">As of June 30, 2022, there were approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_2a2217d98f3948bf90e732047714f903" contextRef="c20220630_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,750,000</ix:nonFraction> stock options outstanding.</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e932" continuedAt="Text_eda783120e194d01aed9005d4512a8e933">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e933" continuedAt="Text_eda783120e194d01aed9005d4512a8e934">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Restricted Stock Units</span></div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e934" continuedAt="Text_eda783120e194d01aed9005d4512a8e935">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>

    <ix:nonNumeric name="btx:ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" id="Text_82480ccdbaf14aaa93f1747e868977fa" contextRef="c20220101to20220630" escape="true" continuedAt="Text_fc1f909572104e3a859ae7f140132a651"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e935" continuedAt="Text_eda783120e194d01aed9005d4512a8e936">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2022 and 2021, the Company granted the
      following restricted stock units (&#8220;RSUs&#8221;) (in thousands):</div>
</ix:continuation></ix:nonNumeric>
    <ix:continuation id="Text_fc1f909572104e3a859ae7f140132a651" continuedAt="Text_fc1f909572104e3a859ae7f140132a652"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e936" continuedAt="Text_eda783120e194d01aed9005d4512a8e937">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_fc1f909572104e3a859ae7f140132a652"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e937" continuedAt="Text_eda783120e194d01aed9005d4512a8e938">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended June 30,</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Six months ended June 30,</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2022<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">RSUs Granted</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_182acec271964550987182c00ad56b3a" contextRef="c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_ab8b9d704290425ca6ee913e0a0522f3" contextRef="c20210401to20210630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">105</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_59fd560094104505b8d5f91cf39d08bf" contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,101</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_2c1a2283d48441ba9ef38c7f88f66288" contextRef="c20210101to20210630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">105</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e938" continuedAt="Text_eda783120e194d01aed9005d4512a8e939">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e939" continuedAt="Text_eda783120e194d01aed9005d4512a8e940">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The Company recognizes the fair value of RSUs granted as expense on
      a straight-line basis over the requisite service period. For performance based RSUs, the Company begins recognizing the expense once the achievement of the related performance goal is determined to be probable.</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e940" continuedAt="Text_eda783120e194d01aed9005d4512a8e941">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e941" continuedAt="Text_eda783120e194d01aed9005d4512a8e942">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">Outstanding RSUs are settled in an equal number of shares of common
      stock on the vesting date of the award. An RSU award is settled only to the extent vested. Vesting generally requires the continued employment or service by the award recipient through the respective vesting date. Because RSUs are settled in an equal
      number of shares of common stock without any offsetting payment by the recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date, which is the grant date.</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e942" continuedAt="Text_eda783120e194d01aed9005d4512a8e943">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e943" continuedAt="Text_eda783120e194d01aed9005d4512a8e944">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">In lieu of paying cash to satisfy withholding taxes due upon the
      settlement of vested RSUs, at the Company&#8217;s discretion, an employee may elect to have shares of common stock withheld that would otherwise be issued at settlement, the value of which is equal to the amount of withholding taxes payable.&#160; <ix:nonNumeric name="btx:ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" id="Text_c47d53b3e1244a578725da6cdb8320a8" contextRef="c20220101to20220630" escape="true" continuedAt="Text_c29de539088a47e5be3e9c74ec14f5441"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The following table shows the number of RSUs that vested and were settled during the three and six months ended
        June 30, 2022, as well as the number of shares of common stock withheld to cover the withholding taxes and the net shares issued upon settlement (in thousands):</span></span></ix:nonNumeric></div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e944" continuedAt="Text_eda783120e194d01aed9005d4512a8e945"><ix:continuation id="Text_c29de539088a47e5be3e9c74ec14f5441" continuedAt="Text_c29de539088a47e5be3e9c74ec14f5442">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br />
      </span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e945" continuedAt="Text_eda783120e194d01aed9005d4512a8e946"><ix:continuation id="Text_c29de539088a47e5be3e9c74ec14f5442" continuedAt="Text_c29de539088a47e5be3e9c74ec14f5443">
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e946" continuedAt="Text_eda783120e194d01aed9005d4512a8e947"><ix:continuation id="Text_c29de539088a47e5be3e9c74ec14f5443">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Three months ended</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Six months ended</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">June 30, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">June 30, 2022</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">RSUs vested</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" id="Fact_7547b422eb9947ed83d93599301da56f" contextRef="c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" id="Fact_ca91031349c742fa8fabd43c23b48346" contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Common stock withheld to cover
              taxes</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(<ix:nonFraction name="btx:CommonStockWithheldToCoverTaxes" id="Fact_136a5d54a4f148c48d7d63019cef3243" contextRef="c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(<ix:nonFraction name="btx:CommonStockWithheldToCoverTaxes" id="Fact_ef427f3492e34c81976e09cdb2a773fd" contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Common stock issued</div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_2bede683e73a4b648362ac183bcddd0c" contextRef="c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_94a92edd9a804a0c9e3fd98ae0bf97f3" contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e947" continuedAt="Text_eda783120e194d01aed9005d4512a8e948">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e948" continuedAt="Text_eda783120e194d01aed9005d4512a8e949">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_c965246ca8514beda0c3ab1f07473c3b" contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_EmployeeMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,101,000</ix:nonFraction> RSUs granted during the six months ended June 30, 2022 are performance-based RSUs (the &#8220;2022 PSUs&#8221;), of which approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_a6e85e41cf474a1b83b71f9646f394ef" contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">414,000</ix:nonFraction> were awarded to Dr. Federoff.&#160; The 2022 PSUs are subject to the achievement of <ix:nonFraction name="btx:NumberOfPerformanceGoalsAreSubjectToAchieve" id="Fact_691961d3f68c42898741d9c01116296f" contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction> performance goals, which are weighted equally.&#160; Once a performance goal is achieved, the tranche of shares allocated to that performance goal will be earned and will begin to vest over a <ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact_c41b0f27a43a4c80bb75ff2d652a3a3a" contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember" format="ixt-sec:durwordsen">three-year</ix:nonNumeric> annual basis beginning on the date the performance goal was achieved.&#160; If a performance goal is not achieved, the tranche of shares allocated
      to that performance goal will be unearned and forfeited.&#160; As of June 30, 2022, <ix:nonFraction name="btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" id="Fact_05559d5f8bf84c7fbfcb76e927aa9f58" contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember" unitRef="U008" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> of the performance goals was not achieved by its due
      date, and as a result, approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_f5480683618f4c0a8602f48527ec286e" contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">275,000</ix:nonFraction> 2022 PSUs were cancelled and any previously recognized stock compensation expense was
      reversed.</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e949" continuedAt="Text_eda783120e194d01aed9005d4512a8e950">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">21</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
          </a></div>

      </div>

    </div>

    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e950" continuedAt="Text_eda783120e194d01aed9005d4512a8e951">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">Pursuant to Dr. Federoff&#8217;s Separation Agreement, Dr. Federoff&#8217;s <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_9b2073c6d6d64de0920d0082c302b845" contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">414,000</ix:nonFraction> 2022 PSUs were canceled in full (a portion of which included the PSUs allocated to the performance goal that was not achieved timely), and&#160;<span style="color: rgb(0, 0, 0);">a lump sum cash severance benefit in the amount of $<ix:nonFraction name="us-gaap:PaymentsForPostemploymentBenefits" id="Fact_6495558c81a145de8ed0ac261e72cecf" contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million was paid to Dr. Federoff, which represents
        the value Dr. Federoff would have received if he were entitled to receive a settlement of a pro rata portion of his 2022 PSUs through the expiration of the Separation Period, assuming the performance metrics were waived and assuming a per share
        value of $<ix:nonFraction name="us-gaap:SharePrice" id="Fact_8404665076be42489483f2c300d63e26" contextRef="c20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.81</ix:nonFraction>. Any stock compensation expense previously recognized on Dr. Federoff&#8217;s 2022 PSUs was reversed and approximately $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_901b359098614bd79242cb6e27b5650f" contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million was recognized as compensation expense.</span></div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e951" continuedAt="Text_eda783120e194d01aed9005d4512a8e952">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e952" continuedAt="Text_eda783120e194d01aed9005d4512a8e953">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">As of June 30, 2022, there were approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_2c36d23f81a941789efdf2e6e8fced53" contextRef="c20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">587,000</ix:nonFraction> RSUs outstanding.<br />
      <br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e953" continuedAt="Text_eda783120e194d01aed9005d4512a8e954">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Restricted Stock</span></div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e954" continuedAt="Text_eda783120e194d01aed9005d4512a8e955">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e955" continuedAt="Text_eda783120e194d01aed9005d4512a8e956">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">Pursuant to the Merger, Brooklyn LLC&#8217;s approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_fb95cebbd68e4e0595316736227ed15c" contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,000</ix:nonFraction> outstanding restricted common units were exchanged for approximately <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_2cabf15d180c4b8ab3b346ed1bcd90ea" contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">630,000</ix:nonFraction> shares of Brooklyn&#8217;s restricted common stock. There were no changes to any conditions and requirements of the restricted common stock. The shares vested quarterly beginning on March
      31, 2021 and were to continue through December 31, 2022, contingent on continued service. Due to the modification of the restricted common units, the fair value of the restricted common stock immediately after the Merger was compared to the fair
      value of the restricted common units immediately prior to the Merger, and the change in fair value of $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_c2451470d5e2426499fc48dc3e458fa4" contextRef="c20210101to20210630_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million was recognized in the
      statement of operations during the six months ended June 30, 2021. The Company recognizes the fair value of restricted common stock as an expense on a straight-line basis over the requisite service period.&#160; During the six months ended June 30, 2022,
      approximately <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_32fedd72dd3c4d8a877600f557c5bc87" contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">78,000</ix:nonFraction> shares of unvested restricted common stock were forfeited due to the holders of such shares no longer providing
      services to the Company.&#160; As of June 30, 2022, there were <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" id="Fact_0618f1c28632459795c7370e23aa730a" contextRef="c20220630_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> shares of unvested restricted stock outstanding.</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e956" continuedAt="Text_eda783120e194d01aed9005d4512a8e957">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e957" continuedAt="Text_eda783120e194d01aed9005d4512a8e958">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Stock-Based Compensation Expense</div>
</ix:continuation>
    <ix:continuation id="Text_eda783120e194d01aed9005d4512a8e958" continuedAt="Text_eda783120e194d01aed9005d4512a8e959">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>
</ix:continuation>

    <ix:nonNumeric name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="Text_2a62e4701a9043609da3bdda0440e3d0" contextRef="c20220101to20220630" escape="true" continuedAt="Text_f35f75ae37c448fda5323835e645ac771"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e959" continuedAt="Text_eda783120e194d01aed9005d4512a8e960">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 36pt; margin-right: 0.5pt;">For the three and six months ended June 30, 2022 and 2021, the
      Company recognized stock-based compensation expense as follows, which includes the expense related to Dr. Federoff&#8217;s modified awards discussed above (in thousands):</div>
</ix:continuation></ix:nonNumeric>
    <ix:continuation id="Text_f35f75ae37c448fda5323835e645ac771" continuedAt="Text_f35f75ae37c448fda5323835e645ac772"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e960" continuedAt="Text_eda783120e194d01aed9005d4512a8e961">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br />
    </div>
</ix:continuation></ix:continuation>
    <ix:continuation id="Text_f35f75ae37c448fda5323835e645ac772"><ix:continuation id="Text_eda783120e194d01aed9005d4512a8e961">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended June 30,</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Six months ended June 30,</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2022<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br />
            </div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">Research and development</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_a92b70cce8294496a56eda599c8623ec" contextRef="c20220401to20220630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">470</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_b11ae5ae0d534106b1d31b466c0cfd45" contextRef="c20210401to20210630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">168</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_b0c70ee3797a4f9bba3683982f4d6325" contextRef="c20220101to20220630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">892</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_3ae33328de4544f6bec092888e7a7424" contextRef="c20210101to20210630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">570</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">General and administrative</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_629c6551f2494d2f8186623865fcc072" contextRef="c20220401to20220630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">409</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_5ce584deef304462a35e08f5781eb3b2" contextRef="c20210401to20210630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">986</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_a288bbd0c71f4ec0a3b33da689c892b4" contextRef="c20220101to20220630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,170</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_33f379dc923440e1b45b1b257775540e" contextRef="c20210101to20210630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,003</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">Total</div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_f15b81da1e16424399815dba5729fabd" contextRef="c20220401to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">879</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_fbad970780414e0399b8dc6d7e4503e5" contextRef="c20210401to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,154</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_fa40a3d2efdc4d16b63a5e16dc48be3d" contextRef="c20220101to20220630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,062</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">
            <div style="color: rgb(0, 0, 0);"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_27942ad712814bea926ceab9c01ee1b0" contextRef="c20210101to20210630" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,573</ix:nonFraction></div>
          </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;"></span></div>

    <div><span style="font-family: 'Times New Roman';"> <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span></div>

    <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>
<div><span style="font-family: 'Times New Roman';"> <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span>
     <span style="font-family: 'Times New Roman';"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
      <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none;">
        <ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Text_b2be21af16d24bb093b1de68f296d004" contextRef="c20220101to20220630" escape="true" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be981">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;">11)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">STOCKHOLDERS&#8217; EQUITY<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>
              </td>

  </tr>


</table>
</ix:nonNumeric>
        <div>
          <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be981" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be982">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"><span style="font-weight: normal;"> <br />
            </span></div>
</ix:continuation>
          <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be982" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be983">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Private Placement of
            Equity</div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be983" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be984">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br />
              </span></div>
</ix:continuation>
            <div style="text-align: justify; text-indent: 36pt;">
              <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be984" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be985">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 6, 2022, the Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with an investor (the &#8220;PIPE Investor&#8221;)
                providing for the private placement (the &#8220;PIPE Transaction&#8221;) to the PIPE Investor of approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_563d12bc7ff9412eabbeb67318c857f4" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">6,857,000</ix:nonFraction> units
                (collectively, the &#8220;Units&#8221;), each Unit consisting of (i) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_7689de62376a48ceb4c4f6a6620f2a4f" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of the Company&#8217;s common stock (or, in lieu thereof, one
                Pre-Funded Warrant to purchase one share of common stock) and (ii) <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_cf4b01859f4b4182b542f5da2b84524a" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> warrant (the &#8220;Common Warrants&#8221;) to purchase one share of
                common stock, for an aggregate gross purchase price of approximately $<ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" id="Fact_187e55a9d8f7417f87dc8a4a7d6a0841" contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.0</ix:nonFraction> million (the &#8220;Subscription Amount&#8221;). The PIPE
                Transaction closed on March 9, 2022. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Pursuant to the Purchase Agreement, the Company is prohibited from issuing equity in variable rate transactions for a period of <ix:nonNumeric name="btx:VariableRateTransactionsPeriod" id="Fact_f61cf46e05df4d7daa3dbc9f44cc8b35" contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember" format="ixt-sec:durwordsen">one-year</ix:nonNumeric> following consummation of the PIPE Transaction, including issuing equity under the Second Purchase Agreement.</span></div>
</ix:continuation>
            </div>

            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be985" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be986">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
              <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>
</ix:continuation>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
              <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">22</span></div>

              <div style="page-break-after: always;" class="DSPFPageBreak">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

              <div style="width: 100%;" class="DSPFPageHeader">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
                  </a></div>

              </div>

            </div>

            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be986" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be987">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each Pre-Funded Warrant has an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_894c3e49dd2a40b385c514545d21ff3c" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal">0.005</ix:nonFraction> per share of common stock, was immediately exercisable, may be
              exercised at any time, has no expiration date and is subject to customary adjustments. The Pre-Funded Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed <ix:nonFraction name="btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="Fact_6e05b7bafecc4b93ae70cbd4bb4dfc3f" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">9.99</ix:nonFraction>% immediately after exercise thereof. Upon the closing of the PIPE Transaction, the Company issued <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_22bfe9902c324d63a5b3cb285743869a" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">5,500,000</ix:nonFraction> shares of common stock and issued Pre-Funded Warrants representing approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_d0b8ff26d23a46cebc9f622bd7b96616" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,357,000</ix:nonFraction> shares of common stock.</div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be987" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be988">
<div style="display:none;"><br /></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
              <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be988" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be989">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Each Common Warrant has an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_5206f805bb76478387b6a7d9c5b0c53c" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.91</ix:nonFraction> per share, becomes exercisable <ix:nonNumeric name="btx:ClassOfWarrantOrRightsExercisableTerm" id="Fact_0bc84526e5aa4ef5847278993fb0e8f1" contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember" format="ixt-sec:durwordsen">six months</ix:nonNumeric> following the closing of the PIPE Transaction, expires <span style="-sec-ix-hidden:Fact_816a5bfe7554457abf9cb7a46a5bdc57">five-and-one-half </span> years from the date of issuance and is subject to customary adjustments. The Common Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed <ix:nonFraction name="btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="Fact_f3d9590fa358412fbc88ceb630a8997f" contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">4.99</ix:nonFraction>% immediately after exercise thereof, subject to increase to <ix:nonFraction name="btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="Fact_6c16e567491547269b9a0c2cf6354f22" contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U004" decimals="4" scale="-2" format="ixt:numdotdecimal">9.99</ix:nonFraction>% at the option of the holder.</div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be989" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9810">
<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">&#160;</div>
</ix:continuation>
          </div>

        </div>

      </div>

      <!--PROfilePageNumberReset%Num%21%%%-->
      <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 28.9pt; text-transform: none;">
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          <div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9810" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9811">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As of June 30, 2022, the Company had <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_b7b3bd305ad94e548e03b21a9666296b" contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">6,857,000</ix:nonFraction>
              Common Warrants outstanding with a weighted average exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_e5040636d3a1415e95e1576e2c069e91" contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.91</ix:nonFraction> per share and a weighted average contractual life of <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_acfee63cb60740df820cf6ce09a2bea1" contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember" format="ixt-sec:duryear">5.2</ix:nonNumeric> years. As of June 30, 2022, the Company had <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_79843868e1e04805ab95e2d8c6c13797" contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,357,000</ix:nonFraction>
              Pre-Funded Warrants outstanding with a weighted average exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_6f257dab2ee04a7e860d66c967c23e70" contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal">0.005</ix:nonFraction> per share. The Pre-Funded Warrants do not expire.</div>
</ix:continuation>
          </div>

          <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9811" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9812">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9812" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9813">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
          <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9813" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9814">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9814" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9815">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">The

































            Common Warrants and Pre-Funded Warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40. These
            warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations.</div>
</ix:continuation>
          <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9815" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9816">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
          <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9816" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9817">
<div style="display:none;"><br /></div>
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
          <div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9817" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9818">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" id="Fact_86d82cc410f44288bada4a6ceb1ce790" contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">12.6</ix:nonFraction> million in the aggregate, which was $<ix:nonFraction name="btx:OverSubscriptionAmountReceived" id="Fact_f00431ac99f54bd4aa172267b7a3baaf" contextRef="c20220630_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million more
              than the Subscription Amount. The excess $<ix:nonFraction name="btx:OverSubscriptionAmountReceived" id="Fact_a9a49ea0cbfb4f4e8c703254b9ae4f2e" contextRef="c20220630_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million represents an inducement to the PIPE Investor to enter into the PIPE
              Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of operations. Given the Company&#8217;s capital requirements and market conditions, the Company consummated this financing on market terms
              available at the time of the transaction.</div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9818" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9819">
<div><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9819" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9820">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; margin-right: 2pt;">The Company incurred fees of approximately $<ix:nonFraction name="btx:TransactionFeesPayable" id="Fact_5f8ec3211de64c488e365e9b6d6a24c7" contextRef="c20220630_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million through June 30, 2022 related to the PIPE Transaction, which were allocated to the fair value of the Common Warrants and the Pre-Funded Warrants and recorded in other expense, net on the
              accompanying condensed consolidated statement of operations.</div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9820" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9821">
<div><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9821" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9822">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the PIPE Transaction, the Company and the PIPE Investor also entered into a registration rights agreement, dated March 6,
              2022, pursuant to which the Company agreed to prepare and file a registration statement with the SEC no later than 15 days following the filing date of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021 (the &#8220;2021
              Annual Report&#8221;) to register the resale of the shares of common stock included in the Units and the shares of common stock issuable upon exercise of the Pre-Funded Warrants and the Common Warrants. The Company agreed to use its best efforts to
              have such registration statement declared effective as promptly as possible after the filing thereof, subject to certain specified penalties if timely effectiveness is not achieved. The Company filed the 2021 Annual Report on April 15, 2022
              and the registration statement on April 29, 2022. The resale registration statement became effective on May 11, 2022.</div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9822" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9823">
<div><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9823" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9824">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the registration rights agreement, the Company is obligated to pay the PIPE Investor liquidated damages equal to <ix:nonFraction name="btx:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" id="Fact_9a4681fca163463aa18d94aa150d7096" contextRef="c20220630_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% of the Subscription Amount per month, with a maximum aggregate payment of <ix:nonFraction name="btx:ObligationToPayLiquidatedDamagesPercentage" id="Fact_e2f45a0b3910437999cb50cc5f0eead0" contextRef="c20220630_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember" unitRef="U004" decimals="2" scale="-2" format="ixt:numdotdecimal">12</ix:nonFraction>% of the Subscription Amount, in the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered for resale
              thereunder for more than <ix:nonNumeric name="btx:ConsecutiveCalendarDays" id="Fact_93ff62bc87de4227a9160a4b6eb81818" contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember" format="ixt-sec:durday">10</ix:nonNumeric> consecutive calendar days or more than an aggregate of <span style="-sec-ix-hidden:Fact_79f909b8446d493ba4844bbccec3c0e8">fifteen</span> calendar days (which need not be consecutive calendar days) during any 12-month period.</div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9824" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9825">
<div><br />
            </div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9825" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9826">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On May 24, 2022, the Company provided the PIPE Investor with notice that it was not able to resell the securities registered for resale under
              the registration agreement because the Company had not timely filed its Quarterly Report on Form 10-Q (the &#8220;Q1 2022 10-Q&#8221;) with the SEC, and that the PIPE Investor could not use the registration statement to resell the related securities
              until the Company filed the Q1 2022 10-Q.&#160; Because the PIPE Investor was unable to use the registration statement for at least <ix:nonNumeric name="btx:ConsecutiveCalendarDays" id="Fact_060d3ab9430f43059992b8f5b69b2855" contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember" format="ixt-sec:durday">10</ix:nonNumeric>
              consecutive calendar days, the Company accrued $<ix:nonFraction name="us-gaap:LossContingencyEstimateOfPossibleLoss" id="Fact_a110b29d6d904ef4838f9207c33083a7" contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million during the first quarter of 2022 for the contingent loss the Company
              incurred as liquidated damages as a result of the late Q1 2022 10Q filing, which is recorded in other expense, net for the six months ended June 30, 2022 in the accompanying condensed consolidated statements of operations.&#160; The Company paid
              such $<ix:nonFraction name="us-gaap:LossContingencyDamagesPaidValue" id="Fact_aa6d71005eb3481893bb3d37ba3d96c1" contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember" unitRef="U002" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million liquidated damages payment in June 2022.</div>
</ix:continuation>
            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9826" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9827">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
            </div>
</ix:continuation>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
              <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">23</span></div>

              <div style="page-break-after: always;" class="DSPFPageBreak">
                <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

              <div style="width: 100%;" class="DSPFPageHeader">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
                  </a></div>

              </div>

            </div>

            <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9827" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9828">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> On June 30, 2022, the Company filed its Q1 2022 10-Q along with the 10-K/A, and on July 1, 2022, the Company provided its notice to the PIPE
              Investor that it may resume use of the resale registration statement.</div>
</ix:continuation>
          </div>

        </div>

        <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9828" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9829">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;">&#160;</div>
</ix:continuation>
        <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9829" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9830">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;"><span style="font-weight: normal;"> <span style="font-style: italic;">Merger</span></span></div>
</ix:continuation>
          <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9830" continuedAt="Text_1332fd6e316e49dd93cca7eb07c5be9831">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-indent: 0px; text-transform: none; background-color: rgb(255, 255, 255);"><span style="font-weight: normal;"> <br />
            </span></div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_1332fd6e316e49dd93cca7eb07c5be9831">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;">Under the terms of the Merger
              Agreement </span></span>(see Note 3)<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;">, on March 25, 2021, Brooklyn issued shares of common stock to the equity holders of Brooklyn LLC. The <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_de9b7152851d46fd815ef2254520b1dd" contextRef="c20210325_StatementClassOfStockAxis_CommonClassAMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">87,000</ix:nonFraction>
              Class A units of Brooklyn LLC were converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_56c4ee6e359f426fbbca4cf416148eac" contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">22,275,000</ix:nonFraction> shares of common stock; the <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_799a095890f344cc936ac132902330a0" contextRef="c20210325_StatementClassOfStockAxis_CommonClassBMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">15,000,000</ix:nonFraction> Class B units were converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_98b0665cffe64a8393d6427acebc0b6a" contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">2,515,000</ix:nonFraction>
              shares of common stock; the <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_7dbb6103dabd45edbd695d7a0893cbd0" contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">10,000,000</ix:nonFraction> Class C units were converted into </span></span>approximately <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_27c326e192164d4a906f780b08217c89" contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,676,000</ix:nonFraction><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common stock; </span></span>approximately <ix:nonFraction name="us-gaap:SharesIssued" id="Fact_061ab6481df44792af6d2fb1005d2abf" contextRef="c20210325_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">630,000</ix:nonFraction><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common units were
              converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" id="Fact_3fd80be6463c4b52a05872c2ce86f643" contextRef="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">630,000</ix:nonFraction> shares of common stock, and <ix:nonFraction name="btx:ClassOfWarrantOrRightIssued" id="Fact_07a9a4d931e64523a66db33102729e92" contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">10,500,000</ix:nonFraction> rights options were converted into </span></span>approximately <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_fc7fdd873cb342e09633f0563fbfc574" contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">11,828,000</ix:nonFraction><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common stock.
              Brooklyn also issued </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> <ix:nonFraction name="btx:StockIssuedDuringPeriodSharesAcquisitions1" id="Fact_0eea871e9e204f5ea743aa3b8b2efeb5" contextRef="c20210325to20210325" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,068,000</ix:nonFraction> shares of common stock to the Financial Advisor pursuant to the Merger Agreement</span></span>.</div>
</ix:continuation>
        </div>

      <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 28.9pt; text-transform: none;"><br />
      </div>

    </div>

    <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
 </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <div>
        <div>
          <ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" id="Text_8268f62872184c44b547e4e59daca28d" contextRef="c20220101to20220630" escape="true" continuedAt="Text_710632dc7a9f4715854c9868816814dd1">
<div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;">12)</td>

    <td style="width: auto; vertical-align: top;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"><span style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">EARNINGS PER SHARE</span> </div>
                  </td>

  </tr>


</table>
          </div>
</ix:nonNumeric>
          <ix:continuation id="Text_710632dc7a9f4715854c9868816814dd1" continuedAt="Text_710632dc7a9f4715854c9868816814dd2">
<div><br /></div>
</ix:continuation>
        </div>

        <ix:continuation id="Text_710632dc7a9f4715854c9868816814dd2" continuedAt="Text_710632dc7a9f4715854c9868816814dd3">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period
          including the weighted average effect of the Pre-Funded Warrants the Company issued in connection with the PIPE Transaction, the exercise of which requires little or no consideration for the delivery of shares of common stock. The Company
          determined that the exercise of the Pre-Funded Warrants requires nominal consideration for the delivery of shares of common stock, and as such, has considered the <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_dcb02023e81e4f1ab27c414ba894958b" contextRef="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,357,000</ix:nonFraction> shares underlying the Pre-Funded Warrants to be outstanding effective on March 9, 2022 for the purposes of calculating basic EPS. Diluted net loss per share is calculated by dividing net loss by the
          weighted-average number of common shares outstanding (including the weighted average effect of the Pre-Funded Warrants) plus dilutive securities. Stock options, RSUs, warrants and other convertible securities are considered potential common
          shares and are included in the calculation of diluted net loss per share using the treasury method when their effect is dilutive. Diluted net loss per share is the same as basic net loss per share in periods where the effect of potentially
          dilutive shares of common stock are antidilutive. <ix:nonNumeric name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="Text_f95b70294eaa41198c37dcff691de5a5" contextRef="c20220101to20220630" escape="true" continuedAt="Text_19abc1faf97740f1be0ade2e6092d2ed1"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The following table presents the amount of stock options, RSUs, warrants and convertible preferred stock that were excluded from the computation of diluted net loss per common share for three
          and six months ended June 30, 2022 and 2021, as their effect was anti-dilutive:</span></ix:nonNumeric></div>
</ix:continuation>
        <ix:continuation id="Text_710632dc7a9f4715854c9868816814dd3" continuedAt="Text_710632dc7a9f4715854c9868816814dd4"><ix:continuation id="Text_19abc1faf97740f1be0ade2e6092d2ed1" continuedAt="Text_19abc1faf97740f1be0ade2e6092d2ed2">
<div><br />
        </div>
</ix:continuation></ix:continuation>
        <ix:continuation id="Text_710632dc7a9f4715854c9868816814dd4"><ix:continuation id="Text_19abc1faf97740f1be0ade2e6092d2ed2">
<table cellspacing="0" cellpadding="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="6" style="vertical-align: bottom;">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">Three and Six months ended June 30,</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2022</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; text-align: center;">&#160;</td>

    <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Stock options</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_aee4d37683474486ad5eb3f271d964ee" contextRef="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_7c6ae32900fa4ac6a715749d4216a8f6" contextRef="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,750</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_7b4ab9f3bc0b4c0391ef72c81d635ec0" contextRef="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_2436aefabc6b4045af5dfa770ceed0de" contextRef="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,366</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">RSUs</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_a276db7e2e6d4aa0ac2d2846ebf612aa" contextRef="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_73469461f5624046821d7ab60c9aa79d" contextRef="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">587</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_a8634324148f4162a0723d8646dddb72" contextRef="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_5fcbb4fa4ccf45afa4c78815a58d601c" contextRef="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">105</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Warrants</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_90c053ecb16e43f38d65d470bd780079" contextRef="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_7132c9659fe04df0a69390bff4dac542" contextRef="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,857</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_e95216e9378f47cab62fa0566a135499" contextRef="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_c70b33d4483245e2b68502d3f325efa4" contextRef="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Preferred stock converted into common stock</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_e2ac0556ff474f149df36d8bbf7005c0" contextRef="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_61cfa18a2f094f62be68253209b8bdf9" contextRef="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">50</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_c470d7205864468f82ad3d14185dfde4" contextRef="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_80c3e269abe1432fb437e7f7d6afb6f1" contextRef="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">42</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Total potential common shares excluded from computation</div>
              </td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_bccaa20c2ab84780a6f8d5b65cdb91ee" contextRef="c20220401to20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_8f486badf8ac43aa89d3226ead8b7d6d" contextRef="c20220101to20220630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,244</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;">&#160;</td>

    <td valign="bottom" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_55eac250830142f8b3ca8c9a132f831b" contextRef="c20210401to20210630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_0ff1ab0ce261434b80a121a6c3b707ab" contextRef="c20210101to20210630" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,513</ix:nonFraction></ix:nonFraction></div>
              </td>

    <td valign="bottom" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;">&#160;</td>

  </tr>


</table>
</ix:continuation></ix:continuation>
         </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);">
    <div><br />
    </div>


    <ix:nonNumeric name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="Text_71749bfdf5ce4d45be3204a3fb4fa9d8" contextRef="c20220101to20220630" escape="true" continuedAt="Text_fa27bb9ae2e84100b827438660000d6b1">
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">13)<br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">RECENT ACCOUNTING PRONOUNCEMENTS</div>
          </td>

  </tr>


</table>
</ix:nonNumeric><ix:continuation id="Text_fa27bb9ae2e84100b827438660000d6b1" continuedAt="Text_fa27bb9ae2e84100b827438660000d6b2">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
     </div>
</ix:continuation>
    <ix:continuation id="Text_fa27bb9ae2e84100b827438660000d6b2"><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Text_ded1775e458c4616b485ea8de8a75a66" contextRef="c20220101to20220630" escape="true">
<div style="display:none;"><br /></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In June 2022, the Financial Accounting Standard Board (the &#8220;FASB&#8221;) issued Accounting Standards Update
        (&#8220;ASU&#8221;) No. 2022-03,&#160;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities&#160;Subject to Contractual Sale Restrictions&#160;(&#8220;ASU 2022-03&#8221;). The FASB issued ASU 2022-03 to (1) clarify the&#160;guidance in Topic 820, Fair Value
        Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new disclosure requirements for
        equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered part of the
        unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years with early adoption
        permitted. The Company is evaluating when to adopt the amendments in ASU 2022-02. The Company does not expect a material impact as a result of adopting this amendment.</span>  </div>
</ix:nonNumeric></ix:continuation>

    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none;"> <br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">24</span></div>

      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      <div style="width: 100%;" class="DSPFPageHeader">
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
          </a></div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;"> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

      <div><ix:nonNumeric name="us-gaap:SubsequentEventsTextBlock" id="Text_677b4506c14f4d87b7c706a033b5aa24" contextRef="c20220101to20220630" escape="true" continuedAt="Text_92edaf6ed76f4595967dcbdf48a62b9e1">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>
</ix:nonNumeric>
        <ix:continuation id="Text_92edaf6ed76f4595967dcbdf48a62b9e1" continuedAt="Text_92edaf6ed76f4595967dcbdf48a62b9e2">
<table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">14)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">SUBSEQUENT EVENT</div>
              </td>

  </tr>


</table>
</ix:continuation>
        <ix:continuation id="Text_92edaf6ed76f4595967dcbdf48a62b9e2" continuedAt="Text_92edaf6ed76f4595967dcbdf48a62b9e3">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>
</ix:continuation>
        <ix:continuation id="Text_92edaf6ed76f4595967dcbdf48a62b9e3" continuedAt="Text_92edaf6ed76f4595967dcbdf48a62b9e4">
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
</ix:continuation>
        <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">
          <ix:continuation id="Text_92edaf6ed76f4595967dcbdf48a62b9e4">
<div style="display:none;"><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On












            July 12, 2022, <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">the PIPE Investor exercised its</span> <ix:nonFraction name="btx:ClassOfWarrantOrRightExercised" id="Fact_afc86420b785424ea670cd09aa7418ef" contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,357,000</ix:nonFraction>
            <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">Pre-Funded Warrants at an exercise price of</span> $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_0df87ba6057a427380cb54ccde9c5697" contextRef="c20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal">0.005</ix:nonFraction>
            <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">per share for an aggregate exercise price of</span> $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" id="Fact_fb0d8c6ed2174a6dabdf382a94db2109" contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">6,786</ix:nonFraction>,
            in cash.&#160; The Company issued <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_abb73b5d85464758a2169c685a730af4" contextRef="c20220714_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,357,000</ix:nonFraction> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">shares of common stock to
              the PIPE Investor on July 14, 2022 upon receipt of the cash proceeds. Subsequent to the exercise,&#160;</span> <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" id="Fact_dffe688a897a49c9a1693ad0e48427fa" contextRef="c20220712_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> Pre-Funded Warrants
            remained outstanding.</div>
</ix:continuation>
        </div>


        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">25</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

          <div style="width: 100%;" class="DSPFPageHeader">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
              </a></div>

          </div>

        </div>

      </div>

    </div>

  </div>


  <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
    <div>
      <a id="ManagementsDiscussionandA"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45pt; vertical-align: top;"><span style="font-weight: bold;">Item 2.</span></td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; font-style: italic;"><span style="color: #000000;">You should read this discussion together with the unaudited interim condensed consolidated financial statements, related notes, and other financial information
          included elsewhere in this Quarterly Report on Form 10-Q together with our audited consolidated financial statements, related notes, and other information contained in </span>the Form 10-K/A filed with the <span style="color: #000000;">Securities










          and Exchange Commission</span> (the &#8220;SEC&#8221;) on June 30, 2022 (the &#8220;10-K/A&#8221;),<span style="color: #000000;"> as well as the information contained in our Annual Report on Form 10-K for the year ended December 31, 2021 (the &#8220;Original 10-K&#8221;), filed
          with the SEC on April 15, 2022, to the extent the information contained in the Original 10-K was not superseded by the information contained in the 10-K/A. The following discussion contains assumptions, estimates and other forward-looking
          statements that involve a number of risks and uncertainties, including those discussed under &#8220;Risk Factors,&#8221; in Part I, Item 1A of the 10-K/A and as described from time to time in our other filings with the SEC. These risks could cause our actual
          results to differ materially from those anticipated in these forward-looking statements.</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; font-weight: bold;">Overview</div>

      <div style="text-align: justify; text-indent: 36pt;"><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">We are a biopharmaceutical company utilizing our mRNA technology platform, including mRNA-based cell reprogramming and gene editing technologies, to create next generation mRNA, gene-editing and
        cell therapies, including iPSC therapies for multiple therapeutic indications.&#160; Our mRNA technology platform, which includes novel lipid nanoparticles (&#8220;LNPs&#8221;) for mRNA delivery and targeted transgene insertion, was acquired through a license with
        Factor Bioscience Limited, or Factor, and through our acquisition of Novellus, Inc. and Novellus, Ltd. in July 2021, which we refer to as the Acquisition.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Merger with NTN Buzztime, Inc.</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">On March 25, 2021, we completed the Merger with NTN Buzztime, Inc. In accordance with the Merger Agreement, on March 25, 2021, Brooklyn amended its restated certificate of incorporation in order to
        effect:</div>

      <div style="text-indent: 36pt;"><br />
      </div>

      <div>
        <div style="margin-left: 36pt; text-indent: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; prior to the Merger, a reverse stock split of its common stock, par value $0.005 per share, at a ratio of one-for-two; and</div>

      </div>

      <div>
        <div style="margin-left: 36pt; text-indent: 36pt;">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; following the Merger, a change in its corporate name from &#8220;NTN Buzztime, Inc.&#8221; to &#8220;Brooklyn ImmunoTherapeutics, Inc.&#8221;</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">On March 26, 2021, we sold the rights, title and interest in and to the assets relating to the business operated under the name &#8220;NTN Buzztime, Inc.&#8221; prior to the Merger to eGames.com Holdings LLC,
        or eGames.com, in exchange for eGames.com&#8217;s payment of a purchase price of $2.0 million and assumption of specified liabilities relating to such pre-Merger business. This transaction, which we refer to as the Disposition, was completed in
        accordance with the terms of an asset purchase agreement dated September 18, 2020, as amended, between us and eGames.com.</div>

      <div style="text-indent: 36pt;"><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">The Merger has been accounted for as a reverse acquisition in accordance with U.S. generally accepted accounting principles, or GAAP. Under this method of accounting, Brooklyn LLC was deemed the
        &#8220;acquiring&#8221; company and Brooklyn (then known as NTN Buzztime, Inc.) was treated as the &#8220;acquired&#8221; company for financial reporting purposes. Operations prior to the Merger are those of Brooklyn LLC, and the historical financial statements of
        Brooklyn LLC became the historical financial statements of Brooklyn with respect to periods prior to the completion of the Merger.</div>

      <div><br />
      </div>

      <div style="text-indent: 36pt;"><span style="text-decoration: underline;">Acquisition of Novellus</span></div>

      <div style="text-indent: 36pt;"><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">On July 16, 2021, we acquired Novellus, Inc. and Novellus, Inc.&#8217;s wholly owned subsidiary, Novellus, Ltd. Brooklyn also acquired 25.0% of the total outstanding equity interests of NoveCite, Inc.&#160;
          As consideration for the Acquisition, we paid $22.9 million in cash and delivered 7,022,000 shares of common stock, which under the terms of the Acquisition Agreement, were valued at a total of $102.0 million based on an agreed upon price of
          $14.5253 per share.&#160; At the date of issuance, the fair value of the shares was approximately $58.7 million.</div>

        <div style="text-align: justify; text-indent: 36pt;"> <br />
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">26</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <div style="text-indent: 36pt; font-weight: normal;"><span style="text-decoration: underline;">mRNA, Gene-Editing, and Cellular Medicines</span></div>

      <div style="text-indent: 36pt;"><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">We are advancing the technology that we obtained through a license with Factor and through the Acquisition of Novellus, Inc. and Novellus, Ltd. in July 2021 to evaluate and develop mRNA,
        gene-editing, and cellular medicines, with an initial focus on hematologic and solid tumors. We expect that the first-generation product candidates will include gene-editing mRNA for in vivo cell engineering and induced pluripotent stem cell
        (&#8220;iPSC&#8221;)-derived cytotoxic lymphocytes (&#8220;iCLs&#8221;) and immune-modulating cells (&#8220;iIMCs&#8221;). We expect to begin preclinical development, including manufacturing process development, of iCLs and iIMCs for clinical indications including hematologic and
        solid tumors, as well as other indications that require overcoming molecular cues of the tissue microenvironment. The prior work of Novellus and NoveCite shows evidence for preclinical efficacy of iPSC-derived cells in inflammatory conditions (for
        example, acute respiratory distress syndrome, or ARDS). Interactions with the FDA provided guidance on Chemistry, Manufacturing and Controls (&#8220;CMC&#8221;), and manufacturing plans, which will be undertaken in a similar manner for additional applications.
        We expect that second generation products will involve more complex gene editing, for which we anticipate using the stepwise addition of genes provided by the in-licensed Factor Bioscience gene editing machinery, NoveSlice, to efficiently place
        genes and regulatory sequences into safe harbor locations. Development of processes to advance CMC and manufacturing will follow the experience from first generation products. We are also exploring opportunities to advance in vivo mRNA cell
        engineering therapies for hematologic and solid tumors by combining the NoveSlice gene editing technology with ToRNAdo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup>, the in-licensed LNP technology.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; font-weight: normal;"><span style="text-decoration: underline;">IRX-2</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">IRX-2 is a mixed, human-derived cytokine product with multiple active constituents including Interleukin-2, or IL2, and other key cytokines. Together, these cytokines are believed to signal,
        enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells, unlike many existing cancer therapies, which rely on targeting the cancer directly. IRX-2 is prepared from the supernatant of
        pooled allogeneic peripheral blood mononuclear cells, known as PBMCs, that have been stimulated using a proprietary process employing a specific population of cells and a specific mitogen.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">Unlike existing recombinant IL2 therapies, IRX-2 is derived from human blood cells. We believe this may promote better tolerance, broader targeting and a natural molecular conformation leading to
        greater activity, and may permit low physiologic dosing, rather than the high doses needed in other existing IL2 therapies.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">Results of the Phase 2b INSPIRE trial, or the INSPIRE trial, released in June 2022, showed outcomes favored IRX-2 in certain predefined subgroups but the INSPIRE trial did not meet the primary
        endpoint of Event-Free Survival (&#8220;EFS&#8221;) at two years of follow up. One hundred and fifty patients were enrolled in the study. At two years of follow-up in the intention-to-treat (ITT, n=105) population the median EFS was 48.3 months and was not
        reached in the control arm (Hazard Ratio 1.10 (95% Confidence Interval, 0.6-2.1; p value=0.62)). Subgroups favoring the IRX-2 arm included patients with later stage (III and IV) disease and those that did not receive chemotherapy. Trends in EFS
        rates as defined by the Kaplan-Meier estimate at two years of follow-up in patients with later stage (III and IV) disease were 57.2 (40.3, 70.9) vs 49.4 (28.3, 67.4) in favor of IRX-2. In patients that did not receive chemotherapy (radiation only)
        as part of adjuvant treatment, the EFS Kaplan-Meier estimate at two years of follow-up was 76.4 (52.2, 89.4) vs 60.6 (29.4, 81.4) in favor of IRX-2. There were no new safety signals observed with IRX-2. We currently do not have plans to further
        develop the IRX-2 product candidate.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Impact of COVID-19 Pandemic</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">The development of our product candidates has been, and could continue to be, disrupted and materially adversely affected by past and continuing impacts of the COVID-19 pandemic. This is largely a
        result of measures imposed by the governments and hospitals in affected regions, businesses and schools were suspended due to quarantines intended to contain this outbreak. The spread of COVID-19 from China to other countries resulted in the
        Director General of the World Health Organization declaring COVID-19 a pandemic in March 2020. Despite progress in vaccination efforts, the longer-term impact of the COVID-19 pandemic on our development plans and on the ability to conduct our
        clinical trials remains uncertain and cannot be predicted with confidence. COVID-19 could continue to disrupt production and cause delays in the supply and delivery of products used in our operations, may affect our operations, including the
        conduct of clinical studies, or the ability of regulatory bodies to grant approvals or supervise our candidates and products, may further divert the attention and efforts of the medical community to coping with the COVID-19 and disrupt the
        marketplace in which we operate and may have a material adverse effects on our operations. COVID-19 may also affect our employees and employees and operations at suppliers that may result in delays or disruptions in supply. In addition, a recession
        or market correction resulting from the spread of COVID-19 could materially affect our business and the value of our common stock. Additionally, if the COVID-19 pandemic has a significant impact on our business and financial results for an extended
        period of time, our liquidity and cash resources could be negatively impacted. The extent to which the COVID-19 pandemic and ongoing global efforts to contain its spread will impact our operations will depend on future developments, which are
        highly uncertain, and include the duration, severity and scope of the pandemic and the actions taken to contain or treat the COVID-19 pandemic. Further, the specific clinical outcomes, or future pandemic related impacts of emerging COVID-19
        variants cannot be reliably predicted.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">27</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Recent Developments</div>

      <div><br />
      </div>

      <div style="text-indent: 36pt; font-weight: normal;"><span style="text-decoration: underline;">PIPE Transaction</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">On March 6, 2022, we entered into a Securities Purchase Agreement with an investor (the &#8220;PIPE Investor&#8221;) providing for the private placement (the &#8220;PIPE Transaction&#8221;) to the PIPE Investor of
        approximately 6,857,000 units (the &#8220;Units&#8221;), each of&#160; which consisted of (i) one share of our common stock (or, in lieu thereof, one pre-funded warrant (the &#8220;Pre-Funded Warrants&#8221;) to purchase one share of common stock) and (ii) one warrant (the
        &#8220;Common Warrants&#8221;) to purchase one share of common stock, for an aggregate purchase price of approximately $12.0 million (the &#8220;Subscription Amount&#8221;). The PIPE Transaction closed on March 9, 2022. We incurred fees of $1.0 million through June 30,
        2022 related to the PIPE Transaction.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Each Pre-Funded Warrant has an exercise price of $0.005 per share of common stock, was immediately exercisable and may be exercised at any time and has no expiration date and is subject to
          customary adjustments. The Pre-Funded Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 9.99% immediately after exercise thereof.</div>

      </div>

      <div>
        <div><br />
        </div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">Each Common Warrant has an exercise price of $1.91 per share, becomes exercisable six months following the closing of the PIPE Transaction, expires five-and-one-half years from the date of
          issuance, and is subject to customary adjustments. The Common Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99% immediately after exercise thereof, subject
          to increase to 9.99% at the option of the holder.</div>

      </div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">The Common Warrants and Pre-Funded Warrants were accounted for as liabilities under ASC 815-40, <span style="font-style: italic;">Derivatives and Hedging, Contracts in Entity&#8217;s Own Equity,</span>
        as these warrants provide for a cashless settlement provision that fails the requirement of the indexation guidance under ASC 815-40.&#160; The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair
        value presented within the statement of operations.</div>

      <div><br />
      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt;">The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more than the Subscription Amount.&#160; The
          excess $0.6 million represents an inducement to the PIPE Investor to enter into the PIPE Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of operations.</div>

        <div><br />
        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt;">In connection with the PIPE Transaction, we and the PIPE Investor also entered into a registration rights agreement, dated March 6, 2022, pursuant to which we agreed to prepare and file a
        registration statement with the Securities and Exchange Commission (the &#8220;SEC&#8221;) to register the resale of the shares of common stock included in the Units and the shares of common stock issuable upon exercise of the Pre-Funded Warrants and the
        Common Warrants. We agreed to use our best efforts to have such registration statement declared effective as promptly as possible after the filing thereof, subject to certain specified penalties if timely effectiveness is not achieved.&#160; We filed
        such registration statement on April 29, 2022, which became effective on May 11, 2022.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">28</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">Pursuant to the registration rights agreement, we are obligated to pay the PIPE Investor liquidated damages equal to 2% of the Subscription Amount per month, with a maximum
        aggregate payment of 12% of the Subscription Amount, in the event the PIPE Investor is not permitted to use the registration statement to resell the related securities for more than 10 consecutive calendar days or more than an aggregate of fifteen
        calendar days (which need not be consecutive calendar days) during any 12-month period.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">On May 24, 2022, we provided the PIPE Investor with notice that it was not able to resell the securities under the registration agreement because we did not timely file our
        Quarterly Report on Form 10-Q (the &#8220;Q1 2022 10-Q&#8221;) with the SEC, and that the PIPE Investor could not use the registration statement to resell the related securities until we filed the Q1 2022 10-Q.&#160; Because the PIPE Investor was unable to use the
        resale registration statement for at least 10 consecutive calendar days, we accrued $0.2 million during the first quarter of 2022 for the estimated contingent loss we expect to incur as a result of the late Q1 2022 10Q filing, which is recorded in
        other expense, net for the six months ended June 30, 2022 in the accompanying condensed consolidated statements of operations.&#160; We paid the $0.2 million liquidated damages payment in June 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">On June 30, 2022, we filed the Q1 2022 10-Q along with the 10-K/A, and on July 1, 2022, we provided notice to the PIPE Investor that it may resume use of the resale
        registration statement.</div>

      <div><br />
      </div>

      <div style="text-align: justify; font-weight: bold;">Basis of Presentation</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Revenues</div>

      <div style="text-indent: 36pt;"><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">We are a development stage company and have had no revenues from product sales to date. We will not have revenues from product sales until such time as we receive regulatory approval of our product
        candidates, successfully commercialize our products or enter into a licensing agreement which may include up-front licensing fees, of which there can be no assurance.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Research and Development Expenses</div>

      <div style="text-indent: 36pt;"><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">We expense our research and development costs as incurred. Our research and development expenses consist of costs incurred for company-sponsored research and development activities, as well as
        support for selected investigator-sponsored research. Upfront payments and milestone payments for the licensing of technology are expensed as research and development in the period in which they are incurred if the technology is not expected to
        have any alternative future uses other than the specific research and development project for which it was intended. In-Process Research and Development (&#8220;IPR&amp;D&#8221;) that is acquired through an asset acquisition and has no alternative future uses
        and, therefore, no separate economic values, is expensed to research and development costs at the time the costs are incurred.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">The major components of research and development costs include preclinical study costs, clinical manufacturing costs, clinical study and trial expenses, insurance coverage for clinical trials,
        expensed licensed technology, consulting, scientific advisors and other third-party costs, salaries and employee benefits, stock-based compensation expense, supplies and materials and allocations of various overhead costs related to our product
        development efforts.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">In the normal course of our business, we contract with third parties to perform various clinical study and trial activities in the on-going development and testing of potential products. The
        financial terms of these agreements are subject to negotiation and vary from contract to contract and may result in uneven payment flows. Payments under the contracts depend on factors such as the achievement of certain events or milestones, the
        successful enrollment of patients, the allocation of responsibilities among the parties to the agreement, and the completion of portions of the clinical study or trial or similar conditions. Preclinical and clinical study and trial associated
        activities such as production and testing of clinical material require significant up-front expenditures. We anticipate paying significant portions of a study&#8217;s or trial&#8217;s cost before such begins and incurring additional expenditures as the study
        or trial progresses and reaches certain milestones.</div>

      <div style="text-align: justify; text-indent: 36pt;"> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">29</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; font-style: italic;">General and Administrative Expenses</div>

      <div style="text-indent: 36pt;"><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">Our general and administrative expenses consist primarily of salaries, benefits and other costs, including equity-based compensation, for our executive and administrative personnel, legal and other
        professional fees, travel, insurance, and other corporate costs.</div>

      <div><br />
      </div>

      <div style="text-align: justify; font-weight: bold;">Results of Operations</div>

      <div><br />
      </div>

      <div style="text-align: justify; font-weight: bold;">Comparison of the Three and Six Months Ended June 30, 2022 and 2021</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" rowspan="2" colspan="1">&#160;&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="2">&#160;&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="6">
              <div style="text-align: center; color: #000000; font-weight: bold;">Three months ended June 30,</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="2">&#160;&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="2">&#160;&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2" rowspan="2">&#160;
              <div style="text-align: center; font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="2">&#160;&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="2">&#160;&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" colspan="6">
              <div style="text-align: center; color: #000000; font-weight: bold;">Six months ended June 30,</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="2">&#160;&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="2">&#160;&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2" rowspan="2">&#160;
              <div style="text-align: center; font-weight: bold;">Change</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1" rowspan="2">&#160;&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;"> 2022</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2021</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2022</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
              <div style="text-align: center; font-weight: bold;">2021</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div style="font-style: italic; font-weight: bold;">(in thousands)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;">
              <div>Operating expenses:</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Research and development</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>1,685</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>5,432</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(3,747</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>3,467</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>$</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>6,965</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(3,498</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; white-space: nowrap;">
              <div>General and administrative</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>6,205</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>4,581</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>1,624</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>10,719</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>6,204</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>4,515</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div>Impairment of in-process research and</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>5,990</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>5,990</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>5,990</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
              <div>5,990</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;">
              <div>Transaction costs</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>5,765</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(5,765</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div style="text-indent: 10pt;">Total operating expenses</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>13,880</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>10,013</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>3,867</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>20,176</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>18,934</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>1,242</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Loss from operations</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(13,880</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(10,013</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(3,867</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(20,176</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(18,934</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>(1,242</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;">
              <div>Other income (expense), net:</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; white-space: nowrap;">
              <div>Loss on sale of NTN assets</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">(50</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">50</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">(9,648</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">9,648</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div>Change in fair value of warrant liabilities</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">10,792</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">10,792</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">9,470</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">9,470</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; white-space: nowrap;">
              <div>Loss on non-controlling investment</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">(296</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">(296</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">(911</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">-</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">(911</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
              <div>Other expense, net</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: #000000;">(14</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: #000000;">(22</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: #000000;">8</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: #000000;">(1,156</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: #000000;">(25</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div style="color: #000000;">(1,131</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
              <div style="color: #000000;">)</div>
            </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; white-space: nowrap;">
              <div style="text-indent: 10pt;">Total other income (expense), net</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>10,482</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(72</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>10,554</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>7,403</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>(9,673</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
              <div>17,076</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 4px; white-space: nowrap;">
              <div>Net loss</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(3,398</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(10,085</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>6,687</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(12,773</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>(28,607</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
              <div>)</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">$</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
              <div>15,834</div>
            </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">30</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Research and Development Expenses</div>

      <div><br />
      </div>

      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="10">
                <div style="text-align: center; color: #000000; font-weight: bold;">Three months ended June 30,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;"> 2022</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Change</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div style="font-style: italic; font-weight: bold;">(in thousands)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>License fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>4,000</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(4,000</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Stock-based compensation</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>470</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>168</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>302</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Payroll-related</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>639</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>593</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>46</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Clinical trials</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>402</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>526</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(124</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Professional fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>79</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>39</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>40</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 2px; white-space: nowrap;">
                <div>Other expenses, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>95</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>106</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(11</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: 10pt;">Total research and development expenses</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>1,685</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>5,432</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(3,747</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>


</table>
      </div>

      <div><br />
      </div>

      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="10">
                <div style="text-align: center; color: #000000; font-weight: bold;">Six months ended June 30,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;"> 2022</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Change</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div style="font-style: italic; font-weight: bold;">(in thousands)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>License fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>4,000</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(4,000</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Payroll-related</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>1,601</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>1,054</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>547</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Stock-based compensation</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>891</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>571</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>320</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Clinical trials</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>632</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>961</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(329</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Professional fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>120</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>126</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(6</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 2px; white-space: nowrap;">
                <div>Other expenses, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>223</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>253</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(30</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: 10pt;">Total research and development expenses</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>3,467</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>6,965</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(3,498</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: justify; text-indent: 36pt;"><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">For the three and six months ended June 30, 2022, our research and development expenses decreased primarily due to a $4.0 million license fee paid in 2021 to Factor and Novellus, Ltd. (the
        &#8220;Licensors&#8221;) under the exclusive license agreement with the Licensors, as well as due to a decrease in clinical trial and other miscellaneous expense, offset by increased stock compensation expense due to increased equity awards granted during
        2022, as compared to equity awards granted in 2021, and increased payroll expense due to increased headcount, as well as increased severance expense when compared to the same periods in 2021.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">In January 2022, we completed a reduction in our workforce involving eight research and development employees.&#160; As a result, we incurred approximately $0.5 million for severance and
        termination-related costs, which we recorded during the first quarter of 2022. In June 2022, we made the decision to consolidated our research and development in Cambridge, Massachusetts, and as a result, we accrued approximately $0.1 million for
        severance and termination-related costs for certain employees in the San Diego, California location.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">31</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; font-style: italic;">General and Administrative Expenses</div>

      <div><br />
      </div>

      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="10">
                <div style="text-align: center; color: #000000; font-weight: bold;">Three months ended June 30,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;"> 2022</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Change</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div style="font-style: italic; font-weight: bold;">(in thousands)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Payroll-related</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>1,533</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>142</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>1,391</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Impairment of ROU asset</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>772</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>772</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Professional fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>2,083</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>2,721</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(638</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Stock-based compensation</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>409</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>986</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(577</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Insurance</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>527</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>367</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>160</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Occupancy expense</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>182</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>150</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>32</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div>Other expenses, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>699</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>215</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>484</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 4px; white-space: nowrap;">
                <div style="text-indent: 10pt;">Total general and administrative expenses</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div>6,205</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div>4,581</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div>1,624</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      </div>

      <div><br />
      </div>

      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 90%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="10">
                <div style="text-align: center; color: #000000; font-weight: bold;">Six months ended June 30,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;"> 2022</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Change</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div style="font-style: italic; font-weight: bold;">(in thousands)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Payroll-related</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>2,282</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>175</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>2,107</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Impairment of ROU asset</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>772</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>772</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Professional fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>3,404</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>4,040</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(636</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Insurance</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>894</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>400</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>494</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Stock-based compensation</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>1,170</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>1,003</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>167</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Occupancy expense</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>382</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>301</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>81</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Loss on disposal of fixed assets</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>274</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>274</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 2px; white-space: nowrap;">
                <div>Other expenses, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>1,541</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>285</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>1,256</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: 10pt;">Total general and administrative expenses</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>10,719</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>6,204</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>4,515</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      </div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">The increase in general and administrative expense for the three and six months ended June 30, 2022 was primarily related to increased headcount as well as severance expense for certain employees,
        including our former Chief Executive Officer, who resigned effective May 26, 2022.&#160; We also recognized a non-cash impairment charge on our San Diego, California right-of-use (&#8220;ROU&#8221;) operating lease asset due to our intent to consolidate our
        research and development activities in Cambridge, Massachusetts and to sublease the San Diego, California facility.&#160; Other increases include premiums for public company insurance policies, non-cash stock-based compensation expense due to increased
        equity awards, increased other expenses, net, primarily due to legal-related matters, and losses on the disposal of fixed assets when compared to the same periods in 2021.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Impairment of In-Process Research and Development</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">As discussed above, in June 2022, we received the results from the INSPIRE phase 2 trial of IRX-2. The IRX-2 multi-cytokine biologic immunotherapy represents substantially all the fair value
        assigned to the technologies of IRX that we acquired in 2018. Despite outcomes that favored IRX-2 in certain predefined subgroups, the INSPIRE trial did not meet the primary endpoint of Event-Free Survival (EFS) at two years of follow up.
        Significant additional clinical development work will be required to advance IRX-2 in the form of additional Phase 2 and 3 studies to further evaluate the treatment effect of IRX-2 in patient subgroups and in combination with checkpoint inhibitor
        therapies.&#160; The INSPIRE trial is the only company sponsored study of IRX-2.&#160; IRX-2 has been studied externally in other clinical settings outside of head and neck cancer in the form of investigator sponsored trials, which have either ended or are
        not currently active. Based on the totality of available information, we currently do not have plans to further develop the IRX-2 product candidate. As such, we determined that the carrying value of the IPR&amp;D asset was impaired and recognized a
        non-cash impairment charge of approximately $6.0 million on the condensed consolidated balance sheet as of June 30, 2022, which reduced the value of this asset to zero.</div>

      <div style="text-align: justify; text-indent: 36pt;"> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">32</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Transaction Costs</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">The $5.8 million in transaction costs during the six months ended June 30, 2021 related to the issuance of common stock to Brooklyn LLC&#8217;s financial advisor upon consummation of the Merger, and
        there were no comparable transaction costs for same periods in 2022.</div>

      <div style="text-align: justify; text-indent: 36pt;"><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Loss on Sales of NTN Assets</div>

      <div style="text-align: justify;"><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">A $0.1 million and $9.6 million loss on the sale of NTN assets for the three and six months ended June 30, 2021, respectively, were incurred when we completed the Disposition, and there were no
        comparable losses on sale for the three and six months ended June 30, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Warrant Liabilities Expense</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">For the three months ended June 30, 2022, we recognized a credit of $10.8 million for the change in the fair value of warrant liabilities due to a decrease in the market price of our common stock
        during the quarter.&#160; For the six months ended June 30, 2022, we recognized a credit of&#160; $10.1 million for the change in the fair value of warrant liabilities, which was offset by $0.6 million in expense related to the excess fair value of the
        Common Warrants and Pre-Funded Warrant issued in connection with the PIPE Transaction over the $12.0 million gross proceeds received. There were no comparable expenses for the three and six months ended June 30, 2021.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Loss on Non-Controlling Investment</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2022, we recognized $0.3 million and $0.9 million of loss on our 25% non-controlling investment in NoveCite, respectively.&#160; Of the $0.9 million loss
        for the six months ended June 30, 2022, $0.5 million relates to the prior year.&#160; We account for our investment in NoveCite under the equity method.&#160; There were no comparable expenses for the three and six months ended June 30, 2021.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; font-style: italic;">Other Expense, Net</div>

      <div><br />
      </div>

      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 90%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="10">
                <div style="text-align: center; color: #000000; font-weight: bold;">Three months ended June 30,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;"> 2022</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Change</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div style="font-style: italic; font-weight: bold;">(in thousands)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>PIPE transaction fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(15</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(15</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Interest expense, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(13</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(22</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>9</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Other (expense) income , net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>14</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">
                <div>14</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 4px; white-space: nowrap;">
                <div style="text-indent: 10pt;">Total other expense, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(14</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>(22</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>8</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>


</table>
      </div>

      <div><br />
      </div>

      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 90%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="10">
                <div style="text-align: center; color: #000000; font-weight: bold;">Six months ended June 30,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;"> 2022</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; font-weight: bold;">Change</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div style="font-style: italic; font-weight: bold;">(in thousands)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>PIPE transaction fees</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(1,007</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(1,007</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div>Liquidated damages</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(240</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>-</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div>(240</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div>Interest expense, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(14</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(36</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>22</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 2px; white-space: nowrap;">
                <div>Other (expense) income , net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>105</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>11</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div>94</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: 10pt;">Total other expense, net</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(1,156</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(25</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>(1,131</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div>)</div>
              </td>

  </tr>


</table>
      </div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">For the three months ended June 30, 2022, we recognized an immaterial decrease in other expense, net when compared to the same period in 2021.&#160; During the six months ended June 30, 2022, our
        increase in other expense, net was primarily due to fees related to the PIPE Transaction, which was allocated to the warrants issued in connection with the transaction. Additionally, we incurred a loss related to the liquidated damages we incurred
        as a result of not timely filing the Q1 2022 10Q with the SEC.&#160; These increases in expense were offset by a decrease in interest expense and an increase in other income for the six months ended June 30, 2022 when compared to the same period in
        2021.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">33</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <div style="text-align: justify; font-weight: bold;">Liquidity and Capital Resources</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">At June 30, 2022, we had cash and cash equivalents of approximately $19.4 million. On March 9, 2022, we issued 5,500,000 shares of common stock and Pre-Funded Warrants representing approximately
        1,357,000 shares of common stock for net proceeds of approximately $11.0 million in connection with the PIPE Transaction.&#160; Pursuant to the purchase agreement entered into in respect of the PIPE Transaction, we are prohibited from issuing equity in
        variable rate transactions for a period of one-year following consummation of the PIPE Transaction, including issuing equity under the Second Purchase Agreement.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">We have to date incurred operating losses, and we expect these losses to continue in the future as we further develop our product development programs and operate as a publicly traded company.&#160;
        Developing product candidates, conducting clinical trials and commercializing products are expensive, and we will need to raise substantial additional funds to achieve our strategic objectives. It will likely be some years before we obtain the
        necessary regulatory approvals to commercialize one or more of our product candidates. Based on our current financial condition and forecasts of available cash, including as mentioned above, we believe we do not have sufficient funds to fund our
        operations for the next twelve months from the filing of the financial statements contained in this Quarterly Report on Form 10-Q for the period ended June 30, 2022 (the &#8220;Q2 2022 10-Q&#8221;). There can be no assurance that we will ever be in a position
        to commercialize IRX-2 or any other product candidate we may acquire, or that we will obtain any additional financing that we require in the future or, even if such financing is available, that it will be obtainable on terms acceptable to us.</div>

      <div style="text-indent: 36pt;"><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">In that regard, our future funding requirements will depend on many factors, including:</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: justify;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="text-align: justify;">the terms and timing of any collaborative, licensing and other agreements that we may establish;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: justify;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="text-align: justify;">the cost and timing of regulatory approvals;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: justify;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="text-align: justify;">the cost and delays in product development as a result of any changes in regulatory oversight applicable to our products;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: justify;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="text-align: justify;">the cost and timing of establishing sales, marketing and distribution capabilities;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: justify;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="text-align: justify;">the effect of competition and market developments;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: justify;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="text-align: justify;">the cost of filing and potentially prosecuting, defending and enforcing any patent claims and other intellectual property rights;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: justify;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="text-align: justify;">the scope, rate of progress and cost of our clinical trials and other product development activities; and</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;"><br />
            </td>

    <td style="width: 18pt; vertical-align: top; text-align: justify;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="text-align: justify;">future clinical trial results.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">We plan to raise additional funds to support our product development activities and working capital requirements through the remaining availability under the Second Purchase Agreement (to the
        extent we are permitted to use such agreement), public or private equity offerings, debt financings, corporate collaborations or other means. We may also seek governmental grants to support our clinical trials and preclinical trials. Further, we
        may seek to raise capital to fund additional product development efforts even if we have sufficient funds for our planned operations. Any sale by us of additional equity or convertible debt securities could result in dilution to our stockholders.
        There can be no assurance that any such required additional funding will be available to us at all or available on terms acceptable to us.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">Further, to the extent that we raise additional funds through collaborative arrangements, it may be necessary to relinquish some rights to our technologies or grant sublicenses on terms that are
        not favorable to us. If we are not able to secure additional funding when needed, we may have to delay the commercialize of our products, reduce the scope of or eliminate one or more research and development programs, which could have an adverse
        effect on our business.</div>

      <div style="text-align: justify; text-indent: 36pt;"> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">34</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <div style="text-indent: 36pt; font-style: italic;">Cash Flows</div>

      <div><br />
      </div>

      <div style="text-indent: 36pt; color: rgb(0, 0, 0); text-align: justify;">Cash flows from operating, investing and financing activities, as reflected in the accompanying consolidated statements of cash flows, are summarized as follows:</div>

      <div><br />
      </div>

      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 90%;" class="cfttable">


  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="6">
                <div style="text-align: center; color: #000000; font-weight: bold;">For the six months ended</div>
                <div style="text-align: center; color: #000000; font-weight: bold;">June 30,</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 54%; white-space: nowrap;">
                <div style="color: #000000; font-style: italic; font-weight: bold;">(in thousands)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: #000000; font-weight: bold;">2022</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: #000000; font-weight: bold;">2021</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="2">
                <div style="text-align: center; color: #000000; font-weight: bold;">Change</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div style="color: #000000;">Cash provided by (used in):</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;" colspan="2">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); white-space: nowrap;">
                <div style="text-indent: 10pt; color: #000000;">Operating activities</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">(9,425</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">(10,234</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">809</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" colspan="1">&#160;</td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; white-space: nowrap;">
                <div style="text-indent: 10pt; color: #000000;">Investing activities</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">(133</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">)</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">266</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">(399</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;">
                <div style="text-indent: 10pt; color: #000000;">Financing activities</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">11,980</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">58,503</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" colspan="1">
                <div style="color: #000000;">(46,523</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">)</div>
              </td>

  </tr>

  <tr>

    <td valign="bottom" style="vertical-align: bottom; width: 54%; padding-bottom: 4px; white-space: nowrap;">
                <div style="color: #000000;">Net increase in cash and cash equivalents</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">2,422</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">48,535</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">&#160;</td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">$</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">(46,113</div>
              </td>

    <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" colspan="1">
                <div style="color: #000000;">)</div>
              </td>

  </tr>


</table>
      </div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="text-decoration: underline;">Net Cash Used in Operating Activities</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The decrease in cash used in operating activities was due to a decrease in net loss of $0.6 million, after giving effect to adjustments made for non-cash transactions, offset by an
        increase in cash provided by operating assets and liabilities of $1.4 million during the six months ended June 30, 2022 compared to the same period in 2021.&#160; The increase in cash provided by operating assets and liabilities was primarily driven by
        increased accrued compensation due to higher headcount and severance as well as accrued costs for litigation matters, offset by a decrease in prepaid expenses and other current assets during the six months ended June 30, 2022 compared to the same
        period in 2021.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="text-decoration: underline;">Net Cash (Used in) Provided by Investing Activities</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">The increase in net cash used in investing activities was primarily due to purchases of capital equipment of $0.2 million offset by proceeds from the sale of fixed assets of $0.1 million during the
        six months ended June 30, 2022 compared to the same period in 2021.&#160; Also, the six months ended June 30, 2021 included proceeds of approximately $0.3 million from the Merger and the Disposition transactions.&#160; There were no similar transactions
        during the six months ended June 30, 2022.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;"><span style="text-decoration: underline;">Net Cash Provided by Financing Activities</span></div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The decrease in net cash provided by financing activities was primarily the result of a decrease in net proceeds from capital raises of approximately $47 million, net, offset by a
        decrease in principal payments made for long-term debt arrangements of $0.5 million during the six months ended June 30, 2022 compared to the same period in 2021.</div>

      <div><br />
      </div>

      <div style="text-align: justify; font-weight: bold;">Critical Accounting Policies and Estimates</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">There were no significant changes in our critical accounting estimates during the three and six months ended June 30, 2022 from those described in &#8220;Management&#8217;s Discussion and Analysis of Financial
        Condition and Results of Operations&#8221; section of the 10-K/A.</div>

      <div><br />
      </div>

      <div style="text-align: justify; font-weight: bold;">Recent Accounting Pronouncements</div>

      <div><br />
      </div>

      <div style="text-align: justify;"><span style="color: rgb(0, 0, 0);">In June 2022, the Financial Accounting Standard Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2022-03, </span><span style="font-style: italic; color: rgb(0, 0, 0);">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions </span><span style="color: rgb(0, 0, 0);">(&#8220;ASU 2022-03&#8221;).</span> The FASB issued ASU 2022-03 to (1) clarify the
        guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce
        new disclosure requirements for equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security
        is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal
        years with early adoption permitted. We are evaluating when to adopt the amendments in ASU 2022-02. We do not expect a material impact as a result of adopting this amendment.</div>

      <div><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">35</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <a id="QuantitativeandQualitativ"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45pt; vertical-align: top;">&#160;<span style="font-weight: bold;">Item 3.</span></td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Quantitative and Qualitative Disclosures About Market Risk.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">Under the rules and regulations of the SEC, as a smaller reporting company we are not required to provide the information otherwise required by this item.</div>

      <div><br />
      </div>

      <a id="ControlsandProcedures."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45pt; vertical-align: top;"><span style="font-weight: bold;">Item 4.</span></td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Controls and Procedures.</div>
            </td>

  </tr>


</table>
      <div>&#160;</div>

      <div style="text-indent: 36pt; font-style: italic;">Disclosure Controls and Procedures</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">We maintain &#8220;disclosure controls and procedures,&#8221; as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act, designed to ensure that information required to be disclosed in
        our reports filed pursuant to the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including
        our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">In designing and evaluating the disclosure controls and procedures, we recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance
        of achieving the desired control objectives, and we were required to apply our judgment in evaluating the cost-benefit relationship of possible controls and procedures. We have carried out an evaluation as of the end of the period covered by this
        Q2 2022 10-Q under the supervision, and with the participation, of our management, including our interim Chief Executive Officer and President (who serves as our principal executive officer) and our Chief Financial Officer (who serves as our
        principal financial officer), of the effectiveness of the design and operation of our disclosure controls and procedures.</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">Based on that evaluation, our interim Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the end of the period
        covered by this Q2 2022 10-Q in providing reasonable assurance of achieving the desired control objectives due primarily to the material weaknesses discussed below.</div>

      <div>&#160;</div>

      <div style="text-indent: 36pt; font-style: italic;">Management&#8217;s Plan for Material Weaknesses in Internal Control over Financial Reporting</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">Upon completion of the Merger in March 2021 and the resulting change in our business model and strategy, we experienced a complete turnover of our employees, including all of the members of our
        executive management team, which resulted in, among other things, our having insufficient accounting staff available to enable and ensure adequate segregation of duties and our lacking appropriate and complete documentation of policies and
        procedures critical to the accomplishment of financial reporting objectives. The accounting personnel and documentation deficiencies each increase the risk that a material misstatement of our financial statements will not be prevented or detected
        on a timely basis.</div>

      <div>&#160;</div>

      <div style="text-align: justify; text-indent: 36pt;">Additionally, we were unable to timely file our Q1 2022 10Q with the SEC due to identifying errors in our financial statements reported in the Original 10-K for the years ended December 31, 2021
        and 2020 during our preparation of the financial statements for the quarter ended March 31, 2022.&#160; Management concluded that the errors were the result of accounting personnel&#8217;s&#8217; lack of technical proficiency in complex matters.&#160; We filed an
        amendment to our Annual Report on Form 10-K/A for the years ended December 31, 2021 and 2020 on June 30, 2022 to correct the errors in our financial statements for the years ended December 31, 2021 and 2020 and for the quarters ended June 30, 2020,
        September 30, 2020, March 31, 2021, June 30, 2021 and September 30, 2021.&#160; See the Form 10-K/A for further detail on the restatement.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">Management plans to implement measures designed to ensure that the deficiencies contributing to the ineffectiveness of our internal controls over financial reporting are promptly remediated, such
        that the internal controls are designed, implemented and operating effectively. The remediation actions planned include:</div>

      <div style="text-align: justify; text-indent: 36pt;"> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">36</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>hiring additional accounting personnel in a number, and with experience, to allow for proper segregation of duties and the accurate application of GAAP, including a chief financial officer, whom we hired in May of 2022;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>developing and implementing, and then monitoring the effectiveness of, written policies and procedures required to achieve our financial reporting objectives in a timely manner, including policies and procedures relating to internal
                control over financial reporting;</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>providing additional training to accounting personnel; and.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>consulting with an accounting advisor for technical, complex and non-recurring matters, with whom we have engaged and begun consulting.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">We are committed to developing a strong internal control environment, and we believe the remediation efforts that we have implemented and will implement will result in significant improvements in
        our control environment. We hired our Vice President of Finance in the second quarter of 2021 to oversee all accounting and financial reporting matters, including implementing a framework for internal controls over financial reporting, and we hired
        a full-time controller at the beginning of 2022. Also, during the fourth quarter of 2021, we engaged a third-party consulting firm with expertise in implementing the framework for internal controls over financial reporting, and we are making
        progress on developing this framework, including identifying key controls, creating process narratives or flowcharts, developing test plans, and beginning the testing of the key controls to ensure the framework is complete and effective. Our
        management will continue to monitor and evaluate the relevance of our risk-based approach and the effectiveness of our internal controls and procedures over financial reporting on an ongoing basis and is committed to taking further action and
        implementing additional enhancements or improvements, as necessary.</div>

      <div>&#160;</div>

      <div style="text-indent: 36pt; font-style: italic;">Changes in Internal Control over Financial Reporting</div>

      <div>&#160;</div>

      <div style="text-indent: 36pt;">Other than described above, there was no change in our internal control over financial reporting during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our
        internal control over financial reporting.</div>

      <div><br />
      </div>

      <div style="text-align: center; font-weight: bold;">PART II &#8212; OTHER INFORMATION</div>

      <div><br />
      </div>

      <a id="LegalProceedings."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45pt; vertical-align: top;"><span style="font-weight: bold;">Item 1.</span></td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Legal Proceedings.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">This information is set forth under &#8220;Note 9&#8212;Commitments and Contingencies&#8212;Legal Matters&#8221; to the condensed consolidated financial statements included in this Q2 2022 10-Q and is incorporated in this
        Item 1 by reference.</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">From time to time we may become involved in legal proceedings arising in the ordinary course of business. Except as described above, we do not believe there is any litigation pending that could
        have, individually or in the aggregate, a material adverse effect on our results of operations, financial condition or cash flows.</div>

      <div><br />
      </div>

      <a id="RiskFactors."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 1A.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Risk Factors.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;"><span style="color: #000000;">During the reporting period covered by this Quarterly Report on Form 10-Q, there have been no material changes to our risk factors as set forth in</span> the 10-K/A
        and Q1 2022 10-Q.</div>

      <div><br />
      </div>

      <a id="UnregisteredSalesofEquity"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45pt; vertical-align: top;"><span style="font-weight: bold;">Item 2.</span></td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">Unregistered Sales of Equity Securities and Use of Proceeds.</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-indent: 36pt;">None</div>

      <div style="text-indent: 36pt;"> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">37</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <a id="DefaultsUponSeniorSecurit"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">Item 3.</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-style: italic; font-weight: bold;">Defaults Upon Senior Securities.</div>
            </td>

  </tr>


</table>
      <div style="text-align: justify; text-indent: -55.45pt; margin-left: 55.45pt;"><br />
      </div>

      <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt;">None.</div>

      <div style="text-align: justify; text-indent: -55.45pt; margin-left: 55.45pt;"><br />
      </div>

      <a id="MineSafetyDisclosures."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45pt; vertical-align: top;"><span style="font-weight: bold; color: #000000;">Item 4.</span></td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-style: italic; font-weight: bold;">Mine Safety Disclosures.</div>
            </td>

  </tr>


</table>
      <div style="text-align: justify; text-indent: -55.45pt; margin-left: 55.45pt;"><br />
      </div>

      <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt;">Not Applicable.</div>

      <div style="text-align: justify; text-indent: -55.45pt; margin-left: 55.45pt;"><br />
      </div>

      <a id="OtherInformation."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45pt; vertical-align: top;"><span style="font-weight: bold; color: #000000;">Item 5.</span></td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-weight: bold;"><span style="font-style: italic;">Other Information</span>.</div>
            </td>

  </tr>


</table>
      <div style="text-align: justify; text-indent: -55.45pt; margin-left: 55.45pt;"><br />
      </div>

      <div style="color: rgb(0, 0, 0); text-indent: 36pt;">None.</div>

      <div><br />
      </div>

      <a id="Exhibits."><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 45pt; vertical-align: top; font-weight: bold;">Item 6.</td>

    <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;"><span style="font-style: italic;">Exhibits.</span></div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 8.01%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="font-weight: bold;">Exhibit</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 64%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="font-weight: bold;">Description</div>
            </td>

    <td style="width: 2%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 24.1%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="font-weight: bold;">Incorporated By</div>
              <div style="font-weight: bold;">Reference</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="https://www.sec.gov/Archives/edgar/data/0000748592/000114036122021148/brhc10038309_ex10-1.htm">10.1</a>*</div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 64%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: rgb(0, 0, 0); text-align: justify;">Amended and Restated Executive Employment Agreement, dated as of May 10, 2022, by and between Brooklyn ImmunoTherapeutics, Inc. and Andrew Jackson.</div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 24.1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Exhibit 10.1 to Form 8-K filed on May 31, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top;">
              <div><a href="https://www.sec.gov/Archives/edgar/data/0000748592/000114036122021148/brhc10038309_ex10-2.htm">10.2</a>*#</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 64%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); text-align: justify;">Separation Agreement and General Release, dated May 25, 2022, by and between Brooklyn ImmunoTherapeutics, Inc. and Howard J. Federoff.</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 24.1%; vertical-align: top;">
              <div style="text-align: justify;">Exhibit 10.2 to Form 8-K filed on May 31, 2022</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="brhc10040603_ex10-3.htm">10.3</a></div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 64%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Torrey Pines Science Center Lease, dated March 31, 2022, between Brooklyn ImmunoTherapeutics, Inc. and Torrey Pines Science Center Limited Partnership..</div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 24.1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top;">
              <div><a href="brhc10040603_ex31-1.htm">31.1</a></div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 64%; vertical-align: top;">
              <div style="text-align: justify;">Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 24.1%; vertical-align: top;">
              <div style="text-align: justify;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="brhc10040603_ex31-2.htm">31.2</a></div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 64%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 24.1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top;">
              <div><a href="brhc10040603_ex32-1.htm">32.1</a></div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 64%; vertical-align: top;">
              <div style="text-align: justify;">Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 24.1%; vertical-align: top;">
              <div style="text-align: justify;">Furnished herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="brhc10040603_ex32-2.htm">32.2</a></div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 64%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 24.1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Furnished herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top;">
              <div>101.INS</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 64%; vertical-align: top;">
              <div style="text-align: justify;">Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 24.1%; vertical-align: top;">
              <div style="text-align: justify;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>101.SCH</div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 64%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Inline XBRL Taxonomy Extension Schema Document</div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 24.1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top;">
              <div>101.CAL</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 64%; vertical-align: top;">
              <div style="text-align: justify;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 24.1%; vertical-align: top;">
              <div style="text-align: justify;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>101.DEF</div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 64%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Inline XBRL Taxonomy Extension Definition Linkbase Document</div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 24.1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top;">
              <div>101.LAB</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 64%; vertical-align: top;">
              <div style="text-align: justify;">Inline XBRL Taxonomy Extension Label Linkbase Document</div>
            </td>

    <td style="width: 2%; vertical-align: top;">&#160;</td>

    <td style="width: 24.1%; vertical-align: top;">
              <div style="text-align: justify;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>101.PRE</div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 64%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</div>
            </td>

    <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 24.1%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify;">Filed herewith</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8.01%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>104</div>
            </td>

    <td style="width: 2%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 64%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify;">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</div>
            </td>

    <td style="width: 2%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>

    <td style="width: 24.1%; vertical-align: top;">&#160;</td>

  </tr>


</table>
      <div><br />
      </div>

      <div style="text-align: justify;">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Management contract or compensation plan or arrangement</div>

      <div style="text-align: justify;">#&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Pursuant to Item 601(a)(5) of Regulation S-K, schedules and similar attachments to this exhibit have been omitted because they do not contain information material to an investment or voting decision and
        such information is not otherwise disclosed in such exhibit.&#160; The Company will supplementally provide a copy of any omitted schedule or similar attachment to the U.S. Securities and Exchange Commission or its staff upon request.</div>

      <div> <br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">38</span></div>

        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

        <div style="width: 100%;" class="DSPFPageHeader">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: italic;"> <a href="#TABLEOFCONTENTS">Table of Contents<br />
            </a></div>

        </div>

      </div>

      <a id="SIGNATURE"><!--Anchor--></a>
      <div style="text-align: center; font-weight: bold;">SIGNATURE</div>

      <div><br />
      </div>

      <div style="text-align: justify; text-indent: 36pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

      <div><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.95%; vertical-align: top;">&#160;</td>

    <td style="width: 50.05%; vertical-align: bottom;" colspan="2">
              <div style="text-align: justify;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.95%; vertical-align: middle;">&#160;</td>

    <td style="width: 3.1%; vertical-align: middle;">&#160;</td>

    <td style="width: 46.96%; vertical-align: middle;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.95%; vertical-align: top;">
              <div style="text-align: justify;">Date: August 11, 2022</div>
            </td>

    <td style="width: 3.1%; vertical-align: bottom;">
              <div style="text-align: justify;">By:</div>
            </td>

    <td style="width: 46.96%; vertical-align: bottom; border-bottom: #000000 2px solid;">
              <div style="text-align: justify;">/s/ Andrew Jackson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.95%; vertical-align: top;">&#160;</td>

    <td style="width: 3.1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.96%; vertical-align: bottom;">
              <div style="text-align: justify;">Andrew Jackson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.95%; vertical-align: top;">&#160;</td>

    <td style="width: 3.1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.96%; vertical-align: bottom;">
              <div style="text-align: justify;">Chief Financial Officer</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.95%; vertical-align: top;">&#160;</td>

    <td style="width: 3.1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46.96%; vertical-align: bottom;">
              <div style="text-align: justify;">(on behalf of the Registrant and as Principal Financial Officer)</div>
            </td>

  </tr>


</table>
      <div><br />
      </div>

    </div>

    <div><br />
    </div>

    <div>
      <div style="text-align: center;"> <span style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">39</span></div>

      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

  </div>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>brhc10040603_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%-%-%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div>
      <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.3</font><br>
      </div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;"><u>TORREY PINES SCIENCE CENTER</u></div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;"><u>LEASE</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 45pt;">This Lease (the "<font style="font-weight: bold;">Lease</font>"), dated as of the date set forth in <u>Section 1</u> of the Summary of Basic Lease Information (the "<font style="font-weight: bold;">Summary</font>"), below, is made by and between TORREY PINES SCIENCE CENTER LIMITED PARTNERSHIP, a Delaware limited partnership ("<font style="font-weight: bold;">Landlord</font>"), and BROOKLYN IMMUNOTHERAPEUTICS INC., a Delaware
        corporation ("<font style="font-weight: bold;">Tenant</font>").</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;"><u>SUMMARY OF BASIC LEASE INFORMATION</u></div>
      <div><br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zbba83e8234564a3592260ecafbc098ee">

          <tr>
            <td rowspan="1" colspan="2">
              <div style="text-align: left;">TERMS OF LEASE</div>
            </td>
            <td style="width: 35%;" rowspan="1" colspan="1"><br>
            </td>
            <td style="width: 50%;">
              <div style="text-align: left;">DESCRIPTION</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%;" rowspan="1"><br>
            </td>
            <td style="width: 35%;" rowspan="1" colspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1">1.<br>
            </td>
            <td rowspan="1" colspan="2">
              <div style="text-align: left;">Date:</div>
            </td>
            <td style="width: 50%;" rowspan="1">
              <div style="text-align: left;">March 31, 2022</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%;" rowspan="1"><br>
            </td>
            <td style="width: 35%;" rowspan="1" colspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1">2.<br>
            </td>
            <td rowspan="1" colspan="2">
              <div style="text-align: left;">Premises </div>
              <div style="text-align: left;">(<u>Article 1</u>).</div>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%;" rowspan="1"><br>
            </td>
            <td style="width: 35%;" rowspan="1" colspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%; text-align: left; vertical-align: top;" rowspan="1">
              <div>2.1</div>
            </td>
            <td style="width: 35%; text-align: left; vertical-align: top;" rowspan="1" colspan="1">
              <div>Building:</div>
            </td>
            <td style="width: 50%;" rowspan="1">
              <div style="text-align: justify;">That certain two (2)-story building located at 10355 Science Center Drive, San Diego, California 92121, containing a total of 46,488 rentable square feet.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%;" rowspan="1"><br>
            </td>
            <td style="width: 35%;" rowspan="1" colspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%; text-align: left; vertical-align: top;" rowspan="1">
              <div>2.2</div>
            </td>
            <td style="width: 35%; text-align: left; vertical-align: top;" rowspan="1" colspan="1">
              <div>Premises:</div>
            </td>
            <td style="width: 50%;" rowspan="1">
              <div style="text-align: left;">Approximately 5,193 rentable square feet of space located on the first (1st) floor of the Building and commonly known as Suite 150, as further set forth in<u>&#160;</u><font style="font-weight: bold;"><u>Exhibit A</u>&#160;</font>to


                the Lease.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%;" rowspan="1"><br>
            </td>
            <td style="width: 35%;" rowspan="1" colspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1">3.<br>
            </td>
            <td rowspan="1" colspan="2">
              <div style="text-align: left;">Lease Term </div>
              <div style="text-align: left;">(<u>Article 2</u>).</div>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%;" rowspan="1"><br>
            </td>
            <td style="width: 35%;" rowspan="1" colspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%;" rowspan="1">
              <div style="text-align: left;">3.1</div>
            </td>
            <td style="width: 35%;" rowspan="1" colspan="1">
              <div style="text-align: left;">Length of Term:</div>
            </td>
            <td style="width: 50%;" rowspan="1">
              <div style="text-align: left;">Five (5) years and two (2) months.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%;" rowspan="1"><br>
            </td>
            <td style="width: 35%;" rowspan="1" colspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%; text-align: left; vertical-align: top;" rowspan="1">
              <div>3.2</div>
            </td>
            <td style="width: 35%; text-align: left; vertical-align: top;" rowspan="1" colspan="1">
              <div>Lease Commencement Date:</div>
            </td>
            <td style="width: 50%;" rowspan="1">
              <div style="text-align: justify;">The earlier to occur of (i) the date upon which Tenant first commences to conduct business in the Premises and (ii) the Possession Date (as that term is defined in<u> Section 1.1.1</u> of this Lease), which
                Possession Date is anticipated to be August 1, 2022 (or earlier if the current tenant&#8217;s lease of the Premises can be terminated early, but in no event prior to April 1, 2022).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%;" rowspan="1"><br>
            </td>
            <td style="width: 35%;" rowspan="1" colspan="1"><br>
            </td>
            <td style="width: 50%;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 7%;" rowspan="1"><br>
            </td>
            <td style="width: 8%; text-align: left; vertical-align: top;" rowspan="1">
              <div>3.3</div>
            </td>
            <td style="width: 35%; text-align: left; vertical-align: top;" rowspan="1" colspan="1">
              <div>Lease Expiration Date:</div>
            </td>
            <td style="width: 50%;" rowspan="1">
              <div style="text-align: justify;">If the Lease Commencement Date shall be the first day of a calendar month, then the day immediately preceding the sixty-second (62nd) month anniversary of the Lease Commencement Date; or, if the Lease
                Commencement Date shall be other than the first day of a calendar month, then the last day of the month in which the sixty-second (62nd) month anniversary of the Lease Commencement Date occurs.</div>
            </td>
          </tr>

      </table>
      <div>
        <div> <br>
        </div>
        <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div id="DSPFPageFooter" style="width: 100%;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 50%; text-align: right; vertical-align: bottom;"><br>
                  </td>
                  <td style="width: 50%; font-size: 8pt;">
                    <div style="text-align: right;">HEALTHPEAK INC. </div>
                    <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                    <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                  </td>
                </tr>

            </table>
          </div>
          <div id="DSPFPageBreak" style="page-break-after:always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          <div style="width: 100%;" id="DSPFPageHeader"></div>
        </div>
      </div>
      <div> </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zfe1d437181e143b29b87f4342d5c6df8">

            <tr>
              <td style="width: 7%;">
                <div style="text-align: left;">4.</div>
              </td>
              <td style="width: 93%;">
                <div style="text-align: left;">Base Rent (<u>Article 3</u>):</div>
              </td>
            </tr>

        </table>
        <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" align="center" style="width: 80%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" id="zda98827e43a84d5f9d9db9294fa58622" class="cfttable">

            <tr>
              <td valign="bottom" style="vertical-align: bottom; width: 19%;">
                <div style="text-align: center;"><u>Lease Year</u></div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 18%;">
                <div style="text-align: center;">Annual</div>
                <div style="text-align: center;"><u>Base Rent</u></div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 18%;">
                <div style="text-align: center;">Monthly</div>
                <div style="text-align: center;">Installment</div>
                <div style="text-align: center;"><u>of Base Rent</u></div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 18%;">
                <div style="text-align: center;">Approximate</div>
                <div style="text-align: center;">Monthly Base</div>
                <div style="text-align: center;">Rent per Rentable</div>
                <div style="text-align: center;"><u>Square Foot*</u></div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: bottom; text-align: center; width: 19%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>1**</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
                <div><br>
                </div>
              </td>
              <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$395,706.60</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$32,975.55</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$6.35</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: bottom; text-align: center; width: 19%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: bottom; text-align: center; width: 19%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>2</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$407,577.84</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$33,964.82</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$6.54</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: bottom; text-align: center; width: 19%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: bottom; text-align: center; width: 19%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>3</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$419,805.12</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$34,983.76</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$6.74</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: bottom; text-align: center; width: 19%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: bottom; text-align: center; width: 19%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>4</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$432,399.24</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$36,033.27</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$6.94</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: bottom; text-align: center; width: 19%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: bottom; text-align: center; width: 19%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>5</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$445,371.24</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$37,114.27</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255); text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
                <div>$7.15</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: bottom; text-align: center; width: 19%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="text-align: right; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td nowrap="nowrap" style="vertical-align: bottom; width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; width: 18%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 19%; text-align: center;">
                <div>6 (2 months)</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="text-align: right; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; background-color: rgb(204, 238, 255); width: 18%;" colspan="1" class="cftnumcell">
                <div>$458,732.40</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; background-color: rgb(204, 238, 255); width: 18%;" colspan="1" class="cftnumcell">
                <div>$38,227.70</div>
              </td>
              <td nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1.13%; text-align: center;" colspan="1" class="cftfncell">&#160;</td>
              <td style="text-align: center; vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1.13%;" colspan="1" class="cftguttercell">&#160;</td>
              <td style="vertical-align: bottom; text-align: center; background-color: rgb(204, 238, 255); width: 18%;" colspan="1" class="cftnumcell">
                <div>$7.36</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; background-color: rgb(204, 238, 255); width: 1.13%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div> <br>
      </div>
      <div>* The calculation of the Monthly Base Rent per Rentable Square Foot reflects an annual increase of 3%, rounded to the nearest cent, after the previous Lease Year.</div>
      <div>&#160;</div>
      <div>** Tenant's obligation to pay Monthly Installment of Base Rent for the second (2nd) full calendar month and the third (3rd) full calendar month of the Lease Term shall be subject to the terms of <u>Section 3.2</u> of the Lease.</div>
      <div><br>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zb207c35152024f08804e9bccef242d85">

            <tr>
              <td style="width: 7%; text-align: left; vertical-align: top;">
                <div>5.</div>
              </td>
              <td style="width: 43%; text-align: left; vertical-align: top;">
                <div>Tenant Improvement Allowance (<font style="font-weight: bold;"><u>Exhibit B</u></font>):</div>
              </td>
              <td style="width: 50%;">
                <div style="text-align: left;">None. Tenant Improvements to be constructed on a</div>
                <div style="text-align: left;">turn-key basis pursuant to the Tenant Work Letter attached hereto as <font style="font-weight: bold;"><u>Exhibit B</u></font>.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%;"><br>
              </td>
              <td style="width: 43%;"><br>
              </td>
              <td style="width: 50%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 7%;">
                <div style="text-align: left;">6.</div>
              </td>
              <td style="width: 43%;">
                <div style="text-align: justify;">Tenant's Share</div>
                <div style="text-align: left;">(<u>Article 4</u>):</div>
              </td>
              <td style="width: 50%; text-align: left; vertical-align: bottom;">
                <div>Eleven and 17/100 percent (11.17%).</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%;"><br>
              </td>
              <td style="width: 43%;"><br>
              </td>
              <td style="width: 50%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; text-align: left; vertical-align: top;">
                <div>7.</div>
              </td>
              <td style="width: 43%; text-align: left; vertical-align: top;">
                <div>Permitted Use</div>
                <div>(<u>Article 5</u>):</div>
              </td>
              <td style="width: 50%;">
                <div style="text-align: left;">The Premises shall be used only for general office, research and development, engineering, laboratory, storage and/or warehouse uses, including, but not limited to, administrative offices and other lawful uses
                  reasonably related to or incidental to such specified uses, all (i) consistent with first class life sciences projects in the La Jolla area of San Diego, California ("<font style="font-weight: bold;">First Class Life Sciences Projects</font>"),


                  and (ii) in compliance with, and subject to, Applicable Laws as that term is defined in Article 24) and the terms of this Lease.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%;"><br>
              </td>
              <td style="width: 43%;"><br>
              </td>
              <td style="width: 50%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; text-align: left; vertical-align: top;">
                <div>8.</div>
              </td>
              <td style="width: 43%;">
                <div style="text-align: left;">Security Deposit</div>
                <div style="text-align: left;">(<u>Article 21</u>):</div>
              </td>
              <td style="width: 50%; text-align: left; vertical-align: bottom;">
                <div>$54,608.24</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7%;"><br>
              </td>
              <td style="width: 43%;"><br>
              </td>
              <td style="width: 50%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 7%; text-align: left; vertical-align: top;">9.<br>
              </td>
              <td style="width: 43%; text-align: left; vertical-align: top;">
                <div>Parking</div>
                <div>(<u>Article 28</u>):</div>
              </td>
              <td style="width: 50%;">
                <div style="text-align: left;">Fourteen (14) unreserved parking spaces at no cost to Tenant (other than those costs which are included within Direct Expenses) during the Lease Term and any Option Term, subject to the terms of <u>Article 28</u>
                  of the Lease.</div>
              </td>
            </tr>

        </table>
        <div><br>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-2-</font>-<br>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="page-break-after: always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            <div style="width: 100%;" id="DSPFPageHeader"></div>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 7%; text-align: left; vertical-align: top;">
                  <div>10.</div>
                </td>
                <td style="width: 43%; text-align: left; vertical-align: top;">
                  <div>Address of Tenant</div>
                  <div> (<u>Section 29.18</u>):</div>
                </td>
                <td style="width: 50%;">
                  <div style="text-align: left;">Brooklyn Immunotherapeutics Inc. </div>
                  <div style="text-align: left;">10531 4S Commons Dr, Suite 166-550 </div>
                  <div style="text-align: left;">San Diego, CA 92127</div>
                  <div style="text-align: left;">(Prior to Lease Commencement Date)</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7%;"><br>
                </td>
                <td style="width: 43%;"><br>
                </td>
                <td style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 7%;"><br>
                </td>
                <td style="width: 43%;"><br>
                </td>
                <td style="width: 50%;">
                  <div style="text-align: left;">and</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7%;"><br>
                </td>
                <td style="width: 43%;"><br>
                </td>
                <td style="width: 50%;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 7%;" rowspan="1"><br>
                </td>
                <td style="width: 43%;" rowspan="1"><br>
                </td>
                <td style="width: 50%;" rowspan="1">
                  <div style="text-align: left;">Brooklyn Immunotherapeutics Inc. </div>
                  <div style="text-align: left;">10355 Science Center Drive, Suite 150 </div>
                  <div style="text-align: left;">San Diego, CA 92121</div>
                  <div style="text-align: left;">(After Lease Commencement Date)</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7%;" rowspan="1"><br>
                </td>
                <td style="width: 43%;" rowspan="1"><br>
                </td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 7%; text-align: left; vertical-align: top;" rowspan="1">
                  <div>11.</div>
                </td>
                <td style="width: 43%;" rowspan="1">
                  <div style="text-align: left;">Address of Landlord</div>
                  <div style="text-align: left;">(<u>Section 29.18</u>):</div>
                </td>
                <td style="width: 50%;" rowspan="1">
                  <div style="text-align: left;">See <u>Section 29.18</u> of the Lease.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7%;" rowspan="1"><br>
                </td>
                <td style="width: 43%;" rowspan="1"><br>
                </td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 7%; text-align: left; vertical-align: top;" rowspan="1">
                  <div>12.</div>
                </td>
                <td style="width: 43%;" rowspan="1">
                  <div style="text-align: left;">Broker(s)</div>
                  <div style="text-align: left;">(<u>Section 29.24</u>):</div>
                </td>
                <td style="width: 50%; text-align: left; vertical-align: bottom;" rowspan="1">
                  <div><font style="font-weight: bold;"><u>Tenant</u></font>: Hughes Marino</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7%;" rowspan="1"><br>
                </td>
                <td style="width: 43%;" rowspan="1"><br>
                </td>
                <td style="width: 50%;" rowspan="1"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 7%;" rowspan="1"><br>
                </td>
                <td style="width: 43%;" rowspan="1"><br>
                </td>
                <td style="width: 50%;" rowspan="1">
                  <div style="text-align: left;"><font style="font-weight: bold;"><u>Landlord</u></font>: None.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div><br>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-3-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z9938c486ed8f41fbb2f6c7ebf4d9738f" class="DSPFListTable">

              <tr style="vertical-align: top;">
                <td style="vertical-align: top; width: 36pt;">
                  <div style="font-weight: bold;"><font style="font-weight: bold;">1.</font></div>
                </td>
                <td style="align: left; vertical-align: top; width: auto;">
                  <div style="font-weight: bold; text-align: justify;">PREMISES, BUILDING, PROJECT, AND COMMON AREAS</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify;">&#160;</div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zd2783f44c5b74d118d79963f4e484e0e" class="DSPFListTable">

              <tr style="vertical-align: top;">
                <td style="width: 36pt; text-align: justify;">&#160;</td>
                <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: justify;">1.1</div>
                </td>
                <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: justify;"><font style="font-weight: bold;"><u>Premises, Building, Project and Common Areas</u></font>.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">1.1.1&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>The Premises</u></font>. Landlord hereby leases to Tenant and Tenant hereby leases from Landlord the premises set forth in <u>Section 2.2</u> of the
        Summary (the "<font style="font-weight: bold;">Premises</font>"). The outline of the Premises is set forth in<u>&#160;</u><font style="font-weight: bold;"><u>Exhibit A</u>&#160;</font>attached hereto. The outline of the "Building" and the "Project," as those
        terms are defined in <u>Section 1.1.2</u> below, are further depicted on the Site Plan attached hereto as <font style="font-weight: bold;"><u>Exhibit A-1</u></font>. The parties hereto agree that the lease of the Premises is upon and subject to
        the terms, covenants and conditions herein set forth, and Tenant covenants as a material part of the consideration for this Lease to keep and perform each and all of such terms, covenants and conditions by it to be kept and performed and that this
        Lease is made upon the condition of such performance. The parties hereto hereby acknowledge that the purpose of <font style="font-weight: bold;"><u>Exhibit A</u>&#160;</font>is to show the approximate location of the Premises only, and such Exhibit is
        not meant to constitute an agreement, representation or warranty as to the construction of the Premises, the precise area thereof or the specific location of the "Common Areas," as that term is&#160; defined&#160; in <u> Section 1.1.3</u>, below, or the
        elements thereof or of the accessways to the Premises or the "Project," as that term is defined in <u>Section 1.1.2</u>, below. Except as specifically set forth in this Lease and in the Tenant Work Letter attached hereto as <font style="font-weight: bold;"><u>Exhibit B</u>&#160;</font>(the "<font style="font-weight: bold;">Tenant Work Letter</font>"), Landlord shall tender possession of the Premises to Tenant in its existing, "as is" condition, and Landlord shall not be
        obligated to provide or pay for any improvement work or services related to the improvement of the Premises. Landlord shall be deemed to have tendered possession of the Premises to Tenant upon the date the Premises is &#8220;Ready for Occupancy,&#8221; as such
        term is defined in the Tenant Work Letter (the ""<font style="font-weight: bold;">Possession Date</font>"), and no action by Tenant shall be required therefor. If for any reason, Landlord is delayed in tendering possession of the Premises to Tenant
        by any particular date, Landlord shall not be subject to any liability for such failure, and the validity of this Lease shall not be impaired. Neither Landlord nor any agent of Landlord has made any representation or warranty regarding the
        condition of the Premises, the Building or the Project or with respect to the suitability of any of the foregoing for the conduct of Tenant's business, except as specifically set forth in this Lease and the Tenant Work Letter. Any process utilities
        shall be provided without warranty, in their currently existing, "as-is" condition.</div>
      <div style="text-indent: 72pt; text-align: justify;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">1.1.2&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>The Building and The Project</u></font>. The Premises constitutes a portion of the building set forth in <u>Section 2.1</u> of the Summary (the "<font style="font-weight: bold;">Building</font>"). The Building is part of an office/laboratory project currently known as "Torrey Pines Science Center." The term "<font style="font-weight: bold;">Project</font>," as used in this Lease, shall mean (i)
        the Building and the Common Areas, (ii) the land (which is improved with landscaping, parking facilities and other improvements) upon which the Building and the Common Areas are located, and (iii) at Landlord's discretion, any additional real
        property, areas, land, buildings or other improvements added thereto outside of the Project.</div>
      <div style="text-indent: 72pt; text-align: justify;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">1.1.3&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Common Areas</u></font>. Tenant shall have the non-exclusive right to use in common with other tenants in the Project, and subject to the rules and
        regulations referred to in <u>Article 5</u> of this Lease, those portions of the Project which are provided, from time to time, for use in common by Landlord, Tenant and any other tenants of the Project (such areas, together with such other
        portions of the Project designated by Landlord, in its discretion, are collectively referred to herein as the "<font style="font-weight: bold;">Common Areas</font>"). The manner in which the Common Areas are maintained and operated shall be at the
        sole discretion of Landlord and the use thereof shall be subject to such rules, regulations and restrictions as Landlord may make from time to time. Landlord reserves the right to close temporarily, make alterations or additions to, or change the
        location of elements of the Project and the Common Areas.</div>
      <div style="text-indent: 72pt; text-align: justify;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">1.2&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Rentable Square Feet of Premises</u></font>. The rentable square footage of the Premises is hereby deemed to be as set forth in <u>Section 2.2</u> of
        the Summary, and shall not be subject to measurement or adjustment during the Lease Term.</div>
      <div style="text-align: justify;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z60d6bdf12a44442bb9650fef02330258" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: justify;"><a name="z_TOC_250014"></a><font style="font-weight: bold;">2.</font></td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold; text-align: justify;">LEASE TERM; OPTION TERM</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Lease Term</u></font>. The terms and provisions of this Lease shall be effective as of the date of this Lease. The term of this Lease (the "<font style="font-weight: bold;">Lease Term</font>") shall be as set forth in <u>Section 3.1</u> of the Summary, shall commence on the date set forth in <u>Section 3.2</u> of the Summary (the "<font style="font-weight: bold;">Lease Commencement Date</font>"),


        and shall terminate on the date set forth in <u>Section 3.3</u> of the Summary (the "<font style="font-weight: bold;">Lease Expiration Date</font>") unless this Lease is sooner terminated as hereinafter provided. For purposes of this Lease, the
        term "<font style="font-weight: bold;">Lease Year</font>" shall mean each consecutive twelve (12) month period during the Lease Term. At any time during the Lease Term, Landlord may deliver to Tenant a notice in the form as set forth in <font style="font-weight: bold;"><u>Exhibit C</u></font>, attached hereto, as a confirmation only of the information set forth therein, which Tenant shall execute and return to Landlord within ten (10) business days of receipt thereof.</div>
      <div style="text-align: justify;">&#160;</div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-4-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div>
      <div style="margin-left: 36pt; text-align: justify;">2.2 &#160; &#160; &#160; &#160;&#160; <font style="font-weight: bold;"><u>Option Term</u></font>.</div>
    </div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">2.2.1&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Option Right</u></font>. Landlord hereby grants to the originally named Tenant herein ("<font style="font-weight: bold;">Original Tenant</font>"), and
      any assignee or Original Tenant&#8217;s entire interest in this Lease pursuant to the terms and condition of Section 14.8, below (a &#8220;<font style="font-weight: bold;">Permitted Transferee Assignee</font>&#8221;), one (1) option to extend the Lease Term for the
      entire Premises for a period of five (5) years (the "<font style="font-weight: bold;">Option Term</font>"), which option shall be irrevocably exercised only by written notice delivered by Tenant to Landlord not earlier than twelve (12) months and not
      later than nine (9) months prior to the expiration of the initial Lease Term, provided that the following conditions <font style="font-weight: bold;">(</font>the "<font style="font-weight: bold;">Option Conditions</font>") are satisfied: (i) as of
      the date of delivery of such notice, Tenant is not in default under this Lease beyond any applicable notice and cure period expressly set forth in this Lease; (ii) Tenant is not in default under this Lease beyond any applicable notice and cure period
      expressly set forth in this Lease at the time Landlord and Tenant execute an amendment to this Lease extending the Lease Term for the Option Term, and as of the end of the Lease Term, Tenant is not in default under this Lease beyond any applicable
      notice and cure period expressly set forth in this Lease; (iii) Tenant has not previously been in default under this Lease, beyond applicable notice and cure periods expressly set forth in this Lease, more than once in the prior twelve (12) month
      period; and (iv) the Lease then remains in full force and effect and Original Tenant occupies the entire Premises at the time the option to extend is exercised and as of the commencement of the Option Term. Landlord may, at Landlord's option,
      exercised in Landlord's sole and absolute discretion, waive any of the Option Conditions in which case the option, if otherwise properly exercised by Tenant, shall remain in full force and effect. Upon the proper exercise of such option to extend,
      and provided that Tenant satisfies all of the Option Conditions (except those, if any, which are waived by Landlord), the Lease Term, as it applies to the Premises, shall be extended for a period of five (5) years. The rights contained in this <u>Section


        2.2</u> shall be personal to Original Tenant and any Permitted Transferee Assignee and may be exercised by Original Tenant or a Permitted Transferee Assignee only (and not by any other assignee, sublessee or "Transferee," as that term is defined in
      <u>Section 14.1</u> of this Lease, of Tenant's interest in this Lease).</div>
    <div style="text-indent: 72pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">2.2.2&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Option Rent</u></font>. The annual Rent payable by Tenant during the Option Term (the "<font style="font-weight: bold;">Option Rent</font>") shall be
      equal to the "Fair Rental Value," as that term is defined below, for the Premises as of the commencement date of the Option Term; provided, however, that the base rent component of Fair Rental Value, shall not be lower than one hundred three percent
      (103%) of the annual then existing "Base Rent," as that term is set forth in <u>Section 3.1</u> of this Lease in effect immediately prior to the commencement of such Option Term (and the Option Rent shall increase by three percent (3%) per year
      during the Option Term on each anniversary of the commencement of the Option Term). The "<font style="font-weight: bold;">Fair Rental Value</font>," as used in this Lease, shall be equal to the annual rent per rentable square foot (including
      additional rent and considering any "base year" or "expense stop" applicable thereto), including all escalations, at which tenants (pursuant to leases consummated within the twelve (12) month period preceding the first day of the Option Term), are
      leasing non-sublease, non-encumbered, non-equity space which is not significantly greater or smaller in size than the subject space, for a comparable lease term, in an arm's length transaction, which comparable space is located in the "Comparable
      Buildings," as that term is defined in this <u>Section 2.2.2</u>, below (transactions satisfying the foregoing criteria shall be known as the "<font style="font-weight: bold;">Comparable Transactions</font>"), taking into consideration the following
      concessions (the "<font style="font-weight: bold;">Concessions</font>"): (a) rental abatement concessions, if any, being granted such tenants in connection with such comparable space; (b) tenant improvements or allowances provided or to be provided
      for such comparable space, and taking into account the value, if any, of the existing improvements in the subject space, such value to be based upon the age, condition, design, quality of finishes and layout of the improvements and the extent to
      which the same can be utilized by a general office user other than Tenant; and (c) other reasonable monetary concessions being granted such tenants in connection with such comparable space; provided, however, that in calculating the Fair Rental
      Value, no consideration shall be given to (i) the fact that Landlord is or is not required to pay a real estate brokerage commission in connection with Tenant's exercise of its right to extend the Lease Term, or the fact that landlords are or are not
      paying real estate brokerage commissions in connection with such comparable space, and (ii) any period of rental abatement, if any, granted to tenants in comparable transactions in connection with the design, permitting and construction of tenant
      improvements in such comparable spaces. The Fair Rental Value shall additionally include a determination as to whether, and if so to what extent, Tenant must provide Landlord with financial security, such as a letter of credit or guaranty, for
      Tenant's Rent obligations in connection with Tenant's lease of the Premises during the Option Term. Such determination shall be made by reviewing the extent of financial security then generally being imposed in Comparable Transactions from tenants of
      comparable financial condition and credit history to the then existing financial condition and credit history of Tenant (with appropriate adjustments to account for differences in the then-existing financial condition of Tenant and such other
      tenants). The Concessions (A) shall be reflected in the effective rental rate (which effective rental rate shall take into consideration the total dollar value of such Concessions as amortized on a straight-line basis over the applicable term of the
      Comparable Transaction (in which case such Concessions evidenced in the effective rental rate shall not be granted to Tenant)) payable by Tenant, or (B) at Landlord&#8217;s election, all such Concessions shall be granted to Tenant in kind. Notwithstanding
      the foregoing, during the Option Term, the Option Rent shall increase by three percent (3%) per annum on each anniversary of the first (1st) day of the Option Term. The term "<font style="font-weight: bold;">Comparable Buildings</font>" shall mean
      the Building and those other first-class institutionally-owned life sciences buildings located in the Torrey Pines market area of San Diego, California that are comparable in age (based on the date of original construction or the latest major
      renovation) location, quality of construction, services and amenities.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-5-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">2.2.3&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Determination of Option Rent</u></font>. In the event Tenant timely and appropriately exercises an option to extend the Lease Term, Landlord shall
      notify Tenant of Landlord's determination of the Option Rent on or before the Lease Expiration Date. If Tenant, on or before the date which is thirty (30) days following the date upon which Tenant receives Landlord's determination of the Option Rent,
      in good faith objects to Landlord's determination of the Option Rent, then Landlord and Tenant shall attempt to agree upon the Option Rent using their best good-faith efforts. If Landlord and Tenant fail to reach agreement on or before the
      commencement of the Option Term (the "<font style="font-weight: bold;">Outside Agreement Date</font>"), then each party shall make a separate determination of the Option Rent, within five (5) days, and such determinations shall be submitted to
      arbitration in accordance with <u>Sections 2.2.3.1</u> through <u>2.2.3.7</u>, below. If Tenant fails to object to Landlord's determination of the Option Rent within the time period set forth herein, then Tenant shall be deemed to have accepted
      Landlord's determination of Option Rent.</div>
    <div style="text-indent: 72pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">2.2.3.1&#160;&#160; Landlord and Tenant shall each appoint one arbitrator who shall be, at the option of the appointing party, a real estate broker, appraiser or attorney who shall have been active over the
      five (5) year period ending on the date of such appointment in the leasing or appraisal, as the case may be, of comparable commercial life science buildings in the La Jolla area of San Diego, California. The determination of the arbitrators shall be
      limited solely to the issue of whether Landlord's or Tenant's submitted Option Rent is the closest to the actual Option Rent, taking into account the requirements of <u>Section 2.2.2</u> of this Lease, as determined by the arbitrators. Each such
      arbitrator shall be appointed within fifteen (15) days after the Outside Agreement Date. Landlord and Tenant may consult with their selected arbitrators prior to appointment and may select an arbitrator who is favorable to their respective positions.
      The arbitrators so selected by Landlord and Tenant shall be deemed "<font style="font-weight: bold;">Advocate Arbitrators</font>."</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">2.2.3.2&#160;&#160; The two (2) Advocate Arbitrators so appointed shall be specifically required pursuant to an engagement letter within ten (10) days of the date of the appointment of the last appointed
      Advocate Arbitrator to agree upon and appoint a third arbitrator ("<font style="font-weight: bold;">Neutral Arbitrator</font>") who shall be qualified under the same criteria set forth hereinabove for qualification of the two Advocate Arbitrators,
      except that neither the Landlord or Tenant or either parties' Advocate Arbitrator may, directly or indirectly, consult with the Neutral Arbitrator prior or subsequent to his or her appearance. The Neutral Arbitrator shall be retained via an
      engagement letter jointly prepared by Landlord's counsel and Tenant&#8217;s counsel.</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">2.2.3.3&#160;&#160; The three arbitrators shall, within thirty (30) days of the appointment of the Neutral Arbitrator, reach a decision as to whether the parties shall use Landlord's or Tenant's submitted
      Option Rent, and shall notify Landlord and Tenant thereof.</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 108pt;">2.2.3.4&#160;&#160; The decision of the majority of the three arbitrators shall be binding upon Landlord and Tenant.</div>
    </div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div>
      <div style="text-align: justify; text-indent: 108pt;">2.2.3.5 &#160;&#160; If either Landlord or Tenant fails to appoint an Advocate Arbitrator within fifteen (15) days after the Outside Agreement Date, then either party may petition the presiding judge of the
        Superior Court of San Diego County to appoint such Advocate Arbitrator subject to the criteria in <u>Section 2.2.3.1</u> of this Lease, or if he or she refuses to act, either party may petition any judge having jurisdiction over the parties to
        appoint such Advocate Arbitrator.</div>
      <div style="margin-right: 43.85pt; margin-left: 5.95pt;"> <br>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-6-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">2.2.3.6&#160;&#160; If the two (2) Advocate Arbitrators fail to agree upon and appoint the Neutral Arbitrator within ten (10) business days following the date of the appointment of the last appointed Advocate
      Arbitrator, then either party may petition the presiding judge of the Superior Court of San Diego County to appoint the Neutral Arbitrator, subject to criteria in <u>Section 2.2.3.2</u> of this Lease, or if he or she refuses to act, either party may
      petition any judge having jurisdiction over the parties to appoint such arbitrator.</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div>
      <div style="text-indent: 108pt; text-align: justify;">2.2.3.7 &#160;&#160; The cost of the arbitration shall be paid by Landlord and Tenant equally.</div>
    </div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">2.2.3.8&#160; &#160; In the event that the Option Rent shall not have been determined pursuant to the terms hereof prior to the commencement of the Option Term, Tenant shall be required to pay the Option Rent
      initially provided by Landlord to Tenant, and upon the final determination of the Option Rent, the payments made by Tenant shall be reconciled with the actual amounts of Option Rent due, and the appropriate party shall make any corresponding payment
      to the other party.</div>
    <div style="text-align: justify;">&#160;</div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zba75561a9e8d4983b2d84112d4ecb9f5" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="vertical-align: top; width: 36pt;">
                <div style="font-weight: bold; text-align: justify;"><font style="font-weight: bold;">3.</font></div>
              </td>
              <td style="align: left; vertical-align: top; width: auto;">
                <div style="font-weight: bold; text-align: justify;">BASE RENT</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Base Rent</u></font>. Tenant shall pay, without prior notice or demand, to Landlord or Landlord's agent at the management office of the Project, or,
      at Landlord's option, at such other place as Landlord may from time to time designate in writing, by a check for currency which, at the time of payment, is legal tender for private or public debts in the United States of America, base rent ("Base
      Rent") as set forth in Section 4 of the Summary, payable in equal monthly installments as set forth in Section 4 of the Summary in advance on or before the first day of each and every calendar month during the Lease Term, without any setoff or
      deduction whatsoever. The Base Rent and Tenant's Share of the estimated Direct Expenses (as those terms are defined in <u>Sections 4.2.6</u> and <u>4.2.2</u> of this Lease) for the first full month of the Lease Term in an amount equal to $47,105.55
      (i.e., $32,975.55 for the Base Rent and $14,130.00 for Tenant's Share of the estimated Direct Expenses for the first full month of the Lease Term) shall be paid at the time of Tenant's execution of this Lease. If any Rent payment date (including the
      Lease Commencement Date) falls on a day of the month other than the first day of such month or if any payment of Rent is for a period which is shorter than one month, the Rent for any fractional month shall accrue on a daily basis for the period from
      the date such payment is due to the end of such calendar month or to the end of the Lease Term at a rate per day which is equal to 1/365 of the applicable annual Rent. All other payments or adjustments required to be made under the terms of this
      Lease that require proration on a time basis shall be prorated on the same basis.</div>
    <div style="text-indent: 36pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Abated Base Rent</u></font>. Provided that Tenant is not then in default of this Lease beyond any applicable notice and cure period expressly set
      forth in this Lease, then during the second (2nd) full calendar month and third (3rd) full calendar month of the Lease Term (the &#8220;<font style="font-weight: bold;">Rent Abatement Period</font>&#8221;), Tenant shall not be obligated to pay any Base Rent
      otherwise attributable to the Premises during such Rent Abatement Period (the &#8220;<font style="font-weight: bold;">Rent Abatement</font>&#8221;). Landlord and Tenant acknowledge that the aggregate amount of the Rent Abatement equals $65,951.10. Tenant
      acknowledges and agrees that the foregoing Rent Abatement has been granted to Tenant as additional consideration for entering into this Lease, and for agreeing to pay the rental and performing the terms and conditions otherwise required under this
      Lease. If Tenant shall be in default under this Lease, and shall fail to cure such default within the notice and cure period, if any, permitted for cure pursuant to the express terms and conditions of the Lease, then the dollar amount of the
      unapplied portion of the Rent Abatement as of the date of such default shall be converted to a credit to be applied to the Base Rent applicable at the end of the Lease Term and Tenant shall immediately be obligated to begin paying Base Rent for the
      Premises in full. In addition, if this Lease is terminated for any reason other than a default by Landlord, then for purposes of determining Landlord&#8217;s damages under Section 1951 of the California Civil Code, if any, the dollar amount of the
      unapplied portion of the Rent Abatement as of the date of such termination shall be converted to a credit to be applied to the Base Rent applicable at the end of the Lease Term.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-7-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z70234764740c44b38c6ab768eabbbac8" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="vertical-align: top; width: 36pt;">
                <div style="font-weight: bold; text-align: justify;"><font style="font-weight: bold;">4.</font></div>
              </td>
              <td style="align: left; vertical-align: top; width: auto;">
                <div style="font-weight: bold; text-align: justify;">ADDITIONAL RENT</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify;">&#160;</div>
    <div>
      <div style="text-indent: 36pt; text-align: justify;">4.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>General Terms</u></font>.</div>
    </div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">4.1.1 &#160; &#160;&#160; <font style="font-weight: bold;"><u>Direct Expenses; Additional Rent</u></font>. In addition to paying the Base Rent specified in<u> Article 3</u> of this Lease, Tenant shall pay "<font style="font-weight: bold;">Tenant's Share</font>" of the annual "<font style="font-weight: bold;">Direct Expenses</font>," as those terms are defined in <u>Sections 4.2.6 and 4.2.2</u> of this Lease, respectively. Such payments by Tenant, together
      with any and all other amounts payable by Tenant to Landlord pursuant to the terms of this Lease, are hereinafter collectively referred to as the "<font style="font-weight: bold;">Additional Rent</font>", and the Base Rent and the Additional Rent are
      herein collectively referred to as "<font style="font-weight: bold;">Rent</font>." All amounts due under this <u>Article 4</u> as Additional Rent shall be payable for the same periods and in the same manner as the Base Rent. Without limitation on
      other obligations of Tenant which survive the expiration of the Lease Term, the obligations of Tenant to pay the Additional Rent provided for in this <u>Article 4</u> shall survive the expiration of the Lease Term.</div>
    <div style="text-indent: 72pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">4.1.2&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Triple Net Lease</u></font>. Landlord and Tenant acknowledge that, except as otherwise provided to the contrary in this Lease, it is their intent and
      agreement that this Lease be a "<font style="font-weight: bold;">TRIPLE NET</font>" lease and that as such, the provisions contained in this Lease are intended to pass on to Tenant or reimburse Landlord for the costs and expenses reasonably
      associated with this Lease, the Building and the Project, and Tenant's operation therefrom. To the extent such costs and expenses payable by Tenant cannot be charged directly to, and paid by, Tenant, such costs and expenses shall be paid by Landlord
      but reimbursed by Tenant as Additional Rent.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Definitions of Key Terms Relating to Additional Rent</u></font>. As used in this <u>Article 4</u>, the following terms shall have the meanings
      hereinafter set forth:</div>
    <div style="text-align: justify;">&#160;</div>
    <div>
      <div style="text-indent: 72pt; text-align: justify;">4.2.1&#160;&#160; &#160; &#160; Intentionally Deleted.</div>
    </div>
    <div style="text-indent: 72pt; text-align: justify;">&#160;</div>
    <div>
      <div style="text-indent: 72pt; text-align: justify;">4.2.2&#160;&#160;&#160;&#160;&#160;&#160; "<font style="font-weight: bold;">Direct Expenses</font>" shall mean "<font style="font-weight: bold;">Operating Expenses</font>" and "<font style="font-weight: bold;">Tax Expenses</font>."</div>
    </div>
    <div style="text-indent: 72pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">4.2.3&#160;&#160;&#160;&#160;&#160; "<font style="font-weight: bold;">Expense Year</font>" shall mean each calendar year in which any portion of the Lease Term falls, through and including the calendar year in which the
      Lease Term expires, provided that Landlord, upon notice to Tenant, may change the Expense Year from time to time to any other twelve (12) consecutive month period, and, in the event of any such change, Tenant's Share of Direct Expenses shall be
      equitably adjusted for any Expense Year involved in any such change.</div>
    <div style="text-indent: 72pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">4.2.4&#160;&#160;&#160; &#160; "<font style="font-weight: bold;">Operating Expenses</font>" shall mean all expenses, costs and amounts of every kind and nature which Landlord pays or accrues during any Expense Year
      because of or in connection with the ownership, management, maintenance, security, repair, replacement, restoration or operation of the Project, or any portion thereof. Without limiting the generality of the foregoing, Operating Expenses shall
      specifically include any and all of the following: (i) the cost of supplying all utilities, the cost of operating, repairing, maintaining, and renovating the utility, telephone, mechanical, sanitary, storm drainage, and elevator systems, and the cost
      of maintenance and service contracts in connection therewith; (ii) the cost of licenses, certificates, permits and inspections and the cost of contesting any governmental enactments which may affect Operating Expenses, and the costs incurred in
      connection with a governmentally mandated transportation system management program or similar program; (iii) the cost of all insurance carried by Landlord in connection with the Project and Premises as reasonably determined by Landlord; (iv) the cost
      of landscaping, relamping, and all supplies, tools, equipment and materials used in the operation, repair and maintenance of the Project, or any portion thereof; (v) the cost of parking area operation, repair, restoration, and maintenance; (vi) fees
      and other costs, including management and/or incentive fees, consulting fees, legal fees and accounting fees, of all contractors and consultants in connection with the management, operation, maintenance and repair of the Project; (vii) payments under
      any equipment rental agreements and the fair rental value of any management office space; (viii) subject to item (f), below, wages, salaries and other compensation and benefits, including taxes levied thereon, of all persons engaged in the operation,
      maintenance and security of the Project; (ix) costs under any instrument pertaining to the sharing of costs by the Project; (x) operation, repair, maintenance and replacement of all systems and equipment and components thereof of the Project; (xi)
      the cost of janitorial, alarm, security and other services, replacement of wall and floor coverings, ceiling tiles and fixtures in common areas, maintenance and replacement of curbs and walkways, repair to roofs and re-roofing; (xii) amortization
      (including interest on the unamortized cost) over such period of time as Landlord shall reasonably determine, of the cost of acquiring or the rental expense of personal property used in the maintenance, operation and repair of the Project, or any
      portion thereof; (xiii) the cost of capital improvements or other costs incurred in connection with the Project (A) which are intended to effect economies in the operation or maintenance of the Project, or any portion thereof, or to reduce current or
      future Operating Expenses or to enhance the safety or security of the Project or its occupants, (B) that are required to comply with present or anticipated conservation programs, (C) which are replacements or modifications of nonstructural items
      located in the Common Areas required to keep the Common Areas in good order or condition, (D) that are required under any governmental law or regulation, or (E) which are repairs, replacements or modifications to the Building Systems (as defined in <u>Section


        7.1</u>, below); provided, however, that any capital expenditure shall be amortized (including interest on the amortized cost) over such period of time as Landlord shall reasonably determine; and (xiv) costs, fees, charges or assessments imposed
      by, or resulting from any mandate imposed on Landlord by, any federal, state or local government for fire and police protection, trash removal, community services, or other services which do not constitute "Tax Expenses" as that term is defined in <u>Section


        4.2.5</u>, below, (xv) cost of tenant relation programs reasonably established by Landlord, and (xvi) payments under any easement, license, operating agreement, declaration, restrictive covenant, or instrument pertaining to the sharing of costs by
      the Building, including, without limitation, any covenants, conditions and restrictions affecting the property, and reciprocal easement agreements affecting the property, any parking licenses, and any agreements with transit agencies affecting the
      Property (collectively, "<font style="font-weight: bold;">Underlying Documents</font>"). Notwithstanding the foregoing, for purposes of this Lease, Operating Expenses shall not, however, include:</div>
    <div style="text-align: justify; text-indent: 72pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-8-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(a)&#160;&#160; &#160; &#160;&#160;&#160; costs, including legal fees, space planners' fees, advertising and promotional expenses (except as otherwise set forth above), and brokerage fees incurred in connection with the original
      construction or development, or original or future leasing of the Project, and costs, including permit, license and inspection costs, incurred with respect to the installation of tenant improvements made for new tenants initially occupying space in
      the Project after the Lease Commencement Date or incurred in renovating or otherwise improving, decorating, painting or redecorating vacant space for tenants or other occupants of the Project (excluding, however, such costs relating to any common
      areas of the Project or parking facilities);</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; except as set forth in items (xii), (xiii), and (xiv) above, depreciation, interest and principal payments on mortgages and other debt costs, if any, penalties and interest;</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; costs for which the Landlord is reimbursed by any tenant or occupant of the Project or by insurance by its carrier or any tenant's carrier or by anyone else, and electric power costs for
      which any tenant directly contracts with the local public service company;</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div>
      <div style="text-indent: 108pt; text-align: justify;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any bad debt loss, rent loss, or reserves for bad debts or rent loss;</div>
    </div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(e)&#160; &#160;&#160; &#160;&#160;&#160; costs associated with the operation of the business of the partnership or entity which constitutes the Landlord, as the same are distinguished from the costs of operation of the Project
      (which shall specifically include, but not be limited to, accounting costs associated with the operation of the Project). Costs associated with the operation of the business of the partnership or entity which constitutes the Landlord include costs of
      partnership accounting and legal matters, costs of defending any lawsuits with any mortgagee (except as the actions of the Tenant may be in issue), costs of selling, syndicating, financing, mortgaging or hypothecating any of the Landlord's interest
      in the Project, and costs incurred in connection with any disputes between Landlord and its employees, between Landlord and Project management, or between Landlord and other tenants or occupants;</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(f)&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160; the wages and benefits of any employee who does not devote substantially all of his or her employed time to the Project unless such wages and benefits are prorated to reflect time spent
      on operating and managing the Project vis-a-vis time spent on matters unrelated to operating and managing the Project; provided, that in no event shall Operating Expenses for purposes of this Lease include wages and/or benefits attributable to
      personnel above the level of Project manager;</div>
    <div style="text-indent: 36pt; text-align: justify;">&#160;</div>
    <div>
      <div style="text-indent: 108pt; text-align: justify;">(g) &#160; &#160;&#160; &#160; &#160; amount paid as ground rental for the Project by the Landlord;</div>
      <div> <br>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-9-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;except for a Project management fee to the extent allowed pursuant to item (l) below, overhead and profit increment paid to the Landlord or to subsidiaries or affiliates of the Landlord
      for services in the Project to the extent the same exceeds the costs of such services rendered by qualified, first-class unaffiliated third parties on a competitive basis;</div>
    <div style="text-indent: 108pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(i)&#160;&#160;&#160;&#160;&#160; &#160; &#160; any compensation paid to clerks, attendants or other persons in commercial concessions operated by the Landlord, provided that any compensation paid to any concierge at the Project
      shall be includable as an Operating Expense;</div>
    <div style="text-indent: 108pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(j)&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; rentals and other related expenses incurred in leasing air conditioning systems, elevators or other equipment which if purchased the cost of which would be excluded from Operating
      Expenses as a capital cost, except equipment not affixed to the Project which is used in providing engineering, janitorial or similar services and, further excepting from this exclusion such equipment rented or leased to remedy or ameliorate an
      emergency condition in the Project ;</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160; all items and services for which Tenant or any other tenant in the Project reimburses Landlord or which Landlord provides selectively to one or more tenants (other than Tenant) without
      reimbursement;</div>
    <div style="text-align: justify;">&#160;</div>
    <div>
      <div style="text-indent: 108pt; text-align: justify;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any costs expressly excluded from Operating Expenses elsewhere in this Lease;</div>
    </div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160; rent for any office space occupied by Project management personnel to the extent the size or rental rate of such office space exceeds the size or fair market rental value of office space
      occupied by management personnel of the comparable buildings in the vicinity of the Building, with adjustment where appropriate for the size of the applicable project;</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;costs arising from the gross negligence or willful misconduct of Landlord in connection with this Lease; and</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;costs incurred to comply with laws relating to the removal of hazardous material (as defined under applicable law) which was in existence in the Building or on the Project prior to the
      Lease Commencement Date, and was of such a nature that a federal, State or municipal governmental authority, if it had then had knowledge of the presence of such hazardous material, in the state, and under the conditions that it then existed in the
      Building or on the Project, would have then required the removal of such hazardous material or other remedial or containment action with respect thereto; and costs incurred to remove, remedy, contain, or treat hazardous material, which hazardous
      material is brought into the Building or onto the Project after the date hereof by Landlord or any other tenant of the Project and is of such a nature, at that time, that a federal, State or municipal governmental authority, if it had then had
      knowledge of the presence of such hazardous material, in the state, and under the conditions, that it then exists in the Building or on the Project, would have then required the removal of such hazardous material or other remedial or containment
      action with respect thereto.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">If Landlord is not furnishing any particular work or service (the cost of which, if performed by Landlord, would be included in Operating Expenses) to a tenant who has undertaken to perform such work
      or service in lieu of the performance thereof by Landlord, Operating Expenses shall be deemed to be increased by an amount equal to the additional Operating Expenses which would reasonably have been incurred during such period by Landlord if it had
      at its own expense furnished such work or service to such tenant. If the Project is not at least one hundred percent (100%) occupied during all or a portion of any Expense Year, Landlord shall make an appropriate adjustment to the components of
      Operating Expenses for such year to determine the amount of Operating Expenses that would have been incurred had the Project been one hundred percent (100%) occupied; and the amount so determined shall be deemed to have been the amount of Operating
      Expenses for such year.</div>
    <div>&#160;</div>
    <div>
      <div style="text-indent: 72pt;">4.2.5 &#160; &#160; &#160; <font style="font-weight: bold;"><u>Taxes</u></font>.</div>
    </div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">4.2.5.1&#160; "<font style="font-weight: bold;">Tax Expenses</font>" shall mean all federal, state, county, or local governmental or municipal taxes, fees, charges or other impositions of every kind and
      nature, whether general, special, ordinary or extraordinary (including, without limitation, real estate taxes, general and special assessments, transit taxes, leasehold taxes or taxes based upon the receipt of rent, including gross receipts or sales
      taxes applicable to the receipt of rent, unless required to be paid by Tenant, personal property taxes imposed upon the fixtures, machinery, equipment, apparatus, systems and equipment, appurtenances, furniture and other personal property used in
      connection with the Project, or any portion thereof), which shall be paid or accrued during any Expense Year (without regard to any different fiscal year used by such governmental or municipal authority) because of or in connection with the
      ownership, leasing and operation of the Project, or any portion thereof.</div>
    <div> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-10-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">4.2.5.2&#160;&#160; Tax Expenses shall include, without limitation: (i) Any tax on the rent, right to rent or other income from the Project, or any portion thereof, or as against the business of leasing the
      Project, or any portion thereof; (ii) Any assessment, tax, fee, levy or charge in addition to, or in substitution, partially or totally, of any assessment, tax, fee, levy or charge previously included within the definition of real property tax; (iii)
      Any assessment, tax, fee, levy, or charge allocable to or measured by the area of the Premises or the Rent payable hereunder, including, without limitation, any business or gross income tax or excise tax with respect to the receipt of such rent, or
      upon or with respect to the possession, leasing, operating, management, maintenance, alteration, repair, use or occupancy by Tenant of the Premises, or any portion thereof; and (iv) Any assessment, tax, fee, levy or charge, upon this transaction or
      any document to which Tenant is a party, creating or transferring an interest or an estate in the Premises or the improvements thereon.</div>
    <div style="text-indent: 108pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">4.2.5.3&#160;&#160; Any costs and expenses (including, without limitation, reasonable attorneys' and consultants' fees) incurred in attempting to protest, reduce or minimize Tax Expenses shall be included in
      Tax Expenses in the Expense Year such expenses are incurred. Tax refunds shall be credited against Tax Expenses and refunded to Tenant regardless of when received, based on the Expense Year to which the refund is applicable, provided that in no event
      shall the amount to be refunded to Tenant for any such Expense Year exceed the total amount paid by Tenant as Additional Rent under this Article 4 for such Expense Year. If Tax Expenses for any period during the Lease Term or any extension thereof
      are increased after payment thereof for any reason, including, without limitation, error or reassessment by applicable governmental or municipal authorities, Tenant shall pay Landlord upon demand Tenant's Share of any such increased Tax Expenses.
      Notwithstanding anything to the contrary contained in this<u> Section 4.2.5</u>, there shall be excluded from Tax Expenses (i) all excess profits taxes, franchise taxes, gift taxes, capital stock taxes, inheritance and succession taxes, estate taxes,
      federal and state income taxes, and other taxes to the extent applicable to Landlord's net income (as opposed to rents, receipts or income attributable to operations at the Project), (ii) any items included as Operating Expenses, and (iii) any items
      paid by Tenant under <u>Section 4.5</u> of this Lease.</div>
    <div>&#160;</div>
    <div>
      <div style="text-indent: 72pt;">4.2.6 "<font style="font-weight: bold;">Tenant's Share</font>" shall mean the percentage set forth in <u>Section 6</u> of the Summary.</div>
    </div>
    <div>&#160;</div>
    <div>
      <div style="text-indent: 36pt;">4.3 &#160; &#160; &#160; &#160; <font style="font-weight: bold;"><u>Allocation of Direct Expenses</u></font>.</div>
    </div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">4.3.1&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Method of Allocation</u></font>. The parties acknowledge that the Building is a part of a multi- building project and that the costs and expenses
      incurred in connection with the Project (i.e., the Direct Expenses) should be shared between the Building and the other buildings in the Project. Accordingly, as set forth in <u>Section 4.2</u> above, Direct Expenses (which consist of Operating
      Expenses and tax Expenses) are determined annually for the Project as a whole, and a portion of the Direct Expenses, which portion shall be determined by Landlord on an equitable basis, shall be allocated to the Building (as opposed to other
      buildings in the Project). Such portion of Direct Expenses allocated to the Building shall include all Direct Expenses attributable solely to the Building and an equitable portion of the Direct Expenses attributable to the Project as a whole, and
      shall not include Direct Expenses attributable solely to other buildings in the Project.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">4.3.2&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Cost Pools</u></font>. Landlord shall have the right, from time to time, to equitably allocate some or all of the Direct Expenses for the Project among
      different portions or occupants of the Project (the "<font style="font-weight: bold;">Cost Pools</font>"), in Landlord's reasonable discretion. Such Cost Pools may include, but shall not be limited to, the office space tenants of a building of the
      Project or of the Project, and the laboratory space tenants of a building of the Project or of the Project. The Direct Expenses within each such Cost Pool shall be allocated and charged to the tenants within such Cost Pool in an equitable manner.</div>
    <div style="text-align: justify; text-indent: 72pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-11-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-indent: 36pt;">4.4&#160; &#160; &#160;&#160;&#160; <font style="font-weight: bold;"><u>Calculation and Payment of Additional Rent</u></font>. Tenant shall pay to Landlord, in the manner set forth in <u>Section 4.4.1</u>, below, and as Additional Rent,
      Tenant's Share of Direct Expenses for each Expense Year.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">4.4.1&#160; &#160; &#160; <font style="font-weight: bold;"><u>Statement of Actual Direct Expenses and Payment by Tenant</u></font>. Landlord shall give to Tenant following the end of each Expense Year, a statement
      (the "<font style="font-weight: bold;">Statement</font>") prepared on a line-item by line-item basis as to general categories, which shall state the Direct Expenses incurred or accrued for such preceding Expense Year, and which shall indicate the
      amount of Tenant's Share of Direct Expenses. Upon receipt of the Statement for each Expense Year commencing or ending during the Lease Term, Tenant shall pay, within thirty (30) days, the full amount of Tenant's Share of Direct Expenses for such
      Expense Year, less the amounts, if any, paid during such Expense Year as "<font style="font-weight: bold;">Estimated Direct Expenses</font>," as that term is defined in <u>Section 4.4.2</u>, below, and if Tenant paid more as Estimated Direct
      Expenses than the actual Tenant's Share of Direct Expenses, Tenant shall receive a credit in the amount of Tenant's overpayment against Rent next due under this Lease. The failure of Landlord to timely furnish the Statement for any Expense Year shall
      not prejudice Landlord or Tenant from enforcing its rights under this <u>Article</u><u> 4.</u> Even though the Lease Term has expired and Tenant has vacated the Premises, when the final determination is made of Tenant's Share of Direct Expenses for
      the Expense Year in which this Lease terminates, Tenant shall pay to Landlord such amount within thirty (30) days of demand therefor, and if Tenant paid more as Estimated Direct Expenses than the actual Tenant's Share of Direct Expenses, Landlord
      shall, within thirty (30) days, deliver a check payable to Tenant in the amount of the overpayment or apply such overpayment against any unpaid Rent. The provisions of this <u>Section 4.4.1</u> shall survive the expiration or earlier termination of
      the Lease Term.</div>
    <div style="text-indent: 72pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">4.4.2&#160;&#160;&#160; <font style="font-weight: bold;"><u>Statement of Estimated Direct Expenses</u></font>. In addition, Landlord shall give Tenant a yearly expense estimate statement (the "<font style="font-weight: bold;">Estimate Statement</font>") which shall set forth Landlord's reasonable estimate (the "<font style="font-weight: bold;">Estimate</font>"), prepared on a line-item by line-item basis as to general categories, of what the
      total amount of Direct Expenses for the then-current Expense Year shall be and the estimated Tenant's Share of Direct Expenses (the "<font style="font-weight: bold;">Estimated Direct Expenses</font>"). The failure of Landlord to timely furnish the
      Estimate Statement for any Expense Year shall not preclude Landlord from enforcing its rights to collect any Estimated Direct Expenses under this <u>Article 4</u>, nor shall Landlord be prohibited from revising any Estimate Statement or Estimated
      Direct Expenses theretofore delivered to the extent necessary. Thereafter, Tenant shall pay, with its next installment of Base Rent due, a fraction of the Estimated Direct Expenses for the then-current Expense Year (reduced by any amounts paid
      pursuant to the last sentence of this <u>Section 4.4.2</u>). Such fraction shall have as its numerator the number of months which have elapsed in such current Expense Year, including the month of such payment, and twelve (12) as its denominator.
      Until a new Estimate Statement is furnished (which Landlord shall have the right to deliver to Tenant at any time), Tenant shall pay monthly, with the monthly Base Rent installments, an amount equal to one-twelfth (1/12) of the total Estimated Direct
      Expenses set forth in the previous Estimate Statement delivered by Landlord to Tenant.</div>
    <div style="text-align: justify;">&#160;</div>
    <div>
      <div style="text-indent: 36pt; text-align: justify;">4.5 &#160; &#160; &#160; &#160; <font style="font-weight: bold;"><u>Taxes and Other Charges for Which Tenant Is Directly Responsible</u></font>.</div>
    </div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">4.5.1&#160;&#160;&#160;&#160;&#160;&#160; Tenant shall be liable for and shall pay ten (10) days before delinquency, taxes levied against Tenant's equipment, furniture, fixtures and any other personal property located in or about
      the Premises. If any such taxes on Tenant's equipment, furniture, fixtures and any other personal property are levied against Landlord or Landlord's property or if the assessed value of Landlord's property is increased by the inclusion therein of a
      value placed upon such equipment, furniture, fixtures or any other personal property and if Landlord pays the taxes based upon such increased assessment, which Landlord shall have the right to do regardless of the validity thereof but only under
      proper protest if requested by Tenant, Tenant shall upon demand repay to Landlord the taxes so levied against Landlord or the proportion of such taxes resulting from such increase in the assessment, as the case may be.</div>
    <div style="text-indent: 72pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">4.5.2&#160;&#160;&#160;&#160;&#160; If the tenant improvements in the Premises, whether installed and/or paid for by Landlord or Tenant and whether or not affixed to the real property so as to become a part thereof, are
      assessed for real property tax purposes at a valuation higher than the valuation at which tenant improvements conforming to Landlord's "building standard" in other space in the Building are assessed, then the Tax Expenses levied against Landlord or
      the property by reason of such excess assessed valuation shall be deemed to be taxes levied against personal property of Tenant and shall be governed by the provisions of <u>Section 4.5.1</u>, above.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">4.5.3&#160;&#160;&#160;&#160;&#160; Notwithstanding any contrary provision herein, Tenant shall pay prior to delinquency any (i) rent tax or sales tax, gross receipts tax, service tax, transfer tax or value added tax,
      business tax or any other applicable tax on the rent or services herein or otherwise respecting this Lease, (ii) taxes assessed upon or with respect to the possession, leasing, operation, management, maintenance, alteration, repair, use or occupancy
      by Tenant of the Premises or any portion of the Project, including the Project parking facility; or (iii) taxes assessed upon this transaction or any document to which Tenant is a party creating or transferring an interest or an estate in the
      Premises.</div>
    <div style="text-indent: 72pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-12-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">4.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Landlord&#8217;s Books and Records</u></font>. Upon Tenant's written request (an "<font style="font-weight: bold;">Audit Request</font>") given not more
      than sixty (60) days after Tenant's receipt of a Statement for a particular Expense Year, and provided that Tenant is not then in default under this Lease, beyond any applicable notice and cure period expressly set forth in this Lease, Landlord shall
      furnish Tenant with such reasonable supporting documentation in connection with said Direct Expenses. Landlord shall provide said information to Tenant within sixty (60) days after Tenant's written request therefor. Within sixty (60) days after
      receipt of such information by Tenant (the "<font style="font-weight: bold;">Review Period</font>"), if Tenant disputes the amount of Direct Expenses set forth in the Statement, an independent Certified Public Accountant (which accountant (A) is a
      Certified Public Accountant, (B) is a member of a nationally recognized accounting firm, and (C) is not working on a contingency fee basis), designated and paid for by Tenant, may, after reasonable notice to Landlord and at reasonable times, inspect
      Landlord's records with respect to the Statement at Landlord's offices, provided that Tenant is not then in default under this Lease, beyond any applicable notice and cure period expressly set forth in this Lease, and Tenant has paid all amounts
      required to be paid under the applicable Estimate Statement and Statement, as the case may be. In connection with such inspection, Tenant and Tenant's agents must agree in advance to follow Landlord's reasonable rules and procedures regarding
      inspections of Landlord's records, and shall execute a commercially reasonable confidentiality agreement regarding such inspection. Tenant's failure to dispute the amount of Direct Expenses set forth in any Statement within the Review Period shall be
      deemed to be Tenant's approval of such Statement and Tenant, thereafter, waives the right or ability to dispute the amounts set forth in such Statement. If after such inspection, Tenant still disputes such Additional Rent, a determination as to the
      proper amount shall be made, at Tenant's expense, by an independent Certified Public Accountant (the "<font style="font-weight: bold;">Accountant</font>") selected by Landlord and subject to Tenant's reasonable approval; provided that if such
      determination by the Accountant proves that Direct Expenses were overstated by more than five percent (5%), then the cost of the Accountant shall be paid for by Landlord. Tenant hereby acknowledges that Tenant's sole right to inspect Landlord's books
      and records and to contest the amount of Direct Expenses payable by Tenant shall be as set forth in this <u>Section 4.6</u> and in no event shall Tenant have the right to inspect Landlord's books and records and/or contest the amount of Direct
      Expenses payable by Tenant more than one (1) time for any Expense Year, and Tenant hereby waives any and all other rights pursuant to applicable law to inspect such books and records and/or to contest the amount of Direct Expenses payable by Tenant.</div>
    <div>&#160;</div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="za01f54c76dcc42e9a562b3f200c1817f" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="vertical-align: top; width: 36pt;">
                <div style="font-weight: bold;"><font style="font-weight: bold;">5.</font></div>
              </td>
              <td style="align: left; vertical-align: top; width: auto;">
                <div style="font-weight: bold;">USE OF PREMISES</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Permitted Use</u></font>. Tenant shall use the Premises solely for the Permitted Use set forth in <u>Section 7</u> of the Summary and Tenant shall not
      use or permit the Premises or the Project to be used for any other purpose or purposes whatsoever without the prior written consent of Landlord, which may be withheld in Landlord's sole discretion.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">5.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Prohibited Uses</u></font>. Tenant further covenants and agrees that Tenant shall not use, or suffer or permit any person or persons to use, the
      Premises or any part thereof for any use or purpose in violation of the laws of the United States of America, the State of California, or the ordinances, regulations or requirements of the local municipal or county governing body or other lawful
      authorities having jurisdiction over the Project) including, without limitation, any such laws, ordinances, regulations or requirements relating to hazardous materials or substances, as those terms are defined by Applicable Laws now or hereafter in
      effect, or any Underlying Documents. Landlord shall have the right to impose reasonable and customary rule and regulations regarding the use of the Project, as reasonably deemed necessary by Landlord with respect to the orderly operation of the
      Project, and Tenant shall comply with such reasonable rules and regulations. Tenant shall not do or permit anything to be done in or about the Premises which will in any way damage the reputation of the Project or obstruct or interfere with the
      rights of other tenants or occupants of the Building, or injure or annoy them or use or allow the Premises to be used for any improper, unlawful or objectionable purpose, nor shall Tenant cause, maintain or permit any nuisance in, on or about the
      Premises. Tenant shall comply with, and Tenant's rights and obligations under the Lease and Tenant's use of the Premises shall be subject and subordinate to, all recorded easements, covenants, conditions, and restrictions now or hereafter affecting
      the Project.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-13-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div>
      <div style="text-indent: 36pt;">5.3 &#160; &#160; &#160; &#160; <font style="font-weight: bold;"><u>Hazardous Materials</u></font>.</div>
    </div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div>
      <div style="text-indent: 72pt;">5.3.1 &#160; &#160; &#160; <font style="font-weight: bold;"><u>Tenant's Obligations</u></font>.</div>
    </div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">5.3.1.1&#160;&#160; <font style="font-weight: bold;"><u>Prohibitions</u></font>. As a material inducement to Landlord to enter into this Lease with Tenant, Tenant has fully and accurately completed
      Landlord&#8217;s Pre-Leasing Environmental Exposure Questionnaire (the &#8220;<font style="font-weight: bold;">Environmental Questionnaire</font>&#8221;), which is attached as <font style="font-weight: bold;"><u>Exhibit E</u></font>. Tenant agrees that except for
      those chemicals or materials, and their respective quantities, specifically listed on the Environmental Questionnaire, neither Tenant nor Tenant&#8217;s employees, contractors and subcontractors of any tier, entities with a contractual relationship with
      Tenant (other than Landlord), or any entity acting as an agent or sub-agent of Tenant (collectively, "<font style="font-weight: bold;">Tenant's Agents</font>") will produce, use, store or generate any "Hazardous Materials," as that term is defined
      below, on, under or about the Premises, nor cause or permit any Hazardous Material to be brought upon, placed, stored, manufactured, generated, blended, handled, recycled, used or "Released," as that term is defined below, on, in, under or about the
      Premises. If any information provided to Landlord by Tenant on the Environmental Questionnaire, or otherwise relating to information concerning Hazardous Materials is false, incomplete, or misleading in any material respect, the same shall be deemed
      an Event of Default by Tenant under this Lease. Landlord&#8217;s prior written consent shall be required to any Hazardous Materials use for the Premises not described on the initial Environmental Questionnaire, such consent to be withheld in Landlord&#8217;s
      sole discretion. Tenant shall not install or permit any underground storage tank on the Premises. For purposes of this Lease, "<font style="font-weight: bold;">Hazardous Materials</font>" means all flammable explosives, petroleum and petroleum
      products, waste oil, radon, radioactive materials, toxic pollutants, asbestos, polychlorinated biphenyls (&#8220;<font style="font-weight: bold;">PCBs</font>&#8221;), medical waste, chemicals known to cause cancer or reproductive toxicity, pollutants,
      contaminants, hazardous wastes, toxic substances or related materials, including without limitation any chemical, element, compound, mixture, solution, substance, object, waste or any combination thereof, which is or may be hazardous to human health,
      safety or to the environment due to its radioactivity, ignitability, corrosiveness, reactivity, explosiveness, toxicity, carcinogenicity, infectiousness or other harmful or potentially harmful properties or effects, or defined as, regulated as or
      included in, the definition of &#8220;hazardous substances,&#8221; &#8220;hazardous wastes,&#8221; &#8220;hazardous materials,&#8221; or &#8220;toxic substances&#8221; under any Environmental Laws. The term &#8220;Hazardous Materials&#8221; for purposes of this Lease shall also include any mold, fungus or
      spores, whether or not the same is defined, listed, or otherwise classified as a &#8220;hazardous material&#8221; under any Environmental Laws, if such mold, fungus or spores may pose a risk to human health or the environment or negatively impact the value of
      the Premises. For purposes of this Lease, "<font style="font-weight: bold;">Release</font>" or "<font style="font-weight: bold;">Released</font>" or "<font style="font-weight: bold;">Releases</font>" shall mean any release, deposit, discharge,
      emission, leaking, spilling, seeping, migrating, injecting, pumping, pouring, emptying, escaping, dumping, disposing, or other movement of Hazardous Materials into the environment.</div>
    <div style="text-indent: 108pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">5.3.1.2&#160;&#160;&#160; <font style="font-weight: bold;"><u>Notices to Landlord</u></font>. Tenant shall notify Landlord in writing as soon as possible but in no event later than five (5) days after (i) the
      occurrence of any actual, alleged or threatened Release of any Hazardous Material in, on, under, from, about or in the vicinity of the Premises (whether past or present), regardless of the source or quantity of any such Release, or (ii) Tenant
      becomes aware of any regulatory actions, inquiries, inspections, investigations, directives, or any cleanup, compliance, enforcement or abatement proceedings (including any threatened or contemplated investigations or proceedings) relating to or
      potentially affecting the Premises, or (iii) Tenant becomes aware of any claims by any person or entity relating to any Hazardous Materials in, on, under, from, about or in the vicinity of the Premises, whether relating to damage, contribution, cost
      recovery, compensation, loss or injury. Collectively, the matters set forth in clauses (i), (ii) and (iii) above are hereinafter referred to as &#8220;<font style="font-weight: bold;">Hazardous Materials Claims</font>&#8221;. Tenant shall promptly forward to
      Landlord copies of all orders, notices, permits, applications and other communications and reports in connection with any Hazardous Materials Claims. Additionally, Tenant shall promptly advise Landlord in writing of Tenant&#8217;s discovery of any
      occurrence or condition on, in, under or about the Premises that could subject Tenant or Landlord to any liability, or restrictions on ownership, occupancy, transferability or use of the Premises under any "Environmental Laws," as that term is
      defined below. Tenant shall not enter into any legal proceeding or other action, settlement, consent decree or other compromise with respect to any Hazardous Materials Claims without first notifying Landlord of Tenant&#8217;s intention to do so and
      affording Landlord the opportunity to join and participate, as a party if Landlord so elects, in such proceedings and in no event shall Tenant enter into any agreements which are binding on Landlord or the Premises without Landlord&#8217;s prior written
      consent. Landlord shall have the right to appear at and participate in, any and all legal or other administrative proceedings concerning any Hazardous Materials Claim. For purposes of this Lease, &#8220;<font style="font-weight: bold;">Environmental Laws</font>&#8221;
      means all applicable present and future laws relating to the protection of human health, safety, wildlife or the environment, including, without limitation, (i) all requirements pertaining to reporting, licensing, permitting, investigation and/or
      remediation of emissions, discharges, Releases, or threatened Releases of Hazardous Materials, whether solid, liquid, or gaseous in nature, into the air, surface water, groundwater, or land, or relating to the manufacture, processing, distribution,
      use, treatment, storage, disposal, transport, or handling of Hazardous Materials; and (ii) all requirements pertaining to the health and safety of employees or the public. Environmental Laws include, but are not limited to, the Comprehensive
      Environmental Response, Compensation and Liability Act of 1980, 42 USC &#167; 9601, et seq., the Hazardous Materials Transportation Authorization Act of 1994, 49 USC &#167; 5101, et seq., the Solid Waste Disposal Act, as amended by the Resource Conservation
      and Recovery Act of 1976, and Hazardous and Solid Waste Amendments of 1984, 42 USC &#167; 6901, et seq., the Federal Water Pollution Control Act, as amended by the Clean Water Act of 1977, 33 USC &#167; 1251, et seq., the Clean Air Act of 1966, 42 USC &#167; 7401,
      et seq., the Toxic Substances Control Act of 1976, 15 USC &#167; 2601, et seq., the Safe Drinking Water Act of 1974, 42 USC &#167;&#167; 300f through 300j, the Occupational Safety and Health Act of 1970, as amended, 29 USC &#167; 651 et seq., the Oil Pollution Act of
      1990, 33 USC &#167; 2701 et seq., the Emergency Planning and Community Right-To-Know Act of 1986, 42 USC &#167; 11001 et seq., the National Environmental Policy Act of 1969, 42 USC &#167; 4321 et seq., the Federal Insecticide, Fungicide and Rodenticide Act of 1947,
      7 USC &#167; 136 et seq., California Carpenter-Presley-Tanner Hazardous Substance Account Act, California Health &amp; Safety Code &#167;&#167; 25300 et seq., Hazardous Materials Release Response Plans and Inventory Act, California Health &amp; Safety Code, &#167;&#167;
      25500 et seq., Underground Storage of Hazardous Substances provisions, California Health &amp; Safety Code, &#167;&#167; 25280 et seq., California Hazardous Waste Control Law, California Health &amp; Safety Code, &#167;&#167; 25100 et seq., and any other state or local
      law counterparts, as amended, as such Applicable Laws, are in effect as of the Lease Commencement Date, or thereafter adopted, published, or promulgated.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-14-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">5.3.1.3&#160;&#160; <font style="font-weight: bold;"><u>Releases of Hazardous Materials</u></font>. If any Release of any Hazardous Material in, on, under, from or about the Premises shall occur at any time
      during the Lease and/or if any other Hazardous Material condition exists at the Premises that requires response actions of any kind, in addition to notifying Landlord as specified above, Tenant, at its own sole cost and expense, shall (i) immediately
      comply with any and all reporting requirements imposed pursuant to any and all Environmental Laws, (ii) provide a written certification to Landlord indicating that Tenant has complied with all applicable reporting requirements, (iii) take any and all
      necessary investigation, corrective and remedial action in accordance with any and all applicable Environmental Laws, utilizing an environmental consultant approved by Landlord, all in accordance with the provisions and requirements of this<u>
        Section 5.3</u>, including, without limitation, <u>Section 5.3.4</u>, and (iv) take any such additional investigative, remedial and corrective actions as Landlord shall in its reasonable discretion deem necessary such that the Premises are
      remediated to the condition existing prior to such Release.</div>
    <div>&#160;</div>
    <div>
      <div style="text-indent: 108pt;">5.3.1.4&#160;&#160; <font style="font-weight: bold;"><u>Indemnification</u></font>.</div>
    </div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 144pt;">5.3.1.4.1&#160;&#160;&#160; <font style="font-weight: bold;"><u>In General</u></font>. Without limiting in any way Tenant&#8217;s obligations under any other provision of this Lease, Tenant shall be solely responsible
      for and shall protect, defend, indemnify and hold the Landlord Parties harmless from and against any and all claims, judgments, losses, damages, costs, expenses, penalties, enforcement actions, taxes, fines, remedial actions, liabilities (including,
      without limitation, actual attorneys&#8217; fees, litigation, arbitration and administrative proceeding costs, expert and consultant fees and laboratory costs) including, without limitation, consequential damages and sums paid in settlement of claims,
      which arise during or after the Lease Term, whether foreseeable or unforeseeable, that arise during or after the Lease Term in whole or in part, foreseeable or unforeseeable, directly or indirectly arising out of or attributable to the presence, use,
      generation, manufacture, treatment, handling, refining, production, processing, storage, Release or presence of Hazardous Materials in, on, under or about the Premises by Tenant or Tenant's Agents.</div>
    <div style="text-indent: 144pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 144pt;">5.3.1.4.2&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Limitations</u></font>. Notwithstanding anything in <u>Section 5.3.1.4</u>, above, to the contrary, Tenant's indemnity of Landlord as set forth in
      <u>Section 5.3.1.4</u>, above, shall not be applicable to claims based upon Hazardous Materials which may exist in, on or about the Premises as of the date of this Lease ("<font style="font-weight: bold;">Existing Hazardous Materials</font>"), except
      to the extent that Tenant's construction activities and/or Tenant's other acts (including Tenant's failure to remove, remediate or otherwise treat or &#8220;Clean-up,&#8221; as that term is defined in <u>Section 5.3.4</u>, below, the subject Existing Hazardous
      Materials during the tenancy of the Premises) caused or exacerbated the subject claim but only to the extent Tenant is notified of the Existing Hazardous Materials by Landlord.</div>
    <div style="text-align: justify; text-indent: 144pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-15-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">5.3.1.5&#160;&#160; <font style="font-weight: bold;"><u>Compliance with Environmental Laws</u></font>. Without limiting the generality of Tenant&#8217;s obligation to comply with Applicable Laws as otherwise
      provided in this Lease, Tenant shall, at its sole cost and expense, comply with all Environmental Laws. Tenant shall obtain and maintain any and all necessary permits, licenses, certifications and approvals appropriate or required for the use,
      handling, storage, and disposal of any Hazardous Materials used, stored, generated, transported, handled, blended, or recycled by Tenant on the Premises. Landlord shall have a continuing right, without obligation, to require Tenant to obtain, and to
      review and inspect any and all such permits, licenses, certifications and approvals, together with copies of any and all Hazardous Materials management plans and programs, any and all Hazardous Materials risk management and pollution prevention
      programs, and any and all Hazardous Materials emergency response and employee training programs respecting Tenant&#8217;s use of Hazardous Materials. Upon request of Landlord, Tenant shall deliver to Landlord a narrative description explaining the nature
      and scope of Tenant&#8217;s activities involving Hazardous Materials and showing to Landlord&#8217;s satisfaction compliance with all Environmental Laws and the terms of this Lease.</div>
    <div style="text-align: justify;">&#160;</div>
    <div>
      <div style="text-indent: 72pt; text-align: justify;">5.3.2&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Assurance of Performance</u></font>.</div>
    </div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">5.3.2.1&#160; <font style="font-weight: bold;"><u>Environmental Assessments In General</u></font>. Landlord may, but shall not be required to, engage from time to time such contractors as Landlord
      determines to be appropriate to perform environmental assessments of a scope reasonably determined by Landlord (an "<font style="font-weight: bold;">Environmental Assessment</font>") to ensure Tenant&#8217;s compliance with the requirements of this Lease
      with respect to Hazardous Materials. .</div>
    <div style="text-indent: 108pt; text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">5.3.2.2&#160; <font style="font-weight: bold;"><u>Costs of Environmental Assessments</u></font>. All costs and expenses incurred by Landlord in connection with any such Environmental Assessment
      initially shall be paid by Landlord; provided that if any such Environmental Assessment shows that Tenant has failed to comply with the provisions of this <u>Section 5.3</u>, then all of the costs and expenses of such Environmental Assessment shall
      be reimbursed by Tenant as Additional Rent within ten (10) days after receipt of written demand therefor.</div>
    <div style="text-align: justify;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">5.3.3&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Tenant&#8217;s Obligations upon Surrender</u></font>. At the expiration or earlier termination of the Lease Term, Tenant, at Tenant&#8217;s sole cost and expense,
      shall: (i) cause all Hazardous Materials to be removed from the Premises and disposed of in accordance with all Environmental Laws and as necessary to allow the Premises to be used for any purpose; and (ii) cause to be removed all containers
      installed or used by Tenant or Tenant&#8217;s Agents to store any Hazardous Materials on the Premises, and cause to be repaired any damage to the Premises caused by such removal.</div>
    <div>&#160;</div>
    <div>
      <div style="text-indent: 72pt;">5.3.4 &#160; &#160;&#160; <font style="font-weight: bold;"><u>Clean-up</u></font>.</div>
    </div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">5.3.4.1&#160; <font style="font-weight: bold;"><u>Environmental Reports; Clean-Up</u></font>. If any written report, including any report containing results of any Environmental Assessment (an &#8220;<font style="font-weight: bold;">Environmental Report</font>&#8221;) shall indicate (i) the presence of any Hazardous Materials as to which Tenant has a removal or remediation obligation under this <u>Section 5.3</u>, and (ii) that as a result of same, the
      investigation, characterization, monitoring, assessment, repair, closure, remediation, removal, or other clean-up (the &#8220;<font style="font-weight: bold;">Clean-up</font>&#8221;) of any Hazardous Materials is required, Tenant shall immediately prepare and
      submit to Landlord within thirty (30) days after receipt of the Environmental Report a comprehensive plan, subject to Landlord&#8217;s written approval, specifying the actions to be taken by Tenant to perform the Clean-up so that the Premises are restored
      to the conditions required by this Lease. Upon Landlord&#8217;s approval of the Clean-up plan, Tenant shall, at Tenant&#8217;s sole cost and expense, without limitation on any rights and remedies of Landlord under this Lease, immediately implement such plan with
      a consultant reasonably acceptable to Landlord and proceed to Clean-Up Hazardous Materials in accordance with all Applicable Laws and as required by such plan and this Lease. If, within thirty (30) days after receiving a copy of such Environmental
      Report, Tenant fails either (a) to complete such Clean- up, or (b) with respect to any Clean-up that cannot be completed within such thirty-day period, fails to proceed with diligence to prepare the Clean-up plan and complete the Clean-up as promptly
      as practicable, then Landlord shall have the right, but not the obligation, and without waiving any other rights under this Lease, to carry out any Clean-up recommended by the Environmental Report or required by any governmental authority having
      jurisdiction over the Premises, and recover all of the costs and expenses thereof from Tenant as Additional Rent, payable within ten (10) days after receipt of written demand therefor.</div>
    <div style="text-align: justify; text-indent: 108pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-16-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 108pt;">5.3.4.2&#160;&#160; <font style="font-weight: bold;"><u>No Rent Abatement</u></font>. Tenant shall continue to pay all Rent due or accruing under this Lease during any Clean-up, and shall not be entitled to
      any reduction, offset or deferral of any Base Rent or Additional Rent due or accruing under this Lease during any such Clean-up.</div>
    <div style="text-indent: 108pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">5.3.4.3&#160;&#160; <font style="font-weight: bold;"><u>Surrender of Premises</u></font>. Tenant shall complete any Clean-up prior to surrender of the Premises upon the expiration or earlier termination of
      this Lease.&#160; Tenant shall obtain and deliver to Landlord a letter or other written determination from the overseeing governmental authority confirming that the Clean-up has been completed in accordance with all requirements of such governmental
      authority and that no further response action of any kind is required for the unrestricted use of the Premises (&#8220;<font style="font-weight: bold;">Closure Letter</font>&#8221;). Upon the expiration or earlier termination of this Lease, Tenant shall also be
      obligated to close all permits obtained in connection with Hazardous Materials in accordance with Applicable Laws.</div>
    <div style="text-indent: 108pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 108pt;">5.3.4.4&#160;&#160; <font style="font-weight: bold;"><u>Failure to Timely Clean-Up</u></font>. Should any Clean-up for which Tenant is responsible not be completed, or should Tenant not receive the Closure
      Letter and any governmental approvals required under Environmental Laws in conjunction with such Clean-up prior to the expiration or earlier termination of this Lease, then Tenant shall be liable to Landlord as a holdover tenant (as more particularly
      provided in <u>Article 16</u>) until Tenant has fully complied with its obligations under this <u>Section 5.3</u>.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">5.3.5&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Confidentiality</u></font>. Unless compelled to do so by Applicable Law, Tenant agrees that Tenant shall not disclose, discuss, disseminate or copy any
      information, data, findings, communications, conclusions and reports regarding the environmental condition of the Premises to any Person (other than Tenant&#8217;s consultants, attorneys, property managers and employees that have a need to know such
      information), including any governmental authority, without the prior written consent of Landlord. In the event Tenant reasonably believes that disclosure is compelled by Applicable Law, it shall provide Landlord ten (10) days&#8217; advance notice of
      disclosure of confidential information so that Landlord may attempt to obtain a protective order. Tenant may additionally release such information to bona fide prospective purchasers or lenders, subject to any such parties&#8217; written agreement to be
      bound by the terms of this <u>Section 5.3</u>.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">5.3.6&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Copies of Environmental Reports</u></font>. Within thirty (30) days of receipt thereof, Tenant shall provide Landlord with a copy of any and all
      environmental assessments, audits, studies and reports regarding Tenant&#8217;s activities with respect to the Premises, or ground water beneath the Land, or the environmental condition or Clean-up thereof. Tenant shall be obligated to provide Landlord
      with a copy of such materials without regard to whether such materials are generated by Tenant or prepared for Tenant, or how Tenant comes into possession of such materials.</div>
    <div>&#160;</div>
    <div>
      <div style="text-indent: 72pt;">5.3.7 &#160; &#160;&#160; <font style="font-weight: bold;"><u>Intentionally Omitted</u></font>.</div>
    </div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">5.3.8&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Signs, Response Plans, Etc</u></font>. Tenant shall be responsible for posting on the Premises any signs required under applicable Environmental Laws.
      Tenant shall also complete and file any business response plans or inventories required by any Applicable Laws. Tenant shall concurrently file a copy of any such business response plan or inventory with Landlord.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">5.3.9&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Survival</u></font>. Each covenant, agreement, representation, warranty and indemnification made by Tenant set forth in this <u>Section 5.3</u> shall
      survive the expiration or earlier termination of this Lease and shall remain effective until all of Tenant&#8217;s obligations under this <u>Section 5.3</u> have been completely performed and satisfied.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3c5f0ff34438413082591d5e46853e05" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top;"><a name="z_TOC_250010"></a><font style="font-weight: bold;">6.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">SERVICES AND UTILITIES</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">6.1&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>In General</u></font>. Landlord shall provide the following services on all days (unless otherwise stated below) during the Lease Term.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">6.1.1&#160;&#160;&#160;&#160;&#160; Subject to limitations imposed by all governmental rules, regulations and guidelines applicable thereto, Landlord shall provide heating, ventilation and air conditioning to the office
      portions of the Premises ("<font style="font-weight: bold;">HVAC</font>") when necessary for normal comfort for normal office use in the Premises from 7:00 A.M. to 6:00 P.M. Monday through Friday (collectively, the "<font style="font-weight: bold;">Building


        Hours</font>"), except for the date of observation of New Year's Day, President's Day, Memorial Day, Independence Day, Labor Day, Thanksgiving Day, Christmas Day and, at Landlord's discretion, other locally or nationally recognized holidays
      (collectively, the "<font style="font-weight: bold;">Holidays</font>"). HVAC to the lab portion of the Premises will be provided 24 hours per day, 7 days per week. Tenant shall cooperate fully with Landlord at all times and abide by all regulations
      and requirements that Landlord may reasonably prescribe for the proper functioning and protection of the HVAC, electrical, mechanical and plumbing systems.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-17-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">6.1.2&#160;&#160;&#160;&#160;&#160; Landlord shall provide reasonably sufficient electricity to the Premises (including adequate electrical wiring and facilities for connection to Tenant's lighting fixtures and incidental
      use equipment), provided that the connected electrical load of Tenant's lighting fixtures and the incidental use equipment does not, in the aggregate, exceed the connected electrical loads typically required at First Class Life Sciences Projects.
      Tenant will design Tenant's electrical system serving any equipment producing nonlinear electrical loads to accommodate such nonlinear electrical loads, including, but not limited to, oversizing neutral conductors, derating transformers and/or
      providing power-line filters. Engineering plans shall include a calculation of Tenant's fully connected electrical design load with and without demand factors and shall indicate the number of watts of unmetered and submetered loads. Tenant shall bear
      the cost of replacement of lamps, starters and ballasts for non-Building standard lighting fixtures within the Premises. If electricity is separately sub-metered, then Tenant shall pay to Landlord the cost of such utilities based on such sub-meter,
      and reimbursement for any penalties for usage or other surcharges imposed by any utility company. If electricity is not separately sub-metered, then the cost of electricity used by Tenant in the Premises shall be equitably allocated by Landlord on a
      basis consistent with commercial reasonable property management practices. Within twenty (20) days after receipt of Landlord's statement of apportionment or statement setting forth the charges payable by Tenant, Tenant shall pay to Landlord, as
      Additional Rent (and not as a Direct Expense), the cost of such electrical services so apportioned or so provided by Landlord. Notwithstanding anything to the contrary set forth herein, to the extent the Premises generates electricity demand on a
      shared resource (e.g. electricity for the central plant), the cost of such electricity shall be allocated to Tenant on a pro rata basis or other reasonable basis consistent with commercial reasonable property management practices.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">6.1.3&#160;&#160;&#160;&#160; Landlord shall provide city water from the regular Building outlets for drinking, kitchen, lavatory and toilet purposes in the Building Common Areas and the Premises.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">6.1.4&#160; &#160;&#160; Landlord shall provide nonexclusive, non-attended automatic passenger elevator service during the Building Hours, shall have one elevator available at all other times, including on the
      Holidays, except in the event of emergency.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">6.1.5&#160;&#160;&#160;&#160; Landlord shall provide shared autoclave, glass wash, and ice machine as well as access to all shared conference rooms within the Building and Project (including neighboring Building) to the
      same extent the foregoing is being provided to other tenants in the Building.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">6.1.6&#160;&#160;&#160;&#160;&#160; Landlord shall not provide janitorial services for the Premises. Tenant shall be solely responsible for performing all janitorial services and other cleaning of the Premises, all in
      compliance with Applicable Laws. The janitorial and cleaning of the Premises shall be adequate to maintain the Premises in a manner consistent with First Class Life Sciences Projects.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">6.1.7&#160;&#160;&#160;&#160;&#160; Landlord shall provide janitorial services for the Common Areas in a manner consistent with First Class Life Sciences Projects.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">6.1.8&#160;&#160;&#160;&#160; If Tenant desires to use HVAC during hours other than those for which Landlord is obligated to supply such utilities pursuant to the terms of <u>Section 6.1.1</u> of this Lease, Tenant
      shall give Landlord such prior notice, if any, as Landlord shall from time to time reasonably establish as appropriate, of Tenant's desired use in order to supply such HVAC, and Landlord shall supply such heat, ventilation or air conditioning to
      Tenant at such hourly cost to Tenant as Landlord shall reasonably determine for the Building.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">6.2&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Interruption of Use</u></font>. Tenant agrees that Landlord shall not be liable for damages, by abatement of Rent or otherwise, except as expressly set
      forth in <u>Section 19.5</u> below, for failure to furnish or delay in furnishing any service (including telephone and telecommunication services), or for any diminution in the quality or quantity thereof, when such failure or delay or diminution is
      occasioned, in whole or in part, by breakage, repairs, replacements, or improvements, by any strike, lockout or other labor trouble, by inability to secure electricity, gas, water, or other fuel at the Building or Project after reasonable effort to
      do so, by any riot or other dangerous condition, emergency, accident or Casualty (as that term is defined in <u>Section 11.1</u> below) whatsoever, by act or default of Tenant or other parties, or by any other cause; and such failures or delays or
      diminution shall never be deemed to constitute an eviction or disturbance of Tenant's use and possession of the Premises or relieve Tenant from paying Rent, except as expressly set forth in <u>Section 19.5</u> below, or performing any of its
      obligations under this Lease. Furthermore, Landlord shall not be liable under any circumstances for a loss of, or injury to, property or for injury to, or interference with, Tenant's business, including, without limitation, loss of profits, however
      occurring, through or in connection with or incidental to a failure to furnish any of the services or utilities as set forth in this <u>Article 6</u>.</div>
    <div style="text-align: justify; text-indent: 72pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-18-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">6.3&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Energy Performance Disclosure Information</u></font>. Tenant hereby acknowledges that Landlord may be required to disclose certain information
      concerning the energy performance of the Building pursuant to California Public Resources Code Section 25402.10 and the regulations adopted pursuant thereto (collectively the &#8220;<font style="font-weight: bold;">Energy Disclosure Requirements</font>&#8221;).
      Tenant hereby acknowledges prior receipt of the Data Verification Checklist, as defined in the Energy Disclosure Requirements (the &#8220;<font style="font-weight: bold;">Energy Disclosure Information</font>&#8221;), and agrees that Landlord has timely complied
      in full with Landlord&#8217;s obligations under the Energy Disclosure Requirements. Tenant acknowledges and agrees that (i) Landlord makes no representation or warranty regarding the energy performance of the Building or the accuracy or completeness of the
      Energy Disclosure Information, (ii) the Energy Disclosure Information is for the current occupancy and use of the Building and that the energy performance of the Building may vary depending on future occupancy and/or use of the Building, and (iii)
      Landlord shall have no liability to Tenant for any errors or omissions in the Energy Disclosure Information. If and to the extent not prohibited by Applicable Laws, Tenant hereby waives any right Tenant may have to receive the Energy Disclosure
      Information, including, without limitation, any right Tenant may have to terminate this Lease as a result of Landlord&#8217;s failure to disclose such information. Further, Tenant hereby releases Landlord from any and all losses, costs, damages, expenses
      and/or liabilities relating to, arising out of and/or resulting from the Energy Disclosure Requirements, including, without limitation, any liabilities arising as a result of Landlord&#8217;s failure to disclose the Energy Disclosure Information to Tenant
      prior to the execution of this Lease. Tenant&#8217;s acknowledgment of the AS-IS condition of the Premises pursuant to the terms of this Lease shall be deemed to include the energy performance of the Building. Tenant further acknowledges that pursuant to
      the Energy Disclosure Requirements, Landlord may be required in the future to disclose information concerning Tenant&#8217;s energy usage to certain third parties, including, without limitation, prospective purchasers, lenders and tenants of the Building
      (the &#8220;<font style="font-weight: bold;">Tenant Energy Use Disclosure</font>&#8221;). Tenant hereby (A) consents to all such Tenant Energy Use Disclosures, and (B) acknowledges that Landlord shall not be required to notify Tenant of any Tenant Energy Use
      Disclosure. Further, Tenant hereby releases Landlord from any and all losses, costs, damages, expenses and liabilities relating to, arising out of and/or resulting from any Tenant Energy Use Disclosure. The terms of this <u>Section 6.3</u> shall
      survive the expiration or earlier termination of this Lease.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">6.4&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Tenant Maintained Security</u></font>. Tenant hereby acknowledges that Landlord shall have no obligation to provide, or otherwise pay for, any guard
      service or other security measures for the benefit of the Premises or the Project. Tenant hereby assumes all responsibility for the protection of Tenant and its agents, employees, contractors, invitees and guests, and the property thereof, from acts
      of third parties, including keeping doors locked and other means of entry to the Premises closed. In accordance with the terms and conditions of <u>Article 8</u> of this Lease, Tenant may, at its own expense, install its own security system (&#8220;<font style="font-weight: bold;">Tenant&#8217;s Security System</font>&#8221;) in the Premises; provided, however, that Tenant shall coordinate the installation and operation of Tenant&#8217;s Security System with Landlord to assure that Tenant&#8217;s Security System is
      compatible with Landlord&#8217;s security system and the Building systems and equipment, and to the extent that Tenant&#8217;s Security System is not compatible with Landlord&#8217;s security system and the Building systems and equipment, Tenant shall not be entitled
      to install or operate the Tenant&#8217;s Security System. Tenant shall be solely responsible, at Tenant&#8217;s sole cost and expense, for the installation, monitoring, operation and removal of Tenant&#8217;s Security System.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za7480bcb7b3442c69ea16bea53899737" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top;"><a name="z_TOC_250009"></a><font style="font-weight: bold;">7.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">REPAIRS</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">7.1&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Tenant Repair Obligations</u></font>. Except as otherwise expressly provided in this Lease, Tenant shall, at Tenant's own expense, keep the Premises,
      including all improvements, fixtures and furnishings therein, and the floor or floors of the Building on which the Premises are located, in good order, repair and condition at all times during the Lease Term. In addition, Tenant shall, at Tenant's
      own expense, but under the supervision and subject to the prior approval of Landlord, and within any reasonable period of time specified by Landlord, promptly and adequately repair all damage to the Premises and replace or repair all damaged, broken,
      or worn fixtures and appurtenances, except for damage caused by ordinary wear and tear or beyond the reasonable control of Tenant; provided however, that, Landlord shall have the exclusive right, at Landlord's option, but not the obligation, to make
      such repairs and replacements, and Tenant shall pay to Landlord the cost thereof, including Landlord's standard fee for its involvement with such repairs and replacements (to be uniformly established for the Building at a commercially reasonable
      level), promptly upon being billed for same. Landlord may, but shall not be required to, enter the Premises pursuant to the terms of <u>Article 27</u>, below, to make such repairs, alterations, improvements or additions to the Premises or to the
      Project or to any equipment located in the Project as Landlord shall desire or deem necessary or as Landlord may be required to do by governmental or quasi-governmental authority or court order or decree. Tenant hereby waives any and all rights under
      and benefits of subsection 1 of Section 1932 and Sections 1941 and 1942 of the California Civil Code or under any similar law, statute, or ordinance now or hereafter in effect.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-19-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">7.2&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Landlord Repair Obligations</u></font>. Notwithstanding the foregoing, Landlord shall be responsible for repairs and replacement as necessary to the
      exterior walls, exterior doors and windows and waterproofing of the Building envelope, foundation and roof (including roof membrane, gutters, flashings, and downspouts) of the Building, utility connections to the Building, the structural portions of
      the floors of the Building (the "<font style="font-weight: bold;">Building Structure</font>"), the base Building plumbing, sewer, drainage, electrical, fire protection, elevator, life safety, heating, ventilation and air-conditioning systems (the "<font style="font-weight: bold;">Building Systems</font>" and together with the Building Structure, the "<font style="font-weight: bold;">Base Building</font>") of the Building, and the Common Areas, except to the extent that such repairs are required
      due to the negligence or willful misconduct of Tenant; provided, however, that if such repairs are due to the negligence or willful misconduct of Tenant, Landlord shall nevertheless make such repairs at Tenant's expense, or, if covered by Landlord's
      insurance, Tenant shall only be obligated to pay any deductible in connection therewith. Subject to the terms of <u>Article 27</u>, below, Landlord may, but shall not be required to, enter the Premises at all reasonable times and upon reasonable
      prior notice to make such repairs, alterations, improvements or additions to the Premises or to the Project or to any equipment located in the Project as Landlord shall desire or deem necessary or as Landlord may be required to do by governmental or
      quasi-governmental authority or court order or decree. Tenant hereby waives any and all rights under and benefits of subsection 1 of Section 1932 and Sections 1941 and 1942 of the California Civil Code or under any similar law, statute, or ordinance
      now or hereafter in effect.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z800670bfcb7b4fe193f2aff4fffbcf70" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top;"><a name="z_TOC_250008"></a><font style="font-weight: bold;">8.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">ADDITIONS AND ALTERATIONS</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">8.1&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Landlord's Consent to Alterations</u></font>. Tenant may not make any improvements, alterations, additions or changes to the Premises or any mechanical,
      plumbing or HVAC facilities or systems pertaining to the Premises (collectively, the "<font style="font-weight: bold;">Alterations</font>") without first procuring the prior written consent of Landlord to such Alterations, which consent shall be
      requested by Tenant not less than thirty (30) days prior to the commencement thereof, and which consent shall not be unreasonably withheld by Landlord, provided it shall be deemed reasonable for Landlord to withhold its consent to any Alteration
      which adversely affects the structural portions or the systems or equipment of the Building or is visible from the exterior of the Building. Notwithstanding the foregoing, Tenant shall be permitted to make Alterations following ten (10) business
      days&#8217; notice to Landlord, but without Landlord's prior consent, to the extent that such Alterations (i) do not affect the Building Systems or Building Structure, (ii) are not visible from the exterior of the Building, (iii) cost less than $100,000.00
      for a particular job of work, and (iv) do not require a building permit and do not diminish the value of the Premises, Building or Project. The construction of the initial improvements to the Premises shall be governed by the terms of the Tenant Work
      Letter and not the terms of this <u>Article 8</u>.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">8.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Manner of Construction</u></font>. Landlord may impose, as a condition of its consent to any and all Alterations or repairs of the Premises or about
      the Premises, such requirements as Landlord in its reasonable discretion may deem desirable, including, but not limited to, the requirement that upon Landlord's request, Tenant shall, at Tenant's expense, remove such Alterations upon the expiration
      or any early termination of the Lease Term. Tenant shall construct such Alterations and perform such repairs in a good and workmanlike manner, in conformance with any and all applicable federal, state, county or municipal laws, rules and regulations
      and pursuant to a valid building permit, issued by the city in which the Building is located (or other applicable governmental authority). Tenant shall not use (and upon notice from Landlord shall cease using) contractors, services, workmen, labor,
      materials or equipment that, in Landlord's reasonable judgment, would disturb labor harmony with the workforce or trades engaged in performing other work, labor or services in or about the Building or the Common Areas. Upon completion of any
      Alterations (or repairs), Tenant shall deliver to Landlord final lien waivers from all contractors, subcontractors and materialmen who performed such work. In addition to Tenant's obligations under <u>Article 9</u> of this Lease, upon completion of
      any Alterations, Tenant agrees to cause a Notice of Completion to be recorded in the office of the Recorder of the County of San Diego in accordance with Section 3093 of the Civil Code of the State of California or any successor statute, and Tenant
      shall deliver to the Project construction manager a reproducible copy of the "<font style="font-weight: bold;">as built</font>" drawings of the Alterations as well as all permits, approvals and other documents issued by any governmental agency in
      connection with the Alterations.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-20-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">8.3&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Payment for Improvements</u></font>. With respect to payments to be made to Tenant's contractors for any Alterations, Tenant shall (i) comply with
      Landlord's reasonable requirements for final lien releases and waivers in connection with Tenant's payment for work to contractors, and (ii) cause Tenant's contractor to sign Landlord's standard contractor's rules and regulations. In addition, in
      connection with all Alterations, Tenant shall pay Landlord an oversight fee equal to four percent (4%) of the cost of such work, and shall reimburse Landlord for Landlord's reasonable, actual, out-of-pocket costs and expenses actually incurred in
      connection with such work.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">8.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Construction Insurance</u></font>. In addition to the requirements of <u>Article 10</u> of this Lease, in the event that Tenant makes any
      Alterations, prior to the commencement of such Alterations, Tenant shall provide Landlord with evidence that Tenant carries "<font style="font-weight: bold;">Builder's All Risk</font>" insurance in an amount approved by Landlord covering the
      construction of such Alterations, and such other insurance as Landlord may reasonably require, it being understood and agreed that all of such Alterations shall be insured by Tenant pursuant to <u>Article 10</u> of this Lease immediately upon
      completion thereof. In addition, Tenant's contractors and subcontractors shall be required to carry (i) Commercial General Liability Insurance in an amount approved by Landlord, with Landlord, and, at Landlord's option, Landlord's property manager
      and project manager, as additional insureds in an amount approved by Landlord, and otherwise in accordance with the requirements of Article 10 of this Lease, and (ii) workers compensation insurance with a waiver of subrogation in favor of Landlord .
      Landlord may, in its discretion, require Tenant to obtain a lien and completion bond or some alternate form of security satisfactory to Landlord in an amount sufficient to ensure the lien-free completion of such Alterations and naming Landlord as a
      co-obligee.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">8.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Landlord's Property</u></font>. All Alterations, improvements, fixtures, equipment and/or appurtenances which may be installed or placed in or about
      the Premises, from time to time, shall be at the sole cost of Tenant and shall be and become the property of Landlord and remain in place at the Premises following the expiration or earlier termination of this Lease. Notwithstanding the foregoing,
      Landlord may, by written notice to Tenant prior to the end of the Lease Term, or given following any earlier termination of this Lease, require Tenant, at Tenant's expense, to remove any Alterations and/or improvements and/or systems and equipment
      within the Premises and to repair any damage to the Premises and Building caused by such removal and return the affected portion of the Premises to a building standard tenant improved condition as determined by Landlord. If Tenant fails to complete
      such removal and/or to repair any damage caused by the removal of any Alterations and/or improvements and/or systems and equipment in the Premises and return the affected portion of the Premises to a building standard tenant improved condition as
      reasonably determined by Landlord, Landlord may do so and may charge the cost thereof to Tenant. Tenant hereby protects, defends, indemnifies and holds Landlord harmless from any liability, cost, obligation, expense or claim of lien in any manner
      relating to the installation, placement, removal or financing of any such Alterations, improvements, fixtures and/or equipment in, on or about the Premises, which obligations of Tenant shall survive the expiration or earlier termination of this
      Lease.</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">COVENANT AGAINST LIENS </font>Tenant shall keep the Project and Premises free from any liens or encumbrances arising out of the work
      performed, materials furnished or obligations incurred by or on behalf of Tenant, and shall protect, defend, indemnify and hold Landlord harmless from and against any claims, liabilities, judgments or costs (including, without limitation, reasonable
      attorneys' fees and costs) arising out of same or in connection therewith. Tenant shall give Landlord notice at least twenty (20) days prior to the commencement of any such work on the Premises (or such additional time as may be necessary under
      Applicable Laws) to afford Landlord the opportunity of posting and recording appropriate notices of non-responsibility (to the extent applicable pursuant to then Applicable Laws). Tenant shall remove any such lien or encumbrance by bond or otherwise
      within ten (10) business days after notice by Landlord, and if Tenant shall fail to do so, Landlord may pay the amount necessary to remove such lien or encumbrance, without being responsible for investigating the validity thereof.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-21-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z07ffec8e241f49378b8252d3aae8b3ac" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;"><a name="z_TOC_250007"></a><font style="font-weight: bold;">10.</font></td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-weight: bold;">INSURANCE</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">10.1&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Indemnification and Waiver</u></font>. Except to the extent caused by Landlord&#8217;s gross negligence or willful misconduct, Tenant hereby assumes all
        risk of damage to property or injury to persons in, upon or about the Premises from any cause whatsoever and agrees that Landlord, its partners, subpartners and their respective officers, agents, servants, employees, lenders, any property manager
        and independent contractors (collectively, "<font style="font-weight: bold;">Landlord Parties</font>") shall not be liable for, and are hereby released from any responsibility for, any damage either to person or property or resulting from the loss
        of use thereof, which damage is sustained by Tenant or by other persons claiming through Tenant. Tenant shall indemnify, defend, protect, and hold harmless the Landlord Parties from any and all claims, loss, cost, damage, injury, expense and
        liability (including without limitation court costs and reasonable attorneys' fees) incurred in connection with or arising from any cause in, on or about the Premises, any acts, omissions or negligence of Tenant or of any person claiming by,
        through or under Tenant, or of the contractors, agents, servants, employees, invitees, guests or licensees of Tenant or any such person, in, on or about the Project or any breach of the terms of this Lease, either prior to, during, or after the
        expiration of the Lease Term, provided that the terms of the foregoing indemnity shall not apply to the extent caused by the gross negligence or willful misconduct of Landlord. Should Landlord be named as a defendant in any suit brought against
        Tenant in connection with or arising out of Tenant's occupancy of the Premises, Tenant shall pay to Landlord its costs and expenses incurred in such suit, including without limitation, its actual professional fees such as reasonable appraisers',
        accountants' and attorneys' fees. The provisions of this <u>Section 10.1</u> shall survive the expiration or sooner termination of this Lease with respect to any claims or liability arising in connection with any event occurring prior to such
        expiration or termination.</div>
      <div style="text-indent: 36pt; text-align: justify;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">10.2&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Tenant's Compliance With Landlord's Property Insurance</u></font>. Landlord shall insure the Building during the Lease Term against loss or damage
        under an "all risk" property insurance policy. Such coverage shall be in such amounts, from such companies, and on such other terms and conditions, as Landlord may from time to time reasonably determine. Additionally, at the option of Landlord,
        such insurance coverage may include the risks of earthquakes and/or flood damage and additional hazards, a rental loss endorsement and one or more loss payee endorsements in favor of the holders of any mortgages or deeds of trust encumbering the
        interest of Landlord in the Building or the ground or underlying lessors of the Building, or any portion thereof. Tenant shall, at Tenant's expense, comply with all insurance company requirements pertaining to the use of the Premises. If Tenant's
        conduct or use of the Premises causes any increase in the premium for such insurance policies then Tenant shall reimburse Landlord for any such increase. Tenant, at Tenant's expense, shall comply with all rules, orders, regulations or requirements
        of the American Insurance Association (formerly the National Board of Fire Underwriters) and with any similar body. Tenant shall also provide Landlord and Landlord&#8217;s insurer(s) with such information regarding the use of the Premises and any damage
        to the Premises as they may require in connection with the placement of insurance for the Premises or the adjusting of any losses to the Premises.</div>
      <div><br>
      </div>
      <div>
        <div style="text-indent: 36pt; text-align: justify;">10.3 &#160; &#160; &#160; <font style="font-weight: bold;"><u>Tenant's Insurance</u></font>. Tenant shall maintain the following coverages in the following amounts.</div>
      </div>
      <div style="text-align: justify;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;">10.3.1&#160;&#160;&#160; Commercial General Liability Insurance on an occurrence form covering the insured against claims of bodily injury, personal injury and property damage (including loss of use thereof)
        arising out of Tenant's operations, and contractual liabilities including a contractual coverage, and including products and completed operations coverage, for limits of liability on a per location basis of not less than (which minimum limits of
        liability insurance may be satisfied through a combination of primary and excess/umbrella insurance):</div>
      <div style="text-align: justify;">&#160;</div>
      <div style="text-align: justify;">
        <table cellspacing="0" cellpadding="0" border="0" align="center" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;" id="z28127a23aba1447b8aafacd8adc3cc85">

            <tr>
              <td style="width: 45%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Bodily Injury and Property Damage Liability</div>
              </td>
              <td style="width: 45%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">$5,000,000 each occurrence</div>
                <div style="text-align: left;">$5,000,000 annual aggregate</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45%;" rowspan="1"><br>
              </td>
              <td style="width: 45%;" rowspan="1"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 45%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">Personal Injury Liability</div>
              </td>
              <td style="width: 45%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left;">$3,000,000 each occurrence</div>
                <div style="text-align: left;">$3,000,000 annual aggregate</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify;"> <br>
      </div>
    </div>
    <div>
      <div style="text-align: justify; text-indent: 72pt;">10.3.2&#160;&#160;&#160; Property Insurance covering (i) all office furniture, business and trade fixtures, office equipment, free-standing cabinet work, movable partitions, merchandise and all other items of
        Tenant's property on the Premises installed by, for, or at the expense of Tenant, (ii) the "<font style="font-weight: bold;">Tenant Improvements</font>," as that term is defined in the Tenant Work Letter, and any other improvements which exist in
        the Premises as of the Lease Commencement Date (excluding the Base Building) (the "<font style="font-weight: bold;">Original Improvements</font>"), and (iii) all other improvements, alterations and additions to the Premises. Such insurance shall be
        written on an "<font style="font-weight: bold;">all risks</font>" of physical loss or damage basis, for the full replacement cost value (subject to reasonable deductible amounts) new without deduction for depreciation of the covered items and in
        amounts that meet any co-insurance clauses of the policies of insurance and shall include coverage for damage or other loss caused by fire or other peril including, but not limited to, vandalism and malicious mischief, theft, water damage of any
        type, including sprinkler leakage, bursting or stoppage of pipes, and explosion.</div>
      <div style="text-align: justify; text-indent: 72pt;"> <br>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-22-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">10.3.3&#160;&#160;&#160; Business Income Interruption for one (1) year plus Extra Expense insurance in such amounts as will reimburse Tenant for actual direct or indirect loss of earnings attributable to the risks
      outlined in<u> Section 10.3.2</u> above.</div>
    <div style="text-align: justify; text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">10.3.4&#160;&#160; Worker's Compensation and Employer's Liability or other similar insurance pursuant to all applicable state and local statutes and regulations. The policy shall include a waiver of
      subrogation in favor of Landlord, its employees, Lenders and any property manager or partners.</div>
    <div style="text-align: justify; text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">10.4&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Form of Policies</u></font>. The minimum limits of policies of insurance required of Tenant under this Lease shall in no event limit the liability of
      Tenant under this Lease. Such insurance shall (i) name Landlord, its subsidiaries and affiliates, its property manager (if any) and any other party the Landlord so specifies, as an additional insured or loss payee, as applicable, including Landlord's
      managing agent, if any; (ii) be issued by an insurance company having a rating of not less than A:IX in Best's Insurance Guide or which is otherwise acceptable to Landlord and licensed to do business in the State of California; (iv) be primary
      insurance as to all claims thereunder and provide that any insurance carried by Landlord is excess and is non-contributing with any insurance required of Tenant; (v) be in form and content reasonably acceptable to Landlord; and (vi) provide that said
      insurance shall not be canceled or coverage changed unless thirty (30) days' prior written notice shall have been given to Landlord and any mortgagee of Landlord (unless such cancellation is the result of non-payment of premiums). Tenant shall
      deliver said policy or policies or certificates thereof to Landlord on or before the Lease Commencement Date and at least ten (10) days before the expiration dates thereof. In the event Tenant shall fail to procure such insurance, or to deliver such
      policies or certificate, Landlord may, at its option, procure such policies for the account of Tenant, and the cost thereof shall be paid to Landlord within five (5) days after delivery to Tenant of bills therefor.</div>
    <div style="text-align: justify; text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">10.5&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Subrogation</u></font>. Landlord and Tenant hereby agree to look solely to, and seek recovery only from, their respective insurance carriers in the
      event of a property or business interruption loss to the extent that such coverage is agreed to be provided hereunder. The parties each hereby waive all rights and claims against each other for such losses, and waive all rights of subrogation of
      their respective insurers, provided such waiver of subrogation shall not affect the right to the insured to recover thereunder. The parties agree that their respective insurance policies do now, or shall, contain the waiver of subrogation.</div>
    <div style="text-align: justify; text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">10.6&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Additional Insurance Obligations</u></font>. Tenant shall carry and maintain during the entire Lease Term, at Tenant's sole cost and expense, increased
      amounts of the insurance required to be carried by Tenant pursuant to this<u> Article 10</u> and such other reasonable types of insurance coverage and in such reasonable amounts covering the Premises and Tenant's operations therein, as may be
      reasonably requested by Landlord or Landlord's lender, but in no event in excess of the amounts and types of insurance then being required by landlords of buildings comparable to and in the vicinity of the Building.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zaffd1acc2ddf4b08b6c5d130bb1a8a2b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top;"><a name="z_TOC_250006"></a><font style="font-weight: bold;">11.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">DAMAGE AND DESTRUCTION</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">11.1&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Repair of Damage</u></font>. Tenant shall promptly notify Landlord of any damage to the Premises resulting from fire or any other casualty ("<font style="font-weight: bold;">Casualty</font>"). If the Premises or any Common Areas serving or providing access to the Premises shall be damaged by fire or other casualty, Landlord shall promptly and diligently, subject to reasonable delays for
      insurance adjustment or other matters beyond Landlord's reasonable control, and subject to all other terms of this <u>Article 11</u>, restore the Base Building and such Common Areas. Such restoration shall be to substantially the same condition of
      the Base Building and the Common Areas prior to the casualty, except for modifications required by zoning and building codes and other laws or by the holder of a mortgage on the Building or Project or any other modifications to the Common Areas
      deemed desirable by Landlord, which are consistent with the character of the Project, provided that access to the Premises shall not be materially impaired. Subject to the terms of Section 11.2, below, Tenant shall, at its sole cost and expense,
      repair any injury or damage to the Tenant Improvements and the Original Improvements installed in the Premises and shall return such Tenant Improvements and Original Improvements to their original condition. Whether or not Landlord delivers a
      &#8220;Landlord Repair Notice,&#8221; as that term is defined in <u>Section 11.2</u> below, prior to the commencement of construction, Tenant shall submit to Landlord, for Landlord's review and approval, all plans, specifications and working drawings relating
      thereto, and Landlord shall select the contractors to perform such improvement work. Tenant shall in addition cooperate with requests for information regarding any repairs from Landlord&#8217;s insurer(s) by providing the requested information within ten
      (10) days after Tenant receives the request. Landlord shall not be liable for any inconvenience or annoyance to Tenant or its visitors, or injury to Tenant's business resulting in any way from such damage or the repair thereof; provided however, that
      if such Casualty shall have damaged the Premises or Common Areas necessary to Tenant's occupancy, and the Premises are not occupied by Tenant as a result thereof, then during the time and to the extent the Premises are unfit for occupancy, the Rent
      shall be abated in proportion to the ratio that the amount of rentable square feet of the Premises which is unfit for occupancy for the purposes permitted under this Lease bears to the total rentable square feet of the Premises. In the event that
      Landlord shall not deliver the Landlord Repair Notice, Tenant's right to rent abatement pursuant to the preceding sentence shall terminate as of the date which is reasonably determined by Landlord to be the date Tenant should have completed repairs
      to the Premises assuming Tenant used reasonable due diligence in connection therewith. Notwithstanding any contrary provision of this <u>Article 11</u>, the parties hereby agree as follows: (i) the closure of the Project, the Building, the Common
      Areas, or any part thereof to protect public health shall not constitute a Casualty for purposes of this Lease, (ii) Casualty covered by this <u>Article 11</u> shall require that the physical or structural integrity of the Premises, the Project, the
      Building, or the Common Areas is degraded as a direct result of such occurrence, and (iii) a Casualty under this <u>Article 11</u> shall not be deemed to occur merely because Tenant is unable to productively use the Premises in the event that the
      physical and structural integrity of the Premises is undamaged.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-23-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">11.2&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Landlord's Option to Repair</u></font>. Upon the occurrence of any damage to the Premises, Landlord may, at Landlord's option, deliver a notice (the "<font style="font-weight: bold;">Landlord Repair Notice</font>") to Tenant, and upon receipt of a Landlord Repair Notice Tenant shall assign to Landlord (or to any party designated by Landlord) all insurance proceeds payable to Tenant under Tenant's
      insurance required under <u>Section 10.3</u> of this Lease, and Landlord shall repair any injury or damage to the Tenant Improvements and the Original Improvements installed in the Premises and shall return such Tenant Improvements and Original
      Improvements to their original condition; provided that if the cost of such repair by Landlord exceeds the amount of insurance proceeds received by Landlord from Tenant's insurance carrier (including by taking into account any deductible or
      self-insured retention), as assigned by Tenant, the cost of such repairs shall be paid by Tenant to Landlord prior to Landlord's commencement of repair of the damage. Notwithstanding the terms of <u>Section 11.1</u> of this Lease, Landlord may elect
      not to rebuild and/or restore the Premises, Building and/or Project, and instead terminate this Lease, by notifying Tenant in writing of such termination within sixty (60) days after the date of discovery of the damage, such notice to include a
      termination date giving Tenant sixty (60) days to vacate the Premises, but Landlord may so elect only if the Building or Project shall be damaged by Casualty or cause, whether or not the Premises are affected, and one or more of the following
      conditions is present: (i) in Landlord's reasonable judgment, repairs cannot reasonably be completed within one hundred fifty (150) days after the date of discovery of the damage (when such repairs are made without the payment of overtime or other
      premiums); (ii) the holder of any mortgage on the Building or Project or ground lessor with respect to the Building or Project shall require that the insurance proceeds or any portion thereof be used to retire the mortgage debt, or shall terminate
      the ground lease, as the case may be; (iii) the damage is not fully covered by Landlord's insurance policies; (iv) Landlord decides to rebuild the Building or Common Areas so that they will be substantially different structurally or architecturally;
      (v) the damage occurs during the last twelve (12) months of the Lease Term; or (vi) any owner of any other portion of the Project, other than Landlord, does not intend to repair the damage to such portion of the Project; provided, however, that if
      Landlord does not elect to terminate this Lease pursuant to Landlord's termination right as provided above, and the repairs cannot, in the reasonable opinion of Landlord, be completed within one (1) year after being commenced, Tenant may elect, no
      earlier than sixty (60) days after the date of the damage and not later than ninety (90) days after the date of such damage, to terminate this Lease by written notice to Landlord effective as of the date specified in the notice, which date shall not
      be less than thirty (30) days nor more than sixty (60) days after the date such notice is given by Tenant. Notwithstanding the provisions of this Section 11.2, Tenant shall have the right to terminate this Lease under this Section 11.2 only if each
      of the following conditions is satisfied: (a) the damage to the Project by Casualty was not caused by the gross negligence or intentional act of Tenant or its partners or subpartners and their respective officers, agents, servants, employees, and
      independent contractors; (b) Tenant is not then in default under this Lease; (c) as a result of the damage, Tenant cannot reasonably conduct business from the Premises; and, (d) as a result of the damage to the Project, Tenant does not occupy or use
      the Premises at all.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-24-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">11.3&#160;&#160;&#160; &#160;&#160; <font style="font-weight: bold;"><u>Waiver of Statutory Provisions</u></font>. The provisions of this Lease, including this <u>Article 11</u>, constitute an express agreement between
      Landlord and Tenant with respect to any and all damage to, or destruction of, all or any part of the Premises, the Building or the Project, and any statute or regulation of the State of California, including, without limitation, Sections 1932(2) and
      1933(4) of the California Civil Code, with respect to any rights or obligations concerning damage or destruction in the absence of an express agreement between the parties, and any other statute or regulation, now or hereafter in effect, shall have
      no application to this Lease or any damage or destruction to all or any part of the Premises, the Building or the Project.</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">12.</font>&#160;&#160; &#160; &#160;&#160;&#160; <font style="font-weight: bold;">NONWAIVER </font>No provision of this Lease shall be deemed waived by either party hereto unless expressly waived in a writing
      signed thereby. The waiver by either party hereto of any breach of any term, covenant or condition herein contained shall not be deemed to be a waiver of any subsequent breach of same or any other term, covenant or condition herein contained. The
      subsequent acceptance of Rent hereunder by Landlord shall not be deemed to be a waiver of any preceding breach by Tenant of any term, covenant or condition of this Lease, other than the failure of Tenant to pay the particular Rent so accepted,
      regardless of Landlord's knowledge of such preceding breach at the time of acceptance of such Rent. No acceptance of a lesser amount than the Rent herein stipulated shall be deemed a waiver of Landlord's right to receive the full amount due, nor
      shall any endorsement or statement on any check or payment or any letter accompanying such check or payment be deemed an accord and satisfaction, and Landlord may accept such check or payment without prejudice to Landlord's right to recover the full
      amount due. No receipt of monies by Landlord from Tenant after the termination of this Lease shall in any way alter the length of the Lease Term or of Tenant's right of possession hereunder, or after the giving of any notice shall reinstate, continue
      or extend the Lease Term or affect any notice given Tenant prior to the receipt of such monies, it being agreed that after the service of notice or the commencement of a suit, or after final judgment for possession of the Premises, Landlord may
      receive and collect any Rent due, and the payment of said Rent shall not waive or affect said notice, suit or judgment.</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">13.&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">CONDEMNATION&#160; </font>If the whole or&#160; any part of the Premises, Building or Project shall be taken by&#160; power of eminent domain or
      condemned by any competent authority for any public or quasi-public use or purpose, or if any adjacent property or street shall be so taken or condemned, or reconfigured or vacated by such authority in such manner as to require the use,
      reconstruction or remodeling of any part of the Premises, Building or Project, or if Landlord shall grant a deed or other instrument in lieu of such taking by eminent domain or condemnation, Landlord shall have the option to terminate this Lease
      effective as of the date possession is required to be surrendered to the authority. Tenant shall not because of such taking assert any claim against Landlord or the authority for any compensation because of such taking and Landlord shall be entitled
      to the entire award or payment in connection therewith, except that Tenant shall have the right to file any separate claim available to Tenant for any taking of Tenant's personal property and fixtures belonging to Tenant and removable by Tenant upon
      expiration of the Lease Term pursuant to the terms of this Lease, and for moving expenses, so long as such claims do not diminish the award available to Landlord, its ground lessor with respect to the Building or Project or its mortgagee, and such
      claim is payable separately to Tenant. All Rent shall be apportioned as of the date of such termination. If any part of the Premises shall be taken, and this Lease shall not be so terminated, the Rent shall be proportionately abated. Tenant hereby
      waives any and all rights it might otherwise have pursuant to Section 1265.130 of The California Code of Civil Procedure. Notwithstanding anything to the contrary contained in this Article 13, in the event of a temporary taking of all or any portion
      of the Premises for a period of one hundred and fifty (150) days or less, then this Lease shall not terminate but the Base Rent and the Additional Rent shall be abated for the period of such taking in proportion to the ratio that the amount of
      rentable square feet of the Premises taken bears to the total rentable square feet of the Premises. Landlord shall be entitled to receive the entire award made in connection with any such temporary taking. Notwithstanding any contrary provision of
      this Lease, the following governmental actions shall not constitute a taking or condemnation, either permanent or temporary: (i) an action that requires Tenant's business or the Building or Project to close during the Lease Term, and (ii) an action
      taken for the purpose of protecting public safety (e.g., to protect against acts of war, the spread of communicable diseases, or an infestation), and no such governmental actions shall entitle Tenant to any compensation from Landlord or any
      authority, or Rent abatement or any other remedy under this Lease.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-25-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z7d3898dc1d24475e866a9cbb53f46e56" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top;"><a name="z_TOC_250005"></a><font style="font-weight: bold;">14.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">ASSIGNMENT AND SUBLETTING</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">14.1&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Transfers</u></font>. Tenant shall not, without the prior written consent of Landlord, assign, mortgage, pledge, hypothecate, encumber, or permit any
      lien to attach to, or otherwise transfer, this Lease or any interest hereunder, permit any assignment, or other transfer of this Lease or any interest hereunder by operation of law, sublet the Premises or any part thereof, or enter into any license
      or concession agreements or otherwise permit the occupancy or use of the Premises or any part thereof by any persons other than Tenant and its employees and contractors (all of the foregoing are hereinafter sometimes referred to collectively as "<font style="font-weight: bold;">Transfers</font>" and any person to whom any Transfer is made or sought to be made is hereinafter sometimes referred to as a "<font style="font-weight: bold;">Transferee</font>"). If Tenant desires Landlord's consent to
      any Transfer, Tenant shall notify Landlord in writing, which notice (the "<font style="font-weight: bold;">Transfer Notice</font>") shall include (i) the proposed effective date of the Transfer, which shall not be less than thirty (30) days nor more
      than one hundred eighty (180) days after the date of delivery of the Transfer Notice, (ii) a description of the portion of the Premises to be transferred (the "<font style="font-weight: bold;">Subject Space</font>"), (iii) all of the terms of the
      proposed Transfer and the consideration therefor, including calculation of the "<font style="font-weight: bold;">Transfer Premium</font>", as that term is defined in <u>Section 14.3</u> below, in connection with such Transfer, the name and address
      of the proposed Transferee, and a copy of all existing executed and/or proposed documentation pertaining to the proposed Transfer, and (iv) current financial statements of the proposed Transferee certified by an officer, partner or owner thereof,
      business credit and personal references and history of the proposed Transferee and any other information reasonably required by Landlord which will enable Landlord to determine the financial responsibility, character, and reputation of the proposed
      Transferee, nature of such Transferee's business and proposed use of the Subject Space. Any Transfer made without Landlord's prior written consent shall, at Landlord's option, be null, void and of no effect, and shall, at Landlord's option,
      constitute an Event of Default by Tenant under this Lease. Whether or not Landlord consents to any proposed Transfer, Tenant shall pay Landlord's reasonable review and processing fees, as well as any reasonable professional fees (including, without
      limitation, attorneys', accountants', architects', engineers' and consultants' fees) incurred by Landlord in an amount not to exceed $3,000.00 for a Transfer in the ordinary course of business, within thirty (30) days after written request by
      Landlord.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">14.2&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Landlord's Consent</u></font>. Landlord shall not unreasonably withhold, condition or delay its consent to any proposed Transfer of the Subject Space
      to the Transferee on the terms specified in the Transfer Notice. Without limitation as to other reasonable grounds for withholding consent, the parties hereby agree that it shall be reasonable under this Lease and under any Applicable Law for
      Landlord to withhold consent to any proposed Transfer where one or more of the following apply:</div>
    <div>&#160;</div>
    <div style="text-indent: 72pt;">14.2.1&#160;&#160;&#160;&#160; The Transferee is of a character or reputation or engaged in a business which is not consistent with the quality of the Building or the Project;</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div>
      <div style="text-indent: 72pt;">14.2.2&#160;&#160;&#160;&#160; The Transferee intends to use the Subject Space for purposes which are not permitted under this Lease;</div>
    </div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div>
      <div style="text-indent: 72pt;">14.2.3 &#160; &#160; The Transferee is either a governmental agency or instrumentality thereof;</div>
    </div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">14.2.4&#160;&#160;&#160; The Transferee is not a party of reasonable financial worth and/or financial stability in light of the responsibilities to be undertaken in connection with the Transfer on the date consent
      is requested; or</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">14.2.5&#160;&#160;&#160; The proposed Transfer would cause a violation of another lease for space in the Project, or would give an occupant of the Project a right to cancel its lease;</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">14.2.6&#160; &#160; Either the proposed Transferee, or any person or entity which directly or indirectly, controls, is controlled by, or is under common control with, the proposed Transferee, (i) occupies
      space in the Project at the time of the request for consent, or (ii) is negotiating with Landlord or has negotiated with Landlord during the six (6) month period immediately preceding the date Landlord receives the Transfer Notice, to lease space in
      the Project.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">If Landlord consents to any Transfer pursuant to the terms of this <u>Section 14.2</u> (and does not exercise any recapture rights Landlord may have under <u>Section 14.4</u> of this Lease), Tenant
      may within six (6) months after Landlord's consent, but not later than the expiration of said six-month period, enter into such Transfer of the Premises or portion thereof, upon substantially the same terms and conditions as are set forth in the
      Transfer Notice furnished by Tenant to Landlord pursuant to <u>Section 14.1</u> of this Lease, provided that if there are any changes in the terms and conditions from those specified in the Transfer Notice such that Landlord would initially have
      been entitled to refuse its consent to such Transfer under this <u>Section 14.2</u>, Tenant shall again submit the Transfer to Landlord for its approval and other action under this <u>Article 14</u> (including Landlord's right of recapture, if any,
      under <u>Section 14.4</u> of this Lease). Notwithstanding anything to the contrary in this Lease, if Tenant or any proposed Transferee claims that Landlord has unreasonably withheld or delayed its consent under <u>Section 14.2</u> or otherwise has
      breached or acted unreasonably under this <u>Article 14</u>, their sole remedies shall be a suit for contract damages (other than damages for injury to, or interference with, Tenant's business including, without limitation, loss of profits, however
      occurring) or declaratory judgment and an injunction for the relief sought, and Tenant hereby waives all other remedies, including, without limitation, any right at law or equity to terminate this Lease, on its own behalf and, to the extent permitted
      under all Applicable Laws, on behalf of the proposed Transferee.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 47.75pt; margin-left: 6pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-26-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">14.3&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Transfer Premium</u></font>. If Landlord consents to a Transfer, as a condition thereto which the parties hereby agree is reasonable, Tenant shall pay
      to Landlord fifty percent (50%) of any "<font style="font-weight: bold;">Transfer Premium</font>," as that term is defined in this <u>Section 14.3</u>, received by Tenant from such Transferee. "<font style="font-weight: bold;">Transfer Premium</font>"
      shall mean all rent, additional rent or other consideration payable by such Transferee in connection with the Transfer in excess of the Rent and Additional Rent payable by Tenant under this Lease during the term of the Transfer on a per rentable
      square foot basis if less than all of the Premises is transferred, and after deduction of (i) any costs of improvements made to the Subject Space in connection with such Transfer, (ii) brokerage commissions paid in connection with such Transfer, and
      (iii) reasonable legal fees incurred in connection with such Transfer. "<font style="font-weight: bold;">Transfer Premium</font>" shall also include, but not be limited to, key money, bonus money or other cash consideration paid by Transferee to
      Tenant in connection with such Transfer, and any payment in excess of fair market value for services rendered by Tenant to Transferee or for assets, fixtures, inventory, equipment, or furniture transferred by Tenant to Transferee in connection with
      such Transfer. The determination of the amount of Landlord's applicable share of the Transfer Premium shall be made on a monthly basis as rent or other consideration is received by Tenant under the Transfer.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">14.4&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Landlord's Option as to Subject Space</u></font>. Notwithstanding anything to the contrary contained in this <u>Article 14</u>, in the event Tenant
      contemplates a Transfer which, together with all prior Transfers then remaining in effect, would cause fifty percent (50%) or more of the Premises to be Transferred for more than fifty percent (50%) of the then remaining Lease Term (taking into
      account any extension of the Lease Term which has irrevocably exercised by Tenant), Tenant shall give Landlord notice (the "<font style="font-weight: bold;">Intention to Transfer Notice</font>") of such contemplated Transfer (whether or not the
      contemplated Transferee or the terms of such contemplated Transfer have been determined). The Intention to Transfer Notice shall specify the portion of and amount of rentable square feet of the Premises which Tenant intends to Transfer (the "<font style="font-weight: bold;">Contemplated Transfer Space</font>"), the contemplated date of commencement of the Contemplated Transfer (the "<font style="font-weight: bold;">Contemplated Effective Date</font>"), and the contemplated length of the term
      of such contemplated Transfer, and shall specify that such Intention to Transfer Notice is delivered to Landlord pursuant to this <u>Section 14.4</u> in order to allow Landlord to elect to recapture the Contemplated Transfer Space. Thereafter,
      Landlord shall have the option, by giving written notice to Tenant within thirty (30) days after receipt of any Intention to Transfer Notice, to recapture the Contemplated Transfer Space. Such recapture shall cancel and terminate this Lease with
      respect to such Contemplated Transfer Space as of the Contemplated Effective Date. In the event of a recapture by Landlord, if this Lease shall be canceled with respect to less than the entire Premises, the Rent reserved herein shall be prorated on
      the basis of the number of rentable square feet retained by Tenant in proportion to the number of rentable square feet contained in the Premises, and this Lease as so amended shall continue thereafter in full force and effect, and upon request of
      either party, the parties shall execute written confirmation of the same. If Landlord declines, or fails to elect in a timely manner, to recapture such Contemplated Transfer Space under this <u>Section 14.4</u>, then, subject to the other terms of
      this <u>Article 14</u>, for a period of nine (9) months (the "<font style="font-weight: bold;">Nine Month Period</font>") commencing on the last day of such thirty (30) day period, Landlord shall not have any right to recapture the Contemplated
      Transfer Space with respect to any Transfer made during the Nine Month Period, provided that any such Transfer is substantially on the terms set forth in the Intention to Transfer Notice, and provided further that any such Transfer shall be subject
      to the remaining terms of this <u>Article 14</u>. If such a Transfer is not so consummated within the Nine Month Period (or if a Transfer is so consummated, then upon the expiration of the term of any Transfer of such Contemplated Transfer Space
      consummated within such Nine Month Period), Tenant shall again be required to submit a new Intention to Transfer Notice to Landlord with respect any contemplated Transfer, as provided above in this <u>Section 14.4</u>.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-27-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">14.5&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Effect of Transfer</u></font>. If Landlord consents to a Transfer, (i) the terms and conditions of this Lease shall in no way be deemed to have been
      waived or modified, (ii) such consent shall not be deemed consent to any further Transfer by either Tenant or a Transferee, (iii) Tenant shall deliver to Landlord, promptly after execution, an original executed copy of all documentation pertaining to
      the Transfer in form reasonably acceptable to Landlord, (iv) Tenant shall furnish upon Landlord's request a complete statement, certified by an independent certified public accountant, or Tenant's chief financial officer, setting forth in detail the
      computation of any Transfer Premium Tenant has derived and shall derive from such Transfer, and (v) no Transfer relating to this Lease or agreement entered into with respect thereto, whether with or without Landlord's consent, shall relieve Tenant or
      any guarantor of the Lease from any liability under this Lease, including, without limitation, in connection with the Subject Space. Landlord or its authorized representatives shall have the right at all reasonable times to audit the books, records
      and papers of Tenant relating to any Transfer, and shall have the right to make copies thereof. If the Transfer Premium respecting any Transfer shall be found understated, Tenant shall, within thirty (30) days after demand, pay the deficiency, and if
      understated by more than two percent (2%), Tenant shall pay Landlord's costs of such audit.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">14.6&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Additional Transfers</u></font>. For purposes of this Lease, the term "<font style="font-weight: bold;">Transfer</font>" shall also include (i) if
      Tenant is a partnership, the withdrawal or change, voluntary, involuntary or by operation of law, of fifty percent (50%) or more of the partners, or transfer of fifty percent (50%) or more of partnership interests, within a twelve (12)-month period,
      or the dissolution of the partnership without immediate reconstitution thereof, and (ii) if Tenant is a closely held corporation (<font style="font-style: italic;">i.e.</font>, whose stock is not publicly held and not traded through an exchange or
      over the counter), (A) the dissolution, merger, consolidation or other reorganization of Tenant or (B) the sale or other transfer of an aggregate of fifty percent (50%) or more of the voting shares of Tenant (other than to immediate family members by
      reason of gift or death), within a twelve (12)-month period, or (C) the sale, mortgage, hypothecation or pledge of an aggregate of fifty percent (50%) or more of the value of the unencumbered assets of Tenant within a twelve (12)-month period.
      Notwithstanding the foregoing, under no circumstances shall the raising of additional capital, or an initial public offering of Tenant's stock on a nationally-recognized stock exchange, be considered a &#8220;Transfer&#8221; under this Lease, so long as Tenant
      is substantially the same legal entity.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">14.7&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Occurrence of Default</u></font>. Any Transfer hereunder shall be subordinate and subject to the provisions of this Lease, and if this Lease shall be
      terminated during the term of any Transfer, Landlord shall have the right to: (i) treat such Transfer as cancelled and repossess the Subject Space by any lawful means, or (ii) require that such Transferee attorn to and recognize Landlord as its
      landlord under any such Transfer. If Tenant shall be in default under this Lease, Landlord is hereby irrevocably authorized, as Tenant's agent and attorney-in-fact, to direct any Transferee to make all payments under or in connection with the
      Transfer directly to Landlord (which Landlord shall apply towards Tenant's obligations under this Lease) until such default is cured. Such Transferee shall rely on any representation by Landlord that Tenant is in default hereunder, without any need
      for confirmation thereof by Tenant. Upon any assignment, the assignee shall assume in writing all obligations and covenants of Tenant thereafter to be performed or observed under this Lease. No collection or acceptance of rent by Landlord from any
      Transferee shall be deemed a waiver of any provision of this <u>Article 14</u> or the approval of any Transferee or a release of Tenant from any obligation under this Lease, whether theretofore or thereafter accruing. In no event shall Landlord's
      enforcement of any provision of this Lease against any Transferee be deemed a waiver of Landlord's right to enforce any term of this Lease against Tenant or any other person. If Tenant's obligations hereunder have been guaranteed, Landlord's consent
      to any Transfer shall not be effective unless the guarantor also consents to such Transfer.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">14.8&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Non-Transfers</u></font>. Notwithstanding anything to the contrary contained in this <u>Article 14</u>, an assignment or subletting of all or a portion
      of the Premises to an affiliate of Tenant (an entity which is controlled by, controls, or is under common control with, Tenant), shall not be deemed a Transfer under this <u>Article 14</u>, provided that Tenant notifies Landlord of any such
      assignment or sublease and promptly supplies Landlord with any documents or information requested by Landlord regarding such assignment or sublease or such affiliate, and further provided that such assignment or sublease is not a subterfuge by Tenant
      to avoid its obligations under this Lease. "<font style="font-weight: bold;">Control</font>," as used in this <u>Section 14.8</u>, shall mean the ownership, directly or indirectly, of at least fifty-one percent (51%) of the voting securities of, or
      possession of the right to vote, in the ordinary direction of its affairs, of at least fifty-one percent (51%) of the voting interest in, any person or entity. No such permitted assignment or subletting shall serve to release Tenant from any of its
      obligations under this Lease. Tenant shall not be required to pay any review fee to Landlord for Non-Transfers pursuant to this Section 14.8.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-28-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zf218d18a551849a895eaf7652be8ae69" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top;"><a name="z_TOC_250004"></a><font style="font-weight: bold;">15.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">SURRENDER OF PREMISES; OWNERSHIP AND REMOVAL OF TRADE FIXTURES</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">15.1&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Surrender of Premises</u></font>. No act or thing done by Landlord or any agent or employee of Landlord during the Lease Term shall be deemed to
      constitute an acceptance by Landlord of a surrender of the Premises unless such intent is specifically acknowledged in writing by Landlord. The delivery of keys to the Premises to Landlord or any agent or employee of Landlord shall not constitute a
      surrender of the Premises or effect a termination of this Lease, whether or not the keys are thereafter retained by Landlord, and notwithstanding such delivery Tenant shall be entitled to the return of such keys at any reasonable time upon request
      until this Lease shall have been properly terminated. The voluntary or other surrender of this Lease by Tenant, whether accepted by Landlord or not, or a mutual termination hereof, shall not work a merger, and at the option of Landlord shall operate
      as an assignment to Landlord of all subleases or subtenancies affecting the Premises or terminate any or all such sublessees or subtenancies.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">15.2&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Removal of Tenant Property by Tenant</u></font>. Upon the expiration of the Lease Term, or upon any earlier termination of this Lease, Tenant shall,
      subject to the provisions of this <u>Article 15</u>, quit and surrender possession of the Premises to Landlord in as good order and condition as when Tenant took possession and as thereafter improved by Landlord and/or Tenant, reasonable wear and
      tear and repairs which are specifically made the responsibility of Landlord hereunder excepted. Upon such expiration or termination, Tenant shall, without expense to Landlord, remove or cause to be removed from the Premises all debris and rubbish,
      and such items of furniture, equipment, free- standing cabinet work, movable partitions and other articles of personal property owned by Tenant or installed or placed by Tenant at its expense in the Premises, and such similar articles of any other
      persons claiming under Tenant, as Landlord may, in its sole discretion, require to be removed, and Tenant shall repair at its own expense all damage to the Premises and Building resulting from such removal.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">15.3&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Environmental Assessment</u></font>. In connection with its surrender of the Premises, Tenant shall submit to Landlord, at least thirty (30) days prior
      to the expiration date of this Lease (or in the event of an earlier termination of this Lease, as soon as reasonably possible following such termination), an environmental Assessment of the Premises by a competent and experienced environmental
      engineer or engineering firm reasonably satisfactory to Landlord (pursuant to a contract approved by Landlord and providing that Landlord can rely on the Environmental Assessment), which (i) evidences that the Premises are in a clean and safe
      condition and free and clear of any Hazardous Materials (except those necessary for Tenant&#8217;s business operations and previously disclosed to Landlord); and (ii) includes a review of the Premises by an environmental consultant for mold, fungus,
      spores, and other moisture conditions, and on-site chemical use. If such Environmental Assessment reveals that remediation or Clean-up is required under any Environmental Laws, Tenant shall submit a remediation plan prepared by a recognized
      environmental consultant and shall be responsible for all costs of remediation and Clean-up, as more particularly provided in <u>Section 5.3</u>, above.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">15.4&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Condition of the Building and Premises Upon Surrender</u></font>. In addition to the above requirements of this <u>Article 15</u>, upon the expiration
      of the Lease Term, or upon any earlier termination of this Lease, Tenant shall, surrender the Premises and Building such that the same are in compliance with all Applicable Laws and with Tenant having complied with all of Tenant&#8217;s obligations under
      this Lease, including those relating to improvement, repair, maintenance, compliance with law, testing and other related obligations of Tenant set forth in <u>Article 7</u> of this Lease. In the event that the Building and Premises shall be
      surrendered in a condition which does not comply with the terms of this <u>Section 15.4</u>, because Tenant failed to comply with its obligations set forth in Lease, then following thirty (30) days&#8217; notice to Tenant, during which thirty (30) day
      period Tenant shall have the right to cure such noncompliance, Landlord shall be entitled to expend all reasonable costs in order to cause the same to comply with the required condition upon surrender and Tenant shall immediately reimburse Landlord
      for all such costs upon notice and Tenant shall be deemed during the period that Tenant or Landlord, as the case may be, perform obligations relating to the Surrender Improvements to be in holdover under <u>Article 16</u> of this Lease.</div>
    <div>&#160;</div>
    <div><font style="font-weight: bold;">16.&#160;&#160; &#160; &#160; &#160;&#160; HOLDING OVER</font>&#160; &#160; &#160; &#160; &#160;&#160; If Tenant holds over after the expiration of the Lease Term or earlier termination thereof, with the express or implied consent of Landlord, such tenancy shall be from
      month-to-month only, and shall not constitute a renewal hereof or an extension for any further term. If Tenant holds over after the expiration of the Lease Term of earlier termination thereof, without the express or implied consent of Landlord, such
      tenancy shall be deemed to be a tenancy by sufferance only, and shall not constitute a renewal hereof or an extension for any further term. In either case, Rent shall be payable at a monthly rate equal to the product of (i) the monthly Rent
      applicable during the last rental period of the Lease Term under this Lease, and (ii) a percentage equal to 150% during the first month immediately following the expiration or earlier termination of the Lease Term, and 200% thereafter. Such
      month-to-month tenancy or tenancy by sufferance, as the case may be, shall be subject to every other applicable term, covenant and agreement contained herein. Nothing contained in this Article 16 shall be construed as consent by Landlord to any
      holding over by Tenant, and Landlord expressly reserves the right to require Tenant to surrender possession of the Premises to Landlord as provided in this Lease upon the expiration or other termination of this Lease. The provisions of this Article
      16 shall not be deemed to limit or constitute a waiver of any other rights or remedies of Landlord provided herein or at law. If Tenant fails to surrender the Premises upon the termination or expiration of this Lease, in addition to any other
      liabilities to Landlord accruing therefrom, Tenant shall protect, defend, indemnify and hold Landlord harmless from all loss, costs (including reasonable attorneys' fees) and liability resulting from such failure, including, without limiting the
      generality of the foregoing, any claims made by any succeeding tenant founded upon such failure to surrender and any lost profits to Landlord resulting therefrom.</div>
    <div style="text-align: justify;">
      <div>
        <div> <br>
        </div>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-29-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">17.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">ESTOPPEL CERTIFICATES&#160;&#160;&#160;&#160;&#160; </font>Within ten (10) business days following a request in writing by Landlord, Tenant shall execute,
      acknowledge and deliver to Landlord an estoppel certificate, which, as submitted by Landlord, shall be substantially in the form of <font style="font-weight: bold;"><u>Exhibit D</u></font>, attached hereto (or such other form as may be required by
      any prospective mortgagee or purchaser of the Project, or any portion thereof), indicating therein any exceptions thereto that may exist at that time, and shall also contain any other information reasonably requested by Landlord or Landlord's
      mortgagee or prospective mortgagee. Any such certificate may be relied upon by any prospective mortgagee or purchaser of all or any portion of the Project. Tenant shall execute and deliver whatever other instruments may be reasonably required for
      such purposes. At any time during the Lease Term but not more than once per calendar year (except in connection with a financing, refinancing or sale of the Building or in connection with Tenant&#8217;s request for Landlord&#8217;s consent to an Alteration or
      Transfer), Landlord may require Tenant to provide Landlord with a current financial statement and financial statements of the two (2) years prior to the current financial statement year. Such statements shall be prepared in accordance with generally
      accepted accounting principles and, if such is the normal practice of Tenant, shall be audited by an independent certified public accountant. Failure of Tenant to timely execute, acknowledge and deliver such estoppel certificate or other instruments
      shall constitute an acceptance of the Premises and an acknowledgment by Tenant that statements included in the estoppel certificate are true and correct, without exception.</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">18.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">SUBORDINATION&#160;&#160;&#160;&#160;&#160;&#160; </font>This Lease shall be subject and subordinate to all present and future ground or underlying leases of the
      Building or Project and to the lien of any mortgage, trust deed or other encumbrances now or hereafter in force against the Building or Project or any part thereof, if any, and to all renewals, extensions, modifications, consolidations and
      replacements thereof, and to all advances made or hereafter to be made upon the security of such mortgages or trust deeds, unless the holders of such mortgages, trust deeds or other encumbrances, or the lessors under such ground lease or underlying
      leases, require in writing that this Lease be superior thereto. Tenant covenants and agrees in the event any proceedings are brought for the foreclosure of any such mortgage or deed in lieu thereof (or if any ground lease is terminated), to attorn,
      without any deductions or set-offs whatsoever, to the lienholder or purchaser or any successors thereto upon any such foreclosure sale or deed in lieu thereof (or to the ground lessor), if so requested to do so by such purchaser or lienholder or
      ground lessor, and to recognize such purchaser or lienholder or ground lessor as the lessor under this Lease, provided such lienholder or purchaser or ground lessor shall agree to accept this Lease and not disturb Tenant's occupancy, so long as
      Tenant timely pays the rent and observes and performs the terms, covenants and conditions of this Lease to be observed and performed by Tenant. Landlord's interest herein may be assigned as security at any time to any lienholder. Tenant shall, within
      ten (10) days of request by Landlord, execute such further instruments or assurances as Landlord may reasonably deem necessary to evidence or confirm the subordination or superiority of this Lease to any such mortgages, trust deeds, ground leases or
      underlying leases. Tenant waives the provisions of any current or future statute, rule or law which may give or purport to give Tenant any right or election to terminate or otherwise adversely affect this Lease and the obligations of the Tenant
      hereunder in the event of any foreclosure proceeding or sale.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z78cdc1d9ac2241f19f9cc478f1dcc189" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top;"><a name="z_TOC_250003"></a><font style="font-weight: bold;">19.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">DEFAULTS; REMEDIES</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">19.1&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Events of Default</u></font>. In addition to any other Events of Default specified in this Lease, the occurrence of any of the following shall constitute a default of this
      Lease by Tenant (each, an &#8220;<font style="font-weight: bold;">Event of Default</font>&#8221;):</div>
    <div style="text-indent: 36pt; margin-right: 47.9pt; margin-left: 6pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-30-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">19.1.1&#160;&#160;&#160; Any failure by Tenant to pay any Rent or any other charge required to be paid under this Lease, or any part thereof, which failure is not cured within five (5) business days after written
      notice from Landlord that said amount was not paid when due, provided that if Tenant has previously received one (1) or more notices from Landlord during the immediately preceding twelve (12) month period stating that Tenant failed to pay any amount
      required to be paid by Tenant under this Lease when due, then Landlord shall not be required to deliver any notice to Tenant and a Event of Default shall immediately occur upon any failure by Tenant to pay any rent or any other charge required to be
      paid under this Lease when due; or</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">19.1.2&#160;&#160;&#160; Except where a specific time period is otherwise set forth for Tenant's performance in this Lease, in which event the failure to perform by Tenant within such time period shall be a default
      by Tenant under this<u> Section 19.1.2</u>, any failure by Tenant to observe or perform any other provision, covenant or condition of this Lease to be observed or performed by Tenant where such failure continues for thirty (30) days after written
      notice thereof from Landlord to Tenant; provided that if the nature of such default is such that the same cannot reasonably be cured within a thirty (30) day period, Tenant shall not be deemed to be in default if it diligently commences such cure
      within such period and thereafter diligently proceeds to rectify and cure such default; or</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div>
      <div style="text-indent: 72pt;">19.1.3&#160;&#160;&#160; Abandonment or vacation of all or a substantial portion of the Premises by Tenant; or</div>
    </div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">19.1.4&#160;&#160;&#160; The failure by Tenant to observe or perform according to the provisions of <u>Articles 5</u>, <u>14</u>,<u> 17</u> or <u>18</u> of this Lease or any provision of the Tenant Work Letter,
      where, in each instance, such failure continues for more than three (3) days after notice from Landlord; or</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">19.1.5&#160;&#160;&#160;&#160; Tenant's failure to occupy the Premises within ten (10) business days after the Lease Commencement Date.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">Any notices to be provided by Landlord under this <u>Section 19.1</u> shall be in lieu of, and not in addition to, any notice required under Section 1161 et seq. of the Code of Civil Procedure, and
      may be served on Tenant in the manner allowed for service of notices under this Lease.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">19.2&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Remedies Upon Event of Default</u></font>. Upon the occurrence of any event of default by Tenant, Landlord shall have, in addition to any other remedies
      available to Landlord at law or in equity (all of which remedies shall be distinct, separate and cumulative), the option to pursue any one or more of the following remedies (including, without limitation, during any eviction moratorium, to the extent
      allowed by Applicable Law), each and all of which shall be cumulative and nonexclusive, without any notice or demand whatsoever.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">19.2.1&#160;&#160;&#160; Terminate this Lease, in which event Tenant shall immediately surrender the Premises to Landlord, and if Tenant fails to do so, Landlord may, without prejudice to any other remedy which it
      may have for possession or arrearages in rent, enter upon and take possession of the Premises and expel or remove Tenant and any other person who may be occupying the Premises or any part thereof, without being liable for prosecution or any claim or
      damages therefor; and Landlord may recover from Tenant the following:</div>
    <div>&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; text-indent: 72pt;">(i)&#160;&#160;&#160;&#160; &#160; &#160;&#160;&#160; The worth at the time of award of the unpaid rent which has been earned at the time of such termination; plus</div>
    <div style="margin-left: 36pt; text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; text-indent: 72pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The worth at the time of award of the amount by which the unpaid rent which would have been earned after termination until the time of award exceeds the amount of such
      rental loss that Tenant proves could have been reasonably avoided; plus</div>
    <div style="margin-left: 36pt; text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; text-indent: 72pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160; The worth at the time of award of the amount by which the unpaid rent for the balance of the Lease Term after the time of award exceeds the amount of such rental loss
      that Tenant proves could have been reasonably avoided; plus</div>
    <div style="margin-left: 36pt; text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; text-indent: 72pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Any other amount necessary to compensate Landlord for all the detriment proximately caused by Tenant's failure to perform its obligations under this Lease or which in
      the ordinary course of things would be likely to result therefrom, specifically including but not limited to, brokerage commissions and advertising expenses incurred, expenses of remodeling the Premises or any portion thereof for a new tenant,
      whether for the same or a different use, and any special concessions made to obtain a new tenant; and</div>
    <div style="text-align: justify; text-indent: 72pt; margin-right: 47.7pt; margin-left: 42pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-31-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="margin-left: 36pt; text-indent: 72pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At Landlord's election, such other amounts in addition to or in lieu of the foregoing as may be permitted from time to time by Applicable Law.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">The term "<font style="font-weight: bold;">rent</font>" as used in this <u>Section 19.2</u> shall be deemed to be and to mean all sums of every nature required to be paid by Tenant pursuant to the
      terms of this Lease, whether to Landlord or to others. As used in <u>Sections</u>&#160;<u>19.2.1(i)</u> and <u>(ii)</u>, above, the "worth at the time of award" shall be computed by allowing interest at the rate set forth in <u>Article 25</u> of this
      Lease, but in no case greater than the maximum amount of such interest permitted by law. As used in <u>Section 19.2.1(iii)</u> above, the "<font style="font-weight: bold;">worth at the time of award</font>" shall be computed by discounting such
      amount at the discount rate of the Federal Reserve Bank of San Francisco at the time of award plus one percent (1%).</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">19.2.2&#160;&#160; Landlord shall have the remedy described in California Civil Code Section 1951.4 (lessor may continue lease in effect after lessee's breach and abandonment and recover rent as it becomes
      due, if lessee has the right to sublet or assign, subject only to reasonable limitations). Accordingly, if Landlord does not elect to terminate this Lease on account of any Event of Default by Tenant, Landlord may, from time to time, without
      terminating this Lease, enforce all of its rights and remedies under this Lease, including the right to recover all rent as it becomes due.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">19.2.3&#160;&#160;&#160; Landlord shall at all times have the rights and remedies (which shall be cumulative with each other and cumulative and in addition to those rights and remedies available under <u>Sections
        19.2.1</u> and <u>19.2.2</u>, above, or any law or other provision of this Lease), without prior demand or notice except as required by applicable law, to seek any declaratory, injunctive or other equitable relief, and specifically enforce this
      Lease, or restrain or enjoin a violation or breach of any provision hereof.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">19.3&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Subleases of Tenant</u></font>. Whether or not Landlord elects to terminate this Lease on account of any Event of Default by Tenant, as set forth in
      this <u>Article 19</u>, Landlord shall have the right to terminate any and all subleases, licenses, concessions or other consensual arrangements for possession entered into by Tenant and affecting the Premises or may, in Landlord's sole discretion,
      succeed to Tenant's interest in such subleases, licenses, concessions or arrangements. In the event of Landlord's election to succeed to Tenant's interest in any such subleases, licenses, concessions or arrangements, Tenant shall, as of the date of
      notice by Landlord of such election, have no further right to or interest in the rent or other consideration receivable thereunder.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">19.4&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Efforts to Relet</u></font>. No re-entry or repossession, repairs, maintenance, changes, alterations and additions, reletting, appointment of a receiver
      to protect Landlord's interests hereunder, or any other action or omission by Landlord shall be construed as an election by Landlord to terminate this Lease or Tenant's right to possession, or to accept a surrender of the Premises, nor shall same
      operate to release Tenant in whole or in part from any of Tenant's obligations hereunder, unless express written notice of such intention is sent by Landlord to Tenant. Tenant hereby irrevocably waives any right otherwise available under any law to
      redeem or reinstate this Lease.</div>
    <div>&#160;</div>
    <div>
      <div style="font-weight: bold; text-indent: 36pt;"><font style="font-weight: normal;">19.5</font>&#160;&#160;&#160;&#160;&#160;&#160; <u>Landlord Default</u></div>
    </div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">19.5.1&#160;&#160;&#160; <font style="font-weight: bold;"><u>General</u></font>. Landlord shall be in default under this Lease if Landlord fails to perform any of its obligations hereunder following the Lease
      Commencement Date and such failure continues for thirty (30) days after Tenant delivers to Landlord written notice specifying such failure; however, if such failure cannot reasonably be cured within such 30-day period, but Landlord commences to cure
      such failure within such 30-day period and thereafter diligently pursues the curing thereof to completion, then Landlord shall not be in default hereunder or liable for damages therefor. Except where the provisions of this Lease grant Tenant an
      express, exclusive remedy, or expressly deny Tenant a remedy, Tenant's exclusive remedy for Landlord's failure to perform its obligations under this Lease shall be limited to damages, injunctive relief, or specific performance; in each case,
      Landlord's liability or obligations with respect to any such remedy shall be limited as provided in <u>Section 29.13</u>.</div>
    <div style="text-align: justify; text-indent: 72pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-32-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;">19.5.2&#160;&#160;&#160; <font style="font-weight: bold;"><u>Abatement of Rent</u></font>. In the event that Tenant is prevented from using, and does not use, the Premises or any portion thereof as a result of (i)
      any repair, maintenance or alteration performed by Landlord, or which Landlord failed to perform, after the Lease Commencement Date and required by this Lease, which substantially interferes with Tenant's use of the Premises, or (ii) any failure to
      provide services, utilities or access to the Premises as required by this Lease (either such set of circumstances as set forth in items (i) or (ii), above, to be known as an "<font style="font-weight: bold;">Abatement Event</font>"), then Tenant
      shall give Landlord notice of such Abatement Event, and if such Abatement Event continues for five (5) consecutive business days after Landlord's receipt of any such notice (the "<font style="font-weight: bold;">Eligibility Period</font>"), then the
      Base Rent, Tenant's Share of Direct Expenses, and Tenant's obligation to pay for parking (to the extent not utilized by Tenant) shall be abated or reduced, as the case may be, after expiration of the Eligibility Period for such time that Tenant
      continues to be so prevented from using, and does not use for the normal conduct of Tenant's business, the Premises or a portion thereof, in the proportion that the rentable area of the portion of the Premises that Tenant is prevented from using, and
      does not use, bears to the total rentable area of the Premises; provided, however, in the event that Tenant is prevented from using, and does not use, a portion of the Premises for a period of time in excess of the Eligibility Period and the
      remaining portion of the Premises is not sufficient to allow Tenant to effectively conduct its business therein, and if Tenant does not conduct its business from such remaining portion, then for such time after expiration of the Eligibility Period
      during which Tenant is so prevented from effectively conducting its business therein, the Base Rent and Tenant's Share of Direct Expenses for the entire Premises and Tenant's obligation to pay for parking shall be abated for such time as Tenant
      continues to be so prevented from using, and does not use, the Premises. If, however, Tenant reoccupies any portion of the Premises during such period, the Rent allocable to such reoccupied portion, based on the proportion that the rentable area of
      such reoccupied portion of the Premises bears to the total rentable area of the Premises, shall be payable by Tenant from the date Tenant reoccupies such portion of the Premises. To the extent an Abatement Event is caused by an event covered by <u>Articles


        11</u> or <u>13</u> of this Lease, then Tenant's right to abate rent shall be governed by the terms of such <u>Article 11</u> or <u>13</u>, as applicable, and the Eligibility Period shall not be applicable thereto. Such right to abate Base Rent
      and Tenant's Share of Direct Expenses shall be Tenant's sole and exclusive remedy for rent abatement at law or in equity for an Abatement Event. Except as provided in this <u>Section 19.5</u>, nothing contained herein shall be interpreted to mean
      that Tenant is excused from paying Rent due hereunder.</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">20.&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">COVENANT OF QUIET ENJOYMENT </font>Landlord covenants that Tenant, on paying the Rent, charges for services and other payments
      herein reserved and on keeping, observing and performing all the other terms, covenants, conditions, provisions and agreements herein contained on the part of Tenant to be kept, observed and performed, shall, during the Lease Term, peaceably and
      quietly have, hold and enjoy the Premises subject to the terms, covenants, conditions, provisions and agreements hereof without interference by any persons lawfully claiming by or through Landlord. The foregoing covenant is in lieu of any other
      covenant express or implied.</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">21.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">SECURITY DEPOSIT </font>Concurrently with Tenant's execution of this Lease, Tenant shall deposit with Landlord a security deposit
      (the "<font style="font-weight: bold;">Security Deposit</font>") in the amount set forth in Section 8 of the Summary, as security for the faithful performance by Tenant of all of its obligations under this Lease. If Tenant defaults with respect to
      any provisions of this Lease, including, but not limited to, the provisions relating to the payment of Rent, the removal of property and the repair of resultant damage, Landlord may, without notice to Tenant, but shall not be required to apply all or
      any part of the Security Deposit for the payment of any Rent or any other sum in default and Tenant shall, within ten (10) business days after written demand therefor, restore the Security Deposit to its original amount (including, without
      limitation, during any eviction moratorium, to the extent allowed by Applicable Law). Any unapplied portion of the Security Deposit shall be returned to Tenant, or, at Landlord's option, to the last assignee of Tenant's interest hereunder, within
      sixty (60) days following the later to occur of (i) the expiration or earlier termination of the Lease Term, or (ii) the date on which Tenant vacates and surrenders the Premises to Landlord. Tenant shall not be entitled to any interest on the
      Security Deposit. Tenant hereby irrevocably waives and relinquishes any and all rights, benefits, or protections, if any, Tenant now has, or in the future may have, under Section 1950.7 of the California Civil Code, any successor statute, and all
      other provisions of law, now or hereafter in effect, including, but not limited to, any provision of law which (i) establishes the time frame by which a landlord must refund a security deposit under a lease, and/or (ii) provides that a landlord may
      claim from a security deposit only those sums reasonably necessary to remedy defaults in the payment of rent, to repair damage caused by a tenant or to clean the subject premises. Tenant acknowledges and agrees that (a) any statutory time frames for
      the return of a security deposit are superseded by the express period identified in this Article 21, above, and (b) rather than be so limited, Landlord may claim from the Security Deposit (1) any and all sums expressly identified in this Article 21,
      above, and (2) any additional sums reasonably necessary to compensate Landlord for any and all losses or damages caused by Tenant's default of this Lease, including, but not limited to, all damages or rent due upon termination of Lease pursuant to
      Section 1951.2 of the California Civil Code.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-33-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">22.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">COMMUNICATIONS AND COMPUTER LINE </font>Tenant may install, maintain, replace, remove or use any communications or computer wires
      and cables serving the Premises (collectively, the "<font style="font-weight: bold;">Lines</font>"), provided that Tenant shall obtain Landlord's prior written consent, use an experienced and qualified contractor approved in writing by Landlord, and
      comply with all of the other provisions of Articles 7 and 8 of this Lease. Tenant shall pay all costs in connection therewith. Landlord reserves the right, upon notice to Tenant prior to the expiration or earlier termination of this Lease, to require
      that Tenant, at Tenant's sole cost and expense, remove any Lines located in or serving the Premises prior to the expiration or earlier termination of this Lease.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9028b971c59d4099b3c091b1896a98a7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top;"><a name="z_TOC_250002"></a><font style="font-weight: bold;">23.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">SIGNS</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">23.1&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Full Floors</u></font>. Subject to Landlord's prior written approval, in its reasonable discretion, and provided all signs are in keeping with the
      quality, design and style of the Building and Project, Tenant, if the Premises comprise an entire floor of the Building, at its sole cost and expense, may install identification signage anywhere in the Premises including in the elevator lobby of the
      Premises, provided that such signs must not be visible from the exterior of the Building.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">23.2&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Multi-Tenant Floors</u></font>. If other tenants occupy space on the floor on which the Premises is located, Tenant's identifying suite entrance signage
      shall be provided by Landlord, at Landlord&#8217;s initial cost (any changes to Tenant's suite entrance signage shall be subject to Landlord's prior written approval and shall be performed at Tenant's sole cost and expense), and such signage shall be
      comparable to that used by Landlord for other similar floors in the Building and shall comply with Landlord's then-current Building standard signage program.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">23.3&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Prohibited Signage and Other Items</u></font>. Except as otherwise set forth in this <u>Section 23.3</u>, any signs, notices, logos, pictures, names or
      advertisements which are installed and that have not been separately approved by Landlord may be removed without notice by Landlord at the sole expense of Tenant. Tenant may not install any signs on the exterior or roof of the Project or the Common
      Areas. Any signs, window coverings, or blinds (even if the same are located behind the Landlord-approved window coverings for the Building), or other items visible from the exterior of the Premises or Building, shall be subject to the prior approval
      of Landlord, in its sole discretion.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">23.4&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Lobby Directory</u></font>. Landlord, at its sole cost and expense, shall install Tenant's name in the Building directory located in the lobby. Any
      changes to Tenant's lobby directory signage shall be subject to Landlord's prior written approval and shall be performed at Tenant's sole cost and expense. Notwithstanding anything to the contrary contained in this Lease, upon the expiration of the
      Lease Term, or upon any earlier termination of this Lease, the removal of Tenant's name initially provided for in the Building directory, shall be at Landlord's sole cost and expense.</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">24.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">COMPLIANCE WITH LAW&#160;&#160; </font>Tenant shall not do anything or suffer anything to be done in or about&#160;&#160; the Premises or the Project
      which will in any way conflict with any law, statute, ordinance or other rule, directive, order, regulation, guideline or requirement of any governmental entity or governmental agency (the &#8220;<font style="font-weight: bold;">Applicable Laws</font>&#8221;)
      now in force or which may hereafter be enacted or promulgated. At its sole cost and expense, Tenant shall promptly comply with all such governmental measures. Should any standard or regulation now or hereafter be imposed on Landlord or Tenant by a
      state, federal or local governmental body charged with the establishment, regulation and enforcement of occupational, health or safety standards for employers, employees, landlords or tenants, then Tenant agrees, at its sole cost and expense, to
      comply promptly with such standards or regulations. Tenant shall be responsible, at its sole cost and expense, to make all alterations to the Building and Premises as are required to comply with the governmental rules, regulations, requirements or
      standards described in this Article 24. The judgment of any court of competent jurisdiction or the admission of Tenant in any judicial action, regardless of whether Landlord is a party thereto, that Tenant has violated any of said governmental
      measures, shall be conclusive of that fact as between Landlord and Tenant. For purposes of Section 1938 of the California Civil Code, Landlord hereby discloses to Tenant, and Tenant hereby acknowledges, that the Project, Building and Premises have
      not undergone inspection by a Certified Access Specialist (CASp). As required by Section 1938(e) of the California Civil Code, Landlord hereby states as follows: "A Certified Access Specialist (CASp) can inspect the subject premises and determine
      whether the subject premises comply with all of the applicable construction-related accessibility standards under state law. Although state law does not require a CASp inspection of the subject premises, the commercial property owner or lessor may
      not prohibit the lessee or tenant from obtaining a CASp inspection of the subject premises for the occupancy or potential occupancy of the lessee or tenant, if requested by the lessee or tenant. The parties shall mutually agree on the arrangements
      for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of construction-related accessibility standards within the premises." In furtherance of
      the foregoing, Landlord and Tenant hereby agree as follows: (a) any CASp inspection requested by Tenant shall be conducted, at Tenant's sole cost and expense, by a CASp approved in advance by Landlord; and (b) pursuant to Article 24 below, Tenant, at
      its cost, is responsible for making any repairs within the Premises to correct violations of construction-related accessibility standards; and, if anything done by or for Tenant in its use or occupancy of the Premises shall require repairs to the
      Building (outside the Premises) to correct violations of construction-related accessibility standards, then Tenant shall, at Landlord's option, either perform such repairs at Tenant's sole cost and expense or reimburse Landlord upon demand, as
      Additional Rent, for the cost to Landlord of performing such repairs.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-34-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">25.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">LATE CHARGES&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If any installment of Rent or any other sum due from Tenant shall not be received by Landlord or
      Landlord's designee within five (5) business days after Tenant's receipt of written notice from Landlord that said amount is due, then Tenant shall pay to Landlord a late charge equal to five percent (5%) of the overdue amount plus any reasonable
      attorneys' fees incurred by Landlord by reason of Tenant's failure to pay Rent and/or other charges when due hereunder. The late charge shall be deemed Additional Rent and the right to require it shall be in addition to all of Landlord's other rights
      and remedies hereunder or at law and shall not be construed as liquidated damages or as limiting Landlord's remedies in any manner. In addition to the late charge described above, any Rent or other amounts owing hereunder which are not paid within
      ten (10) days after the date they are due shall bear interest from the date when due until paid at a rate per annum equal to the lesser of (i) the annual "Bank Prime Loan" rate cited in the Federal Reserve Statistical Release Publication G.13(415),
      published on the first Tuesday of each calendar month (or such other comparable index as Landlord and Tenant shall reasonably agree upon if such rate ceases to be published) plus four (4) percentage points, and (ii) the highest rate permitted by
      Applicable Law.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zff0e25a3a6bb4ede9f73c9c3cfa1e875" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top;"><a name="z_TOC_250001"></a><font style="font-weight: bold;">26.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">LANDLORD'S RIGHT TO CURE DEFAULT; PAYMENTS BY TENANT</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">26.1&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Landlord's Cure</u></font>. All covenants and agreements to be kept or performed by Tenant under this Lease shall be performed by Tenant at Tenant's
      sole cost and expense and without any reduction of Rent, except to the extent, if any, otherwise expressly provided herein. If Tenant shall fail to perform any obligation under this Lease, and such failure shall continue in excess of the time allowed
      under <u>Section 19.1.2</u>, above, unless a specific time period is otherwise stated in this Lease, Landlord may, but shall not be obligated to, make any such payment or perform any such act on Tenant's part without waiving its rights based upon
      any default of Tenant and without releasing Tenant from any obligations hereunder.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">26.2&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Tenant's Reimbursement</u></font>. Except as may be specifically provided to the contrary in this Lease, Tenant shall pay to Landlord, within thirty
      (30) days of delivery by Landlord to Tenant of statements therefor: (i) sums equal to expenditures reasonably made and obligations incurred by Landlord in connection with the remedying by Landlord of Tenant's defaults pursuant to the provisions of <u>Section


        26.1</u>; (ii) sums equal to all losses, costs, liabilities, damages and expenses referred to in <u>Article 10</u> of this Lease; and (iii) sums equal to all expenditures made and obligations incurred by Landlord in collecting or attempting to
      collect the Rent or in enforcing or attempting to enforce any rights of Landlord under this Lease or pursuant to law, including, without limitation, all reasonable legal fees and other amounts so expended. Tenant's obligations under this <u>Section
        26.2</u> shall survive the expiration or sooner termination of the Lease Term.</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">27.</font>&#160;&#160; &#160; &#160;&#160; <font style="font-weight: bold;">ENTRY BY LANDLORD&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Landlord reserves the right at all reasonable times and upon reasonable notice (not less than 48
      hours prior notice for Landlord&#8217;s entry into the laboratory areas within the Premises) to Tenant (except in the case of an emergency) to enter the Premises to (i) inspect them; (ii) show the Premises to prospective purchasers, or to current or
      prospective mortgagees, ground or underlying lessors or insurers or, during the last twelve (12) months of the Lease Term, to prospective tenants; (iii) post notices of nonresponsibility (to the extent applicable pursuant to then Applicable Law); or
      (iv) alter, improve or repair the Premises or the Building, or for structural alterations, repairs or improvements to the Building or the Building's systems and equipment. Landlord may make any such entries without the abatement of Rent, except as
      otherwise provided in this Lease, including, without limitation, as expressly set forth in <u>Section 19.5</u>, and may take such reasonable steps as required to accomplish the stated purposes. In an emergency, Landlord shall have the right to use
      any means that Landlord may deem proper to open the doors in and to the Premises. Any entry into the Premises by Landlord in the manner hereinbefore described shall not be deemed to be a forcible or unlawful entry into, or a detainer of, the
      Premises, or an actual or constructive eviction of Tenant from any portion of the Premises.</div>
    <div style="text-align: justify; margin-right: 47.75pt; margin-left: 5.95pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-35-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify;"><font style="font-weight: bold;">28.&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;">TENANT PARKING&#160;&#160; </font>Tenant shall have the right to use the amount of parking set forth in Section 9 of the Summary at no cost
      to Tenant (other than those costs included within Direct Expenses) during the Lease Term and any Option Term, in the on-site and/or off-site, as the case may be, parking facility (or facilities) which serve the Project. Tenant shall abide by all
      reasonable rules and regulations which are prescribed from time to time for the orderly operation and use of the parking facility where the parking passes are located (including any sticker or other identification system established by Landlord and
      the prohibition of vehicle repair and maintenance activities in the parking facilities), and shall cooperate in seeing that Tenant's employees and visitors also comply with such rules and regulations. Tenant's use of the Project parking facility
      shall be at Tenant's sole risk and Tenant acknowledges and agrees that Landlord shall have no liability whatsoever for damage to the vehicles of Tenant, its employees and/or visitors, or for other personal injury or property damage or theft relating
      to or connected with the parking rights granted herein or any of Tenant's, its employees' and/or visitors' use of the parking facilities.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za2c72d6e91bc42e5970fb2c98e92fde5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt; vertical-align: top;"><a name="z_TOC_250000"></a><font style="font-weight: bold;">29.</font></td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;">MISCELLANEOUS PROVISIONS</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.1&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Terms; Captions</u></font>. The words "<font style="font-weight: bold;">Landlord</font>" and "<font style="font-weight: bold;">Tenant</font>" as used
      herein shall include the plural as well as the singular. The necessary grammatical changes required to make the provisions hereof apply either to corporations or partnerships or individuals, men or women, as the case may require, shall in all cases
      be assumed as though in each case fully expressed. The captions of Articles and Sections are for convenience only and shall not be deemed to limit, construe, affect or alter the meaning of such Articles and Sections.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.2&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Binding Effect</u></font>. Subject to all other provisions of this Lease, each of the covenants, conditions and provisions of this Lease shall extend to
      and shall, as the case may require, bind or inure to the benefit not only of Landlord and of Tenant, but also of their respective heirs, personal representatives, successors or assigns, provided this clause shall not permit any assignment by Tenant
      contrary to the provisions of <u>Article 14</u> of this Lease.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.3&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>No Air Rights</u></font>. No rights to any view or to light or air over any property, whether belonging to Landlord or any other person, are granted to
      Tenant by this Lease. If at any time any windows of the Premises are temporarily darkened or the light or view therefrom is obstructed by reason of any repairs, improvements, maintenance or cleaning in or about the Project, the same shall be without
      liability to Landlord and without any reduction or diminution of Tenant's obligations under this Lease.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.4&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Modification of Lease</u></font>. Should any current or prospective mortgagee or ground lessor for the Building or Project require a modification of
      this Lease, which modification will not cause an increased cost or expense to Tenant or in any other way materially and adversely change the rights and obligations of Tenant hereunder, then and in such event, Tenant agrees that this Lease may be so
      modified and agrees to execute whatever documents are reasonably required therefor and to deliver the same to Landlord within ten (10) business days following a request therefor. At the request of Landlord or any mortgagee or ground lessor, Tenant
      agrees to execute a short form of Lease and deliver the same to Landlord within ten (10) business days following the request therefor.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.5&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Transfer of Landlord's Interest</u></font>. Tenant acknowledges that Landlord has the right to transfer all or any portion of its interest in the
      Project or Building and in this Lease, and Tenant agrees that in the event of any such transfer, Landlord shall automatically be released from all liability under this Lease and Tenant agrees to look solely to such transferee for the performance of
      Landlord's obligations hereunder after the date of transfer and such transferee shall be deemed to have fully assumed and be liable for all obligations of this Lease to be performed by Landlord, including the return of any Security Deposit, and
      Tenant shall attorn to such transferee.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 47.75pt; margin-left: 5.95pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-36-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">29.6&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Prohibition Against Recording</u></font>. Except as provided in <u>Section 29.4</u> of this Lease, neither this Lease, nor any memorandum, affidavit
      or other writing with respect thereto, shall be recorded by Tenant or by anyone acting through, under or on behalf of Tenant.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.7&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Landlord's Title</u></font>. Landlord's title is and always shall be paramount to the title of Tenant. Nothing herein contained shall empower Tenant to
      do any act which can, shall or may encumber the title of Landlord.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.8&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Relationship of Parties</u></font>. Nothing contained in this Lease shall be deemed or construed by the parties hereto or by any third party to create
      the relationship of principal and agent, partnership, joint venturer or any association between Landlord and Tenant.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.9&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Application of Payments</u></font>. Landlord shall have the right to apply payments received from Tenant pursuant to this Lease, regardless of Tenant's
      designation of such payments, to satisfy any obligations of Tenant hereunder, in such order and amounts as Landlord, in its sole discretion, may elect.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.10&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Time of Essence</u></font>. Time is of the essence with respect to the performance of every provision of this Lease in which time of performance is a
      factor.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.11&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Partial Invalidity</u></font>. If any term, provision or condition contained in this Lease shall, to any extent, be invalid or unenforceable, the
      remainder of this Lease, or the application of such term, provision or condition to persons or circumstances other than those with respect to which it is invalid or unenforceable, shall not be affected thereby, and each and every other term,
      provision and condition of this Lease shall be valid and enforceable to the fullest extent possible permitted by law.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.12&#160;&#160;&#160; <font style="font-weight: bold;"><u>No Warranty</u></font>. In executing and delivering this Lease, Tenant has not relied on any representations, including, but not limited to, any
      representation as to the amount of any item comprising Additional Rent or the amount of the Additional Rent in the aggregate or that Landlord is furnishing the same services to other tenants, at all, on the same level or on the same basis, or any
      warranty or any statement of Landlord which is not set forth herein or in one or more of the exhibits attached hereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.13&#160;&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Landlord Exculpation</u></font>. The liability of Landlord or the Landlord Parties to Tenant for any default by Landlord under this Lease or arising in
      connection herewith or with Landlord's operation, management, leasing, repair, renovation, alteration or any other matter relating to the Project or the Premises shall be limited solely and exclusively to an amount which is equal to the lesser of (a)
      the interest of Landlord in the Building or (b) the equity interest Landlord would have in the Building if the Building were encumbered by third-party debt in an amount equal to eighty percent (80%) of the value of the Building (as such value is
      determined by Landlord), provided that in no event shall such liability extend to any sales or insurance proceeds received by Landlord or the Landlord Parties in connection with the Project, Building or Premises. Neither Landlord, nor any of the
      Landlord Parties shall have any personal liability therefor, and Tenant hereby expressly waives and releases such personal liability on behalf of itself and all persons claiming by, through or under Tenant. The limitations of liability contained in
      this <u>Section 29.13</u> shall inure to the benefit of Landlord's and the Landlord Parties' present and future partners, beneficiaries, officers, directors, trustees, shareholders, agents and employees, and their respective partners, heirs,
      successors and assigns. Under no circumstances shall any present or future partner of Landlord (if Landlord is a partnership), or trustee or beneficiary (if Landlord or any partner of Landlord is a trust), have any liability for the performance of
      Landlord's obligations under this Lease. Notwithstanding any contrary provision herein, neither Landlord nor the Landlord Parties shall be liable under any circumstances for injury or damage to, or interference with, Tenant's business, including but
      not limited to, loss of profits, loss of rents or other revenues, loss of business opportunity, loss of goodwill or loss of use, in each case, however occurring, or loss to inventory, scientific research, scientific experiments, laboratory animals,
      products, specimens, samples, and/or scientific, business, accounting and other records of every kind and description kept at the premises and any and all income derived or derivable therefrom.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.14&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Entire Agreement</u></font>. It is understood and acknowledged that there are no oral agreements between the parties hereto affecting this Lease and
      this Lease constitutes the parties' entire agreement with respect to the leasing of the Premises and supersedes and cancels any and all previous negotiations, arrangements, brochures, agreements and understandings, if any, between the parties hereto
      or displayed by Landlord to Tenant with respect to the subject matter thereof, and none thereof shall be used to interpret or construe this Lease. None of the terms, covenants, conditions or provisions of this Lease can be modified, deleted or added
      to except in writing signed by the parties hereto.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div style="text-align: justify;"> </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-37-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">29.15&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Right to Lease</u></font>. Landlord reserves the absolute right to effect such other tenancies in the Project as Landlord in the exercise of its sole
      business judgment shall determine to best promote the interests of the Building or Project. Tenant does not rely on the fact, nor does Landlord represent, that any specific tenant or type or number of tenants shall, during the Lease Term, occupy any
      space in the Building or Project.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.16&#160;&#160;&#160; <font style="font-weight: bold;"><u>Force Majeure</u></font>. Notwithstanding anything to the contrary contained in this Lease, any prevention, delay or stoppage due to strikes, lockouts,
      labor disputes, acts of God, acts of war, terrorist acts, inability to obtain services, labor, or materials or reasonable substitutes therefor, governmental actions, civil commotions, Casualty, actual or threatened public health emergency (including,
      without limitation, epidemic, pandemic, famine, disease, plague, quarantine, and other significant public health risk), governmental edicts, actions, declarations or quarantines by a governmental entity or health organization (including, without
      limitation, any shelter-in-place orders, stay at home orders or any restrictions on travel related thereto that preclude Tenant, its agents, contractors or its employees from accessing the Premises, national or regional emergency), breaches in
      cybersecurity, and other causes beyond the reasonable control of the party obligated to perform, regardless of whether such other causes are (i) foreseeable or unforeseeable or (ii) related to the specifically enumerated events in this paragraph
      (collectively, a "<font style="font-weight: bold;">Force Majeure</font>"), shall excuse the performance of such party for a period equal to any such prevention, delay or stoppage. If this Lease specifies a time period for performance of an obligation
      of either party, that time period shall be extended by the period of any delay in such party's performance caused by a Force Majeure. Notwithstanding anything to the contrary in this Lease, no event of Force Majeure shall (i) excuse Tenant's
      obligations to pay Rent and other charges due pursuant to this Lease, or (ii) be grounds for Tenant to abate any portion of Rent due pursuant to this Lease, or entitle either party to terminate this Lease, except as allowed pursuant to <u>Articles
        11 and 13</u> of this Lease.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.17&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Waiver of Redemption by Tenant</u></font>. Tenant hereby waives, for Tenant and for all those claiming under Tenant, any and all rights now or hereafter
      existing to redeem by order or judgment of any court or by any legal process or writ, Tenant's right of occupancy of the Premises after any termination of this Lease.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.18&#160;&#160;&#160; <font style="font-weight: bold;"><u>Notices</u></font>. All notices, demands, statements, designations, approvals or other communications (collectively, "<font style="font-weight: bold;">Notices</font>")


      given or required to be given by either party to the other hereunder or by law shall be in writing, shall be (A) sent by United States certified or registered mail, postage prepaid, return receipt requested ("<font style="font-weight: bold;">Mail</font>"),


      (B) transmitted by telecopy, if such telecopy is promptly followed by a Notice sent by Mail, (C) delivered by a nationally recognized overnight courier, or (D) delivered personally. Any Notice shall be sent, transmitted, or delivered, as the case may
      be, to Tenant at the appropriate address set forth in <u>Section 10</u> of the Summary, or to such other place as Tenant may from time to time designate in a Notice to Landlord, or to Landlord at the addresses set forth below, or to such other
      places as Landlord may from time to time designate in a Notice to Tenant. Any Notice will be deemed given (i) three (3) days after the date it is posted if sent by Mail, (ii) the date the telecopy is transmitted, (iii) the date the overnight courier
      delivery is made, or (iv) the date personal delivery is made. As of the date of this Lease, any Notices to Landlord must be sent, transmitted, or delivered, as the case may be, to the following addresses:</div>
    <div>&#160;</div>
    <div> </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" id="z4e69b721e16b44ba9ca0c4e12a3274d5" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div style="text-align: justify;">Torrey Pines Science Center Limited Partnership</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div style="text-align: justify;">c/o Healthpeak Properties, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div style="text-align: justify;">420 Stevens Avenue, Suite 170</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div style="text-align: justify;">Solana Beach, California 92075</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div style="text-align: justify;">Attention: Mike Dorris</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div style="text-align: justify;">with a copy to:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div>Torrey Pines Science Center Limited Partnership</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div>c/o Healthpeak Properties, Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div>5050 S Syracuse St. #800</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div>Denver, CO 80237</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div>Attn: Legal Department</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div>and</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div>Allen Matkins Leck Gamble Mallory &amp; Natsis LLP</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div>1901 Avenue of the Stars, Suite 1800</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div>Los Angeles, California 90067</div>
            </td>
          </tr>
          <tr>
            <td style="width: 36%; vertical-align: top;"><br>
            </td>
            <td style="width: 64%; vertical-align: top;">
              <div>Attention: Anton N. Natsis, Esq.</div>
            </td>
          </tr>

      </table>
    </div>
    <br>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-38-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">29.19&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Joint and Several</u></font>. If there is more than one tenant, the obligations imposed upon Tenant under this Lease shall be joint and several.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.20&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Authority</u></font>. If Tenant is a corporation, trust or partnership, each individual executing this Lease on behalf of Tenant hereby represents
      and warrants that Tenant is a duly formed and existing entity qualified to do business in the State of California and that Tenant has full right and authority to execute and deliver this Lease and that each person signing on behalf of Tenant is
      authorized to do so. In such event, Tenant shall, within ten (10) days after execution of this Lease, deliver to Landlord satisfactory evidence of such authority and, if a corporation, upon demand by Landlord, also deliver to Landlord satisfactory
      evidence of (i) good standing in Tenant's state of incorporation and (ii) qualification to do business in the State of California.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.21&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Attorneys' Fees</u></font>. In the event that either Landlord or Tenant should bring suit for the possession of the Premises, for the recovery of
      any sum due under this Lease, or because of the breach of any provision of this Lease or for any other relief against the other, then all costs and expenses, including reasonable attorneys' fees, incurred by the prevailing party therein shall be paid
      by the other party, which obligation on the part of the other party shall be deemed to have accrued on the date of the commencement of such action and shall be enforceable whether or not the action is prosecuted to judgment.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-39-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">29.22&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>Governing Law; WAIVER OF TRIAL BY JURY; JUDICIAL REFERENCE</u></font>. This Lease shall be construed and enforced in accordance with the laws of the
      State of California. IN ANY ACTION OR PROCEEDING ARISING HEREFROM, LANDLORD AND TENANT HEREBY CONSENT TO (I) THE JURISDICTION OF ANY COMPETENT COURT WITHIN THE STATE OF CALIFORNIA, (II) SERVICE OF PROCESS BY ANY MEANS AUTHORIZED BY CALIFORNIA LAW,
      AND (III) IN THE INTEREST OF SAVING TIME AND EXPENSE, TRIAL WITHOUT A JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY EITHER OF THE PARTIES HERETO AGAINST THE OTHER OR THEIR SUCCESSORS IN RESPECT OF ANY MATTER ARISING OUT OF OR IN
      CONNECTION WITH THIS LEASE, THE RELATIONSHIP OF LANDLORD AND TENANT, TENANT'S USE OR OCCUPANCY OF THE PREMISES, AND/OR ANY CLAIM FOR INJURY OR DAMAGE, OR ANY EMERGENCY OR STATUTORY REMEDY. IN THE EVENT LANDLORD COMMENCES ANY SUMMARY PROCEEDINGS OR
      ACTION FOR NONPAYMENT OF BASE RENT OR ADDITIONAL RENT, TENANT SHALL NOT INTERPOSE ANY COUNTERCLAIM OF ANY NATURE OR DESCRIPTION (UNLESS SUCH COUNTERCLAIM SHALL BE MANDATORY) IN ANY SUCH PROCEEDING OR ACTION, BUT SHALL BE RELEGATED TO AN INDEPENDENT
      ACTION AT LAW. IF THE JURY WAIVER PROVISIONS OF THIS SECTION 29.22 ARE NOT ENFORCEABLE UNDER CALIFORNIA LAW, THEN THE FOLLOWING PROVISIONS SHALL APPLY. IT IS THE DESIRE AND INTENTION OF THE PARTIES TO AGREE UPON A MECHANISM AND PROCEDURE UNDER WHICH
      CONTROVERSIES AND DISPUTES ARISING OUT OF THIS LEASE OR RELATED TO THE PREMISES WILL BE RESOLVED IN A PROMPT AND EXPEDITIOUS MANNER. ACCORDINGLY, EXCEPT WITH RESPECT TO ACTIONS FOR UNLAWFUL OR FORCIBLE DETAINER OR WITH RESPECT TO THE PREJUDGMENT
      REMEDY OF ATTACHMENT, ANY ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY EITHER PARTY HERETO AGAINST THE OTHER (AND/OR AGAINST ITS OFFICERS, DIRECTORS, EMPLOYEES, AGENTS OR SUBSIDIARIES OR AFFILIATED ENTITIES) ON ANY MATTERS WHATSOEVER ARISING OUT OF
      OR IN ANY WAY CONNECTED WITH THIS LEASE, TENANT'S USE OR OCCUPANCY OF THE PREMISES AND/OR ANY CLAIM OF INJURY OR DAMAGE, WHETHER SOUNDING IN CONTRACT, TORT, OR OTHERWISE, SHALL BE HEARD AND RESOLVED BY A REFEREE UNDER THE PROVISIONS OF THE CALIFORNIA
      CODE OF CIVIL PROCEDURE, SECTIONS 638 &#8212; 645.1, INCLUSIVE (AS SAME MAY BE AMENDED, OR ANY SUCCESSOR STATUTE(S) THERETO) (THE "<font style="font-weight: bold;">REFEREE SECTIONS</font>"). ANY FEE TO INITIATE THE JUDICIAL REFERENCE PROCEEDINGS AND ALL
      FEES CHARGED AND COSTS INCURRED BY THE REFEREE SHALL BE PAID BY THE PARTY INITIATING SUCH PROCEDURE (EXCEPT THAT IF A REPORTER IS REQUESTED BY EITHER PARTY, THEN A REPORTER SHALL BE PRESENT AT ALL PROCEEDINGS WHERE REQUESTED AND THE FEES OF SUCH
      REPORTER &#8211; EXCEPT FOR COPIES ORDERED BY THE OTHER PARTIES &#8211; SHALL BE BORNE BY THE PARTY REQUESTING THE REPORTER); PROVIDED HOWEVER, THAT ALLOCATION OF THE COSTS AND FEES, INCLUDING ANY INITIATION FEE, OF SUCH PROCEEDING SHALL BE ULTIMATELY DETERMINED
      IN ACCORDANCE WITH SECTION 29.22 ABOVE. THE VENUE OF THE PROCEEDINGS SHALL BE IN THE COUNTY IN WHICH THE PREMISES ARE LOCATED. WITHIN TEN (10) DAYS OF RECEIPT BY ANY PARTY OF A WRITTEN REQUEST TO RESOLVE ANY DISPUTE OR CONTROVERSY PURSUANT TO THIS
      SECTION 29.22, THE PARTIES SHALL AGREE UPON A SINGLE REFEREE WHO SHALL TRY ALL ISSUES, WHETHER OF FACT OR LAW, AND REPORT A FINDING AND JUDGMENT ON SUCH ISSUES AS REQUIRED BY THE REFEREE SECTIONS. IF THE PARTIES ARE UNABLE TO AGREE UPON A REFEREE
      WITHIN SUCH TEN (10) DAY PERIOD, THEN ANY PARTY MAY THEREAFTER FILE A LAWSUIT IN THE COUNTY IN WHICH THE PREMISES ARE LOCATED FOR THE PURPOSE OF APPOINTMENT OF A REFEREE UNDER THE REFEREE SECTIONS. IF THE REFEREE IS APPOINTED BY THE COURT, THE
      REFEREE SHALL BE A NEUTRAL AND IMPARTIAL RETIRED JUDGE WITH SUBSTANTIAL EXPERIENCE IN THE RELEVANT MATTERS TO BE DETERMINED, FROM JAMS, THE AMERICAN ARBITRATION ASSOCIATION OR SIMILAR MEDIATION/ARBITRATION ENTITY. THE PROPOSED REFEREE MAY BE
      CHALLENGED BY ANY PARTY FOR ANY OF THE GROUNDS LISTED IN THE REFEREE SECTIONS. THE REFEREE SHALL HAVE THE POWER TO DECIDE ALL ISSUES OF FACT AND LAW AND REPORT HIS OR HER DECISION ON SUCH ISSUES, AND TO ISSUE ALL RECOGNIZED REMEDIES AVAILABLE AT LAW
      OR IN EQUITY FOR ANY CAUSE OF ACTION THAT IS BEFORE THE REFEREE, INCLUDING AN AWARD OF ATTORNEYS' FEES AND COSTS IN ACCORDANCE WITH THIS LEASE. THE REFEREE SHALL NOT, HOWEVER, HAVE THE POWER TO AWARD PUNITIVE DAMAGES, NOR ANY OTHER DAMAGES WHICH ARE
      NOT PERMITTED BY THE EXPRESS PROVISIONS OF THIS LEASE, AND THE PARTIES HEREBY WAIVE ANY RIGHT TO RECOVER ANY SUCH DAMAGES. THE PARTIES SHALL BE ENTITLED TO CONDUCT ALL DISCOVERY AS PROVIDED IN THE CALIFORNIA CODE OF CIVIL PROCEDURE, AND THE REFEREE
      SHALL OVERSEE DISCOVERY AND MAY ENFORCE ALL DISCOVERY ORDERS IN THE SAME MANNER AS ANY TRIAL COURT JUDGE, WITH RIGHTS TO REGULATE DISCOVERY AND TO ISSUE AND ENFORCE SUBPOENAS, PROTECTIVE ORDERS AND OTHER LIMITATIONS ON DISCOVERY AVAILABLE UNDER
      CALIFORNIA LAW. THE REFERENCE PROCEEDING SHALL BE CONDUCTED IN ACCORDANCE WITH CALIFORNIA LAW (INCLUDING THE RULES OF EVIDENCE), AND IN ALL REGARDS, THE REFEREE SHALL FOLLOW CALIFORNIA LAW APPLICABLE AT THE TIME OF THE REFERENCE PROCEEDING. THE
      PARTIES SHALL PROMPTLY AND DILIGENTLY COOPERATE WITH ONE ANOTHER AND THE REFEREE, AND SHALL PERFORM SUCH ACTS AS MAY BE NECESSARY TO OBTAIN A PROMPT AND EXPEDITIOUS RESOLUTION OF THE DISPUTE OR CONTROVERSY IN ACCORDANCE WITH THE TERMS OF THIS SECTION
      29.22. IN THIS REGARD, THE PARTIES AGREE THAT THE PARTIES AND THE REFEREE SHALL USE BEST EFFORTS TO ENSURE THAT (A) DISCOVERY BE CONDUCTED FOR A PERIOD NO LONGER THAN SIX (6) MONTHS FROM THE DATE THE REFEREE IS APPOINTED, EXCLUDING MOTIONS REGARDING
      DISCOVERY, AND (B) A TRIAL DATE BE SET WITHIN NINE (9) MONTHS OF THE DATE THE REFEREE IS APPOINTED. IN ACCORDANCE WITH SECTION 644 OF THE CALIFORNIA CODE OF CIVIL PROCEDURE, THE DECISION OF THE REFEREE UPON THE WHOLE ISSUE MUST STAND AS THE DECISION
      OF THE COURT, AND UPON THE FILING OF THE STATEMENT OF DECISION WITH THE CLERK OF THE COURT, OR WITH THE JUDGE IF THERE IS NO CLERK, JUDGMENT MAY BE ENTERED THEREON IN THE SAME MANNER AS IF THE ACTION HAD BEEN TRIED BY THE COURT. ANY DECISION OF THE
      REFEREE AND/OR JUDGMENT OR OTHER ORDER ENTERED THEREON SHALL BE APPEALABLE TO THE SAME EXTENT AND IN THE SAME MANNER THAT SUCH DECISION, JUDGMENT, OR ORDER WOULD BE APPEALABLE IF RENDERED BY A JUDGE OF THE SUPERIOR COURT IN WHICH VENUE IS PROPER
      HEREUNDER. THE REFEREE SHALL IN HIS/HER STATEMENT OF DECISION SET FORTH HIS/HER FINDINGS OF FACT AND CONCLUSIONS OF LAW. THE PARTIES INTEND THIS GENERAL REFERENCE AGREEMENT TO BE SPECIFICALLY ENFORCEABLE IN ACCORDANCE WITH THE CODE OF CIVIL
      PROCEDURE. NOTHING IN THIS SECTION 29.22 SHALL PREJUDICE THE RIGHT OF ANY PARTY TO OBTAIN PROVISIONAL RELIEF OR OTHER EQUITABLE REMEDIES FROM A COURT OF COMPETENT JURISDICTION AS SHALL OTHERWISE BE AVAILABLE UNDER THE CODE OF CIVIL PROCEDURE AND/OR
      APPLICABLE COURT RULES.</div>
    <div style="text-align: justify; text-indent: 36pt;"> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-40-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">29.23&#160;&#160;&#160; <font style="font-weight: bold;"><u>Submission of Lease</u></font>. Submission of this instrument for examination or signature by Tenant does not constitute a reservation of, option for or
      option to lease, and it is not effective as a lease or otherwise until execution and delivery by both Landlord and Tenant.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.24&#160;&#160; &#160; <font style="font-weight: bold;"><u>Brokers</u></font>. Landlord and Tenant hereby warrant to each other that they have had no dealings with any real estate broker or agent in connection
      with the negotiation of this Lease, excepting only the real estate brokers or agents specified in <u>Section 12</u> of the Summary (the "<font style="font-weight: bold;">Brokers</font>"), and that they know of no other real estate broker or agent
      who is entitled to a commission in connection with this Lease. Each party agrees to indemnify and defend the other party against and hold the other party harmless from any and all claims, demands, losses, liabilities, lawsuits, judgments, costs and
      expenses (including without limitation reasonable attorneys' fees) with respect to any leasing commission or equivalent compensation alleged to be owing on account of any dealings with any real estate broker or agent, other than the Brokers,
      occurring by, through, or under the indemnifying party. The terms of this <u>Section 29.24</u> shall survive the expiration or earlier termination of the Lease Term.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.25&#160;&#160;&#160; <font style="font-weight: bold;"><u>Independent Covenants</u></font>. This Lease shall be construed as though the covenants herein between Landlord and Tenant are independent and not
      dependent and Tenant hereby expressly waives the benefit of any statute to the contrary and agrees that if Landlord fails to perform its obligations set forth herein, Tenant shall not be entitled to make any repairs or perform any acts hereunder at
      Landlord's expense or to any setoff of the Rent or other amounts owing hereunder against Landlord.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.26&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Project or Building Name, Address and Signage</u></font>. Landlord shall have the right at any time to change the name and/or address of the Project or
      Building and to install, affix and maintain any and all signs on the exterior and on the interior of the Project or Building as Landlord may, in Landlord's sole discretion, desire. Tenant shall not use the name of the Project or Building or use
      pictures or illustrations of the Project or Building in advertising or other publicity or for any purpose other than as the address of the business to be conducted by Tenant in the Premises, without the prior written consent of Landlord.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.27&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Counterparts</u></font>. This Lease may be executed in counterparts with the same effect as if both parties hereto had executed the same document. Both
      counterparts shall be construed together and shall constitute a single lease. Such counterparts may be delivered by the parties hereto by electronic means, including by electronic mail or facsimile transmission and, when so fully delivered, such
      copies shall be binding as if ink originals.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.28&#160;&#160;&#160;&#160; <font style="font-weight: bold;"><u>Confidentiality</u></font>. Tenant acknowledges that the content of this Lease and any related documents are confidential information. Tenant shall keep
      such confidential information strictly confidential and shall not disclose such confidential information to any person or entity other than Tenant's financial, legal, and space planning consultants.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div>
      <div style="text-indent: 36pt;">29.29 &#160; &#160; <font style="font-weight: bold;"><u>Development of the Project</u></font>.</div>
    </div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">29.29.1&#160;&#160; <font style="font-weight: bold;"><u>Subdivision</u></font>. Landlord reserves the right to subdivide all or a portion of the buildings and Common Areas. Tenant agrees to execute and
      deliver, upon demand by Landlord and in the form requested by Landlord, any additional documents needed to conform this Lease to the circumstances resulting from a subdivision and any all maps in connection therewith. Notwithstanding anything to the
      contrary set forth in this Lease, the separate ownership of any buildings and/or Common Areas by an entity other than Landlord shall not affect the calculation of Direct Expenses or Tenant's payment of Tenant's Share of Direct Expenses.</div>
    <div style="text-indent: 72pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">29.29.2&#160; <font style="font-weight: bold;"><u>Construction of Property and Other Improvements</u></font>. Tenant acknowledges that portions of the Project may be under construction following Tenant's
      occupancy of the Premises, and that such construction may result in levels of noise, dust, obstruction of access, etc. which are in excess of that present in a fully constructed project. Tenant hereby waives any and all rent offsets (except as
      specifically set forth in <u>Section 19.5</u> of this Lease) or claims of constructive eviction which may arise in connection with such construction.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">29.30&#160;&#160;&#160; <font style="font-weight: bold;"><u>No Violation</u></font>. Tenant hereby warrants and represents that neither its execution of nor performance under this Lease shall cause Tenant to be in
      violation of any agreement, instrument, contract, law, rule or regulation by which Tenant is bound, and Tenant shall protect, defend, indemnify and hold Landlord harmless against any claims, demands, losses, damages, liabilities, costs and expenses,
      including, without limitation, reasonable attorneys' fees and costs, arising from Tenant's breach of this warranty and representation.</div>
    <div style="text-align: justify; text-indent: 36pt;"><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
              <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-41-</font>-<br>
              </td>
              <td style="width: 33%; font-size: 8pt;">
                <div style="text-align: right;">HEALTHPEAK INC. </div>
                <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
              </td>
            </tr>

        </table>
      </div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" id="DSPFPageHeader"></div>
    </div>
    <div>
      <div>
        <div>
          <div>
            <div style="text-align: justify; text-indent: 36pt;">29.31&#160;&#160;&#160; <font style="font-weight: bold;"><u>Transportation Management</u></font>. Tenant shall fully comply with all present or future programs intended to manage parking, transportation or
              traffic in and around the Project and/or the Building, and in connection therewith, Tenant shall take responsible action for the transportation planning and management of all employees located at the Premises by working directly with
              Landlord, any governmental transportation management organization or any other transportation-related committees or entities. Such programs may include, without limitation: (i) restrictions on the number of peak-hour vehicle trips generated
              by Tenant; (ii) increased vehicle occupancy; (iii) implementation of an in-house ridesharing program and an employee transportation coordinator; (iv) working with employees and any Project, Building or area-wide ridesharing program manager;
              (v) instituting employer-sponsored incentives (financial or in-kind) to encourage employees to rideshare; and (vi) utilizing flexible work shifts for employees.</div>
            <div>&#160;</div>
            <div style="text-align: justify; text-indent: 36pt;">29.32&#160;&#160;&#160; <font style="font-weight: bold;"><u>Signatures</u></font>. The parties hereto consent and agree that this Lease may be signed and/or transmitted by facsimile, e-mail of a .pdf
              document or using electronic signature technology (e.g., via DocuSign or similar electronic signature technology), and that such signed electronic record shall be valid and as effective to bind the party so signing as a paper copy bearing
              such party&#8217;s handwritten signature. The parties further consent and agree that (1) to the extent a party signs this Lease using electronic signature technology, by clicking &#8220;SIGN&#8221;, such party is signing this Lease electronically, and (2) the
              electronic signatures appearing on this Lease shall be treated, for purposes of validity, enforceability and admissibility, the same as handwritten signatures.</div>
            <div style="text-align: center;"> <br>
            </div>
            <div style="text-align: center;">&#160;[signature page to follow]</div>
            <div><br>
              <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
                <div id="DSPFPageFooter" style="width: 100%;">
                  <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                      <tr>
                        <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                        <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-42-</font>-<br>
                        </td>
                        <td style="width: 33%; font-size: 8pt;">
                          <div style="text-align: right;">HEALTHPEAK INC. </div>
                          <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                          <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="page-break-after: always;" id="DSPFPageBreak">
                  <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
              </div>
            </div>
          </div>
          <div>IN WITNESS WHEREOF, Landlord and Tenant have caused this Lease to be executed the day and date first above written.
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z8af9b4d59bae4889aeda4a2e2952bd20">

                <tr>
                  <td colspan="3" style="vertical-align: top;">
                    <div><u>LANDLORD</u>:</div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">
                    <div><u>TENANT</u>:</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="3" style="vertical-align: top;">
                    <div>TORREY PINES SCIENCE CENTER LIMITED PARTNERSHIP<font style="font-weight: bold;">,&#160;</font></div>
                  </td>
                  <td colspan="2" style="vertical-align: top;">
                    <div>BROOKLYN IMMUNOTHERAPEUTICS INC.,&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">a Delaware limited partnership</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top;">a Delaware corporation</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                    <div>By: <br>
                    </div>
                  </td>
                  <td colspan="2" style="width: 47%; vertical-align: top; padding-bottom: 2px;">
                    <div>HCP-Torrey Pines Science Center, Inc., a Delaware corporation, <br>
                      <div>its General Partner</div>
                    </div>
                  </td>
                  <td style="width: 3%; vertical-align: bottom; padding-bottom: 2px;">
                    <div>By: </div>
                  </td>
                  <td style="width: 47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div>
                      <div>/s/ Howard J Federoff</div>
                    </div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                    <div>By: </div>
                  </td>
                  <td style="width: 23.5%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div>
                      <div>/s/ Michael Dorris</div>
                    </div>
                  </td>
                  <td style="width: 23.5%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="margin-left: 9pt;">Howard J Federoff</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 3%; vertical-align: top;">&#160;</td>
                  <td colspan="2" rowspan="1" style="width: 47%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" colspan="2" style="vertical-align: top; text-align: center;">&#160;Print Name</td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z8a31025d86214795ba3b25d3d716843d">

                <tr>
                  <td style="width: 25%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="margin-left: 9pt;">Michael Dorris</div>
                  </td>
                  <td style="width: 25.02%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td style="vertical-align: top; padding-bottom: 2px;">
                    <div>Its: <br>
                    </div>
                  </td>
                  <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">CEO</td>
                </tr>
                <tr>
                  <td style="vertical-align: top;">
                    <div style="text-align: center;">Print Name</div>
                  </td>
                  <td style="vertical-align: top;">&#160;</td>
                  <td style="width: 3%; vertical-align: top;"><br>
                  </td>
                  <td style="width: 47%; vertical-align: top;">&#160;</td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z1eb5e3eb5c2e4033927d047f818156c3">

                <tr>
                  <td rowspan="1" style="vertical-align: top; padding-bottom: 2px; width: 3%;">Its: </td>
                  <td rowspan="1" style="vertical-align: top; width: 23.5%; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">Senior Vice President</td>
                  <td rowspan="1" style="vertical-align: top; width: 23.5%; padding-bottom: 2px;">&#160;</td>
                  <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                    <div>By:</div>
                  </td>
                  <td rowspan="1" style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="3" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="3" style="vertical-align: top;">&#160;</td>
                  <td rowspan="1" style="width: 3%; vertical-align: top;">&#160;</td>
                  <td rowspan="1" style="width: 47%; vertical-align: top; text-align: center;">&#160;Print Name</td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="3" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
                  <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                    <div>Its: </div>
                  </td>
                  <td rowspan="1" style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                </tr>

            </table>
            <div>&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
              <div id="DSPFPageFooter" style="width: 100%;">
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                      <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">-<font id="DSPFPageNumber">-43-</font>-<br>
                      </td>
                      <td style="width: 33%; font-size: 8pt;">
                        <div style="text-align: right;">HEALTHPEAK INC. </div>
                        <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                        <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="page-break-after:always;" id="DSPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: center; font-weight: bold;"><u>EXHIBIT A</u></div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;"><u>TORREY PINES SCIENCE CENTER</u></div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;"><u>OUTLINE OF PREMISES</u></div>
            <div><br>
            </div>
            <div style="text-align: center;"><img src="ex10_3image00001.jpg"></div>
            <div>&#160;</div>
            <div> </div>
            <div> </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
              <div id="DSPFPageFooter" style="width: 100%;">
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                      <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                        <div>&#160;</div>
                        <div>EXHIBIT A</div>
                        <div>
                          <div>-1-</div>
                        </div>
                      </td>
                      <td style="width: 33%; font-size: 8pt;">
                        <div style="text-align: right;">HEALTHPEAK INC. </div>
                        <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                        <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="page-break-after:always;" id="DSPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: center; font-weight: bold;"><u>EXHIBIT A-1</u></div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;"><u>TORREY PINES SCIENCE CENTER</u></div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;"><u>PROJECT SITE PLAN</u></div>
            <div><br>
            </div>
            <div style="text-align: center;"><img src="ex10_3image00002.jpg"></div>
            <div>&#160;
              <div> </div>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
              <div id="DSPFPageFooter" style="width: 100%;">
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                      <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                        <div>&#160;</div>
                        <div>EXHIBIT A-1<br>
                        </div>
                        <div>
                          <div>-1-</div>
                        </div>
                      </td>
                      <td style="width: 33%; font-size: 8pt;">
                        <div style="text-align: right;">HEALTHPEAK INC. </div>
                        <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                        <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="page-break-after:always;" id="DSPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: center; font-weight: bold;"><u>EXHIBIT B</u></div>
            <div style="text-align: center;">&#160; <br>
            </div>
            <div style="text-align: center; font-weight: bold;"><u>TORREY PINES SCIENCE CENTER</u></div>
            <div><br>
            </div>
            <div style="text-align: center; font-weight: bold;"><u>TENANT WORK LETTER</u></div>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3151f0565f674cc4a3aea0fb8e59bb50">

                <tr>
                  <td style="width: 23.95pt;"><br>
                  </td>
                  <td style="width: 18pt; vertical-align: top; font-weight: bold;">1.</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><font style="font-weight: bold;"><u>Landlord Improvements</u></font>. Except as specifically set forth herein, Landlord shall not be obligated to construct or install any improvements or facilities of any kind in the Premises, and
                      Tenant shall accept the Premises in its currently-existing, "as-is" condition. Notwithstanding the foregoing, Landlord hereby agrees, at Landlord's sole cost and expense, to (i) re-carpet the interior floors of the entire Premises,
                      (ii) clean the VCT tile in the lab area of the Premises, and (iii) apply touch-up paint to the painted surfaces of the interior walls of the Premises to the extent necessary in Landlord&#8217;s reasonable discretion (collectively, the "<font style="font-weight: bold;">Tenant Improvements</font>"). All such Tenant Improvements shall be completed to Landlord's "Building standard" condition, using Building standard methods, materials and procedures, in "Building standard"
                      color or colors (if applicable) to be designated by Landlord. Tenant shall make no changes or modifications to the Tenant Improvements without the prior written consent of Landlord, which consent may be withheld in Landlord's sole
                      discretion. The Premises shall be deemed "<font style="font-weight: bold;">Ready for Occupancy</font>" upon the substantial completion of construction of the Tenant Improvements with the exception of any punch list items and any
                      tenant fixtures, work-stations, built-in furniture, or equipment to be installed by Tenant. In the event that the acts or omissions of Tenant or its agents or employees shall delay the substantial completion of the Tenant
                      Improvements, then the Lease Commencement Date shall be deemed to be the date the substantial completion of the Tenant Improvements would have occurred but for such acts or omissions of Tenant or its agents or employees. Provided that
                      Tenant and its agents do not interfere with Landlord&#8217;s work in the Building and the Premises, Landlord shall allow Tenant access to the Premises prior to Lease Commencement Date for the purpose of Tenant installing equipment or
                      fixtures (including Tenant's data and telephone equipment) in the Premises. Prior to Tenant's entry into the Premises as permitted by this agreement, Tenant shall submit a schedule to Landlord, for its approval, which schedule shall
                      detail the timing and purpose of Tenant's entry and Tenant shall deliver to Landlord the policies or certificates evidencing Tenant's insurance as required under the terms this Lease.</div>
                  </td>
                </tr>

            </table>
            <div>&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf602d826f44b461a9b3333ff0742c16c">

                <tr>
                  <td style="width: 23.95pt;"><br>
                  </td>
                  <td style="width: 20.6pt; vertical-align: top; font-weight: bold;">2.</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><font style="font-weight: bold;"><u>Landlord Warranty</u></font>. Notwithstanding anything set forth in this Lease to the contrary, upon the Possession Date, the Building Systems shall be in good working condition. If it is
                      determined that any portions of the Building Systems were not in good working condition on the Possession Date, provided that the need to repair or replace was not caused by the misuse, misconduct, damage, destruction, omissions,
                      and/or negligence (collectively, "<font style="font-weight: bold;">Tenant Damage</font>") of Tenant, its subtenants and/or assignees, if any, or any company which is acquired, sold or merged with Tenant, or by any modifications,
                      Alterations, or improvements constructed by or on behalf of Tenant, Landlord, at no cost to Tenant and which shall not be included in Operating Expenses, shall promptly commence such work or take such other action as may be necessary
                      to place the same in good working condition. To the extent repairs which Landlord is required to make pursuant to this Tenant Work Letter are necessitated in part by Tenant Damage, then Tenant shall reimburse Landlord for an equitable
                      proportion of the reasonable cost of such repair. Following the Landlord Possession Date, Landlord's repair and maintenance obligations shall be governed by the terms of <u>Article 7</u> of this Lease, below.</div>
                  </td>
                </tr>

            </table>
            <div><br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
              <div id="DSPFPageFooter" style="width: 100%;">
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                      <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                        <div>&#160;</div>
                        <div>EXHIBIT B<br>
                        </div>
                        <div>
                          <div>-1-</div>
                        </div>
                      </td>
                      <td style="width: 33%; font-size: 8pt;">
                        <div style="text-align: right;">HEALTHPEAK INC. </div>
                        <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                        <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="page-break-after:always;" id="DSPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <div style="text-align: center; font-weight: bold;"><u>EXHIBIT C</u></div>
            <div>&#160;</div>
            <div style="text-align: center; font-weight: bold;"><u>TORREY PINES SCIENCE CENTER</u></div>
            <div style="text-align: center;">&#160;</div>
            <div style="text-align: center; font-weight: bold;"><u>NOTICE OF LEASE TERM DATES</u></div>
            <div style="text-align: center;">&#160;</div>
            <div><br>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" id="z9fbf7b50a8f24e7b8f5d944165071afa" style="width: 30%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">

                  <tr>
                    <td style="width: 5%; padding-bottom: 2px;">
                      <div>To:&#160; <br>
                      </div>
                    </td>
                    <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0);">
                      <div>&#160;</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 5%; padding-bottom: 2px;">
                      <div>&#160;</div>
                    </td>
                    <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0);">
                      <div>&#160;</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 5%; padding-bottom: 2px;">
                      <div>&#160;</div>
                    </td>
                    <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0);">
                      <div>&#160;</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width: 5%; padding-bottom: 2px;">
                      <div>&#160;</div>
                    </td>
                    <td style="width: 25%; border-bottom: 2px solid rgb(0, 0, 0);">
                      <div>&#160;</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div><br>
            </div>
            <div>
              <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf6a58b33c30f4de59f0601eaf9c7da6e" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

                  <tr style="vertical-align: top;">
                    <td style="width: 36pt;">&#160;</td>
                    <td style="vertical-align: top; width: 27pt;">
                      <div style="text-align: left;">Re:</div>
                    </td>
                    <td style="vertical-align: top;">
                      <div style="text-align: left;">Lease dated<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>, 20<u>&#160; &#160; </u> between<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>, a<u> </u><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u>("<font style="font-weight: bold;">Landlord</font>"),&#160; and<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>,&#160; a<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>("<font style="font-weight: bold;">Tenant</font>") concerning Suite<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u>on floor(s)<u> &#160; &#160; &#160;&#160;</u> of the building located at&#160;<u>&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; </u>, California.</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div><br>
          </div>
          <div>Gentlemen:</div>
          <div>&#160;</div>
          <div style="margin-left: 36pt;">In accordance with the Lease (the "<font style="font-weight: bold;">Lease</font>"), we wish to advise you and/or confirm as follows:</div>
          <div>&#160;<br>
            <div>
              <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z8d39b7dcd40843a1a156c73f20abb379" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

                  <tr style="vertical-align: top;">
                    <td style="width: 36pt;">&#160;</td>
                    <td style="vertical-align: top; width: 27pt;">
                      <div>1.</div>
                    </td>
                    <td style="vertical-align: top;">
                      <div>The Lease Term shall commence on or has commenced on<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>for a term of<u>&#160;&#160;&#160;&#160;&#160;&#160; </u>ending on<u> &#160; &#160; &#160; &#160;&#160;</u><u> &#160;&#160;&#160;&#160; </u>.</div>
                    </td>
                  </tr>

              </table>
            </div>
            <br>
          </div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z218abadea5484e1d92d7078730771458" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

                <tr style="vertical-align: top;">
                  <td style="width: 36pt;">&#160;</td>
                  <td style="vertical-align: top; width: 27pt;">
                    <div>2.</div>
                  </td>
                  <td style="vertical-align: top;">
                    <div>Rent commenced to accrue on<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>, in the amount of&#160;<u>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; </u>.</div>
                  </td>
                </tr>

            </table>
          </div>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb2d6e6ebd3764479840791edbd4d64ba">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top;">3.</td>
                <td style="vertical-align: top;">
                  <div>If the Lease Commencement Date is other than the first day of the month, the first billing will contain a pro rata adjustment. Each billing thereafter, with the exception of the final billing, shall be for the full amount of the
                    monthly installment as provided for in the Lease.</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zb4d51128c18040da8b4f888012503554" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

                <tr style="vertical-align: top;">
                  <td style="width: 36pt;">&#160;</td>
                  <td style="vertical-align: top; width: 27pt;">
                    <div>4.</div>
                  </td>
                  <td style="vertical-align: top;">
                    <div>Your rent checks should be made payable to<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>at<u>&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160; </u>.</div>
                  </td>
                </tr>

            </table>
          </div>
          <div><br>
          </div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z328bd35ba84a4b9381c06626137c73aa" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

                <tr style="vertical-align: top;">
                  <td style="width: 36pt;">&#160;</td>
                  <td style="vertical-align: top; width: 27pt;">
                    <div>5.</div>
                  </td>
                  <td style="vertical-align: top;">
                    <div>The exact number of rentable/usable square feet within the Premises is<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>square feet.</div>
                  </td>
                </tr>

            </table>
          </div>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5d6166c2a6f14d3fbb03a97aa30e7488">

              <tr>
                <td style="width: 36pt;"><br>
                </td>
                <td style="width: 27pt; vertical-align: top;">6.</td>
                <td style="vertical-align: top;">
                  <div>Tenant's Share as adjusted based upon the exact number of usable square feet within the Premises is<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u>%.</div>
                </td>
              </tr>

          </table>
          <div>&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7a7f965d5f494660ae21289bc5f16bd2">

              <tr>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
                <td style="width: 3%; vertical-align: top;">
                  <div style="font-weight: bold;">"Landlord":</div>
                </td>
                <td style="vertical-align: top;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td rowspan="1" colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;&#160;</td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3263486bdba545a1b42ae794dab8329b">

              <tr>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                  <div>a </div>
                </td>
                <td rowspan="1" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
                <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;&#160;</td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6c9108e6455a49479e149dae94361a4f">

              <tr>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                  <div>By:</div>
                </td>
                <td colspan="2" rowspan="1" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">Its: <br>
                </td>
                <td rowspan="1" style="width: 44%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                      <div>&#160;</div>
                      <div>EXHIBIT C<br>
                      </div>
                      <div>
                        <div>-1-</div>
                      </div>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0d3e0a1e2dd34e6db1440332b4b3b325">

              <tr>
                <td colspan="2" style="vertical-align: top;">
                  <div>Agreed to and Accepted as of , 202&#160;.</div>
                </td>
                <td style="width: 50%; vertical-align: top;"><br>
                </td>
              </tr>
              <tr>
                <td colspan="2" style="vertical-align: top;">&#160;</td>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
              </tr>
              <tr>
                <td colspan="2" style="vertical-align: top;">
                  <div style="font-weight: bold;">"Tenant":</div>
                </td>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
              </tr>
              <tr>
                <td colspan="2" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                  <div>a</div>
                </td>
                <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td colspan="2" style="vertical-align: top;">&#160;</td>
                <td style="width: 50%; vertical-align: top;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                  <div>By:</div>
                </td>
                <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf71bdfc17cc247efba01b432bd1797e6">

              <tr>
                <td rowspan="1" style="width: 3%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
                <td rowspan="1" style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">Its:</td>
                <td rowspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                      <div>&#160;</div>
                      <div>EXHIBIT C<br>
                      </div>
                      <div>
                        <div>-2-</div>
                      </div>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
        </div>
      </div>
      <font style="color: rgb(0, 0, 0);"></font>
      <div>
        <div style="color: #2E74B5;">
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"><u>EXHIBIT D</u></div>
          <div style="color: rgb(0, 0, 0); text-align: center;">&#160;</div>
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"><u>TORREY PINES SCIENCE CENTER</u></div>
          <div style="color: rgb(0, 0, 0); text-align: center;">&#160;</div>
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"><u>FORM OF TENANT'S ESTOPPEL CERTIFICATE</u></div>
          <div style="color: rgb(0, 0, 0); text-align: center;">&#160;</div>
          <div style="text-align: justify; color: rgb(0, 0, 0);">The undersigned as Tenant under that certain Lease (the "<font style="font-weight: bold;">Lease</font>") made and entered into as of<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>, 20<u>&#160; &#160; &#160; </u> by and between<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>as


            Landlord, and the undersigned as Tenant, for Premises consisting of the entire office building located at<u>&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160;&#160; </u>, California, certifies as follows:</div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-indent: 36pt;">
            <div>
              <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">1.&#160;&#160; &#160; &#160;&#160; Attached hereto as <font style="font-weight: bold;"><u>Exhibit A</u>&#160;</font>is a true and correct copy of the Lease and all amendments and modifications thereto.
                  The documents contained in <font style="font-weight: bold;"><u>Exhibit A</u>&#160;</font>represent the entire agreement between the parties as to the Premises.</font></div>
            </div>
          </div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The undersigned currently occupies the Premises described in the Lease, the Lease Term commenced on<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>, and the Lease Term expires
              on<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>, and the undersigned has no option to terminate or cancel the Lease or to purchase all or any part of the Premises, the Building and/or the Project.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="color: rgb(0, 0, 0); text-indent: 36pt;"><font style="color: rgb(0, 0, 0);"><font style="color: rgb(0, 0, 0);">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Base Rent became payable on&#160;<u> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; </u>.<br>
            </font></div>
          <div style="color: rgb(0, 0, 0); text-indent: 36pt;"><font style="color: rgb(0, 0, 0);"> <br>
            </font></div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Lease is in full force and effect and has not been modified, supplemented or amended in any way except as provided in <font style="font-weight: bold;"><u>Exhibit A</u></font>.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Tenant has not transferred, assigned, or sublet any portion of the Premises nor entered into any license or concession agreements with respect thereto except as
              follows:</font></div>
          <div style="color: rgb(0, 0, 0);"><br>
          </div>
          <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Tenant shall not modify the documents contained in <font style="font-weight: bold;"><u>Exhibit A</u>&#160;</font>without the prior written consent of Landlord's mortgagee.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; All monthly installments of Base Rent, all Additional Rent and all monthly installments of estimated Additional Rent have been paid when due through&#160;<u> &#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160;&#160; &#160;
              </u>. The current monthly installment of Base Rent is $<u>&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; </u>.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">8.&#160;&#160;&#160;&#160; &#160;&#160; All conditions of the Lease to be performed by Landlord necessary to the enforceability of the Lease have been satisfied and Landlord is not in
              default thereunder. In addition, the undersigned has not delivered any notice to Landlord regarding a default by Landlord thereunder. The Lease does not require Landlord to provide any rental concessions or to pay any leasing brokerage
              commissions.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160; No rental has been paid more than thirty (30) days in advance and no security has been deposited with Landlord except as provided in the Lease.
              Neither Landlord, nor its successors or assigns, shall in any event be liable or responsible for, or with respect to, the retention, application and/or return to Tenant of any security deposit paid to any prior landlord of the Premises,
              whether or not still held by any such prior landlord, unless and until the party from whom the security deposit is being sought, whether it be a lender, or any of its successors or assigns, has actually received for its own account, as
              landlord, the full amount of such security deposit.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">10.&#160;&#160;&#160;&#160;&#160; As of the date hereof, there are no existing defenses or offsets, or, to the undersigned's knowledge, claims or any basis for a claim, that the
              undersigned has against Landlord.</font></div>
        </div>
        <div style="color: #2E74B5;"><br>
          <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                      <div>&#160;</div>
                      <div>EXHIBIT D<br>
                      </div>
                      <div>
                        <div>-1-</div>
                      </div>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div id="DSPFPageBreak" style="page-break-after: always;">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">11.&#160;&#160;&#160;&#160;&#160;&#160; If Tenant is a corporation or partnership, each individual executing this Estoppel Certificate on behalf of Tenant hereby represents and warrants
              that Tenant is a duly formed and existing entity qualified to do business in California and that Tenant has full right and authority to execute and deliver this Estoppel Certificate and that each person signing on behalf of Tenant is
              authorized to do so.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">12.&#160;&#160;&#160;&#160;&#160;&#160; There are no actions pending against the undersigned under the bankruptcy or similar laws of the United States or any state.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">13.&#160;&#160;&#160;&#160;&#160;&#160; Tenant is in full compliance with all federal, state and local laws, ordinances, rules and regulations affecting its use of the Premises, including,
              but not limited to, those laws, ordinances, rules or regulations relating to hazardous or toxic materials. Tenant has never permitted or suffered, nor does Tenant have any knowledge of, the generation, manufacture, treatment, use, storage,
              disposal or discharge of any hazardous, toxic or dangerous waste, substance or material in, on, under or about the Project or the Premises or any adjacent premises or property in violation of any federal, state or local law, ordinance, rule
              or regulation.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">14.&#160;&#160;&#160;&#160;&#160;&#160; To the undersigned's knowledge, all tenant improvement work to be performed by Landlord under the Lease has been completed in accordance with the
              Lease and has been accepted by the undersigned and all reimbursements and allowances due to the undersigned under the Lease in connection with any tenant improvement work have been paid in full. All work (if any) in the common areas required
              by the Lease to be completed by Landlord has been completed and all parking spaces required by the Lease have been furnished and/or all parking ratios required by the Lease have been met.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt;">The undersigned acknowledges that this Estoppel Certificate may be delivered to Landlord or to a prospective mortgagee or prospective purchaser, and acknowledges that said
            prospective mortgagee or prospective purchaser will be relying upon the statements contained herein in making the loan or acquiring the property of which the Premises are a part and that receipt by it of this certificate is a condition of
            making such loan or acquiring such property.</div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">Executed at<u>&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160;&#160; </u>on the<u>&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; </u>day of<u>&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; </u>, 202_.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                <td colspan="2" style="vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="font-weight: bold;">"Tenant":</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 50%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                <td rowspan="1" colspan="2" style="vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 49%; vertical-align: top; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 1%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">
                  <div>,</div>
                </td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 2%; vertical-align: top; padding-bottom: 2px;">
                  <div><font style="color: rgb(0, 0, 0);">a</font></div>
                </td>
                <td style="width: 48%; vertical-align: top; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">
                  <div>By:</div>
                </td>
                <td style="width: 47%; vertical-align: top; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 53%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">
                  <div>Its: </div>
                </td>
                <td style="width: 44%; vertical-align: top; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">
                  <div>By:</div>
                </td>
                <td style="width: 47%; vertical-align: top; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 53%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">
                  <div>Its: </div>
                </td>
                <td style="width: 44%; vertical-align: top; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              </tr>

          </table>
          <div><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                      <div>&#160;</div>
                      <div>EXHIBIT D<br>
                      </div>
                      <div>
                        <div>-2-</div>
                      </div>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <!--PROfilePageNumberReset%Num%1%-%-%-->
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"><u>EXHIBIT E</u></div>
          <div style="color: rgb(0, 0, 0); text-align: center;">&#160;</div>
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);">TORREY PINES SCIENCE CENTER</div>
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"><u> <br>
            </u></div>
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"><u>ENVIRONMENTAL QUESTIONNAIRE</u></div>
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"><u> <br>
            </u></div>
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);">ENVIRONMENTAL QUESTIONNAIRE</div>
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);">FOR COMMERCIAL AND INDUSTRIAL PROPERTIES</div>
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"> <br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 12%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">
                  <div style="font-weight: bold;">Tenant Name:</div>
                </td>
                <td style="width: 68%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 20%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 12%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">
                  <div style="font-weight: bold;">Lease Address:</div>
                </td>
                <td style="width: 68%; vertical-align: top; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td style="width: 20%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
              </tr>

          </table>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td style="width: 58%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="font-weight: bold;">Lease Type (check correct box &#8211; <font style="font-style: italic;">right click to properties</font>):</div>
                </td>
                <td style="width: 2%; vertical-align: top; color: rgb(0, 0, 0);">&#9744;</td>
                <td colspan="2" rowspan="1" style="vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="font-weight: bold;">Primary Lease/Lessee</div>
                </td>
              </tr>
              <tr>
                <td style="width: 58%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 2%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#9744;</td>
                <td style="width: 12%; vertical-align: top; padding-bottom: 2px;">
                  <div style="font-weight: bold;"><font style="color: rgb(0, 0, 0);"><u>&#160;</u>Sublease from:</font></div>
                </td>
                <td style="width: 28%; vertical-align: top; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);"><br>
          </div>
          <div style="margin-right: 51.8pt;"><font style="font-weight: bold; color: rgb(0, 0, 0);"><u>Instructions</u></font><font style="color: rgb(0, 0, 0);">: The following questionnaire is to be completed by the Lessee representative with knowledge of
              the planned operations for the specified building/location. Please print clearly and attach additional sheets as necessary.</font></div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0);">1.0</td>
                <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="font-weight: bold;"><u>PROCESS INFORMATION</u></div>
                </td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="margin-right: 43.85pt; margin-left: 36pt; color: rgb(0, 0, 0);">Describe planned site use, including a brief description of manufacturing processes and/or pilot plants planned for this site, if any.</div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

              <tr>
                <td colspan="1" style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 94%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 94%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 94%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0); clear: both;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0);">2.0</td>
                <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="font-weight: bold;"><u>HAZARDOUS MATERIALS &#8211; OTHER THAN WASTE</u></div>
                </td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="margin-right: 51.8pt; margin-left: 36pt; color: rgb(0, 0, 0);">Will (or are) non-waste hazardous materials be/being used or stored at this site? If so, continue with the next question. If not, go to Section 3.0.</div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                  <tr>
                    <td style="width: 6%; color: rgb(0, 0, 0);"><br>
                    </td>
                    <td style="width: 4%; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0);">2.1</td>
                    <td style="width: 42%; vertical-align: top;"><font style="color: rgb(0, 0, 0);">Are any of the following materials handled on the Property?</font></td>
                    <td style="width: 8%; vertical-align: top;"><font style="color: rgb(0, 0, 0);">&#9744; Yes<br>
                      </font></td>
                    <td style="width: 40%; vertical-align: top; color: rgb(0, 0, 0);">&#9744; No</td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="color: rgb(0, 0, 0); margin-left: 63pt;">[<font style="font-style: italic;">A material is handled if it is used, generated, processed, produced, packaged, treated, stored, emitted, discharged, or disposed.] </font>If YES, check <font style="font-style: italic;">(right click to properties) </font>the applicable correct <u>Fire Code</u>&#160;<u>hazard categories</u> below.<br>
            <br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); text-align: right; padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>Combustible dusts/fibers</div>
                </td>
                <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                  <div style="color: rgb(0, 0, 0); text-align: right;">&#9744;</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>Explosives</div>
                </td>
                <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                  <div>Flammable liquids</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); text-align: right; padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div><font style="color: rgb(0, 0, 0);">Combustible liquids (e.g., oils)</font></div>
                </td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Compressed gas - inert</div>
                </td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Flammable solids/pyrophorics</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); text-align: right; padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Cryogenic liquids - inert</div>
                </td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Compressed gas - flammable/pyrophoric</div>
                </td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Organic peroxides</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); text-align: right; padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="color: rgb(0, 0, 0);">Cryogenic liquids -</div>
                  <div style="color: rgb(0, 0, 0);">flammable</div>
                </td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Compressed gas - oxidizing</div>
                </td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Oxidizers - solid or liquid</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="color: rgb(0, 0, 0); text-align: right;">&#160;&#9744;</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Cryogenic liquids - oxidizing</div>
                </td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: right; color: rgb(0, 0, 0);">&#9744;</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Compressed gas - toxic</div>
                </td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Reactives - unstable or water reactive</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right; padding-bottom: 2px;">&#160;</td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Corrosives - solid or liquid</div>
                </td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Compressed gas - corrosive</div>
                </td>
                <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                  <div>Toxics - solid or liquid</div>
                </td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0); clear: both;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">2-2.</td>
                <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>For all materials checked in Section 2.1 above, please list the specific material(s), use(s), and quantities of each used or stored on the site in the table below; or attach a separate inventory. <font style="font-style: italic;">NOTE:


                      If proprietary, the constituents need not be named but the hazard information and volumes are required.</font></div>
                </td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);"><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                      <div>&#160;</div>
                      <div>EXHIBIT E<br>
                      </div>
                      <div>
                        <div><font id="DSPFPageNumber">-1-</font></div>
                      </div>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

              <tr>
                <td colspan="1" style="width: 10%; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); text-align: center; padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: center;">
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">Material/</div>
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">Chemical</div>
                </td>
                <td style="width: 9.9%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: center;">
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">Physical</div>
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">State (Solid,</div>
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">Liquid, or</div>
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">Gas)</div>
                </td>
                <td style="width: 15%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: center;">
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">Container Size</div>
                </td>
                <td style="width: 15%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: center;">
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">Number of Containers</div>
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">Used &amp; Stored</div>
                </td>
                <td style="width: 12%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: center;">
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">Total Quantity</div>
                </td>
                <td style="width: 12%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: center;">
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">Units (pounds</div>
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">for solids,</div>
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">gallons or liters</div>
                  <div style="font-weight: bold; color: rgb(0, 0, 0);">for liquids, &amp;</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 26%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 9.9%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 12%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0); clear: both;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">2-3.</td>
                <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Describe the planned storage area location(s) for the materials in Section 2-2 above. Include site maps and drawings as appropriate.</div>
                </td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="color: rgb(0, 0, 0);">
            <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>

            </table>
          </div>
          <div style="color: rgb(0, 0, 0);"> <br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                      <div>&#160;</div>
                      <div>EXHIBIT E<br>
                      </div>
                      <div>
                        <div><font id="DSPFPageNumber">-2-</font></div>
                      </div>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">2-4.</td>
                <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Other hazardous materials. Check below (<font style="font-style: italic;">right click to properties) </font>if applicable. <font style="font-style: italic;">NOTE: If either of the latter </font>two are checked (BSL-3 and/or
                    radioisotope/radiation), be advised that not all lease locations/cities or lease agreements allow these hazards; and if either of these hazards are planned, additional information will be required with copies of oversight agency
                    authorizations/licenses as they become available.</div>
                </td>
              </tr>

          </table>
          <br>
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); text-align: right; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                    <div>Risk Group 2/Biosafety Level-2 Biohazards</div>
                  </td>
                  <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                    <div>Risk Group 3/Biosafety Level-3 Biohazards</div>
                  </td>
                  <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                    <div>Radioisotopes/Radiation</div>
                  </td>
                </tr>

            </table>
            <div> <br>
            </div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0);">3.0</td>
                  <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                    <div style="font-weight: bold;"><u>HAZARDOUS WASTE (i.e., REGULATED CHEMICAL WASTE)</u></div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <div style="margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">Are (or will) hazardous wastes (be) generated?&#160;&#160;&#160;&#160;&#160; &#9744; Yes&#160;&#160;&#160; &#9744; No</font></div>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <div style="margin-left: 36pt; color: rgb(0, 0, 0);">If YES, continue with the next question. If not, skip this section and go to section 4.0.</div>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                  </td>
                  <td style="width: 27pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0);">3.1</td>
                  <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>Are or will any of the following hazardous (CHEMICAL) wastes generated, handled, or disposed of (where applicable and allowed) on the property?</div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                    <div>Liquids</div>
                  </td>
                  <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                    <div>Process sludges</div>
                  </td>
                  <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                    <div>PCBs</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right; padding-bottom: 2px;">&#160;</td>
                  <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                    <div>Solids</div>
                  </td>
                  <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                    <div>Metals</div>
                  </td>
                  <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                    <div>wastewater</div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                  </td>
                  <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">3-2.</td>
                  <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>List and estimate the quantities of hazardous waste identified in Question 3-1 above.</div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 16%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td colspan="2" style="vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0); color: rgb(0, 0, 0);">
                    <div style="text-align: center; font-weight: bold;">WASTE TYPE</div>
                  </td>
                  <td style="width: 10%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="width: 10%; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); text-align: center;">&#160;</td>
                  <td rowspan="1" style="width: 24%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">&#160;</td>
                  <td rowspan="1" style="width: 16%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">&#160;</td>
                  <td rowspan="1" style="width: 8%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">&#160;</td>
                  <td rowspan="1" style="width: 8%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">&#160;</td>
                  <td rowspan="1" style="width: 10%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">&#160;</td>
                  <td rowspan="1" style="width: 24%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: center;">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); text-align: center;"><br>
                  </td>
                  <td style="width: 24%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">HAZRDOUS (CHEMICAL)</div>
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">WASTE GENERATED</div>
                  </td>
                  <td style="width: 16%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">SOURCE</div>
                  </td>
                  <td style="width: 8%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">RCRA</div>
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">listed (federal)</div>
                  </td>
                  <td style="width: 8%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">Non-</div>
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">RCRA</div>
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">(Calif-</div>
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">ornia</div>
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">ONLY or recycle)</div>
                  </td>
                  <td style="width: 10%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">APPROX. MONTHLY QUANTITY</div>
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">with units</div>
                  </td>
                  <td style="width: 24%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold;">DISPOSITION [e.g., off-site</div>
                    <div style="font-weight: bold;">landfill, incineration, fuel</div>
                    <div style="font-weight: bold;">blending scrap metal;</div>
                    <div style="font-weight: bold;">wastewater neutralization (onsite</div>
                    <div style="font-weight: bold;">or off-site)]</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" rowspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td rowspan="1" style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td rowspan="1" style="width: 16%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td rowspan="1" style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td rowspan="1" style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td rowspan="1" style="width: 10%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td rowspan="1" style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 16%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">&#9744;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">&#9744;</td>
                  <td style="width: 10%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 16%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">&#9744;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">&#9744;</td>
                  <td style="width: 10%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 16%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">&#9744;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">&#9744;</td>
                  <td style="width: 10%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 16%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">&#9744;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">&#9744;</td>
                  <td style="width: 10%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 16%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">&#9744;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: center;">&#9744;</td>
                  <td style="width: 10%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 24%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0); clear: both;">&#160;</div>
          </div>
          <div style="color: rgb(0, 0, 0);">
            <div>
              <table cellspacing="0" cellpadding="0" border="0" align="right" id="z283db4db328847358d03654a853cf902" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 5%;">&#160;</td>
                    <td style="width: 4%;">3-3.</td>
                    <td style="width: 18%;">Waste characterization by:</td>
                    <td style="width: 18%;">Process knowledge &#9744;</td>
                    <td style="width: 18%;">EPA lab analysis &#9744;</td>
                    <td style="width: 27%;">Both &#9744;</td>
                  </tr>

              </table>
            </div>
            <div style="clear: both;"><br>
            </div>
          </div>
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                  </td>
                  <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">3-4.</td>
                  <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>Please include name, location, and permit number (e.g. EPA ID No.) for transporter and disposal facility if applicable. Attach separate pages as necessary. <font style="font-style: italic;">If not yet known, write &#8220;TBD.&#8221;</font></div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);"><br>
            </div>
            <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 28%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0); color: rgb(0, 0, 0);">
                    <div style="text-align: center; font-weight: bold;">Hazardous Waste</div>
                    <div style="text-align: center; font-weight: bold;">Transporter/Disposal Facility Name</div>
                  </td>
                  <td style="width: 28%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                    <div style="color: rgb(0, 0, 0); text-align: center;">&#160;</div>
                    <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);">Facility Location</div>
                  </td>
                  <td style="width: 16.27%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0); color: rgb(0, 0, 0);">
                    <div style="text-align: center; font-weight: bold;">Transporter (T) or</div>
                    <div style="text-align: center; font-weight: bold;">Disposal (D) Facility</div>
                  </td>
                  <td style="width: 18%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
                    <div style="color: rgb(0, 0, 0); text-align: center;">&#160;</div>
                    <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);">Permit Number</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 28%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 28%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 16.27%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 18%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 28%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 28%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 16.27%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 18%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 28%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 28%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 16.27%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 18%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0); clear: both;">&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                  </td>
                  <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">3-5.</td>
                  <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>Are pollution controls or monitoring employed in the process to prevent or minimize the release of wastes into the environment? <font style="font-style: italic;">NOTE: This does NOT mean fume hoods; examples include air scrubbers,
                        cyclones, carbon or HEPA filters at building exhaust fans, sedimentation tanks, pH neutralization systems for wastewater, etc.</font></div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <div style="color: rgb(0, 0, 0);">
              <table cellspacing="0" cellpadding="0" border="0" align="" id="z12f02c80b85241f5a38d1a1f5a373878" style="width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">

                  <tr>
                    <td colspan="1" style="width: 10%;">&#160;</td>
                    <td style="width: 6%;"><font style="color: rgb(0, 0, 0);">&#9744; Yes</font></td>
                    <td style="width: 84%;"><font style="color: rgb(0, 0, 0);"> &#9744; No</font></td>
                  </tr>

              </table>
            </div>
            <div style="margin-left: 63pt; clear: both;"><font style="color: rgb(0, 0, 0);">&#160; &#160;&#160;&#160; <br>
              </font></div>
            <div style="color: rgb(0, 0, 0);">
              <table cellspacing="0" cellpadding="0" border="0" align="" id="zd44ba9426a2441d886220f6aacacde42" style="width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">

                  <tr>
                    <td colspan="1" style="width: 10%; padding-bottom: 2px;">&#160;</td>
                    <td style="width: 18%; padding-bottom: 2px;">If YES, please list/describe:</td>
                    <td style="width: 72%; border-bottom: 2px solid rgb(0, 0, 0);">
                      <div>&#160;</div>
                    </td>
                  </tr>
                  <tr>
                    <td colspan="1" rowspan="1" style="width: 10%; padding-bottom: 2px;">&#160;</td>
                    <td rowspan="1" style="width: 18%; padding-bottom: 2px;">&#160;</td>
                    <td rowspan="1" style="width: 72%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  </tr>

              </table>
              <div> <br>
              </div>
            </div>
          </div>
          <div>
            <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
              <div id="DSPFPageFooter" style="width: 100%;">
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                      <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                        <div>&#160;</div>
                        <div>EXHIBIT E<br>
                        </div>
                        <div>
                          <div><font id="DSPFPageNumber">-3-</font></div>
                        </div>
                      </td>
                      <td style="width: 33%; font-size: 8pt;">
                        <div style="text-align: right;">HEALTHPEAK INC. </div>
                        <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                        <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                      </td>
                    </tr>

                </table>
              </div>
              <div id="DSPFPageBreak" style="page-break-after: always;">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0);">4.0</td>
                  <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                    <div style="font-weight: bold;"><u>OTHER REGULATED WASTE (i.e., REGULATED BIOLOGICAL WASTE, referred to as &#8220;Medical Waste&#8221; in California)</u></div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <div style="margin-left: 36pt;"><font style="color: rgb(0, 0, 0);">4-1.&#160;&#160;&#160;&#160;&#160; Will (or do) you generate medical waste?&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#9744; Yes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#9744; No If NO, skip to Section 5.0.</font></div>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <div>
              <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zfdad2c2625ef42fda1792f49c5db66de" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

                  <tr style="vertical-align: top;">
                    <td style="width: 36pt;">&#160;</td>
                    <td style="vertical-align: top; width: 27pt;">
                      <div style="text-align: left;"><font style="color: rgb(0, 0, 0);">4-2.</font></div>
                    </td>
                    <td style="vertical-align: top; width: auto;">
                      <div style="text-align: left;"><font style="color: rgb(0, 0, 0);">Check the types of waste that will be generated, all of which fall under the California Medical Waste Act:</font></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                    <div>Contaminated sharps (i.e., if contaminated with &#8805; Risk Group 2 materials)</div>
                  </td>
                  <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                    <div style="color: rgb(0, 0, 0);">Animal carcasses</div>
                  </td>
                  <td style="width: 3%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
                    <div>Pathology waste known or suspected to be contaminated with &#8805; Risk Group 2 pathogens)</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">
                    <div>Red bag biohazardous waste (i.e., with &#8805; Risk Group 2 materials) for autoclaving</div>
                  </td>
                  <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="color: rgb(0, 0, 0);">Human or non-human primate blood, tissues, etc.</div>
                    <div style="color: rgb(0, 0, 0);">(e.g., clinical specimens)</div>
                  </td>
                  <td style="width: 3%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); text-align: right;">&#9744;</td>
                  <td colspan="1" style="width: 1%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 26%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
                    <div style="color: rgb(0, 0, 0);">Trace Chemotherapeutic Waste and/or Pharmaceutical waste</div>
                    <div style="color: rgb(0, 0, 0);">NOT otherwise regulated as RCRA chemical waste</div>
                  </td>
                </tr>

            </table>
            <div> <br>
            </div>
            <div style="color: rgb(0, 0, 0);">
              <div>
                <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z00f9b075103e471bbc1628973c1d28d4" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

                    <tr style="vertical-align: top;">
                      <td style="width: 36pt;">
                        <div><br>
                        </div>
                      </td>
                      <td style="vertical-align: top; width: 27pt;">
                        <div>4-3.</div>
                      </td>
                      <td style="vertical-align: top; width: auto;">
                        <div>What vendor will be used for off-site autoclaving and/or incineration?</div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="color: rgb(0, 0, 0);">
              <table cellspacing="0" cellpadding="0" border="0" align="" id="z6c4288a758e64c0287a774a4170125cf" style="width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">

                  <tr>
                    <td colspan="1" style="width: 10%; padding-bottom: 2px;">&#160;</td>
                    <td style="width: 90%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="color: rgb(0, 0, 0); clear: both;"><br>
          </div>
          <div style="color: rgb(0, 0, 0); clear: both;">
            <table cellspacing="0" cellpadding="0" border="0" align="" id="z8085c8dff4ac443981778126f3e82b58" style="width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">

                <tr>
                  <td colspan="1" style="width: 6%;"><br>
                  </td>
                  <td style="width: 4%;">4-5.</td>
                  <td style="width: 38%;">
                    <div>Do you have a Medical Waste Permit for this site?</div>
                  </td>
                  <td style="width: 8%;">&#9744; Yes</td>
                  <td style="width: 44%;">&#9744; No, not required.</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 6%;"><br>
                  </td>
                  <td colspan="2"><br>
                  </td>
                  <td colspan="2" rowspan="1">&#9744; No, but an application will be submitted</td>
                </tr>

            </table>
          </div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0);">5.0</td>
                  <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                    <div style="font-weight: bold;"><u>UNDERGROUND STORAGE TANKS (USTS) &amp; ABOVEGROUND STORAGE TANKS (ASTS)</u></div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                  </td>
                  <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">5-1.</td>
                  <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>Are underground storage tanks (USTs), aboveground storage tanks (ASTs), or associated pipelines used for the storage of petroleum products, chemicals, or liquid wastes present on site (lease renewals) or required for planned
                      operations (new tenants)?YesNo</div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <div style="text-align: justify; font-style: italic; margin-left: 63pt;"><font style="color: rgb(0, 0, 0);"><u>NOTE</u>: If you will have your own diesel emergency power generator, then you will have at least one AST! [NOTE: If a backup
                generator services multiple tenants, then the landlord usually handles the permits.]</font></div>
            <div style="color: rgb(0, 0, 0); margin-left: 63pt;">&#160;</div>
            <div style="text-align: justify; color: rgb(0, 0, 0); margin-left: 63pt;">If NO, skip to section 6.0. If YES, please describe capacity, contents, age, type of the USTs or ASTs, as well any associated leak detection/spill prevention measures.
              Please attach additional pages if necessary.</div>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;"><br>
                  </td>
                  <td style="width: 8%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold;">UST or</div>
                    <div style="font-weight: bold;">AST</div>
                  </td>
                  <td style="width: 9.99%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold;">Capacity (gallons)</div>
                  </td>
                  <td style="width: 20%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">Contents</div>
                  </td>
                  <td style="width: 7.99%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold;">Year</div>
                    <div style="font-weight: bold;">Installed</div>
                  </td>
                  <td style="width: 22%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0);">&#160;Type (Steel, Fiberglass, etc.)</div>
                  </td>
                  <td style="width: 22%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0) rgb(0, 0, 0) rgb(0, 0, 0); color: rgb(0, 0, 0); text-align: center;">
                    <div style="font-weight: bold;">Associated Leak Detection /</div>
                    <div style="font-weight: bold;">Spill Prevention Measures*</div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 9.99%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 7.99%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 22%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 22%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 9.99%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 7.99%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 22%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 22%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="width: 10%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                  <td style="width: 8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 9.99%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 7.99%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 22%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 22%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0); clear: both;">&#160;</div>
            <div style="text-indent: -36pt; margin-right: 43.85pt; margin-left: 99pt; color: rgb(0, 0, 0);">*<u>NOTE</u>: The following are examples of leak detection / spill prevention measures: integrity testing, inventory reconciliation, leak detection
              system, overfill spill protection, secondary containment, cathodic protection.</div>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                  </td>
                  <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">5-2.</td>
                  <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>Please provide copies of written tank integrity test results and/or monitoring documentation, if available.</div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <div>
              <div>
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 6%; color: rgb(0, 0, 0);"><br>
                      </td>
                      <td style="width: 4%; vertical-align: top;"><font style="color: rgb(0, 0, 0);">5-3.<br>
                        </font></td>
                      <td style="width: 58%; vertical-align: top;"><font style="color: rgb(0, 0, 0);">Is the UST/AST registered and permitted with the appropriate regulatory agencies?&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
                      <td style="width: 32%; vertical-align: top; color: rgb(0, 0, 0);">&#9744; Yes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#9744; No, not yet</td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <div style="color: rgb(0, 0, 0); margin-left: 63pt;">If YES, please attach a copy of the required permit(s). <font style="font-style: italic;">See Section 7-1 for the oversight agencies that issue permits, with the exception of those for
                diesel emergency power generators which are permitted by the local Air Quality District (Bay Area Air Quality Management District = BAAQMD; or San Diego Air Pollution Control District = San Diego APCD).</font></div>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
              <div id="DSPFPageFooter" style="width: 100%;">
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                      <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                        <div>&#160;</div>
                        <div>EXHIBIT E<br>
                        </div>
                        <div>
                          <div><font id="DSPFPageNumber">-4-</font></div>
                        </div>
                      </td>
                      <td style="width: 33%; font-size: 8pt;">
                        <div style="text-align: right;">HEALTHPEAK INC. </div>
                        <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                        <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="page-break-after:always;" id="DSPFPageBreak">
                <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
            </div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                  </td>
                  <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">5-4.</td>
                  <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>If this Questionnaire is being completed for a lease renewal, and if any of the USTs/ASTs have leaked, please state the substance released, the media(s) impacted (e.g., soil, water, asphalt, etc.), the actions taken, and all
                      remedial responses to the incident.</div>
                  </td>
                </tr>

            </table>
          </div>
          <br>
          <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0); clear: both;">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">5-5.</td>
                <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>If this Questionnaire is being completed for a lease renewal, have USTs/ASTs been removed from the Property?</div>
                </td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);">
            <table cellspacing="0" cellpadding="0" border="0" id="z338c016d5adf4723906271f30a16d585" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 10%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 8%;"><font style="color: rgb(0, 0, 0);">&#9744; Yes<br>
                    </font></td>
                  <td style="width: 82%;"><font style="color: rgb(0, 0, 0);">&#9744; No</font></td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 10%;">&#160;</td>
                  <td colspan="2" rowspan="1">If YES, please provide any official closure letters or reports and supporting documentation (e.g., analytical test results, remediation report results, etc.).</td>
                </tr>

            </table>
            <div> <br>
            </div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">5-6.</td>
                <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>For Lease renewals, are there any above or below ground pipelines on site used to transfer chemicals or wastes?</div>
                </td>
              </tr>

          </table>
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 10%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 8%;"><font style="color: rgb(0, 0, 0);">&#9744; Yes <br>
                    </font></td>
                  <td style="width: 82%;"><font style="color: rgb(0, 0, 0);">&#9744; No</font></td>
                </tr>

            </table>
          </div>
          <div><font style="color: rgb(0, 0, 0);"> </font>
            <table cellspacing="0" cellpadding="0" border="0" id="z9b5c5f98be454812b56606fb2d6e6240" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 10%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 54%;">For new tenants, are installations of this type required for the planned operations? <br>
                  </td>
                  <td style="width: 8%;">&#9744; Yes <br>
                  </td>
                  <td style="width: 28%;"><font style="color: rgb(0, 0, 0);">&#9744; No</font></td>
                </tr>
                <tr>
                  <td style="width: 10%;">
                    <div>&#160;</div>
                  </td>
                  <td colspan="3" rowspan="1">If YES to either question in this section 5-6, please describe.</td>
                </tr>

            </table>
          </div>
          <br>
          <table cellspacing="0" cellpadding="0" border="0" align="" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>
              <tr>
                <td colspan="1" style="width: 10%; vertical-align: top; color: rgb(0, 0, 0); padding-bottom: 2px;">&#160;</td>
                <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); color: rgb(0, 0, 0);">&#160;</td>
              </tr>

          </table>
          <div> <br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 32.95pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0);">6.0</td>
                <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="font-weight: bold;"><u>ASBESTOS CONTAINING BUILDING MATERIALS</u></div>
                </td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="text-align: justify; margin-right: 7.2pt; margin-left: 36pt; color: rgb(0, 0, 0);">Please be advised that an asbestos survey may have been performed at the Property. If provided, please review the information that identifies the
            locations of known asbestos containing material or presumed asbestos containing material. All personnel and appropriate subcontractors should be notified of the presence of these materials, and informed not to disturb these materials. Any
            activity that involves the disturbance or removal of these materials must&#160; be done by an appropriately trained individual/contractor.</div>
          <div style="color: rgb(0, 0, 0);"><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 33pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0);">7.0</td>
                <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="font-weight: bold;">OTHER <u>REGULATORY PERMITS/REQUIREMENTS</u></div>
                </td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">7-1.</td>
                <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Does the operation have or require an industrial wastewater permit to discharge into the local National Pollutant Discharge Elimination System (NPDES)? <font style="font-style: italic;">[Example: This applies when wastewater from
                      equipment cleaning is routed through a pH neutralization system prior to discharge into the sanitary or lab sewer for certain pharmaceutical manufacturing wastewater; etc.] </font>Permits are obtained from the regional sanitation
                    district that is treating wastewater.</div>
                </td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <div style="color: rgb(0, 0, 0);">
            <table cellspacing="0" cellpadding="0" border="0" id="zb4a5431412e14076bd6f47cc4de483f6" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 10%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 90%;">
                    <div style="text-align: left;"><font style="color: rgb(0, 0, 0);">&#9744;Yes&#160;&#160; &#9744;&#160; No&#160;&#160; &#9744; No, but one will be prepared and submitted to the Landlord property management company.</font></div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 10%;">
                    <div>&#160;</div>
                  </td>
                  <td style="width: 90%;">If so, please attach a copy of this permit or provide it later when it has been prepared.</td>
                </tr>

            </table>
            <div> <br>
            </div>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

              <tr>
                <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">7-2.</td>
                <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Has a Hazardous Materials Business Plan (HMBP) been developed for the site and submitted via the State of California Electronic Reporting System (CERS)? <font style="font-style: italic;">[NOTE: The trigger limits for having to do
                      this are &#8805; 200 cubic feet if any one type of compressed gas(except for carbon dioxide and inert simple asphyxiant gases, which have a higher trigger limit of &#8805; 1,000 cubic feet); &#8805; 55 gallons if any one type of hazardous chemical
                      liquid; and &#8805;500 pounds of any one type of hazardous chemical solid. So a full-sixe gas cylinder and a 260- liter of liquid nitrogen are triggers! Don&#8217;t forget the diesel fuel in a backup emergency generator if the diesel tank size is
                      &#8805; 55 gallons and it is permitted under the tenant (rather than under the landlord).] </font>NOTE: Each local Certified Unified Program Agency (CUPA) in California governs the HMBP process so start there. Examples: the CUPA for cities
                    in San Mateo County is the County Environmental Health Department; the CUPA for the City of Hayward, CA is the Hayward Fire Department; the CUPA for Mountain View is the Mountain View Fire Department; and, the CUPA for San Diego is the
                    County of San Diego Hazardous Materials Division (HMD),</div>
                </td>
              </tr>

          </table>
          <div> <br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                      <div>&#160;</div>
                      <div>EXHIBIT E<br>
                      </div>
                      <div>
                        <div><font id="DSPFPageNumber">-5-</font></div>
                      </div>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div>
            <div style="color: rgb(0, 0, 0);">
              <table cellspacing="0" cellpadding="0" border="0" id="z3fc3983da9d0482895391a90c22eb3f9" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 10%;">
                      <div>&#160;</div>
                    </td>
                    <td style="width: 90%;">&#9744; Yes&#160; &#9744; No, not required. &#9744; No, but one will be prepared and submitted, and a copy will be provided to the landlord property management company.</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="width: 10%;">&#160;</td>
                    <td rowspan="1" style="width: 90%;">&#160;</td>
                  </tr>
                  <tr>
                    <td rowspan="1" style="width: 10%;">&#160;</td>
                    <td rowspan="1" style="width: 90%;">If one has been completed, please attach a copy. <u>Continue to provide updated versions as they are</u>&#160;<u>completed. This is a legal requirement in that State law requires that the owner/operator
                        of a business located</u>&#160;<u>on leased or rented real property shall notify, in writing, the owner of the property that the business is subject</u>&#160;<u>to and is in compliance with the Hazardous Materials Business Plan requirements
                        (Health and Safety Code</u>&#160;<u>Chapter 6.95 Section 25505.1).</u></td>
                  </tr>

              </table>
            </div>
            <div style="margin-right: 29.7pt; margin-left: 69pt; color: rgb(0, 0, 0);"> <br>
            </div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt; color: rgb(0, 0, 0);"><br>
                  </td>
                  <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">7-3.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><font style="color: rgb(0, 0, 0);"><u>NOTE</u>: Please be advised that if you are involved in any tenant improvements that require a construction permit, you will be asked to provide the local city with a Hazardous Materials
                        Inventory Statement (HMIS) to ensure that your hazardous chemicals fall within the applicable Fire Code fire control area limits for the applicable construction occupancy of the particular building. The HMIS will include much of the
                        information listed in Section 2-2. Neither the landlord nor the landlord&#8217;s property management company expressly warrants that the inventory provided in Section 2-2 will necessarily meet the applicable California Fire Code fire
                        control area limits for building occupancy, especially in shared tenant occupancy situations. It is the responsibility of the tenant to ensure that a facility and site can legally handle the intended operations and hazardous
                        materials desired/ needed for its operations, but the landlord is happy to assist in this determination when possible.</font></div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);"><br>
            </div>
            <div style="font-weight: bold; color: rgb(0, 0, 0);"><u>CERTIFICATION</u></div>
            <div style="color: rgb(0, 0, 0);">&#160;</div>
            <div style="text-align: justify; margin-right: 88.6pt; color: rgb(0, 0, 0);">I am familiar with the real property described in this questionnaire. By signing below, I represent and warrant that&#160; the answers to the above questions are complete
              and accurate to the best of my knowledge.&#160;&#160; I also understand that&#160; Lessor will rely on&#160; the completeness and accuracy of my answers in assessing&#160; &#160; any environmental liability risks associated with the property.</div>
            <div style="color: rgb(0, 0, 0);"><br>
            </div>
            <div style="color: rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 5%; padding-bottom: 2px;"><br>
                      </td>
                      <td style="width: 8%; padding-bottom: 2px;">Signature:</td>
                      <td style="width: 62%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                      </td>
                      <td style="width: 25%; padding-bottom: 2px;">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
            <div style="color: rgb(0, 0, 0);"><br>
            </div>
            <div style="color: rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">
                <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                    <tr>
                      <td style="width: 5%; padding-bottom: 2px;">
                        <div>&#160;</div>
                      </td>
                      <td style="width: 5%; padding-bottom: 2px;">Name:</td>
                      <td style="width: 65%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                      </td>
                      <td style="width: 25%; padding-bottom: 2px;">&#160;</td>
                    </tr>

                </table>
                <div> <br>
                </div>
              </div>
            </div>
            <div style="color: rgb(0, 0, 0);">
              <table cellspacing="0" cellpadding="0" border="0" id="zc9cbc502762846e3af5dcc31951834cb" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 5%; padding-bottom: 2px;">
                      <div>&#160;</div>
                    </td>
                    <td style="width: 4%; padding-bottom: 2px;">Title:</td>
                    <td style="width: 66%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                    </td>
                    <td style="width: 25%; padding-bottom: 2px;">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="color: rgb(0, 0, 0);"><br>
            </div>
            <div style="color: rgb(0, 0, 0);">
              <table cellspacing="0" cellpadding="0" border="0" id="z2e63886775e548dfb10a34c1163d8078" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 5%; padding-bottom: 2px;">
                      <div>&#160;</div>
                    </td>
                    <td style="width: 4%; padding-bottom: 2px;">Date:</td>
                    <td style="width: 66%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                    </td>
                    <td style="width: 25%; padding-bottom: 2px;">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="color: rgb(0, 0, 0);"><br>
            </div>
            <div style="color: rgb(0, 0, 0);">
              <table cellspacing="0" cellpadding="0" border="0" id="z2c1b1a13129c406191229212cf0c1e60" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 12%; padding-bottom: 2px;">Telephone:</td>
                    <td style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                    </td>
                    <td style="width: 68%; padding-bottom: 2px;">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="color: rgb(0, 0, 0);"><br>
            </div>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: right; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: center; vertical-align: bottom; font-size: 8pt;">
                      <div>&#160;</div>
                      <div>EXHIBIT E<br>
                      </div>
                      <div>
                        <div><font id="DSPFPageNumber">-6-</font></div>
                      </div>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div>
            <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"><u>LEASE</u></div>
            <div style="color: rgb(0, 0, 0);"><br>
            </div>
            <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);">TORREY PINES SCIENCE CENTER</div>
            <div style="color: rgb(0, 0, 0);"><br>
            </div>
            <div style="text-align: center; color: rgb(0, 0, 0);">TORREY PINES SCIENCE CENTER LIMITED PARTNERSHIP,</div>
            <div style="text-align: center; color: rgb(0, 0, 0);">a Delaware limited partnership,</div>
            <div style="text-align: center; color: rgb(0, 0, 0);"> <br>
            </div>
            <div style="text-align: center; color: rgb(0, 0, 0);">as Landlord,<br>
              <br>
            </div>
            <div style="text-align: center; color: rgb(0, 0, 0);">and</div>
            <div style="color: rgb(0, 0, 0);"><br>
            </div>
            <div style="text-align: center; color: rgb(0, 0, 0);">BROOKLYN IMMUNOTHERAPEUTICS INC.,</div>
            <div style="text-align: center; color: rgb(0, 0, 0);">a Delaware corporation,</div>
            <div style="text-align: center; color: rgb(0, 0, 0);"><br>
              as Tenant.<br>
            </div>
            <div style="color: rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);"><br>
              </div>
            </div>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td style="width: 50.79%; text-align: left; vertical-align: bottom; font-size: 8pt;"><br>
                    </td>
                    <td style="width: 49.21%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <!--PROfilePageNumberReset%LCR%1%(%)%-->
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"><u>TABLE OF CONTENTS</u></div>
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"><u> <br>
            </u></div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                <td rowspan="1" style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                <td rowspan="1" style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); text-align: right; font-weight: bold;"><u>Page</u></td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>1.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>PREMISES, BUILDING, PROJECT, AND COMMON AREAS</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">5</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>2.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>LEASE TERM; OPTION TERM</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">6</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>3.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>BASE RENT</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">6</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>4.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>ADDITIONAL RENT</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">6</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>5.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>USE OF PREMISES</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">11</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>6.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>SERVICES AND UTILITIES</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">16</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>7.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>REPAIRS</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">17</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>8.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>ADDITIONS AND ALTERATIONS</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">17</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>9.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>COVENANT AGAINST LIENS</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">19</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>10.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>INSURANCE</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">19</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>11.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>DAMAGE AND DESTRUCTION</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">21</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>12.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>NONWAIVER</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">22</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>13.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>CONDEMNATION</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">23</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>14.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>ASSIGNMENT AND SUBLETTING</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">23</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>15.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>SURRENDER OF PREMISES; OWNERSHIP AND REMOVAL OF TRADE FIXTURES</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">26</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>16.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>HOLDING OVER</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">27</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>17.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>ESTOPPEL CERTIFICATES</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">27</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>18.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>SUBORDINATION</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">28</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>19.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>DEFAULTS; REMEDIES</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">28</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>20.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>COVENANT OF QUIET ENJOYMENT</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">30</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>21.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>SECURITY DEPOSIT</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">30</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>22.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>COMMUNICATIONS AND COMPUTER LINE</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">30</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>23.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>SIGNS</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">30</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>24.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>COMPLIANCE WITH LAW</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">31</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>25.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>LATE CHARGES</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">31</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>26.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>LANDLORD'S RIGHT TO CURE DEFAULT; PAYMENTS BY TENANT</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">32</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>27.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>ENTRY BY LANDLORD</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">32</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>28.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>TENANT PARKING</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">32</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>29.</div>
                </td>
                <td style="width: 89%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>MISCELLANEOUS PROVISIONS</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">32</div>
                </td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);"><br>
          </div>
          <div style="color: rgb(0, 0, 0);">EXHIBITS</div>
          <div style="color: rgb(0, 0, 0);">&#160;</div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>A</div>
                </td>
                <td style="width: 95%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>OUTLINE OF PREMISES <br>
                  </div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">B</td>
                <td rowspan="1" style="width: 95%; vertical-align: top; color: rgb(0, 0, 0);">TENANT WORK LETTER</td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>C</div>
                </td>
                <td style="width: 95%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>FORM OF NOTICE OF LEASE TERM DATES</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>D</div>
                </td>
                <td style="width: 95%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>FORM OF TENANT'S ESTOPPEL CERTIFICATE <br>
                  </div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">E</td>
                <td rowspan="1" style="width: 95%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">ENVIRONMENTAL QUESTIONNAIRE</td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);"><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: left; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: left; vertical-align: bottom; font-size: 8pt;">
                      <div style="text-align: center;"><br>
                        <font id="DSPFPageNumber">(i)</font></div>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div style="text-align: center; font-weight: bold; color: rgb(0, 0, 0);"><u>INDEX</u></div>
          <div style="color: rgb(0, 0, 0);"><br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right; font-weight: bold;"><u>Page(s)</u></div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); text-align: right;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Abatement Event</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">33</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Accountant</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">13</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Advocate Arbitrators</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">6</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Alterations</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">20</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Base Rent</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">7</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Brokers</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">41</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Building</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Building Hours</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">17</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Building Structure</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">20</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Building Systems</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">20</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Casualty</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">23</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Common Areas</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Comparable Buildings</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">6</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Contemplated Effective Date</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">27</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Contemplated Transfer Space</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">27</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Direct Expenses</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">8</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Eligibility Period</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">33</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Estimate</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">12</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Estimate Statement</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">12</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Estimated Direct Expenses</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">12</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Existing Hazardous Materials</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">15</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Expense Year</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">8</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Force Majeure</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">38</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Holidays</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">18</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>HVAC</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">17</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Intention to Transfer Notice</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">27</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Landlord</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">1</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Landlord Parties</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">22</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Landlord Repair Notice</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">24</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Lease</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">1</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Lease Commencement Date</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Lease Expiration Date</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Lease Term</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Lease Year</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">5</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Lines</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">34</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Mail</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">38</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Neutral Arbitrator</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">6</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Nine Month Period</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">27</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Notices</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">38</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Operating Expenses</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">8</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Option Conditions</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">5</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Option Rent</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">5</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Option Term</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">5</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Original Improvements</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">23</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Original Tenant</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">5</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Outside Agreement Date</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">6</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Possession Date</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Premises</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div>Project,</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                  <div style="text-align: right;">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div>Review Period</div>
                </td>
                <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                  <div style="text-align: right;">13</div>
                </td>
              </tr>

          </table>
          <div style="color: rgb(0, 0, 0);"><br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: left; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: left; vertical-align: bottom; font-size: 8pt;">
                      <div style="text-align: center;"><br>
                        <font id="DSPFPageNumber">(ii)</font></div>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="page-break-after:always;" id="DSPFPageBreak">
              <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
          </div>
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">&#160;</td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                    <div style="text-align: right; font-weight: bold;"><u>Page(s)</u></div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div>Security Deposit</div>
                  </td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="text-align: right;">33</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>Statement</div>
                  </td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                    <div style="text-align: right;">12</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div>Subject Space</div>
                  </td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="text-align: right;">26</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>Summary.</div>
                  </td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                    <div style="text-align: right;">1</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div>Tax Expenses</div>
                  </td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="text-align: right;">10</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>Tenant</div>
                  </td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                    <div style="text-align: right;">1</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div>Tenant Work Letter</div>
                  </td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="text-align: right;">4</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>Tenant&#8217;s Security System</div>
                  </td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                    <div style="text-align: right;">19</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div>Tenant's Share</div>
                  </td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="text-align: right;">11</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0);">
                    <div>Transfer Notice</div>
                  </td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0);">
                    <div style="text-align: right;">26</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 94%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div>Transferee</div>
                  </td>
                  <td style="width: 6%; vertical-align: top; color: rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
                    <div style="text-align: right;">26</div>
                  </td>
                </tr>

            </table>
            <div style="color: rgb(0, 0, 0);"><br>
            </div>
            <br>
            <div id="DSPFPageFooter" style="width: 100%;">
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

                  <tr>
                    <td colspan="1" style="width: 33%; text-align: left; vertical-align: bottom; font-size: 8pt;">&#160;</td>
                    <td style="width: 34%; text-align: left; vertical-align: bottom; font-size: 8pt;">
                      <div style="text-align: center;"><br>
                        <font id="DSPFPageNumber">(iii)</font></div>
                    </td>
                    <td style="width: 33%; font-size: 8pt;">
                      <div style="text-align: right;">HEALTHPEAK INC. </div>
                      <div style="text-align: right;">10355 SCIENCE CENTER DR </div>
                      <div style="text-align: right;">BROOKLYN IMMUNOTHERAPEUTICS</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
    </div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>brhc10040603_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">Exhibit 31.1</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</div>
    <div style="text-align: center; font-weight: bold;">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div><br>
    </div>
    <div style="text-align: justify;">I, Matthew Angel, certify that:</div>
    <div><br>
    </div>
    <div>1. I have reviewed this Quarterly Report on Form 10-Q of Brooklyn ImmunoTherapeutics, Inc.</div>
    <div><br>
    </div>
    <div>2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
      misleading with respect to the period covered by this report.</div>
    <div><br>
    </div>
    <div>3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for,
      the periods presented in this report.</div>
    <div><br>
    </div>
    <div>4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
      defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
    <div><br>
    </div>
    <div>(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
      is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
    <div><br>
    </div>
    <div>(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
      preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
    <div><br>
    </div>
    <div>(c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
      report based on such evaluation; and</div>
    <div><br>
    </div>
    <div>(d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the
      registrant&#8217;s internal control over financial reporting.</div>
    <div><br>
    </div>
    <div>5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors:</div>
    <div><br>
    </div>
    <div>(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report
      financial information; and</div>
    <div><br>
    </div>
    <div>(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2046eeafdb9f47088a80636bcdff06e9">

        <tr>
          <td style="width: 49.98%; vertical-align: top;">
            <div>Date: August 11, 2022</div>
          </td>
          <td style="width: 50.02%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: justify;">/s/ Matthew Angel</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.98%; vertical-align: top;">&#160;</td>
          <td style="width: 50.02%; vertical-align: bottom;">
            <div style="text-align: justify;">Matthew Angel</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.98%; vertical-align: top;">&#160;</td>
          <td style="width: 50.02%; vertical-align: bottom;">
            <div style="text-align: justify;">Interim Chief Executive Officer and President</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.98%; vertical-align: top;">&#160;</td>
          <td style="width: 50.02%; vertical-align: bottom;">
            <div style="text-align: justify; font-style: italic;">(Principal Executive Officer)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
  <div><br>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>brhc10040603_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">Exhibit 31.2</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</div>
    <div style="text-align: center; font-weight: bold;">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div><br>
    </div>
    <div style="text-align: justify;">I, Andrew Jackson, certify that:</div>
    <div><br>
    </div>
    <div>1. I have reviewed this Quarterly Report on Form 10-Q of Brooklyn ImmunoTherapeutics, Inc.</div>
    <div><br>
    </div>
    <div>2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
      misleading with respect to the period covered by this report.</div>
    <div><br>
    </div>
    <div>3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for,
      the periods presented in this report.</div>
    <div><br>
    </div>
    <div>4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
      defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
    <div>(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
      is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
    <div><br>
    </div>
    <div>(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
      preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
    <div><br>
    </div>
    <div>(c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
      report based on such evaluation; and</div>
    <div><br>
    </div>
    <div>(d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the
      registrant&#8217;s internal control over financial reporting.</div>
    <div><br>
    </div>
    <div>5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors:</div>
    <div><br>
    </div>
    <div>(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report
      financial information; and</div>
    <div><br>
    </div>
    <div>(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z36dcc4d12af44d07acd2c5b127fda413">

        <tr>
          <td style="width: 49.98%; vertical-align: top;">
            <div>Date: August 11, 2022</div>
          </td>
          <td style="width: 50.02%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: justify;">/s/ Andrew Jackson</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.98%; vertical-align: top;">&#160;</td>
          <td style="width: 50.02%; vertical-align: bottom;">
            <div style="text-align: justify;">Andrew Jackson</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.98%; vertical-align: top;">&#160;</td>
          <td style="width: 50.02%; vertical-align: bottom;">
            <div style="text-align: justify;">Chief Financial Officer</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.98%; vertical-align: top;">&#160;</td>
          <td style="width: 50.02%; vertical-align: bottom;">
            <div style="text-align: justify; font-style: italic;">(Principal Financial Officer)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>brhc10040603_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">Exhibit 32.1</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CERTIFICATION PURSUANT TO 18 U.S.C. 1350,</div>
    <div style="text-align: center; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div><br>
    </div>
    <div>In connection with the Quarterly Report on Form 10-Q of Brooklyn ImmunoTherapeutics, Inc. for the quarterly period ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned
      certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge on the date hereof:</div>
    <div><br>
    </div>
    <div>1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
    <div><br>
    </div>
    <div>2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Brooklyn ImmunoTherapeutics, Inc. for the period presented therein.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z7a426cd0b2e14eb98e0c6fc6e41843d0">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>Date: August 11, 2022</div>
          </td>
          <td style="width: 50%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify;">/s/ Matthew Angel</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: justify;">Matthew Angel</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: justify;">Interim Chief Executive Officer and President</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: justify; font-style: italic;">(Principal Executive Officer)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify;">The foregoing certification is being furnished solely pursuant to 18 U.S.C. &#167; 1350 and is not being filed as part of the Report or as a separate disclosure document.</div>
  </div>
  <div>
    <div><br>
    </div>
    <div><br>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>brhc10040603_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">Exhibit 32.2</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CERTIFICATION PURSUANT TO 18 U.S.C. 1350,</div>
    <div style="text-align: center; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div><br>
    </div>
    <div>In connection with the Quarterly Report on Form 10-Q of Brooklyn ImmunoTherapeutics, Inc. for the quarterly period ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned
      certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge on the date hereof:</div>
    <div><br>
    </div>
    <div>1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
    <div><br>
    </div>
    <div>2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Brooklyn ImmunoTherapeutics, Inc. for the period presented therein.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0bc0acc09755490f99ca9d9b60faa62f">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>Date: August 11, 2022</div>
          </td>
          <td style="width: 50%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: justify;">/s/ Andrew Jackson</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: justify;">Andrew Jackson</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: justify;">Chief Financial Officer</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: justify; font-style: italic;">(Principal Financial Officer)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify;">The foregoing certification is being furnished solely pursuant to 18 U.S.C. &#167; 1350 and is not being filed as part of the Report or as a separate disclosure document.</div>
  </div>
  <div><br>
  </div>
  <div><br>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>btx-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<xs:schema targetNamespace="http://brooklynitx.com/20220630" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:btx="http://brooklynitx.com/20220630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
        <link:definition>010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
        <!--Parent Role: CONDENSED CONSOLIDATED BALANCE SHEETS-->
        <link:definition>010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
        <link:definition>020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity" id="CondensedConsolidatedStatementsOfStockholdersAndMembersEquity">
        <link:definition>030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
        <link:definition>040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation" id="DescriptionOfBusinessAndBasisOfPresentation">
        <link:definition>060100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResources" id="LiquidityAndCapitalResources">
        <link:definition>060200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions" id="MergerDispositionAndAcquisitionTransactions">
        <link:definition>060300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstruments" id="FairValueOfFinancialInstruments">
        <link:definition>060400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/Leases" id="Leases">
        <link:definition>060500 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwill" id="InprocessResearchDevelopmentAndGoodwill">
        <link:definition>060600 - Disclosure - IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CeoSeparationAgreement" id="CeoSeparationAgreement">
        <link:definition>060700 - Disclosure - CEO SEPARATION AGREEMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/AccruedExpenses" id="AccruedExpenses">
        <link:definition>060800 - Disclosure - ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>060900 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensation" id="StockbasedCompensation">
        <link:definition>061000 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockholdersEquity" id="StockholdersEquity">
        <link:definition>061100 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/EarningsPerShare" id="EarningsPerShare">
        <link:definition>061200 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/RecentAccountingPronouncements" id="RecentAccountingPronouncements">
        <link:definition>061300 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/SubsequentEvent" id="SubsequentEvent">
        <link:definition>061400 - Disclosure - SUBSEQUENT EVENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" id="DescriptionOfBusinessAndBasisOfPresentationPolicies">
        <!--Parent Role: DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION-->
        <link:definition>070100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies" id="RecentAccountingPronouncementsPolicies">
        <!--Parent Role: RECENT ACCOUNTING PRONOUNCEMENTS-->
        <link:definition>071300 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables" id="MergerDispositionAndAcquisitionTransactionsTables">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>080300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables" id="FairValueOfFinancialInstrumentsTables">
        <!--Parent Role: FAIR VALUE OF FINANCIAL INSTRUMENTS-->
        <link:definition>080400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesTables" id="LeasesTables">
        <!--Parent Role: LEASES-->
        <link:definition>080500 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
        <!--Parent Role: ACCRUED EXPENSES-->
        <link:definition>080800 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationTables" id="StockbasedCompensationTables">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>081000 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/EarningsPerShareTables" id="EarningsPerShareTables">
        <!--Parent Role: EARNINGS PER SHARE-->
        <link:definition>081200 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails" id="DescriptionOfBusinessAndBasisOfPresentationDetails">
        <!--Parent Role: DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION-->
        <link:definition>090100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails" id="LiquidityAndCapitalResourcesDetails">
        <!--Parent Role: LIQUIDITY AND CAPITAL RESOURCES-->
        <link:definition>090200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails" id="MergerDispositionAndAcquisitionTransactionsMergerDetails">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>090300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" id="MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>090302 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails" id="MergerDispositionAndAcquisitionTransactionsDispositionDetails">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>090304 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" id="MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>090306 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" id="MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails">
        <!--Parent Role: MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS-->
        <link:definition>090308 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" id="FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
        <!--Parent Role: FAIR VALUE OF FINANCIAL INSTRUMENTS-->
        <link:definition>090400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" id="FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
        <!--Parent Role: FAIR VALUE OF FINANCIAL INSTRUMENTS-->
        <link:definition>090402 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseDetails" id="LeasesOperatingLeaseDetails">
        <!--Parent Role: LEASES-->
        <link:definition>090500 - Disclosure - LEASES, Operating Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails" id="LeasesNetOperatingLeaseExpensesDetails">
        <!--Parent Role: LEASES-->
        <link:definition>090502 - Disclosure - LEASES, Net Operating Lease Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" id="LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails">
        <!--Parent Role: LEASES-->
        <link:definition>090504 - Disclosure - LEASES, Operating Lease Right-of-use Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" id="LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
        <!--Parent Role: LEASES-->
        <link:definition>090506 - Disclosure - LEASES, Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" id="LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2">
        <!--Parent Role: LEASES, Maturities of Operating Lease Liabilities (Details)-->
        <link:definition>090508 - Disclosure - LEASES, Maturities of Operating Lease Liabilities (Details) Calc 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails" id="InprocessResearchDevelopmentAndGoodwillDetails">
        <!--Parent Role: IN-PROCESS RESEARCH & DEVELOPMENT AND GOODWILL-->
        <link:definition>090600 - Disclosure - IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CeoSeparationAgreementDetails" id="CeoSeparationAgreementDetails">
        <!--Parent Role: CEO SEPARATION AGREEMENT-->
        <link:definition>090700 - Disclosure - CEO SEPARATION AGREEMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
        <!--Parent Role: ACCRUED EXPENSES-->
        <link:definition>090800 - Disclosure - ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails" id="CommitmentsAndContingenciesLegalMattersDetails">
        <!--Parent Role: COMMITMENTS AND CONTINGENCIES-->
        <link:definition>090900 - Disclosure - COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" id="CommitmentsAndContingenciesLicensingAgreementsDetails">
        <!--Parent Role: COMMITMENTS AND CONTINGENCIES-->
        <link:definition>090902 - Disclosure - COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails" id="CommitmentsAndContingenciesRoyaltyAgreementsDetails">
        <!--Parent Role: COMMITMENTS AND CONTINGENCIES-->
        <link:definition>090904 - Disclosure - COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails" id="StockbasedCompensationStockOptionActivityDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>091000 - Disclosure - STOCK-BASED COMPENSATION, Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails" id="StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>091002 - Disclosure - STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Stock Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" id="StockbasedCompensationSummaryOfStockOptionsDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>091004 - Disclosure - STOCK-BASED COMPENSATION, Summary of Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationRsusDetails" id="StockbasedCompensationRsusDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>091006 - Disclosure - STOCK-BASED COMPENSATION, RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails" id="StockbasedCompensationNumberOfRsusVestedAndSettledDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>091008 - Disclosure - STOCK-BASED COMPENSATION, Number of RSUs Vested and Settled (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails" id="StockbasedCompensationSummaryOfRsusDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>091010 - Disclosure - STOCK-BASED COMPENSATION, Summary of RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails" id="StockbasedCompensationRestrictedStockDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>091012 - Disclosure - STOCK-BASED COMPENSATION, Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails" id="StockbasedCompensationStockbasedCompensationExpenseDetails">
        <!--Parent Role: STOCK-BASED COMPENSATION-->
        <link:definition>091014 - Disclosure - STOCK-BASED COMPENSATION, Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails" id="StockholdersEquityPrivatePlacementOfEquityDetails">
        <!--Parent Role: STOCKHOLDERS' EQUITY-->
        <link:definition>091100 - Disclosure - STOCKHOLDERS' EQUITY, Private Placement of Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/StockholdersEquityMergerDetails" id="StockholdersEquityMergerDetails">
        <!--Parent Role: STOCKHOLDERS' EQUITY-->
        <link:definition>091104 - Disclosure - STOCKHOLDERS' EQUITY, Merger (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/EarningsPerShareDetails" id="EarningsPerShareDetails">
        <!--Parent Role: EARNINGS PER SHARE-->
        <link:definition>091200 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://brooklynitx.com/role/SubsequentEventDetails" id="SubsequentEventDetails">
        <!--Parent Role: SUBSEQUENT EVENT-->
        <link:definition>091400 - Disclosure - SUBSEQUENT EVENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" id="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PaymentsOfPaycheckProtectionProgramLoan" id="btx_PaymentsOfPaycheckProtectionProgramLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="CashPaidDuringThePeriodForAbstract" id="btx_CashPaidDuringThePeriodForAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="GainOnTerminationOfLease" id="btx_GainOnTerminationOfLease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="LossOnNonControllingInvestment" id="btx_LossOnNonControllingInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="WarrantLiabilitiesExpense" id="btx_WarrantLiabilitiesExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" id="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IncreaseDecreaseInOperatingLeaseLiabilities" id="btx_IncreaseDecreaseInOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="GainLossOnDisposalOfFixedAssets" id="btx_GainLossOnDisposalOfFixedAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="InitialMeasurementOfRightOfUseAssetsAndLiabilities" id="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ProceedsFromIssuanceOfCommonStockToLincolnPark" id="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" id="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PercentageOfAdditionalRightsOffering" id="btx_PercentageOfAdditionalRightsOffering" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ProceedsFromSaleOfRights" id="btx_ProceedsFromSaleOfRights" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" id="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BeneficialHoldersContractualCommitmentsToInvest" id="btx_BeneficialHoldersContractualCommitmentsToInvest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ProFormaFairValueAdjustmentToAssetsMember" id="btx_ProFormaFairValueAdjustmentToAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PurchasePriceAllocationMember" id="btx_PurchasePriceAllocationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" id="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NTNBuzztimeIncMember" id="btx_NTNBuzztimeIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DispositionAbstract" id="btx_DispositionAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" id="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" id="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" id="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ProceedsFromDispositionAbstract" id="btx_ProceedsFromDispositionAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NTNBusinessMember" id="btx_NTNBusinessMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" id="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NoveCiteINCMember" id="btx_NoveCiteINCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NovellusTherapeuticsLimitedMember" id="btx_NovellusTherapeuticsLimitedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" id="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodRestrictedSharesAcquisitions" id="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfDiscountOnFairValueOfRestrictedShares" id="btx_PercentageOfDiscountOnFairValueOfRestrictedShares" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AssetAcquisitionRestrictedSharesSharePrice" id="btx_AssetAcquisitionRestrictedSharesSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="EachLockUpAgreementExtendsTerm" id="btx_EachLockUpAgreementExtendsTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PaymentsToAcquireProductiveAssetsNet" id="btx_PaymentsToAcquireProductiveAssetsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="LockUpPeriodForRestrictedShares" id="btx_LockUpPeriodForRestrictedShares" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AcquisitionAgreementNonCompetitivePeriod" id="btx_AcquisitionAgreementNonCompetitivePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AssetAcquisitionSharePrice" id="btx_AssetAcquisitionSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="EscrowShares" id="btx_EscrowShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ResearchAndDevelopmentInProcessAssetAcquisition" id="btx_ResearchAndDevelopmentInProcessAssetAcquisition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="AssetAcquisitionFairValueOfConsiderationPaid" id="btx_AssetAcquisitionFairValueOfConsiderationPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="EscrowPeriod" id="btx_EscrowPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfCommonStockSubjectToLockUpAgreement" id="btx_PercentageOfCommonStockSubjectToLockUpAgreement" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AssetAcquisitionUnrestrictedSharesSharePrice" id="btx_AssetAcquisitionUnrestrictedSharesSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" id="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" id="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NovellusIncMember" id="btx_NovellusIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" id="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfBoardSeats" id="btx_NumberOfBoardSeats" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CitiusPharmaceuticalsIncMember" id="btx_CitiusPharmaceuticalsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LIQUIDITYANDCAPITALRESOURCESAbstract" id="btx_LIQUIDITYANDCAPITALRESOURCESAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LiquidityAndCapitalResourcesTextBlock" id="btx_LiquidityAndCapitalResourcesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RoyaltyAgreementsAbstract" id="btx_RoyaltyAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" id="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" id="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="InvestorRoyaltyAgreementMember" id="btx_InvestorRoyaltyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CollaboratorRoyaltyAgreementMember" id="btx_CollaboratorRoyaltyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LicensingAgreementsAbstract" id="btx_LicensingAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LossContingencyNonRefundableOptionFee" id="btx_LossContingencyNonRefundableOptionFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="InitialLicenseFees" id="btx_InitialLicenseFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="AdditionalFeesObligatedToPay" id="btx_AdditionalFeesObligatedToPay" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="MilestonePayments" id="btx_MilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="UniversityOfSouthFloridaMember" id="btx_UniversityOfSouthFloridaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AmountObligatedToPayInYearTwo" id="btx_AmountObligatedToPayInYearTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="LossContingencyPercentageOfRoyaltyPayable" id="btx_LossContingencyPercentageOfRoyaltyPayable" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AmountObligatedToPayInYearOne" id="btx_AmountObligatedToPayInYearOne" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PercentageOfRevenue" id="btx_PercentageOfRevenue" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NovellusLtdAndFactorBioscienceMember" id="btx_NovellusLtdAndFactorBioscienceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NoveCiteMember" id="btx_NoveCiteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AmountRequireToPayInitialLicenseFees" id="btx_AmountRequireToPayInitialLicenseFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DheshGovenderMember" id="btx_DheshGovenderMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LegalMattersAbstract" id="btx_LegalMattersAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LossContingencyDamagesSoughtExpectedSalary" id="btx_LossContingencyDamagesSoughtExpectedSalary" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="LossContingencyNumberOfArbitrationPanel" id="btx_LossContingencyNumberOfArbitrationPanel" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LossContingencyDamagesSoughtExpectedEquityPercentage" id="btx_LossContingencyDamagesSoughtExpectedEquityPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PreFundedWarrantsMember" id="btx_PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PrivatePlacementOfEquityAbstract" id="btx_PrivatePlacementOfEquityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ObligationToPayLiquidatedDamagesPercentage" id="btx_ObligationToPayLiquidatedDamagesPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="TransactionFeesPayable" id="btx_TransactionFeesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="OverSubscriptionAmountReceived" id="btx_OverSubscriptionAmountReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" id="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="VariableRateTransactionsPeriod" id="btx_VariableRateTransactionsPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CommonWarrantsMember" id="btx_CommonWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" id="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PIPEInvestorMember" id="btx_PIPEInvestorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRightsExercisableTerm" id="btx_ClassOfWarrantOrRightsExercisableTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ConsecutiveCalendarDays" id="btx_ConsecutiveCalendarDays" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AggregateCalendarDays" id="btx_AggregateCalendarDays" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfAwardsVestedAndSettledAbstract" id="btx_NumberOfAwardsVestedAndSettledAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CommonStockWithheldToCoverTaxes" id="btx_CommonStockWithheldToCoverTaxes" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CEOSEPARATIONAGREEMENTAbstract" id="btx_CEOSEPARATIONAGREEMENTAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ChiefExecutiveOfficerSeparationAgreementTextBlock" id="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SeparationAgreementAbstract" id="btx_SeparationAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" id="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PaymentToOfficerBaseSalary" id="btx_PaymentToOfficerBaseSalary" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="MilestoneOptionsMember" id="btx_MilestoneOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MergerAbstract" id="btx_MergerAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClassOfWarrantOrRightIssued" id="btx_ClassOfWarrantOrRightIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="StockIssuedDuringPeriodSharesAcquisitions1" id="btx_StockIssuedDuringPeriodSharesAcquisitions1" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" id="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AccruedResearchAndDevelopmentExpenses" id="btx_AccruedResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="AccruedGeneralAndAdministrativeExpenses" id="btx_AccruedGeneralAndAdministrativeExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ClassOfWarrantOrRightExercised" id="btx_ClassOfWarrantOrRightExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" id="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" id="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" id="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="InitialMeasurementOfOperatingLeaseLiabilities" id="btx_InitialMeasurementOfOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PrincipalPaymentsOnOperatingLeaseLiabilities" id="btx_PrincipalPaymentsOnOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="WriteOffOfOperatingLeaseLiability" id="btx_WriteOffOfOperatingLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="OperatingLeaseAssestAbstract" id="btx_OperatingLeaseAssestAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="WriteOffOfOperatingLeaseRightOfUseAsset" id="btx_WriteOffOfOperatingLeaseRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="InitialMeasurementOfOperatingLeaseROUAssets" id="btx_InitialMeasurementOfOperatingLeaseROUAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="PercentageBaseRentIncreaseOnEachAnniversary" id="btx_PercentageBaseRentIncreaseOnEachAnniversary" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="BaseRentPerSquareFoot" id="btx_BaseRentPerSquareFoot" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LesseeCommitmentToPurchaseProperty" id="btx_LesseeCommitmentToPurchaseProperty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="UnamortizedLeaseholdImprovements" id="btx_UnamortizedLeaseholdImprovements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="OperatingLeaseArea" id="btx_OperatingLeaseArea" type="dtr-types:areaItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PerformanceBasedStockOptionGrantMember" id="btx_PerformanceBasedStockOptionGrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TimeBasedStockOptionGrantMember" id="btx_TimeBasedStockOptionGrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfPerformanceGoalsAreSubjectToAchieve" id="btx_NumberOfPerformanceGoalsAreSubjectToAchieve" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmployeeMember" id="btx_EmployeeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ChiefExecutiveOfficerAndPresidentMember" id="btx_ChiefExecutiveOfficerAndPresidentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="Two022PerformanceBasedRestrictedStockUnitsMember" id="btx_Two022PerformanceBasedRestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" id="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" id="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" id="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CommonStockToBeRetainedByNTNValueStockholders" id="btx_CommonStockToBeRetainedByNTNValueStockholders" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="CommonStockToBeRetainedByNTNSharesStockholders" id="btx_CommonStockToBeRetainedByNTNSharesStockholders" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValueStockPurchaseAgreement" id="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodSharesStockPurchaseAgreement" id="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValueInLieuOfDividends" id="btx_StockIssuedDuringPeriodValueInLieuOfDividends" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodSharesInLieuOfDividends" id="btx_StockIssuedDuringPeriodSharesInLieuOfDividends" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CommonUnitsMember" id="btx_CommonUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodSharesPrivateOffering" id="btx_StockIssuedDuringPeriodSharesPrivateOffering" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" id="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="StockIssuedDuringPeriodValueAcquisitions1" id="btx_StockIssuedDuringPeriodValueAcquisitions1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" id="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="StockIssuedDuringPeriodValuePrivateOffering" id="btx_StockIssuedDuringPeriodValuePrivateOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" id="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="MembershipEquityMember" id="btx_MembershipEquityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" id="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" id="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" id="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>btx-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedBalanceSheets" />
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="calculation: Assets to OperatingLeaseRightOfUseAsset" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="calculation: Assets to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="Cash" xlink:title="calculation: AssetsCurrent to Cash" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="calculation: AssetsCurrent to PrepaidExpenseAndOtherAssetsCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="OtherReceivablesNetCurrent" xlink:title="calculation: AssetsCurrent to OtherReceivablesNetCurrent" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="AssetsCurrent" xlink:title="calculation: Assets to AssetsCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositAssets" xlink:label="DepositAssets" xlink:title="DepositAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="DepositAssets" xlink:title="calculation: Assets to DepositAssets" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="calculation: Assets to PropertyPlantAndEquipmentNet" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="EquityMethodInvestments" xlink:title="calculation: Assets to EquityMethodInvestments" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="Goodwill" xlink:title="calculation: Assets to Goodwill" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="AdditionalPaidInCapital" xlink:title="calculation: StockholdersEquity to AdditionalPaidInCapital" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="CommonStockValue" xlink:title="calculation: StockholdersEquity to CommonStockValue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="PreferredStockValue" xlink:title="calculation: StockholdersEquity to PreferredStockValue" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="calculation: StockholdersEquity to RetainedEarningsAccumulatedDeficit" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="StockholdersEquity" xlink:title="calculation: LiabilitiesAndStockholdersEquity to StockholdersEquity" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="calculation: Liabilities to OperatingLeaseLiabilityNoncurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="calculation: LiabilitiesCurrent to OperatingLeaseLiabilityCurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableCurrent" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccruedLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to AccruedLiabilitiesCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OtherLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to OtherLiabilitiesCurrent" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LiabilitiesCurrent" xlink:title="calculation: Liabilities to LiabilitiesCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to OtherLiabilitiesNoncurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to DerivativeLiabilitiesNoncurrent" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="Liabilities" xlink:title="calculation: LiabilitiesAndStockholdersEquity to Liabilities" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="PreferredStockDividendsAndOtherAdjustments" xlink:title="PreferredStockDividendsAndOtherAdjustments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="PreferredStockDividendsAndOtherAdjustments" xlink:title="calculation: NetIncomeLossAvailableToCommonStockholdersBasic to PreferredStockDividendsAndOtherAdjustments" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="NoncashMergerRelatedCosts" xlink:title="calculation: OperatingExpenses to NoncashMergerRelatedCosts" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="ImpairmentOfOngoingProject" xlink:title="calculation: OperatingExpenses to ImpairmentOfOngoingProject" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="ResearchAndDevelopmentExpense" xlink:title="calculation: OperatingExpenses to ResearchAndDevelopmentExpense" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="GeneralAndAdministrativeExpense" xlink:title="calculation: OperatingExpenses to GeneralAndAdministrativeExpense" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="OperatingExpenses" xlink:title="calculation: OperatingIncomeLoss to OperatingExpenses" order="0.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="OperatingIncomeLoss" xlink:title="calculation: NetIncomeLoss to OperatingIncomeLoss" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="GainLossOnDispositionOfAssets1" xlink:title="calculation: NonoperatingIncomeExpense to GainLossOnDispositionOfAssets1" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="calculation: NonoperatingIncomeExpense to OtherNonoperatingIncomeExpense" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="LossOnNonControllingInvestment" xlink:title="calculation: NonoperatingIncomeExpense to LossOnNonControllingInvestment" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="WarrantLiabilitiesExpense" xlink:title="calculation: NonoperatingIncomeExpense to WarrantLiabilitiesExpense" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="NonoperatingIncomeExpense" xlink:title="calculation: NetIncomeLoss to NonoperatingIncomeExpense" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="NetIncomeLoss" xlink:title="calculation: NetIncomeLossAvailableToCommonStockholdersBasic to NetIncomeLoss" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ShareBasedCompensation" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnDispositionOfAssets1" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnDispositionOfAssets1" order="7.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnDisposalOfFixedAssets" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="NetIncomeLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to NetIncomeLoss" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="WarrantLiabilitiesExpense" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to WarrantLiabilitiesExpense" order="10.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DepreciationDepletionAndAmortization" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DepreciationDepletionAndAmortization" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherReceivables" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherReceivables" order="12.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="NoncashMergerRelatedCosts" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to NoncashMergerRelatedCosts" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="13.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:label="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:title="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" order="14.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOperatingLeaseLiabilities" order="16.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingLiabilities" order="17.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="LossOnNonControllingInvestment" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to LossOnNonControllingInvestment" order="11.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to OperatingLeaseRightOfUseAssetAmortizationExpense" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="15.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainOnTerminationOfLease" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainOnTerminationOfLease" order="9.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to OperatingLeaseImpairmentLoss" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ImpairmentOfOngoingProject" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ImpairmentOfOngoingProject" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInOperatingActivities" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromIssuanceOfCommonStock" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PaymentsOfPaycheckProtectionProgramLoan" xlink:label="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="PaymentsOfPaycheckProtectionProgramLoan" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfPaycheckProtectionProgramLoan" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="ProceedsFromOtherEquity" xlink:title="ProceedsFromOtherEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromOtherEquity" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromOtherEquity" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:label="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:title="ProceedsFromIssuanceOfCommonStockToLincolnPark" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromIssuanceOfCommonStockToLincolnPark" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="5.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="PaymentsOfDividendsPreferredStockAndPreferenceStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsPreferredStockAndPreferenceStock" order="6.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" xlink:label="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" xlink:title="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" order="8.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromStockOptionsExercised" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromStockOptionsExercised" order="9.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInFinancingActivities" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromDivestitureOfBusinesses" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:label="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="ProceedsFromSalesOfAssetsInvestingActivities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSalesOfAssetsInvestingActivities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSaleOfPropertyPlantAndEquipment" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to NetCashProvidedByUsedInInvestingActivities" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="CashAcquiredFromAcquisition" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to CashAcquiredFromAcquisition" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to PaymentsToAcquireProductiveAssets" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="calculation: AssetAcquisitionFairValueOfConsiderationPaid to StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="SubleaseIncome" xlink:title="calculation: LeaseCost to SubleaseIncome" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="VariableLeaseCost" xlink:title="calculation: LeaseCost to VariableLeaseCost" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="OperatingLeaseCost" xlink:title="calculation: LeaseCost to OperatingLeaseCost" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="OperatingLeaseLiability" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to OperatingLeaseLiability" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to EmployeeRelatedLiabilitiesCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AccruedResearchAndDevelopmentExpenses" xlink:label="AccruedResearchAndDevelopmentExpenses" xlink:title="AccruedResearchAndDevelopmentExpenses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedResearchAndDevelopmentExpenses" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedResearchAndDevelopmentExpenses" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AccruedGeneralAndAdministrativeExpenses" xlink:label="AccruedGeneralAndAdministrativeExpenses" xlink:title="AccruedGeneralAndAdministrativeExpenses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedGeneralAndAdministrativeExpenses" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedGeneralAndAdministrativeExpenses" order="1.0" weight="1.0" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>btx-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://brooklynitx.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#SubsequentEventDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquityMergerDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockholdersEquityMergerDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockholdersEquityPrivatePlacementOfEquityDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationStockbasedCompensationExpenseDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationRestrictedStockDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationSummaryOfRsusDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationNumberOfRsusVestedAndSettledDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationRsusDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationRsusDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationSummaryOfStockOptionsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationStockOptionActivityDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#CommitmentsAndContingenciesRoyaltyAgreementsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#CommitmentsAndContingenciesLicensingAgreementsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#CommitmentsAndContingenciesLegalMattersDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CeoSeparationAgreementDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#CeoSeparationAgreementDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#InprocessResearchDevelopmentAndGoodwillDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesOperatingLeaseDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsDispositionDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsMergerDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LiquidityAndCapitalResourcesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#DescriptionOfBusinessAndBasisOfPresentationDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="btx-20220630.xsd#EarningsPerShareTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="btx-20220630.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesTables" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables" xlink:type="simple" xlink:href="btx-20220630.xsd#FairValueOfFinancialInstrumentsTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="btx-20220630.xsd#RecentAccountingPronouncementsPolicies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:type="simple" xlink:href="btx-20220630.xsd#DescriptionOfBusinessAndBasisOfPresentationPolicies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/SubsequentEvent" xlink:type="simple" xlink:href="btx-20220630.xsd#SubsequentEvent" />
  <link:roleRef roleURI="http://brooklynitx.com/role/RecentAccountingPronouncements" xlink:type="simple" xlink:href="btx-20220630.xsd#RecentAccountingPronouncements" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShare" xlink:type="simple" xlink:href="btx-20220630.xsd#EarningsPerShare" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquity" xlink:type="simple" xlink:href="btx-20220630.xsd#StockholdersEquity" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensation" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="btx-20220630.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpenses" xlink:type="simple" xlink:href="btx-20220630.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CeoSeparationAgreement" xlink:type="simple" xlink:href="btx-20220630.xsd#CeoSeparationAgreement" />
  <link:roleRef roleURI="http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwill" xlink:type="simple" xlink:href="btx-20220630.xsd#InprocessResearchDevelopmentAndGoodwill" />
  <link:roleRef roleURI="http://brooklynitx.com/role/Leases" xlink:type="simple" xlink:href="btx-20220630.xsd#Leases" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstruments" xlink:type="simple" xlink:href="btx-20220630.xsd#FairValueOfFinancialInstruments" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactions" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResources" xlink:type="simple" xlink:href="btx-20220630.xsd#LiquidityAndCapitalResources" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" xlink:href="btx-20220630.xsd#DescriptionOfBusinessAndBasisOfPresentation" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedStatementsOfStockholdersAndMembersEquity" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="btx-20220630.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DocumentAndEntityInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsAbstract" xlink:title="definition: StatementLineItems to AssetsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="definition: StatementLineItems to LiabilitiesAndStockholdersEquityAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesCurrentAbstract" xlink:title="definition: StatementLineItems to LiabilitiesCurrentAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="definition: StatementLineItems to DerivativeLiabilitiesNoncurrent" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="definition: StatementLineItems to OperatingLeaseLiabilityNoncurrent" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="definition: StatementLineItems to OtherLiabilitiesNoncurrent" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Liabilities" xlink:title="definition: StatementLineItems to Liabilities" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="EquityAbstract" xlink:title="definition: StatementLineItems to EquityAbstract" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="definition: StatementLineItems to LiabilitiesAndStockholdersEquity" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PreferredStockValue" xlink:title="definition: StatementLineItems to PreferredStockValue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CommonStockValue" xlink:title="definition: StatementLineItems to CommonStockValue" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdditionalPaidInCapital" xlink:title="definition: StatementLineItems to AdditionalPaidInCapital" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="definition: StatementLineItems to RetainedEarningsAccumulatedDeficit" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquity" xlink:title="definition: StatementLineItems to StockholdersEquity" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AccountsPayableCurrent" xlink:title="definition: StatementLineItems to AccountsPayableCurrent" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AccruedLiabilitiesCurrent" xlink:title="definition: StatementLineItems to AccruedLiabilitiesCurrent" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="definition: StatementLineItems to OperatingLeaseLiabilityCurrent" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherLiabilitiesCurrent" xlink:title="definition: StatementLineItems to OtherLiabilitiesCurrent" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LiabilitiesCurrent" xlink:title="definition: StatementLineItems to LiabilitiesCurrent" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsCurrentAbstract" xlink:title="definition: StatementLineItems to AssetsCurrentAbstract" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Cash" xlink:title="definition: StatementLineItems to Cash" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherReceivablesNetCurrent" xlink:title="definition: StatementLineItems to OtherReceivablesNetCurrent" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="definition: StatementLineItems to PrepaidExpenseAndOtherAssetsCurrent" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AssetsCurrent" xlink:title="definition: StatementLineItems to AssetsCurrent" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="definition: StatementLineItems to PropertyPlantAndEquipmentNet" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="definition: StatementLineItems to OperatingLeaseRightOfUseAsset" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Goodwill" xlink:title="definition: StatementLineItems to Goodwill" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="definition: StatementLineItems to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="EquityMethodInvestments" xlink:title="definition: StatementLineItems to EquityMethodInvestments" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositAssets" xlink:label="DepositAssets" xlink:title="DepositAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DepositAssets" xlink:title="definition: StatementLineItems to DepositAssets" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="Assets" xlink:title="definition: StatementLineItems to Assets" order="31.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="32.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: StatementTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="definition: ClassOfStockDomain to SeriesAPreferredStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="definition: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquity" xlink:title="definition: StatementLineItems to StockholdersEquity" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesOutstanding" xlink:title="definition: StatementLineItems to SharesOutstanding" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:label="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:label="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueAcquisitions1" xlink:label="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="StockIssuedDuringPeriodValueAcquisitions1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueAcquisitions1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesAcquisitions1" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountAcquisitions" xlink:label="PartnersCapitalAccountAcquisitions" xlink:title="PartnersCapitalAccountAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PartnersCapitalAccountAcquisitions" xlink:title="definition: StatementLineItems to PartnersCapitalAccountAcquisitions" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountUnitsAcquisitions" xlink:label="PartnersCapitalAccountUnitsAcquisitions" xlink:title="PartnersCapitalAccountUnitsAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PartnersCapitalAccountUnitsAcquisitions" xlink:title="definition: StatementLineItems to PartnersCapitalAccountUnitsAcquisitions" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueAcquisitions" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesAcquisitions" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValuePrivateOffering" xlink:label="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="StockIssuedDuringPeriodValuePrivateOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValuePrivateOffering" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesPrivateOffering" xlink:label="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="StockIssuedDuringPeriodSharesPrivateOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesPrivateOffering" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonStockToBeRetainedByNTNValueStockholders" xlink:label="CommonStockToBeRetainedByNTNValueStockholders" xlink:title="CommonStockToBeRetainedByNTNValueStockholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CommonStockToBeRetainedByNTNValueStockholders" xlink:title="definition: StatementLineItems to CommonStockToBeRetainedByNTNValueStockholders" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonStockToBeRetainedByNTNSharesStockholders" xlink:label="CommonStockToBeRetainedByNTNSharesStockholders" xlink:title="CommonStockToBeRetainedByNTNSharesStockholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CommonStockToBeRetainedByNTNSharesStockholders" xlink:title="definition: StatementLineItems to CommonStockToBeRetainedByNTNSharesStockholders" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueStockOptionsExercised" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesStockOptionsExercised" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodValueStockPurchaseAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueStockPurchaseAgreement" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodSharesStockPurchaseAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesStockPurchaseAgreement" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueInLieuOfDividends" xlink:label="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:title="StockIssuedDuringPeriodValueInLieuOfDividends" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueInLieuOfDividends" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:label="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:title="StockIssuedDuringPeriodSharesInLieuOfDividends" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesInLieuOfDividends" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="definition: StatementLineItems to SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DividendsPreferredStockCash" xlink:title="definition: StatementLineItems to DividendsPreferredStockCash" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="PreferredStockDividendsShares" xlink:title="PreferredStockDividendsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PreferredStockDividendsShares" xlink:title="definition: StatementLineItems to PreferredStockDividendsShares" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: StatementLineItems to NetIncomeLoss" order="31.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="32.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: StatementTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MembershipEquityMember" xlink:label="MembershipEquityMember" xlink:title="MembershipEquityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="MembershipEquityMember" xlink:title="definition: EquityComponentDomain to MembershipEquityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="PreferredStockMember" xlink:title="definition: EquityComponentDomain to PreferredStockMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="AdditionalPaidInCapitalMember" xlink:title="definition: EquityComponentDomain to AdditionalPaidInCapitalMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="RetainedEarningsMember" xlink:title="definition: EquityComponentDomain to RetainedEarningsMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: StatementTable to StatementClassOfStockAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="definition: ClassOfStockDomain to CommonClassAMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="definition: ClassOfStockDomain to CommonClassBMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="definition: ClassOfStockDomain to CommonClassCMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonUnitsMember" xlink:label="CommonUnitsMember" xlink:title="CommonUnitsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonUnitsMember" xlink:title="definition: ClassOfStockDomain to CommonUnitsMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="definition: ClassOfStockDomain to SeriesAPreferredStockMember" order="5.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LiquidityAndCapitalResources" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstruments" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/Leases" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwill" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CeoSeparationAgreement" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpenses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquity" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShare" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/RecentAccountingPronouncements" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/SubsequentEvent" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpensesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShareTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentOwnershipPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain_2" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain_2" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="definition: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodSharesIssuedForServices" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="BusinessAcquisitionSharePrice" xlink:title="BusinessAcquisitionSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionSharePrice" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="CommonStockSharesOutstanding" xlink:title="definition: BusinessAcquisitionLineItems to CommonStockSharesOutstanding" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="Goodwill" xlink:title="definition: BusinessAcquisitionLineItems to Goodwill" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:label="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="definition: BusinessAcquisitionLineItems to ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_BeneficialHoldersContractualCommitmentsToInvest" xlink:label="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="BeneficialHoldersContractualCommitmentsToInvest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="definition: BusinessAcquisitionLineItems to BeneficialHoldersContractualCommitmentsToInvest" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfAdditionalRightsOffering" xlink:label="PercentageOfAdditionalRightsOffering" xlink:title="PercentageOfAdditionalRightsOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfAdditionalRightsOffering" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfAdditionalRightsOffering" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProceedsFromSaleOfRights" xlink:label="ProceedsFromSaleOfRights" xlink:title="ProceedsFromSaleOfRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ProceedsFromSaleOfRights" xlink:title="definition: BusinessAcquisitionLineItems to ProceedsFromSaleOfRights" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="Goodwill" xlink:title="definition: BusinessAcquisitionLineItems to Goodwill" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="16.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="NonrecurringAdjustmentAxis" xlink:title="NonrecurringAdjustmentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="NonrecurringAdjustmentAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to NonrecurringAdjustmentAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain" xlink:title="NonrecurringAdjustmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="NonrecurringAdjustmentAxis" xlink:to="NonrecurringAdjustmentDomain" xlink:title="definition: NonrecurringAdjustmentAxis to NonrecurringAdjustmentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain_2" xlink:title="NonrecurringAdjustmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="NonrecurringAdjustmentAxis" xlink:to="NonrecurringAdjustmentDomain_2" xlink:title="definition: NonrecurringAdjustmentAxis to NonrecurringAdjustmentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProFormaFairValueAdjustmentToAssetsMember" xlink:label="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="ProFormaFairValueAdjustmentToAssetsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NonrecurringAdjustmentDomain" xlink:to="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="definition: NonrecurringAdjustmentDomain to ProFormaFairValueAdjustmentToAssetsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PurchasePriceAllocationMember" xlink:label="PurchasePriceAllocationMember" xlink:title="PurchasePriceAllocationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="NonrecurringAdjustmentDomain" xlink:to="PurchasePriceAllocationMember" xlink:title="definition: NonrecurringAdjustmentDomain to PurchasePriceAllocationMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DispositionAbstract" xlink:label="DispositionAbstract" xlink:title="DispositionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DispositionAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DispositionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:label="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProceedsFromDispositionAbstract" xlink:label="ProceedsFromDispositionAbstract" xlink:title="ProceedsFromDispositionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="ProceedsFromDispositionAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to ProceedsFromDispositionAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationTransactionCosts" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:label="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:label="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationLeaseLiability" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="DisposalGroupIncludingDiscontinuedOperationGoodwill1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationGoodwill1" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationOtherAssets" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="25.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to DisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NTNBusinessMember" xlink:label="NTNBusinessMember" xlink:title="NTNBusinessMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="NTNBusinessMember" xlink:title="definition: DisposalGroupsIncludingDiscontinuedOperationsNameDomain to NTNBusinessMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentOwnershipPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="PaymentsToAcquireOtherProductiveAssets" xlink:title="PaymentsToAcquireOtherProductiveAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireOtherProductiveAssets" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireOtherProductiveAssets" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodSharesAcquisitions" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodValueAcquisitions" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionSharePrice" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodValueNewIssues" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodValueNewIssues" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EscrowShares" xlink:label="EscrowShares" xlink:title="EscrowShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EscrowShares" xlink:title="definition: BusinessAcquisitionLineItems to EscrowShares" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EscrowPeriod" xlink:label="EscrowPeriod" xlink:title="EscrowPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EscrowPeriod" xlink:title="definition: BusinessAcquisitionLineItems to EscrowPeriod" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AcquisitionAgreementNonCompetitivePeriod" xlink:label="AcquisitionAgreementNonCompetitivePeriod" xlink:title="AcquisitionAgreementNonCompetitivePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AcquisitionAgreementNonCompetitivePeriod" xlink:title="definition: BusinessAcquisitionLineItems to AcquisitionAgreementNonCompetitivePeriod" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodSharesIssuedForServices" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EachLockUpAgreementExtendsTerm" xlink:label="EachLockUpAgreementExtendsTerm" xlink:title="EachLockUpAgreementExtendsTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EachLockUpAgreementExtendsTerm" xlink:title="definition: BusinessAcquisitionLineItems to EachLockUpAgreementExtendsTerm" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfCommonStockSubjectToLockUpAgreement" xlink:label="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="PercentageOfCommonStockSubjectToLockUpAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfCommonStockSubjectToLockUpAgreement" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PaymentsToAcquireProductiveAssetsNet" xlink:label="PaymentsToAcquireProductiveAssetsNet" xlink:title="PaymentsToAcquireProductiveAssetsNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireProductiveAssetsNet" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireProductiveAssetsNet" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodRestrictedSharesAcquisitions" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LockUpPeriodForRestrictedShares" xlink:label="LockUpPeriodForRestrictedShares" xlink:title="LockUpPeriodForRestrictedShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="LockUpPeriodForRestrictedShares" xlink:title="definition: BusinessAcquisitionLineItems to LockUpPeriodForRestrictedShares" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionUnrestrictedSharesSharePrice" xlink:label="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="AssetAcquisitionUnrestrictedSharesSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionUnrestrictedSharesSharePrice" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:label="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="PercentageOfDiscountOnFairValueOfRestrictedShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfDiscountOnFairValueOfRestrictedShares" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionRestrictedSharesSharePrice" xlink:label="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="AssetAcquisitionRestrictedSharesSharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionRestrictedSharesSharePrice" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireProductiveAssets" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="CashAcquiredFromAcquisition" xlink:title="definition: BusinessAcquisitionLineItems to CashAcquiredFromAcquisition" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="definition: BusinessAcquisitionLineItems to StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="definition: BusinessAcquisitionLineItems to AssetAcquisitionFairValueOfConsiderationPaid" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="PaymentsToAcquireInvestments" xlink:title="PaymentsToAcquireInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireInvestments" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireInvestments" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="definition: BusinessAcquisitionLineItems to ResearchAndDevelopmentInProcessAssetAcquisition" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="28.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain_2" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain_2" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="definition: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="AssetAcquisitionAxis" xlink:title="AssetAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="AssetAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to AssetAcquisitionAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain" xlink:title="AssetAcquisitionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AssetAcquisitionAxis" xlink:to="AssetAcquisitionDomain" xlink:title="definition: AssetAcquisitionAxis to AssetAcquisitionDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain_2" xlink:title="AssetAcquisitionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AssetAcquisitionAxis" xlink:to="AssetAcquisitionDomain_2" xlink:title="definition: AssetAcquisitionAxis to AssetAcquisitionDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="definition: AssetAcquisitionDomain to NovellusTherapeuticsLimitedMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusIncMember" xlink:label="NovellusIncMember" xlink:title="NovellusIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetAcquisitionDomain" xlink:to="NovellusIncMember" xlink:title="definition: AssetAcquisitionDomain to NovellusIncMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RelatedPartyTransactionsByRelatedPartyAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" xlink:label="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" xlink:title="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" xlink:title="definition: RelatedPartyDomain to ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract" xlink:label="InvestmentsAbstract" xlink:title="InvestmentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="InvestmentsAbstract" xlink:title="definition: BusinessAcquisitionLineItems to InvestmentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentOwnershipPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="MinorityInterestOwnershipPercentageByParent" xlink:title="definition: BusinessAcquisitionLineItems to MinorityInterestOwnershipPercentageByParent" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NumberOfBoardSeats" xlink:label="NumberOfBoardSeats" xlink:title="NumberOfBoardSeats" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBoardSeats" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBoardSeats" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestments" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestments" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="definition: BusinessAcquisitionLineItems to EquityMethodInvestmentRealizedGainLossOnDisposal" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain_2" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain_2" xlink:title="definition: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="definition: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="definition: OwnershipAxis to OwnershipDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain_2" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain_2" xlink:title="definition: OwnershipAxis to OwnershipDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CitiusPharmaceuticalsIncMember" xlink:label="CitiusPharmaceuticalsIncMember" xlink:title="CitiusPharmaceuticalsIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OwnershipDomain" xlink:to="CitiusPharmaceuticalsIncMember" xlink:title="definition: OwnershipDomain to CitiusPharmaceuticalsIncMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueNetAssetLiabilityAbstract" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueNetAssetLiabilityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesFairValueDisclosureAbstract" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to LiabilitiesFairValueDisclosureAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesFairValueDisclosure" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to LiabilitiesFairValueDisclosure" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel1Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel1Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByLiabilityClassAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByLiabilityClassAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="definition: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" xlink:title="definition: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to DerivativeFinancialInstrumentsLiabilitiesMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="OverSubscriptionAmountReceived" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to OverSubscriptionAmountReceived" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to StockRepurchaseProgramAuthorizedAmount1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="LiabilitiesFairValueAdjustment" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to LiabilitiesFairValueAdjustment" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesOperatingLeaseDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CeoSeparationAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_SeparationAgreementAbstract" xlink:label="SeparationAgreementAbstract" xlink:title="SeparationAgreementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="SeparationAgreementAbstract" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to SeparationAgreementAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPostemploymentBenefits" xlink:label="PaymentsForPostemploymentBenefits" xlink:title="PaymentsForPostemploymentBenefits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="PaymentsForPostemploymentBenefits" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to PaymentsForPostemploymentBenefits" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PaymentToOfficerBaseSalary" xlink:label="PaymentToOfficerBaseSalary" xlink:title="PaymentToOfficerBaseSalary" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="PaymentToOfficerBaseSalary" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to PaymentToOfficerBaseSalary" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:label="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:title="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="SharePrice" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to SharePrice" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="ChiefExecutiveOfficerMember" xlink:title="ChiefExecutiveOfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to AwardTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MilestoneOptionsMember" xlink:label="MilestoneOptionsMember" xlink:title="MilestoneOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="MilestoneOptionsMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to MilestoneOptionsMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="RestructuringCostAndReserveLineItems" xlink:title="RestructuringCostAndReserveLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="AccruedLiabilitiesCurrentAbstract" xlink:title="AccruedLiabilitiesCurrentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RestructuringCostAndReserveLineItems" xlink:to="AccruedLiabilitiesCurrentAbstract" xlink:title="definition: RestructuringCostAndReserveLineItems to AccruedLiabilitiesCurrentAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RestructuringCostAndReserveLineItems" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="definition: RestructuringCostAndReserveLineItems to EmployeeRelatedLiabilitiesCurrent" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AccruedResearchAndDevelopmentExpenses" xlink:label="AccruedResearchAndDevelopmentExpenses" xlink:title="AccruedResearchAndDevelopmentExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RestructuringCostAndReserveLineItems" xlink:to="AccruedResearchAndDevelopmentExpenses" xlink:title="definition: RestructuringCostAndReserveLineItems to AccruedResearchAndDevelopmentExpenses" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AccruedGeneralAndAdministrativeExpenses" xlink:label="AccruedGeneralAndAdministrativeExpenses" xlink:title="AccruedGeneralAndAdministrativeExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RestructuringCostAndReserveLineItems" xlink:to="AccruedGeneralAndAdministrativeExpenses" xlink:title="definition: RestructuringCostAndReserveLineItems to AccruedGeneralAndAdministrativeExpenses" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RestructuringCostAndReserveLineItems" xlink:to="AccruedLiabilitiesCurrent" xlink:title="definition: RestructuringCostAndReserveLineItems to AccruedLiabilitiesCurrent" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RestructuringCostAndReserveLineItems" xlink:to="AccruedProfessionalFeesCurrent" xlink:title="definition: RestructuringCostAndReserveLineItems to AccruedProfessionalFeesCurrent" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="ScheduleOfRestructuringAndRelatedCostsTable" xlink:title="ScheduleOfRestructuringAndRelatedCostsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="RestructuringCostAndReserveLineItems" xlink:to="ScheduleOfRestructuringAndRelatedCostsTable" xlink:title="definition: RestructuringCostAndReserveLineItems to ScheduleOfRestructuringAndRelatedCostsTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="RestructuringCostAndReserveAxis" xlink:title="RestructuringCostAndReserveAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="RestructuringCostAndReserveAxis" xlink:title="definition: ScheduleOfRestructuringAndRelatedCostsTable to RestructuringCostAndReserveAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="TypeOfRestructuringDomain" xlink:title="TypeOfRestructuringDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RestructuringCostAndReserveAxis" xlink:to="TypeOfRestructuringDomain" xlink:title="definition: RestructuringCostAndReserveAxis to TypeOfRestructuringDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="TypeOfRestructuringDomain_2" xlink:title="TypeOfRestructuringDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RestructuringCostAndReserveAxis" xlink:to="TypeOfRestructuringDomain_2" xlink:title="definition: RestructuringCostAndReserveAxis to TypeOfRestructuringDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="EmployeeSeveranceMember" xlink:title="EmployeeSeveranceMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TypeOfRestructuringDomain" xlink:to="EmployeeSeveranceMember" xlink:title="definition: TypeOfRestructuringDomain to EmployeeSeveranceMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfRestructuringAndRelatedCostsTable to TitleOfIndividualAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="ChiefExecutiveOfficerMember" xlink:title="ChiefExecutiveOfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LegalMattersAbstract" xlink:label="LegalMattersAbstract" xlink:title="LegalMattersAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LegalMattersAbstract" xlink:title="definition: LossContingenciesLineItems to LegalMattersAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyDamagesSoughtExpectedSalary" xlink:label="LossContingencyDamagesSoughtExpectedSalary" xlink:title="LossContingencyDamagesSoughtExpectedSalary" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyDamagesSoughtExpectedSalary" xlink:title="definition: LossContingenciesLineItems to LossContingencyDamagesSoughtExpectedSalary" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:label="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:title="LossContingencyDamagesSoughtExpectedEquityPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:title="definition: LossContingenciesLineItems to LossContingencyDamagesSoughtExpectedEquityPercentage" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="LossContingencyDamagesSoughtValue" xlink:title="LossContingencyDamagesSoughtValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyDamagesSoughtValue" xlink:title="definition: LossContingenciesLineItems to LossContingencyDamagesSoughtValue" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyNumberOfArbitrationPanel" xlink:label="LossContingencyNumberOfArbitrationPanel" xlink:title="LossContingencyNumberOfArbitrationPanel" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyNumberOfArbitrationPanel" xlink:title="definition: LossContingenciesLineItems to LossContingencyNumberOfArbitrationPanel" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="LitigationSettlementAmountAwardedToOtherParty" xlink:title="LitigationSettlementAmountAwardedToOtherParty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LitigationSettlementAmountAwardedToOtherParty" xlink:title="definition: LossContingenciesLineItems to LitigationSettlementAmountAwardedToOtherParty" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LossContingenciesLineItems" xlink:to="LossContingenciesTable" xlink:title="definition: LossContingenciesLineItems to LossContingenciesTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: LossContingenciesTable to RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="definition: RelatedPartyDomain to NovellusTherapeuticsLimitedMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DheshGovenderMember" xlink:label="DheshGovenderMember" xlink:title="DheshGovenderMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="DheshGovenderMember" xlink:title="definition: RelatedPartyDomain to DheshGovenderMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="RangeAxis" xlink:title="definition: LossContingenciesTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: LossContingenciesTable to SubsequentEventTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LicensingAgreementsAbstract" xlink:label="LicensingAgreementsAbstract" xlink:title="LicensingAgreementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LicensingAgreementsAbstract" xlink:title="definition: LossContingenciesLineItems to LicensingAgreementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyPercentageOfRoyaltyPayable" xlink:label="LossContingencyPercentageOfRoyaltyPayable" xlink:title="LossContingencyPercentageOfRoyaltyPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyPercentageOfRoyaltyPayable" xlink:title="definition: LossContingenciesLineItems to LossContingencyPercentageOfRoyaltyPayable" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyNonRefundableOptionFee" xlink:label="LossContingencyNonRefundableOptionFee" xlink:title="LossContingencyNonRefundableOptionFee" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="LossContingencyNonRefundableOptionFee" xlink:title="definition: LossContingenciesLineItems to LossContingencyNonRefundableOptionFee" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InitialLicenseFees" xlink:label="InitialLicenseFees" xlink:title="InitialLicenseFees" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="InitialLicenseFees" xlink:title="definition: LossContingenciesLineItems to InitialLicenseFees" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AdditionalFeesObligatedToPay" xlink:label="AdditionalFeesObligatedToPay" xlink:title="AdditionalFeesObligatedToPay" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="AdditionalFeesObligatedToPay" xlink:title="definition: LossContingenciesLineItems to AdditionalFeesObligatedToPay" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AmountRequireToPayInitialLicenseFees" xlink:label="AmountRequireToPayInitialLicenseFees" xlink:title="AmountRequireToPayInitialLicenseFees" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="AmountRequireToPayInitialLicenseFees" xlink:title="definition: LossContingenciesLineItems to AmountRequireToPayInitialLicenseFees" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AmountObligatedToPayInYearOne" xlink:label="AmountObligatedToPayInYearOne" xlink:title="AmountObligatedToPayInYearOne" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="AmountObligatedToPayInYearOne" xlink:title="definition: LossContingenciesLineItems to AmountObligatedToPayInYearOne" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AmountObligatedToPayInYearTwo" xlink:label="AmountObligatedToPayInYearTwo" xlink:title="AmountObligatedToPayInYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="AmountObligatedToPayInYearTwo" xlink:title="definition: LossContingenciesLineItems to AmountObligatedToPayInYearTwo" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MilestonePayments" xlink:label="MilestonePayments" xlink:title="MilestonePayments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="MilestonePayments" xlink:title="definition: LossContingenciesLineItems to MilestonePayments" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfRevenue" xlink:label="PercentageOfRevenue" xlink:title="PercentageOfRevenue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="PercentageOfRevenue" xlink:title="definition: LossContingenciesLineItems to PercentageOfRevenue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LossContingenciesLineItems" xlink:to="LossContingenciesTable" xlink:title="definition: LossContingenciesLineItems to LossContingenciesTable" order="11.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="LegalEntityAxis" xlink:title="definition: LossContingenciesTable to LegalEntityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="definition: LegalEntityAxis to EntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="EntityDomain_2" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LegalEntityAxis" xlink:to="EntityDomain_2" xlink:title="definition: LegalEntityAxis to EntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_UniversityOfSouthFloridaMember" xlink:label="UniversityOfSouthFloridaMember" xlink:title="UniversityOfSouthFloridaMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityDomain" xlink:to="UniversityOfSouthFloridaMember" xlink:title="definition: EntityDomain to UniversityOfSouthFloridaMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="definition: LossContingenciesTable to RelatedPartyTransactionsByRelatedPartyAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain_2" xlink:title="RelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain_2" xlink:title="definition: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="definition: RelatedPartyDomain to NovellusTherapeuticsLimitedMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusLtdAndFactorBioscienceMember" xlink:label="NovellusLtdAndFactorBioscienceMember" xlink:title="NovellusLtdAndFactorBioscienceMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="NovellusLtdAndFactorBioscienceMember" xlink:title="definition: RelatedPartyDomain to NovellusLtdAndFactorBioscienceMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoveCiteMember" xlink:label="NoveCiteMember" xlink:title="NoveCiteMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RelatedPartyDomain" xlink:to="NoveCiteMember" xlink:title="definition: RelatedPartyDomain to NoveCiteMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="StatementScenarioAxis" xlink:title="definition: LossContingenciesTable to StatementScenarioAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain_2" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain_2" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="ScenarioForecastMember" xlink:title="definition: ScenarioUnspecifiedDomain to ScenarioForecastMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="RangeAxis" xlink:title="definition: LossContingenciesTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_RoyaltyAgreementsAbstract" xlink:label="RoyaltyAgreementsAbstract" xlink:title="RoyaltyAgreementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="RoyaltyAgreementsAbstract" xlink:title="definition: LossContingenciesLineItems to RoyaltyAgreementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:label="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:title="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:title="definition: LossContingenciesLineItems to PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:label="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LossContingenciesLineItems" xlink:to="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="definition: LossContingenciesLineItems to PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LossContingenciesLineItems" xlink:to="LossContingenciesTable" xlink:title="definition: LossContingenciesLineItems to LossContingenciesTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LossContingenciesTable" xlink:to="TypeOfArrangementAxis" xlink:title="definition: LossContingenciesTable to TypeOfArrangementAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember_2" xlink:title="definition: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InvestorRoyaltyAgreementMember" xlink:label="InvestorRoyaltyAgreementMember" xlink:title="InvestorRoyaltyAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="InvestorRoyaltyAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to InvestorRoyaltyAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CollaboratorRoyaltyAgreementMember" xlink:label="CollaboratorRoyaltyAgreementMember" xlink:title="CollaboratorRoyaltyAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="CollaboratorRoyaltyAgreementMember" xlink:title="definition: ArrangementsAndNonarrangementTransactionsMember to CollaboratorRoyaltyAgreementMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesStockOptionsExercised" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ProceedsFromStockOptionsExercised" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ProceedsFromStockOptionsExercised" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="14.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_TimeBasedStockOptionGrantMember" xlink:label="TimeBasedStockOptionGrantMember" xlink:title="TimeBasedStockOptionGrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="TimeBasedStockOptionGrantMember" xlink:title="definition: EmployeeStockOptionMember to TimeBasedStockOptionGrantMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PerformanceBasedStockOptionGrantMember" xlink:label="PerformanceBasedStockOptionGrantMember" xlink:title="PerformanceBasedStockOptionGrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeStockOptionMember" xlink:to="PerformanceBasedStockOptionGrantMember" xlink:title="definition: EmployeeStockOptionMember to PerformanceBasedStockOptionGrantMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="VestingAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to VestingAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="VestingAxis" xlink:to="VestingDomain" xlink:title="definition: VestingAxis to VestingDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain_2" xlink:title="VestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="VestingAxis" xlink:to="VestingDomain_2" xlink:title="definition: VestingAxis to VestingDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheOneMember" xlink:title="definition: VestingDomain to ShareBasedCompensationAwardTrancheOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to TitleOfIndividualAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="ChiefExecutiveOfficerMember" xlink:title="ChiefExecutiveOfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationRsusDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NumberOfAwardsVestedAndSettledAbstract" xlink:label="NumberOfAwardsVestedAndSettledAbstract" xlink:title="NumberOfAwardsVestedAndSettledAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="NumberOfAwardsVestedAndSettledAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to NumberOfAwardsVestedAndSettledAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonStockWithheldToCoverTaxes" xlink:label="CommonStockWithheldToCoverTaxes" xlink:title="CommonStockWithheldToCoverTaxes" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="CommonStockWithheldToCoverTaxes" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to CommonStockWithheldToCoverTaxes" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:label="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:title="NumberOfPerformanceGoalsAreSubjectToAchieve" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to NumberOfPerformanceGoalsAreSubjectToAchieve" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPostemploymentBenefits" xlink:label="PaymentsForPostemploymentBenefits" xlink:title="PaymentsForPostemploymentBenefits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="PaymentsForPostemploymentBenefits" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to PaymentsForPostemploymentBenefits" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharePrice" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharePrice" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="11.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_Two022PerformanceBasedRestrictedStockUnitsMember" xlink:label="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:title="Two022PerformanceBasedRestrictedStockUnitsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:title="definition: RestrictedStockUnitsRSUMember to Two022PerformanceBasedRestrictedStockUnitsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to TitleOfIndividualAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeeMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to EmployeeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ChiefExecutiveOfficerAndPresidentMember" xlink:label="ChiefExecutiveOfficerAndPresidentMember" xlink:title="ChiefExecutiveOfficerAndPresidentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerAndPresidentMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerAndPresidentMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:label="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain_2" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain_2" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="PrivatePlacementOfEquityAbstract" xlink:title="definition: SubsidiarySaleOfStockLineItems to PrivatePlacementOfEquityAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="definition: SubsidiarySaleOfStockLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="definition: SubsidiarySaleOfStockLineItems to StockRepurchaseProgramAuthorizedAmount1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_VariableRateTransactionsPeriod" xlink:label="VariableRateTransactionsPeriod" xlink:title="VariableRateTransactionsPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="VariableRateTransactionsPeriod" xlink:title="definition: SubsidiarySaleOfStockLineItems to VariableRateTransactionsPeriod" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:label="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightsExercisableTerm" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="definition: SubsidiarySaleOfStockLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="definition: SubsidiarySaleOfStockLineItems to WarrantsAndRightsOutstandingTerm" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="definition: SubsidiarySaleOfStockLineItems to ClassOfWarrantOrRightOutstanding" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="definition: SubsidiarySaleOfStockLineItems to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="OverSubscriptionAmountReceived" xlink:title="definition: SubsidiarySaleOfStockLineItems to OverSubscriptionAmountReceived" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="definition: SubsidiarySaleOfStockLineItems to ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ObligationToPayLiquidatedDamagesPercentage" xlink:title="definition: SubsidiarySaleOfStockLineItems to ObligationToPayLiquidatedDamagesPercentage" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="TransactionFeesPayable" xlink:title="definition: SubsidiarySaleOfStockLineItems to TransactionFeesPayable" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ConsecutiveCalendarDays" xlink:label="ConsecutiveCalendarDays" xlink:title="ConsecutiveCalendarDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="ConsecutiveCalendarDays" xlink:title="definition: SubsidiarySaleOfStockLineItems to ConsecutiveCalendarDays" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AggregateCalendarDays" xlink:label="AggregateCalendarDays" xlink:title="AggregateCalendarDays" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="AggregateCalendarDays" xlink:title="definition: SubsidiarySaleOfStockLineItems to AggregateCalendarDays" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="LossContingencyEstimateOfPossibleLoss" xlink:title="definition: SubsidiarySaleOfStockLineItems to LossContingencyEstimateOfPossibleLoss" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="LossContingencyDamagesPaidValue" xlink:title="LossContingencyDamagesPaidValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="LossContingencyDamagesPaidValue" xlink:title="definition: SubsidiarySaleOfStockLineItems to LossContingencyDamagesPaidValue" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="definition: SubsidiarySaleOfStockLineItems to SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="21.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="InvestmentTypeAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to InvestmentTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember_2" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember_2" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="definition: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to ClassOfWarrantOrRightAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RangeAxis" xlink:title="definition: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquityMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MergerAbstract" xlink:label="MergerAbstract" xlink:title="MergerAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="MergerAbstract" xlink:title="definition: ClassOfStockLineItems to MergerAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="SharesIssued" xlink:title="SharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SharesIssued" xlink:title="definition: ClassOfStockLineItems to SharesIssued" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="ConversionOfStockSharesConverted1" xlink:title="ConversionOfStockSharesConverted1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ConversionOfStockSharesConverted1" xlink:title="definition: ClassOfStockLineItems to ConversionOfStockSharesConverted1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightIssued" xlink:label="ClassOfWarrantOrRightIssued" xlink:title="ClassOfWarrantOrRightIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightIssued" xlink:title="definition: ClassOfStockLineItems to ClassOfWarrantOrRightIssued" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: ClassOfStockLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesAcquisitions1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfStockLineItems" xlink:to="ScheduleOfStockByClassTable" xlink:title="definition: ClassOfStockLineItems to ScheduleOfStockByClassTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: ScheduleOfStockByClassTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: ScheduleOfStockByClassTable to StatementClassOfStockAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="definition: ClassOfStockDomain to CommonClassAMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="definition: ClassOfStockDomain to CommonClassBMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="definition: ClassOfStockDomain to CommonClassCMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfStockByClassTable to BusinessAcquisitionAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to EarningsPerShareDilutedOtherDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to ClassOfWarrantOrRightAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="definition: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain_2" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain_2" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to WarrantMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="ConvertiblePreferredStockMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to ConvertiblePreferredStockMember" order="4.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="definition: SubsequentEventLineItems to WarrantsAndRightsNoteDisclosureAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightExercised" xlink:label="ClassOfWarrantOrRightExercised" xlink:title="ClassOfWarrantOrRightExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ClassOfWarrantOrRightExercised" xlink:title="definition: SubsequentEventLineItems to ClassOfWarrantOrRightExercised" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: SubsequentEventLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="definition: SubsequentEventLineItems to ProceedsFromIssuanceOfWarrants" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: SubsequentEventLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="definition: SubsequentEventLineItems to ClassOfWarrantOrRightOutstanding" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SubsequentEventLineItems" xlink:to="SubsequentEventTable" xlink:title="definition: SubsequentEventLineItems to SubsequentEventTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: SubsequentEventTable to SubsequentEventTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="InvestmentTypeAxis" xlink:title="definition: SubsequentEventTable to InvestmentTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember_2" xlink:title="InvestmentTypeCategorizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember_2" xlink:title="definition: InvestmentTypeAxis to InvestmentTypeCategorizationMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="definition: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="definition: SubsequentEventTable to ClassOfWarrantOrRightAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain_2" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain_2" xlink:title="definition: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="definition: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>btx-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" id="us-gaap_AwardTypeAxis_lbl">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:title="label: AwardTypeAxis to us-gaap_AwardTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US" id="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:title="label: ArrangementsAndNonarrangementTransactionsMember to us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl1">Accounts Payable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl1" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl">ACCRUED EXPENSES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedProfessionalFeesCurrent_lbl">Legal expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:title="label: AccruedProfessionalFeesCurrent to us-gaap_AccruedProfessionalFeesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedProfessionalFeesCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedProfessionalFeesCurrent_lbl1">Accrued Professional Fees, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl1" xlink:title="label: AccruedProfessionalFeesCurrent to us-gaap_AccruedProfessionalFeesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl1">Total accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl2" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl2">Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="AccruedLiabilitiesCurrentAbstract" xlink:title="AccruedLiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl">Accrued Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" xlink:title="label: AccruedLiabilitiesCurrentAbstract to us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl1">Accrued Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl1" xlink:title="label: AccruedLiabilitiesCurrentAbstract to us-gaap_AccruedLiabilitiesCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl1">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl1">Stock-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl2">Stock-based compensation expense recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesNameDomain_lbl">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:title="label: AntidilutiveSecuritiesNameDomain to us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl">Total potential common shares excluded from computation (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:label="AssetAcquisitionTableTextBlock" xlink:title="AssetAcquisitionTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_AssetAcquisitionTableTextBlock_lbl">Fair Value of Asset Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionTableTextBlock" xlink:to="us-gaap_AssetAcquisitionTableTextBlock_lbl" xlink:title="label: AssetAcquisitionTableTextBlock to us-gaap_AssetAcquisitionTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="AssetAcquisitionAxis" xlink:title="AssetAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionAxis_lbl" xml:lang="en-US" id="us-gaap_AssetAcquisitionAxis_lbl">Asset Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionAxis_lbl" xlink:title="label: AssetAcquisitionAxis to us-gaap_AssetAcquisitionAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain" xlink:title="AssetAcquisitionDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetAcquisitionDomain_lbl" xml:lang="en-US" id="us-gaap_AssetAcquisitionDomain_lbl">Asset Acquisition [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionDomain" xlink:to="us-gaap_AssetAcquisitionDomain_lbl" xlink:title="label: AssetAcquisitionDomain to us-gaap_AssetAcquisitionDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl1">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:label="AssetsAndLiabilitiesLesseeAbstract" xlink:title="AssetsAndLiabilitiesLesseeAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl">Assets and Liabilities, Lessee [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" xlink:title="label: AssetsAndLiabilitiesLesseeAbstract to us-gaap_AssetsAndLiabilitiesLesseeAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Assets_lbl" xml:lang="en-US" id="us-gaap_Assets_lbl">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl" xlink:title="label: Assets to us-gaap_Assets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Assets_lbl1" xml:lang="en-US" id="us-gaap_Assets_lbl1">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl1" xlink:title="label: Assets to us-gaap_Assets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl1">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl1" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl">Carrying value of assets sold [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:title="label: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl">Intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl">Accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl">Accounts payable, accrued liabilities and other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl">Prepaid expense and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAxis_lbl">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:title="label: BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="BusinessAcquisitionSharePrice" xlink:title="BusinessAcquisitionSharePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionSharePrice_lbl">Closing price of common stock (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:title="label: BusinessAcquisitionSharePrice to us-gaap_BusinessAcquisitionSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionSharePrice_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionSharePrice_lbl1">Business Acquisition, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl1" xlink:title="label: BusinessAcquisitionSharePrice to us-gaap_BusinessAcquisitionSharePrice_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAcquireeDomain_lbl">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:title="label: BusinessAcquisitionAcquireeDomain to us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationsAbstract_lbl">MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:title="label: BusinessCombinationsAbstract to us-gaap_BusinessCombinationsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionLineItems_lbl">Business Acquisition [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:title="label: BusinessAcquisitionLineItems to us-gaap_BusinessAcquisitionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl">Number of common stock issued in exchange of membership interests (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:title="label: BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued to us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" xlink:title="label: BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued to us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl">Percentage of outstanding common stock received by members and financial adviser</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl">Total consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityTransactionCosts to us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1">Purchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityTransactionCosts to us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl">Description of Business [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl1">Acquisitions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl1" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl2" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl2">Merger Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl2" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl">Net assets acquired, excluding goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl">Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl">Cash and cash equivalents at beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1">Cash and cash equivalents at end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl">Net increase in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Cash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_Cash_lbl" xml:lang="en-US" id="us-gaap_Cash_lbl">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Cash" xlink:to="us-gaap_Cash_lbl" xlink:title="label: Cash to us-gaap_Cash_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Cash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Cash_lbl1" xml:lang="en-US" id="us-gaap_Cash_lbl1">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Cash" xlink:to="us-gaap_Cash_lbl1" xlink:title="label: Cash to us-gaap_Cash_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US" id="us-gaap_CashAcquiredFromAcquisition_lbl">Cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:title="label: CashAcquiredFromAcquisition to us-gaap_CashAcquiredFromAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAcquiredFromAcquisition_lbl1" xml:lang="en-US" id="us-gaap_CashAcquiredFromAcquisition_lbl1">Cash Acquired from Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl1" xlink:title="label: CashAcquiredFromAcquisition to us-gaap_CashAcquiredFromAcquisition_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl">Supplemental disclosure of non-cash investing and financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl">Number of rights options converted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1">Warrants exercisable (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2">Warrants to be outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightAxis_lbl">Class of Warrant or Right [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:title="label: ClassOfWarrantOrRightAxis to us-gaap_ClassOfWarrantOrRightAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockLineItems_lbl">Class of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:title="label: ClassOfStockLineItems to us-gaap_ClassOfStockLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl">Number of common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl">Warrants exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightDomain_lbl">Class of Warrant or Right [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:title="label: ClassOfWarrantOrRightDomain to us-gaap_ClassOfWarrantOrRightDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightOutstanding_lbl">Warrants outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:title="label: ClassOfWarrantOrRightOutstanding to us-gaap_ClassOfWarrantOrRightOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl">COMMITMENTS AND CONTINGENCIES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureAbstract to us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl1" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonClassCMember_lbl" xml:lang="en-US" id="us-gaap_CommonClassCMember_lbl">Common Class C [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:title="label: CommonClassCMember to us-gaap_CommonClassCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonClassCMember_lbl1" xml:lang="en-US" id="us-gaap_CommonClassCMember_lbl1">Class C [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl1" xlink:title="label: CommonClassCMember to us-gaap_CommonClassCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassCMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonClassCMember_lbl2" xml:lang="en-US" id="us-gaap_CommonClassCMember_lbl2">Common Class C [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl2" xlink:title="label: CommonClassCMember to us-gaap_CommonClassCMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonClassAMember_lbl" xml:lang="en-US" id="us-gaap_CommonClassAMember_lbl">Common Class A [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:title="label: CommonClassAMember to us-gaap_CommonClassAMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonClassAMember_lbl1" xml:lang="en-US" id="us-gaap_CommonClassAMember_lbl1">Class A [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl1" xlink:title="label: CommonClassAMember to us-gaap_CommonClassAMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonClassAMember_lbl2" xml:lang="en-US" id="us-gaap_CommonClassAMember_lbl2">Common Class A [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl2" xlink:title="label: CommonClassAMember to us-gaap_CommonClassAMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonClassBMember_lbl" xml:lang="en-US" id="us-gaap_CommonClassBMember_lbl">Common Class B [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:title="label: CommonClassBMember to us-gaap_CommonClassBMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonClassBMember_lbl1" xml:lang="en-US" id="us-gaap_CommonClassBMember_lbl1">Class B [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl1" xlink:title="label: CommonClassBMember to us-gaap_CommonClassBMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonClassBMember_lbl2" xml:lang="en-US" id="us-gaap_CommonClassBMember_lbl2">Common Class B [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl2" xlink:title="label: CommonClassBMember to us-gaap_CommonClassBMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl">Common stock, $0.005 par value, 100,000 shares authorized at June 30, 2022 and December 31, 2021; 57,469 and 52,021 issued and outstanding at June 30, 2022 and December 31, 2021, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl">Common stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl">Common stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl">Common stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl1">Number of shares of common stock owned by Brooklyn stockholders immediately before the Merger (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="ConversionOfStockSharesConverted1" xlink:title="ConversionOfStockSharesConverted1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US" id="us-gaap_ConversionOfStockSharesConverted1_lbl">Number of shares converted to common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:title="label: ConversionOfStockSharesConverted1 to us-gaap_ConversionOfStockSharesConverted1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConversionOfStockSharesConverted1_lbl1" xml:lang="en-US" id="us-gaap_ConversionOfStockSharesConverted1_lbl1">Conversion of Stock, Shares Converted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl1" xlink:title="label: ConversionOfStockSharesConverted1 to us-gaap_ConversionOfStockSharesConverted1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="us-gaap_ConvertiblePreferredStockMember_lbl">Preferred Stock Converted into Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:title="label: ConvertiblePreferredStockMember to us-gaap_ConvertiblePreferredStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US" id="us-gaap_CustomerRelationshipsMember_lbl">Customers [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:title="label: CustomerRelationshipsMember to us-gaap_CustomerRelationshipsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CustomerRelationshipsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CustomerRelationshipsMember_lbl1" xml:lang="en-US" id="us-gaap_CustomerRelationshipsMember_lbl1">Customer Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl1" xlink:title="label: CustomerRelationshipsMember to us-gaap_CustomerRelationshipsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xml:lang="en-US" id="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl">Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:title="label: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositAssets" xlink:label="DepositAssets" xlink:title="DepositAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepositAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepositAssets_lbl" xml:lang="en-US" id="us-gaap_DepositAssets_lbl">Security deposits and other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositAssets" xlink:to="us-gaap_DepositAssets_lbl" xlink:title="label: DepositAssets to us-gaap_DepositAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepositAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepositAssets_lbl1" xml:lang="en-US" id="us-gaap_DepositAssets_lbl1">Security deposit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepositAssets" xlink:to="us-gaap_DepositAssets_lbl1" xlink:title="label: DepositAssets to us-gaap_DepositAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl1" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl1">Depreciation, Depletion and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" xml:lang="en-US" id="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl">Warrant Liabilities [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:to="us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" xlink:title="label: DerivativeFinancialInstrumentsLiabilitiesMember to us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_DerivativeLiabilitiesNoncurrent_lbl">Warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:title="label: DerivativeLiabilitiesNoncurrent to us-gaap_DerivativeLiabilitiesNoncurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl">STOCK-BASED COMPENSATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl">STOCK-BASED COMPENSATION [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="DisposalGroupIncludingDiscontinuedOperationGoodwill1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationGoodwill1 to us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1">Disposal Group, Including Discontinued Operation, Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationGoodwill1 to us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl">Intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationIntangibleAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationIntangibleAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl">Prepaids and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationDeferredRevenue to us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment to us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment to us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents to us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents to us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl">Other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities to us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl">Accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet to us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationOtherAssets to us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl">Disposal Group Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xlink:title="label: DisposalGroupsIncludingDiscontinuedOperationsNameDomain to us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" xml:lang="en-US" id="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl">Total loss on sale of assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" xlink:title="label: DisposalGroupNotDiscontinuedOperationGainLossOnDisposal to us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPreferredStockCash_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DividendsPreferredStockCash_lbl" xml:lang="en-US" id="us-gaap_DividendsPreferredStockCash_lbl">Cash dividends to Series A preferred stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_lbl" xlink:title="label: DividendsPreferredStockCash to us-gaap_DividendsPreferredStockCash_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPreferredStockCash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DividendsPreferredStockCash_lbl1" xml:lang="en-US" id="us-gaap_DividendsPreferredStockCash_lbl1">Dividends, Preferred Stock, Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_lbl1" xlink:title="label: DividendsPreferredStockCash to us-gaap_DividendsPreferredStockCash_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl">Anti-dilutive Securities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" xlink:title="label: EarningsPerShareDilutedOtherDisclosuresAbstract to us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl">Net loss per common share - basic (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl1">Earnings Per Share, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareDiluted_lbl">Net loss per common share - diluted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:title="label: EarningsPerShareDiluted to us-gaap_EarningsPerShareDiluted_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl">EARNINGS PER SHARE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl1">Earnings Per Share [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl1" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareAbstract_lbl">EARNINGS PER SHARE [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:title="label: EarningsPerShareAbstract to us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" id="us-gaap_EmployeeStockOptionMember_lbl">Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:title="label: EmployeeStockOptionMember to us-gaap_EmployeeStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeStockOptionMember_lbl1" xml:lang="en-US" id="us-gaap_EmployeeStockOptionMember_lbl1">Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl1" xlink:title="label: EmployeeStockOptionMember to us-gaap_EmployeeStockOptionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="EmployeeSeveranceMember" xlink:title="EmployeeSeveranceMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeSeveranceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeSeveranceMember_lbl" xml:lang="en-US" id="us-gaap_EmployeeSeveranceMember_lbl">Employee Severance [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeSeveranceMember" xlink:to="us-gaap_EmployeeSeveranceMember_lbl" xlink:title="label: EmployeeSeveranceMember to us-gaap_EmployeeSeveranceMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl">Accrued compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="us-gaap_EquityAbstract_lbl">Stockholders' equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:title="label: EquityAbstract to us-gaap_EquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_EquityAbstract_lbl1">Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl1" xlink:title="label: EquityAbstract to us-gaap_EquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl">Percentage of total outstanding equity interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:title="label: EquityMethodInvestmentOwnershipPercentage to us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1">Ownership percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" xlink:title="label: EquityMethodInvestmentOwnershipPercentage to us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl">Losses on investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xlink:title="label: EquityMethodInvestmentRealizedGainLossOnDisposal to us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="us-gaap_EquityComponentDomain_lbl">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xlink:title="label: EquityComponentDomain to us-gaap_EquityComponentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US" id="us-gaap_EquityMethodInvestments_lbl">Investment in non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xlink:title="label: EquityMethodInvestments to us-gaap_EquityMethodInvestments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityMethodInvestments_lbl1" xml:lang="en-US" id="us-gaap_EquityMethodInvestments_lbl1">Investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl1" xlink:title="label: EquityMethodInvestments to us-gaap_EquityMethodInvestments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueNetAssetLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueNetAssetLiabilityAbstract_lbl" xml:lang="en-US" id="us-gaap_FairValueNetAssetLiabilityAbstract_lbl">Fair Value Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueNetAssetLiabilityAbstract" xlink:to="us-gaap_FairValueNetAssetLiabilityAbstract_lbl" xlink:title="label: FairValueNetAssetLiabilityAbstract to us-gaap_FairValueNetAssetLiabilityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByLiabilityClassAxis_lbl" xml:lang="en-US" id="us-gaap_FairValueByLiabilityClassAxis_lbl">Liability Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:title="label: FairValueByLiabilityClassAxis to us-gaap_FairValueByLiabilityClassAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresAbstract_lbl">FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:title="label: FairValueDisclosuresAbstract to us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl">Liabilities Measured at Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" id="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:title="label: FairValueByFairValueHierarchyLevelAxis to us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl">Warrants fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1">Fair value at March 9, 2022 (issuance date)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl">Fair value, end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1">Fair value, beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xml:lang="en-US" id="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" xlink:title="label: FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:title="label: FairValueMeasurementsFairValueHierarchyDomain to us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl">Fair Value by Liability Class [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl">FAIR VALUE OF FINANCIAL INSTRUMENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl1">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel1Member_lbl">Level 1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:title="label: FairValueInputsLevel1Member to us-gaap_FairValueInputsLevel1Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel2Member_lbl">Level 2 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:title="label: FairValueInputsLevel2Member to us-gaap_FairValueInputsLevel2Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel3Member_lbl">Level 3 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:title="label: FairValueInputsLevel3Member to us-gaap_FairValueInputsLevel3Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl">Changes in Fair Value of Warrant Liabilities [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:title="label: FiniteLivedIntangibleAssetsMajorClassNameDomain to us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:title="label: FiniteLivedIntangibleAssetsByMajorClassAxis to us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US" id="us-gaap_GainLossOnDispositionOfAssets1_lbl">Loss on sale of NTN assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:title="label: GainLossOnDispositionOfAssets1 to us-gaap_GainLossOnDispositionOfAssets1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GainLossOnDispositionOfAssets1_lbl1" xml:lang="en-US" id="us-gaap_GainLossOnDispositionOfAssets1_lbl1">Loss on sale of NTN assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl1" xlink:title="label: GainLossOnDispositionOfAssets1 to us-gaap_GainLossOnDispositionOfAssets1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpense_lbl">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:title="label: GeneralAndAdministrativeExpense to us-gaap_GeneralAndAdministrativeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GeneralAndAdministrativeExpense_lbl1" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpense_lbl1">General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl1" xlink:title="label: GeneralAndAdministrativeExpense to us-gaap_GeneralAndAdministrativeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpenseMember_lbl">General and Administrative [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:title="label: GeneralAndAdministrativeExpenseMember to us-gaap_GeneralAndAdministrativeExpenseMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US" id="us-gaap_GoodwillImpairmentLoss_lbl">Impairment of goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:title="label: GoodwillImpairmentLoss to us-gaap_GoodwillImpairmentLoss_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl">IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Goodwill_lbl" xml:lang="en-US" id="us-gaap_Goodwill_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl">IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureAbstract to us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOfOngoingProject_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ImpairmentOfOngoingProject_lbl" xml:lang="en-US" id="us-gaap_ImpairmentOfOngoingProject_lbl">Impairment of in-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOfOngoingProject" xlink:to="us-gaap_ImpairmentOfOngoingProject_lbl" xlink:title="label: ImpairmentOfOngoingProject to us-gaap_ImpairmentOfOngoingProject_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOfOngoingProject_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ImpairmentOfOngoingProject_lbl1" xml:lang="en-US" id="us-gaap_ImpairmentOfOngoingProject_lbl1">Impairment of in-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOfOngoingProject" xlink:to="us-gaap_ImpairmentOfOngoingProject_lbl1" xlink:title="label: ImpairmentOfOngoingProject to us-gaap_ImpairmentOfOngoingProject_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOfOngoingProject_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ImpairmentOfOngoingProject_lbl2" xml:lang="en-US" id="us-gaap_ImpairmentOfOngoingProject_lbl2">Non-cash impairment charges</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOfOngoingProject" xlink:to="us-gaap_ImpairmentOfOngoingProject_lbl2" xlink:title="label: ImpairmentOfOngoingProject to us-gaap_ImpairmentOfOngoingProject_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementLocationAxis_lbl">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:title="label: IncomeStatementLocationAxis to us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementLocationDomain_lbl">Income Statement Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" xlink:title="label: IncomeStatementLocationDomain to us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xlink:title="label: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementAbstract_lbl">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:title="label: IncomeStatementAbstract to us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xlink:title="label: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl">Disposal Group Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:title="label: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl">Income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherReceivables_lbl">Other receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:title="label: IncreaseDecreaseInOtherReceivables to us-gaap_IncreaseDecreaseInOtherReceivables_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1">Increase (Decrease) in Other Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" xlink:title="label: IncreaseDecreaseInOtherReceivables to us-gaap_IncreaseDecreaseInOtherReceivables_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl">Other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US" id="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl">In-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwill to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xml:lang="en-US" id="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xlink:title="label: IndefiniteLivedIntangibleAssetsExcludingGoodwill to us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl">Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestPaidNet_lbl1" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl1">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl1" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentTypeCategorizationMember_lbl" xml:lang="en-US" id="us-gaap_InvestmentTypeCategorizationMember_lbl">Investments [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:title="label: InvestmentTypeCategorizationMember to us-gaap_InvestmentTypeCategorizationMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US" id="us-gaap_InvestmentTypeAxis_lbl">Investment Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" xlink:title="label: InvestmentTypeAxis to us-gaap_InvestmentTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract" xlink:label="InvestmentsAbstract" xlink:title="InvestmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsAbstract_lbl" xml:lang="en-US" id="us-gaap_InvestmentsAbstract_lbl">Investments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsAbstract" xlink:to="us-gaap_InvestmentsAbstract_lbl" xlink:title="label: InvestmentsAbstract to us-gaap_InvestmentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeasesTextBlock_lbl">LEASES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:title="label: LesseeOperatingLeasesTextBlock to us-gaap_LesseeOperatingLeasesTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear to us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear to us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="LesseeOperatingLeaseRenewalTerm" xlink:title="LesseeOperatingLeaseRenewalTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl">Extended lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:title="label: LesseeOperatingLeaseRenewalTerm to us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseTermOfContract_lbl">Lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:title="label: LesseeOperatingLeaseTermOfContract to us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFour to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearThree to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl">Less: Imputed interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl">Maturities of Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityMaturityTableTextBlock to us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl">Total payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US" id="us-gaap_LeaseCostAbstract_lbl">Net Operating Lease Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" xlink:title="label: LeaseCostAbstract to us-gaap_LeaseCostAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LeaseCost_lbl" xml:lang="en-US" id="us-gaap_LeaseCost_lbl">Total lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCost_lbl1" xml:lang="en-US" id="us-gaap_LeaseCost_lbl1">Lease, Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl1" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LeaseCostTableTextBlock_lbl">Net Operating Lease Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:title="label: LeaseCostTableTextBlock to us-gaap_LeaseCostTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeasesAbstract_lbl" xml:lang="en-US" id="us-gaap_LeasesAbstract_lbl">LEASES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:title="label: LeasesAbstract to us-gaap_LeasesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueAdjustment_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueAdjustment_lbl">Change in fair value of warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueAdjustment" xlink:to="us-gaap_LiabilitiesFairValueAdjustment_lbl" xlink:title="label: LiabilitiesFairValueAdjustment to us-gaap_LiabilitiesFairValueAdjustment_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosure_lbl">Liabilities, fair value disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:title="label: LiabilitiesFairValueDisclosure to us-gaap_LiabilitiesFairValueDisclosure_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosure_lbl1">Liabilities, Fair Value Disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl1" xlink:title="label: LiabilitiesFairValueDisclosure to us-gaap_LiabilitiesFairValueDisclosure_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl">Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:title="label: LiabilitiesFairValueDisclosureAbstract to us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl">Liabilities transferred upon sale [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" xlink:title="label: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl">Total liabilities and stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl1">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Liabilities_lbl" xml:lang="en-US" id="us-gaap_Liabilities_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Liabilities_lbl1" xml:lang="en-US" id="us-gaap_Liabilities_lbl1">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl1" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl1">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl1" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="LitigationSettlementAmountAwardedToOtherParty" xlink:title="LitigationSettlementAmountAwardedToOtherParty" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xml:lang="en-US" id="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl">Litigation settlement, amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementAmountAwardedToOtherParty" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:title="label: LitigationSettlementAmountAwardedToOtherParty to us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl1" xml:lang="en-US" id="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl1">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LitigationSettlementAmountAwardedToOtherParty" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl1" xlink:title="label: LitigationSettlementAmountAwardedToOtherParty to us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="LossContingencyDamagesPaidValue" xlink:title="LossContingencyDamagesPaidValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyDamagesPaidValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyDamagesPaidValue_lbl" xml:lang="en-US" id="us-gaap_LossContingencyDamagesPaidValue_lbl">Liquidated damages payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesPaidValue" xlink:to="us-gaap_LossContingencyDamagesPaidValue_lbl" xlink:title="label: LossContingencyDamagesPaidValue to us-gaap_LossContingencyDamagesPaidValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="LossContingencyDamagesSoughtValue" xlink:title="LossContingencyDamagesSoughtValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyDamagesSoughtValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyDamagesSoughtValue_lbl" xml:lang="en-US" id="us-gaap_LossContingencyDamagesSoughtValue_lbl">Loss contingency, damages sought, value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtValue" xlink:to="us-gaap_LossContingencyDamagesSoughtValue_lbl" xlink:title="label: LossContingencyDamagesSoughtValue to us-gaap_LossContingencyDamagesSoughtValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US" id="us-gaap_LossContingenciesLineItems_lbl">Loss Contingencies [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" xlink:title="label: LossContingenciesLineItems to us-gaap_LossContingenciesLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingenciesTable_lbl" xml:lang="en-US" id="us-gaap_LossContingenciesTable_lbl">Loss Contingencies [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" xlink:title="label: LossContingenciesTable to us-gaap_LossContingenciesTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" xml:lang="en-US" id="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl">Estimated contingent loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyEstimateOfPossibleLoss" xlink:to="us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" xlink:title="label: LossContingencyEstimateOfPossibleLoss to us-gaap_LossContingencyEstimateOfPossibleLoss_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:title="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xml:lang="en-US" id="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl">MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xlink:title="label: MergersAcquisitionsAndDispositionsDisclosuresTextBlock to us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl">Ownership percentage by Citius</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:title="label: MinorityInterestOwnershipPercentageByParent to us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="NonrecurringAdjustmentAxis" xlink:title="NonrecurringAdjustmentAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonrecurringAdjustmentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonrecurringAdjustmentAxis_lbl" xml:lang="en-US" id="us-gaap_NonrecurringAdjustmentAxis_lbl">Nonrecurring Adjustment [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonrecurringAdjustmentAxis" xlink:to="us-gaap_NonrecurringAdjustmentAxis_lbl" xlink:title="label: NonrecurringAdjustmentAxis to us-gaap_NonrecurringAdjustmentAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain" xlink:title="NonrecurringAdjustmentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonrecurringAdjustmentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonrecurringAdjustmentDomain_lbl" xml:lang="en-US" id="us-gaap_NonrecurringAdjustmentDomain_lbl">Nonrecurring Adjustment [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonrecurringAdjustmentDomain" xlink:to="us-gaap_NonrecurringAdjustmentDomain_lbl" xlink:title="label: NonrecurringAdjustmentDomain to us-gaap_NonrecurringAdjustmentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl">Cash flows provided by financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl">Net cash (used in) provided by investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl">Net cash provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl">Cash flows (used in) provided by investing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Cash flows used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl1">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetIncomeLoss_lbl2" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl2">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl2" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl">Net loss attributable to common stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasic to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl">RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:title="label: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl">RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xlink:title="label: NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock to us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl">Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashMergerRelatedCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncashMergerRelatedCosts_lbl" xml:lang="en-US" id="us-gaap_NoncashMergerRelatedCosts_lbl">Transaction costs - shares to Financial Advisor</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashMergerRelatedCosts" xlink:to="us-gaap_NoncashMergerRelatedCosts_lbl" xlink:title="label: NoncashMergerRelatedCosts to us-gaap_NoncashMergerRelatedCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashMergerRelatedCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_NoncashMergerRelatedCosts_lbl1" xml:lang="en-US" id="us-gaap_NoncashMergerRelatedCosts_lbl1">Transaction costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashMergerRelatedCosts" xlink:to="us-gaap_NoncashMergerRelatedCosts_lbl1" xlink:title="label: NoncashMergerRelatedCosts to us-gaap_NoncashMergerRelatedCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashMergerRelatedCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncashMergerRelatedCosts_lbl2" xml:lang="en-US" id="us-gaap_NoncashMergerRelatedCosts_lbl2">Noncash Merger Related Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashMergerRelatedCosts" xlink:to="us-gaap_NoncashMergerRelatedCosts_lbl2" xlink:title="label: NoncashMergerRelatedCosts to us-gaap_NoncashMergerRelatedCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl">Total other income (expense), net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl1">Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseImpairmentLoss_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseImpairmentLoss_lbl">Impairment of right-of-use asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl" xlink:title="label: OperatingLeaseImpairmentLoss to us-gaap_OperatingLeaseImpairmentLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_OperatingLeaseImpairmentLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseImpairmentLoss_lbl1">Impairment of ROU assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl1" xlink:title="label: OperatingLeaseImpairmentLoss to us-gaap_OperatingLeaseImpairmentLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl">Weighted average discount rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:title="label: OperatingLeaseWeightedAverageDiscountRatePercent to us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl">Weighted average remaining lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:title="label: OperatingLeaseWeightedAverageRemainingLeaseTerm1 to us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl">Operating lease liabilities, non-current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1">Less non-current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl">Amortization of right-of-use asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1">Amortization of operating lease ROU assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" xlink:title="label: OperatingLeaseRightOfUseAssetAmortizationExpense to us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl">Operating lease liabilities, current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl1">Current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl2">Operating Lease, Liability, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="OperatingLeaseLiabilityAbstract" xlink:title="OperatingLeaseLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityAbstract_lbl">Operating Lease, Liability [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:title="label: OperatingLeaseLiabilityAbstract to us-gaap_OperatingLeaseLiabilityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl">Maturities of Operating Lease Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:title="label: OperatingLeaseLiabilitiesPaymentsDueAbstract to us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl">Total operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl1">Operating lease liabilities, Beginning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl1" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl2">Operating lease liabilities, Ending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl2" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl">Right-of-use assets - operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl1">Operating lease ROU assets, Beginning</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl2">Operating lease ROU assets, Ending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl2" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseCost_lbl">Operating lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:title="label: OperatingLeaseCost to us-gaap_OperatingLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl1">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl1" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl">Operating expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl1">Operating Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl1" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" id="us-gaap_OperatingExpenses_lbl">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:title="label: OperatingExpenses to us-gaap_OperatingExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingExpenses_lbl1" xml:lang="en-US" id="us-gaap_OperatingExpenses_lbl1">Operating Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl1" xlink:title="label: OperatingExpenses to us-gaap_OperatingExpenses_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherReceivablesNetCurrent_lbl">Other receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:title="label: OtherReceivablesNetCurrent to us-gaap_OtherReceivablesNetCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract" xlink:label="OtherExpensesAbstract" xlink:title="OtherExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_OtherExpensesAbstract_lbl">Other income (expense), net:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherExpensesAbstract" xlink:to="us-gaap_OtherExpensesAbstract_lbl" xlink:title="label: OtherExpensesAbstract to us-gaap_OtherExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_OtherExpensesAbstract_lbl1">Other Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherExpensesAbstract" xlink:to="us-gaap_OtherExpensesAbstract_lbl1" xlink:title="label: OtherExpensesAbstract to us-gaap_OtherExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherLiabilitiesCurrent_lbl">Other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:title="label: OtherLiabilitiesCurrent to us-gaap_OtherLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesCurrent_lbl1">Other Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl1" xlink:title="label: OtherLiabilitiesCurrent to us-gaap_OtherLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl">Other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl1">Other Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpense_lbl">Other expense, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:title="label: OtherNonoperatingIncomeExpense to us-gaap_OtherNonoperatingIncomeExpense_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountUnitsAcquisitions" xlink:label="PartnersCapitalAccountUnitsAcquisitions" xlink:title="PartnersCapitalAccountUnitsAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl">Issuance of common stock to Brooklyn members (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountUnitsAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" xlink:title="label: PartnersCapitalAccountUnitsAcquisitions to us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1">Partners' Capital Account, Units, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountUnitsAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" xlink:title="label: PartnersCapitalAccountUnitsAcquisitions to us-gaap_PartnersCapitalAccountUnitsAcquisitions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountAcquisitions" xlink:label="PartnersCapitalAccountAcquisitions" xlink:title="PartnersCapitalAccountAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PartnersCapitalAccountAcquisitions_lbl" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountAcquisitions_lbl">Issuance of common stock to Brooklyn members</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountAcquisitions_lbl" xlink:title="label: PartnersCapitalAccountAcquisitions to us-gaap_PartnersCapitalAccountAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PartnersCapitalAccountAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PartnersCapitalAccountAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_PartnersCapitalAccountAcquisitions_lbl1">Partners' Capital Account, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PartnersCapitalAccountAcquisitions" xlink:to="us-gaap_PartnersCapitalAccountAcquisitions_lbl1" xlink:title="label: PartnersCapitalAccountAcquisitions to us-gaap_PartnersCapitalAccountAcquisitions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US" id="us-gaap_PayablesAndAccrualsAbstract_lbl">ACCRUED EXPENSES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:title="label: PayablesAndAccrualsAbstract to us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl">Payroll tax remitted on net share settlement of equity awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:title="label: PaymentsRelatedToTaxWithholdingForShareBasedCompensation to us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xlink:title="label: PaymentsRelatedToTaxWithholdingForShareBasedCompensation to us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="PaymentsOfDividendsPreferredStockAndPreferenceStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl">Dividends paid to Series A preferred stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl" xlink:title="label: PaymentsOfDividendsPreferredStockAndPreferenceStock to us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1">Payments of Ordinary Dividends, Preferred Stock and Preference Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" xlink:title="label: PaymentsOfDividendsPreferredStockAndPreferenceStock to us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPostemploymentBenefits" xlink:label="PaymentsForPostemploymentBenefits" xlink:title="PaymentsForPostemploymentBenefits" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsForPostemploymentBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsForPostemploymentBenefits_lbl" xml:lang="en-US" id="us-gaap_PaymentsForPostemploymentBenefits_lbl">Severance benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsForPostemploymentBenefits" xlink:to="us-gaap_PaymentsForPostemploymentBenefits_lbl" xlink:title="label: PaymentsForPostemploymentBenefits to us-gaap_PaymentsForPostemploymentBenefits_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsForPostemploymentBenefits_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_PaymentsForPostemploymentBenefits_lbl1" xml:lang="en-US" id="us-gaap_PaymentsForPostemploymentBenefits_lbl1">Lump sum cash severance paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsForPostemploymentBenefits" xlink:to="us-gaap_PaymentsForPostemploymentBenefits_lbl1" xlink:title="label: PaymentsForPostemploymentBenefits to us-gaap_PaymentsForPostemploymentBenefits_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsForPostemploymentBenefits_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsForPostemploymentBenefits_lbl2" xml:lang="en-US" id="us-gaap_PaymentsForPostemploymentBenefits_lbl2">Payments for Postemployment Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsForPostemploymentBenefits" xlink:to="us-gaap_PaymentsForPostemploymentBenefits_lbl2" xlink:title="label: PaymentsForPostemploymentBenefits to us-gaap_PaymentsForPostemploymentBenefits_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="PaymentsToAcquireInvestments" xlink:title="PaymentsToAcquireInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInvestments_lbl">Less amount of cash paid for NoveCite investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:title="label: PaymentsToAcquireInvestments to us-gaap_PaymentsToAcquireInvestments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireInvestments_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInvestments_lbl1">Payments to Acquire Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl1" xlink:title="label: PaymentsToAcquireInvestments to us-gaap_PaymentsToAcquireInvestments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="PaymentsToAcquireOtherProductiveAssets" xlink:title="PaymentsToAcquireOtherProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireOtherProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl" xlink:title="label: PaymentsToAcquireOtherProductiveAssets to us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl1">Payments to Acquire Other Productive Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireOtherProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl1" xlink:title="label: PaymentsToAcquireOtherProductiveAssets to us-gaap_PaymentsToAcquireOtherProductiveAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl">Purchase of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireProductiveAssets_lbl">Cash paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:title="label: PaymentsToAcquireProductiveAssets to us-gaap_PaymentsToAcquireProductiveAssets_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockMember_lbl" xml:lang="en-US" id="us-gaap_PreferredStockMember_lbl">Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:title="label: PreferredStockMember to us-gaap_PreferredStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="PreferredStockLiquidationPreferenceValue" xlink:title="PreferredStockLiquidationPreferenceValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xml:lang="en-US" id="us-gaap_PreferredStockLiquidationPreferenceValue_lbl">Preferred stock, liquidation preference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xlink:title="label: PreferredStockLiquidationPreferenceValue to us-gaap_PreferredStockLiquidationPreferenceValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="PreferredStockDividendsShares" xlink:title="PreferredStockDividendsShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockDividendsShares_lbl" xml:lang="en-US" id="us-gaap_PreferredStockDividendsShares_lbl">Cash dividends to Series A preferred stockholders (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsShares" xlink:to="us-gaap_PreferredStockDividendsShares_lbl" xlink:title="label: PreferredStockDividendsShares to us-gaap_PreferredStockDividendsShares_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="PreferredStockDividendsAndOtherAdjustments" xlink:title="PreferredStockDividendsAndOtherAdjustments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xml:lang="en-US" id="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl">Series A preferred stock dividend</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsAndOtherAdjustments" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xlink:title="label: PreferredStockDividendsAndOtherAdjustments to us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1">Preferred Stock Dividends and Other Adjustments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockDividendsAndOtherAdjustments" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" xlink:title="label: PreferredStockDividendsAndOtherAdjustments to us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl">Preferred stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl1">Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl">Preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl">Preferred stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl1">Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl">Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated, issued and outstanding of Series A convertible preferred stock at June 30, 2022 and December 31, 2021, $156 liquidation preference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl">Preferred stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl1">Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="PriorPeriodReclassificationAdjustmentDescription" xlink:title="PriorPeriodReclassificationAdjustmentDescription" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US" id="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl">Reclassifications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:title="label: PriorPeriodReclassificationAdjustmentDescription to us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:label="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="ProceedsFromSalesOfAssetsInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl">Purchase of NTN, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfAssetsInvestingActivities" xlink:to="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" xlink:title="label: ProceedsFromSalesOfAssetsInvestingActivities to us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1">Proceeds from Sales of Assets, Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfAssetsInvestingActivities" xlink:to="us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" xlink:title="label: ProceedsFromSalesOfAssetsInvestingActivities to us-gaap_ProceedsFromSalesOfAssetsInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:label="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl">Sale of rights, title and interest in and to the assets relating to the business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" xlink:title="label: ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets to us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" xlink:title="label: ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets to us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl">Proceeds from the sale of NTN assets, net of cash disposed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDivestitureOfBusinesses" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:title="label: ProceedsFromDivestitureOfBusinesses to us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl">Proceeds from issuance of common stock and warrants in connection with private offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1">Proceeds from Issuance of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="ProceedsFromOtherEquity" xlink:title="ProceedsFromOtherEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromOtherEquity_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromOtherEquity_lbl">Proceeds from sale of members' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl" xlink:title="label: ProceedsFromOtherEquity to us-gaap_ProceedsFromOtherEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromOtherEquity_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromOtherEquity_lbl1">Proceeds from Other Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl1" xlink:title="label: ProceedsFromOtherEquity to us-gaap_ProceedsFromOtherEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfWarrants_lbl">Aggregate exercise price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:title="label: ProceedsFromIssuanceOfWarrants to us-gaap_ProceedsFromIssuanceOfWarrants_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1">Proceeds from Issuance of Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xlink:title="label: ProceedsFromIssuanceOfWarrants to us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl">Proceeds from the sales of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:title="label: ProceedsFromSaleOfPropertyPlantAndEquipment to us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromStockOptionsExercised_lbl">Proceeds from stock options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:title="label: ProceedsFromStockOptionsExercised to us-gaap_ProceedsFromStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromStockOptionsExercised_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromStockOptionsExercised_lbl1">Proceeds from the exercise of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl1" xlink:title="label: ProceedsFromStockOptionsExercised to us-gaap_ProceedsFromStockOptionsExercised_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyDomain_lbl">Related Party [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" xlink:title="label: RelatedPartyDomain to us-gaap_RelatedPartyDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" id="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl">Related Party [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:title="label: RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpense_lbl">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:title="label: ResearchAndDevelopmentExpense to us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseMember_lbl">Research and Development [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:title="label: ResearchAndDevelopmentExpenseMember to us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl">RSUs [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl1">RSU [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl2" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl2">Restricted Common Units [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl2" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" id="us-gaap_RestrictedStockMember_lbl">Restricted Common Shares [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:title="label: RestrictedStockMember to us-gaap_RestrictedStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="RestructuringCostAndReserveLineItems" xlink:title="RestructuringCostAndReserveLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US" id="us-gaap_RestructuringCostAndReserveLineItems_lbl">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:title="label: RestructuringCostAndReserveLineItems to us-gaap_RestructuringCostAndReserveLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="RestructuringCostAndReserveAxis" xlink:title="RestructuringCostAndReserveAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestructuringCostAndReserveAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestructuringCostAndReserveAxis_lbl" xml:lang="en-US" id="us-gaap_RestructuringCostAndReserveAxis_lbl">Restructuring Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestructuringCostAndReserveAxis" xlink:to="us-gaap_RestructuringCostAndReserveAxis_lbl" xlink:title="label: RestructuringCostAndReserveAxis to us-gaap_RestructuringCostAndReserveAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl">Accumulated Deficit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsMember_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl1">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl1" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubleaseIncome_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_SubleaseIncome_lbl" xml:lang="en-US" id="us-gaap_SubleaseIncome_lbl">Sublease income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl" xlink:title="label: SubleaseIncome to us-gaap_SubleaseIncome_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubleaseIncome_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubleaseIncome_lbl1" xml:lang="en-US" id="us-gaap_SubleaseIncome_lbl1">Sublease Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl1" xlink:title="label: SubleaseIncome to us-gaap_SubleaseIncome_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl">Warrant expiration term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl">Number of accelerated vesting stock option (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl">Vesting percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl">Expected term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl">Incremental fair value of stock options recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl">Options exercisable period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:title="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl">Tangible and Intangible Assets Acquired and Liabilities Assumed, Based on Estimated Fair Values</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:title="label: ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock to us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl">Weighted-Average Assumptions Used for Stock Options Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl1">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl1" xlink:title="label: ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl">Changes in Warrant Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xlink:title="label: ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock to us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl">Computation of Diluted Net Loss per Common Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTable to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:title="label: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl">Stock-Based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock to us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock to us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:title="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl">Disposition Details</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:title="label: ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock to us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="ScheduleOfRestructuringAndRelatedCostsTable" xlink:title="ScheduleOfRestructuringAndRelatedCostsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:title="label: ScheduleOfRestructuringAndRelatedCostsTable to us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfStockByClassTable_lbl">Schedule of Stock by Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:title="label: ScheduleOfStockByClassTable to us-gaap_ScheduleOfStockByClassTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US" id="us-gaap_SeriesAPreferredStockMember_lbl">Series A Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:title="label: SeriesAPreferredStockMember to us-gaap_SeriesAPreferredStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SeriesAPreferredStockMember_lbl1" xml:lang="en-US" id="us-gaap_SeriesAPreferredStockMember_lbl1">Series A Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl1" xlink:title="label: SeriesAPreferredStockMember to us-gaap_SeriesAPreferredStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl">Vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl1">Restricted stock units vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl">Vesting on one-year Anniversary [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:title="label: ShareBasedCompensationAwardTrancheOneMember to us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" xlink:title="label: ShareBasedCompensationAwardTrancheOneMember to us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl">Number of stock option awards granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1">Stock options granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:label="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl">Stock-Based Compensation Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:to="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl" xlink:title="label: ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract to us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:to="us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" xlink:title="label: ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract to us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharePrice_lbl" xml:lang="en-US" id="us-gaap_SharePrice_lbl">Share price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:title="label: SharePrice to us-gaap_SharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_SharePrice_lbl1" xml:lang="en-US" id="us-gaap_SharePrice_lbl1">Share price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePrice" xlink:to="us-gaap_SharePrice_lbl1" xlink:title="label: SharePrice to us-gaap_SharePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharePrice_lbl2" xml:lang="en-US" id="us-gaap_SharePrice_lbl2">Stock price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharePrice" xlink:to="us-gaap_SharePrice_lbl2" xlink:title="label: SharePrice to us-gaap_SharePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl">Stock-based Compensation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl">Share-Based Compensation Abstract [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl">RSUs Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1">Number of RSUs granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl2">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl">Number of RSUs cancelled (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1">Unvested restricted common stock forfeited (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl1">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl">Number of stock units awards outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1">Unvested restricted stock outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl">RSUs vested (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl">Weightage-Average Assumptions Used for Stock Options Granted [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl">Stock options exercised, intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl">Weighted average volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl">Weighted average risk-free rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl">Dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl">Number of stock option awards outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1">Stock option outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl">Award Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl1">Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl2">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl2" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="SharesIssued" xlink:title="SharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharesIssued_lbl" xml:lang="en-US" id="us-gaap_SharesIssued_lbl">Number of shares issued in merger agreement (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:title="label: SharesIssued to us-gaap_SharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesIssued_lbl1" xml:lang="en-US" id="us-gaap_SharesIssued_lbl1">Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssued" xlink:to="us-gaap_SharesIssued_lbl1" xlink:title="label: SharesIssued to us-gaap_SharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfFinancialPositionAbstract_lbl">CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:title="label: StatementOfFinancialPositionAbstract to us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementEquityComponentsAxis_lbl">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:title="label: StatementEquityComponentsAxis to us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="us-gaap_StatementLineItems_lbl">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:title="label: StatementLineItems to us-gaap_StatementLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfCashFlowsAbstract_lbl">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:title="label: StatementOfCashFlowsAbstract to us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementTable_lbl" xml:lang="en-US" id="us-gaap_StatementTable_lbl">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:title="label: StatementTable to us-gaap_StatementTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfStockholdersEquityAbstract_lbl">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:title="label: StatementOfStockholdersEquityAbstract to us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl">Aggregate gross purchase price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:title="label: StockRepurchaseProgramAuthorizedAmount1 to us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1">Gross proceeds received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" xlink:title="label: StockRepurchaseProgramAuthorizedAmount1 to us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1" xlink:label="StockIssued1" xlink:title="StockIssued1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssued1_lbl" xml:lang="en-US" id="us-gaap_StockIssued1_lbl">Issuance of common stock for business combination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:title="label: StockIssued1 to us-gaap_StockIssued1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssued1_lbl1" xml:lang="en-US" id="us-gaap_StockIssued1_lbl1">Stock Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssued1" xlink:to="us-gaap_StockIssued1_lbl1" xlink:title="label: StockIssued1 to us-gaap_StockIssued1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl">Private placement (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl">Issuance of common stock from vested restricted stock units (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1">Restricted stock replaced during the period (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl">Acquisition of common stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions to us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1">Issuance of common stock to Financial Advisor upon consummation of merger (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions to us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl">Lock-up agreements shares received in acquisition (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:title="label: StockIssuedDuringPeriodSharesIssuedForServices to us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1">Number of common stock issued as compensation for services (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesIssuedForServices to us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl">Common stock issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl">Fair value of shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1">Stock Issued During Period, Value, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl">Issuance of common stock from the exercise of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:title="label: StockIssuedDuringPeriodValueStockOptionsExercised to us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl">Acquisition agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions to us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1">Issuance of common stock to Financial Advisor upon consummation of merger</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions to us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions to us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl">Issuance of common stock from the exercise of stock options (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1">Stock option exercised (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl">Issuance of common stock from vested restricted stock units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl">Total stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl1">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl2">Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquity_lbl3" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl3">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl3" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl">STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteAbstract_lbl">STOCKHOLDERS' EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:title="label: StockholdersEquityNoteAbstract to us-gaap_StockholdersEquityNoteAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsTextBlock_lbl">SUBSEQUENT EVENT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:title="label: SubsequentEventsTextBlock to us-gaap_SubsequentEventsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventsTextBlock_lbl1">Subsequent Events [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl1" xlink:title="label: SubsequentEventsTextBlock to us-gaap_SubsequentEventsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTable_lbl">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:title="label: SubsequentEventTable to us-gaap_SubsequentEventTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeDomain_lbl">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" xlink:title="label: SubsequentEventTypeDomain to us-gaap_SubsequentEventTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventMember_lbl">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:title="label: SubsequentEventMember to us-gaap_SubsequentEventMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeAxis_lbl">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:title="label: SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventLineItems_lbl">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:title="label: SubsequentEventLineItems to us-gaap_SubsequentEventLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsAbstract_lbl">SUBSEQUENT EVENT [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:title="label: SubsequentEventsAbstract to us-gaap_SubsequentEventsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US" id="us-gaap_SubsidiarySaleOfStockLineItems_lbl">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:title="label: SubsidiarySaleOfStockLineItems to us-gaap_SubsidiarySaleOfStockLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US" id="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:title="label: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl">Supplemental disclosures of cash flow information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TradeNamesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TradeNamesMember_lbl" xml:lang="en-US" id="us-gaap_TradeNamesMember_lbl">Trade Names [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl" xlink:title="label: TradeNamesMember to us-gaap_TradeNamesMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="TypeOfRestructuringDomain" xlink:title="TypeOfRestructuringDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TypeOfRestructuringDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TypeOfRestructuringDomain_lbl" xml:lang="en-US" id="us-gaap_TypeOfRestructuringDomain_lbl">Type of Restructuring [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfRestructuringDomain" xlink:to="us-gaap_TypeOfRestructuringDomain_lbl" xlink:title="label: TypeOfRestructuringDomain to us-gaap_TypeOfRestructuringDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US" id="us-gaap_TypeOfArrangementAxis_lbl">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:title="label: TypeOfArrangementAxis to us-gaap_TypeOfArrangementAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VestingAxis_lbl" xml:lang="en-US" id="us-gaap_VestingAxis_lbl">Vesting [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" xlink:title="label: VestingAxis to us-gaap_VestingAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VestingDomain_lbl" xml:lang="en-US" id="us-gaap_VestingDomain_lbl">Vesting [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VestingDomain" xlink:to="us-gaap_VestingDomain_lbl" xlink:title="label: VestingDomain to us-gaap_VestingDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US" id="us-gaap_VariableLeaseCost_lbl">Variable lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:title="label: VariableLeaseCost to us-gaap_VariableLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WarrantMember_lbl" xml:lang="en-US" id="us-gaap_WarrantMember_lbl">Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:title="label: WarrantMember to us-gaap_WarrantMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantMember_lbl1" xml:lang="en-US" id="us-gaap_WarrantMember_lbl1">Warrant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantMember" xlink:to="us-gaap_WarrantMember_lbl1" xlink:title="label: WarrantMember to us-gaap_WarrantMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US" id="us-gaap_WarrantsAndRightsOutstandingTerm_lbl">Warrants outstanding weighted average contractual life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:title="label: WarrantsAndRightsOutstandingTerm to us-gaap_WarrantsAndRightsOutstandingTerm_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl">Warrant [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:title="label: WarrantsAndRightsNoteDisclosureAbstract to us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl1" xml:lang="en-US" id="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl1">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl1" xlink:title="label: WarrantsAndRightsNoteDisclosureAbstract to us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl">Weighted average shares outstanding - diluted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:title="label: WeightedAverageNumberOfDilutedSharesOutstanding to us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl">Weighted average shares outstanding - basic (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingBasic to us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="ChiefExecutiveOfficerMember" xlink:title="ChiefExecutiveOfficerMember" />
    <link:label xlink:type="resource" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US" id="srt_ChiefExecutiveOfficerMember_lbl">Dr. Federoffs's [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xlink:title="label: ChiefExecutiveOfficerMember to srt_ChiefExecutiveOfficerMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_ChiefExecutiveOfficerMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ChiefExecutiveOfficerMember_lbl1" xml:lang="en-US" id="srt_ChiefExecutiveOfficerMember_lbl1">Chief Executive Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl1" xlink:title="label: ChiefExecutiveOfficerMember to srt_ChiefExecutiveOfficerMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:label xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US" id="srt_EquityMethodInvesteeNameDomain_lbl">Investment, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl" xlink:title="label: EquityMethodInvesteeNameDomain to srt_EquityMethodInvesteeNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MaximumMember_lbl" xml:lang="en-US" id="srt_MaximumMember_lbl">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:title="label: MaximumMember to srt_MaximumMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MinimumMember_lbl" xml:lang="en-US" id="srt_MinimumMember_lbl">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:title="label: MinimumMember to srt_MinimumMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipDomain_lbl" xml:lang="en-US" id="srt_OwnershipDomain_lbl">Ownership [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl" xlink:title="label: OwnershipDomain to srt_OwnershipDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipAxis_lbl" xml:lang="en-US" id="srt_OwnershipAxis_lbl">Ownership [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:title="label: OwnershipAxis to srt_OwnershipAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_RangeAxis_lbl" xml:lang="en-US" id="srt_RangeAxis_lbl">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:title="label: RangeAxis to srt_RangeAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeAxis_lbl1" xml:lang="en-US" id="srt_RangeAxis_lbl1">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl1" xlink:title="label: RangeAxis to srt_RangeAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeMember_lbl" xml:lang="en-US" id="srt_RangeMember_lbl">Statistical Measurement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="srt_RangeMember_lbl" xlink:title="label: RangeMember to srt_RangeMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:label xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScenarioForecastMember_lbl" xml:lang="en-US" id="srt_ScenarioForecastMember_lbl">Forecast [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:title="label: ScenarioForecastMember to srt_ScenarioForecastMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" id="srt_ScenarioUnspecifiedDomain_lbl">Scenario [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xlink:title="label: ScenarioUnspecifiedDomain to srt_ScenarioUnspecifiedDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US" id="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl">Investment, Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:title="label: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:label xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_StatementScenarioAxis_lbl" xml:lang="en-US" id="srt_StatementScenarioAxis_lbl">Scenario [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:title="label: StatementScenarioAxis to srt_StatementScenarioAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US" id="srt_TitleOfIndividualAxis_lbl">Title of Individual [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:title="label: TitleOfIndividualAxis to srt_TitleOfIndividualAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" id="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl">Title of Individual [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:title="label: TitleOfIndividualWithRelationshipToEntityDomain to srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="DocumentQuarterlyReport" xlink:title="DocumentQuarterlyReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US" id="dei_DocumentQuarterlyReport_lbl">Document Quarterly Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:title="label: DocumentQuarterlyReport to dei_DocumentQuarterlyReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentTransitionReport_lbl" xml:lang="en-US" id="dei_DocumentTransitionReport_lbl">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:title="label: DocumentTransitionReport to dei_DocumentTransitionReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:label xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" id="dei_EntityInteractiveDataCurrent_lbl">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:title="label: EntityInteractiveDataCurrent to dei_EntityInteractiveDataCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:label xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LegalEntityAxis_lbl" xml:lang="en-US" id="dei_LegalEntityAxis_lbl">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:title="label: LegalEntityAxis to dei_LegalEntityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:label xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityDomain_lbl" xml:lang="en-US" id="dei_EntityDomain_lbl">Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityDomain" xlink:to="dei_EntityDomain_lbl" xlink:title="label: EntityDomain to dei_EntityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" id="dei_EntityCurrentReportingStatus_lbl">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:title="label: EntityCurrentReportingStatus to dei_EntityCurrentReportingStatus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityShellCompany_lbl" xml:lang="en-US" id="dei_EntityShellCompany_lbl">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:title="label: EntityShellCompany to dei_EntityShellCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="dei_EntityFilerCategory_lbl">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:title="label: EntityFilerCategory to dei_EntityFilerCategory_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:label xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntitySmallBusiness_lbl" xml:lang="en-US" id="dei_EntitySmallBusiness_lbl">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:title="label: EntitySmallBusiness to dei_EntitySmallBusiness_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding_lbl">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:title="label: EntityCommonStockSharesOutstanding to dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl">Equity impact of the shares of new stock issued of preferred stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:title="label: StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1">Stock Issued During Period, Shares, New Issues of Preferred Stock, Retained by Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2">Series A preferred stock retained in business combination (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:label xlink:type="resource" xlink:label="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xml:lang="en-US" id="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl">Number of shares Forfeiture of unvested restricted stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xml:lang="en-US" id="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1">Shares Issued, Shares, Forfeiture of unvested restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" xml:lang="en-US" id="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2">Forfeiture of unvested restricted stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:to="btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" xlink:title="label: SharesIssuedSharesForfeitureOfUnvestedRestrictedStock to btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:label="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl">Value of stock issued pursuant to rights offering membership units during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:to="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" xlink:title="label: StockIssuedDuringPeriodValueRightsOfferingMembershipUnits to btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1">Stock Issued During Period, Value, Rights Offering Membership Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:to="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" xlink:title="label: StockIssuedDuringPeriodValueRightsOfferingMembershipUnits to btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2">Brooklyn rights offerings membership units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:to="btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" xlink:title="label: StockIssuedDuringPeriodValueRightsOfferingMembershipUnits to btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MembershipEquityMember" xlink:label="MembershipEquityMember" xlink:title="MembershipEquityMember" />
    <link:label xlink:type="resource" xlink:label="btx_MembershipEquityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_MembershipEquityMember_lbl" xml:lang="en-US" id="btx_MembershipEquityMember_lbl">Equity membership interest in entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MembershipEquityMember" xlink:to="btx_MembershipEquityMember_lbl" xlink:title="label: MembershipEquityMember to btx_MembershipEquityMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_MembershipEquityMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_MembershipEquityMember_lbl1" xml:lang="en-US" id="btx_MembershipEquityMember_lbl1">Membership Equity [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MembershipEquityMember" xlink:to="btx_MembershipEquityMember_lbl1" xlink:title="label: MembershipEquityMember to btx_MembershipEquityMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_MembershipEquityMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_MembershipEquityMember_lbl2" xml:lang="en-US" id="btx_MembershipEquityMember_lbl2">Membership Equity [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MembershipEquityMember" xlink:to="btx_MembershipEquityMember_lbl2" xlink:title="label: MembershipEquityMember to btx_MembershipEquityMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl">Equity impact of the value of new stock issued of preferred stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" xlink:title="label: StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1">Stock Issued During Period, Value, New Issues of Preferred Stock, Retained by Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" xlink:title="label: StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2">Series A preferred stock retained in business combination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:to="btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" xlink:title="label: StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders to btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValuePrivateOffering" xlink:label="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="StockIssuedDuringPeriodValuePrivateOffering" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl">Equity impact of the value of stock that has been issued in private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValuePrivateOffering" xlink:to="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl" xlink:title="label: StockIssuedDuringPeriodValuePrivateOffering to btx_StockIssuedDuringPeriodValuePrivateOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl1">Stock Issued During Period, Value, Private Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValuePrivateOffering" xlink:to="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl1" xlink:title="label: StockIssuedDuringPeriodValuePrivateOffering to btx_StockIssuedDuringPeriodValuePrivateOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl2">Issuance of common stock in connection with private offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValuePrivateOffering" xlink:to="btx_StockIssuedDuringPeriodValuePrivateOffering_lbl2" xlink:title="label: StockIssuedDuringPeriodValuePrivateOffering to btx_StockIssuedDuringPeriodValuePrivateOffering_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl">Value of stock related to Forfeiture of unvested restricted stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1">Stock Issued During Period, Value, Forfeiture of Unvested Restricted Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2">Forfeiture of unvested restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:to="btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" xlink:title="label: StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock to btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueAcquisitions1" xlink:label="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="StockIssuedDuringPeriodValueAcquisitions1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl">Value of stock issued pursuant to acquisitions during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions1 to btx_StockIssuedDuringPeriodValueAcquisitions1_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl1">Stock Issued During Period, Value, Acquisitions1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl1" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions1 to btx_StockIssuedDuringPeriodValueAcquisitions1_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl2">Issuance of common stock for business combination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodValueAcquisitions1_lbl2" xlink:title="label: StockIssuedDuringPeriodValueAcquisitions1 to btx_StockIssuedDuringPeriodValueAcquisitions1_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:label="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" />
    <link:label xlink:type="resource" xlink:label="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" xml:lang="en-US" id="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl">Amount of decrease (increase) in additional paid in capital (APIC) for the increase in redemption of temporary equity as the result of a triggering event associated with the temporary equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:to="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity to btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" xml:lang="en-US" id="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1">Adjustments to Additional Paid in Capital, Elimination Historical Member Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:to="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity to btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" xml:lang="en-US" id="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2">Elimination of Brooklyn's historical members' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:to="btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity to btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesPrivateOffering" xlink:label="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="StockIssuedDuringPeriodSharesPrivateOffering" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl">Number of shares that have been issued in private offering during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesPrivateOffering" xlink:to="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl" xlink:title="label: StockIssuedDuringPeriodSharesPrivateOffering to btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl1">Stock Issued During Period, Shares, Private Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesPrivateOffering" xlink:to="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesPrivateOffering to btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl2">Issuance of common stock in connection with private offering (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesPrivateOffering" xlink:to="btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesPrivateOffering to btx_StockIssuedDuringPeriodSharesPrivateOffering_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonUnitsMember" xlink:label="CommonUnitsMember" xlink:title="CommonUnitsMember" />
    <link:label xlink:type="resource" xlink:label="btx_CommonUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_CommonUnitsMember_lbl" xml:lang="en-US" id="btx_CommonUnitsMember_lbl">Classification of common stock that has different rights than provided to common units, representing ownership interest in a corporation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonUnitsMember" xlink:to="btx_CommonUnitsMember_lbl" xlink:title="label: CommonUnitsMember to btx_CommonUnitsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_CommonUnitsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CommonUnitsMember_lbl1" xml:lang="en-US" id="btx_CommonUnitsMember_lbl1">Common Units [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonUnitsMember" xlink:to="btx_CommonUnitsMember_lbl1" xlink:title="label: CommonUnitsMember to btx_CommonUnitsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_CommonUnitsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="btx_CommonUnitsMember_lbl2" xml:lang="en-US" id="btx_CommonUnitsMember_lbl2">Common [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonUnitsMember" xlink:to="btx_CommonUnitsMember_lbl2" xlink:title="label: CommonUnitsMember to btx_CommonUnitsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:label="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:title="StockIssuedDuringPeriodSharesInLieuOfDividends" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl">Number of shares issued during the period in lieu of dividends to be paid.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:to="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl" xlink:title="label: StockIssuedDuringPeriodSharesInLieuOfDividends to btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl1">Stock Issued During Period, Shares, in Lieu of Dividends</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:to="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesInLieuOfDividends to btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl2">Issuance of common stock in lieu of cash dividend to Series A preferred stockholders (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:to="btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesInLieuOfDividends to btx_StockIssuedDuringPeriodSharesInLieuOfDividends_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueInLieuOfDividends" xlink:label="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:title="StockIssuedDuringPeriodValueInLieuOfDividends" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl">Value of stock issued during the period in Lieu of Dividends to be paid.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:to="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl" xlink:title="label: StockIssuedDuringPeriodValueInLieuOfDividends to btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl1">Stock Issued During Period, Value, in Lieu of Dividends</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:to="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl1" xlink:title="label: StockIssuedDuringPeriodValueInLieuOfDividends to btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl2">Issuance of common stock in lieu of cash dividend to Series A preferred stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:to="btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl2" xlink:title="label: StockIssuedDuringPeriodValueInLieuOfDividends to btx_StockIssuedDuringPeriodValueInLieuOfDividends_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodSharesStockPurchaseAgreement" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl">Number of shares that have been issued in a stock purchase agreement during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:to="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" xlink:title="label: StockIssuedDuringPeriodSharesStockPurchaseAgreement to btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1">Stock Issued During Period, Shares, Stock Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:to="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesStockPurchaseAgreement to btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl2">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:to="btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesStockPurchaseAgreement to btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodValueStockPurchaseAgreement" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl">Equity impact of the value of stock that has been issued in a stock purchase agreement during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:to="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" xlink:title="label: StockIssuedDuringPeriodValueStockPurchaseAgreement to btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1">Stock Issued During Period, Value, Stock Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:to="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" xlink:title="label: StockIssuedDuringPeriodValueStockPurchaseAgreement to btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl2">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:to="btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl2" xlink:title="label: StockIssuedDuringPeriodValueStockPurchaseAgreement to btx_StockIssuedDuringPeriodValueStockPurchaseAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonStockToBeRetainedByNTNSharesStockholders" xlink:label="CommonStockToBeRetainedByNTNSharesStockholders" xlink:title="CommonStockToBeRetainedByNTNSharesStockholders" />
    <link:label xlink:type="resource" xlink:label="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl" xml:lang="en-US" id="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl">Number of shares of common stock to be retained by NTN stockholders during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockToBeRetainedByNTNSharesStockholders" xlink:to="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl" xlink:title="label: CommonStockToBeRetainedByNTNSharesStockholders to btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl1" xml:lang="en-US" id="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl1">Common Stock to be Retained by NTN, Shares, Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockToBeRetainedByNTNSharesStockholders" xlink:to="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl1" xlink:title="label: CommonStockToBeRetainedByNTNSharesStockholders to btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl2" xml:lang="en-US" id="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl2">Common stock to be retained by NTN stockholders (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockToBeRetainedByNTNSharesStockholders" xlink:to="btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl2" xlink:title="label: CommonStockToBeRetainedByNTNSharesStockholders to btx_CommonStockToBeRetainedByNTNSharesStockholders_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonStockToBeRetainedByNTNValueStockholders" xlink:label="CommonStockToBeRetainedByNTNValueStockholders" xlink:title="CommonStockToBeRetainedByNTNValueStockholders" />
    <link:label xlink:type="resource" xlink:label="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl" xml:lang="en-US" id="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl">Value of common stock to be retained by NTN stockholders during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockToBeRetainedByNTNValueStockholders" xlink:to="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl" xlink:title="label: CommonStockToBeRetainedByNTNValueStockholders to btx_CommonStockToBeRetainedByNTNValueStockholders_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl1" xml:lang="en-US" id="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl1">Common Stock to be Retained by NTN, Value, Stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockToBeRetainedByNTNValueStockholders" xlink:to="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl1" xlink:title="label: CommonStockToBeRetainedByNTNValueStockholders to btx_CommonStockToBeRetainedByNTNValueStockholders_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl2" xml:lang="en-US" id="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl2">Common stock to be retained by NTN stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockToBeRetainedByNTNValueStockholders" xlink:to="btx_CommonStockToBeRetainedByNTNValueStockholders_lbl2" xlink:title="label: CommonStockToBeRetainedByNTNValueStockholders to btx_CommonStockToBeRetainedByNTNValueStockholders_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:label="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:title="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl" xml:lang="en-US" id="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl">Tabular disclosure of the number RSUs vested and settled.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:to="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl" xlink:title="label: ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock to btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl1" xml:lang="en-US" id="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl1">Schedule of Restricted Stock Units Vested and Settled [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:to="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl1" xlink:title="label: ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock to btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl2" xml:lang="en-US" id="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl2">RSUs Vested and Settled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:to="btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl2" xlink:title="label: ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock to btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" xlink:label="ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" xlink:title="ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl" xml:lang="en-US" id="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl">Tabular disclosure of the equity options or other equity instruments granted during the year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" xlink:to="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl" xlink:title="label: ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock to btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl1" xml:lang="en-US" id="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl1">Share-Based Payment Arrangement, Restricted Stock Unit, Grant in Period [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" xlink:to="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl1" xlink:title="label: ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock to btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl2" xml:lang="en-US" id="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl2">RSU Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" xlink:to="btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl2" xlink:title="label: ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock to btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" xlink:label="ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" xlink:title="ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl" xml:lang="en-US" id="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl">Tabular disclosure for stock option granted during the year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" xlink:to="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl" xlink:title="label: ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock to btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl1" xml:lang="en-US" id="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl1">Share-Based Payment Arrangement, Option, Grants in Period [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" xlink:to="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl1" xlink:title="label: ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock to btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl2" xml:lang="en-US" id="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl2">Stock Option Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" xlink:to="btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl2" xlink:title="label: ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock to btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_Two022PerformanceBasedRestrictedStockUnitsMember" xlink:label="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:title="Two022PerformanceBasedRestrictedStockUnitsMember" />
    <link:label xlink:type="resource" xlink:label="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl" xml:lang="en-US" id="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl">The name of awards.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:to="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl" xlink:title="label: Two022PerformanceBasedRestrictedStockUnitsMember to btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl1" xml:lang="en-US" id="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl1">2022 Performance-Based Restricted Stock Units [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:to="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl1" xlink:title="label: Two022PerformanceBasedRestrictedStockUnitsMember to btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl2" xml:lang="en-US" id="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl2">2022 PSUs [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:to="btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl2" xlink:title="label: Two022PerformanceBasedRestrictedStockUnitsMember to btx_Two022PerformanceBasedRestrictedStockUnitsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ChiefExecutiveOfficerAndPresidentMember" xlink:label="ChiefExecutiveOfficerAndPresidentMember" xlink:title="ChiefExecutiveOfficerAndPresidentMember" />
    <link:label xlink:type="resource" xlink:label="btx_ChiefExecutiveOfficerAndPresidentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ChiefExecutiveOfficerAndPresidentMember_lbl" xml:lang="en-US" id="btx_ChiefExecutiveOfficerAndPresidentMember_lbl">Person with designation of chief executive officer and president.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChiefExecutiveOfficerAndPresidentMember_lbl" xlink:title="label: ChiefExecutiveOfficerAndPresidentMember to btx_ChiefExecutiveOfficerAndPresidentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ChiefExecutiveOfficerAndPresidentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ChiefExecutiveOfficerAndPresidentMember_lbl1" xml:lang="en-US" id="btx_ChiefExecutiveOfficerAndPresidentMember_lbl1">Chief Executive Officer and President [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChiefExecutiveOfficerAndPresidentMember_lbl1" xlink:title="label: ChiefExecutiveOfficerAndPresidentMember to btx_ChiefExecutiveOfficerAndPresidentMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ChiefExecutiveOfficerAndPresidentMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ChiefExecutiveOfficerAndPresidentMember_lbl2" xml:lang="en-US" id="btx_ChiefExecutiveOfficerAndPresidentMember_lbl2">Dr. Federoff [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChiefExecutiveOfficerAndPresidentMember_lbl2" xlink:title="label: ChiefExecutiveOfficerAndPresidentMember to btx_ChiefExecutiveOfficerAndPresidentMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:label xlink:type="resource" xlink:label="btx_EmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_EmployeeMember_lbl" xml:lang="en-US" id="btx_EmployeeMember_lbl">One of the employee of the entity, appointed to the position.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="btx_EmployeeMember_lbl" xlink:title="label: EmployeeMember to btx_EmployeeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_EmployeeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_EmployeeMember_lbl1" xml:lang="en-US" id="btx_EmployeeMember_lbl1">Employee [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="btx_EmployeeMember_lbl1" xlink:title="label: EmployeeMember to btx_EmployeeMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_EmployeeMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_EmployeeMember_lbl2" xml:lang="en-US" id="btx_EmployeeMember_lbl2">Employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="btx_EmployeeMember_lbl2" xlink:title="label: EmployeeMember to btx_EmployeeMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl">Represents the number of performance goals not achieved under share-based payment arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl1" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl1">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Performance Goal not Achieved</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl2" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl2">Number of performance goals not achieved</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:label="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:title="NumberOfPerformanceGoalsAreSubjectToAchieve" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl" xml:lang="en-US" id="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl">The number of performance goals are subject to achieve under 2022 performance based restricted stock units.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:to="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl" xlink:title="label: NumberOfPerformanceGoalsAreSubjectToAchieve to btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl1" xml:lang="en-US" id="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl1">Number of Performance Goals are Subject to Achieve</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:to="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl1" xlink:title="label: NumberOfPerformanceGoalsAreSubjectToAchieve to btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl2" xml:lang="en-US" id="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl2">Number of performance goals are subject to achieve</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:to="btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl2" xlink:title="label: NumberOfPerformanceGoalsAreSubjectToAchieve to btx_NumberOfPerformanceGoalsAreSubjectToAchieve_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl">The number of monthly installments for vesting of remaining shares in share-based compensation arrangement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares to btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl1" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl1">Share-based Compensation Arrangement by Share-based Payment, Number of Monthly Installments for Vesting of Remaining Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares to btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl2" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl2">Number of monthly installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares to btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl">The number of extended post-termination exercise period under the share-based compensation arrangements, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1">Share-based Compensation Arrangement By Share-based Payment Award, Extended Post-Termination, Exercise Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl2" xml:lang="en-US" id="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl2">Exercise period of extended post-termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:to="btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod to btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_TimeBasedStockOptionGrantMember" xlink:label="TimeBasedStockOptionGrantMember" xlink:title="TimeBasedStockOptionGrantMember" />
    <link:label xlink:type="resource" xlink:label="btx_TimeBasedStockOptionGrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_TimeBasedStockOptionGrantMember_lbl" xml:lang="en-US" id="btx_TimeBasedStockOptionGrantMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on time basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimeBasedStockOptionGrantMember" xlink:to="btx_TimeBasedStockOptionGrantMember_lbl" xlink:title="label: TimeBasedStockOptionGrantMember to btx_TimeBasedStockOptionGrantMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_TimeBasedStockOptionGrantMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_TimeBasedStockOptionGrantMember_lbl1" xml:lang="en-US" id="btx_TimeBasedStockOptionGrantMember_lbl1">Time-Based Stock Option Grant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimeBasedStockOptionGrantMember" xlink:to="btx_TimeBasedStockOptionGrantMember_lbl1" xlink:title="label: TimeBasedStockOptionGrantMember to btx_TimeBasedStockOptionGrantMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_TimeBasedStockOptionGrantMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_TimeBasedStockOptionGrantMember_lbl2" xml:lang="en-US" id="btx_TimeBasedStockOptionGrantMember_lbl2">Time-Based Grant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TimeBasedStockOptionGrantMember" xlink:to="btx_TimeBasedStockOptionGrantMember_lbl2" xlink:title="label: TimeBasedStockOptionGrantMember to btx_TimeBasedStockOptionGrantMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PerformanceBasedStockOptionGrantMember" xlink:label="PerformanceBasedStockOptionGrantMember" xlink:title="PerformanceBasedStockOptionGrantMember" />
    <link:label xlink:type="resource" xlink:label="btx_PerformanceBasedStockOptionGrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PerformanceBasedStockOptionGrantMember_lbl" xml:lang="en-US" id="btx_PerformanceBasedStockOptionGrantMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on performance basis.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerformanceBasedStockOptionGrantMember" xlink:to="btx_PerformanceBasedStockOptionGrantMember_lbl" xlink:title="label: PerformanceBasedStockOptionGrantMember to btx_PerformanceBasedStockOptionGrantMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PerformanceBasedStockOptionGrantMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PerformanceBasedStockOptionGrantMember_lbl1" xml:lang="en-US" id="btx_PerformanceBasedStockOptionGrantMember_lbl1">Performance-Based Stock Option Grant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerformanceBasedStockOptionGrantMember" xlink:to="btx_PerformanceBasedStockOptionGrantMember_lbl1" xlink:title="label: PerformanceBasedStockOptionGrantMember to btx_PerformanceBasedStockOptionGrantMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PerformanceBasedStockOptionGrantMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PerformanceBasedStockOptionGrantMember_lbl2" xml:lang="en-US" id="btx_PerformanceBasedStockOptionGrantMember_lbl2">Milestone Grant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PerformanceBasedStockOptionGrantMember" xlink:to="btx_PerformanceBasedStockOptionGrantMember_lbl2" xlink:title="label: PerformanceBasedStockOptionGrantMember to btx_PerformanceBasedStockOptionGrantMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_OperatingLeaseArea" xlink:label="OperatingLeaseArea" xlink:title="OperatingLeaseArea" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseArea_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_OperatingLeaseArea_lbl" xml:lang="en-US" id="btx_OperatingLeaseArea_lbl">Area of leased property under operating lease.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseArea" xlink:to="btx_OperatingLeaseArea_lbl" xlink:title="label: OperatingLeaseArea to btx_OperatingLeaseArea_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseArea_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_OperatingLeaseArea_lbl1" xml:lang="en-US" id="btx_OperatingLeaseArea_lbl1">Operating Lease Area</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseArea" xlink:to="btx_OperatingLeaseArea_lbl1" xlink:title="label: OperatingLeaseArea to btx_OperatingLeaseArea_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseArea_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_OperatingLeaseArea_lbl2" xml:lang="en-US" id="btx_OperatingLeaseArea_lbl2">Operating lease area</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseArea" xlink:to="btx_OperatingLeaseArea_lbl2" xlink:title="label: OperatingLeaseArea to btx_OperatingLeaseArea_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_UnamortizedLeaseholdImprovements" xlink:label="UnamortizedLeaseholdImprovements" xlink:title="UnamortizedLeaseholdImprovements" />
    <link:label xlink:type="resource" xlink:label="btx_UnamortizedLeaseholdImprovements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_UnamortizedLeaseholdImprovements_lbl" xml:lang="en-US" id="btx_UnamortizedLeaseholdImprovements_lbl">The amount of unamortized leasehold improvements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnamortizedLeaseholdImprovements" xlink:to="btx_UnamortizedLeaseholdImprovements_lbl" xlink:title="label: UnamortizedLeaseholdImprovements to btx_UnamortizedLeaseholdImprovements_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_UnamortizedLeaseholdImprovements_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_UnamortizedLeaseholdImprovements_lbl1" xml:lang="en-US" id="btx_UnamortizedLeaseholdImprovements_lbl1">Unamortized Leasehold Improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnamortizedLeaseholdImprovements" xlink:to="btx_UnamortizedLeaseholdImprovements_lbl1" xlink:title="label: UnamortizedLeaseholdImprovements to btx_UnamortizedLeaseholdImprovements_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_UnamortizedLeaseholdImprovements_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_UnamortizedLeaseholdImprovements_lbl2" xml:lang="en-US" id="btx_UnamortizedLeaseholdImprovements_lbl2">Unamortized leasehold improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnamortizedLeaseholdImprovements" xlink:to="btx_UnamortizedLeaseholdImprovements_lbl2" xlink:title="label: UnamortizedLeaseholdImprovements to btx_UnamortizedLeaseholdImprovements_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LesseeCommitmentToPurchaseProperty" xlink:label="LesseeCommitmentToPurchaseProperty" xlink:title="LesseeCommitmentToPurchaseProperty" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeCommitmentToPurchaseProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LesseeCommitmentToPurchaseProperty_lbl" xml:lang="en-US" id="btx_LesseeCommitmentToPurchaseProperty_lbl">The amount of property for which lessee committed to purchase.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="btx_LesseeCommitmentToPurchaseProperty_lbl" xlink:title="label: LesseeCommitmentToPurchaseProperty to btx_LesseeCommitmentToPurchaseProperty_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeCommitmentToPurchaseProperty_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LesseeCommitmentToPurchaseProperty_lbl1" xml:lang="en-US" id="btx_LesseeCommitmentToPurchaseProperty_lbl1">Lessee, Commitment to Purchase Property</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="btx_LesseeCommitmentToPurchaseProperty_lbl1" xlink:title="label: LesseeCommitmentToPurchaseProperty to btx_LesseeCommitmentToPurchaseProperty_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeCommitmentToPurchaseProperty_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LesseeCommitmentToPurchaseProperty_lbl2" xml:lang="en-US" id="btx_LesseeCommitmentToPurchaseProperty_lbl2">Commitment to purchase equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeCommitmentToPurchaseProperty" xlink:to="btx_LesseeCommitmentToPurchaseProperty_lbl2" xlink:title="label: LesseeCommitmentToPurchaseProperty to btx_LesseeCommitmentToPurchaseProperty_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_BaseRentPerSquareFoot" xlink:label="BaseRentPerSquareFoot" xlink:title="BaseRentPerSquareFoot" />
    <link:label xlink:type="resource" xlink:label="btx_BaseRentPerSquareFoot_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_BaseRentPerSquareFoot_lbl" xml:lang="en-US" id="btx_BaseRentPerSquareFoot_lbl">Amount of base rent expense per square foot for leased asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BaseRentPerSquareFoot" xlink:to="btx_BaseRentPerSquareFoot_lbl" xlink:title="label: BaseRentPerSquareFoot to btx_BaseRentPerSquareFoot_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_BaseRentPerSquareFoot_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_BaseRentPerSquareFoot_lbl1" xml:lang="en-US" id="btx_BaseRentPerSquareFoot_lbl1">Base Rent per Square Foot</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BaseRentPerSquareFoot" xlink:to="btx_BaseRentPerSquareFoot_lbl1" xlink:title="label: BaseRentPerSquareFoot to btx_BaseRentPerSquareFoot_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_BaseRentPerSquareFoot_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_BaseRentPerSquareFoot_lbl2" xml:lang="en-US" id="btx_BaseRentPerSquareFoot_lbl2">Base rent (per square foot)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BaseRentPerSquareFoot" xlink:to="btx_BaseRentPerSquareFoot_lbl2" xlink:title="label: BaseRentPerSquareFoot to btx_BaseRentPerSquareFoot_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageBaseRentIncreaseOnEachAnniversary" xlink:label="PercentageBaseRentIncreaseOnEachAnniversary" xlink:title="PercentageBaseRentIncreaseOnEachAnniversary" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl" xml:lang="en-US" id="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl">The percentage of base rent increase on each anniversary.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageBaseRentIncreaseOnEachAnniversary" xlink:to="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl" xlink:title="label: PercentageBaseRentIncreaseOnEachAnniversary to btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl1" xml:lang="en-US" id="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl1">Percentage, Base Rent Increase on each Anniversary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageBaseRentIncreaseOnEachAnniversary" xlink:to="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl1" xlink:title="label: PercentageBaseRentIncreaseOnEachAnniversary to btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl2" xml:lang="en-US" id="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl2">Percentage of increase in base rent on each year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageBaseRentIncreaseOnEachAnniversary" xlink:to="btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl2" xlink:title="label: PercentageBaseRentIncreaseOnEachAnniversary to btx_PercentageBaseRentIncreaseOnEachAnniversary_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InitialMeasurementOfOperatingLeaseROUAssets" xlink:label="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:label xlink:type="resource" xlink:label="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl" xml:lang="en-US" id="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl">The fair value of initial measurement of operating lease ROU assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseROUAssets" xlink:to="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl" xlink:title="label: InitialMeasurementOfOperatingLeaseROUAssets to btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" xml:lang="en-US" id="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl1">Initial Measurement of Operating Lease ROU Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseROUAssets" xlink:to="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" xlink:title="label: InitialMeasurementOfOperatingLeaseROUAssets to btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" xml:lang="en-US" id="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl2">Initial measurement of operating lease ROU assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseROUAssets" xlink:to="btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" xlink:title="label: InitialMeasurementOfOperatingLeaseROUAssets to btx_InitialMeasurementOfOperatingLeaseROUAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_WriteOffOfOperatingLeaseRightOfUseAsset" xlink:label="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:title="WriteOffOfOperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl">Write-off of operating lease right-of-use asset due to lease termination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:to="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" xlink:title="label: WriteOffOfOperatingLeaseRightOfUseAsset to btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1">Write-off of Operating Lease Right-of-use Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:to="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" xlink:title="label: WriteOffOfOperatingLeaseRightOfUseAsset to btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2">Write off of ROU asset due to lease termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:to="btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" xlink:title="label: WriteOffOfOperatingLeaseRightOfUseAsset to btx_WriteOffOfOperatingLeaseRightOfUseAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_OperatingLeaseAssestAbstract" xlink:label="OperatingLeaseAssestAbstract" xlink:title="OperatingLeaseAssestAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseAssestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_OperatingLeaseAssestAbstract_lbl1" xml:lang="en-US" id="btx_OperatingLeaseAssestAbstract_lbl1">Operating Lease, Asset [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseAssestAbstract" xlink:to="btx_OperatingLeaseAssestAbstract_lbl1" xlink:title="label: OperatingLeaseAssestAbstract to btx_OperatingLeaseAssestAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_WriteOffOfOperatingLeaseLiability" xlink:label="WriteOffOfOperatingLeaseLiability" xlink:title="WriteOffOfOperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_WriteOffOfOperatingLeaseLiability_lbl" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseLiability_lbl">Write-off of operating lease liability due to lease termination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseLiability" xlink:to="btx_WriteOffOfOperatingLeaseLiability_lbl" xlink:title="label: WriteOffOfOperatingLeaseLiability to btx_WriteOffOfOperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_WriteOffOfOperatingLeaseLiability_lbl1" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseLiability_lbl1">Write- off of Operating Lease Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseLiability" xlink:to="btx_WriteOffOfOperatingLeaseLiability_lbl1" xlink:title="label: WriteOffOfOperatingLeaseLiability to btx_WriteOffOfOperatingLeaseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_WriteOffOfOperatingLeaseLiability_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_WriteOffOfOperatingLeaseLiability_lbl2" xml:lang="en-US" id="btx_WriteOffOfOperatingLeaseLiability_lbl2">Write off of operating lease liability due to lease termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WriteOffOfOperatingLeaseLiability" xlink:to="btx_WriteOffOfOperatingLeaseLiability_lbl2" xlink:title="label: WriteOffOfOperatingLeaseLiability to btx_WriteOffOfOperatingLeaseLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:label="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="PrincipalPaymentsOnOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xml:lang="en-US" id="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl">Principal payments on operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xml:lang="en-US" id="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1">Principal payments on operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" xml:lang="en-US" id="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2">Principal payments on operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:to="btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" xlink:title="label: PrincipalPaymentsOnOperatingLeaseLiabilities to btx_PrincipalPaymentsOnOperatingLeaseLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InitialMeasurementOfOperatingLeaseLiabilities" xlink:label="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl" xml:lang="en-US" id="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl">The fair value of initial measurement of operating lease liabilities in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseLiabilities" xlink:to="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl" xlink:title="label: InitialMeasurementOfOperatingLeaseLiabilities to btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" xml:lang="en-US" id="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl1">Initial Measurement of Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseLiabilities" xlink:to="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" xlink:title="label: InitialMeasurementOfOperatingLeaseLiabilities to btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" xml:lang="en-US" id="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl2">Initial measurement of operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfOperatingLeaseLiabilities" xlink:to="btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" xlink:title="label: InitialMeasurementOfOperatingLeaseLiabilities to btx_InitialMeasurementOfOperatingLeaseLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:label="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl">Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1">Operating Lease Right-of-use Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" xml:lang="en-US" id="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2">Operating Lease Right-of-use Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:to="btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" xlink:title="label: OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock to btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl" xml:lang="en-US" id="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl">Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fourth fiscal year following latest fiscal year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour to btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl1" xml:lang="en-US" id="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl1">Lessee, Operating Lease, Liability, Payments Due after Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour to btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl2" xml:lang="en-US" id="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl2">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl2" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour to btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:label="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl" xml:lang="en-US" id="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl">No definition available.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl" xlink:title="label: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xml:lang="en-US" id="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1">Lessee Operating Lease Weighted Average Remaining Lease Term And Discount Rate Abstract [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" xlink:title="label: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" xml:lang="en-US" id="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2">Weighted Average Remaining Lease Term and Discount Rate [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" xlink:title="label: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightExercised" xlink:label="ClassOfWarrantOrRightExercised" xlink:title="ClassOfWarrantOrRightExercised" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US" id="btx_ClassOfWarrantOrRightExercised_lbl">Number of warrants or rights exercised during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercised" xlink:to="btx_ClassOfWarrantOrRightExercised_lbl" xlink:title="label: ClassOfWarrantOrRightExercised to btx_ClassOfWarrantOrRightExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ClassOfWarrantOrRightExercised_lbl1" xml:lang="en-US" id="btx_ClassOfWarrantOrRightExercised_lbl1">Class of Warrant or Right Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercised" xlink:to="btx_ClassOfWarrantOrRightExercised_lbl1" xlink:title="label: ClassOfWarrantOrRightExercised to btx_ClassOfWarrantOrRightExercised_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightExercised_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="btx_ClassOfWarrantOrRightExercised_lbl2" xml:lang="en-US" id="btx_ClassOfWarrantOrRightExercised_lbl2">Warrants exercised (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercised" xlink:to="btx_ClassOfWarrantOrRightExercised_lbl2" xlink:title="label: ClassOfWarrantOrRightExercised to btx_ClassOfWarrantOrRightExercised_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AccruedGeneralAndAdministrativeExpenses" xlink:label="AccruedGeneralAndAdministrativeExpenses" xlink:title="AccruedGeneralAndAdministrativeExpenses" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedGeneralAndAdministrativeExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AccruedGeneralAndAdministrativeExpenses_lbl" xml:lang="en-US" id="btx_AccruedGeneralAndAdministrativeExpenses_lbl">Amount of accrued general and administrative expenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedGeneralAndAdministrativeExpenses" xlink:to="btx_AccruedGeneralAndAdministrativeExpenses_lbl" xlink:title="label: AccruedGeneralAndAdministrativeExpenses to btx_AccruedGeneralAndAdministrativeExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedGeneralAndAdministrativeExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AccruedGeneralAndAdministrativeExpenses_lbl1" xml:lang="en-US" id="btx_AccruedGeneralAndAdministrativeExpenses_lbl1">Accrued General and Administrative Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedGeneralAndAdministrativeExpenses" xlink:to="btx_AccruedGeneralAndAdministrativeExpenses_lbl1" xlink:title="label: AccruedGeneralAndAdministrativeExpenses to btx_AccruedGeneralAndAdministrativeExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedGeneralAndAdministrativeExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AccruedGeneralAndAdministrativeExpenses_lbl2" xml:lang="en-US" id="btx_AccruedGeneralAndAdministrativeExpenses_lbl2">Accrued general and administrative expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedGeneralAndAdministrativeExpenses" xlink:to="btx_AccruedGeneralAndAdministrativeExpenses_lbl2" xlink:title="label: AccruedGeneralAndAdministrativeExpenses to btx_AccruedGeneralAndAdministrativeExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AccruedResearchAndDevelopmentExpenses" xlink:label="AccruedResearchAndDevelopmentExpenses" xlink:title="AccruedResearchAndDevelopmentExpenses" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedResearchAndDevelopmentExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AccruedResearchAndDevelopmentExpenses_lbl" xml:lang="en-US" id="btx_AccruedResearchAndDevelopmentExpenses_lbl">Amount of accrued research and development expenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedResearchAndDevelopmentExpenses" xlink:to="btx_AccruedResearchAndDevelopmentExpenses_lbl" xlink:title="label: AccruedResearchAndDevelopmentExpenses to btx_AccruedResearchAndDevelopmentExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedResearchAndDevelopmentExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AccruedResearchAndDevelopmentExpenses_lbl1" xml:lang="en-US" id="btx_AccruedResearchAndDevelopmentExpenses_lbl1">Accrued Research and Development Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedResearchAndDevelopmentExpenses" xlink:to="btx_AccruedResearchAndDevelopmentExpenses_lbl1" xlink:title="label: AccruedResearchAndDevelopmentExpenses to btx_AccruedResearchAndDevelopmentExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AccruedResearchAndDevelopmentExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AccruedResearchAndDevelopmentExpenses_lbl2" xml:lang="en-US" id="btx_AccruedResearchAndDevelopmentExpenses_lbl2">Accrued research and development expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedResearchAndDevelopmentExpenses" xlink:to="btx_AccruedResearchAndDevelopmentExpenses_lbl2" xlink:title="label: AccruedResearchAndDevelopmentExpenses to btx_AccruedResearchAndDevelopmentExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:label="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:title="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" xml:lang="en-US" id="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1">Detailed information about Liquidity and Capital Resources [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" xlink:title="label: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" xml:lang="en-US" id="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2">Liquidity and Capital Resources [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" xlink:title="label: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl">Number of shares of stock issued during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl1">Stock Issued During Period, Shares, Acquisitions1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl2">Stock issued, shares, acquisition (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl2" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" xml:lang="en-US" id="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl3">Issuance of common stock for business combination (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesAcquisitions1" xlink:to="btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" xlink:title="label: StockIssuedDuringPeriodSharesAcquisitions1 to btx_StockIssuedDuringPeriodSharesAcquisitions1_lbl3" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightIssued" xlink:label="ClassOfWarrantOrRightIssued" xlink:title="ClassOfWarrantOrRightIssued" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ClassOfWarrantOrRightIssued_lbl" xml:lang="en-US" id="btx_ClassOfWarrantOrRightIssued_lbl">Number of shares issued into which the class of warrant or right may be converted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightIssued" xlink:to="btx_ClassOfWarrantOrRightIssued_lbl" xlink:title="label: ClassOfWarrantOrRightIssued to btx_ClassOfWarrantOrRightIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ClassOfWarrantOrRightIssued_lbl1" xml:lang="en-US" id="btx_ClassOfWarrantOrRightIssued_lbl1">Class of Warrant or Right, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightIssued" xlink:to="btx_ClassOfWarrantOrRightIssued_lbl1" xlink:title="label: ClassOfWarrantOrRightIssued to btx_ClassOfWarrantOrRightIssued_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightIssued_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ClassOfWarrantOrRightIssued_lbl2" xml:lang="en-US" id="btx_ClassOfWarrantOrRightIssued_lbl2">Number of rights options issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightIssued" xlink:to="btx_ClassOfWarrantOrRightIssued_lbl2" xlink:title="label: ClassOfWarrantOrRightIssued to btx_ClassOfWarrantOrRightIssued_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MergerAbstract" xlink:label="MergerAbstract" xlink:title="MergerAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_MergerAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_MergerAbstract_lbl1" xml:lang="en-US" id="btx_MergerAbstract_lbl1">Merger [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAbstract" xlink:to="btx_MergerAbstract_lbl1" xlink:title="label: MergerAbstract to btx_MergerAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MilestoneOptionsMember" xlink:label="MilestoneOptionsMember" xlink:title="MilestoneOptionsMember" />
    <link:label xlink:type="resource" xlink:label="btx_MilestoneOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_MilestoneOptionsMember_lbl" xml:lang="en-US" id="btx_MilestoneOptionsMember_lbl">Share-based payment arrangement granting right, subject to vesting and other restrictions based on milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestoneOptionsMember" xlink:to="btx_MilestoneOptionsMember_lbl" xlink:title="label: MilestoneOptionsMember to btx_MilestoneOptionsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_MilestoneOptionsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_MilestoneOptionsMember_lbl1" xml:lang="en-US" id="btx_MilestoneOptionsMember_lbl1">Milestone Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestoneOptionsMember" xlink:to="btx_MilestoneOptionsMember_lbl1" xlink:title="label: MilestoneOptionsMember to btx_MilestoneOptionsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_MilestoneOptionsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_MilestoneOptionsMember_lbl2" xml:lang="en-US" id="btx_MilestoneOptionsMember_lbl2">Milestone Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestoneOptionsMember" xlink:to="btx_MilestoneOptionsMember_lbl2" xlink:title="label: MilestoneOptionsMember to btx_MilestoneOptionsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PaymentToOfficerBaseSalary" xlink:label="PaymentToOfficerBaseSalary" xlink:title="PaymentToOfficerBaseSalary" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentToOfficerBaseSalary_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PaymentToOfficerBaseSalary_lbl" xml:lang="en-US" id="btx_PaymentToOfficerBaseSalary_lbl">Amount of cash outflows for payment of annual base salary for a period of twelve months after the expiration of the applicable revocation period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentToOfficerBaseSalary" xlink:to="btx_PaymentToOfficerBaseSalary_lbl" xlink:title="label: PaymentToOfficerBaseSalary to btx_PaymentToOfficerBaseSalary_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentToOfficerBaseSalary_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PaymentToOfficerBaseSalary_lbl1" xml:lang="en-US" id="btx_PaymentToOfficerBaseSalary_lbl1">Payment to Officer Base Salary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentToOfficerBaseSalary" xlink:to="btx_PaymentToOfficerBaseSalary_lbl1" xlink:title="label: PaymentToOfficerBaseSalary to btx_PaymentToOfficerBaseSalary_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentToOfficerBaseSalary_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PaymentToOfficerBaseSalary_lbl2" xml:lang="en-US" id="btx_PaymentToOfficerBaseSalary_lbl2">Payment of annual base salary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentToOfficerBaseSalary" xlink:to="btx_PaymentToOfficerBaseSalary_lbl2" xlink:title="label: PaymentToOfficerBaseSalary to btx_PaymentToOfficerBaseSalary_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:label="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:title="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" />
    <link:label xlink:type="resource" xlink:label="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl" xml:lang="en-US" id="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl">Amount of severance benefit, would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:to="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl" xlink:title="label: SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits to btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl1" xml:lang="en-US" id="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl1">Severance Benefit Receivable Based on Performance Restricted Stock Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:to="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl1" xlink:title="label: SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits to btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl2" xml:lang="en-US" id="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl2">Severance benefit receivable based on performance restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:to="btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl2" xlink:title="label: SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits to btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_SeparationAgreementAbstract" xlink:label="SeparationAgreementAbstract" xlink:title="SeparationAgreementAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_SeparationAgreementAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_SeparationAgreementAbstract_lbl1" xml:lang="en-US" id="btx_SeparationAgreementAbstract_lbl1">Separation Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeparationAgreementAbstract" xlink:to="btx_SeparationAgreementAbstract_lbl1" xlink:title="label: SeparationAgreementAbstract to btx_SeparationAgreementAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_SeparationAgreementAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_SeparationAgreementAbstract_lbl2" xml:lang="en-US" id="btx_SeparationAgreementAbstract_lbl2">Separation Agreement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeparationAgreementAbstract" xlink:to="btx_SeparationAgreementAbstract_lbl2" xlink:title="label: SeparationAgreementAbstract to btx_SeparationAgreementAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ChiefExecutiveOfficerSeparationAgreementTextBlock" xlink:label="ChiefExecutiveOfficerSeparationAgreementTextBlock" xlink:title="ChiefExecutiveOfficerSeparationAgreementTextBlock" />
    <link:label xlink:type="resource" xlink:label="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl" xml:lang="en-US" id="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl">The entire disclosure pertaining to chief executive officer separation agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerSeparationAgreementTextBlock" xlink:to="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl" xlink:title="label: ChiefExecutiveOfficerSeparationAgreementTextBlock to btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl1" xml:lang="en-US" id="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl1">Chief Executive Officer Separation Agreement [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerSeparationAgreementTextBlock" xlink:to="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl1" xlink:title="label: ChiefExecutiveOfficerSeparationAgreementTextBlock to btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl2" xml:lang="en-US" id="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl2">CEO SEPARATION AGREEMENT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChiefExecutiveOfficerSeparationAgreementTextBlock" xlink:to="btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl2" xlink:title="label: ChiefExecutiveOfficerSeparationAgreementTextBlock to btx_ChiefExecutiveOfficerSeparationAgreementTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CEOSEPARATIONAGREEMENTAbstract" xlink:label="CEOSEPARATIONAGREEMENTAbstract" xlink:title="CEOSEPARATIONAGREEMENTAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_CEOSEPARATIONAGREEMENTAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CEOSEPARATIONAGREEMENTAbstract_lbl1" xml:lang="en-US" id="btx_CEOSEPARATIONAGREEMENTAbstract_lbl1">CEO SEPARATION AGREEMENT [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CEOSEPARATIONAGREEMENTAbstract" xlink:to="btx_CEOSEPARATIONAGREEMENTAbstract_lbl1" xlink:title="label: CEOSEPARATIONAGREEMENTAbstract to btx_CEOSEPARATIONAGREEMENTAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonStockWithheldToCoverTaxes" xlink:label="CommonStockWithheldToCoverTaxes" xlink:title="CommonStockWithheldToCoverTaxes" />
    <link:label xlink:type="resource" xlink:label="btx_CommonStockWithheldToCoverTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_CommonStockWithheldToCoverTaxes_lbl" xml:lang="en-US" id="btx_CommonStockWithheldToCoverTaxes_lbl">The number of shares of common stock withheld to cover the withholding taxes.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockWithheldToCoverTaxes" xlink:to="btx_CommonStockWithheldToCoverTaxes_lbl" xlink:title="label: CommonStockWithheldToCoverTaxes to btx_CommonStockWithheldToCoverTaxes_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_CommonStockWithheldToCoverTaxes_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CommonStockWithheldToCoverTaxes_lbl1" xml:lang="en-US" id="btx_CommonStockWithheldToCoverTaxes_lbl1">Common Stock Withheld to Cover Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockWithheldToCoverTaxes" xlink:to="btx_CommonStockWithheldToCoverTaxes_lbl1" xlink:title="label: CommonStockWithheldToCoverTaxes to btx_CommonStockWithheldToCoverTaxes_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_CommonStockWithheldToCoverTaxes_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_CommonStockWithheldToCoverTaxes_lbl2" xml:lang="en-US" id="btx_CommonStockWithheldToCoverTaxes_lbl2">Common stock withheld to cover taxes (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockWithheldToCoverTaxes" xlink:to="btx_CommonStockWithheldToCoverTaxes_lbl2" xlink:title="label: CommonStockWithheldToCoverTaxes to btx_CommonStockWithheldToCoverTaxes_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NumberOfAwardsVestedAndSettledAbstract" xlink:label="NumberOfAwardsVestedAndSettledAbstract" xlink:title="NumberOfAwardsVestedAndSettledAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfAwardsVestedAndSettledAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NumberOfAwardsVestedAndSettledAbstract_lbl1" xml:lang="en-US" id="btx_NumberOfAwardsVestedAndSettledAbstract_lbl1">Number of Awards Vested and Settled [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="btx_NumberOfAwardsVestedAndSettledAbstract_lbl1" xlink:title="label: NumberOfAwardsVestedAndSettledAbstract to btx_NumberOfAwardsVestedAndSettledAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfAwardsVestedAndSettledAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NumberOfAwardsVestedAndSettledAbstract_lbl2" xml:lang="en-US" id="btx_NumberOfAwardsVestedAndSettledAbstract_lbl2">Number of RSUs Vested and Settled [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="btx_NumberOfAwardsVestedAndSettledAbstract_lbl2" xlink:title="label: NumberOfAwardsVestedAndSettledAbstract to btx_NumberOfAwardsVestedAndSettledAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AggregateCalendarDays" xlink:label="AggregateCalendarDays" xlink:title="AggregateCalendarDays" />
    <link:label xlink:type="resource" xlink:label="btx_AggregateCalendarDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AggregateCalendarDays_lbl" xml:lang="en-US" id="btx_AggregateCalendarDays_lbl">In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified aggregate calendar days (which need not be consecutive calendar days) during any 12-month period for resale, Updated definition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateCalendarDays" xlink:to="btx_AggregateCalendarDays_lbl" xlink:title="label: AggregateCalendarDays to btx_AggregateCalendarDays_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AggregateCalendarDays_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AggregateCalendarDays_lbl1" xml:lang="en-US" id="btx_AggregateCalendarDays_lbl1">Aggregate Calendar Days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateCalendarDays" xlink:to="btx_AggregateCalendarDays_lbl1" xlink:title="label: AggregateCalendarDays to btx_AggregateCalendarDays_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AggregateCalendarDays_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AggregateCalendarDays_lbl2" xml:lang="en-US" id="btx_AggregateCalendarDays_lbl2">Aggregate calendar days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateCalendarDays" xlink:to="btx_AggregateCalendarDays_lbl2" xlink:title="label: AggregateCalendarDays to btx_AggregateCalendarDays_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ConsecutiveCalendarDays" xlink:label="ConsecutiveCalendarDays" xlink:title="ConsecutiveCalendarDays" />
    <link:label xlink:type="resource" xlink:label="btx_ConsecutiveCalendarDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ConsecutiveCalendarDays_lbl" xml:lang="en-US" id="btx_ConsecutiveCalendarDays_lbl">In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified consecutive calendar days for resale, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsecutiveCalendarDays" xlink:to="btx_ConsecutiveCalendarDays_lbl" xlink:title="label: ConsecutiveCalendarDays to btx_ConsecutiveCalendarDays_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ConsecutiveCalendarDays_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ConsecutiveCalendarDays_lbl1" xml:lang="en-US" id="btx_ConsecutiveCalendarDays_lbl1">Consecutive Calendar Days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsecutiveCalendarDays" xlink:to="btx_ConsecutiveCalendarDays_lbl1" xlink:title="label: ConsecutiveCalendarDays to btx_ConsecutiveCalendarDays_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ConsecutiveCalendarDays_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ConsecutiveCalendarDays_lbl2" xml:lang="en-US" id="btx_ConsecutiveCalendarDays_lbl2">Consecutive calendar days</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsecutiveCalendarDays" xlink:to="btx_ConsecutiveCalendarDays_lbl2" xlink:title="label: ConsecutiveCalendarDays to btx_ConsecutiveCalendarDays_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightsExercisableTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ClassOfWarrantOrRightsExercisableTerm_lbl" xml:lang="en-US" id="btx_ClassOfWarrantOrRightsExercisableTerm_lbl">Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="btx_ClassOfWarrantOrRightsExercisableTerm_lbl" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to btx_ClassOfWarrantOrRightsExercisableTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightsExercisableTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ClassOfWarrantOrRightsExercisableTerm_lbl1" xml:lang="en-US" id="btx_ClassOfWarrantOrRightsExercisableTerm_lbl1">Class of Warrant or Rights Exercisable Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="btx_ClassOfWarrantOrRightsExercisableTerm_lbl1" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to btx_ClassOfWarrantOrRightsExercisableTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightsExercisableTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ClassOfWarrantOrRightsExercisableTerm_lbl2" xml:lang="en-US" id="btx_ClassOfWarrantOrRightsExercisableTerm_lbl2">Warrant exercisable term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightsExercisableTerm" xlink:to="btx_ClassOfWarrantOrRightsExercisableTerm_lbl2" xlink:title="label: ClassOfWarrantOrRightsExercisableTerm to btx_ClassOfWarrantOrRightsExercisableTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:label xlink:type="resource" xlink:label="btx_PIPEInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PIPEInvestorMember_lbl" xml:lang="en-US" id="btx_PIPEInvestorMember_lbl">A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="btx_PIPEInvestorMember_lbl" xlink:title="label: PIPEInvestorMember to btx_PIPEInvestorMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PIPEInvestorMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PIPEInvestorMember_lbl1" xml:lang="en-US" id="btx_PIPEInvestorMember_lbl1">PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="btx_PIPEInvestorMember_lbl1" xlink:title="label: PIPEInvestorMember to btx_PIPEInvestorMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PIPEInvestorMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PIPEInvestorMember_lbl2" xml:lang="en-US" id="btx_PIPEInvestorMember_lbl2">PIPE Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PIPEInvestorMember" xlink:to="btx_PIPEInvestorMember_lbl2" xlink:title="label: PIPEInvestorMember to btx_PIPEInvestorMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:label="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" xml:lang="en-US" id="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl">Percentage of securities that would be issuable upon the exercise of warrants or rights.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:to="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" xlink:title="label: ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights to btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" xml:lang="en-US" id="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1">Class of Warrant or Right Percent of Securities that Would be Issuable Upon Exercise of Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:to="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" xlink:title="label: ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights to btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" xml:lang="en-US" id="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2">Percentage of warrants exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:to="btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" xlink:title="label: ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights to btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:label xlink:type="resource" xlink:label="btx_CommonWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_CommonWarrantsMember_lbl" xml:lang="en-US" id="btx_CommonWarrantsMember_lbl">A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="btx_CommonWarrantsMember_lbl" xlink:title="label: CommonWarrantsMember to btx_CommonWarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_CommonWarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CommonWarrantsMember_lbl1" xml:lang="en-US" id="btx_CommonWarrantsMember_lbl1">Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="btx_CommonWarrantsMember_lbl1" xlink:title="label: CommonWarrantsMember to btx_CommonWarrantsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_CommonWarrantsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_CommonWarrantsMember_lbl2" xml:lang="en-US" id="btx_CommonWarrantsMember_lbl2">Common Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonWarrantsMember" xlink:to="btx_CommonWarrantsMember_lbl2" xlink:title="label: CommonWarrantsMember to btx_CommonWarrantsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_VariableRateTransactionsPeriod" xlink:label="VariableRateTransactionsPeriod" xlink:title="VariableRateTransactionsPeriod" />
    <link:label xlink:type="resource" xlink:label="btx_VariableRateTransactionsPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_VariableRateTransactionsPeriod_lbl" xml:lang="en-US" id="btx_VariableRateTransactionsPeriod_lbl">Pursuant to the Purchase Agreement, the Company is prohibited from issuing equity in variable rate transactions for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateTransactionsPeriod" xlink:to="btx_VariableRateTransactionsPeriod_lbl" xlink:title="label: VariableRateTransactionsPeriod to btx_VariableRateTransactionsPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_VariableRateTransactionsPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_VariableRateTransactionsPeriod_lbl1" xml:lang="en-US" id="btx_VariableRateTransactionsPeriod_lbl1">Variable Rate Transactions Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateTransactionsPeriod" xlink:to="btx_VariableRateTransactionsPeriod_lbl1" xlink:title="label: VariableRateTransactionsPeriod to btx_VariableRateTransactionsPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_VariableRateTransactionsPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_VariableRateTransactionsPeriod_lbl2" xml:lang="en-US" id="btx_VariableRateTransactionsPeriod_lbl2">Variable rate transaction period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateTransactionsPeriod" xlink:to="btx_VariableRateTransactionsPeriod_lbl2" xlink:title="label: VariableRateTransactionsPeriod to btx_VariableRateTransactionsPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl">Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1">Obligation to Pay Liquidated Damages Percentage on Subscription Amount per Month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2">Obligation to pay liquidated damages per month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" xlink:title="label: ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth to btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:label xlink:type="resource" xlink:label="btx_OverSubscriptionAmountReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_OverSubscriptionAmountReceived_lbl" xml:lang="en-US" id="btx_OverSubscriptionAmountReceived_lbl">Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="btx_OverSubscriptionAmountReceived_lbl" xlink:title="label: OverSubscriptionAmountReceived to btx_OverSubscriptionAmountReceived_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_OverSubscriptionAmountReceived_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_OverSubscriptionAmountReceived_lbl1" xml:lang="en-US" id="btx_OverSubscriptionAmountReceived_lbl1">Over-Subscription Amount Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="btx_OverSubscriptionAmountReceived_lbl1" xlink:title="label: OverSubscriptionAmountReceived to btx_OverSubscriptionAmountReceived_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_OverSubscriptionAmountReceived_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_OverSubscriptionAmountReceived_lbl2" xml:lang="en-US" id="btx_OverSubscriptionAmountReceived_lbl2">Over-subscription amount received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OverSubscriptionAmountReceived" xlink:to="btx_OverSubscriptionAmountReceived_lbl2" xlink:title="label: OverSubscriptionAmountReceived to btx_OverSubscriptionAmountReceived_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:label xlink:type="resource" xlink:label="btx_TransactionFeesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_TransactionFeesPayable_lbl" xml:lang="en-US" id="btx_TransactionFeesPayable_lbl">Fees incurred related to PIPE transaction.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="btx_TransactionFeesPayable_lbl" xlink:title="label: TransactionFeesPayable to btx_TransactionFeesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_TransactionFeesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_TransactionFeesPayable_lbl1" xml:lang="en-US" id="btx_TransactionFeesPayable_lbl1">Transaction Fees Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="btx_TransactionFeesPayable_lbl1" xlink:title="label: TransactionFeesPayable to btx_TransactionFeesPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_TransactionFeesPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_TransactionFeesPayable_lbl2" xml:lang="en-US" id="btx_TransactionFeesPayable_lbl2">Transaction fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransactionFeesPayable" xlink:to="btx_TransactionFeesPayable_lbl2" xlink:title="label: TransactionFeesPayable to btx_TransactionFeesPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentage_lbl" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentage_lbl">Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentage_lbl" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to btx_ObligationToPayLiquidatedDamagesPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentage_lbl1" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentage_lbl1">Obligation to Pay Liquidated Damages Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentage_lbl1" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to btx_ObligationToPayLiquidatedDamagesPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ObligationToPayLiquidatedDamagesPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ObligationToPayLiquidatedDamagesPercentage_lbl2" xml:lang="en-US" id="btx_ObligationToPayLiquidatedDamagesPercentage_lbl2">Obligated to pay liquidated damages percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligationToPayLiquidatedDamagesPercentage" xlink:to="btx_ObligationToPayLiquidatedDamagesPercentage_lbl2" xlink:title="label: ObligationToPayLiquidatedDamagesPercentage to btx_ObligationToPayLiquidatedDamagesPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_PrivatePlacementOfEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PrivatePlacementOfEquityAbstract_lbl1" xml:lang="en-US" id="btx_PrivatePlacementOfEquityAbstract_lbl1">Private Placement of Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="btx_PrivatePlacementOfEquityAbstract_lbl1" xlink:title="label: PrivatePlacementOfEquityAbstract to btx_PrivatePlacementOfEquityAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PrivatePlacementOfEquityAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PrivatePlacementOfEquityAbstract_lbl2" xml:lang="en-US" id="btx_PrivatePlacementOfEquityAbstract_lbl2">Private Placement of Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="btx_PrivatePlacementOfEquityAbstract_lbl2" xlink:title="label: PrivatePlacementOfEquityAbstract to btx_PrivatePlacementOfEquityAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:label xlink:type="resource" xlink:label="btx_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PreFundedWarrantsMember_lbl" xml:lang="en-US" id="btx_PreFundedWarrantsMember_lbl">A pre-funded warrant that allows the warrant holder to purchase a specified number of a company's securities at a nominal exercise price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="btx_PreFundedWarrantsMember_lbl" xlink:title="label: PreFundedWarrantsMember to btx_PreFundedWarrantsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PreFundedWarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PreFundedWarrantsMember_lbl1" xml:lang="en-US" id="btx_PreFundedWarrantsMember_lbl1">Pre-funded Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="btx_PreFundedWarrantsMember_lbl1" xlink:title="label: PreFundedWarrantsMember to btx_PreFundedWarrantsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PreFundedWarrantsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PreFundedWarrantsMember_lbl2" xml:lang="en-US" id="btx_PreFundedWarrantsMember_lbl2">Pre-funded Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreFundedWarrantsMember" xlink:to="btx_PreFundedWarrantsMember_lbl2" xlink:title="label: PreFundedWarrantsMember to btx_PreFundedWarrantsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:label="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:title="LossContingencyDamagesSoughtExpectedEquityPercentage" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl">The percentage of equity promised to the plaintiff seeks in the legal matter.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:to="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl" xlink:title="label: LossContingencyDamagesSoughtExpectedEquityPercentage to btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl1" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl1">Loss Contingency, Damages Sought, Expected Equity Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:to="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl1" xlink:title="label: LossContingencyDamagesSoughtExpectedEquityPercentage to btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl2" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl2">Percentage of equity promised against plaintiff</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:to="btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl2" xlink:title="label: LossContingencyDamagesSoughtExpectedEquityPercentage to btx_LossContingencyDamagesSoughtExpectedEquityPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyNumberOfArbitrationPanel" xlink:label="LossContingencyNumberOfArbitrationPanel" xlink:title="LossContingencyNumberOfArbitrationPanel" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNumberOfArbitrationPanel_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossContingencyNumberOfArbitrationPanel_lbl" xml:lang="en-US" id="btx_LossContingencyNumberOfArbitrationPanel_lbl">Represents the number member in arbitration panel pertaining to a loss contingency during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNumberOfArbitrationPanel" xlink:to="btx_LossContingencyNumberOfArbitrationPanel_lbl" xlink:title="label: LossContingencyNumberOfArbitrationPanel to btx_LossContingencyNumberOfArbitrationPanel_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNumberOfArbitrationPanel_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossContingencyNumberOfArbitrationPanel_lbl1" xml:lang="en-US" id="btx_LossContingencyNumberOfArbitrationPanel_lbl1">Loss Contingency, Number of Arbitration Panel Member</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNumberOfArbitrationPanel" xlink:to="btx_LossContingencyNumberOfArbitrationPanel_lbl1" xlink:title="label: LossContingencyNumberOfArbitrationPanel to btx_LossContingencyNumberOfArbitrationPanel_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNumberOfArbitrationPanel_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossContingencyNumberOfArbitrationPanel_lbl2" xml:lang="en-US" id="btx_LossContingencyNumberOfArbitrationPanel_lbl2">Number of member arbitration panel</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNumberOfArbitrationPanel" xlink:to="btx_LossContingencyNumberOfArbitrationPanel_lbl2" xlink:title="label: LossContingencyNumberOfArbitrationPanel to btx_LossContingencyNumberOfArbitrationPanel_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyDamagesSoughtExpectedSalary" xlink:label="LossContingencyDamagesSoughtExpectedSalary" xlink:title="LossContingencyDamagesSoughtExpectedSalary" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedSalary_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossContingencyDamagesSoughtExpectedSalary_lbl" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedSalary_lbl">The monetary amount of salary promised to the plaintiff seeks in the legal matter.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedSalary" xlink:to="btx_LossContingencyDamagesSoughtExpectedSalary_lbl" xlink:title="label: LossContingencyDamagesSoughtExpectedSalary to btx_LossContingencyDamagesSoughtExpectedSalary_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedSalary_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossContingencyDamagesSoughtExpectedSalary_lbl1" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedSalary_lbl1">Loss Contingency, Damages Sought, Expected Salary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedSalary" xlink:to="btx_LossContingencyDamagesSoughtExpectedSalary_lbl1" xlink:title="label: LossContingencyDamagesSoughtExpectedSalary to btx_LossContingencyDamagesSoughtExpectedSalary_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyDamagesSoughtExpectedSalary_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossContingencyDamagesSoughtExpectedSalary_lbl2" xml:lang="en-US" id="btx_LossContingencyDamagesSoughtExpectedSalary_lbl2">Defendants salary promised against plaintiff</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyDamagesSoughtExpectedSalary" xlink:to="btx_LossContingencyDamagesSoughtExpectedSalary_lbl2" xlink:title="label: LossContingencyDamagesSoughtExpectedSalary to btx_LossContingencyDamagesSoughtExpectedSalary_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LegalMattersAbstract" xlink:label="LegalMattersAbstract" xlink:title="LegalMattersAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_LegalMattersAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LegalMattersAbstract_lbl1" xml:lang="en-US" id="btx_LegalMattersAbstract_lbl1">Legal Matters [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalMattersAbstract" xlink:to="btx_LegalMattersAbstract_lbl1" xlink:title="label: LegalMattersAbstract to btx_LegalMattersAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LegalMattersAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LegalMattersAbstract_lbl2" xml:lang="en-US" id="btx_LegalMattersAbstract_lbl2">Legal Matters [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalMattersAbstract" xlink:to="btx_LegalMattersAbstract_lbl2" xlink:title="label: LegalMattersAbstract to btx_LegalMattersAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DheshGovenderMember" xlink:label="DheshGovenderMember" xlink:title="DheshGovenderMember" />
    <link:label xlink:type="resource" xlink:label="btx_DheshGovenderMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DheshGovenderMember_lbl" xml:lang="en-US" id="btx_DheshGovenderMember_lbl">Dhesh Govender, a former short-term consultant of the entity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DheshGovenderMember" xlink:to="btx_DheshGovenderMember_lbl" xlink:title="label: DheshGovenderMember to btx_DheshGovenderMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DheshGovenderMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DheshGovenderMember_lbl1" xml:lang="en-US" id="btx_DheshGovenderMember_lbl1">Dhesh Govender [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DheshGovenderMember" xlink:to="btx_DheshGovenderMember_lbl1" xlink:title="label: DheshGovenderMember to btx_DheshGovenderMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DheshGovenderMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DheshGovenderMember_lbl2" xml:lang="en-US" id="btx_DheshGovenderMember_lbl2">Govender [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DheshGovenderMember" xlink:to="btx_DheshGovenderMember_lbl2" xlink:title="label: DheshGovenderMember to btx_DheshGovenderMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AmountRequireToPayInitialLicenseFees" xlink:label="AmountRequireToPayInitialLicenseFees" xlink:title="AmountRequireToPayInitialLicenseFees" />
    <link:label xlink:type="resource" xlink:label="btx_AmountRequireToPayInitialLicenseFees_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AmountRequireToPayInitialLicenseFees_lbl" xml:lang="en-US" id="btx_AmountRequireToPayInitialLicenseFees_lbl">Amount require to pay out of the total initial license fees.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountRequireToPayInitialLicenseFees" xlink:to="btx_AmountRequireToPayInitialLicenseFees_lbl" xlink:title="label: AmountRequireToPayInitialLicenseFees to btx_AmountRequireToPayInitialLicenseFees_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AmountRequireToPayInitialLicenseFees_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AmountRequireToPayInitialLicenseFees_lbl1" xml:lang="en-US" id="btx_AmountRequireToPayInitialLicenseFees_lbl1">Amount Require to Pay Initial License Fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountRequireToPayInitialLicenseFees" xlink:to="btx_AmountRequireToPayInitialLicenseFees_lbl1" xlink:title="label: AmountRequireToPayInitialLicenseFees to btx_AmountRequireToPayInitialLicenseFees_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AmountRequireToPayInitialLicenseFees_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AmountRequireToPayInitialLicenseFees_lbl2" xml:lang="en-US" id="btx_AmountRequireToPayInitialLicenseFees_lbl2">Amount obligated to pay in license agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountRequireToPayInitialLicenseFees" xlink:to="btx_AmountRequireToPayInitialLicenseFees_lbl2" xlink:title="label: AmountRequireToPayInitialLicenseFees to btx_AmountRequireToPayInitialLicenseFees_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoveCiteMember" xlink:label="NoveCiteMember" xlink:title="NoveCiteMember" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NoveCiteMember_lbl" xml:lang="en-US" id="btx_NoveCiteMember_lbl">The name of company involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteMember" xlink:to="btx_NoveCiteMember_lbl" xlink:title="label: NoveCiteMember to btx_NoveCiteMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NoveCiteMember_lbl1" xml:lang="en-US" id="btx_NoveCiteMember_lbl1">NoveCite [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteMember" xlink:to="btx_NoveCiteMember_lbl1" xlink:title="label: NoveCiteMember to btx_NoveCiteMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NoveCiteMember_lbl2" xml:lang="en-US" id="btx_NoveCiteMember_lbl2">NoveCite [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteMember" xlink:to="btx_NoveCiteMember_lbl2" xlink:title="label: NoveCiteMember to btx_NoveCiteMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusLtdAndFactorBioscienceMember" xlink:label="NovellusLtdAndFactorBioscienceMember" xlink:title="NovellusLtdAndFactorBioscienceMember" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusLtdAndFactorBioscienceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NovellusLtdAndFactorBioscienceMember_lbl" xml:lang="en-US" id="btx_NovellusLtdAndFactorBioscienceMember_lbl">The name of companies involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusLtdAndFactorBioscienceMember" xlink:to="btx_NovellusLtdAndFactorBioscienceMember_lbl" xlink:title="label: NovellusLtdAndFactorBioscienceMember to btx_NovellusLtdAndFactorBioscienceMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusLtdAndFactorBioscienceMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NovellusLtdAndFactorBioscienceMember_lbl1" xml:lang="en-US" id="btx_NovellusLtdAndFactorBioscienceMember_lbl1">Novellus Ltd. and Factor Bioscience [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusLtdAndFactorBioscienceMember" xlink:to="btx_NovellusLtdAndFactorBioscienceMember_lbl1" xlink:title="label: NovellusLtdAndFactorBioscienceMember to btx_NovellusLtdAndFactorBioscienceMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusLtdAndFactorBioscienceMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NovellusLtdAndFactorBioscienceMember_lbl2" xml:lang="en-US" id="btx_NovellusLtdAndFactorBioscienceMember_lbl2">Licensors [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusLtdAndFactorBioscienceMember" xlink:to="btx_NovellusLtdAndFactorBioscienceMember_lbl2" xlink:title="label: NovellusLtdAndFactorBioscienceMember to btx_NovellusLtdAndFactorBioscienceMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfRevenue" xlink:label="PercentageOfRevenue" xlink:title="PercentageOfRevenue" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfRevenue_lbl" xml:lang="en-US" id="btx_PercentageOfRevenue_lbl">Percentage of revenue from receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd shall remit to NoveCite.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRevenue" xlink:to="btx_PercentageOfRevenue_lbl" xlink:title="label: PercentageOfRevenue to btx_PercentageOfRevenue_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRevenue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfRevenue_lbl1" xml:lang="en-US" id="btx_PercentageOfRevenue_lbl1">Percentage of Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRevenue" xlink:to="btx_PercentageOfRevenue_lbl1" xlink:title="label: PercentageOfRevenue to btx_PercentageOfRevenue_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRevenue_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfRevenue_lbl2" xml:lang="en-US" id="btx_PercentageOfRevenue_lbl2">Percentage of revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRevenue" xlink:to="btx_PercentageOfRevenue_lbl2" xlink:title="label: PercentageOfRevenue to btx_PercentageOfRevenue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AmountObligatedToPayInYearOne" xlink:label="AmountObligatedToPayInYearOne" xlink:title="AmountObligatedToPayInYearOne" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AmountObligatedToPayInYearOne_lbl" xml:lang="en-US" id="btx_AmountObligatedToPayInYearOne_lbl">The entity is obligated to pay additional fees to the Licensors in first year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearOne" xlink:to="btx_AmountObligatedToPayInYearOne_lbl" xlink:title="label: AmountObligatedToPayInYearOne to btx_AmountObligatedToPayInYearOne_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearOne_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AmountObligatedToPayInYearOne_lbl1" xml:lang="en-US" id="btx_AmountObligatedToPayInYearOne_lbl1">Amount Obligated to Pay in Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearOne" xlink:to="btx_AmountObligatedToPayInYearOne_lbl1" xlink:title="label: AmountObligatedToPayInYearOne to btx_AmountObligatedToPayInYearOne_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearOne_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AmountObligatedToPayInYearOne_lbl2" xml:lang="en-US" id="btx_AmountObligatedToPayInYearOne_lbl2">Additional fees obligated to pay in 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearOne" xlink:to="btx_AmountObligatedToPayInYearOne_lbl2" xlink:title="label: AmountObligatedToPayInYearOne to btx_AmountObligatedToPayInYearOne_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyPercentageOfRoyaltyPayable" xlink:label="LossContingencyPercentageOfRoyaltyPayable" xlink:title="LossContingencyPercentageOfRoyaltyPayable" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyPercentageOfRoyaltyPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossContingencyPercentageOfRoyaltyPayable_lbl" xml:lang="en-US" id="btx_LossContingencyPercentageOfRoyaltyPayable_lbl">Percentage of royalty payable from one party to another in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyPercentageOfRoyaltyPayable" xlink:to="btx_LossContingencyPercentageOfRoyaltyPayable_lbl" xlink:title="label: LossContingencyPercentageOfRoyaltyPayable to btx_LossContingencyPercentageOfRoyaltyPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyPercentageOfRoyaltyPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossContingencyPercentageOfRoyaltyPayable_lbl1" xml:lang="en-US" id="btx_LossContingencyPercentageOfRoyaltyPayable_lbl1">Loss contingency, Percentage of Royalty Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyPercentageOfRoyaltyPayable" xlink:to="btx_LossContingencyPercentageOfRoyaltyPayable_lbl1" xlink:title="label: LossContingencyPercentageOfRoyaltyPayable to btx_LossContingencyPercentageOfRoyaltyPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyPercentageOfRoyaltyPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossContingencyPercentageOfRoyaltyPayable_lbl2" xml:lang="en-US" id="btx_LossContingencyPercentageOfRoyaltyPayable_lbl2">Percentage of royalty payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyPercentageOfRoyaltyPayable" xlink:to="btx_LossContingencyPercentageOfRoyaltyPayable_lbl2" xlink:title="label: LossContingencyPercentageOfRoyaltyPayable to btx_LossContingencyPercentageOfRoyaltyPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AmountObligatedToPayInYearTwo" xlink:label="AmountObligatedToPayInYearTwo" xlink:title="AmountObligatedToPayInYearTwo" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AmountObligatedToPayInYearTwo_lbl" xml:lang="en-US" id="btx_AmountObligatedToPayInYearTwo_lbl">The entity is obligated to pay additional fees to the Licensors in second year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearTwo" xlink:to="btx_AmountObligatedToPayInYearTwo_lbl" xlink:title="label: AmountObligatedToPayInYearTwo to btx_AmountObligatedToPayInYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AmountObligatedToPayInYearTwo_lbl1" xml:lang="en-US" id="btx_AmountObligatedToPayInYearTwo_lbl1">Amount Obligated to Pay in Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearTwo" xlink:to="btx_AmountObligatedToPayInYearTwo_lbl1" xlink:title="label: AmountObligatedToPayInYearTwo to btx_AmountObligatedToPayInYearTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AmountObligatedToPayInYearTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AmountObligatedToPayInYearTwo_lbl2" xml:lang="en-US" id="btx_AmountObligatedToPayInYearTwo_lbl2">Additional fees obligated to pay in 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountObligatedToPayInYearTwo" xlink:to="btx_AmountObligatedToPayInYearTwo_lbl2" xlink:title="label: AmountObligatedToPayInYearTwo to btx_AmountObligatedToPayInYearTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_UniversityOfSouthFloridaMember" xlink:label="UniversityOfSouthFloridaMember" xlink:title="UniversityOfSouthFloridaMember" />
    <link:label xlink:type="resource" xlink:label="btx_UniversityOfSouthFloridaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_UniversityOfSouthFloridaMember_lbl" xml:lang="en-US" id="btx_UniversityOfSouthFloridaMember_lbl">Legal entity involved in litigation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UniversityOfSouthFloridaMember" xlink:to="btx_UniversityOfSouthFloridaMember_lbl" xlink:title="label: UniversityOfSouthFloridaMember to btx_UniversityOfSouthFloridaMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_UniversityOfSouthFloridaMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_UniversityOfSouthFloridaMember_lbl1" xml:lang="en-US" id="btx_UniversityOfSouthFloridaMember_lbl1">University of South Florida [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UniversityOfSouthFloridaMember" xlink:to="btx_UniversityOfSouthFloridaMember_lbl1" xlink:title="label: UniversityOfSouthFloridaMember to btx_UniversityOfSouthFloridaMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_UniversityOfSouthFloridaMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_UniversityOfSouthFloridaMember_lbl2" xml:lang="en-US" id="btx_UniversityOfSouthFloridaMember_lbl2">University of South Florida [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UniversityOfSouthFloridaMember" xlink:to="btx_UniversityOfSouthFloridaMember_lbl2" xlink:title="label: UniversityOfSouthFloridaMember to btx_UniversityOfSouthFloridaMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MilestonePayments" xlink:label="MilestonePayments" xlink:title="MilestonePayments" />
    <link:label xlink:type="resource" xlink:label="btx_MilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_MilestonePayments_lbl" xml:lang="en-US" id="btx_MilestonePayments_lbl">The amount of milestones upfront payment on licenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestonePayments" xlink:to="btx_MilestonePayments_lbl" xlink:title="label: MilestonePayments to btx_MilestonePayments_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_MilestonePayments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_MilestonePayments_lbl1" xml:lang="en-US" id="btx_MilestonePayments_lbl1">Milestone Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestonePayments" xlink:to="btx_MilestonePayments_lbl1" xlink:title="label: MilestonePayments to btx_MilestonePayments_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_MilestonePayments_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_MilestonePayments_lbl2" xml:lang="en-US" id="btx_MilestonePayments_lbl2">Milestone payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestonePayments" xlink:to="btx_MilestonePayments_lbl2" xlink:title="label: MilestonePayments to btx_MilestonePayments_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AdditionalFeesObligatedToPay" xlink:label="AdditionalFeesObligatedToPay" xlink:title="AdditionalFeesObligatedToPay" />
    <link:label xlink:type="resource" xlink:label="btx_AdditionalFeesObligatedToPay_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AdditionalFeesObligatedToPay_lbl" xml:lang="en-US" id="btx_AdditionalFeesObligatedToPay_lbl">The entity is obligated to pay additional fees to Licensors.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalFeesObligatedToPay" xlink:to="btx_AdditionalFeesObligatedToPay_lbl" xlink:title="label: AdditionalFeesObligatedToPay to btx_AdditionalFeesObligatedToPay_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AdditionalFeesObligatedToPay_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AdditionalFeesObligatedToPay_lbl1" xml:lang="en-US" id="btx_AdditionalFeesObligatedToPay_lbl1">Additional Fees Obligated to Pay</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalFeesObligatedToPay" xlink:to="btx_AdditionalFeesObligatedToPay_lbl1" xlink:title="label: AdditionalFeesObligatedToPay to btx_AdditionalFeesObligatedToPay_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AdditionalFeesObligatedToPay_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AdditionalFeesObligatedToPay_lbl2" xml:lang="en-US" id="btx_AdditionalFeesObligatedToPay_lbl2">Amount require to pay of initial license fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalFeesObligatedToPay" xlink:to="btx_AdditionalFeesObligatedToPay_lbl2" xlink:title="label: AdditionalFeesObligatedToPay to btx_AdditionalFeesObligatedToPay_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InitialLicenseFees" xlink:label="InitialLicenseFees" xlink:title="InitialLicenseFees" />
    <link:label xlink:type="resource" xlink:label="btx_InitialLicenseFees_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_InitialLicenseFees_lbl" xml:lang="en-US" id="btx_InitialLicenseFees_lbl">Initial license fees required to pay including non-refundable fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFees" xlink:to="btx_InitialLicenseFees_lbl" xlink:title="label: InitialLicenseFees to btx_InitialLicenseFees_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_InitialLicenseFees_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_InitialLicenseFees_lbl1" xml:lang="en-US" id="btx_InitialLicenseFees_lbl1">Initial License Fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFees" xlink:to="btx_InitialLicenseFees_lbl1" xlink:title="label: InitialLicenseFees to btx_InitialLicenseFees_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_InitialLicenseFees_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_InitialLicenseFees_lbl2" xml:lang="en-US" id="btx_InitialLicenseFees_lbl2">Initial license fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialLicenseFees" xlink:to="btx_InitialLicenseFees_lbl2" xlink:title="label: InitialLicenseFees to btx_InitialLicenseFees_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyNonRefundableOptionFee" xlink:label="LossContingencyNonRefundableOptionFee" xlink:title="LossContingencyNonRefundableOptionFee" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNonRefundableOptionFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossContingencyNonRefundableOptionFee_lbl" xml:lang="en-US" id="btx_LossContingencyNonRefundableOptionFee_lbl">The amount of Non-refundable option fee in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNonRefundableOptionFee" xlink:to="btx_LossContingencyNonRefundableOptionFee_lbl" xlink:title="label: LossContingencyNonRefundableOptionFee to btx_LossContingencyNonRefundableOptionFee_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNonRefundableOptionFee_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossContingencyNonRefundableOptionFee_lbl1" xml:lang="en-US" id="btx_LossContingencyNonRefundableOptionFee_lbl1">Loss Contingency, Non-refundable Option Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNonRefundableOptionFee" xlink:to="btx_LossContingencyNonRefundableOptionFee_lbl1" xlink:title="label: LossContingencyNonRefundableOptionFee to btx_LossContingencyNonRefundableOptionFee_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossContingencyNonRefundableOptionFee_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossContingencyNonRefundableOptionFee_lbl2" xml:lang="en-US" id="btx_LossContingencyNonRefundableOptionFee_lbl2">Non-refundable option fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossContingencyNonRefundableOptionFee" xlink:to="btx_LossContingencyNonRefundableOptionFee_lbl2" xlink:title="label: LossContingencyNonRefundableOptionFee to btx_LossContingencyNonRefundableOptionFee_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LicensingAgreementsAbstract" xlink:label="LicensingAgreementsAbstract" xlink:title="LicensingAgreementsAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_LicensingAgreementsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LicensingAgreementsAbstract_lbl1" xml:lang="en-US" id="btx_LicensingAgreementsAbstract_lbl1">Licensing Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicensingAgreementsAbstract" xlink:to="btx_LicensingAgreementsAbstract_lbl1" xlink:title="label: LicensingAgreementsAbstract to btx_LicensingAgreementsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LicensingAgreementsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LicensingAgreementsAbstract_lbl2" xml:lang="en-US" id="btx_LicensingAgreementsAbstract_lbl2">Licensing Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LicensingAgreementsAbstract" xlink:to="btx_LicensingAgreementsAbstract_lbl2" xlink:title="label: LicensingAgreementsAbstract to btx_LicensingAgreementsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CollaboratorRoyaltyAgreementMember" xlink:label="CollaboratorRoyaltyAgreementMember" xlink:title="CollaboratorRoyaltyAgreementMember" />
    <link:label xlink:type="resource" xlink:label="btx_CollaboratorRoyaltyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_CollaboratorRoyaltyAgreementMember_lbl" xml:lang="en-US" id="btx_CollaboratorRoyaltyAgreementMember_lbl">Collaborative royalty arrangement in licensing deal with the company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaboratorRoyaltyAgreementMember" xlink:to="btx_CollaboratorRoyaltyAgreementMember_lbl" xlink:title="label: CollaboratorRoyaltyAgreementMember to btx_CollaboratorRoyaltyAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_CollaboratorRoyaltyAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CollaboratorRoyaltyAgreementMember_lbl1" xml:lang="en-US" id="btx_CollaboratorRoyaltyAgreementMember_lbl1">Collaborator Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaboratorRoyaltyAgreementMember" xlink:to="btx_CollaboratorRoyaltyAgreementMember_lbl1" xlink:title="label: CollaboratorRoyaltyAgreementMember to btx_CollaboratorRoyaltyAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_CollaboratorRoyaltyAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_CollaboratorRoyaltyAgreementMember_lbl2" xml:lang="en-US" id="btx_CollaboratorRoyaltyAgreementMember_lbl2">Collaborator Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CollaboratorRoyaltyAgreementMember" xlink:to="btx_CollaboratorRoyaltyAgreementMember_lbl2" xlink:title="label: CollaboratorRoyaltyAgreementMember to btx_CollaboratorRoyaltyAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InvestorRoyaltyAgreementMember" xlink:label="InvestorRoyaltyAgreementMember" xlink:title="InvestorRoyaltyAgreementMember" />
    <link:label xlink:type="resource" xlink:label="btx_InvestorRoyaltyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_InvestorRoyaltyAgreementMember_lbl" xml:lang="en-US" id="btx_InvestorRoyaltyAgreementMember_lbl">Arrangement other than collaborative applicable to investor royalty.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestorRoyaltyAgreementMember" xlink:to="btx_InvestorRoyaltyAgreementMember_lbl" xlink:title="label: InvestorRoyaltyAgreementMember to btx_InvestorRoyaltyAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_InvestorRoyaltyAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_InvestorRoyaltyAgreementMember_lbl1" xml:lang="en-US" id="btx_InvestorRoyaltyAgreementMember_lbl1">Investor Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestorRoyaltyAgreementMember" xlink:to="btx_InvestorRoyaltyAgreementMember_lbl1" xlink:title="label: InvestorRoyaltyAgreementMember to btx_InvestorRoyaltyAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_InvestorRoyaltyAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_InvestorRoyaltyAgreementMember_lbl2" xml:lang="en-US" id="btx_InvestorRoyaltyAgreementMember_lbl2">Investor Royalty Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestorRoyaltyAgreementMember" xlink:to="btx_InvestorRoyaltyAgreementMember_lbl2" xlink:title="label: InvestorRoyaltyAgreementMember to btx_InvestorRoyaltyAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:label="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:title="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl" xml:lang="en-US" id="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl">Percentage of royalty receive equal to revenues generated from disposition of business.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:to="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl" xlink:title="label: PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness to btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl1" xml:lang="en-US" id="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl1">Percentage of Royalty Receive Equal to Revenues from Sale of Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:to="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl1" xlink:title="label: PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness to btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl2" xml:lang="en-US" id="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl2">Percentage of royalty receive equal to revenues from sale of business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:to="btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl2" xlink:title="label: PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness to btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:label="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" xml:lang="en-US" id="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl">Percentage of additional royalty payable on gross sales by the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:to="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" xlink:title="label: PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales to btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" xml:lang="en-US" id="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1">Percentage of Payment Of Additional Royalty On Gross Sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:to="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" xlink:title="label: PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales to btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" xml:lang="en-US" id="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2">Percentage of payment of additional royalty on gross sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:to="btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" xlink:title="label: PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales to btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_RoyaltyAgreementsAbstract" xlink:label="RoyaltyAgreementsAbstract" xlink:title="RoyaltyAgreementsAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_RoyaltyAgreementsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_RoyaltyAgreementsAbstract_lbl1" xml:lang="en-US" id="btx_RoyaltyAgreementsAbstract_lbl1">Royalty Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RoyaltyAgreementsAbstract" xlink:to="btx_RoyaltyAgreementsAbstract_lbl1" xlink:title="label: RoyaltyAgreementsAbstract to btx_RoyaltyAgreementsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_RoyaltyAgreementsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_RoyaltyAgreementsAbstract_lbl2" xml:lang="en-US" id="btx_RoyaltyAgreementsAbstract_lbl2">Royalty Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RoyaltyAgreementsAbstract" xlink:to="btx_RoyaltyAgreementsAbstract_lbl2" xlink:title="label: RoyaltyAgreementsAbstract to btx_RoyaltyAgreementsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LiquidityAndCapitalResourcesTextBlock" xlink:label="LiquidityAndCapitalResourcesTextBlock" xlink:title="LiquidityAndCapitalResourcesTextBlock" />
    <link:label xlink:type="resource" xlink:label="btx_LiquidityAndCapitalResourcesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LiquidityAndCapitalResourcesTextBlock_lbl" xml:lang="en-US" id="btx_LiquidityAndCapitalResourcesTextBlock_lbl">The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="btx_LiquidityAndCapitalResourcesTextBlock_lbl" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to btx_LiquidityAndCapitalResourcesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LiquidityAndCapitalResourcesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LiquidityAndCapitalResourcesTextBlock_lbl1" xml:lang="en-US" id="btx_LiquidityAndCapitalResourcesTextBlock_lbl1">Liquidity And Capital Resources [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="btx_LiquidityAndCapitalResourcesTextBlock_lbl1" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to btx_LiquidityAndCapitalResourcesTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LiquidityAndCapitalResourcesTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LiquidityAndCapitalResourcesTextBlock_lbl2" xml:lang="en-US" id="btx_LiquidityAndCapitalResourcesTextBlock_lbl2">LIQUIDITY AND CAPITAL RESOURCES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiquidityAndCapitalResourcesTextBlock" xlink:to="btx_LiquidityAndCapitalResourcesTextBlock_lbl2" xlink:title="label: LiquidityAndCapitalResourcesTextBlock to btx_LiquidityAndCapitalResourcesTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:label="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:title="LIQUIDITYANDCAPITALRESOURCESAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" xml:lang="en-US" id="btx_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1">LIQUIDITY AND CAPITAL RESOURCES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:to="btx_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" xlink:title="label: LIQUIDITYANDCAPITALRESOURCESAbstract to btx_LIQUIDITYANDCAPITALRESOURCESAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CitiusPharmaceuticalsIncMember" xlink:label="CitiusPharmaceuticalsIncMember" xlink:title="CitiusPharmaceuticalsIncMember" />
    <link:label xlink:type="resource" xlink:label="btx_CitiusPharmaceuticalsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_CitiusPharmaceuticalsIncMember_lbl" xml:lang="en-US" id="btx_CitiusPharmaceuticalsIncMember_lbl">Represents Citius Pharmaceuticals, Inc. Ownership interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CitiusPharmaceuticalsIncMember" xlink:to="btx_CitiusPharmaceuticalsIncMember_lbl" xlink:title="label: CitiusPharmaceuticalsIncMember to btx_CitiusPharmaceuticalsIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_CitiusPharmaceuticalsIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CitiusPharmaceuticalsIncMember_lbl1" xml:lang="en-US" id="btx_CitiusPharmaceuticalsIncMember_lbl1">Citius Pharmaceuticals, Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CitiusPharmaceuticalsIncMember" xlink:to="btx_CitiusPharmaceuticalsIncMember_lbl1" xlink:title="label: CitiusPharmaceuticalsIncMember to btx_CitiusPharmaceuticalsIncMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NumberOfBoardSeats" xlink:label="NumberOfBoardSeats" xlink:title="NumberOfBoardSeats" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfBoardSeats_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NumberOfBoardSeats_lbl" xml:lang="en-US" id="btx_NumberOfBoardSeats_lbl">Number of members of the company's management holds board seats on board of directors.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBoardSeats" xlink:to="btx_NumberOfBoardSeats_lbl" xlink:title="label: NumberOfBoardSeats to btx_NumberOfBoardSeats_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfBoardSeats_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NumberOfBoardSeats_lbl1" xml:lang="en-US" id="btx_NumberOfBoardSeats_lbl1">Number of Board Seats</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBoardSeats" xlink:to="btx_NumberOfBoardSeats_lbl1" xlink:title="label: NumberOfBoardSeats to btx_NumberOfBoardSeats_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NumberOfBoardSeats_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NumberOfBoardSeats_lbl2" xml:lang="en-US" id="btx_NumberOfBoardSeats_lbl2">Number of board seats</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBoardSeats" xlink:to="btx_NumberOfBoardSeats_lbl2" xlink:title="label: NumberOfBoardSeats to btx_NumberOfBoardSeats_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" xlink:label="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" xlink:title="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" />
    <link:label xlink:type="resource" xlink:label="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl" xml:lang="en-US" id="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl">Person with designation of chair of the board of directors, former chief executive officer and president.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl" xlink:title="label: ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember to btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl1" xml:lang="en-US" id="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl1">Chair of the Board of Directors, Former Chief Executive Officer and President [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl1" xlink:title="label: ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember to btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl2" xml:lang="en-US" id="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl2">Chair of the Board of Directors, Former Chief Executive Officer and President [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" xlink:to="btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl2" xlink:title="label: ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember to btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusIncMember" xlink:label="NovellusIncMember" xlink:title="NovellusIncMember" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NovellusIncMember_lbl" xml:lang="en-US" id="btx_NovellusIncMember_lbl">The name of company involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusIncMember" xlink:to="btx_NovellusIncMember_lbl" xlink:title="label: NovellusIncMember to btx_NovellusIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NovellusIncMember_lbl1" xml:lang="en-US" id="btx_NovellusIncMember_lbl1">Novellus, Inc. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusIncMember" xlink:to="btx_NovellusIncMember_lbl1" xlink:title="label: NovellusIncMember to btx_NovellusIncMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl">Value of stock issued without any restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1">Stock Issued During Period, Unrestricted Shares, Value, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2">Unrestricted shares, value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl">Value of stock issued with restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1">Stock Issued During Period, Restricted Shares, Value, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2">Restricted shares, value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesValueAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionUnrestrictedSharesSharePrice" xlink:label="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="AssetAcquisitionUnrestrictedSharesSharePrice" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" xml:lang="en-US" id="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl">Price of a single share of a number of saleable stocks paid or offered without any restrictions to be paid in asset acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" xlink:title="label: AssetAcquisitionUnrestrictedSharesSharePrice to btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" xml:lang="en-US" id="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1">Asset Acquisition, Unrestricted Shares, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" xlink:title="label: AssetAcquisitionUnrestrictedSharesSharePrice to btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" xml:lang="en-US" id="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2">Unrestricted shares, fair value per share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" xlink:title="label: AssetAcquisitionUnrestrictedSharesSharePrice to btx_AssetAcquisitionUnrestrictedSharesSharePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfCommonStockSubjectToLockUpAgreement" xlink:label="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="PercentageOfCommonStockSubjectToLockUpAgreement" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" xml:lang="en-US" id="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl">The percentage of shares of common stock subject to the lock-up agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:to="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" xlink:title="label: PercentageOfCommonStockSubjectToLockUpAgreement to btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" xml:lang="en-US" id="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1">Percentage of Common Stock Subject to Lock-up Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:to="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" xlink:title="label: PercentageOfCommonStockSubjectToLockUpAgreement to btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" xml:lang="en-US" id="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2">Percentage of common stock subject to the lock-up agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:to="btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" xlink:title="label: PercentageOfCommonStockSubjectToLockUpAgreement to btx_PercentageOfCommonStockSubjectToLockUpAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EscrowPeriod" xlink:label="EscrowPeriod" xlink:title="EscrowPeriod" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_EscrowPeriod_lbl" xml:lang="en-US" id="btx_EscrowPeriod_lbl">The period of secure indemnification obligations to acquisition agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowPeriod" xlink:to="btx_EscrowPeriod_lbl" xlink:title="label: EscrowPeriod to btx_EscrowPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_EscrowPeriod_lbl1" xml:lang="en-US" id="btx_EscrowPeriod_lbl1">Escrow Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowPeriod" xlink:to="btx_EscrowPeriod_lbl1" xlink:title="label: EscrowPeriod to btx_EscrowPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_EscrowPeriod_lbl2" xml:lang="en-US" id="btx_EscrowPeriod_lbl2">Period of escrow</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowPeriod" xlink:to="btx_EscrowPeriod_lbl2" xlink:title="label: EscrowPeriod to btx_EscrowPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xml:lang="en-US" id="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl">Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xml:lang="en-US" id="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl1">Asset Acquisition, Fair Value of Consideration Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" xml:lang="en-US" id="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl2">Total fair value of consideration paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionFairValueOfConsiderationPaid" xlink:to="btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" xlink:title="label: AssetAcquisitionFairValueOfConsiderationPaid to btx_AssetAcquisitionFairValueOfConsiderationPaid_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:label xlink:type="resource" xlink:label="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xml:lang="en-US" id="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl">The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xml:lang="en-US" id="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1">Research and Development in Process, Asset Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xml:lang="en-US" id="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2">Acquired in-process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:to="btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" xlink:title="label: ResearchAndDevelopmentInProcessAssetAcquisition to btx_ResearchAndDevelopmentInProcessAssetAcquisition_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EscrowShares" xlink:label="EscrowShares" xlink:title="EscrowShares" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_EscrowShares_lbl" xml:lang="en-US" id="btx_EscrowShares_lbl">Number of shares have been placed in escrow shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowShares" xlink:to="btx_EscrowShares_lbl" xlink:title="label: EscrowShares to btx_EscrowShares_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_EscrowShares_lbl1" xml:lang="en-US" id="btx_EscrowShares_lbl1">Escrow Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowShares" xlink:to="btx_EscrowShares_lbl1" xlink:title="label: EscrowShares to btx_EscrowShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_EscrowShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_EscrowShares_lbl2" xml:lang="en-US" id="btx_EscrowShares_lbl2">Escrow shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EscrowShares" xlink:to="btx_EscrowShares_lbl2" xlink:title="label: EscrowShares to btx_EscrowShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AssetAcquisitionSharePrice_lbl" xml:lang="en-US" id="btx_AssetAcquisitionSharePrice_lbl">Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="btx_AssetAcquisitionSharePrice_lbl" xlink:title="label: AssetAcquisitionSharePrice to btx_AssetAcquisitionSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AssetAcquisitionSharePrice_lbl1" xml:lang="en-US" id="btx_AssetAcquisitionSharePrice_lbl1">Asset Acquisition, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="btx_AssetAcquisitionSharePrice_lbl1" xlink:title="label: AssetAcquisitionSharePrice to btx_AssetAcquisitionSharePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionSharePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AssetAcquisitionSharePrice_lbl2" xml:lang="en-US" id="btx_AssetAcquisitionSharePrice_lbl2">Share price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionSharePrice" xlink:to="btx_AssetAcquisitionSharePrice_lbl2" xlink:title="label: AssetAcquisitionSharePrice to btx_AssetAcquisitionSharePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AcquisitionAgreementNonCompetitivePeriod" xlink:label="AcquisitionAgreementNonCompetitivePeriod" xlink:title="AcquisitionAgreementNonCompetitivePeriod" />
    <link:label xlink:type="resource" xlink:label="btx_AcquisitionAgreementNonCompetitivePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AcquisitionAgreementNonCompetitivePeriod_lbl" xml:lang="en-US" id="btx_AcquisitionAgreementNonCompetitivePeriod_lbl">The Acquisition Agreement contains non-competition and non-solicitation provisions pursuant to which the Seller has agreed not to engage in certain competitive activities for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionAgreementNonCompetitivePeriod" xlink:to="btx_AcquisitionAgreementNonCompetitivePeriod_lbl" xlink:title="label: AcquisitionAgreementNonCompetitivePeriod to btx_AcquisitionAgreementNonCompetitivePeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AcquisitionAgreementNonCompetitivePeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AcquisitionAgreementNonCompetitivePeriod_lbl1" xml:lang="en-US" id="btx_AcquisitionAgreementNonCompetitivePeriod_lbl1">Acquisition Agreement, Non Competitive Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionAgreementNonCompetitivePeriod" xlink:to="btx_AcquisitionAgreementNonCompetitivePeriod_lbl1" xlink:title="label: AcquisitionAgreementNonCompetitivePeriod to btx_AcquisitionAgreementNonCompetitivePeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AcquisitionAgreementNonCompetitivePeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AcquisitionAgreementNonCompetitivePeriod_lbl2" xml:lang="en-US" id="btx_AcquisitionAgreementNonCompetitivePeriod_lbl2">Non-compete period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionAgreementNonCompetitivePeriod" xlink:to="btx_AcquisitionAgreementNonCompetitivePeriod_lbl2" xlink:title="label: AcquisitionAgreementNonCompetitivePeriod to btx_AcquisitionAgreementNonCompetitivePeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LockUpPeriodForRestrictedShares" xlink:label="LockUpPeriodForRestrictedShares" xlink:title="LockUpPeriodForRestrictedShares" />
    <link:label xlink:type="resource" xlink:label="btx_LockUpPeriodForRestrictedShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LockUpPeriodForRestrictedShares_lbl" xml:lang="en-US" id="btx_LockUpPeriodForRestrictedShares_lbl">The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForRestrictedShares" xlink:to="btx_LockUpPeriodForRestrictedShares_lbl" xlink:title="label: LockUpPeriodForRestrictedShares to btx_LockUpPeriodForRestrictedShares_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LockUpPeriodForRestrictedShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LockUpPeriodForRestrictedShares_lbl1" xml:lang="en-US" id="btx_LockUpPeriodForRestrictedShares_lbl1">Lock-up Period for Restricted Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForRestrictedShares" xlink:to="btx_LockUpPeriodForRestrictedShares_lbl1" xlink:title="label: LockUpPeriodForRestrictedShares to btx_LockUpPeriodForRestrictedShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LockUpPeriodForRestrictedShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LockUpPeriodForRestrictedShares_lbl2" xml:lang="en-US" id="btx_LockUpPeriodForRestrictedShares_lbl2">Lock-up period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LockUpPeriodForRestrictedShares" xlink:to="btx_LockUpPeriodForRestrictedShares_lbl2" xlink:title="label: LockUpPeriodForRestrictedShares to btx_LockUpPeriodForRestrictedShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PaymentsToAcquireProductiveAssetsNet" xlink:label="PaymentsToAcquireProductiveAssetsNet" xlink:title="PaymentsToAcquireProductiveAssetsNet" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsToAcquireProductiveAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PaymentsToAcquireProductiveAssetsNet_lbl" xml:lang="en-US" id="btx_PaymentsToAcquireProductiveAssetsNet_lbl">The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets excluding cash acquired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssetsNet" xlink:to="btx_PaymentsToAcquireProductiveAssetsNet_lbl" xlink:title="label: PaymentsToAcquireProductiveAssetsNet to btx_PaymentsToAcquireProductiveAssetsNet_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsToAcquireProductiveAssetsNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PaymentsToAcquireProductiveAssetsNet_lbl1" xml:lang="en-US" id="btx_PaymentsToAcquireProductiveAssetsNet_lbl1">Cash paid, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssetsNet" xlink:to="btx_PaymentsToAcquireProductiveAssetsNet_lbl1" xlink:title="label: PaymentsToAcquireProductiveAssetsNet to btx_PaymentsToAcquireProductiveAssetsNet_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsToAcquireProductiveAssetsNet_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PaymentsToAcquireProductiveAssetsNet_lbl2" xml:lang="en-US" id="btx_PaymentsToAcquireProductiveAssetsNet_lbl2">Cash paid, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssetsNet" xlink:to="btx_PaymentsToAcquireProductiveAssetsNet_lbl2" xlink:title="label: PaymentsToAcquireProductiveAssetsNet to btx_PaymentsToAcquireProductiveAssetsNet_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EachLockUpAgreementExtendsTerm" xlink:label="EachLockUpAgreementExtendsTerm" xlink:title="EachLockUpAgreementExtendsTerm" />
    <link:label xlink:type="resource" xlink:label="btx_EachLockUpAgreementExtendsTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_EachLockUpAgreementExtendsTerm_lbl" xml:lang="en-US" id="btx_EachLockUpAgreementExtendsTerm_lbl">The period of lock-up agreement extend term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EachLockUpAgreementExtendsTerm" xlink:to="btx_EachLockUpAgreementExtendsTerm_lbl" xlink:title="label: EachLockUpAgreementExtendsTerm to btx_EachLockUpAgreementExtendsTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_EachLockUpAgreementExtendsTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_EachLockUpAgreementExtendsTerm_lbl1" xml:lang="en-US" id="btx_EachLockUpAgreementExtendsTerm_lbl1">Each Lock-up Agreement Extends Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EachLockUpAgreementExtendsTerm" xlink:to="btx_EachLockUpAgreementExtendsTerm_lbl1" xlink:title="label: EachLockUpAgreementExtendsTerm to btx_EachLockUpAgreementExtendsTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_EachLockUpAgreementExtendsTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_EachLockUpAgreementExtendsTerm_lbl2" xml:lang="en-US" id="btx_EachLockUpAgreementExtendsTerm_lbl2">Each lock-up agreement extend term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EachLockUpAgreementExtendsTerm" xlink:to="btx_EachLockUpAgreementExtendsTerm_lbl2" xlink:title="label: EachLockUpAgreementExtendsTerm to btx_EachLockUpAgreementExtendsTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionRestrictedSharesSharePrice" xlink:label="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="AssetAcquisitionRestrictedSharesSharePrice" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl" xml:lang="en-US" id="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl">Price of a single share of a number of saleable stocks paid or offered with restrictions to be paid in asset acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionRestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl" xlink:title="label: AssetAcquisitionRestrictedSharesSharePrice to btx_AssetAcquisitionRestrictedSharesSharePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl1" xml:lang="en-US" id="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl1">Asset Acquisition, Restricted Shares, Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionRestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl1" xlink:title="label: AssetAcquisitionRestrictedSharesSharePrice to btx_AssetAcquisitionRestrictedSharesSharePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl2" xml:lang="en-US" id="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl2">Restricted shares, fair value per share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetAcquisitionRestrictedSharesSharePrice" xlink:to="btx_AssetAcquisitionRestrictedSharesSharePrice_lbl2" xlink:title="label: AssetAcquisitionRestrictedSharesSharePrice to btx_AssetAcquisitionRestrictedSharesSharePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:label="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="PercentageOfDiscountOnFairValueOfRestrictedShares" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" xml:lang="en-US" id="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl">Percentage of discount on restricted shares, which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:to="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" xlink:title="label: PercentageOfDiscountOnFairValueOfRestrictedShares to btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" xml:lang="en-US" id="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1">Percentage of Discount on Fair Value of Restricted Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:to="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" xlink:title="label: PercentageOfDiscountOnFairValueOfRestrictedShares to btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" xml:lang="en-US" id="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2">Percentage of discount on fair value restricted shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:to="btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" xlink:title="label: PercentageOfDiscountOnFairValueOfRestrictedShares to btx_PercentageOfDiscountOnFairValueOfRestrictedShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl">Number of shares of stock issued with restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1">Stock Issued During Period, Restricted Shares, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2">Restricted shares, issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodRestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl">Number of shares of stock issued without any restrictions during the period pursuant to acquisitions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1">Stock Issued During Period, Unrestricted Shares, Acquisitions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" xml:lang="en-US" id="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2">Unrestricted shares, issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:to="btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" xlink:title="label: StockIssuedDuringPeriodUnrestrictedSharesAcquisitions to btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusTherapeuticsLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NovellusTherapeuticsLimitedMember_lbl" xml:lang="en-US" id="btx_NovellusTherapeuticsLimitedMember_lbl">The name of company involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusTherapeuticsLimitedMember" xlink:to="btx_NovellusTherapeuticsLimitedMember_lbl" xlink:title="label: NovellusTherapeuticsLimitedMember to btx_NovellusTherapeuticsLimitedMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusTherapeuticsLimitedMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NovellusTherapeuticsLimitedMember_lbl1" xml:lang="en-US" id="btx_NovellusTherapeuticsLimitedMember_lbl1">Novellus Therapeutics Limited [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusTherapeuticsLimitedMember" xlink:to="btx_NovellusTherapeuticsLimitedMember_lbl1" xlink:title="label: NovellusTherapeuticsLimitedMember to btx_NovellusTherapeuticsLimitedMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NovellusTherapeuticsLimitedMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NovellusTherapeuticsLimitedMember_lbl2" xml:lang="en-US" id="btx_NovellusTherapeuticsLimitedMember_lbl2">Novellus, Ltd. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovellusTherapeuticsLimitedMember" xlink:to="btx_NovellusTherapeuticsLimitedMember_lbl2" xlink:title="label: NovellusTherapeuticsLimitedMember to btx_NovellusTherapeuticsLimitedMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteINCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NoveCiteINCMember_lbl" xml:lang="en-US" id="btx_NoveCiteINCMember_lbl">The name of company involved in licensing agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="btx_NoveCiteINCMember_lbl" xlink:title="label: NoveCiteINCMember to btx_NoveCiteINCMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteINCMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NoveCiteINCMember_lbl1" xml:lang="en-US" id="btx_NoveCiteINCMember_lbl1">NoveCite, INC. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="btx_NoveCiteINCMember_lbl1" xlink:title="label: NoveCiteINCMember to btx_NoveCiteINCMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NoveCiteINCMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NoveCiteINCMember_lbl2" xml:lang="en-US" id="btx_NoveCiteINCMember_lbl2">NoveCite, INC. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoveCiteINCMember" xlink:to="btx_NoveCiteINCMember_lbl2" xlink:title="label: NoveCiteINCMember to btx_NoveCiteINCMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl">Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromCash to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromCash to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2">Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromCash to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:label="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl">Amount classified as Lease liability attributable to disposal group held for sale or disposed of.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationLeaseLiability to btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1">Disposal Group, Including Discontinued Operation, Lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationLeaseLiability to btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2">Lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationLeaseLiability to btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl">Aggregate proceeds received from assume advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Assume Advance/Loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2">Assume advance/loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NTNBusinessMember" xlink:label="NTNBusinessMember" xlink:title="NTNBusinessMember" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBusinessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NTNBusinessMember_lbl" xml:lang="en-US" id="btx_NTNBusinessMember_lbl">Name of the disposal group.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBusinessMember" xlink:to="btx_NTNBusinessMember_lbl" xlink:title="label: NTNBusinessMember to btx_NTNBusinessMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBusinessMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NTNBusinessMember_lbl1" xml:lang="en-US" id="btx_NTNBusinessMember_lbl1">NTN Business [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBusinessMember" xlink:to="btx_NTNBusinessMember_lbl1" xlink:title="label: NTNBusinessMember to btx_NTNBusinessMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBusinessMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NTNBusinessMember_lbl2" xml:lang="en-US" id="btx_NTNBusinessMember_lbl2">NTN Business [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBusinessMember" xlink:to="btx_NTNBusinessMember_lbl2" xlink:title="label: NTNBusinessMember to btx_NTNBusinessMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl">Aggregate proceeds received from interest on advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Interest on Advance/Loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2">Interest on advance/loans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl">Aggregate proceeds received from escrow deposits in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1">Disposal Group, Including Discontinued Operation, Proceeds from Escrow</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2">Escrow</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow to btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProceedsFromDispositionAbstract" xlink:label="ProceedsFromDispositionAbstract" xlink:title="ProceedsFromDispositionAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromDispositionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ProceedsFromDispositionAbstract_lbl1" xml:lang="en-US" id="btx_ProceedsFromDispositionAbstract_lbl1">Proceeds from Disposition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDispositionAbstract" xlink:to="btx_ProceedsFromDispositionAbstract_lbl1" xlink:title="label: ProceedsFromDispositionAbstract to btx_ProceedsFromDispositionAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromDispositionAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ProceedsFromDispositionAbstract_lbl2" xml:lang="en-US" id="btx_ProceedsFromDispositionAbstract_lbl2">Proceeds from sale [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDispositionAbstract" xlink:to="btx_ProceedsFromDispositionAbstract_lbl2" xlink:title="label: ProceedsFromDispositionAbstract to btx_ProceedsFromDispositionAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:label="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl">Amount classified as Obligations under finance leases attributable to disposal group held for sale or disposed of.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases to btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1">Disposal Group, Including Discontinued Operation, Obligations under finance leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases to btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2">Obligations under finance leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases to btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl">Amount classified as software development cost attributable to disposal group held for sale or disposed of.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts to btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1">Disposal Group, Including Discontinued Operation, Software development costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts to btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2">Software development costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts to btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl">Amount of costs of the business disposal including legal, accounting, and other costs incurred to consummate the business disposition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationTransactionCosts to btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1">Disposal Group, Including Discontinued Operation, Transaction Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationTransactionCosts to btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" xml:lang="en-US" id="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2">Transaction costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:to="btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" xlink:title="label: DisposalGroupIncludingDiscontinuedOperationTransactionCosts to btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DispositionAbstract" xlink:label="DispositionAbstract" xlink:title="DispositionAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_DispositionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_DispositionAbstract_lbl1" xml:lang="en-US" id="btx_DispositionAbstract_lbl1">Disposition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DispositionAbstract" xlink:to="btx_DispositionAbstract_lbl1" xlink:title="label: DispositionAbstract to btx_DispositionAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBuzztimeIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NTNBuzztimeIncMember_lbl" xml:lang="en-US" id="btx_NTNBuzztimeIncMember_lbl">Name of acquiree entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBuzztimeIncMember" xlink:to="btx_NTNBuzztimeIncMember_lbl" xlink:title="label: NTNBuzztimeIncMember to btx_NTNBuzztimeIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBuzztimeIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NTNBuzztimeIncMember_lbl1" xml:lang="en-US" id="btx_NTNBuzztimeIncMember_lbl1">NTN Buzztime, Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBuzztimeIncMember" xlink:to="btx_NTNBuzztimeIncMember_lbl1" xlink:title="label: NTNBuzztimeIncMember to btx_NTNBuzztimeIncMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NTNBuzztimeIncMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NTNBuzztimeIncMember_lbl2" xml:lang="en-US" id="btx_NTNBuzztimeIncMember_lbl2">NTN Buzztime, Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTNBuzztimeIncMember" xlink:to="btx_NTNBuzztimeIncMember_lbl2" xlink:title="label: NTNBuzztimeIncMember to btx_NTNBuzztimeIncMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:label="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" />
    <link:label xlink:type="resource" xlink:label="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" xml:lang="en-US" id="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl">Amount of cash and cash equivalents obligated to maintain under merger agreement on balance sheet at the effective time of the merger.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:to="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" xlink:title="label: ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement to btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" xml:lang="en-US" id="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1">Obligated to Maintain Cash and Cash Equivalents Under Merger Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:to="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" xlink:title="label: ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement to btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" xml:lang="en-US" id="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2">Cash and cash equivalents obligated to have under merger agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:to="btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" xlink:title="label: ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement to btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PurchasePriceAllocationMember" xlink:label="PurchasePriceAllocationMember" xlink:title="PurchasePriceAllocationMember" />
    <link:label xlink:type="resource" xlink:label="btx_PurchasePriceAllocationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PurchasePriceAllocationMember_lbl" xml:lang="en-US" id="btx_PurchasePriceAllocationMember_lbl">Purchase price allocation of acquisition-date assets and liability assumed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchasePriceAllocationMember" xlink:to="btx_PurchasePriceAllocationMember_lbl" xlink:title="label: PurchasePriceAllocationMember to btx_PurchasePriceAllocationMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PurchasePriceAllocationMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PurchasePriceAllocationMember_lbl1" xml:lang="en-US" id="btx_PurchasePriceAllocationMember_lbl1">Purchase Price Allocation [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchasePriceAllocationMember" xlink:to="btx_PurchasePriceAllocationMember_lbl1" xlink:title="label: PurchasePriceAllocationMember to btx_PurchasePriceAllocationMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProFormaFairValueAdjustmentToAssetsMember" xlink:label="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="ProFormaFairValueAdjustmentToAssetsMember" />
    <link:label xlink:type="resource" xlink:label="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl" xml:lang="en-US" id="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl">Fair value adjustment to acquisition-date assets reported in proforma information.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProFormaFairValueAdjustmentToAssetsMember" xlink:to="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl" xlink:title="label: ProFormaFairValueAdjustmentToAssetsMember to btx_ProFormaFairValueAdjustmentToAssetsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl1" xml:lang="en-US" id="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl1">Pro Forma Fair Value Adjustment to Assets [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProFormaFairValueAdjustmentToAssetsMember" xlink:to="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl1" xlink:title="label: ProFormaFairValueAdjustmentToAssetsMember to btx_ProFormaFairValueAdjustmentToAssetsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl2" xml:lang="en-US" id="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl2">Fair Value Adjustment to Assets [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProFormaFairValueAdjustmentToAssetsMember" xlink:to="btx_ProFormaFairValueAdjustmentToAssetsMember_lbl2" xlink:title="label: ProFormaFairValueAdjustmentToAssetsMember to btx_ProFormaFairValueAdjustmentToAssetsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_BeneficialHoldersContractualCommitmentsToInvest" xlink:label="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="BeneficialHoldersContractualCommitmentsToInvest" />
    <link:label xlink:type="resource" xlink:label="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl" xml:lang="en-US" id="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl">Amount of contractual commitment made by beneficial holders to invest in the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialHoldersContractualCommitmentsToInvest" xlink:to="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl" xlink:title="label: BeneficialHoldersContractualCommitmentsToInvest to btx_BeneficialHoldersContractualCommitmentsToInvest_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl1" xml:lang="en-US" id="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl1">Beneficial Holders Contractual Commitments To Invest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialHoldersContractualCommitmentsToInvest" xlink:to="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl1" xlink:title="label: BeneficialHoldersContractualCommitmentsToInvest to btx_BeneficialHoldersContractualCommitmentsToInvest_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl2" xml:lang="en-US" id="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl2">Beneficial holders contractual commitments to invest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BeneficialHoldersContractualCommitmentsToInvest" xlink:to="btx_BeneficialHoldersContractualCommitmentsToInvest_lbl2" xlink:title="label: BeneficialHoldersContractualCommitmentsToInvest to btx_BeneficialHoldersContractualCommitmentsToInvest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" />
    <link:label xlink:type="resource" xlink:label="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" xml:lang="en-US" id="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl">The amount of software development costs recognized as of the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:to="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts to btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" xml:lang="en-US" id="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Software Development Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:to="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts to btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" xml:lang="en-US" id="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2">Software development costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:to="btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts to btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProceedsFromSaleOfRights" xlink:label="ProceedsFromSaleOfRights" xlink:title="ProceedsFromSaleOfRights" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromSaleOfRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ProceedsFromSaleOfRights_lbl" xml:lang="en-US" id="btx_ProceedsFromSaleOfRights_lbl">The cash inflow from the sale of rights during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRights" xlink:to="btx_ProceedsFromSaleOfRights_lbl" xlink:title="label: ProceedsFromSaleOfRights to btx_ProceedsFromSaleOfRights_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromSaleOfRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ProceedsFromSaleOfRights_lbl1" xml:lang="en-US" id="btx_ProceedsFromSaleOfRights_lbl1">Proceeds From Sale Of Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRights" xlink:to="btx_ProceedsFromSaleOfRights_lbl1" xlink:title="label: ProceedsFromSaleOfRights to btx_ProceedsFromSaleOfRights_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromSaleOfRights_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ProceedsFromSaleOfRights_lbl2" xml:lang="en-US" id="btx_ProceedsFromSaleOfRights_lbl2">Proceeds from right offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRights" xlink:to="btx_ProceedsFromSaleOfRights_lbl2" xlink:title="label: ProceedsFromSaleOfRights to btx_ProceedsFromSaleOfRights_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfAdditionalRightsOffering" xlink:label="PercentageOfAdditionalRightsOffering" xlink:title="PercentageOfAdditionalRightsOffering" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfAdditionalRightsOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PercentageOfAdditionalRightsOffering_lbl" xml:lang="en-US" id="btx_PercentageOfAdditionalRightsOffering_lbl">Percentage of additional right offering made by the entity for unit holders.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAdditionalRightsOffering" xlink:to="btx_PercentageOfAdditionalRightsOffering_lbl" xlink:title="label: PercentageOfAdditionalRightsOffering to btx_PercentageOfAdditionalRightsOffering_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfAdditionalRightsOffering_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PercentageOfAdditionalRightsOffering_lbl1" xml:lang="en-US" id="btx_PercentageOfAdditionalRightsOffering_lbl1">Percentage of Additional Rights Offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAdditionalRightsOffering" xlink:to="btx_PercentageOfAdditionalRightsOffering_lbl1" xlink:title="label: PercentageOfAdditionalRightsOffering to btx_PercentageOfAdditionalRightsOffering_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PercentageOfAdditionalRightsOffering_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_PercentageOfAdditionalRightsOffering_lbl2" xml:lang="en-US" id="btx_PercentageOfAdditionalRightsOffering_lbl2">Percentage of additional rights offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfAdditionalRightsOffering" xlink:to="btx_PercentageOfAdditionalRightsOffering_lbl2" xlink:title="label: PercentageOfAdditionalRightsOffering to btx_PercentageOfAdditionalRightsOffering_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" xlink:label="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" xlink:title="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" />
    <link:label xlink:type="resource" xlink:label="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl" xml:lang="en-US" id="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl">The cash inflow from the fees incurred in connection with the common stock issued to Lincoln Park to the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" xlink:to="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl" xlink:title="label: FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark to btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl1" xml:lang="en-US" id="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl1">Fees Incurred in Connection With the Common Stock Issued to Lincoln Park</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" xlink:to="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl1" xlink:title="label: FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark to btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl2" xml:lang="en-US" id="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl2">Fees incurred in connection with the common stock issued to Lincoln Park</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" xlink:to="btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl2" xlink:title="label: FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark to btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:label="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:title="ProceedsFromIssuanceOfCommonStockToLincolnPark" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl" xml:lang="en-US" id="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl">The cash inflow from the proceeds from issuance of common stock to Lincoln Park to the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:to="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl" xlink:title="label: ProceedsFromIssuanceOfCommonStockToLincolnPark to btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl1" xml:lang="en-US" id="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl1">Proceeds From Issuance of Common Stock to Lincoln Park</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:to="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl1" xlink:title="label: ProceedsFromIssuanceOfCommonStockToLincolnPark to btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl2" xml:lang="en-US" id="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl2">Proceeds from issuance of common stock to Lincoln Park</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:to="btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl2" xlink:title="label: ProceedsFromIssuanceOfCommonStockToLincolnPark to btx_ProceedsFromIssuanceOfCommonStockToLincolnPark_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities" xlink:label="InitialMeasurementOfRightOfUseAssetsAndLiabilities" xlink:title="InitialMeasurementOfRightOfUseAssetsAndLiabilities" />
    <link:label xlink:type="resource" xlink:label="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl" xml:lang="en-US" id="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl">The fair value of Initial measurement of ROU assets and liabilities in noncash financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfRightOfUseAssetsAndLiabilities" xlink:to="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl" xlink:title="label: InitialMeasurementOfRightOfUseAssetsAndLiabilities to btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl1" xml:lang="en-US" id="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl1">Initial Measurement of Right-of-Use Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfRightOfUseAssetsAndLiabilities" xlink:to="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl1" xlink:title="label: InitialMeasurementOfRightOfUseAssetsAndLiabilities to btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl2" xml:lang="en-US" id="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl2">Initial measurement of ROU assets and liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InitialMeasurementOfRightOfUseAssetsAndLiabilities" xlink:to="btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl2" xlink:title="label: InitialMeasurementOfRightOfUseAssetsAndLiabilities to btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:label xlink:type="resource" xlink:label="btx_GainLossOnDisposalOfFixedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_GainLossOnDisposalOfFixedAssets_lbl" xml:lang="en-US" id="btx_GainLossOnDisposalOfFixedAssets_lbl">Amount of gain (loss) on sale or disposal of fixed assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="btx_GainLossOnDisposalOfFixedAssets_lbl" xlink:title="label: GainLossOnDisposalOfFixedAssets to btx_GainLossOnDisposalOfFixedAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_GainLossOnDisposalOfFixedAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_GainLossOnDisposalOfFixedAssets_lbl1" xml:lang="en-US" id="btx_GainLossOnDisposalOfFixedAssets_lbl1">Gain (Loss) on Disposal of Fixed Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="btx_GainLossOnDisposalOfFixedAssets_lbl1" xlink:title="label: GainLossOnDisposalOfFixedAssets to btx_GainLossOnDisposalOfFixedAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_GainLossOnDisposalOfFixedAssets_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_GainLossOnDisposalOfFixedAssets_lbl2" xml:lang="en-US" id="btx_GainLossOnDisposalOfFixedAssets_lbl2">Loss on disposal of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnDisposalOfFixedAssets" xlink:to="btx_GainLossOnDisposalOfFixedAssets_lbl2" xlink:title="label: GainLossOnDisposalOfFixedAssets to btx_GainLossOnDisposalOfFixedAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xml:lang="en-US" id="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl">The increase (decrease) during the reporting period in the operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xml:lang="en-US" id="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" xml:lang="en-US" id="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2">Operating lease liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" xlink:title="label: IncreaseDecreaseInOperatingLeaseLiabilities to btx_IncreaseDecreaseInOperatingLeaseLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:label="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:title="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl" xml:lang="en-US" id="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl">The increase (decrease) during the reporting period in moneys or securities given as security deposits and also includes any other non-current assets which are not separately reported in during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:to="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl" xlink:title="label: IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets to btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl1" xml:lang="en-US" id="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl1">Increase (Decrease) in Deposit Assets and Other Non-current Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:to="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl1" xlink:title="label: IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets to btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl2" xml:lang="en-US" id="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl2">Security deposits and other non-current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:to="btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl2" xlink:title="label: IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets to btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:label xlink:type="resource" xlink:label="btx_WarrantLiabilitiesExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_WarrantLiabilitiesExpense_lbl" xml:lang="en-US" id="btx_WarrantLiabilitiesExpense_lbl">Amount of expenses related to warrant liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="btx_WarrantLiabilitiesExpense_lbl" xlink:title="label: WarrantLiabilitiesExpense to btx_WarrantLiabilitiesExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_WarrantLiabilitiesExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_WarrantLiabilitiesExpense_lbl1" xml:lang="en-US" id="btx_WarrantLiabilitiesExpense_lbl1">Warrant Liabilities Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="btx_WarrantLiabilitiesExpense_lbl1" xlink:title="label: WarrantLiabilitiesExpense to btx_WarrantLiabilitiesExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_WarrantLiabilitiesExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_WarrantLiabilitiesExpense_lbl2" xml:lang="en-US" id="btx_WarrantLiabilitiesExpense_lbl2">Gain on warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="btx_WarrantLiabilitiesExpense_lbl2" xlink:title="label: WarrantLiabilitiesExpense to btx_WarrantLiabilitiesExpense_lbl2" />
    <link:label xlink:type="resource" xlink:label="btx_WarrantLiabilitiesExpense_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_WarrantLiabilitiesExpense_lbl3" xml:lang="en-US" id="btx_WarrantLiabilitiesExpense_lbl3">Change in fair value of warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantLiabilitiesExpense" xlink:to="btx_WarrantLiabilitiesExpense_lbl3" xlink:title="label: WarrantLiabilitiesExpense to btx_WarrantLiabilitiesExpense_lbl3" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:label xlink:type="resource" xlink:label="btx_LossOnNonControllingInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_LossOnNonControllingInvestment_lbl" xml:lang="en-US" id="btx_LossOnNonControllingInvestment_lbl">Amount of loss on non-controlling investment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="btx_LossOnNonControllingInvestment_lbl" xlink:title="label: LossOnNonControllingInvestment to btx_LossOnNonControllingInvestment_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_LossOnNonControllingInvestment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_LossOnNonControllingInvestment_lbl1" xml:lang="en-US" id="btx_LossOnNonControllingInvestment_lbl1">Loss on Non-controlling Investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="btx_LossOnNonControllingInvestment_lbl1" xlink:title="label: LossOnNonControllingInvestment to btx_LossOnNonControllingInvestment_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_LossOnNonControllingInvestment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_LossOnNonControllingInvestment_lbl2" xml:lang="en-US" id="btx_LossOnNonControllingInvestment_lbl2">Loss on non-controlling investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="btx_LossOnNonControllingInvestment_lbl2" xlink:title="label: LossOnNonControllingInvestment to btx_LossOnNonControllingInvestment_lbl2" />
    <link:label xlink:type="resource" xlink:label="btx_LossOnNonControllingInvestment_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_LossOnNonControllingInvestment_lbl3" xml:lang="en-US" id="btx_LossOnNonControllingInvestment_lbl3">Loss on non-controlling investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnNonControllingInvestment" xlink:to="btx_LossOnNonControllingInvestment_lbl3" xlink:title="label: LossOnNonControllingInvestment to btx_LossOnNonControllingInvestment_lbl3" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:label xlink:type="resource" xlink:label="btx_GainOnTerminationOfLease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_GainOnTerminationOfLease_lbl" xml:lang="en-US" id="btx_GainOnTerminationOfLease_lbl">Amount of gain on termination of lease before expiration of lease term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="btx_GainOnTerminationOfLease_lbl" xlink:title="label: GainOnTerminationOfLease to btx_GainOnTerminationOfLease_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_GainOnTerminationOfLease_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_GainOnTerminationOfLease_lbl1" xml:lang="en-US" id="btx_GainOnTerminationOfLease_lbl1">Gain on Termination of Lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="btx_GainOnTerminationOfLease_lbl1" xlink:title="label: GainOnTerminationOfLease to btx_GainOnTerminationOfLease_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_GainOnTerminationOfLease_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_GainOnTerminationOfLease_lbl2" xml:lang="en-US" id="btx_GainOnTerminationOfLease_lbl2">Gain on lease termination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnTerminationOfLease" xlink:to="btx_GainOnTerminationOfLease_lbl2" xlink:title="label: GainOnTerminationOfLease to btx_GainOnTerminationOfLease_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CashPaidDuringThePeriodForAbstract" xlink:label="CashPaidDuringThePeriodForAbstract" xlink:title="CashPaidDuringThePeriodForAbstract" />
    <link:label xlink:type="resource" xlink:label="btx_CashPaidDuringThePeriodForAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_CashPaidDuringThePeriodForAbstract_lbl1" xml:lang="en-US" id="btx_CashPaidDuringThePeriodForAbstract_lbl1">Cash Paid During the Period for [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="btx_CashPaidDuringThePeriodForAbstract_lbl1" xlink:title="label: CashPaidDuringThePeriodForAbstract to btx_CashPaidDuringThePeriodForAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_CashPaidDuringThePeriodForAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_CashPaidDuringThePeriodForAbstract_lbl2" xml:lang="en-US" id="btx_CashPaidDuringThePeriodForAbstract_lbl2">Cash paid during the period for:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="btx_CashPaidDuringThePeriodForAbstract_lbl2" xlink:title="label: CashPaidDuringThePeriodForAbstract to btx_CashPaidDuringThePeriodForAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PaymentsOfPaycheckProtectionProgramLoan" xlink:label="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="PaymentsOfPaycheckProtectionProgramLoan" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl" xml:lang="en-US" id="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl">The amount of cash outflow for payment of paycheck protection program loans.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfPaycheckProtectionProgramLoan" xlink:to="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl" xlink:title="label: PaymentsOfPaycheckProtectionProgramLoan to btx_PaymentsOfPaycheckProtectionProgramLoan_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl1" xml:lang="en-US" id="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl1">Payments of Paycheck Protection Program Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfPaycheckProtectionProgramLoan" xlink:to="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl1" xlink:title="label: PaymentsOfPaycheckProtectionProgramLoan to btx_PaymentsOfPaycheckProtectionProgramLoan_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl2" xml:lang="en-US" id="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl2">Repayment of NTN's PPP loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfPaycheckProtectionProgramLoan" xlink:to="btx_PaymentsOfPaycheckProtectionProgramLoan_lbl2" xlink:title="label: PaymentsOfPaycheckProtectionProgramLoan to btx_PaymentsOfPaycheckProtectionProgramLoan_lbl2" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:label="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:title="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" />
    <link:label xlink:type="resource" xlink:label="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" xml:lang="en-US" id="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl">The fair value of preferred stock issued in a reverse merger transaction in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:to="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" xlink:title="label: NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger to btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl" />
    <link:label xlink:type="resource" xlink:label="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" xml:lang="en-US" id="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1">Noncash or Part Noncash Acquisition, Preferred Shares Issued in Connection with Reverse Merger</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:to="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" xlink:title="label: NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger to btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl1" />
    <link:label xlink:type="resource" xlink:label="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" xml:lang="en-US" id="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2">Series A preferred stock retained in business combination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:to="btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" xlink:title="label: NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger to btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger_lbl2" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>btx-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://brooklynitx.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#SubsequentEventDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquityMergerDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockholdersEquityMergerDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockholdersEquityPrivatePlacementOfEquityDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationStockbasedCompensationExpenseDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationRestrictedStockDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationSummaryOfRsusDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationNumberOfRsusVestedAndSettledDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationRsusDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationRsusDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationSummaryOfStockOptionsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationStockOptionActivityDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#CommitmentsAndContingenciesRoyaltyAgreementsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#CommitmentsAndContingenciesLicensingAgreementsDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#CommitmentsAndContingenciesLegalMattersDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CeoSeparationAgreementDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#CeoSeparationAgreementDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#InprocessResearchDevelopmentAndGoodwillDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesNetOperatingLeaseExpensesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesOperatingLeaseDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesOperatingLeaseDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsAcquisitionDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsDispositionDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsMergerDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#LiquidityAndCapitalResourcesDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails" xlink:type="simple" xlink:href="btx-20220630.xsd#DescriptionOfBusinessAndBasisOfPresentationDetails" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="btx-20220630.xsd#EarningsPerShareTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensationTables" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensationTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="btx-20220630.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LeasesTables" xlink:type="simple" xlink:href="btx-20220630.xsd#LeasesTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables" xlink:type="simple" xlink:href="btx-20220630.xsd#FairValueOfFinancialInstrumentsTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactionsTables" />
  <link:roleRef roleURI="http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="btx-20220630.xsd#RecentAccountingPronouncementsPolicies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:type="simple" xlink:href="btx-20220630.xsd#DescriptionOfBusinessAndBasisOfPresentationPolicies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/SubsequentEvent" xlink:type="simple" xlink:href="btx-20220630.xsd#SubsequentEvent" />
  <link:roleRef roleURI="http://brooklynitx.com/role/RecentAccountingPronouncements" xlink:type="simple" xlink:href="btx-20220630.xsd#RecentAccountingPronouncements" />
  <link:roleRef roleURI="http://brooklynitx.com/role/EarningsPerShare" xlink:type="simple" xlink:href="btx-20220630.xsd#EarningsPerShare" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockholdersEquity" xlink:type="simple" xlink:href="btx-20220630.xsd#StockholdersEquity" />
  <link:roleRef roleURI="http://brooklynitx.com/role/StockbasedCompensation" xlink:type="simple" xlink:href="btx-20220630.xsd#StockbasedCompensation" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="btx-20220630.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://brooklynitx.com/role/AccruedExpenses" xlink:type="simple" xlink:href="btx-20220630.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CeoSeparationAgreement" xlink:type="simple" xlink:href="btx-20220630.xsd#CeoSeparationAgreement" />
  <link:roleRef roleURI="http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwill" xlink:type="simple" xlink:href="btx-20220630.xsd#InprocessResearchDevelopmentAndGoodwill" />
  <link:roleRef roleURI="http://brooklynitx.com/role/Leases" xlink:type="simple" xlink:href="btx-20220630.xsd#Leases" />
  <link:roleRef roleURI="http://brooklynitx.com/role/FairValueOfFinancialInstruments" xlink:type="simple" xlink:href="btx-20220630.xsd#FairValueOfFinancialInstruments" />
  <link:roleRef roleURI="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions" xlink:type="simple" xlink:href="btx-20220630.xsd#MergerDispositionAndAcquisitionTransactions" />
  <link:roleRef roleURI="http://brooklynitx.com/role/LiquidityAndCapitalResources" xlink:type="simple" xlink:href="btx-20220630.xsd#LiquidityAndCapitalResources" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" xlink:href="btx-20220630.xsd#DescriptionOfBusinessAndBasisOfPresentation" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedStatementsOfStockholdersAndMembersEquity" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedStatementsOfOperations" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="btx-20220630.xsd#CondensedConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="btx-20220630.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="DocumentQuarterlyReport" xlink:title="DocumentQuarterlyReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentQuarterlyReport" xlink:title="presentation: CoverAbstract to DocumentQuarterlyReport" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: CoverAbstract to CurrentFiscalYearEndDate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentTransitionReport" xlink:title="presentation: CoverAbstract to DocumentTransitionReport" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCurrentReportingStatus" xlink:title="presentation: CoverAbstract to EntityCurrentReportingStatus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityInteractiveDataCurrent" xlink:title="presentation: CoverAbstract to EntityInteractiveDataCurrent" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFilerCategory" xlink:title="presentation: CoverAbstract to EntityFilerCategory" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntitySmallBusiness" xlink:title="presentation: CoverAbstract to EntitySmallBusiness" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityShellCompany" xlink:title="presentation: CoverAbstract to EntityShellCompany" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCommonStockSharesOutstanding" xlink:title="presentation: CoverAbstract to EntityCommonStockSharesOutstanding" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="presentation: ClassOfStockDomain to SeriesAPreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: StatementTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="Cash" xlink:title="presentation: AssetsCurrentAbstract to Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="OtherReceivablesNetCurrent" xlink:title="OtherReceivablesNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="OtherReceivablesNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to OtherReceivablesNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to AssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: AssetsCurrentAbstract to PropertyPlantAndEquipmentNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: AssetsCurrentAbstract to OperatingLeaseRightOfUseAsset" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="Goodwill" xlink:title="presentation: AssetsCurrentAbstract to Goodwill" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="presentation: AssetsCurrentAbstract to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="EquityMethodInvestments" xlink:title="presentation: AssetsCurrentAbstract to EquityMethodInvestments" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositAssets" xlink:label="DepositAssets" xlink:title="DepositAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="DepositAssets" xlink:title="presentation: AssetsCurrentAbstract to DepositAssets" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="Assets" xlink:title="presentation: AssetsCurrentAbstract to Assets" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="AssetsAbstract" xlink:title="presentation: StatementLineItems to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OperatingLeaseLiabilityCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OtherLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OtherLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesCurrentAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="DerivativeLiabilitiesNoncurrent" xlink:title="DerivativeLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DerivativeLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DerivativeLiabilitiesNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OperatingLeaseLiabilityNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OtherLiabilitiesNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="Liabilities" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to Liabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockValue" xlink:title="presentation: EquityAbstract to PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="CommonStockValue" xlink:title="presentation: EquityAbstract to CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: EquityAbstract to AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: EquityAbstract to RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="StockholdersEquity" xlink:title="presentation: EquityAbstract to StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="EquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to EquityAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementLineItems to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfFinancialPositionAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="presentation: EquityAbstract to PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: EquityAbstract to PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: EquityAbstract to PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: EquityAbstract to PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="PreferredStockLiquidationPreferenceValue" xlink:title="PreferredStockLiquidationPreferenceValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="PreferredStockLiquidationPreferenceValue" xlink:title="presentation: EquityAbstract to PreferredStockLiquidationPreferenceValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: EquityAbstract to CommonStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: EquityAbstract to CommonStockSharesAuthorized" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: EquityAbstract to CommonStockSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="CommonStockSharesOutstanding" xlink:title="presentation: EquityAbstract to CommonStockSharesOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="EquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to EquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ResearchAndDevelopmentExpense" xlink:title="presentation: OperatingExpensesAbstract to ResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="GeneralAndAdministrativeExpense" xlink:title="GeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="GeneralAndAdministrativeExpense" xlink:title="presentation: OperatingExpensesAbstract to GeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ImpairmentOfOngoingProject" xlink:title="presentation: OperatingExpensesAbstract to ImpairmentOfOngoingProject" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="NoncashMergerRelatedCosts" xlink:title="presentation: OperatingExpensesAbstract to NoncashMergerRelatedCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="OperatingExpenses" xlink:title="presentation: OperatingExpensesAbstract to OperatingExpenses" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingExpensesAbstract" xlink:title="presentation: IncomeStatementAbstract to OperatingExpensesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to OperatingIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract" xlink:label="OtherExpensesAbstract" xlink:title="OtherExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="GainLossOnDispositionOfAssets1" xlink:title="presentation: OtherExpensesAbstract to GainLossOnDispositionOfAssets1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="WarrantLiabilitiesExpense" xlink:title="presentation: OtherExpensesAbstract to WarrantLiabilitiesExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="LossOnNonControllingInvestment" xlink:title="presentation: OtherExpensesAbstract to LossOnNonControllingInvestment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="presentation: OtherExpensesAbstract to OtherNonoperatingIncomeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherExpensesAbstract" xlink:to="NonoperatingIncomeExpense" xlink:title="presentation: OtherExpensesAbstract to NonoperatingIncomeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OtherExpensesAbstract" xlink:title="presentation: IncomeStatementAbstract to OtherExpensesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="PreferredStockDividendsAndOtherAdjustments" xlink:title="PreferredStockDividendsAndOtherAdjustments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="PreferredStockDividendsAndOtherAdjustments" xlink:title="presentation: IncomeStatementAbstract to PreferredStockDividendsAndOtherAdjustments" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLossAvailableToCommonStockholdersBasic" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLossAvailableToCommonStockholdersBasic" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareBasic" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareBasic" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareDiluted" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareDiluted" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfSharesOutstandingBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfDilutedSharesOutstanding" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MembershipEquityMember" xlink:label="MembershipEquityMember" xlink:title="MembershipEquityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="MembershipEquityMember" xlink:title="presentation: StatementEquityComponentsAxis to MembershipEquityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="CommonStockMember" xlink:title="presentation: StatementEquityComponentsAxis to CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="PreferredStockMember" xlink:title="presentation: StatementEquityComponentsAxis to PreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="AdditionalPaidInCapitalMember" xlink:title="presentation: StatementEquityComponentsAxis to AdditionalPaidInCapitalMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="RetainedEarningsMember" xlink:title="presentation: StatementEquityComponentsAxis to RetainedEarningsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: StatementTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="presentation: ClassOfStockDomain to CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="presentation: ClassOfStockDomain to CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="presentation: ClassOfStockDomain to CommonClassCMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonUnitsMember" xlink:label="CommonUnitsMember" xlink:title="CommonUnitsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonUnitsMember" xlink:title="presentation: ClassOfStockDomain to CommonUnitsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="SeriesAPreferredStockMember" xlink:title="SeriesAPreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="SeriesAPreferredStockMember" xlink:title="presentation: ClassOfStockDomain to SeriesAPreferredStockMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: StatementTable to StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquity" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:label="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueRightsOfferingMembershipUnits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:label="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueAcquisitions1" xlink:label="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="StockIssuedDuringPeriodValueAcquisitions1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueAcquisitions1" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueAcquisitions1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesAcquisitions1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:label="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountAcquisitions" xlink:label="PartnersCapitalAccountAcquisitions" xlink:title="PartnersCapitalAccountAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="PartnersCapitalAccountAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to PartnersCapitalAccountAcquisitions" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountUnitsAcquisitions" xlink:label="PartnersCapitalAccountUnitsAcquisitions" xlink:title="PartnersCapitalAccountUnitsAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="PartnersCapitalAccountUnitsAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to PartnersCapitalAccountUnitsAcquisitions" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueAcquisitions" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesAcquisitions" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValuePrivateOffering" xlink:label="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="StockIssuedDuringPeriodValuePrivateOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValuePrivateOffering" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValuePrivateOffering" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesPrivateOffering" xlink:label="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="StockIssuedDuringPeriodSharesPrivateOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesPrivateOffering" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesPrivateOffering" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonStockToBeRetainedByNTNValueStockholders" xlink:label="CommonStockToBeRetainedByNTNValueStockholders" xlink:title="CommonStockToBeRetainedByNTNValueStockholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="CommonStockToBeRetainedByNTNValueStockholders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to CommonStockToBeRetainedByNTNValueStockholders" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonStockToBeRetainedByNTNSharesStockholders" xlink:label="CommonStockToBeRetainedByNTNSharesStockholders" xlink:title="CommonStockToBeRetainedByNTNSharesStockholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="CommonStockToBeRetainedByNTNSharesStockholders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to CommonStockToBeRetainedByNTNSharesStockholders" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueStockOptionsExercised" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesStockOptionsExercised" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodValueStockPurchaseAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueStockPurchaseAgreement" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueStockPurchaseAgreement" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:label="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="StockIssuedDuringPeriodSharesStockPurchaseAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesStockPurchaseAgreement" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesStockPurchaseAgreement" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueInLieuOfDividends" xlink:label="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:title="StockIssuedDuringPeriodValueInLieuOfDividends" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueInLieuOfDividends" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueInLieuOfDividends" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:label="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:title="StockIssuedDuringPeriodSharesInLieuOfDividends" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesInLieuOfDividends" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesInLieuOfDividends" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:label="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:label="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesIssuedSharesForfeitureOfUnvestedRestrictedStock" order="23.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="DividendsPreferredStockCash" xlink:title="DividendsPreferredStockCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="DividendsPreferredStockCash" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to DividendsPreferredStockCash" order="27.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsShares" xlink:label="PreferredStockDividendsShares" xlink:title="PreferredStockDividendsShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="PreferredStockDividendsShares" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to PreferredStockDividendsShares" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NetIncomeLoss" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NetIncomeLoss" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity_2" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquity_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquity" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding_2" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="presentation: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfStockholdersEquityAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DepreciationDepletionAndAmortization" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ShareBasedCompensation" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to OperatingLeaseRightOfUseAssetAmortizationExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to OperatingLeaseImpairmentLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ImpairmentOfOngoingProject" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ImpairmentOfOngoingProject" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashMergerRelatedCosts" xlink:label="NoncashMergerRelatedCosts" xlink:title="NoncashMergerRelatedCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NoncashMergerRelatedCosts" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to NoncashMergerRelatedCosts" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="GainLossOnDispositionOfAssets1" xlink:title="GainLossOnDispositionOfAssets1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnDispositionOfAssets1" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnDispositionOfAssets1" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_GainLossOnDisposalOfFixedAssets" xlink:label="GainLossOnDisposalOfFixedAssets" xlink:title="GainLossOnDisposalOfFixedAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnDisposalOfFixedAssets" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnDisposalOfFixedAssets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_GainOnTerminationOfLease" xlink:label="GainOnTerminationOfLease" xlink:title="GainOnTerminationOfLease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainOnTerminationOfLease" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainOnTerminationOfLease" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_WarrantLiabilitiesExpense" xlink:label="WarrantLiabilitiesExpense" xlink:title="WarrantLiabilitiesExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="WarrantLiabilitiesExpense" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to WarrantLiabilitiesExpense" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossOnNonControllingInvestment" xlink:label="LossOnNonControllingInvestment" xlink:title="LossOnNonControllingInvestment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="LossOnNonControllingInvestment" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to LossOnNonControllingInvestment" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="IncreaseDecreaseInOtherReceivables" xlink:title="IncreaseDecreaseInOtherReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherReceivables" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:label="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:title="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="IncreaseDecreaseInOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOperatingLeaseLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="ProceedsFromSaleOfPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfAssetsInvestingActivities" xlink:label="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="ProceedsFromSalesOfAssetsInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSalesOfAssetsInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSalesOfAssetsInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromDivestitureOfBusinesses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfCommonStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:label="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="PaymentsOfDividendsPreferredStockAndPreferenceStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsPreferredStockAndPreferenceStock" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:label="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:title="ProceedsFromIssuanceOfCommonStockToLincolnPark" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfCommonStockToLincolnPark" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfCommonStockToLincolnPark" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" xlink:label="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" xlink:title="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="ProceedsFromOtherEquity" xlink:title="ProceedsFromOtherEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromOtherEquity" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromOtherEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromStockOptionsExercised" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromStockOptionsExercised" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PaymentsOfPaycheckProtectionProgramLoan" xlink:label="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="PaymentsOfPaycheckProtectionProgramLoan" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfPaycheckProtectionProgramLoan" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfPaycheckProtectionProgramLoan" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to NetCashProvidedByUsedInFinancingActivities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CashPaidDuringThePeriodForAbstract" xlink:label="CashPaidDuringThePeriodForAbstract" xlink:title="CashPaidDuringThePeriodForAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="InterestPaidNet" xlink:title="presentation: CashPaidDuringThePeriodForAbstract to InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="IncomeTaxesPaidNet" xlink:title="presentation: CashPaidDuringThePeriodForAbstract to IncomeTaxesPaidNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="CashPaidDuringThePeriodForAbstract" xlink:title="presentation: SupplementalCashFlowInformationAbstract to CashPaidDuringThePeriodForAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="SupplementalCashFlowInformationAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to SupplementalCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssued1" xlink:label="StockIssued1" xlink:title="StockIssued1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="StockIssued1" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to StockIssued1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:label="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:title="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities" xlink:label="InitialMeasurementOfRightOfUseAssetsAndLiabilities" xlink:title="InitialMeasurementOfRightOfUseAssetsAndLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="InitialMeasurementOfRightOfUseAssetsAndLiabilities" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to InitialMeasurementOfRightOfUseAssetsAndLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LiquidityAndCapitalResources">
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:label="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:title="LIQUIDITYANDCAPITALRESOURCESAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LiquidityAndCapitalResourcesTextBlock" xlink:label="LiquidityAndCapitalResourcesTextBlock" xlink:title="LiquidityAndCapitalResourcesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:to="LiquidityAndCapitalResourcesTextBlock" xlink:title="presentation: LIQUIDITYANDCAPITALRESOURCESAbstract to LiquidityAndCapitalResourcesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:title="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to MergersAcquisitionsAndDispositionsDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstruments">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueDisclosuresTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/Leases">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeasesTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwill">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CeoSeparationAgreement">
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CEOSEPARATIONAGREEMENTAbstract" xlink:label="CEOSEPARATIONAGREEMENTAbstract" xlink:title="CEOSEPARATIONAGREEMENTAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ChiefExecutiveOfficerSeparationAgreementTextBlock" xlink:label="ChiefExecutiveOfficerSeparationAgreementTextBlock" xlink:title="ChiefExecutiveOfficerSeparationAgreementTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CEOSEPARATIONAGREEMENTAbstract" xlink:to="ChiefExecutiveOfficerSeparationAgreementTextBlock" xlink:title="presentation: CEOSEPARATIONAGREEMENTAbstract to ChiefExecutiveOfficerSeparationAgreementTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpenses">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingencies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="StockholdersEquityNoteDisclosureTextBlock" xlink:title="presentation: StockholdersEquityNoteAbstract to StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShare">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/RecentAccountingPronouncements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:title="presentation: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/SubsequentEvent">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventsTextBlock" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="PriorPeriodReclassificationAdjustmentDescription" xlink:title="PriorPeriodReclassificationAdjustmentDescription" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="PriorPeriodReclassificationAdjustmentDescription" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to PriorPeriodReclassificationAdjustmentDescription" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="presentation: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to NewAccountingPronouncementsPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:title="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:title="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionTableTextBlock" xlink:label="AssetAcquisitionTableTextBlock" xlink:title="AssetAcquisitionTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="AssetAcquisitionTableTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to AssetAcquisitionTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LeaseCostTableTextBlock" xlink:title="presentation: LeasesAbstract to LeaseCostTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:label="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" xlink:title="presentation: LeasesAbstract to OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpensesTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to ScheduleOfAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" xlink:label="ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" xlink:title="ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" xlink:label="ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" xlink:title="ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:label="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:title="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShareTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="presentation: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="presentation: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails">
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:label="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:title="LIQUIDITYANDCAPITALRESOURCESAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:label="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:title="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="Cash" xlink:title="Cash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="Cash" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to RetainedEarningsAccumulatedDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to NetIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: DetailedInformationAboutLiquidityAndCapitalResourcesAbstract to NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LIQUIDITYANDCAPITALRESOURCESAbstract" xlink:to="DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" xlink:title="presentation: LIQUIDITYANDCAPITALRESOURCESAbstract to DetailedInformationAboutLiquidityAndCapitalResourcesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodSharesIssuedForServices" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="BusinessAcquisitionSharePrice" xlink:title="BusinessAcquisitionSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionSharePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="CommonStockSharesOutstanding" xlink:title="presentation: BusinessCombinationDescriptionAbstract to CommonStockSharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="Goodwill" xlink:title="presentation: BusinessCombinationDescriptionAbstract to Goodwill" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="NonrecurringAdjustmentAxis" xlink:title="NonrecurringAdjustmentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="NonrecurringAdjustmentDomain" xlink:title="NonrecurringAdjustmentDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProFormaFairValueAdjustmentToAssetsMember" xlink:label="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="ProFormaFairValueAdjustmentToAssetsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonrecurringAdjustmentDomain" xlink:to="ProFormaFairValueAdjustmentToAssetsMember" xlink:title="presentation: NonrecurringAdjustmentDomain to ProFormaFairValueAdjustmentToAssetsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PurchasePriceAllocationMember" xlink:label="PurchasePriceAllocationMember" xlink:title="PurchasePriceAllocationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonrecurringAdjustmentDomain" xlink:to="PurchasePriceAllocationMember" xlink:title="presentation: NonrecurringAdjustmentDomain to PurchasePriceAllocationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonrecurringAdjustmentAxis" xlink:to="NonrecurringAdjustmentDomain" xlink:title="presentation: NonrecurringAdjustmentAxis to NonrecurringAdjustmentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="NonrecurringAdjustmentAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to NonrecurringAdjustmentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="Goodwill" xlink:title="presentation: BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract to Goodwill" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:label="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" xlink:title="presentation: BusinessAcquisitionLineItems to ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_BeneficialHoldersContractualCommitmentsToInvest" xlink:label="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="BeneficialHoldersContractualCommitmentsToInvest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BeneficialHoldersContractualCommitmentsToInvest" xlink:title="presentation: BusinessAcquisitionLineItems to BeneficialHoldersContractualCommitmentsToInvest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfAdditionalRightsOffering" xlink:label="PercentageOfAdditionalRightsOffering" xlink:title="PercentageOfAdditionalRightsOffering" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfAdditionalRightsOffering" xlink:title="presentation: BusinessAcquisitionLineItems to PercentageOfAdditionalRightsOffering" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProceedsFromSaleOfRights" xlink:label="ProceedsFromSaleOfRights" xlink:title="ProceedsFromSaleOfRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="ProceedsFromSaleOfRights" xlink:title="presentation: BusinessAcquisitionLineItems to ProceedsFromSaleOfRights" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NTNBusinessMember" xlink:label="NTNBusinessMember" xlink:title="NTNBusinessMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="NTNBusinessMember" xlink:title="presentation: DisposalGroupsIncludingDiscontinuedOperationsNameDomain to NTNBusinessMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis to DisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="CustomerRelationshipsMember" xlink:title="CustomerRelationshipsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="CustomerRelationshipsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to CustomerRelationshipsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember" xlink:label="TradeNamesMember" xlink:title="TradeNamesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TradeNamesMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TradeNamesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DispositionAbstract" xlink:label="DispositionAbstract" xlink:title="DispositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:label="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:title="presentation: DispositionAbstract to ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ProceedsFromDispositionAbstract" xlink:label="ProceedsFromDispositionAbstract" xlink:title="ProceedsFromDispositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromCash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:label="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProceedsFromDispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" xlink:title="presentation: ProceedsFromDispositionAbstract to DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="ProceedsFromDispositionAbstract" xlink:title="presentation: DispositionAbstract to ProceedsFromDispositionAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:label="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:label="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:label="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="DisposalGroupIncludingDiscontinuedOperationGoodwill1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationGoodwill1" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationGoodwill1" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:title="presentation: AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationOtherAssets" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="presentation: DispositionAbstract to AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:label="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:label="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationLeaseLiability" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:label="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" xlink:title="presentation: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract to DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:title="presentation: DispositionAbstract to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:label="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="DisposalGroupIncludingDiscontinuedOperationTransactionCosts" xlink:title="presentation: DispositionAbstract to DisposalGroupIncludingDiscontinuedOperationTransactionCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:label="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DispositionAbstract" xlink:to="DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:title="presentation: DispositionAbstract to DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="DispositionAbstract" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems to DispositionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:title="presentation: IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:title="presentation: BusinessCombinationsAbstract to IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="presentation: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="presentation: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="AssetAcquisitionAxis" xlink:title="AssetAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="AssetAcquisitionDomain" xlink:title="AssetAcquisitionDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="presentation: AssetAcquisitionDomain to NovellusTherapeuticsLimitedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusIncMember" xlink:label="NovellusIncMember" xlink:title="NovellusIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionDomain" xlink:to="NovellusIncMember" xlink:title="presentation: AssetAcquisitionDomain to NovellusIncMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetAcquisitionAxis" xlink:to="AssetAcquisitionDomain" xlink:title="presentation: AssetAcquisitionAxis to AssetAcquisitionDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="AssetAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to AssetAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" xlink:label="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" xlink:title="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" xlink:title="presentation: RelatedPartyDomain to ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RelatedPartyTransactionsByRelatedPartyAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:label="PaymentsToAcquireOtherProductiveAssets" xlink:title="PaymentsToAcquireOtherProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireOtherProductiveAssets" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireOtherProductiveAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="StockIssuedDuringPeriodSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodSharesAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodSharesAcquisitions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="StockIssuedDuringPeriodValueAcquisitions" xlink:title="StockIssuedDuringPeriodValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodValueAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodValueAcquisitions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionSharePrice" xlink:label="AssetAcquisitionSharePrice" xlink:title="AssetAcquisitionSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionSharePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodValueNewIssues" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodValueNewIssues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EscrowShares" xlink:label="EscrowShares" xlink:title="EscrowShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EscrowShares" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EscrowShares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EscrowPeriod" xlink:label="EscrowPeriod" xlink:title="EscrowPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EscrowPeriod" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EscrowPeriod" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AcquisitionAgreementNonCompetitivePeriod" xlink:label="AcquisitionAgreementNonCompetitivePeriod" xlink:title="AcquisitionAgreementNonCompetitivePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AcquisitionAgreementNonCompetitivePeriod" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AcquisitionAgreementNonCompetitivePeriod" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodSharesIssuedForServices" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EachLockUpAgreementExtendsTerm" xlink:label="EachLockUpAgreementExtendsTerm" xlink:title="EachLockUpAgreementExtendsTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EachLockUpAgreementExtendsTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EachLockUpAgreementExtendsTerm" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfCommonStockSubjectToLockUpAgreement" xlink:label="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="PercentageOfCommonStockSubjectToLockUpAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfCommonStockSubjectToLockUpAgreement" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfCommonStockSubjectToLockUpAgreement" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PaymentsToAcquireProductiveAssetsNet" xlink:label="PaymentsToAcquireProductiveAssetsNet" xlink:title="PaymentsToAcquireProductiveAssetsNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireProductiveAssetsNet" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireProductiveAssetsNet" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodUnrestrictedSharesAcquisitions" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodRestrictedSharesAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodRestrictedSharesAcquisitions" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LockUpPeriodForRestrictedShares" xlink:label="LockUpPeriodForRestrictedShares" xlink:title="LockUpPeriodForRestrictedShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="LockUpPeriodForRestrictedShares" xlink:title="presentation: BusinessCombinationDescriptionAbstract to LockUpPeriodForRestrictedShares" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionUnrestrictedSharesSharePrice" xlink:label="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="AssetAcquisitionUnrestrictedSharesSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionUnrestrictedSharesSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionUnrestrictedSharesSharePrice" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:label="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="PercentageOfDiscountOnFairValueOfRestrictedShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfDiscountOnFairValueOfRestrictedShares" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfDiscountOnFairValueOfRestrictedShares" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionRestrictedSharesSharePrice" xlink:label="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="AssetAcquisitionRestrictedSharesSharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionRestrictedSharesSharePrice" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionRestrictedSharesSharePrice" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireProductiveAssets" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="CashAcquiredFromAcquisition" xlink:title="presentation: BusinessCombinationDescriptionAbstract to CashAcquiredFromAcquisition" order="20.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:label="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" xlink:title="presentation: BusinessCombinationDescriptionAbstract to StockIssuedDuringPeriodRestrictedSharesValueAcquisitions" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AssetAcquisitionFairValueOfConsiderationPaid" xlink:label="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="AssetAcquisitionFairValueOfConsiderationPaid" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AssetAcquisitionFairValueOfConsiderationPaid" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AssetAcquisitionFairValueOfConsiderationPaid" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="PaymentsToAcquireInvestments" xlink:title="PaymentsToAcquireInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireInvestments" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireInvestments" order="24.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ResearchAndDevelopmentInProcessAssetAcquisition" xlink:label="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="ResearchAndDevelopmentInProcessAssetAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="ResearchAndDevelopmentInProcessAssetAcquisition" xlink:title="presentation: BusinessCombinationDescriptionAbstract to ResearchAndDevelopmentInProcessAssetAcquisition" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="EquityMethodInvesteeNameDomain" xlink:title="EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoveCiteINCMember" xlink:label="NoveCiteINCMember" xlink:title="NoveCiteINCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityMethodInvesteeNameDomain" xlink:to="NoveCiteINCMember" xlink:title="presentation: EquityMethodInvesteeNameDomain to NoveCiteINCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="EquityMethodInvesteeNameDomain" xlink:title="presentation: ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to EquityMethodInvesteeNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CitiusPharmaceuticalsIncMember" xlink:label="CitiusPharmaceuticalsIncMember" xlink:title="CitiusPharmaceuticalsIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipDomain" xlink:to="CitiusPharmaceuticalsIncMember" xlink:title="presentation: OwnershipDomain to CitiusPharmaceuticalsIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="presentation: OwnershipAxis to OwnershipDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="OwnershipAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to OwnershipAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAbstract" xlink:label="InvestmentsAbstract" xlink:title="InvestmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="EquityMethodInvestmentOwnershipPercentage" xlink:title="EquityMethodInvestmentOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="EquityMethodInvestmentOwnershipPercentage" xlink:title="presentation: InvestmentsAbstract to EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="MinorityInterestOwnershipPercentageByParent" xlink:title="MinorityInterestOwnershipPercentageByParent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="MinorityInterestOwnershipPercentageByParent" xlink:title="presentation: InvestmentsAbstract to MinorityInterestOwnershipPercentageByParent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NumberOfBoardSeats" xlink:label="NumberOfBoardSeats" xlink:title="NumberOfBoardSeats" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="NumberOfBoardSeats" xlink:title="presentation: InvestmentsAbstract to NumberOfBoardSeats" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments" xlink:label="EquityMethodInvestments" xlink:title="EquityMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="EquityMethodInvestments" xlink:title="presentation: InvestmentsAbstract to EquityMethodInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="EquityMethodInvestmentRealizedGainLossOnDisposal" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsAbstract" xlink:to="EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:title="presentation: InvestmentsAbstract to EquityMethodInvestmentRealizedGainLossOnDisposal" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="InvestmentsAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to InvestmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel1Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel1Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="presentation: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="FairValueByLiabilityClassAxis" xlink:title="FairValueByLiabilityClassAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="DerivativeFinancialInstrumentsLiabilitiesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="DerivativeFinancialInstrumentsLiabilitiesMember" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain to DerivativeFinancialInstrumentsLiabilitiesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByLiabilityClassAxis" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:title="presentation: FairValueByLiabilityClassAxis to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByLiabilityClassAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByLiabilityClassAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiabilityAbstract" xlink:label="FairValueNetAssetLiabilityAbstract" xlink:title="FairValueNetAssetLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="LiabilitiesFairValueDisclosureAbstract" xlink:title="LiabilitiesFairValueDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="LiabilitiesFairValueDisclosure" xlink:title="LiabilitiesFairValueDisclosure" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="LiabilitiesFairValueDisclosure" xlink:title="presentation: LiabilitiesFairValueDisclosureAbstract to LiabilitiesFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesFairValueDisclosureAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: LiabilitiesFairValueDisclosureAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueNetAssetLiabilityAbstract" xlink:to="LiabilitiesFairValueDisclosureAbstract" xlink:title="presentation: FairValueNetAssetLiabilityAbstract to LiabilitiesFairValueDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueNetAssetLiabilityAbstract" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueNetAssetLiabilityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="presentation: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="OverSubscriptionAmountReceived" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to OverSubscriptionAmountReceived" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to StockRepurchaseProgramAuthorizedAmount1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:label="LiabilitiesFairValueAdjustment" xlink:title="LiabilitiesFairValueAdjustment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="LiabilitiesFairValueAdjustment" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to LiabilitiesFairValueAdjustment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward to FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesOperatingLeaseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_OperatingLeaseArea" xlink:label="OperatingLeaseArea" xlink:title="OperatingLeaseArea" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseArea" xlink:title="presentation: LeasesAbstract to OperatingLeaseArea" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseTermOfContract" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseTermOfContract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_BaseRentPerSquareFoot" xlink:label="BaseRentPerSquareFoot" xlink:title="BaseRentPerSquareFoot" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="BaseRentPerSquareFoot" xlink:title="presentation: LeasesAbstract to BaseRentPerSquareFoot" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageBaseRentIncreaseOnEachAnniversary" xlink:label="PercentageBaseRentIncreaseOnEachAnniversary" xlink:title="PercentageBaseRentIncreaseOnEachAnniversary" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="PercentageBaseRentIncreaseOnEachAnniversary" xlink:title="presentation: LeasesAbstract to PercentageBaseRentIncreaseOnEachAnniversary" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="LesseeOperatingLeaseRenewalTerm" xlink:title="LesseeOperatingLeaseRenewalTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseRenewalTerm" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseRenewalTerm" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InitialMeasurementOfOperatingLeaseROUAssets" xlink:label="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="presentation: LeasesAbstract to InitialMeasurementOfOperatingLeaseROUAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InitialMeasurementOfOperatingLeaseLiabilities" xlink:label="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="presentation: LeasesAbstract to InitialMeasurementOfOperatingLeaseLiabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="presentation: LeasesAbstract to OperatingLeaseImpairmentLoss" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LesseeCommitmentToPurchaseProperty" xlink:label="LesseeCommitmentToPurchaseProperty" xlink:title="LesseeCommitmentToPurchaseProperty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeCommitmentToPurchaseProperty" xlink:title="presentation: LeasesAbstract to LesseeCommitmentToPurchaseProperty" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_UnamortizedLeaseholdImprovements" xlink:label="UnamortizedLeaseholdImprovements" xlink:title="UnamortizedLeaseholdImprovements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="UnamortizedLeaseholdImprovements" xlink:title="presentation: LeasesAbstract to UnamortizedLeaseholdImprovements" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositAssets" xlink:label="DepositAssets" xlink:title="DepositAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="DepositAssets" xlink:title="presentation: LeasesAbstract to DepositAssets" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="OperatingLeaseCost" xlink:title="presentation: LeaseCostAbstract to OperatingLeaseCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome" xlink:label="SubleaseIncome" xlink:title="SubleaseIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="SubleaseIncome" xlink:title="presentation: LeaseCostAbstract to SubleaseIncome" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="VariableLeaseCost" xlink:title="presentation: LeaseCostAbstract to VariableLeaseCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="LeaseCost" xlink:title="presentation: LeaseCostAbstract to LeaseCost" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LeaseCostAbstract" xlink:title="presentation: LeasesAbstract to LeaseCostAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAndLiabilitiesLesseeAbstract" xlink:label="AssetsAndLiabilitiesLesseeAbstract" xlink:title="AssetsAndLiabilitiesLesseeAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_OperatingLeaseAssestAbstract" xlink:label="OperatingLeaseAssestAbstract" xlink:title="OperatingLeaseAssestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InitialMeasurementOfOperatingLeaseROUAssets" xlink:label="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="InitialMeasurementOfOperatingLeaseROUAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="InitialMeasurementOfOperatingLeaseROUAssets" xlink:title="presentation: OperatingLeaseAssestAbstract to InitialMeasurementOfOperatingLeaseROUAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="OperatingLeaseRightOfUseAssetAmortizationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAssetAmortizationExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="OperatingLeaseImpairmentLoss" xlink:title="OperatingLeaseImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseImpairmentLoss" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseImpairmentLoss" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_WriteOffOfOperatingLeaseRightOfUseAsset" xlink:label="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:title="WriteOffOfOperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="WriteOffOfOperatingLeaseRightOfUseAsset" xlink:title="presentation: OperatingLeaseAssestAbstract to WriteOffOfOperatingLeaseRightOfUseAsset" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset_2" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseAssestAbstract" xlink:to="OperatingLeaseRightOfUseAsset_2" xlink:title="presentation: OperatingLeaseAssestAbstract to OperatingLeaseRightOfUseAsset" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="OperatingLeaseAssestAbstract" xlink:title="presentation: AssetsAndLiabilitiesLesseeAbstract to OperatingLeaseAssestAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="OperatingLeaseLiabilityAbstract" xlink:title="OperatingLeaseLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InitialMeasurementOfOperatingLeaseLiabilities" xlink:label="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="InitialMeasurementOfOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="InitialMeasurementOfOperatingLeaseLiabilities" xlink:title="presentation: OperatingLeaseLiabilityAbstract to InitialMeasurementOfOperatingLeaseLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:label="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="PrincipalPaymentsOnOperatingLeaseLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="PrincipalPaymentsOnOperatingLeaseLiabilities" xlink:title="presentation: OperatingLeaseLiabilityAbstract to PrincipalPaymentsOnOperatingLeaseLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_WriteOffOfOperatingLeaseLiability" xlink:label="WriteOffOfOperatingLeaseLiability" xlink:title="WriteOffOfOperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="WriteOffOfOperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilityAbstract to WriteOffOfOperatingLeaseLiability" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability_2" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiability_2" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiability" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAndLiabilitiesLesseeAbstract" xlink:to="OperatingLeaseLiabilityAbstract" xlink:title="presentation: AssetsAndLiabilitiesLesseeAbstract to OperatingLeaseLiabilityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="AssetsAndLiabilitiesLesseeAbstract" xlink:title="presentation: LeasesAbstract to AssetsAndLiabilitiesLesseeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:label="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="presentation: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="presentation: LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract to OperatingLeaseWeightedAverageDiscountRatePercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to OperatingLeaseLiability" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="presentation: LeasesAbstract to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2" />
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="Goodwill" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to Goodwill" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfOngoingProject" xlink:label="ImpairmentOfOngoingProject" xlink:title="ImpairmentOfOngoingProject" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="ImpairmentOfOngoingProject" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to ImpairmentOfOngoingProject" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="SharePrice" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to SharePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillImpairmentLoss" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillImpairmentLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CeoSeparationAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CEOSEPARATIONAGREEMENTAbstract" xlink:label="CEOSEPARATIONAGREEMENTAbstract" xlink:title="CEOSEPARATIONAGREEMENTAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="ChiefExecutiveOfficerMember" xlink:title="ChiefExecutiveOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MilestoneOptionsMember" xlink:label="MilestoneOptionsMember" xlink:title="MilestoneOptionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="MilestoneOptionsMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to MilestoneOptionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_SeparationAgreementAbstract" xlink:label="SeparationAgreementAbstract" xlink:title="SeparationAgreementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPostemploymentBenefits" xlink:label="PaymentsForPostemploymentBenefits" xlink:title="PaymentsForPostemploymentBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="PaymentsForPostemploymentBenefits" xlink:title="presentation: SeparationAgreementAbstract to PaymentsForPostemploymentBenefits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PaymentToOfficerBaseSalary" xlink:label="PaymentToOfficerBaseSalary" xlink:title="PaymentToOfficerBaseSalary" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="PaymentToOfficerBaseSalary" xlink:title="presentation: SeparationAgreementAbstract to PaymentToOfficerBaseSalary" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: SeparationAgreementAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:title="presentation: SeparationAgreementAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:label="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:title="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" xlink:title="presentation: SeparationAgreementAbstract to SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeparationAgreementAbstract" xlink:to="SharePrice" xlink:title="presentation: SeparationAgreementAbstract to SharePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="SeparationAgreementAbstract" xlink:title="presentation: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to SeparationAgreementAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CEOSEPARATIONAGREEMENTAbstract" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="presentation: CEOSEPARATIONAGREEMENTAbstract to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="ScheduleOfRestructuringAndRelatedCostsTable" xlink:title="ScheduleOfRestructuringAndRelatedCostsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="RestructuringCostAndReserveAxis" xlink:title="RestructuringCostAndReserveAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="TypeOfRestructuringDomain" xlink:title="TypeOfRestructuringDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="EmployeeSeveranceMember" xlink:title="EmployeeSeveranceMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfRestructuringDomain" xlink:to="EmployeeSeveranceMember" xlink:title="presentation: TypeOfRestructuringDomain to EmployeeSeveranceMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestructuringCostAndReserveAxis" xlink:to="TypeOfRestructuringDomain" xlink:title="presentation: RestructuringCostAndReserveAxis to TypeOfRestructuringDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="RestructuringCostAndReserveAxis" xlink:title="presentation: ScheduleOfRestructuringAndRelatedCostsTable to RestructuringCostAndReserveAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="ChiefExecutiveOfficerMember" xlink:title="ChiefExecutiveOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfRestructuringAndRelatedCostsTable to TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="RestructuringCostAndReserveLineItems" xlink:title="RestructuringCostAndReserveLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="AccruedLiabilitiesCurrentAbstract" xlink:title="AccruedLiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAbstract" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="presentation: AccruedLiabilitiesCurrentAbstract to EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AccruedResearchAndDevelopmentExpenses" xlink:label="AccruedResearchAndDevelopmentExpenses" xlink:title="AccruedResearchAndDevelopmentExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAbstract" xlink:to="AccruedResearchAndDevelopmentExpenses" xlink:title="presentation: AccruedLiabilitiesCurrentAbstract to AccruedResearchAndDevelopmentExpenses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AccruedGeneralAndAdministrativeExpenses" xlink:label="AccruedGeneralAndAdministrativeExpenses" xlink:title="AccruedGeneralAndAdministrativeExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAbstract" xlink:to="AccruedGeneralAndAdministrativeExpenses" xlink:title="presentation: AccruedLiabilitiesCurrentAbstract to AccruedGeneralAndAdministrativeExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: AccruedLiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="AccruedProfessionalFeesCurrent" xlink:title="AccruedProfessionalFeesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAbstract" xlink:to="AccruedProfessionalFeesCurrent" xlink:title="presentation: AccruedLiabilitiesCurrentAbstract to AccruedProfessionalFeesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestructuringCostAndReserveLineItems" xlink:to="AccruedLiabilitiesCurrentAbstract" xlink:title="presentation: RestructuringCostAndReserveLineItems to AccruedLiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="RestructuringCostAndReserveLineItems" xlink:title="presentation: ScheduleOfRestructuringAndRelatedCostsTable to RestructuringCostAndReserveLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="ScheduleOfRestructuringAndRelatedCostsTable" xlink:title="presentation: PayablesAndAccrualsAbstract to ScheduleOfRestructuringAndRelatedCostsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="presentation: RelatedPartyDomain to NovellusTherapeuticsLimitedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_DheshGovenderMember" xlink:label="DheshGovenderMember" xlink:title="DheshGovenderMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="DheshGovenderMember" xlink:title="presentation: RelatedPartyDomain to DheshGovenderMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: LossContingenciesTable to RelatedPartyTransactionsByRelatedPartyAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="RangeAxis" xlink:title="presentation: LossContingenciesTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: LossContingenciesTable to SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LegalMattersAbstract" xlink:label="LegalMattersAbstract" xlink:title="LegalMattersAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyDamagesSoughtExpectedSalary" xlink:label="LossContingencyDamagesSoughtExpectedSalary" xlink:title="LossContingencyDamagesSoughtExpectedSalary" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LossContingencyDamagesSoughtExpectedSalary" xlink:title="presentation: LegalMattersAbstract to LossContingencyDamagesSoughtExpectedSalary" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:label="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:title="LossContingencyDamagesSoughtExpectedEquityPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LossContingencyDamagesSoughtExpectedEquityPercentage" xlink:title="presentation: LegalMattersAbstract to LossContingencyDamagesSoughtExpectedEquityPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="LossContingencyDamagesSoughtValue" xlink:title="LossContingencyDamagesSoughtValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LossContingencyDamagesSoughtValue" xlink:title="presentation: LegalMattersAbstract to LossContingencyDamagesSoughtValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyNumberOfArbitrationPanel" xlink:label="LossContingencyNumberOfArbitrationPanel" xlink:title="LossContingencyNumberOfArbitrationPanel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LossContingencyNumberOfArbitrationPanel" xlink:title="presentation: LegalMattersAbstract to LossContingencyNumberOfArbitrationPanel" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="LitigationSettlementAmountAwardedToOtherParty" xlink:title="LitigationSettlementAmountAwardedToOtherParty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalMattersAbstract" xlink:to="LitigationSettlementAmountAwardedToOtherParty" xlink:title="presentation: LegalMattersAbstract to LitigationSettlementAmountAwardedToOtherParty" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesLineItems" xlink:to="LegalMattersAbstract" xlink:title="presentation: LossContingenciesLineItems to LegalMattersAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LossContingenciesLineItems" xlink:title="presentation: LossContingenciesTable to LossContingenciesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LossContingenciesTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LossContingenciesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_UniversityOfSouthFloridaMember" xlink:label="UniversityOfSouthFloridaMember" xlink:title="UniversityOfSouthFloridaMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityDomain" xlink:to="UniversityOfSouthFloridaMember" xlink:title="presentation: EntityDomain to UniversityOfSouthFloridaMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="presentation: LegalEntityAxis to EntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LegalEntityAxis" xlink:title="presentation: LossContingenciesTable to LegalEntityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="RelatedPartyDomain" xlink:title="RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusTherapeuticsLimitedMember" xlink:label="NovellusTherapeuticsLimitedMember" xlink:title="NovellusTherapeuticsLimitedMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="NovellusTherapeuticsLimitedMember" xlink:title="presentation: RelatedPartyDomain to NovellusTherapeuticsLimitedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NovellusLtdAndFactorBioscienceMember" xlink:label="NovellusLtdAndFactorBioscienceMember" xlink:title="NovellusLtdAndFactorBioscienceMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="NovellusLtdAndFactorBioscienceMember" xlink:title="presentation: RelatedPartyDomain to NovellusLtdAndFactorBioscienceMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NoveCiteMember" xlink:label="NoveCiteMember" xlink:title="NoveCiteMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyDomain" xlink:to="NoveCiteMember" xlink:title="presentation: RelatedPartyDomain to NoveCiteMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RelatedPartyDomain" xlink:title="presentation: RelatedPartyTransactionsByRelatedPartyAxis to RelatedPartyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="presentation: LossContingenciesTable to RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="ScenarioForecastMember" xlink:title="presentation: ScenarioUnspecifiedDomain to ScenarioForecastMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="presentation: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="StatementScenarioAxis" xlink:title="presentation: LossContingenciesTable to StatementScenarioAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="RangeAxis" xlink:title="presentation: LossContingenciesTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LicensingAgreementsAbstract" xlink:label="LicensingAgreementsAbstract" xlink:title="LicensingAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyPercentageOfRoyaltyPayable" xlink:label="LossContingencyPercentageOfRoyaltyPayable" xlink:title="LossContingencyPercentageOfRoyaltyPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="LossContingencyPercentageOfRoyaltyPayable" xlink:title="presentation: LicensingAgreementsAbstract to LossContingencyPercentageOfRoyaltyPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_LossContingencyNonRefundableOptionFee" xlink:label="LossContingencyNonRefundableOptionFee" xlink:title="LossContingencyNonRefundableOptionFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="LossContingencyNonRefundableOptionFee" xlink:title="presentation: LicensingAgreementsAbstract to LossContingencyNonRefundableOptionFee" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InitialLicenseFees" xlink:label="InitialLicenseFees" xlink:title="InitialLicenseFees" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="InitialLicenseFees" xlink:title="presentation: LicensingAgreementsAbstract to InitialLicenseFees" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AdditionalFeesObligatedToPay" xlink:label="AdditionalFeesObligatedToPay" xlink:title="AdditionalFeesObligatedToPay" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="AdditionalFeesObligatedToPay" xlink:title="presentation: LicensingAgreementsAbstract to AdditionalFeesObligatedToPay" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AmountRequireToPayInitialLicenseFees" xlink:label="AmountRequireToPayInitialLicenseFees" xlink:title="AmountRequireToPayInitialLicenseFees" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="AmountRequireToPayInitialLicenseFees" xlink:title="presentation: LicensingAgreementsAbstract to AmountRequireToPayInitialLicenseFees" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AmountObligatedToPayInYearOne" xlink:label="AmountObligatedToPayInYearOne" xlink:title="AmountObligatedToPayInYearOne" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="AmountObligatedToPayInYearOne" xlink:title="presentation: LicensingAgreementsAbstract to AmountObligatedToPayInYearOne" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AmountObligatedToPayInYearTwo" xlink:label="AmountObligatedToPayInYearTwo" xlink:title="AmountObligatedToPayInYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="AmountObligatedToPayInYearTwo" xlink:title="presentation: LicensingAgreementsAbstract to AmountObligatedToPayInYearTwo" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MilestonePayments" xlink:label="MilestonePayments" xlink:title="MilestonePayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="MilestonePayments" xlink:title="presentation: LicensingAgreementsAbstract to MilestonePayments" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfRevenue" xlink:label="PercentageOfRevenue" xlink:title="PercentageOfRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LicensingAgreementsAbstract" xlink:to="PercentageOfRevenue" xlink:title="presentation: LicensingAgreementsAbstract to PercentageOfRevenue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesLineItems" xlink:to="LicensingAgreementsAbstract" xlink:title="presentation: LossContingenciesLineItems to LicensingAgreementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LossContingenciesLineItems" xlink:title="presentation: LossContingenciesTable to LossContingenciesLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LossContingenciesTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LossContingenciesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="LossContingenciesTable" xlink:title="LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="TypeOfArrangementAxis" xlink:title="TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="ArrangementsAndNonarrangementTransactionsMember" xlink:title="ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_InvestorRoyaltyAgreementMember" xlink:label="InvestorRoyaltyAgreementMember" xlink:title="InvestorRoyaltyAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="InvestorRoyaltyAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to InvestorRoyaltyAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CollaboratorRoyaltyAgreementMember" xlink:label="CollaboratorRoyaltyAgreementMember" xlink:title="CollaboratorRoyaltyAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ArrangementsAndNonarrangementTransactionsMember" xlink:to="CollaboratorRoyaltyAgreementMember" xlink:title="presentation: ArrangementsAndNonarrangementTransactionsMember to CollaboratorRoyaltyAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfArrangementAxis" xlink:to="ArrangementsAndNonarrangementTransactionsMember" xlink:title="presentation: TypeOfArrangementAxis to ArrangementsAndNonarrangementTransactionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="TypeOfArrangementAxis" xlink:title="presentation: LossContingenciesTable to TypeOfArrangementAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="LossContingenciesLineItems" xlink:title="LossContingenciesLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_RoyaltyAgreementsAbstract" xlink:label="RoyaltyAgreementsAbstract" xlink:title="RoyaltyAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:label="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:title="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RoyaltyAgreementsAbstract" xlink:to="PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" xlink:title="presentation: RoyaltyAgreementsAbstract to PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:label="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RoyaltyAgreementsAbstract" xlink:to="PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" xlink:title="presentation: RoyaltyAgreementsAbstract to PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesLineItems" xlink:to="RoyaltyAgreementsAbstract" xlink:title="presentation: LossContingenciesLineItems to RoyaltyAgreementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LossContingenciesTable" xlink:to="LossContingenciesLineItems" xlink:title="presentation: LossContingenciesTable to LossContingenciesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="LossContingenciesTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to LossContingenciesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_TimeBasedStockOptionGrantMember" xlink:label="TimeBasedStockOptionGrantMember" xlink:title="TimeBasedStockOptionGrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="TimeBasedStockOptionGrantMember" xlink:title="presentation: EmployeeStockOptionMember to TimeBasedStockOptionGrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PerformanceBasedStockOptionGrantMember" xlink:label="PerformanceBasedStockOptionGrantMember" xlink:title="PerformanceBasedStockOptionGrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeStockOptionMember" xlink:to="PerformanceBasedStockOptionGrantMember" xlink:title="presentation: EmployeeStockOptionMember to PerformanceBasedStockOptionGrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheOneMember" xlink:title="presentation: VestingDomain to ShareBasedCompensationAwardTrancheOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VestingAxis" xlink:to="VestingDomain" xlink:title="presentation: VestingAxis to VestingDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="VestingAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to VestingAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="ChiefExecutiveOfficerMember" xlink:title="ChiefExecutiveOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to TitleOfIndividualAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to AllocatedShareBasedCompensationExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to StockIssuedDuringPeriodSharesStockOptionsExercised" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ProceedsFromStockOptionsExercised" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ProceedsFromStockOptionsExercised" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationRsusDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NumberOfAwardsVestedAndSettledAbstract" xlink:label="NumberOfAwardsVestedAndSettledAbstract" xlink:title="NumberOfAwardsVestedAndSettledAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="presentation: NumberOfAwardsVestedAndSettledAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonStockWithheldToCoverTaxes" xlink:label="CommonStockWithheldToCoverTaxes" xlink:title="CommonStockWithheldToCoverTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="CommonStockWithheldToCoverTaxes" xlink:title="presentation: NumberOfAwardsVestedAndSettledAbstract to CommonStockWithheldToCoverTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumberOfAwardsVestedAndSettledAbstract" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="presentation: NumberOfAwardsVestedAndSettledAbstract to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="NumberOfAwardsVestedAndSettledAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to NumberOfAwardsVestedAndSettledAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_Two022PerformanceBasedRestrictedStockUnitsMember" xlink:label="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:title="Two022PerformanceBasedRestrictedStockUnitsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="Two022PerformanceBasedRestrictedStockUnitsMember" xlink:title="presentation: RestrictedStockUnitsRSUMember to Two022PerformanceBasedRestrictedStockUnitsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeeMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to EmployeeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ChiefExecutiveOfficerAndPresidentMember" xlink:label="ChiefExecutiveOfficerAndPresidentMember" xlink:title="ChiefExecutiveOfficerAndPresidentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ChiefExecutiveOfficerAndPresidentMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to ChiefExecutiveOfficerAndPresidentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:label="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:title="NumberOfPerformanceGoalsAreSubjectToAchieve" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="NumberOfPerformanceGoalsAreSubjectToAchieve" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to NumberOfPerformanceGoalsAreSubjectToAchieve" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPostemploymentBenefits" xlink:label="PaymentsForPostemploymentBenefits" xlink:title="PaymentsForPostemploymentBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="PaymentsForPostemploymentBenefits" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to PaymentsForPostemploymentBenefits" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="SharePrice" xlink:title="SharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="SharePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to SharePrice" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to AllocatedShareBasedCompensationExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to AllocatedShareBasedCompensationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="presentation: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:label="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract to AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="presentation: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="presentation: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="InvestmentTypeAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to InvestmentTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="RangeAxis" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="SubsidiarySaleOfStockLineItems" xlink:title="SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PrivatePlacementOfEquityAbstract" xlink:label="PrivatePlacementOfEquityAbstract" xlink:title="PrivatePlacementOfEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="presentation: PrivatePlacementOfEquityAbstract to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="StockRepurchaseProgramAuthorizedAmount1" xlink:title="StockRepurchaseProgramAuthorizedAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="StockRepurchaseProgramAuthorizedAmount1" xlink:title="presentation: PrivatePlacementOfEquityAbstract to StockRepurchaseProgramAuthorizedAmount1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_VariableRateTransactionsPeriod" xlink:label="VariableRateTransactionsPeriod" xlink:title="VariableRateTransactionsPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="VariableRateTransactionsPeriod" xlink:title="presentation: PrivatePlacementOfEquityAbstract to VariableRateTransactionsPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:label="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightsExercisableTerm" xlink:label="ClassOfWarrantOrRightsExercisableTerm" xlink:title="ClassOfWarrantOrRightsExercisableTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightsExercisableTerm" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightsExercisableTerm" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="presentation: PrivatePlacementOfEquityAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="presentation: PrivatePlacementOfEquityAbstract to WarrantsAndRightsOutstandingTerm" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ClassOfWarrantOrRightOutstanding" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="presentation: PrivatePlacementOfEquityAbstract to FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_OverSubscriptionAmountReceived" xlink:label="OverSubscriptionAmountReceived" xlink:title="OverSubscriptionAmountReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="OverSubscriptionAmountReceived" xlink:title="presentation: PrivatePlacementOfEquityAbstract to OverSubscriptionAmountReceived" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:label="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ObligationToPayLiquidatedDamagesPercentage" xlink:label="ObligationToPayLiquidatedDamagesPercentage" xlink:title="ObligationToPayLiquidatedDamagesPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ObligationToPayLiquidatedDamagesPercentage" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ObligationToPayLiquidatedDamagesPercentage" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_TransactionFeesPayable" xlink:label="TransactionFeesPayable" xlink:title="TransactionFeesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="TransactionFeesPayable" xlink:title="presentation: PrivatePlacementOfEquityAbstract to TransactionFeesPayable" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ConsecutiveCalendarDays" xlink:label="ConsecutiveCalendarDays" xlink:title="ConsecutiveCalendarDays" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="ConsecutiveCalendarDays" xlink:title="presentation: PrivatePlacementOfEquityAbstract to ConsecutiveCalendarDays" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_AggregateCalendarDays" xlink:label="AggregateCalendarDays" xlink:title="AggregateCalendarDays" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="AggregateCalendarDays" xlink:title="presentation: PrivatePlacementOfEquityAbstract to AggregateCalendarDays" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:label="LossContingencyEstimateOfPossibleLoss" xlink:title="LossContingencyEstimateOfPossibleLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="LossContingencyEstimateOfPossibleLoss" xlink:title="presentation: PrivatePlacementOfEquityAbstract to LossContingencyEstimateOfPossibleLoss" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="LossContingencyDamagesPaidValue" xlink:title="LossContingencyDamagesPaidValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PrivatePlacementOfEquityAbstract" xlink:to="LossContingencyDamagesPaidValue" xlink:title="presentation: PrivatePlacementOfEquityAbstract to LossContingencyDamagesPaidValue" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiarySaleOfStockLineItems" xlink:to="PrivatePlacementOfEquityAbstract" xlink:title="presentation: SubsidiarySaleOfStockLineItems to PrivatePlacementOfEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="SubsidiarySaleOfStockLineItems" xlink:title="presentation: SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable to SubsidiarySaleOfStockLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:title="presentation: StockholdersEquityNoteAbstract to SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/StockholdersEquityMergerDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="StockholdersEquityNoteAbstract" xlink:title="StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="presentation: EquityComponentDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: ScheduleOfStockByClassTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="presentation: ClassOfStockDomain to CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="CommonClassBMember" xlink:title="CommonClassBMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassBMember" xlink:title="presentation: ClassOfStockDomain to CommonClassBMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="CommonClassCMember" xlink:title="CommonClassCMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassCMember" xlink:title="presentation: ClassOfStockDomain to CommonClassCMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: ScheduleOfStockByClassTable to StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_NTNBuzztimeIncMember" xlink:label="NTNBuzztimeIncMember" xlink:title="NTNBuzztimeIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NTNBuzztimeIncMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NTNBuzztimeIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfStockByClassTable to BusinessAcquisitionAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_MergerAbstract" xlink:label="MergerAbstract" xlink:title="MergerAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="SharesIssued" xlink:title="SharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="SharesIssued" xlink:title="presentation: MergerAbstract to SharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="ConversionOfStockSharesConverted1" xlink:title="ConversionOfStockSharesConverted1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="ConversionOfStockSharesConverted1" xlink:title="presentation: MergerAbstract to ConversionOfStockSharesConverted1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightIssued" xlink:label="ClassOfWarrantOrRightIssued" xlink:title="ClassOfWarrantOrRightIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="ClassOfWarrantOrRightIssued" xlink:title="presentation: MergerAbstract to ClassOfWarrantOrRightIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: MergerAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_StockIssuedDuringPeriodSharesAcquisitions1" xlink:label="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="StockIssuedDuringPeriodSharesAcquisitions1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergerAbstract" xlink:to="StockIssuedDuringPeriodSharesAcquisitions1" xlink:title="presentation: MergerAbstract to StockIssuedDuringPeriodSharesAcquisitions1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="MergerAbstract" xlink:title="presentation: ClassOfStockLineItems to MergerAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="ClassOfStockLineItems" xlink:title="presentation: ScheduleOfStockByClassTable to ClassOfStockLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteAbstract" xlink:to="ScheduleOfStockByClassTable" xlink:title="presentation: StockholdersEquityNoteAbstract to ScheduleOfStockByClassTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to ClassOfWarrantOrRightAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to WarrantMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="ConvertiblePreferredStockMember" xlink:title="ConvertiblePreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="ConvertiblePreferredStockMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to ConvertiblePreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareDilutedOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: EarningsPerShareDilutedOtherDisclosuresAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="presentation: EarningsPerShareDilutedOtherDisclosuresAbstract to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to EarningsPerShareDilutedOtherDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: SubsequentEventTable to SubsequentEventTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="InvestmentTypeAxis" xlink:title="InvestmentTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="InvestmentTypeCategorizationMember" xlink:title="InvestmentTypeCategorizationMember" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PIPEInvestorMember" xlink:label="PIPEInvestorMember" xlink:title="PIPEInvestorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeCategorizationMember" xlink:to="PIPEInvestorMember" xlink:title="presentation: InvestmentTypeCategorizationMember to PIPEInvestorMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentTypeAxis" xlink:to="InvestmentTypeCategorizationMember" xlink:title="presentation: InvestmentTypeAxis to InvestmentTypeCategorizationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="InvestmentTypeAxis" xlink:title="presentation: SubsequentEventTable to InvestmentTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="ClassOfWarrantOrRightAxis" xlink:title="ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="ClassOfWarrantOrRightDomain" xlink:title="ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_PreFundedWarrantsMember" xlink:label="PreFundedWarrantsMember" xlink:title="PreFundedWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="PreFundedWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to PreFundedWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_CommonWarrantsMember" xlink:label="CommonWarrantsMember" xlink:title="CommonWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightDomain" xlink:to="CommonWarrantsMember" xlink:title="presentation: ClassOfWarrantOrRightDomain to CommonWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfWarrantOrRightAxis" xlink:to="ClassOfWarrantOrRightDomain" xlink:title="presentation: ClassOfWarrantOrRightAxis to ClassOfWarrantOrRightDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="ClassOfWarrantOrRightAxis" xlink:title="presentation: SubsequentEventTable to ClassOfWarrantOrRightAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="WarrantsAndRightsNoteDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="btx-20220630.xsd#btx_ClassOfWarrantOrRightExercised" xlink:label="ClassOfWarrantOrRightExercised" xlink:title="ClassOfWarrantOrRightExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightExercised" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightExercised" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="ProceedsFromIssuanceOfWarrants" xlink:title="ProceedsFromIssuanceOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ProceedsFromIssuanceOfWarrants" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ProceedsFromIssuanceOfWarrants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="ClassOfWarrantOrRightOutstanding" xlink:title="ClassOfWarrantOrRightOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ClassOfWarrantOrRightOutstanding" xlink:title="presentation: WarrantsAndRightsNoteDisclosureAbstract to ClassOfWarrantOrRightOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="WarrantsAndRightsNoteDisclosureAbstract" xlink:title="presentation: SubsequentEventLineItems to WarrantsAndRightsNoteDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventLineItems" xlink:title="presentation: SubsequentEventTable to SubsequentEventLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventTable" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex10_3image00001.jpg
<TEXT>
begin 644 ex10_3image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %( FX# 2(  A$! Q$!_\0
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MZXK=T'4=3OK0&XW_ &A=V_RDCV<,5XR?:NAO!_H<_P#US;^58'@O_4O]&_\
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MPP<JJ@_J*W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH SM9^Y%]3676IK/W(OJ:RZM;"ZB]J@OO\
M4I_UUC_]"%3]JK:@P2V#-PJNC,<= &&30(B_Y:?]O8_]!JQIW_'E%^/\S5)9
MXG7S@Z^5]K!W'@=*N:80UC$0<@@D$?4T 6NU5[V\@LEC-PSC?DX2-GVJ.K'
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MAKI:Q?"5S%=Z:\D#;D\S;G&.0J@_J*VJ "BBB@ HHHH **** "BBB@ HHHH
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M_OZW_P 36O10!D?VNW]VV_[^M_\ $U6U+5Y!83[(XG8H5 CD8MSQP-M=!10
MV)!'&B+T4 "LSQ2COHDYB4NT923:.K;6!Q^E:M% '#?\)Z[/((=%NY0C%2T9
MW#(_"MZ/67D@5S' A9<[6E8$9'0_+2WNE:3$S2S!HBW)"3,FX^P!Y-6M$M?L
MMF1M=!(Y<([EBH/09- &'\-3C0IXV!61+F3<I!!&<&NLH  S@ 9ZT4 %%%%
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M XQNR_'O]ZMBB@#D_P#A'-;_ .AGN?\ OT/\:U1IUX% -Z2<=<O_ /%5KT4
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MN2>5IG\P+N9-AP%&/_UUTE !6,NHW4^MW5C D*K"H.]\DG(!Z#ZULUSVF_\
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M^XASY2?\M3ZM[587_D*?]L/_ &:EC_Y"4_\ UR3^;4#$TLL8)#( K>=)D Y
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M=%_ST3_OH4>=%_ST3_OH4 244 Y&1R** "BBB@ HHHH ***:TB*<,Z@^A.*
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M/^0I_P!L/_9J6/\ Y"4__7)/YM0 FF+LMY%W,V)I.6.2?F-7!533_P#5R_\
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MWY_G6??7,T]E/$EA<EGN%E&Y#C 93_2@"]J&?[0U7_5X_L\=>O5_TI8\_:M
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M=IR1D8R>E;=% ''WW@6UOB9;R]N'NV(+3JJH3@@XP!C!"@$5FZCH&@K.L?\
M:IMHXXO[.DBW%BQ(9L9)SG#$UZ%6!JWA/2M5N_M-Y"[3B3S5<2%=IVA>,=L
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MA1^^C_[Z% R*Z_X_K'_>?_T$U<K/NIX?MUE^]C^\_P#$/[IJW]HA_P">T?\
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G HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex10_3image00002.jpg
<TEXT>
begin 644 ex10_3image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" (7 <8# 2(  A$! Q$!_\0
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MRDV!0V24/*L?0GKC^5-9V.@I.[%YK)MS/W8Q,5?'^\%8?\"HD)M/%4)'$=]
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MWE/*(I-^Q5F4QESG'R[@-WU&10!;HHHH **** "BBB@ HHHH **** "BBB@
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M[J2X\Y#;V#ELN;<ES)ZDYVJ3U'S*V,Y%;%4O)OI?]9=QPJ><0199?;<V0?\
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M444 %%%% !1110 4444 %%%% !1110 4444 %48?W6K7*=%GC691_>8?*Q_
M"/\ .KU8OB1IK?['=VLBQRH[1$N<(589"GY23EUC  Y). <F@"GJ2F+PZ&52
M9-,N%*)_LH^%W?5"#^.:Z52&4%2"",@CO7)V]]?7$E_9RZ3.YND5GD@?:J[@
M8R<2A&Z(IP V,GD\5H:!-?7>BV;0_98$6)4#-NF+;?E/'R8Y'J: -VLO7)&M
MA:72RPPB.78\DI^4*X*C/3/S%.,CI4WV!I/^/B]NI5Z[581 'V* -^!)J&[T
MJV:UE:UMXC> ;HYFY?>IRN7.2<,!U]* (/M/GX_TZYN,\8L;?$;^V_#8/;.\
M8]JMZ;%*DKGR[B&#: $N)O-8MGKG<V!CWY]!CG0HH **** *MQ>>7*8X8)KB
M0#++%M&W/J6('X9S26VH0S.L3AX+AND,PVL<=<=FQZJ2/>H0EW;W5T;>"*43
MR"0,\NP+\BK@\$Y^7T[T3VEW>1F*[EME@?[\:P[R.^-S'!YQU3\J -&BL?2X
M+D6:M;W;LR.\3K<?O%<HY4MV*D[>QVCLM6OMY@!^WPM;X&3(/GBQU)W ?*!W
M+!?QH KZS-J\-Q;'2K>WN("V)D?Y6 P3PVX#G@=#ZU>L;DW=N)3!/;G)4QS+
MM88/\JR9YM=LKN!%ABU&V=R9'C41NB^F"X&<D8/H#D=ZWJ &QQI'OV* 7;<Q
M[D^_Z#Z 55C1K#3I"%:>50\I"#!=R2Q '.,D\>E7** * SIFD\XEF4?[OFRL
M?TW.WT&?2A\Z;I(6,B290%4L,>9*QP"<>K-D_4U<DB20H7&=C;E]CC']:BF@
M:6\MI"1Y<.YMO?>1@'Z8+_F* ,J]TFRM;1)(K=#?@"&*X VRL['&69<,1GYF
M]LFJVIV&H6<Z3V5XD[R,L8651',[=/\ 6*-I &3AHVQR<ULLK3ZHI(/E6R[A
MD<-(W''^ZN?^^_:D7_2=5<]8[1=@_P"NC $\>H7&#_MD>M &?::K<;GMM8LM
MC,2H"#?O7&3\O\77!V%O4@5+82V\ZF30;V&5$)5[8R912#@CNT9&,;>@P05S
MTN)_I&J2,?\ 5VHV*/\ IHP!)Q[*5 /^TPJ+5-,BN6^T)#$]RG(#C(DQV/H?
M1AR#CJ,@@%NSN4NHRRAD=3MDC;&Z-L [6QGGD>Q!!&00:GK%AN8WT^WU>UWK
M"L>)!(Q9FA!/)Y^\OWN<G[PZGC:H *I:C^^EM;4?\M'\Q^>0B8)_\>V CT8U
M=J"$F6XDEW1-&O[N/;R1@_-D]N1C'^S[X !/1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5'7"
M$TJXF)_U %Q]?+(?'X[<5>HZ]: *-W^[U2PE/._S+?'ID!\_^0\?C5?0Y66?
M4;.5LM;SED&.%C?YE'\_I42DIX=@;/S614.W_7)\2$?4*WYTY?\ 1_%;C[L=
MW;!B3_'(AQ@?1: 'ZKH-OJE[;SW<UR4A.1 KA4;Y6&#@;L'=D@$9*KGI5C23
MIL<#6FDM:^7;LRM% P.QMS;L@=#N#9SSG.><U)J.GV^HQ)'="1HU;?M25D#<
M$8;:1N'/0\9P>PINF:99Z9"T5C (D9BQ )/))8]>V68X]2?6@!=+E>6S'FDL
M\;O$6/5MK%=WXXS^-6ZR[>_L(Y+AH+H7/FR>85MP9MGR@=$!P#MSSW)J?[5=
M2<06#CN&GD5%(_#<V?J!0!=HJ"RN/M-OYA780[QL,YY5BIY],BIZ (+G[22B
MVHA .=SR$G;Z84?>_,8]Z@^RWDG,VH,A':WB5 ?KNW'/T(JU<&81'[.D;R9&
M!(Q48SSR >W^1UJK]GOG&)KY$'8V\ 5O_'RPQ^% %:2RBL+JVN(7G ><+,7G
M=P0RE1P21RQ3I5[4)WM[1WB"F8D)&&&1O8@+GVR1GVS6?JUB(].GN&GNI9[=
M?/4M*P5F0[P"JX4C(&>*M$BZU95!#1V@W-CG$K# _$(3D'M(I]* )?W>F:8H
M&]X[>(*HZL^!@#W)X'U-2)(T-FLEZ\8=(]TSKP@('S$9Z#K5>Z_TC4+>V&"D
M7^D2_AP@Q[MEL_\ 3/WI=1_?26]F.DK;Y/\ KFN"1[Y)52/1C0!<4[E!&<$9
MY&*6JFI._EQP0L5EN'\L,.JKU8^QV@X/KBIKJX6WC#,&8L0J(@RSL>@'^< 9
M)P 30!+15>UNEN"ZF.2&9,;XI,;@#T/!((/J">A'4$"Q0 5'!"D",L><,[.<
MG/+$D_SJ2H+JX-OM)@FD0YW-&H;9]1G<?P!H R=)1EB6*"\:*^ ,D]O."X+L
M<NP!PV-Q.-IV>@HU[4-1MM'NVCTN>6=8B=UO/&%7U(9BIR!D_=[8K3_T/4H?
M^65PB-[$H^/S5AGV(S6%JUM<FXE@M]0NC9"(126S$'>TAVJ!+@NI')))/# ]
M* '^#;^6^%\\D,%LF]3';Q,7V#&W.X@#!V_=VC!!SG.:UM%'EZ>D'_/NS0#U
MVHQ5<^^T FLO2-$@T76XQ:3W;B:VDWK-,7!VM'M..F1N//N:U=.YN-1;^%KC
MY?PC0']0: )[V<6MI-.5+>6A;:.K$= /<]*;80&VLXHG8/(!EW QN<\LWXDD
M_C3+Z/SY;:+<FT2"5T)P65>1CZ/L/^<&W0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M8%W>6]HNIV=VDGDNQ8 85=CJ,G>Q"Y+E^,Y]!BJ$&HZK>_V+??9(K(3#R2;Q
M\.=Z;CF-1\IW(, MGL0,\:T]E&_B>&>0*Q>VX!'0QOD?A^\SCU4'L,4]4B8^
M']3BC_UUM<-+N'\/SB7(]PK?SH U_LES)S<7T@[%8$5%(_'<P^H:D_LFR/\
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M?W'[R$'<0@+CDDL=A.X?@S>RTL-S&]C]DMKA6U"=OWPC8[XBW+M@C*A0?EW
M?PCN* +VF_OFGO#SY[8C/_3->%^H)+,#Z-[5>IL:+'&J1J%10%50,  =J=0
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MR([B!&8C@Y8,AQ^"K4NM<:;)(>D+).?<(P<C_P =I;CY-7LW/"/')%GU8[6
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M* "BBB@ JEI_%YJ0/!,ZL/IY2#/Y@_E5VLS39UN;^::+<(YK6"8!NOS;^OX
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M2V4G&(95YCY(RSY^7=RQ)Q5+4KZ&PCNM2MYG!7>Z-!)S*?M!54'9OD0@*<C
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M4 %%%% !1110 4444 %8FA9CN!&V/EMQ;J1W\F1T)/IG(..>_ISMUAZ8<:C
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M3CG(_, KZ24O==O/)B6*UTYUMD5. 2J<# Z;=[\>FPUK##ZT?6&W&/;>Q_\
MC=4?!EJUKX=M3)GS9P;AR1S\YR ?HNT=^G4]:NP_\AR[_P"O>'_T*6@"]501
MN^JF5E(CBAV(?[Q8Y;\MJ8^IJW51DEM=S6Z-.C.7="_S#/\ =)Z\]B>_!  %
M %NBHK:XBN8]\+;AG!!!!4^A!Y!]CS4M !1110 4444 %%%% !1110 4444
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M\B/RU4'9&0S]/5L$?-UZXP"0=BL37+R6'4--AB9D!N8][!OO*P<;2/3(%;=
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MN(SY7V6$ D$ 'Y>@VX93DX ##.#Q4JVLD[B2_*MM(*0J<HI'0G(^8Y[G@8&
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M1:W;W=G9:N;"SLC;36[,29C$00A!^4(0>W.:GM?^1GN/^VO_ *!;4 ;E%%%
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M HHHH **** "BBB@ HHHH **** "LG7V2*;2)WCWM'?($^;&"Z/'G\ YX_\
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M@6-&4]2Q'L,9ZCW P0#JZ*QE\2Z7$ +^]M+1^G[RX38W^Z^<'H>#@XY(%;-
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M)M7ELS+,UA+(KR1^6JO&,J[+G?EO0?PU9.H2P_\ 'Y8W,8'62$><A/L%^?\
M$J.GTR[1O^/23_KXG_\ 1KU>H S(I&5/M&EM#>6;LS&.-QD$DDE&S@\_PG')
M/S#&*N6MQ!>)OBY*-@JRX9&QT(/(.#^1]#45Q8))-Y\#-;W/&9(_X\=G'1AV
MYY&3@CK57#W%QMD(M-4C7Y)%&Y)5]<<;ESU7@J>XR&(!:DN)K61C<+OMB<B5
M!S&/1AZ=/F'X@ 9-M6#J&0AE89!!R"*KV=SYX9)4\JYCP)(MV=OH0>ZGL?S
M((#IDECB LEA!!R4<$!ASQD=#GO@_2@">BH+6Z2X+)AHYE +Q2##+_B.O(R.
M#S4] !5$0S67_'J&GM_^>!8;D_W&/;V)[\$  5>HH BM[B.YCWPMN&<$$$%3
MZ$'D'V-2U!<0%ED:W98;A@H\T(&)P<@'U'48XX)P0>:;]K5;GR9U,3,<1LQ^
M63C/!]>O!YX.,@9H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA16&W*D;1EN_. >G72M]4^TS8M[XRC<%(CFB;!)P,X3-<C;Z#\2K>U2W2_\
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M*MU!,<X!P!%#,Q)XPAKT6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O,OCI_Q[>!O^QMTW_T-J]-KSGXT"$CP,+DXB_X
M2JP]?O?/MZ?[6V@#KO#OW]1_Z^Y/_0S5S6#C2+XC@^1)_P"@FJ?AW_6:E_U]
MR?\ H1JYK/\ R![[_KA)_P"@F@!MSB/4-/?'#;X !VRN[/\ Y#/YU>JC?_\
M'UI?_7P?_1,E7J "BBB@ ILT:RQ/&^=KJ5."0<'W'(IU% %6UE=93:W+;IE7
M<CD8\U?7'J#P<>H/&0*M4$ XR <<CVJO9SF52DP"7,8 D0=/J/53S@_4=00
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M$E!,;!@K%3CL0<$4ZJ=Q$\,_VJW!8D8FC'\8[$?[0_4<'H,7* "J\D#"Z6>
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MO'$>A.[H)%6\E)0]&_?/Q0!T=4=9_P"/2/\ Z^(/_1J5>JCK/_'I'_U\0?\
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MO6((."/]*JS>267_  D1BOXX'_<PRQ&4*=CJ\F& /((R,,.GMQFMJP)\*W0
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MPUN4 8W_  D^D?\ /W_Y"?\ PJ2W\0Z7<3QPQ70,DAVJ"C#)],D5JUC>)?\
MF%?]?\7]: -FJ.L_\>D?_7Q!_P"C4J]5'6/^/2/_ *^(/_1J4 $/_(<N_P#K
MWA_]"EJ]5&'_ )#=W_U[P_\ H4M7J "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "J.L_\>D?_ %\0?^C4J]5'6?\ CTC_ .OB#_T:E %Z
MBBB@ HHHH QKRQ6_U:[BDE=8OLT.Y D;J_S2]0ZFL.\TC[-IVH>1J=W!&MS&
MFTB-HE&8\'84P /08%=2O_(9?WMUS[_,:Q/$)"^'];+$ "=223@#_5T 6_\
MA&K3^_\ ^2UO_P#&Z?=Z!'=P107-W/)!$P9(VBAVJ1TX\O' S^=7H]2L9=_E
M7ML^Q2[;95.U1U)YX'O2R:E8QI&\EY;(D@RC-*H##U'/- &.GA&P2\^U*Q$V
M2=WD0<<*/^>?^R/U]:NW6C+=[?M5W-/MSM\R&!L9ZXS'[5/_ &QIO_01L_\
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MC[-)NS_N[<X]\8H LJBJ6*J 6.6P.I]?TI:BMYUN(]\8D SC]Y&R'\F -2T
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MI:W AMH)!)''Y2L4&V12J]L$2L.03C\,;UK;QVMND,((1?4Y))Y))[DG))H
MEHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J>L?\>#_ .^G
M_H8JY5?4-_V5O*<(^Y?F+8_B&>: +%%%% !1110!3'_(9;_KW'_H1INN_P#(
M#U#_ *]Y/_032L=NM(#_ ,M+=L>VUAG_ -#'ZTFN_P#(#U#_ *]Y/_030!>H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *1T5UVNH9?0C(HHH 6BBB@ HHHH 0HID#E1O *AL<@'&1^@_
M*B1%DC9)%#(PVLK#((]#110 M%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
;%%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !  /X# 2(  A$! Q$!_\0
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M3G5G/25CA])^(7C[7+:'0](NKBYO7=I&FC0&9EXXSC"J/7WKU67QC?\ P_\
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MC-8SZ=\&Y;:\OIK^Y26#S+F;&Z1MXR>.@]!7 > #K$/P9\0WOAZ\FM+VSO\
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MWV2 #ED ^:1O1>P]3GL*Z8U.3!)K>QSRASXVS[GNGQ"%Q)X;>&TD,;SRI$S
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M MWJ4T]C+>"[1$ C<+MVDGO]:]'_ .&@[+_H7[K_ ,"%_P *[?\ X5/X*_Z
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:U4C&$-$CCP]"5.4ISW84445RG4%%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227159030400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Aug. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Brooklyn ImmunoTherapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000748592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-1103425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10355 Science Center Drive, Suite 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">582-1199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.005 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BTX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,825,739<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227160078624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 19,407,000<span></span>
</td>
<td class="nump">$ 16,985,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivable</a></td>
<td class="nump">694,000<span></span>
</td>
<td class="nump">684,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,824,000<span></span>
</td>
<td class="nump">1,097,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">21,925,000<span></span>
</td>
<td class="nump">18,766,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">424,000<span></span>
</td>
<td class="nump">670,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets - operating leases</a></td>
<td class="nump">1,943,000<span></span>
</td>
<td class="nump">2,567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,044,000<span></span>
</td>
<td class="nump">2,044,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,990,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment in non-controlling interest</a></td>
<td class="nump">89,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Security deposits and other assets</a></td>
<td class="nump">477,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">26,902,000<span></span>
</td>
<td class="nump">31,525,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,478,000<span></span>
</td>
<td class="nump">1,755,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">3,821,000<span></span>
</td>
<td class="nump">1,249,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">390,000<span></span>
</td>
<td class="nump">426,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">1,429,000<span></span>
</td>
<td class="nump">247,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">7,118,000<span></span>
</td>
<td class="nump">3,677,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant liabilities</a></td>
<td class="nump">2,524,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">2,433,000<span></span>
</td>
<td class="nump">2,297,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">48,000<span></span>
</td>
<td class="nump">48,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">12,123,000<span></span>
</td>
<td class="nump">6,022,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.005 par value, 100,000 shares authorized at June 30, 2022 and December 31, 2021; 57,469 and 52,021 issued and outstanding at June 30, 2022 and December 31, 2021, respectively</a></td>
<td class="nump">287,000<span></span>
</td>
<td class="nump">260,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">167,974,000<span></span>
</td>
<td class="nump">165,944,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(153,483,000)<span></span>
</td>
<td class="num">(140,702,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">14,779,000<span></span>
</td>
<td class="nump">25,503,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">26,902,000<span></span>
</td>
<td class="nump">31,525,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated, issued and outstanding of Series A convertible preferred stock at June 30, 2022 and December 31, 2021, $156 liquidation preference</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227158993840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Preferred stock, liquidation preference</a></td>
<td class="nump">$ 156<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">57,469<span></span>
</td>
<td class="nump">52,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">57,469<span></span>
</td>
<td class="nump">52,021<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227160144544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 1,685<span></span>
</td>
<td class="nump">$ 5,432<span></span>
</td>
<td class="nump">$ 3,467<span></span>
</td>
<td class="nump">$ 6,965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">6,205<span></span>
</td>
<td class="nump">4,581<span></span>
</td>
<td class="nump">10,719<span></span>
</td>
<td class="nump">6,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfOngoingProject', window );">Impairment of in-process research and development</a></td>
<td class="nump">5,990<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,990<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashMergerRelatedCosts', window );">Transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,765<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">13,880<span></span>
</td>
<td class="nump">10,013<span></span>
</td>
<td class="nump">20,176<span></span>
</td>
<td class="nump">18,934<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(13,880)<span></span>
</td>
<td class="num">(10,013)<span></span>
</td>
<td class="num">(20,176)<span></span>
</td>
<td class="num">(18,934)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>Other income (expense), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on sale of NTN assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,648)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_WarrantLiabilitiesExpense', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">10,792<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,470<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossOnNonControllingInvestment', window );">Loss on non-controlling investment</a></td>
<td class="num">(296)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(911)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(1,156)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">10,482<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="nump">7,403<span></span>
</td>
<td class="num">(9,673)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3,398)<span></span>
</td>
<td class="num">(10,085)<span></span>
</td>
<td class="num">(12,773)<span></span>
</td>
<td class="num">(28,607)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustments', window );">Series A preferred stock dividend</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (3,406)<span></span>
</td>
<td class="num">$ (10,093)<span></span>
</td>
<td class="num">$ (12,781)<span></span>
</td>
<td class="num">$ (28,615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (in dollars per share)</a></td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.81)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding - basic (in shares)</a></td>
<td class="nump">58,805<span></span>
</td>
<td class="nump">42,448<span></span>
</td>
<td class="nump">56,230<span></span>
</td>
<td class="nump">35,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding - diluted (in shares)</a></td>
<td class="nump">58,805<span></span>
</td>
<td class="nump">42,448<span></span>
</td>
<td class="nump">56,230<span></span>
</td>
<td class="nump">35,187<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossOnNonControllingInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss on non-controlling investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossOnNonControllingInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_WarrantLiabilitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_WarrantLiabilitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfOngoingProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfOngoingProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashMergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashMergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227150266544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Class A [Member]</div>
</th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Class B [Member]</div>
</th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Class C [Member]</div>
</th>
<th class="th">
<div>Membership Equity [Member] </div>
<div>Common [Member]</div>
</th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th">
<div>Preferred Stock [Member] </div>
<div>Series A Preferred Stock [Member]</div>
</th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 23,202<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 198<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (18,141)<span></span>
</td>
<td class="nump">$ 7,659<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits', window );">Brooklyn rights offerings membership units</a></td>
<td class="nump">10,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity', window );">Elimination of Brooklyn's historical members' equity</a></td>
<td class="num">(33,702)<span></span>
</td>
<td class="num">(1,400)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(198)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">36,300<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueAcquisitions1', window );">Issuance of common stock for business combination</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">8,170<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesAcquisitions1', window );">Issuance of common stock for business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,514<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders', window );">Series A preferred stock retained in business combination</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders', window );">Series A preferred stock retained in business combination (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountAcquisitions', window );">Issuance of common stock to Brooklyn members</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountUnitsAcquisitions', window );">Issuance of common stock to Brooklyn members (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,924<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock to Financial Advisor upon consummation of merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">5,760<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock to Financial Advisor upon consummation of merger (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,068<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueStockPurchaseAgreement', window );">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">48,509<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">48,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement', window );">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,212<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueInLieuOfDividends', window );">Issuance of common stock in lieu of cash dividend to Series A preferred stockholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesInLieuOfDividends', window );">Issuance of common stock in lieu of cash dividend to Series A preferred stockholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,573<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(28,607)<span></span>
</td>
<td class="num">(28,607)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 224<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">100,134<span></span>
</td>
<td class="num">(46,756)<span></span>
</td>
<td class="nump">53,603<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,707<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">50,453<span></span>
</td>
<td class="num">(36,663)<span></span>
</td>
<td class="nump">13,999<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,506<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_CommonStockToBeRetainedByNTNValueStockholders', window );">Common stock to be retained by NTN stockholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_CommonStockToBeRetainedByNTNSharesStockholders', window );">Common stock to be retained by NTN stockholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueStockPurchaseAgreement', window );">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">48,509<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">48,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement', window );">Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,212<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueInLieuOfDividends', window );">Issuance of common stock in lieu of cash dividend to Series A preferred stockholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesInLieuOfDividends', window );">Issuance of common stock in lieu of cash dividend to Series A preferred stockholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,085)<span></span>
</td>
<td class="num">(10,085)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 224<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">100,134<span></span>
</td>
<td class="num">(46,756)<span></span>
</td>
<td class="nump">53,603<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,707<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 260<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">165,944<span></span>
</td>
<td class="num">(140,702)<span></span>
</td>
<td class="nump">25,503<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,021<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValuePrivateOffering', window );">Issuance of common stock in connection with private offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesPrivateOffering', window );">Issuance of common stock in connection with private offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock', window );">Forfeiture of unvested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of common stock from vested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock from vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,062<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Cash dividends to Series A preferred stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Cash dividends to Series A preferred stockholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,773)<span></span>
</td>
<td class="num">(12,773)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">167,974<span></span>
</td>
<td class="num">(153,483)<span></span>
</td>
<td class="nump">14,779<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,469<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">167,100<span></span>
</td>
<td class="num">(150,077)<span></span>
</td>
<td class="nump">17,311<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,452<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of common stock from vested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of common stock from vested restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">879<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Cash dividends to Series A preferred stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Cash dividends to Series A preferred stockholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,398)<span></span>
</td>
<td class="num">(3,398)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 167,974<span></span>
</td>
<td class="num">$ (153,483)<span></span>
</td>
<td class="nump">$ 14,779<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,469<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease (increase) in additional paid in capital (APIC) for the increase in redemption of temporary equity as the result of a triggering event associated with the temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_CommonStockToBeRetainedByNTNSharesStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock to be retained by NTN stockholders during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_CommonStockToBeRetainedByNTNSharesStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_CommonStockToBeRetainedByNTNValueStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of common stock to be retained by NTN stockholders during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_CommonStockToBeRetainedByNTNValueStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares Forfeiture of unvested restricted stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodSharesAcquisitions1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodSharesAcquisitions1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodSharesInLieuOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period in lieu of dividends to be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodSharesInLieuOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the shares of new stock issued of preferred stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodSharesPrivateOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been issued in private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodSharesPrivateOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been issued in a stock purchase agreement during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValueAcquisitions1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValueAcquisitions1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Forfeiture of unvested restricted stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValueInLieuOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period in Lieu of Dividends to be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValueInLieuOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued of preferred stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValuePrivateOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been issued in private offering during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValuePrivateOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to rights offering membership units during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodValueStockPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been issued in a stock purchase agreement during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodValueStockPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in the different classes of partners' capital accounts during the year due to acquisitions. Partners include general, limited and preferred partners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 4.F)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountUnitsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in the number of units for each class of partners' capital accounts during the year due to acquisitions. Partners include general, limited and preferred partners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=66023778&amp;loc=d3e9334-128500<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=66023778&amp;loc=d3e9337-128500<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=66023778&amp;loc=d3e9298-128500<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 05<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=66006417&amp;loc=d3e8580-128490<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountUnitsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227147717616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (12,773)<span></span>
</td>
<td class="num">$ (28,607)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">2,062<span></span>
</td>
<td class="nump">1,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use asset</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of right-of-use asset</a></td>
<td class="nump">772<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfOngoingProject', window );">Impairment of in-process research and development</a></td>
<td class="nump">5,990<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashMergerRelatedCosts', window );">Transaction costs - shares to Financial Advisor</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on sale of NTN assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_GainLossOnDisposalOfFixedAssets', window );">Loss on disposal of fixed assets</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_GainOnTerminationOfLease', window );">Gain on lease termination</a></td>
<td class="num">(85)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_WarrantLiabilitiesExpense', window );">Gain on warrant liabilities</a></td>
<td class="num">(9,470)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossOnNonControllingInvestment', window );">Loss on non-controlling investment</a></td>
<td class="nump">911<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivable</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(727)<span></span>
</td>
<td class="num">(1,508)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets', window );">Security deposits and other non-current assets</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">2,295<span></span>
</td>
<td class="nump">1,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liability</a></td>
<td class="num">(153)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">1,183<span></span>
</td>
<td class="nump">982<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(9,425)<span></span>
</td>
<td class="num">(10,234)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows (used in) provided by investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(233)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from the sales of fixed assets</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfAssetsInvestingActivities', window );">Purchase of NTN, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from the sale of NTN assets, net of cash disposed</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(133)<span></span>
</td>
<td class="nump">266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows provided by financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock and warrants in connection with private offering</a></td>
<td class="nump">11,993<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payroll tax remitted on net share settlement of equity awards</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock', window );">Dividends paid to Series A preferred stockholders</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ProceedsFromIssuanceOfCommonStockToLincolnPark', window );">Proceeds from issuance of common stock to Lincoln Park</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark', window );">Fees incurred in connection with the common stock issued to Lincoln Park</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,972)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from sale of members' equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PaymentsOfPaycheckProtectionProgramLoan', window );">Repayment of NTN's PPP loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(532)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">11,980<span></span>
</td>
<td class="nump">58,503<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">2,422<span></span>
</td>
<td class="nump">48,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">16,985<span></span>
</td>
<td class="nump">1,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">19,407<span></span>
</td>
<td class="nump">50,165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_CashPaidDuringThePeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of common stock for business combination</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger', window );">Series A preferred stock retained in business combination</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities', window );">Initial measurement of ROU assets and liabilities</a></td>
<td class="nump">$ 1,706<span></span>
</td>
<td class="nump">$ 874<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_CashPaidDuringThePeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_CashPaidDuringThePeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the fees incurred in connection with the common stock issued to Lincoln Park to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_GainLossOnDisposalOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of fixed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_GainLossOnDisposalOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_GainOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_GainOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in moneys or securities given as security deposits and also includes any other non-current assets which are not separately reported in during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of Initial measurement of ROU assets and liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossOnNonControllingInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss on non-controlling investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossOnNonControllingInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of preferred stock issued in a reverse merger transaction in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PaymentsOfPaycheckProtectionProgramLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for payment of paycheck protection program loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PaymentsOfPaycheckProtectionProgramLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ProceedsFromIssuanceOfCommonStockToLincolnPark">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the proceeds from issuance of common stock to Lincoln Park to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ProceedsFromIssuanceOfCommonStockToLincolnPark</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_WarrantLiabilitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_WarrantLiabilitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfOngoingProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfOngoingProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashMergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashMergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions that are classified as investing activities in which assets, which may include one or more investments, are sold to third-party buyers. This element can be used by entities to aggregate proceeds from all asset sales that are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156283792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
         </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></div>
              </td>

  </tr>


</table>

<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Description of Business</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Brooklyn ImmunoTherapeutics Inc., a Delaware corporation (&#8220;Brooklyn&#8221; or the &#8220;Company&#8221;), together with its subsidiaries including Brooklyn
              ImmunoTherapeutics LLC (&#8220;Brooklyn LLC&#8221;), Novellus, Inc. (&#8220;Novellus&#8221;) and Novellus Therapeutics, Ltd. (&#8220;Novellus, Ltd.&#8221;), is a biopharmaceutical company utilizing its mRNA technology platform, including mRNA-based cell reprogramming and gene
              editing technologies, to create next generation mRNA, gene editing and cell therapies, including iPSC therapies for multiple therapeutic indications. As used herein, the &#8220;Company&#8221; refers collectively to Brooklyn and its subsidiaries.</div>

<div><br/></div>

<div><span style="font-family: 'Times New Roman';"> </span></div>

<div><span style="font-family: 'Times New Roman';"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On August 12, 2020, Brooklyn (then known as &#8220;NTN Buzztime, Inc.&#8221;), Brooklyn LLC and BIT Merger Sub, Inc., a wholly owned subsidiary of
              Brooklyn (the &#8220;Merger Sub&#8221;), entered into an agreement and plan of merger and reorganization (the &#8220;Merger Agreement&#8221;) pursuant to which, among other matters, Merger Sub merged with and into Brooklyn LLC, with Brooklyn LLC continuing as a
              wholly owned subsidiary of Brooklyn and as the surviving company of the merger (the &#8220;Merger&#8221;). The Merger closed on March 25, 2021. After the Merger, Brooklyn changed its name from &#8220;NTN Buzztime, Inc.&#8221; to &#8220;Brooklyn ImmunoTherapeutics, Inc.&#8221;
              The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 26, 2021, Brooklyn sold (the &#8220;Disposition&#8221;) its rights, title and interest in and to the assets relating to the business operated
              under the name &#8220;NTN Buzztime, Inc.&#8221; prior to the Merger to eGames.com Holdings LLC (&#8220;eGames.com&#8221;) in accordance with the terms of an asset purchase agreement dated September 18, 2020, as amended, between Brooklyn and eGames.com (the &#8220;Asset
              Purchase Agreement&#8221;). </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span> </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On July 16, 2021, Brooklyn and its newly formed, wholly owned subsidiary Brooklyn Acquisition Sub, Inc. entered into an
          agreement and plan of acquisition (the &#8220;Acquisition Agreement&#8221;) with (a) Novellus LLC, (b) Novellus (the sole equity holder of Novellus, Ltd. and, prior to the closing under the Acquisition Agreement, a subsidiary of Novellus, LLC), and (c) a
          seller representative (the &#8220;Acquisition&#8221;), pursuant to which Brooklyn acquired Novellus and its subsidiary, Novellus, Ltd. As part of the Acquisition, Brooklyn also acquired 25.0% of the total outstanding equity interests of NoveCite, Inc. (&#8220;NoveCite&#8221;), a corporation focused on developing an allogeneic mesenchymal stem cell product for patients with acute
          respiratory distress syndrome, including from COVID-19. </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span> </div>

<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The














          accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial statements and with the instructions to
          Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the unaudited financial statements include all the
          normal recurring adjustments that are necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.<br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">These
































          condensed consolidated financial statements should be read together with the audited consolidated financial statements and notes thereto contained in Brooklyn&#8217;s Annual Report on Form 10-K/A for the year ended December 31, 2021 filed with the
          Securities and Exchange Commission (the &#8220;SEC&#8221;) on June 30, 2022 (the &#8220;10-K/A&#8221;). The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements contained in the 10-K/A but does
          not include all of the information and footnotes required by GAAP for complete financial statements. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be anticipated for
          the entire year ending December 31, 2022, or any other period.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div>
         <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-style: italic;">Reclassifications</span><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Certain reclassifications have been made
          to Brooklyn&#8217;s prior years&#8217; financial statements to conform to the current year presentation. These reclassifications had no effect on Brooklyn&#8217;s previously reported results of operations or accumulated deficit.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156383968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LIQUIDITY AND CAPITAL RESOURCES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LIQUIDITYANDCAPITALRESOURCESAbstract', window );"><strong>LIQUIDITY AND CAPITAL RESOURCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LiquidityAndCapitalResourcesTextBlock', window );">LIQUIDITY AND CAPITAL RESOURCES</a></td>
<td class="text">
<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">LIQUIDITY AND CAPITAL RESOURCES</div>
              </td>

  </tr>


</table>

<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has incurred significant operating losses and has an accumulated deficit as a result of ongoing efforts to develop product candidates, including conducting clinical trials and providing general and
              administrative support for operations. As of June 30, 2022, the Company had a cash balance of approximately $19.4 million and an
              accumulated deficit of approximately $153.5 million. For the three and six months ended June 30, 2022, the Company incurred a net
              loss of $3.4 million and $12.8
              million, respectively, and the Company used cash in operating activities of $9.4</span><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> million.</span><br/>
            </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160; <br/>
              </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">In connection with preparing the accompanying condensed consolidated financial statements as of and for the three months ended June 30, 2022, the Company&#8217;s management concluded that there is substantial doubt regarding the Company&#8217;s
              ability to continue as a going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these financial statements. The Company
              will need to raise additional capital, which could be through the remaining availability under an equity line purchase agreement with Lincoln Park Capital Fund, LLC (the &#8220;Second Purchase Agreement&#8221;) (to the extent the Company is permitted to
              use such agreement) (see Note 11), public or private equity offerings, debt financings, corporate collaborations or other means. The Company may also seek governmental grants to support its clinical trials and preclinical trials. The Company
              currently has no arrangements for such capital and no assurances can be given that it will be able to raise such capital when needed, on acceptable terms, or at all.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The accompanying condensed
                consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying condensed consolidated
                financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the
                Company&#8217;s ability to continue as a going concern</span>.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LIQUIDITYANDCAPITALRESOURCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LIQUIDITYANDCAPITALRESOURCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LiquidityAndCapitalResourcesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LiquidityAndCapitalResourcesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227159017920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</a></td>
<td class="text">
<div>
            <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">3)</div>
                  </td>

    <td style="align: left; vertical-align: top; width: auto;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</div>
                  </td>

  </tr>


</table>
          </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 27pt; margin-left: 9pt; font-variant: normal; text-transform: none;">Merger</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On August 12, 2020, Brooklyn, Brooklyn LLC and the Merger Sub
          entered into the Merger Agreement, and the Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes. Brooklyn LLC, as the accounting
          acquirer, recorded the assets acquired and liabilities assumed of Brooklyn in the Merger at their fair values as of the acquisition date.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Brooklyn LLC was determined to be the accounting acquirer
          based upon the terms of the Merger and other factors including that (i) Brooklyn LLC members, received common stock in the Merger that represented 96.35%
          of Brooklyn&#8217;s outstanding common stock on a fully diluted basis, (ii) all of the directors of Brooklyn immediately after the Merger were designated by Brooklyn LLC under the terms of the Merger Agreement and (iii) existing members of Brooklyn
          LLC&#8217;s management became the management of Brooklyn immediately after the Merger.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">At the closing of the Merger, all the outstanding membership
          interests of Brooklyn LLC converted into the right to receive an aggregate of approximately 39,992,000 shares of common stock, of
          which 1,068,000 shares were issued as compensation to Maxim Group LLC, Brooklyn LLC&#8217;s financial advisor (the &#8220;Financial Advisor&#8221;) for
          its services to Brooklyn LLC in connection with the Merger.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The purchase price of $8.2 million, which represents the consideration transferred in the Merger to stockholders of Brooklyn immediately before the Merger, was calculated
          based on the closing price of $5.40 per share for approximately 1,514,000 shares common stock that those stockholders owned on March 25, 2021 immediately prior to the Merger because that represented a more reliable measure of the fair value of
          consideration transferred in the Merger.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Under the acquisition method of accounting, the total
          purchase price has been allocated to the acquired tangible and intangible assets and assumed liabilities of Brooklyn based on their estimated fair values as of March 25, 2021, the Merger closing date. Because the consideration paid by Brooklyn
          LLC in the Merger is more than the estimated fair values of Brooklyn&#8217;s net assets deemed to be acquired, goodwill is equal to the difference of approximately $8.6 million, which has been calculated using the fair values of the net assets of Brooklyn as of March 25, 2021.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The allocation of the purchase price to the tangible and
          intangible assets acquired and liabilities deemed to be assumed from Brooklyn, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; font-weight: bold;">Historical</div>
                <div style="text-align: center; font-weight: bold;">Balance</div>
                <div style="text-align: center; font-weight: bold;">Sheet of</div>
                <div style="text-align: center; font-weight: bold;">Brooklyn at</div>
                <div style="text-align: center; font-weight: bold;">March 25, 2021</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; font-weight: bold;">Fair Value</div>
                <div style="text-align: center; font-weight: bold;">Adjustment</div>
                <div style="text-align: center; font-weight: bold;">to Brooklyn</div>
                <div style="text-align: center; font-weight: bold;">Pre-Merger</div>
                <div style="text-align: center; font-weight: bold;">Assets</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; white-space: nowrap;" valign="bottom">
                <div style="font-weight: bold;">
                  <div><span style="font-weight: bold;">Purchase</span></div>
                </div>
                <div><span style="font-weight: bold;">Price</span></div>
                <div><span style="font-weight: bold;">Allocation</span></div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>148</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>148</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Prepaid expense and other current assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>329</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>329</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>1,015</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>1,015</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>1,296</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>(368</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>928</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Customers</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Accounts payable, accrued liabilities and other current</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>(3,781</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>(3,781</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>(890</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>479</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>(411</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Total consideration</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>8,178</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div>(411</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>8,589</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Brooklyn LLC was obligated under the Merger Agreement to have
          $10.0 million in cash and cash equivalents on its balance sheet at the effective time of the Merger. To ensure Brooklyn LLC had the
          required funds, certain beneficial holders of Brooklyn LLC&#8217;s Class A membership interests entered into contractual commitments to invest $10.0
          million into Brooklyn LLC immediately prior to the closing of the Merger. During March 2021, Brooklyn offered its Class A unit holders an additional 5%
          rights offering for an additional $0.5 million to be raised by a rights offering. Brooklyn received funds from the rights offering
          between February 17, 2021 and April 5, 2021.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-indent: 36pt;">Disposition</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On March 26, 2021, Brooklyn sold its rights, title and
          interest in and to the assets relating to the business it operated (under the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of the
          Disposition are as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Proceeds from sale:</div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">Cash</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">132</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Escrow</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>50</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Assume advance/loans</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>1,700</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Interest on advance/loans</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>68</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Carrying value of assets sold:</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(14</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(75</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Prepaids and other current assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(124</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(1,014</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(927</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Customers</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(8,589</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Other assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Liabilities transferred upon sale:</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Accounts payable and accrued expenses</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>113</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Obligations under finance leases</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>17</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Lease liability</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>26</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Deferred revenue</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>55</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Other current liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>149</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Transaction costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(265</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Total loss on sale of assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div style="font-weight: bold;">$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div style="font-weight: bold;">(9,648</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="font-weight: bold;">)</div>
              </td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 36pt; font-variant: normal; text-transform: none;">Acquisition</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On July 16, 2021, Brooklyn and Brooklyn Acquisition Sub, Inc.
          entered into the Acquisition Agreement. The Acquisition closed contemporaneously with the execution and delivery of the Acquisition Agreement. At the closing:</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: left;">&#8226;</div>
                </td>

    <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: justify;">Brooklyn acquired all of the outstanding equity interests of Novellus, Inc. as the result of the merger of Brooklyn Acquisition Sub, Inc. with and into Novellus, Inc., following which, Novellus, Inc., as
                    the surviving corporation, became Brooklyn&#8217;s wholly owned subsidiary and Novellus Ltd. became Brooklyn&#8217;s indirectly owned subsidiary; and</div>
                </td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt;">&#160;</td>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: left;">&#8226;</div>
                </td>

    <td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                  <div style="text-align: justify;">Brooklyn acquired 25.0% of the total outstanding equity interests of NoveCite.</div>
                </td>

  </tr>


</table>

<div> <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As consideration for the Acquisition, Brooklyn paid $22.9 million in cash and delivered approximately 7,022,000
          shares of common stock, which under the terms of the Acquisition Agreement, were valued at a total of $102.0 million based on an agreed
          upon price of $14.5253 per share. At the date of issuance, the fair value of the shares was approximately $58.6 million.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Acquisition Agreement contained customary
          representations, warranties and certain indemnification provisions. Approximately 741,000 of the shares issued as consideration were
          placed in escrow for a period of up to 12 months in order to secure indemnification obligations to Brooklyn under the Acquisition
          Agreement. The Acquisition Agreement also contains certain non-competition and non-solicitation provisions pursuant to which Novellus LLC agreed not to engage in certain competitive activities for a period of five years following the closing, including customary restrictions relating to employees. No employees of Novellus Ltd. or Novellus, Inc. prior to the
          Acquisition continued their employment, or were otherwise engaged by Brooklyn, following the Acquisition.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In connection with the Acquisition, the co-founders of
          Novellus, Inc. entered into lock-up agreements with respect to approximately 3,378,000 of the shares of common stock received in the
          Acquisition, and Brooklyn&#8217;s Chairman of the Board of Directors (the &#8220;Board&#8221;) and its former Chief Executive Officer and President entered into identical lock-up agreements with respect to their current holdings of Brooklyn stock. Each lock-up
          agreement extends for a period of three years, provided that up to 75% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock on the Nasdaq exceeds specified
          thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period. </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company expects the Acquisition will advance its
          evolution into a platform company with a pipeline of next generation mRNA cellular and gene editing programs. In addition, the acquisition of Novellus, Ltd. builds on the License Agreement. (See Note 9). The completion of the acquisition of
          Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor Bioscience
          Limited (&#8220;Factor&#8221;) under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene editing and cell therapy products, remained unchanged.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Although Brooklyn acquired all of the outstanding equity
          interests of Novellus, Inc., the Company accounted for the Acquisition as an asset acquisition (as the assets acquired did not constitute a business as defined in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 805,&#160;<span style="font-style: italic;">Business Combinations</span>),&#160;and was measured by the amount of cash paid and by the fair value of the shares of common stock issued. As a result, substantially all of the value acquired was attributed to in-process research and
          development (IPR&amp;D), with the exception of the cash paid for the investment in NoveCite, which is being accounted for as an investment in equity securities, as discussed further below.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Brooklyn paid $22.9 million in cash, net of cash acquired, as part of the consideration for the Acquisition, of which $1.0 million was paid in cash for the investment in NoveCite. Brooklyn also issued approximately 7,022,000 shares of the Company&#8217;s common stock, of which approximately 3,644,000 shares are unrestricted and 3,378,000
          shares are subject to the three-year lockup. The unrestricted shares were valued at $10.05 per share, which was the closing price of Brooklyn&#8217;s common stock on July 16, 2021. The fair value of the restricted shares was discounted by approximately 35% to $6.53 per restricted share,
          which was derived from the average discount rate between the Black Scholes and Finnerty valuation models. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal;">The resulting fair value of the asset acquired is as follows (in thousands):</span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Fair Value of</div>
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Consideration</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Cash paid</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>22,882</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Cash acquired</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(28</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Unrestricted shares</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>36,628</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Restricted shares</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div>22,056</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Total fair value of consideration paid</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>81,538</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Less amount of cash paid for NoveCite investment</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div>(1,000</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Fair value of IPR&amp;D acquired</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div>80,538</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">IPR&amp;D that is acquired through an asset purchase that has
          no alternative future uses and no separate economic values from its original intended purpose is expensed in the period the cost is incurred. Accordingly, the Company expensed the fair value of the IPR&amp;D during the third quarter of 2021 in
          the amount of $80.5 million.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-decoration: underline;">Investment in NoveCite</span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">As a result of the Acquisition,&#160; Brooklyn acquired and
          currently owns 25% of NoveCite and Citius Pharmaceuticals, Inc. (&#8220;Citius&#8221;) owns the remaining 75%. A member of the Company&#8217;s management holds one of three
          board seats on NoveCite&#8217;s board of directors. Citius&#8217; s officers and directors hold the other two board seats. The Company is accounting for its interest in NoveCite under ASC Topic 323,&#160;<span style="font-style: italic;">Investments&#160;&#8211;&#160;Equity
            Method and Joint&#160;Ventures</span>.&#160;The investment was recorded at cost, which was $1.0 million&#160;and is adjusted for the Company&#8217;s share
          of&#160;NoveCite&#8217;s earnings or losses, which are reflected in the accompanying condensed consolidated statement of operations. The investment may also reflect an equity loss in the event that circumstances indicate an other-than-temporary impairment.
          For the three and six months ended June 30, 2022, the Company recorded $0.3 million and $0.9 million, respectively, in losses from its investment in NoveCite, and of the $0.9
          million loss for the six months ended June 30, 2022, $0.5 million related to NoveCite&#8217;s year ended December 31, 2021.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227161054064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE OF FINANCIAL INSTRUMENTS</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold;">4)<br/>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold;">FAIR VALUE OF FINANCIAL INSTRUMENTS</div>
              </td>

  </tr>


</table>

<div>&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Fair












          value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest
          priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:</div>

<div>&#160;</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div>
                <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8226;</span></div>
                      </td>

    <td style="align: left; vertical-align: top; width: auto;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Level
                          1 Inputs &#8211; Valued based on quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</div>
                      </td>

  </tr>


</table>
              </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div>
                <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8226;</span></div>
                      </td>

    <td style="align: left; vertical-align: top; width: auto;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Level
                          2 Inputs &#8211; Valued based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in
                          active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities,
                          prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.</div>
                      </td>

  </tr>


</table>
              </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div>
                <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="width: 36pt;">&#160;</td>

    <td style="vertical-align: top; width: 18pt;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8226;</span></div>
                      </td>

    <td style="align: left; vertical-align: top; width: auto;">
                        <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Level
                          3 Inputs &#8211; Valued based on inputs for which there is little or no market value, which require the reporting entity to develop its own assumptions.</div>
                      </td>

  </tr>


</table>
              </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
        <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The following tables summarize the liabilities that are measured at fair value as of June 30, 2022 (in thousands).&#160; There were no liabilities measured at fair value as of Decem</span>ber 31, 2021:</div>

<div> <br/>
          </div>

<div>
            <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of June 30,
                      2022</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 1</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 2</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 3</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Liabilities:</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Pre-Funded Warrants</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">702</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Common Warrants</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,822</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">702</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,822</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
          </div>

<div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">  <br/></div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">On
          March 9, 2022, the Company issued pre-funded warrants exercisable for approximately 1,357,000 shares of common stock (the &#8220;Pre-Funded
          Warrants&#8221;) and warrants exercisable for approximately 6,857,000 shares of common stock (the &#8220;Common Warrants&#8221;) in connection with the
          PIPE Transaction (as defined below).&#160; See Note 11 for more information related to the PIPE Transaction. </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Common Warrants and Pre-Funded Warrants were accounted for as liabilities under ASC
              815-40,&#160;Derivatives and Hedging, Contracts in Entity&#8217;s Own Equity&#160;(&#8220;ASC 815-40&#8221;), as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant
              liabilities were measured at fair value at inception and are then subsequently measured on a recurring basis, with changes in fair value presented within the Company&#8217;s statement of operations.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Company uses a Black-Scholes option pricing model to estimate the fair value of the Common
              Warrants, which is considered a Level 3 fair value measurement.&#160; Certain inputs used in this Black-Scholes pricing model may fluctuate in future periods based upon factors that are outside of the Company&#8217;s control.&#160; A significant change in
              one or more of these inputs used in the calculation of the fair value may cause a significant change to the fair value of the Company&#8217;s warrant liabilities, which could also result in material non-cash gains or losses being reported in the
              Company&#8217;s consolidated statement of operations.</div>

<div><br/>
              </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The estimated fair value of the Pre-Funded Warrants was deemed a Level 2 measurement as of June 30, 2022, as all significant inputs to the valuation model used to estimate the fair value of the Pre-Funded Warrants
                  were directly observable from the Company&#8217;s publicly-traded common stock.</span> </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
          </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more
            than the $12.0 million proceeds received in the PIPE Transaction.&#160; The excess $0.6 million represents an inducement to the purchaser to enter into the PIPE Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of
            operations.&#160; Given the Company&#8217;s capital requirements and market conditions, the Company consummated this financing on market terms available at the time of the transaction. </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/>
        </div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company remeasured the fair value of the warrant liabilities as of June 30, 2022, and the following table presents the changes in the
            warrant liabilities from the issuance date (in thousands): </div>

<div>&#160;</div>

<div>
            <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pre-Funded <span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                      </span></div>
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Warrants<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                      </span></div>
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 2)</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common</div>
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Warrants<br/>
                      </span>(Level 3)</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Warrant<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                      </span>Liabilities</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at January 1, 2022</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 9, 2022 (issuance date)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,646</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,943</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,589</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in fair value of warrant liabilities</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,944</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(8,121</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10,065</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at June 30, 2022</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">702</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,822</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,524</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
            </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227161209536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>LEASES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;">5)</td>

    <td style="width: auto; vertical-align: top;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">LEASES</div>
            </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> The Company has operating leases for office and laboratory space in the borough of
        Manhattan in New York, New York and in Cambridge, Massachusetts, which expire in 2026 and 2028, respectively. On March 31, 2022, the Company entered into the Torrey Pines Science Center Lease in San Diego, California (the &#8220;San Diego Lease&#8221;) with<span style="font-family: 'Times New Roman'; font-size: 10pt;"> Torrey Pines Science Center Limited Partnership for approximately 5,200
          square feet of lab and office space. The term of the San Diego Lease is 62 months and the lease commencement date was April 19, 2022.
          The San Diego Lease will expire in June</span> 2027.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Base rent for the San Diego Lease is $6.35
          per square foot in the first year of the San Diego Lease, with a rent abatement for the second and third full months of the first year. The base rent will increase by approximately 3% on each anniversary of the lease commencement date. The Company is also required to pay its share of operating expenses and property taxes. The San Diego Lease provides for a one-time
          option to extend the lease term for an additional five years at the then fair rental value. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Company recorded a $1.7 million right-of-use (&#8220;ROU&#8221;) asset and $1.7 million lease liabilities
            for the San Diego Lease.</span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
          </span></div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">During the second quarter of 2022, the Company made the decision to consolidate its research and
            development efforts in Cambridge, Massachusetts, and the Company intends to sublease the San Diego lab and office space.&#160; As a result, the Company recognized an impairment charge of approximately $0.8 million on the San Diego Lease ROU asset.</span> </div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On March 5, 2022, the Company entered into an Agreement to Assign Space Lease with Regen Lab USA LLC (&#8220;Regen&#8221;) pursuant to which the Company
          agreed to assign its Brooklyn, New York lease (the &#8220;Brooklyn Lease&#8221;) to Regen. The effective date of the assignment was contingent upon, among other things, a consent from BioBat, Inc. (the &#8220;Landlord&#8221;) to assign the Brooklyn Lease.&#160; Additionally,
          Regen agreed to purchase certain equipment from the Company for $50,000, partly reimburse the Company $50,000 toward certain existing unamortized leasehold improvements, and to reimburse the Company for the existing security deposit the Company had
          under the Brooklyn Lease of approximately $63,000.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 27pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On March 25, 2022, the Company entered into an Assignment and Assumption of Lease Agreement (the
              &#8220;Assignment Agreement&#8221;) with Regen, the consent of which was provided by the Landlord in the Assignment Agreement. The effective date of the assignment was March 28, 2022.&#160; Under the Assignment Agreement, Regen (i) accepts the assignment of
              the Brooklyn Lease; (ii) assumes all of the obligations, liabilities, covenants and conditions of the Company&#8217;s as tenant under the Brooklyn Lease; (iii) assumes and agrees to perform and observe all of the obligations, terms, requirements,
              covenants and conditions to be performed or observed by the Company under the Brooklyn Lease; and (iv) makes all of the representations and warranties binding under the Brooklyn Lease with the same force and effect as if Regens had executed
              the Brooklyn Lease originally as the tenant.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Notwithstanding the above assumptions by Regen, the Company shall be and remain liable and
              responsible for the due keeping, and full performance and observance, of all the provisions of the Brooklyn Lease on the part of the tenant to be kept, performed and observed.&#160; As a result of the Assignment Agreement, the Company wrote off
              the remaining ROU asset balance and the corresponding lease liability.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 27pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Company accounts for leases under ASC 842,</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-style: normal;">&#160;Leases</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">. Operating leases are included in
          &#8220;Right-of use assets - operating leases&#8221; within the Company&#8217;s balance sheets and represent the Company&#8217;s right to use an underlying asset for the lease term. The Company&#8217;s related obligation to make lease payments are included in &#8220;Operating lease
          liabilities, non-current&#8221; and &#8220;Operating lease liabilities, current&#8221; within the Company&#8217;s balance sheets. ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Because the
          rate implicit in the lease is not readily determinable, the Company uses its incremental borrowing rates based on the information available at the lease commencement date in determining the present value of lease payments. Lease expense for lease
          payments is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet and are recognized as lease expense on a straight-line basis over the lease term.</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Some leasing arrangements require variable payments that are dependent on usage or may vary for other reasons, such as
        payments for insurance, tax payments and other miscellaneous costs. The variable portion of lease payments is not included in the ROU assets or lease liabilities. Rather, variable payments, other than those dependent upon an index or rate, are
        expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease contract are accounted for as lease expenses.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2022 and 2021, the net operating lease expenses were as follows (in thousands):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">Three months ended June 30,</span><br/>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">2021</span> <br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">146</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">164</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Sublease income</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(21</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(21</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Variable lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">51</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">176</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">144</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">Six months ended June 30,</span></td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom">2022</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">2021<br/>
                </span></td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating lease expense</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">333</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">315</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Sublease income</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(42</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(42</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Variable lease expense</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">53</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">10</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total lease expense</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">344</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">283</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
         </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">The tables below show the beginning
          balances of the operating ROU assets and lease liabilities as of January 1, 2022 and the ending balances as of June 30, 2022, including the changes during the period (in thousands).</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 36pt; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/>
          </span></div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating Lease</div>
              <span style="font-weight: bold;"> </span>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">ROU Assets</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease ROU assets at
                January 1, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2,567</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Initial measurement of operating lease ROU assets</span></td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1,706</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Amortization of operating lease
                ROU assets</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(186</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Impairment of ROU assets</span></td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(772</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Write off of ROU asset due to lease termination</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(1,372</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease ROU assets at
                June 30, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,943</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="letter-spacing: normal; white-space: normal; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-weight: 400; text-align: left; text-indent: 0px; text-transform: none;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating Lease</div>
              <span style="font-weight: bold;"> </span>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Liabilities</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease liabilities at
                January 1, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2,723</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Initial measurement of operating lease liabilities</span></td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1,706</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Principal payments on operating
                lease liabilities</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(153</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Write off of operating lease liability due to lease termination</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(1,453</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease liabilities at
                June 30, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2,823</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Less non-current portion</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2,433</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Current portion at June 30, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">390</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 36pt;">As of June 30, 2022, the Company&#8217;s operating leases had a weighted-average remaining
        life of 5.2 years with a weighted-average discount rate of 8.97%.&#160; <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-weight: 400; font-variant: normal;">The maturities of the operating lease liabilities are as follows (in thousands):</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">June 30, 2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2022</span><br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">299</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2023</span><br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">673</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2024</span><br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">688</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2025</span><br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">703</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2026</span><br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">708</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Thereafter</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">470</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Total payments</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <br/>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,541</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">Less imputed interest</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">(718</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Total operating lease liabilities</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,823</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156579616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">6)<br/>
              </td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL<br/>
                </div>
              </td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In 2018, the Company acquired IRX Therapeutics (&#8220;IRX&#8221;), which was accounted for as a business combination. The Company recorded IPR&amp;D in the
          amount of $6.0 million, which represents the fair value assigned to technologies that were acquired in connection with the IRX
          acquisition and which have not reached technological feasibility and have no alternative future use. IPR&amp;D assets acquired in a business combination are considered to be indefinite lived until the completion or abandonment of the associated
          research and development projects. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize products associated with the IPR&amp;D assets, these assets are then deemed
          definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a full or partial impairment charge related to the IPR&amp;D assets,
          calculated as the excess of carrying value of the IPR&amp;D assets over fair value</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company also recorded goodwill in the amount of $2.0
          million related to the IRX acquisition. Goodwill and indefinite-lived IPR&amp;D assets are not amortized but are tested for impairment annually, or more frequently if the Company becomes aware of any events occurring or changes in circumstances
          that indicate that the fair value of the entity is less than its carrying values.</div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As of June 30, 2022, the Company performed a qualitative assessment to determine whether it is more likely than not that the fair value of the
          entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and other relevant events.<br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">In June 2022, the Company received results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnosed stage II, III or IVA squamous cell carcinoma of the oral
            cavity. The IRX-2 multi-cytokine biologic immunotherapy represents substantially all the fair value assigned to the technologies of IRX that the Company acquired. Despite outcomes that favored IRX-2 in certain predefined subgroups, the INSPIRE
            trial did not meet the primary endpoint of Event-Free Survival (at two years of follow up. Significant additional clinical development work would be required to advance IRX-2 in the form of additional Phase 2 and 3 studies to further evaluate
            the treatment effect of IRX-2 in patient subgroups and in combination with checkpoint inhibitor therapies.&#160; The INSPIRE trial is the only Company-sponsored study of IRX-2.&#160; IRX-2 has been studied externally in other clinical settings outside of
            head and neck cancer in the form of investigator sponsored trials, which have either ended or are not currently active. Based on the totality of available information, the Company currently does not have plans to further develop the IRX-2
            product candidate. As such, the Company determined that the carrying value of the IPR&amp;D asset was impaired and recognized a non-cash impairment charge of approximately $6.0 million on the condensed consolidated statement of operations for the three and six months ended June 30, 2022, which reduced the value of the asset to zero.</span> </div>

<div><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Company also determined that there were qualitative indications of a goodwill impairment, namely the Company&#8217;s stock price declined from $2.05 per share as of March 31, 2022 to $0.52 per share as of June 30,
            2022.&#160; Accordingly, the Company proceeded to the first step in the quantitative assessment of impairment and determined that the fair value of the reporting unit exceeded the carrying amount of the reporting unit, and therefore, the goodwill
            was not impaired as of June 30, 2022</span>.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156579616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CEO SEPARATION AGREEMENT<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_CEOSEPARATIONAGREEMENTAbstract', window );"><strong>CEO SEPARATION AGREEMENT [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ChiefExecutiveOfficerSeparationAgreementTextBlock', window );">CEO SEPARATION AGREEMENT</a></td>
<td class="text">
<div>
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                  <div style="font-weight: bold;">7)</div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="font-weight: bold;">CEO SEPARATION AGREEMENT</div>
                </td>

  </tr>


</table>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">On May 24, 2022, Dr. Howard J. Federoff resigned as the Company&#8217;s Chief Executive
        Officer and President effective May 26, 2022.&#160; In connection with Dr. Federoff&#8217;s resignation, the Company entered into a&#160;<span style="color: rgb(0, 0, 0);">Separation Agreement and General Release with Dr. Federoff (the &#8220;Separation Agreement&#8221;),
          pursuant to which Dr. Federoff resigned from his positions as Chief Executive Officer and as an officer, director and employee of the Company and all subsidiaries.&#160; Dr. Federoff&#8217;s resignation from the Board was not due to any disagreement with
          the Company on any matter relating to the Company&#8217;s operations, policies or practices. In consideration for Dr. Federoff&#8217;s execution of the Separation Agreement and non-revocation of a waiver and release of claims relating thereto, Dr. Federoff
          will receive following benefits under the Separation Agreement:</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">a lump sum cash severance benefit in the amount of $0.2 million, representing Dr. Federoff&#8217;s
                target bonus for 2022;</div>
            </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">payment of Dr. Federoff&#8217;s annual base salary for a period of twelve months after the expiration of the applicable revocation period (the &#8220;Separation Period&#8221;), for a total gross amount equal to $0.5 million;</div>
            </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">payment of Dr. Federoff&#8217;s premiums for continued health benefits provided under COBRA for the Separation Period;</div>
            </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">full acceleration of the vesting of all outstanding options (with the exception of the Milestone Grant (as defined below) options) that would have vested during the Separation Period, and such options,
                together with outstanding options that vested prior to the separation date, representing collectively approximately 1,523,000
                shares of common stock, may be exercised for a period of thirty-six months after the separation date.&#160; (See Note 10 for
                modification accounting impact);</div>
            </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><span style="color: rgb(0, 0, 0); font-size: 10pt;">acceleration and vesting of 25/36</span><span style="font-size: 10pt;"><sup style="color: rgb(0, 0, 0); vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup><span style="color: rgb(0, 0, 0);">&#160;of the Milestone Grant options, representing collectively approximately 415,000 shares of
                    common stock, may be exercised for a period of thirty-six months after the separation date.&#160; (See Note 10 for modification
                    accounting impact); and</span></span></div>
            </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
            </td>

    <td style="width: 18pt; vertical-align: top; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">a lump sum cash severance benefit in the amount of $0.1 million, representing the value Dr.
                Federoff would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period, assuming the performance metrics were waived and
                assuming a per share value of $0.81.</div>
            </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">The Separation Agreement also includes certain other customary representations,
        warranties and covenants of Dr. Federoff, and provides for reimbursement of certain expenses incurred by Dr Federoff. The Separation Agreement supersedes all other agreements or arrangements between Dr. Federoff and the Company regarding the
        subject matter of the agreement, including those with respect to severance payments and benefits.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_CEOSEPARATIONAGREEMENTAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_CEOSEPARATIONAGREEMENTAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ChiefExecutiveOfficerSeparationAgreementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure pertaining to chief executive officer separation agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ChiefExecutiveOfficerSeparationAgreementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227161209536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCRUED EXPENSES</a></td>
<td class="text">
<div>
          <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: left;"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">8)</span>
                  </div>
                </td>

    <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: bold;">ACCRUED EXPENSES</span></div>
                </td>

  </tr>


</table>
        </div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued expenses consisted of the following (in thousands):</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; width: 100%;">


  <tr>

    <td style="vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">June 30,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
                    </span></span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
                    </span></span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued compensation<br/>
                </div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,613</div>
              </td>

    <td colspan="1" style="font-family: &amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">656</div>
              </td>

    <td colspan="1" style="font-family: &amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued research and development expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">388</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">222</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued general and administrative expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,820</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">371</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Total accrued expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">3,821</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,249</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
          </span> </div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt; text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued compensation includes $1.0 million of severance, of which, approximately $0.5
                million relates to severance for Dr. Federoff pursuant to the Separation Agreement discussed above.</span> </span>Accrued general and administration expenses includes $1.2 million for legal-related matters.</span><br/>
        </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156468176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">9)<br/>
                </span> </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">COMMITMENTS AND CONTINGENCIES</div>
              </td>

  </tr>


</table>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Legal Matters<br/>
        </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs
            associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the
            amount can be reasonably estimated.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); text-indent: 36pt;"><span style="text-decoration: underline;"><span style="font-style: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Dhesh Govender v. Brooklyn
                Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)</span></span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">On or about February 5, 2021, Dhesh Govender, a former short-term consultant of Brooklyn LLC, filed a complaint against Brooklyn LLC and certain individuals that plaintiff alleges were directors of Brooklyn LLC. The complaint is
              captioned, Dhesh Govender v. Brooklyn Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021). Plaintiff alleges that Brooklyn LLC and certain of its officers and directors (&#8220;defendants&#8221;) engaged in unlawful and
              discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserts various breach of contract, fraud and quantum meruit claims based on an alleged oral agreement pursuant to which he alleges Brooklyn
              LLC agreed to hire him as an executive once the Merger was completed. In particular, plaintiff alleges that, in exchange for transferring an opportunity to obtain an agreement to acquire a license from Novellus for its mRNA-based gene editing
              and cell reprogramming technology to Brooklyn LLC, he was promised a $0.5 million salary and 7% of the equity of Brooklyn LLC. Based on these and other allegations, plaintiff seeks damages of not less than $10 million<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">. By Order dated November 10,&#160;2021, the Court granted defendants&#8217; motion to compel Govender to arbitrate all of his claims against them, based on the arbitration clause
                of his consulting agreement with Brooklyn LLC.&#160; Govender thereafter filed his Statement of Claim (the &#8220;Demand&#8221;) with the American Arbitration Association (&#8220;AAA&#8221;), Case No. 01-21-0017-9417, on December 15,&#160;2021 against the same defendants,
                and served it on defendants&#8217; counsel on February 3,&#160;2022. In his Demand, Govender continues to assert statutory discrimination claims against all defendants, claims against Brooklyn LLC premised on the breach of an alleged oral promise to
                issue Govender 7% of the equity of Brooklyn LLC and to employ Govender at a $0.5 million annual salary in exchange for allegedly arranging and negotiating the Novellus license, common law fraud claims against Brooklyn LLC and Cherington based on
                the breach of these same promises and a claim for quantum meruit against the Brooklyn LLC. In his Demand, Govender now claims that the fair and reasonable value of his services on the quantum meruit claim exceeded $100 million and is seeking damages in an amount to be determined at the hearing. Defendants filed an answering statement to the Demand on
                February 28,&#160;2022 and the parties have selected a three</span><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">-member arbitration panel. The
                  arbitration is scheduled to begin December 5, 2022. Defendants intend to vigorously defend themselv</span>es against these claims.</span> At this stage in the litigation, the Company is not able to predict the probability of a favorable
              or unfavorable outcome. </div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; text-indent: 36pt;"><span style="text-decoration: underline;">Emerald Private Equity Fund, LLC Matter</span></div>

<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
                          </span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#8220;Emerald&#8221;), a stockholder of Brooklyn, made a demand pursuant
                            to 8 Del. C. 220 to inspect certain books and records of Brooklyn. The stated purpose of the demand was to investigate possible wrongdoing by persons responsible for the implementation of the Merger and the issuance of paper
                            stock certificates, including investigating whether: (i) Brooklyn&#8217;s stock certificates were issued in accordance with the Merger Agreement; (ii)&#160;certain restrictions on the sale of Brooklyn common stock following the Merger were
                            proper and applied without favor; (iii) anyone received priority in post-Merger issuances of Brooklyn&#8217;s stock certificates that allowed them to benefit from an increase in the trading price of Brooklyn&#8217;s common stock; and (iv)
                            it<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> should pursue
                              remedial measures and/or report alleged misconduct to the SEC. Brooklyn responded to the demand letter and produced certain information to Emerald in connection with the demand, which is subject to the terms of a
                              confidentiality agreement entered into among the parties, including certain additional stockholders who subsequently joined as parties to such agreement. In October 2021, Emerald requested that Brooklyn produce additional
                              information related to the authority, purpose and justification for the restriction imposed on the sale of Brooklyn common stock following the Merger and the timing of share delivery to Brooklyn stockholders, following which
                              request Brooklyn agreed to produce certain additional information and emails relating to these topics.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
                            </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On March 30,&#160;2022, counsel to Emerald advised the Company that it was prepared to file suit against the Company, certain current and former directors of the
                                Company, and the Company&#8217;s financial advisor in connection with the Merger, on behalf of Emerald and a class of similarly situated stockholders with respect to some or all of the foregoing matters, alleging claims for breach
                                of fiduciary duty, conversion and aiding and abetting breach of fiduciary duty. Emerald&#8217;s counsel expressed a willingness to engage in private pre-suit early resolution discussions with the Company and its financial advisor
                                on behalf of individual stockholders whom counsel represents in addition to Emerald (collectively, the &#8220;Emerald Plaintiffs&#8221;); and the Company engaged in such discussions in lieu of incurring the legal costs anticipated in
                                respect of litigating </span>the Emerald Plaintiffs&#8217; claims, all of which the Company disputes.&#160; Following such discussions, with no admission of wrongdoing, the Company and the Emerald Plaintiffs entered into a
                              confidential settlement agreement, pursuant to which the Company agreed to pay $1.2 million in full settlement of
                              all of the Emerald Plaintiffs&#8217; purported claims, including a release by the Emerald Plaintiffs in favor of the Company in respect of any and all such claims<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">. The Company
                                  subsequently made such payment.</span><br/>
                              </span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="text-decoration: underline;">John Westman v. Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949
                                (Middlesex County (Massachusetts) Superior Court)</span></div>

<div><br/>
                            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> or about September 7, 2021, John Westman, a former employee of Novellus, Inc. filed a Complaint in Middlesex
                                County (Massachusetts) Superior Court against Novellus, Inc. and the company&#8217;s founders and former executives, Dr. Christopher Rohde and Dr. Matthew Angel (collectively, &#8220;Defendants&#8221;). The case includes allegations that
                                Novellus, Inc. violated the Massachusetts Wage Act.. Brooklyn acquired Novellus, Inc. on July 16,&#160;2021. Mr. Westman&#8217;s claims relate to alleged conduct that took place before Brooklyn acquired Novellus, Inc. Defense and
                                liability in association with any Wage Act claims have been assumed by Dr. Rohde and Dr. Angel. On December 24,&#160;2021, Westman dismissed the case without prejudice so the parties could mediate the matter. The parties&#8217;
                                February 2022 mediation was unsuccessful and the dispute is currently pending in arbitration.</span></div>

<div><span style="font-style: italic;"><br/>
                              </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-left: 36pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;"><span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; font-style: normal;">Novellus, Inc</span><span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">. <span style="font-style: normal;">v. Sowyrda et al</span></span><span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; font-style: normal;">., C.A. No.
                                    2184CV02436-BLS2</span></span></div>

<div><span style="font-style: normal;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; background-color: rgb(255, 255, 255);"><br/>
                              </div>

<div style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);">On October 25, 2021 Novellus, Inc. filed a complaint in the Superior Court of
                                Massachusetts, Suffolk County, against former Novellus, Inc. employees Paul Sowyrda and John Westman and certain other former investors in Novellus LLC (Novellus, Inc.&#8217;s former parent company prior to the Company&#8217;s
                                acquisition of Novellus, Inc.), alleging breach of fiduciary duty, breach of contract and civil conspiracy. Brooklyn acquired Novellus, Inc. on July 16, 2021. On May 27, 2022 Novellus, Inc. amended the complaint to withdraw
                                all claims against all defendants except Paul Sowyrda and John Westman. On July 1, 2022, Westman filed a motion to compel arbitration or in the alternative, to stay the litigation pending the disposition of certain
                                litigations in the Court of Chancery for the State of Delaware filed by Mr. Sowyrda against Novellus LLC, Dr. Christopher Rohde, Dr. Matthew Angel, Leonard Mazur and Factor Bioscience, Inc. captioned&#160;<span style="font-style: italic;">Zelickson et al., v. Angel et al.,</span>&#160;C.A. 2021-1014-JRS and by Westman against Novellus LLC captioned&#160;<span style="font-style: italic;">Westman v. Novellus LLC</span>, C.A. No. 2021-0882-NAC (the &#8220;Delaware
                                Actions&#8221;). On July 1, 2022, Sowyrda answered the complaint and asserted counterclaims against Novellus, Inc, and third-party defendants Dr. Matthew Angel and Dr. Christopher Rohde alleging violations of the Massachusetts
                                Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, breach of contract, unjust enrichment and quantum meruit. Sowyrda also joined in Westman&#8217;s motion to stay the case pending the Delaware Actions.
                                Novellus, Inc.&#8217;s claims and Mr. Sowyrda&#8217;s counterclaims relate to alleged conduct that took place before Brooklyn acquired Novellus, Inc. Defense and liability in association with any Wage Act claims have been assumed by Dr.
                                Rohde and Dr. Angel. The Company believes that the plaintiffs<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#8217; claims in the foregoing matters are without merit, and the Company intends to defend against them vigorously</span>.</div>

<div style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);"> <br/>
                              </div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Under applicable Delaware law and Novellus Inc.&#8217;s organizational documents, the Company may be required to advance or reimburse certain legal
                                  expenses incurred by former officers and directors of Novellus, Inc. in connection with the foregoing Westman and Sowyrda matters.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Licensing Agreements</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">USF</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Brooklyn LLC has license agreements with University
                  of South Florida Research Association, Inc. (&#8220;USF&#8221;), granting Brooklyn LLC the right to sell, market, and distribute IRX-2, subject to a 7%
                  royalty payable to USF based on a percentage of gross product sales. Under the license agreement with USF, Brooklyn LLC is obligated to repay patent prosecution expenses incurred by USF. To date, Brooklyn LLC has not recorded any product
                  sales, or obligations related to USF patent prosecution expenses. The license agreement terminates upon the expiration of the IRX-2 patents.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Novellus, Ltd. and Factor <br/>
                  </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">In December 2020, Brooklyn LLC entered into option agreements (the
                    &#8220;Option Agreements&#8221;) with Novellus, Ltd. and Factor (together, the &#8220;Licensors&#8221;) to obtain the right to exclusively license the Licensors&#8217; intellectual property and mRNA cell reprogramming and gene editing technology for use in the
                    development of certain cell-based therapies to be evaluated and developed for treating human diseases, including certain types of cancer, sickle cell disease, and beta thalassemia (the &#8220;Licensed Technology&#8221;). The option was exercisable
                    before February 28, 2021 (or April 30, 2021 if the Merger had not closed by that date) and required Brooklyn LLC to pay a non-refundable option fee of $0.5 million and then an initial license fee of $4.0 million <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">(including the non-refundable fee of $0.5 million) in order to exercise the option.</span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"> <br/>
                  </div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"> In April 2021, Brooklyn LLC and the Licensors amended the Option Agreements to extend the exercise period to May 21, 2021 and to require Brooklyn, LLC to pay a
                    total $1.0 million of the $4.0
                    million initial license fees to the Licensors by April 15, 2021.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> <br/>
                    </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">In April 2021, Brooklyn LLC and the Licensors entered into an exclusive license agreement (the &#8220;License Agreement&#8221;) pursuant to which Brooklyn LLC acquired an exclusive worldwide license to the Licensed Technology <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">for
                        use in the development of certain mRNA, gene-editing, and cellular therapies to be evaluated and developed for treating human diseases, including certain types of cancer, sickle cell disease, and beta thalassemia. </span>Under the
                      terms of the License Agreement, Brooklyn LLC is obligated to pay the Licensors a total of $4.0 million in connection with
                      the execution of the License Agreement, all of which was paid as of June 2021.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The completion of the acquisition of Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical
                        development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene
                        editing and cell therapy products, remained unchanged. Accordingly, Brooklyn LLC is obligated to pay to Factor a fee</span> of $3.5
                      million in October 2022, which will be in addition to a fee of $2.5 million paid to Factor in October 2021.</span> </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"><br/>
                  </div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Brooklyn



                      LLC is also required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization milestones. In general, upon its
                      achievement of these milestones, Brooklyn LLC will be obligated to pay, in the case of development and regulatory milestones, milestone payments to the Licensors in specified amounts and, in the case of commercialization milestones,
                      specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers. In the event Brooklyn LLC fails to timely achieve certain delineated milestones, the Licensors will have the right to terminate
                      Brooklyn LLC&#8217;s rights under provisions of the License Agreement relating to those milestones.</span> </div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">Novellus, Ltd. also has a license agreement with Factor, which was entered into in February 2015, amended in June 2018 and March 2020, and then amended and restated
                    in November 2020. This license agreement provides for Novellus, Ltd. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">to use certain technology owned by Factor for the development of certain cellular therapies to be evaluation and developed for treating diseases.</span></div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;">Novellus, Ltd. is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory
                    milestones and specified commercialization milestones. In general, upon its achievement of these milestones, Novellus, Ltd. will be obligated, in the case of development and regulatory milestones, to make milestone payments of up to $51.0 million in aggregate to Factor and, in the case of commercialization milestones, specified royalties with respect to product sales,
                    sublicense fees or sales of pediatric review vouchers. In the event Novellus, Ltd. fails to timely achieve certain delineated milestones, Factor may have the right to terminate Novellus, Ltd.&#8217;s rights under provisions of the License
                    Agreement relating to those milestones.</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;">&#160;</div>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">NoveCite</span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;"> <br/>
                            </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;"> </span>In October 2020, Novellus, Ltd. (as
                            sublicensor) and NoveCite (as sublicensee) entered into an exclusive license agreement (the &#8220;Sublicense&#8221;) to license novel cellular therapy for acute respiratory distress syndrome, which NoveCite is licensing from Factor. Under
                            the sublicense agreement, NoveCite is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization
                            milestones. In general, upon its achievement of these milestones, NoveCite will be obligated, in the case of development and regulatory milestones, to make milestone payments to the Novellus, Ltd. in specified amounts and, in
                            the case of commercialization milestones, specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers.</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"><span style="text-decoration: underline;"><br/>
                            </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Under the terms of the Sublicense, in the
                            event that Novellus, Ltd. receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd. shall remit to NoveCite 50% of such revenue.<span style="text-decoration: underline;"><br/>
                            </span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;">Royalty Agreements</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Collaborator Royalty Agreement</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;">Effective June 22, 2018, IRX terminated its Research,
          Development and Option Facilitation Agreement and its Options Agreement (the &#8220;RDO and Options Agreements&#8221;) with a collaborative partner (the &#8220;Collaborator&#8221;), pursuant to a termination agreement (the &#8220;Termination Agreement&#8221;). <span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">The Termination Agreement was assigned to Brooklyn, LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. </span>In
          connection with the Termination Agreement, all of the rights granted to the Collaborator under the RDO and Options Agreements were terminated, and Brooklyn LLC has no obligation to refund any payments received from the Collaborator. As
          consideration for entering into the Termination Agreement, the Collaborator will receive a royalty equal to 6% of revenues from the
          sale of IRX-2, for the period of time beginning with the first sale of IRX-2 through the later of (i) the twelfth anniversary of the first sale of IRX-2 or (ii) the expiration of the last IRX patent, or other exclusivity of IRX-2.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"> <span style="text-decoration: underline;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Royalty Agreement with certain former IRX Therapeutics Investors</span></span> </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"> <br/>
          </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;">On May 1, 2012, IRX Therapeutics entered into a royalty agreement (the &#8220;IRX Investor Royalty Agreement<span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">&#8221;</span>)
              with certain investors who participated in a financing transaction. The IRX Investor Royalty Agreement was assigned to Brooklyn LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. Pursuant to the IRX Investor Royalty Agreement,
              when Brooklyn LLC becomes obligated to pay royalties to USF under the agreement described above under &#8220;Licensing Agreements-USF,&#8221; it will pay an additional royalty of 1% of gross sales to an entity organized by the investors who participated in such financing transaction. There are no termination provisions in the IRX Investor Royalty
              Agreement. Brooklyn LLC has not recognized any revenues to date, and no royalties are due pursuant to any of the above-mentioned royalty agreements.</span> </div>

<div><span style="text-decoration: underline;"> <br/>
        </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"><span style="text-decoration: underline;">Investor Royalty Agreement</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-indent: 36pt;">On




            March 22, 2021, Brooklyn LLC restated its royalty agreement with certain beneficial holders of Brooklyn ImmunoTherapeutics Investors GP LLC and Brooklyn ImmunoTherapeutics Investors LP, whereby such beneficial holders will continue to receive,
            on an annual basis, royalties in an aggregate amount equal to 4% of the net revenues of IRX-2, a cytokine-based therapy being
            developed by Brooklyn LLC to treat patients with cancer.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156335104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>STOCK-BASED COMPENSATION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
      <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">10)<br/>
              </span> </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
                <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;">STOCK-BASED COMPENSATION</div>
              </div>
            </td>

  </tr>


</table>
    </div>

<div><span style="font-family: 'Times New Roman';">&#160; <span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </span>
     <br/></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Stock Options</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2022 and 2021, the Company granted the
        following stock options (in thousands):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended June 30,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Six months ended June 30,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Stock options granted</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">723</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,366</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,981</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,366</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"> <br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The following weighted-average assumptions were used for stock options granted during the three and six months ended June
        30, 2022 and 2021:</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; font-size: 10pt; font-weight: bold; text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">Three months ended June 30,</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: center; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: right; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: bold; text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average risk-free rate</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">2.74%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">1.06%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average volatility</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">92.74%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">134.30%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Dividend yield</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">0%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <br/>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">0%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Expected term</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">4.15 years</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">6.08 years</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
      </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Six months ended June 30,</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average risk-free rate</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">2.42%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">1.06%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average volatility</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">92.85%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">134.30%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Dividend yield</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">0%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">0%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Expected term</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">4.79 years</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">6.08 years</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">  </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Of the 1,981,000 stock options granted during the six months ended June 30, 2022, approximately 414,000 stock
      options were granted in March 2022 to Dr. Howard J. Federoff, who served as the Company&#8217;s Chief Executive Officer and President until May 26, 2022 (the &#8220;March 2022 Stock Option Grant&#8221;).&#160; The March 2022 Stock Option Grant vests in 36 substantially equal monthly installments from the grant date and had an exercise price equal to the closing price of the Company&#8217;s common stock on the
      grant date.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Of the 3,366,000 stock options granted during the six months ended June 30, 2021, approximately 3,225,000 stock
      options were granted to Dr. Federoff upon his appointment as Chief Executive Officer and President in April 2021. 2,628,000 stock options
      were under a time-based grant (the &#8220;Time-Based Grant&#8221;) and 597,000 were under a performance-based grant (the &#8220;Milestone Grant&#8221;).&#160; The
      Time-Based Grant vests over four years, with 25%
      vesting on the one-year anniversary of the grant date and the remaining options vesting in 36 substantially equal monthly installments
      thereafter.&#160; The Milestone Grant vests upon the first concurrence by the U.S. Food and Drug Administration that a proposed investigation may proceed following review of a Company filed investigational new drug application in connection with that the
      License Agreement. Both the Time-Based Grant and the Milestone Grant had an exercise price equal to the closing price of the Company&#8217;s common stock on the grant date.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">Vesting of all stock options grants is subject to continuous service with the Company
      through such vesting dates.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">As discussed above, pursuant to the Separation Agreement that the Company entered into
      with Dr. Federoff, the Company&#160;<span style="color: rgb(0, 0, 0);">accelerated the vesting of approximately 138,000 stock options under the
        March 2022 Stock Option Grant and approximately 657,000 stock options under the Time-Based Grant.&#160; The Company also waived the
        performance condition under the Milestone Grant and accelerated the vesting of approximately 415,000 stock options under the Milestone
        Grant.&#160; Lastly, the Company extended the post-termination exercise period from 90 days to 36 months immediately following the Separation Date for all options that were vested after such accelerations.</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="color: rgb(0, 0, 0); font-size: 10pt;">The above modifications to Dr. Federoff&#8217;s stock options grants resulted in modification accounting under ASC 718,&#160;</span><span style="font-style: italic; color: rgb(0, 0, 0); font-size: 10pt;">Compensation &#8211; Stock Compensation.&#160;</span><span style="color: rgb(0, 0, 0); font-size: 10pt;">As a result, the Company immediately recognized approximately $0.1 million for the incremental fair value of stock options that were vested prior to the modification by calculating the difference&#160;</span><span style="font-size: 10pt;">between
        the fair value of the modified award and the fair value of the original award immediately before it was modified.&#160; For stock options that were not vested prior to the modification but then vested as a result of the acceleration, the Company
        reversed any stock compensation expense previously recognized, remeasured the fair value of the modified award and immediately recognized approximately $0.1
        million of stock compensation expense in full since there was no future service period required to be provided.</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2021, there were 1,300 options exercised for total cash proceeds of $10,202.&#160;























      The options exercised had a total intrinsic value of $57,212.&#160; There were no options exercised during the three and six months ended June 30, 2022.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">As of June 30, 2022, there were approximately 3,750,000 stock options outstanding.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Restricted Stock Units</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2022 and 2021, the Company granted the
      following restricted stock units (&#8220;RSUs&#8221;) (in thousands):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended June 30,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Six months ended June 30,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2022<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">RSUs Granted</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">105</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">1,101</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">105</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The Company recognizes the fair value of RSUs granted as expense on
      a straight-line basis over the requisite service period. For performance based RSUs, the Company begins recognizing the expense once the achievement of the related performance goal is determined to be probable.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">Outstanding RSUs are settled in an equal number of shares of common
      stock on the vesting date of the award. An RSU award is settled only to the extent vested. Vesting generally requires the continued employment or service by the award recipient through the respective vesting date. Because RSUs are settled in an equal
      number of shares of common stock without any offsetting payment by the recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date, which is the grant date.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">In lieu of paying cash to satisfy withholding taxes due upon the
      settlement of vested RSUs, at the Company&#8217;s discretion, an employee may elect to have shares of common stock withheld that would otherwise be issued at settlement, the value of which is equal to the amount of withholding taxes payable.&#160; <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The following table shows the number of RSUs that vested and were settled during the three and six months ended
        June 30, 2022, as well as the number of shares of common stock withheld to cover the withholding taxes and the net shares issued upon settlement (in thousands):</span></span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
      </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Three months ended</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Six months ended</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">June 30, 2022</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">June 30, 2022</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">RSUs vested</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">26</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">35</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Common stock withheld to cover
              taxes</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(9</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(9</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Common stock issued</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">17</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">26</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The 1,101,000 RSUs granted during the six months ended June 30, 2022 are performance-based RSUs (the &#8220;2022 PSUs&#8221;), of which approximately 414,000 were awarded to Dr. Federoff.&#160; The 2022 PSUs are subject to the achievement of four performance goals, which are weighted equally.&#160; Once a performance goal is achieved, the tranche of shares allocated to that performance goal will be earned and will begin to vest over a three-year annual basis beginning on the date the performance goal was achieved.&#160; If a performance goal is not achieved, the tranche of shares allocated
      to that performance goal will be unearned and forfeited.&#160; As of June 30, 2022, one of the performance goals was not achieved by its due
      date, and as a result, approximately 275,000 2022 PSUs were cancelled and any previously recognized stock compensation expense was
      reversed.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">Pursuant to Dr. Federoff&#8217;s Separation Agreement, Dr. Federoff&#8217;s 414,000 2022 PSUs were canceled in full (a portion of which included the PSUs allocated to the performance goal that was not achieved timely), and&#160;<span style="color: rgb(0, 0, 0);">a lump sum cash severance benefit in the amount of $0.1 million was paid to Dr. Federoff, which represents
        the value Dr. Federoff would have received if he were entitled to receive a settlement of a pro rata portion of his 2022 PSUs through the expiration of the Separation Period, assuming the performance metrics were waived and assuming a per share
        value of $0.81. Any stock compensation expense previously recognized on Dr. Federoff&#8217;s 2022 PSUs was reversed and approximately $0.1 million was recognized as compensation expense.</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">As of June 30, 2022, there were approximately 587,000 RSUs outstanding.<br/>
      <br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"><span style="text-decoration: underline;">Restricted Stock</span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">Pursuant to the Merger, Brooklyn LLC&#8217;s approximately 3,000 outstanding restricted common units were exchanged for approximately 630,000 shares of Brooklyn&#8217;s restricted common stock. There were no changes to any conditions and requirements of the restricted common stock. The shares vested quarterly beginning on March
      31, 2021 and were to continue through December 31, 2022, contingent on continued service. Due to the modification of the restricted common units, the fair value of the restricted common stock immediately after the Merger was compared to the fair
      value of the restricted common units immediately prior to the Merger, and the change in fair value of $0.3 million was recognized in the
      statement of operations during the six months ended June 30, 2021. The Company recognizes the fair value of restricted common stock as an expense on a straight-line basis over the requisite service period.&#160; During the six months ended June 30, 2022,
      approximately 78,000 shares of unvested restricted common stock were forfeited due to the holders of such shares no longer providing
      services to the Company.&#160; As of June 30, 2022, there were no shares of unvested restricted stock outstanding.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Stock-Based Compensation Expense</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 36pt; margin-right: 0.5pt;">For the three and six months ended June 30, 2022 and 2021, the
      Company recognized stock-based compensation expense as follows, which includes the expense related to Dr. Federoff&#8217;s modified awards discussed above (in thousands):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended June 30,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Six months ended June 30,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2022<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">Research and development</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">470</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">168</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">892</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">570</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">General and administrative</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">409</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">986</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">1,170</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">1,003</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">Total</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">879</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">1,154</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">2,062</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">1,573</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227157621472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCKHOLDERS' EQUITY [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;">11)</td>

    <td style="width: auto; vertical-align: top;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">STOCKHOLDERS&#8217; EQUITY<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>
              </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"><span style="font-weight: normal;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Private Placement of
            Equity</div>

<div><span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/>
              </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 6, 2022, the Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with an investor (the &#8220;PIPE Investor&#8221;)
                providing for the private placement (the &#8220;PIPE Transaction&#8221;) to the PIPE Investor of approximately 6,857,000 units
                (collectively, the &#8220;Units&#8221;), each Unit consisting of (i) one share of the Company&#8217;s common stock (or, in lieu thereof, one
                Pre-Funded Warrant to purchase one share of common stock) and (ii) one warrant (the &#8220;Common Warrants&#8221;) to purchase one share of
                common stock, for an aggregate gross purchase price of approximately $12.0 million (the &#8220;Subscription Amount&#8221;). The PIPE
                Transaction closed on March 9, 2022. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Pursuant to the Purchase Agreement, the Company is prohibited from issuing equity in variable rate transactions for a period of one-year following consummation of the PIPE Transaction, including issuing equity under the Second Purchase Agreement.</span></div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
              <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Each Pre-Funded Warrant has an exercise price of $0.005 per share of common stock, was immediately exercisable, may be
              exercised at any time, has no expiration date and is subject to customary adjustments. The Pre-Funded Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 9.99% immediately after exercise thereof. Upon the closing of the PIPE Transaction, the Company issued 5,500,000 shares of common stock and issued Pre-Funded Warrants representing approximately 1,357,000 shares of common stock.</div>

<div style="display:none;"><br/></div>
<div style="text-indent: 36pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
              <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span> </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">Each Common Warrant has an exercise price of $1.91 per share, becomes exercisable six months following the closing of the PIPE Transaction, expires <span style="-sec-ix-hidden:Fact_816a5bfe7554457abf9cb7a46a5bdc57">five-and-one-half </span> years from the date of issuance and is subject to customary adjustments. The Common Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99% immediately after exercise thereof, subject to increase to 9.99% at the option of the holder.</div>

<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">As of June 30, 2022, the Company had 6,857,000
              Common Warrants outstanding with a weighted average exercise price of $1.91 per share and a weighted average contractual life of 5.2 years. As of June 30, 2022, the Company had 1,357,000
              Pre-Funded Warrants outstanding with a weighted average exercise price of $0.005 per share. The Pre-Funded Warrants do not expire.</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">The

































            Common Warrants and Pre-Funded Warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40. These
            warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations.</div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more
              than the Subscription Amount. The excess $0.6 million represents an inducement to the PIPE Investor to enter into the PIPE
              Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of operations. Given the Company&#8217;s capital requirements and market conditions, the Company consummated this financing on market terms
              available at the time of the transaction.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; margin-right: 2pt;">The Company incurred fees of approximately $1.0 million through June 30, 2022 related to the PIPE Transaction, which were allocated to the fair value of the Common Warrants and the Pre-Funded Warrants and recorded in other expense, net on the
              accompanying condensed consolidated statement of operations.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the PIPE Transaction, the Company and the PIPE Investor also entered into a registration rights agreement, dated March 6,
              2022, pursuant to which the Company agreed to prepare and file a registration statement with the SEC no later than 15 days following the filing date of the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021 (the &#8220;2021
              Annual Report&#8221;) to register the resale of the shares of common stock included in the Units and the shares of common stock issuable upon exercise of the Pre-Funded Warrants and the Common Warrants. The Company agreed to use its best efforts to
              have such registration statement declared effective as promptly as possible after the filing thereof, subject to certain specified penalties if timely effectiveness is not achieved. The Company filed the 2021 Annual Report on April 15, 2022
              and the registration statement on April 29, 2022. The resale registration statement became effective on May 11, 2022.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the registration rights agreement, the Company is obligated to pay the PIPE Investor liquidated damages equal to 2% of the Subscription Amount per month, with a maximum aggregate payment of 12% of the Subscription Amount, in the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered for resale
              thereunder for more than 10 consecutive calendar days or more than an aggregate of <span style="-sec-ix-hidden:Fact_79f909b8446d493ba4844bbccec3c0e8">fifteen</span> calendar days (which need not be consecutive calendar days) during any 12-month period.</div>

<div><br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On May 24, 2022, the Company provided the PIPE Investor with notice that it was not able to resell the securities registered for resale under
              the registration agreement because the Company had not timely filed its Quarterly Report on Form 10-Q (the &#8220;Q1 2022 10-Q&#8221;) with the SEC, and that the PIPE Investor could not use the registration statement to resell the related securities
              until the Company filed the Q1 2022 10-Q.&#160; Because the PIPE Investor was unable to use the registration statement for at least 10
              consecutive calendar days, the Company accrued $0.2 million during the first quarter of 2022 for the contingent loss the Company
              incurred as liquidated damages as a result of the late Q1 2022 10Q filing, which is recorded in other expense, net for the six months ended June 30, 2022 in the accompanying condensed consolidated statements of operations.&#160; The Company paid
              such $0.2 million liquidated damages payment in June 2022.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
            </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> On June 30, 2022, the Company filed its Q1 2022 10-Q along with the 10-K/A, and on July 1, 2022, the Company provided its notice to the PIPE
              Investor that it may resume use of the resale registration statement.</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;"><span style="font-weight: normal;"> <span style="font-style: italic;">Merger</span></span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-indent: 0px; text-transform: none; background-color: rgb(255, 255, 255);"><span style="font-weight: normal;"> <br/>
            </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;">Under the terms of the Merger
              Agreement </span></span>(see Note 3)<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;">, on March 25, 2021, Brooklyn issued shares of common stock to the equity holders of Brooklyn LLC. The 87,000
              Class A units of Brooklyn LLC were converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> 22,275,000 shares of common stock; the 15,000,000 Class B units were converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> 2,515,000
              shares of common stock; the 10,000,000 Class C units were converted into </span></span>approximately 1,676,000<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common stock; </span></span>approximately 630,000<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common units were
              converted into </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> 630,000 shares of common stock, and 10,500,000 rights options were converted into </span></span>approximately 11,828,000<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> shares of common stock.
              Brooklyn also issued </span></span>approximately<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"> 1,068,000 shares of common stock to the Financial Advisor pursuant to the Merger Agreement</span></span>.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156226240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>EARNINGS PER SHARE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">
<div>
            <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;">12)</td>

    <td style="width: auto; vertical-align: top;">
                    <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"><span style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">EARNINGS PER SHARE</span> </div>
                  </td>

  </tr>


</table>
          </div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period
          including the weighted average effect of the Pre-Funded Warrants the Company issued in connection with the PIPE Transaction, the exercise of which requires little or no consideration for the delivery of shares of common stock. The Company
          determined that the exercise of the Pre-Funded Warrants requires nominal consideration for the delivery of shares of common stock, and as such, has considered the 1,357,000 shares underlying the Pre-Funded Warrants to be outstanding effective on March 9, 2022 for the purposes of calculating basic EPS. Diluted net loss per share is calculated by dividing net loss by the
          weighted-average number of common shares outstanding (including the weighted average effect of the Pre-Funded Warrants) plus dilutive securities. Stock options, RSUs, warrants and other convertible securities are considered potential common
          shares and are included in the calculation of diluted net loss per share using the treasury method when their effect is dilutive. Diluted net loss per share is the same as basic net loss per share in periods where the effect of potentially
          dilutive shares of common stock are antidilutive. <span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The following table presents the amount of stock options, RSUs, warrants and convertible preferred stock that were excluded from the computation of diluted net loss per common share for three
          and six months ended June 30, 2022 and 2021, as their effect was anti-dilutive:</span></div>

<div><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom;" valign="bottom">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">Three and Six months ended June 30,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2022</div>
              </td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; text-align: center;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2021</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Stock options</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">3,750</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">3,366</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">RSUs</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">587</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">105</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Warrants</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">6,857</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Preferred stock converted into common stock</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">50</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">42</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Total potential common shares excluded from computation</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">11,244</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">3,513</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156331872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING PRONOUNCEMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">13)<br/>
          </td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">RECENT ACCOUNTING PRONOUNCEMENTS</div>
          </td>

  </tr>


</table>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">&#160;</span>
     </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In June 2022, the Financial Accounting Standard Board (the &#8220;FASB&#8221;) issued Accounting Standards Update
        (&#8220;ASU&#8221;) No. 2022-03,&#160;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities&#160;Subject to Contractual Sale Restrictions&#160;(&#8220;ASU 2022-03&#8221;). The FASB issued ASU 2022-03 to (1) clarify the&#160;guidance in Topic 820, Fair Value
        Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new disclosure requirements for
        equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered part of the
        unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years with early adoption
        permitted. The Company is evaluating when to adopt the amendments in ASU 2022-02. The Company does not expect a material impact as a result of adopting this amendment.</span>  </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227150255840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>SUBSEQUENT EVENT [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENT</a></td>
<td class="text">
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">14)</td>

    <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">SUBSEQUENT EVENT</div>
              </td>

  </tr>


</table>

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On












            July 12, 2022, <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">the PIPE Investor exercised its</span> 1,357,000
            <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">Pre-Funded Warrants at an exercise price of</span> $0.005
            <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">per share for an aggregate exercise price of</span> $6,786,
            in cash.&#160; The Company issued 1,357,000 <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">shares of common stock to
              the PIPE Investor on July 14, 2022 upon receipt of the cash proceeds. Subsequent to the exercise,&#160;</span> no Pre-Funded Warrants
            remained outstanding.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156279328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
          </span> </div>

<div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The














          accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial statements and with the instructions to
          Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the unaudited financial statements include all the
          normal recurring adjustments that are necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.<br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">These
































          condensed consolidated financial statements should be read together with the audited consolidated financial statements and notes thereto contained in Brooklyn&#8217;s Annual Report on Form 10-K/A for the year ended December 31, 2021 filed with the
          Securities and Exchange Commission (the &#8220;SEC&#8221;) on June 30, 2022 (the &#8220;10-K/A&#8221;). The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements contained in the 10-K/A but does
          not include all of the information and footnotes required by GAAP for complete financial statements. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be anticipated for
          the entire year ending December 31, 2022, or any other period.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">
<div>
         <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-style: italic;">Reclassifications</span><br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
        </div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Certain reclassifications have been made
          to Brooklyn&#8217;s prior years&#8217; financial statements to conform to the current year presentation. These reclassifications had no effect on Brooklyn&#8217;s previously reported results of operations or accumulated deficit.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156333104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING PRONOUNCEMENTS (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In June 2022, the Financial Accounting Standard Board (the &#8220;FASB&#8221;) issued Accounting Standards Update
        (&#8220;ASU&#8221;) No. 2022-03,&#160;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities&#160;Subject to Contractual Sale Restrictions&#160;(&#8220;ASU 2022-03&#8221;). The FASB issued ASU 2022-03 to (1) clarify the&#160;guidance in Topic 820, Fair Value
        Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new disclosure requirements for
        equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered part of the
        unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years with early adoption
        permitted. The Company is evaluating when to adopt the amendments in ASU 2022-02. The Company does not expect a material impact as a result of adopting this amendment.</span>  </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227157688992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Tangible and Intangible Assets Acquired and Liabilities Assumed, Based on Estimated Fair Values</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The allocation of the purchase price to the tangible and
          intangible assets acquired and liabilities deemed to be assumed from Brooklyn, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; font-weight: bold;">Historical</div>
                <div style="text-align: center; font-weight: bold;">Balance</div>
                <div style="text-align: center; font-weight: bold;">Sheet of</div>
                <div style="text-align: center; font-weight: bold;">Brooklyn at</div>
                <div style="text-align: center; font-weight: bold;">March 25, 2021</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; font-weight: bold;">Fair Value</div>
                <div style="text-align: center; font-weight: bold;">Adjustment</div>
                <div style="text-align: center; font-weight: bold;">to Brooklyn</div>
                <div style="text-align: center; font-weight: bold;">Pre-Merger</div>
                <div style="text-align: center; font-weight: bold;">Assets</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; white-space: nowrap;" valign="bottom">
                <div style="font-weight: bold;">
                  <div><span style="font-weight: bold;">Purchase</span></div>
                </div>
                <div><span style="font-weight: bold;">Price</span></div>
                <div><span style="font-weight: bold;">Allocation</span></div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>148</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>148</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Prepaid expense and other current assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>329</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>329</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>1,015</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>1,015</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>1,296</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>(368</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>928</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Customers</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Accounts payable, accrued liabilities and other current</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>(3,781</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>-</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">
                <div>(3,781</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>(890</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>479</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>(411</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom">
                <div style="text-align: left;">Total consideration</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>8,178</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Net assets acquired, excluding goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div>(411</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div>8,589</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposition Details</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On March 26, 2021, Brooklyn sold its rights, title and
          interest in and to the assets relating to the business it operated (under the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of the
          Disposition are as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Proceeds from sale:</div>
              </td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">Cash</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">132</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Escrow</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>50</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Assume advance/loans</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>1,700</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Interest on advance/loans</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>68</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Carrying value of assets sold:</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Cash and cash equivalents</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(14</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Accounts receivable</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(75</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Prepaids and other current assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(124</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Property and equipment, net</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(1,014</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Software development costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(927</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Customers</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(548</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Trade name</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(299</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Goodwill</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(8,589</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Other assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>(103</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Liabilities transferred upon sale:</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Accounts payable and accrued expenses</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>113</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Obligations under finance leases</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>17</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Lease liability</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>26</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div style="text-align: left;">Deferred revenue</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">
                <div>55</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Other current liabilities</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>149</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Transaction costs</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(265</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px;" valign="bottom">
                <div style="text-align: left; font-weight: bold;">Total loss on sale of assets</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div style="font-weight: bold;">$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom">
                <div style="font-weight: bold;">(9,648</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="font-weight: bold;">)</div>
              </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTableTextBlock', window );">Fair Value of Asset Acquired</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal;">The resulting fair value of the asset acquired is as follows (in thousands):</span>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">&#160;</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Fair Value of</div>
                <div style="text-align: center; text-indent: -9pt; font-weight: bold;">Consideration</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Cash paid</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>22,882</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom">
                <div style="text-align: left;">Cash acquired</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div>(28</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Unrestricted shares</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>36,628</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Restricted shares</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div>22,056</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Total fair value of consideration paid</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div>81,538</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left;">Less amount of cash paid for NoveCite investment</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div>(1,000</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                <div>)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left;">Fair value of IPR&amp;D acquired</div>
              </td>

    <td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div>$</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div>80,538</div>
              </td>

    <td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6911878&amp;loc=d3e8732-128492<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156276048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Liabilities Measured at Fair Value</a></td>
<td class="text">
<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span>
        <span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The following tables summarize the liabilities that are measured at fair value as of June 30, 2022 (in thousands).&#160; There were no liabilities measured at fair value as of Decem</span>ber 31, 2021:</div>

<div> <br/>
          </div>

<div>
            <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of June 30,
                      2022</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 1</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 2</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Level 3</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Liabilities:</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Pre-Funded Warrants</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">702</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Warrant liabilities - Common Warrants</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,822</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">702</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,822</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
          </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Changes in Warrant Liabilities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company remeasured the fair value of the warrant liabilities as of June 30, 2022, and the following table presents the changes in the
            warrant liabilities from the issuance date (in thousands): </div>

<div>&#160;</div>

<div>
            <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pre-Funded <span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                      </span></div>
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Warrants<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                      </span></div>
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Level 2)</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common</div>
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Warrants<br/>
                      </span>(Level 3)</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Warrant<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/>
                      </span>Liabilities</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at January 1, 2022</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at March 9, 2022 (issuance date)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,646</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">9,943</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">12,589</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Change in fair value of warrant liabilities</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(1,944</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(8,121</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(10,065</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                  </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                    <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Fair value at June 30, 2022</div>
                  </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">702</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1,822</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                  </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">2,524</div>
                  </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
            </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227157863664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>LEASES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Net Operating Lease Expense</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2022 and 2021, the net operating lease expenses were as follows (in thousands):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">Three months ended June 30,</span><br/>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">2021</span> <br/>
            </td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">146</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">164</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Sublease income</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(21</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">(21</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Variable lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">51</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total lease expense</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">176</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">144</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;">
        <table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">Six months ended June 30,</span></td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom">2022</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"><span style="font-weight: bold;">2021<br/>
                </span></td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Operating lease expense</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">333</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">315</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Sublease income</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(42</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">(42</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">)</div>
              </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Variable lease expense</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">53</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">10</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
                <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Total lease expense</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">344</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom">
                <div style="color: rgb(0, 0, 0);">283</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
         </div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock', window );">Operating Lease Right-of-use Assets and Liabilities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;">The tables below show the beginning
          balances of the operating ROU assets and lease liabilities as of January 1, 2022 and the ending balances as of June 30, 2022, including the changes during the period (in thousands).</div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 36pt; text-transform: none;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><br/>
          </span></div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating Lease</div>
              <span style="font-weight: bold;"> </span>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">ROU Assets</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease ROU assets at
                January 1, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2,567</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Initial measurement of operating lease ROU assets</span></td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1,706</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Amortization of operating lease
                ROU assets</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(186</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Impairment of ROU assets</span></td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">(772</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Write off of ROU asset due to lease termination</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(1,372</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease ROU assets at
                June 30, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,943</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div style="letter-spacing: normal; white-space: normal; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-weight: 400; text-align: left; text-indent: 0px; text-transform: none;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating Lease</div>
              <span style="font-weight: bold;"> </span>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Liabilities</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease liabilities at
                January 1, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2,723</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Initial measurement of operating lease liabilities</span></td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">1,706</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Principal payments on operating
                lease liabilities</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(153</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Write off of operating lease liability due to lease termination</span></div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(1,453</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">)</div>
            </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Operating lease liabilities at
                June 30, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2,823</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Less non-current portion</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2,433</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Current portion at June 30, 2022</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">390</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Operating Lease Liabilities</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-weight: 400; font-variant: normal;">The maturities of the operating lease liabilities are as follows (in thousands):</span>
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">As of</div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">June 30, 2022</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2022</span><br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">$</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">299</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2023</span><br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">673</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2024</span><br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">688</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2025</span><br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">703</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"><span style="text-indent: 0pt;">2026</span><br/>
              </div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">708</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Thereafter</div>
            </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">470</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Total payments</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <br/>
            </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,541</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">Less imputed interest</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">(718</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">)</td>

  </tr>

  <tr>

    <td rowspan="1" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Total operating lease liabilities</td>

    <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">$</td>

    <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,823</td>

    <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156276608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued expenses consisted of the following (in thousands):</div>

<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; width: 100%;">


  <tr>

    <td style="vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">June 30,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
                    </span></span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">December 31,</div>
                <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</span><span style="text-decoration: underline;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
                    </span></span></div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued compensation<br/>
                </div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,613</div>
              </td>

    <td colspan="1" style="font-family: &amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="font-family: &amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">656</div>
              </td>

    <td colspan="1" style="font-family: &amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued research and development expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">388</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">222</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Accrued general and administrative expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,820</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">371</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Total accrued expenses</div>
              </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">3,821</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">$</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1,249</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227155355120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>STOCK-BASED COMPENSATION [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock', window );">Stock Option Granted</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2022 and 2021, the Company granted the
        following stock options (in thousands):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
      </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended June 30,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Six months ended June 30,</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">&#160;</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
              </div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);">Stock options granted</div>
            </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">723</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,366</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">1,981</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
              <div style="color: rgb(0, 0, 0);">3,366</div>
            </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-Average Assumptions Used for Stock Options Granted</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;">The following weighted-average assumptions were used for stock options granted during the three and six months ended June
        30, 2022 and 2021:</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"> <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
        </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td rowspan="1" style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="6" rowspan="1" style="vertical-align: bottom; font-size: 10pt; font-weight: bold; text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">Three months ended June 30,</td>

    <td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: center; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; text-align: right; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: bold; text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average risk-free rate</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">2.74%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">1.06%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average volatility</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">92.74%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">134.30%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Dividend yield</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">0%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <br/>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">0%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Expected term</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">4.15 years</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">6.08 years</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/>
      </span> </div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Six months ended June 30,</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2021</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average risk-free rate</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">2.42%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">1.06%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Weighted average volatility</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">92.85%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">134.30%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Dividend yield</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">0%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;">0%</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);"><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Expected term</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">4.79 years</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">6.08 years</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock', window );">RSU Granted</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;">During the three and six months ended June 30, 2022 and 2021, the Company granted the
      following restricted stock units (&#8220;RSUs&#8221;) (in thousands):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended June 30,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Six months ended June 30,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2022<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">RSUs Granted</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">-</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">105</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">1,101</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">105</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock', window );">RSUs Vested and Settled</a></td>
<td class="text"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The following table shows the number of RSUs that vested and were settled during the three and six months ended
        June 30, 2022, as well as the number of shares of common stock withheld to cover the withholding taxes and the net shares issued upon settlement (in thousands):</span></span>
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/>
      </span></div>

<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Three months ended</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Six months ended</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">&#160;</div>
          </td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">June 30, 2022</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">June 30, 2022</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">RSUs vested</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">26</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">35</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Common stock withheld to cover
              taxes</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(9</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">(9</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">)</div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Common stock issued</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">17</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">26</div>
          </td>

    <td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 36pt; margin-right: 0.5pt;">For the three and six months ended June 30, 2022 and 2021, the
      Company recognized stock-based compensation expense as follows, which includes the expense related to Dr. Federoff&#8217;s modified awards discussed above (in thousands):</div>

<div style="display:none;"><br/></div>
<div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/>
    </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">


  <tr>

    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Three months ended June 30,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Six months ended June 30,</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">&#160;</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"> 2022<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2022<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">2021<br/>
            </div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">Research and development</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">470</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">168</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">892</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">570</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">General and administrative</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">409</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">986</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">1,170</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">1,003</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">Total</div>
          </td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">879</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">1,154</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">2,062</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">$</div>
          </td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">
            <div style="color: rgb(0, 0, 0);">1,573</div>
          </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number RSUs vested and settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option granted during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227156507488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>EARNINGS PER SHARE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Computation of Diluted Net Loss per Common Share</a></td>
<td class="text"><span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;">The following table presents the amount of stock options, RSUs, warrants and convertible preferred stock that were excluded from the computation of diluted net loss per common share for three
          and six months ended June 30, 2022 and 2021, as their effect was anti-dilutive:</span>
<div><br/>
        </div>

<table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">


  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="6" style="vertical-align: bottom;" valign="bottom">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">Three and Six months ended June 30,</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2022</div>
              </td>

    <td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; text-align: center;" valign="bottom">&#160;</td>

    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;">2021</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Stock options</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">3,750</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">3,366</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%;" valign="bottom">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">RSUs</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">587</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">105</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Warrants</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">6,857</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">-</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Preferred stock converted into common stock</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">50</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">42</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">Total potential common shares excluded from computation</div>
              </td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">11,244</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom">&#160;</td>

    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom">
                <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;">3,513</div>
              </td>

    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom">&#160;</td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227248349536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)<br></strong></div></th>
<th class="th"><div>Jul. 16, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember', window );">NoveCite, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Description of Business [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of total outstanding equity interests</a></td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227160003008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LIQUIDITY AND CAPITAL RESOURCES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract', window );"><strong>Liquidity and Capital Resources [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 19,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(153,483)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(153,483)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (140,702)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (3,398)<span></span>
</td>
<td class="num">$ (10,085)<span></span>
</td>
<td class="num">(12,773)<span></span>
</td>
<td class="num">$ (28,607)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,425)<span></span>
</td>
<td class="num">$ (10,234)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227157650912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Merger Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of shares of common stock owned by Brooklyn stockholders immediately before the Merger (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,469,000<span></span>
</td>
<td class="nump">52,021,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Merger Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of outstanding common stock received by members and financial adviser</a></td>
<td class="nump">96.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of common stock issued in exchange of membership interests (in shares)</a></td>
<td class="nump">39,992,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of common stock issued as compensation for services (in shares)</a></td>
<td class="nump">1,068,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Purchase price</a></td>
<td class="nump">$ 8,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Closing price of common stock (in dollars per share)</a></td>
<td class="nump">$ 5.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Number of shares of common stock owned by Brooklyn stockholders immediately before the Merger (in shares)</a></td>
<td class="nump">1,514,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 8,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227153903664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expense and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable, accrued liabilities and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(890)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement', window );">Cash and cash equivalents obligated to have under merger agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_BeneficialHoldersContractualCommitmentsToInvest', window );">Beneficial holders contractual commitments to invest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfAdditionalRightsOffering', window );">Percentage of additional rights offering</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ProceedsFromSaleOfRights', window );">Proceeds from right offering</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Fair Value Adjustment to Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expense and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(368)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable, accrued liabilities and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Fair Value Adjustment to Assets [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Fair Value Adjustment to Assets [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Purchase Price Allocation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expense and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable, accrued liabilities and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(411)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Purchase Price Allocation [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember', window );">NTN Buzztime, Inc [Member] | Purchase Price Allocation [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_BeneficialHoldersContractualCommitmentsToInvest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual commitment made by beneficial holders to invest in the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_BeneficialHoldersContractualCommitmentsToInvest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of software development costs recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents obligated to maintain under merger agreement on balance sheet at the effective time of the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfAdditionalRightsOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of additional right offering made by the entity for unit holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfAdditionalRightsOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ProceedsFromSaleOfRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of rights during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ProceedsFromSaleOfRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=btx_NTNBuzztimeIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=btx_ProFormaFairValueAdjustmentToAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=btx_ProFormaFairValueAdjustmentToAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=btx_PurchasePriceAllocationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=btx_PurchasePriceAllocationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227147658448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details) - NTN Business [Member]<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 26, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DispositionAbstract', window );"><strong>Disposition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Sale of rights, title and interest in and to the assets relating to the business</a></td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ProceedsFromDispositionAbstract', window );"><strong>Proceeds from sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash', window );">Cash</a></td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow', window );">Escrow</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans', window );">Assume advance/loans</a></td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans', window );">Interest on advance/loans</a></td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Carrying value of assets sold [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable</a></td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets', window );">Prepaids and other current assets</a></td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="num">(1,014)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts', window );">Software development costs</a></td>
<td class="num">(927)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1', window );">Goodwill</a></td>
<td class="num">(8,589)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets</a></td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities transferred upon sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases', window );">Obligations under finance leases</a></td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability', window );">Lease liability</a></td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts', window );">Transaction costs</a></td>
<td class="num">(265)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Total loss on sale of assets</a></td>
<td class="num">(9,648)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=btx_NTNBusinessMember', window );">Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Carrying value of assets sold [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(548)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=btx_NTNBusinessMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Carrying value of assets sold [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">$ (299)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as Lease liability attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as Obligations under finance leases attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate proceeds received from assume advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate proceeds received from escrow deposits in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate proceeds received from interest on advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as software development cost attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of the business disposal including legal, accounting, and other costs incurred to consummate the business disposition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_DispositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_DispositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ProceedsFromDispositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ProceedsFromDispositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred revenue attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=btx_NTNBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=btx_NTNBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227152930592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 16, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,765,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=btx_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherProductiveAssets', window );">Cash</a></td>
<td class="nump">$ 22,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisition of common stock (in shares)</a></td>
<td class="nump">7,022,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition agreement</a></td>
<td class="nump">$ 102,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AssetAcquisitionSharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 14.5253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Fair value of shares issued</a></td>
<td class="nump">$ 58,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_EscrowShares', window );">Escrow shares (in shares)</a></td>
<td class="nump">741,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AcquisitionAgreementNonCompetitivePeriod', window );">Non-compete period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PaymentsToAcquireProductiveAssetsNet', window );">Cash paid, net</a></td>
<td class="nump">$ 22,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions', window );">Unrestricted shares, issued (in shares)</a></td>
<td class="nump">3,644,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions', window );">Restricted shares, issued (in shares)</a></td>
<td class="nump">3,378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LockUpPeriodForRestrictedShares', window );">Lock-up period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AssetAcquisitionUnrestrictedSharesSharePrice', window );">Unrestricted shares, fair value per share (in dollars per share)</a></td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfDiscountOnFairValueOfRestrictedShares', window );">Percentage of discount on fair value restricted shares</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AssetAcquisitionRestrictedSharesSharePrice', window );">Restricted shares, fair value per share (in dollars per share)</a></td>
<td class="nump">$ 6.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Cash paid</a></td>
<td class="nump">$ 22,882,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="num">(28,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions', window );">Unrestricted shares, value</a></td>
<td class="nump">36,628,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions', window );">Restricted shares, value</a></td>
<td class="nump">22,056,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AssetAcquisitionFairValueOfConsiderationPaid', window );">Total fair value of consideration paid</a></td>
<td class="nump">81,538,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Less amount of cash paid for NoveCite investment</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ResearchAndDevelopmentInProcessAssetAcquisition', window );">Acquired in-process research and development</a></td>
<td class="nump">$ 80,538,000<span></span>
</td>
<td class="nump">$ 80.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=btx_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_EscrowPeriod', window );">Period of escrow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=btx_NovellusIncMember', window );">Novellus, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_EachLockUpAgreementExtendsTerm', window );">Each lock-up agreement extend term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=btx_NovellusIncMember', window );">Novellus, Inc. [Member] | Chair of the Board of Directors, Former Chief Executive Officer and President [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Lock-up agreements shares received in acquisition (in shares)</a></td>
<td class="nump">3,378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=btx_NovellusIncMember', window );">Novellus, Inc. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfCommonStockSubjectToLockUpAgreement', window );">Percentage of common stock subject to the lock-up agreement</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember', window );">NoveCite, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Acquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of total outstanding equity interests</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AcquisitionAgreementNonCompetitivePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Acquisition Agreement contains non-competition and non-solicitation provisions pursuant to which the Seller has agreed not to engage in certain competitive activities for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AcquisitionAgreementNonCompetitivePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AssetAcquisitionFairValueOfConsiderationPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AssetAcquisitionFairValueOfConsiderationPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AssetAcquisitionRestrictedSharesSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered with restrictions to be paid in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AssetAcquisitionRestrictedSharesSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AssetAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AssetAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AssetAcquisitionUnrestrictedSharesSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered without any restrictions to be paid in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AssetAcquisitionUnrestrictedSharesSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_EachLockUpAgreementExtendsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period of lock-up agreement extend term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_EachLockUpAgreementExtendsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_EscrowPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period of secure indemnification obligations to acquisition agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_EscrowPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_EscrowShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares have been placed in escrow shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_EscrowShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LockUpPeriodForRestrictedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LockUpPeriodForRestrictedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PaymentsToAcquireProductiveAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets excluding cash acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PaymentsToAcquireProductiveAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfCommonStockSubjectToLockUpAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of shares of common stock subject to the lock-up agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfCommonStockSubjectToLockUpAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfDiscountOnFairValueOfRestrictedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of discount on restricted shares, which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfDiscountOnFairValueOfRestrictedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ResearchAndDevelopmentInProcessAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ResearchAndDevelopmentInProcessAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued with restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued with restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued without any restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued without any restrictions during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=btx_NovellusTherapeuticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=btx_NovellusTherapeuticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=btx_NovellusIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=btx_NovellusIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227152819392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 16, 2021 </div>
<div>USD ($) </div>
<div>BoardMember</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember', window );">NoveCite, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_NumberOfBoardSeats', window );">Number of board seats | BoardMember</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Losses on investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember', window );">NoveCite, INC. [Member] | Citius Pharmaceuticals, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by Citius</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_NumberOfBoardSeats">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of members of the company's management holds board seats on board of directors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_NumberOfBoardSeats</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=btx_NoveCiteINCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=btx_CitiusPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=btx_CitiusPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227147861360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 09, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,357,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember', window );">Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,857,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Pre-funded Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | Common Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">702,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Pre-funded Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">702,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Common Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">1,822,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Pre-funded Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Common Warrants [Member] | Warrant Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value disclosure</a></td>
<td class="nump">$ 1,822,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227157652976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Changes in Fair Value of Warrant Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OverSubscriptionAmountReceived', window );">Over-subscription amount received</a></td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Gross proceeds received</a></td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Fair value at March 9, 2022 (issuance date)</a></td>
<td class="nump">12,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(10,065)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, end of period</a></td>
<td class="nump">2,524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Changes in Fair Value of Warrant Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Fair value at March 9, 2022 (issuance date)</a></td>
<td class="nump">2,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(1,944)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, end of period</a></td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 [Member] | Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Changes in Fair Value of Warrant Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Fair value at March 9, 2022 (issuance date)</a></td>
<td class="nump">9,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(8,121)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value, end of period</a></td>
<td class="nump">$ 1,822<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_OverSubscriptionAmountReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_OverSubscriptionAmountReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227154532544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES, Operating Lease (Details)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 05, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>LEASES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OperatingLeaseArea', window );">Operating lease area | ft&#178;</a></td>
<td class="nump">5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">62 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_BaseRentPerSquareFoot', window );">Base rent (per square foot) | ft&#178;</a></td>
<td class="nump">6.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageBaseRentIncreaseOnEachAnniversary', window );">Percentage of increase in base rent on each year</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extended lease term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_InitialMeasurementOfOperatingLeaseROUAssets', window );">Initial measurement of operating lease ROU assets</a></td>
<td class="nump">$ 1,706,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_InitialMeasurementOfOperatingLeaseLiabilities', window );">Initial measurement of operating lease liabilities</a></td>
<td class="nump">1,706,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of ROU assets</a></td>
<td class="num">(772,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LesseeCommitmentToPurchaseProperty', window );">Commitment to purchase equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_UnamortizedLeaseholdImprovements', window );">Unamortized leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Security deposit</a></td>
<td class="nump">$ 477,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,000<span></span>
</td>
<td class="nump">$ 488,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_BaseRentPerSquareFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of base rent expense per square foot for leased asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_BaseRentPerSquareFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_InitialMeasurementOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_InitialMeasurementOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_InitialMeasurementOfOperatingLeaseROUAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease ROU assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_InitialMeasurementOfOperatingLeaseROUAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LesseeCommitmentToPurchaseProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property for which lessee committed to purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LesseeCommitmentToPurchaseProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_OperatingLeaseArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of leased property under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_OperatingLeaseArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageBaseRentIncreaseOnEachAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of base rent increase on each anniversary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageBaseRentIncreaseOnEachAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_UnamortizedLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of unamortized leasehold improvements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_UnamortizedLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227159991968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES, Net Operating Lease Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Net Operating Lease Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 146<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">$ 333<span></span>
</td>
<td class="nump">$ 315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease expense</a></td>
<td class="nump">$ 176<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 344<span></span>
</td>
<td class="nump">$ 283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227160088176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES, Operating Lease Right-of-use Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OperatingLeaseAssestAbstract', window );"><strong>Operating Lease, Asset [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease ROU assets, Beginning</a></td>
<td class="nump">$ 2,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_InitialMeasurementOfOperatingLeaseROUAssets', window );">Initial measurement of operating lease ROU assets</a></td>
<td class="nump">1,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease ROU assets</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">$ (149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of ROU assets</a></td>
<td class="num">(772)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_WriteOffOfOperatingLeaseRightOfUseAsset', window );">Write off of ROU asset due to lease termination</a></td>
<td class="num">(1,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease ROU assets, Ending</a></td>
<td class="nump">1,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating Lease, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, Beginning</a></td>
<td class="nump">2,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_InitialMeasurementOfOperatingLeaseLiabilities', window );">Initial measurement of operating lease liabilities</a></td>
<td class="nump">1,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrincipalPaymentsOnOperatingLeaseLiabilities', window );">Principal payments on operating lease liabilities</a></td>
<td class="num">(153)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_WriteOffOfOperatingLeaseLiability', window );">Write off of operating lease liability due to lease termination</a></td>
<td class="num">(1,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities, Ending</a></td>
<td class="nump">2,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Less non-current portion</a></td>
<td class="nump">2,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion</a></td>
<td class="nump">$ 390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_InitialMeasurementOfOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease liabilities in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_InitialMeasurementOfOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_InitialMeasurementOfOperatingLeaseROUAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of initial measurement of operating lease ROU assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_InitialMeasurementOfOperatingLeaseROUAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_OperatingLeaseAssestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_OperatingLeaseAssestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PrincipalPaymentsOnOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal payments on operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PrincipalPaymentsOnOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_WriteOffOfOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of operating lease liability due to lease termination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_WriteOffOfOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_WriteOffOfOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of operating lease right-of-use asset due to lease termination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_WriteOffOfOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227150724480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES, Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract', window );"><strong>Weighted Average Remaining Lease Term and Discount Rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">8.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Maturities of Operating Lease Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">708<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total payments</a></td>
<td class="nump">3,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(718)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 2,823<span></span>
</td>
<td class="nump">$ 2,723<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227152923360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,990<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfOngoingProject', window );">Non-cash impairment charges</a></td>
<td class="nump">$ 5,990<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,990<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (in dollars per share)</a></td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfOngoingProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfOngoingProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227159012224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CEO SEPARATION AGREEMENT (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th"><div>May 24, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SeparationAgreementAbstract', window );"><strong>Separation Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Dr. Federoffs's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SeparationAgreementAbstract', window );"><strong>Separation Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForPostemploymentBenefits', window );">Severance benefit</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PaymentToOfficerBaseSalary', window );">Payment of annual base salary</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option outstanding (in shares)</a></td>
<td class="nump">1,523,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable period</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits', window );">Severance benefit receivable based on performance restricted stock</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Dr. Federoffs's [Member] | Milestone Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_SeparationAgreementAbstract', window );"><strong>Separation Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option outstanding (in shares)</a></td>
<td class="nump">415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable period</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PaymentToOfficerBaseSalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflows for payment of annual base salary for a period of twelve months after the expiration of the applicable revocation period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PaymentToOfficerBaseSalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_SeparationAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_SeparationAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of severance benefit, would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflows for payments of postemployment benefits (such as severance pay and health insurance benefits) recognized during the period. Postemployment benefits are benefits paid to employees after employment but before retirement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=btx_MilestoneOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=btx_MilestoneOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227160001248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 1,613<span></span>
</td>
<td class="nump">$ 656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AccruedResearchAndDevelopmentExpenses', window );">Accrued research and development expenses</a></td>
<td class="nump">388<span></span>
</td>
<td class="nump">222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AccruedGeneralAndAdministrativeExpenses', window );">Accrued general and administrative expenses</a></td>
<td class="nump">1,820<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">3,821<span></span>
</td>
<td class="nump">$ 1,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal expenses</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Dr. Federoffs's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AccruedGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AccruedGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AccruedResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AccruedResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227147889328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Aug. 05, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 15, 2021 </div>
<div>USD ($) </div>
<div>BoardMember</div>
</th>
<th class="th">
<div>Feb. 05, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement, amount</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyDamagesSoughtExpectedSalary', window );">Defendants salary promised against plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyDamagesSoughtExpectedEquityPercentage', window );">Percentage of equity promised against plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_DheshGovenderMember', window );">Govender [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyDamagesSoughtExpectedSalary', window );">Defendants salary promised against plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyDamagesSoughtExpectedEquityPercentage', window );">Percentage of equity promised against plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyNumberOfArbitrationPanel', window );">Number of member arbitration panel | BoardMember</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_DheshGovenderMember', window );">Govender [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LegalMattersAbstract', window );"><strong>Legal Matters [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LegalMattersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LegalMattersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossContingencyDamagesSoughtExpectedEquityPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of equity promised to the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossContingencyDamagesSoughtExpectedEquityPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossContingencyDamagesSoughtExpectedSalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The monetary amount of salary promised to the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossContingencyDamagesSoughtExpectedSalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossContingencyNumberOfArbitrationPanel">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number member in arbitration panel pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossContingencyNumberOfArbitrationPanel</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_DheshGovenderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_DheshGovenderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227147670048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Apr. 15, 2021</div></th>
<th class="th"><div>Apr. 13, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Apr. 26, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember', window );">Novellus, Ltd. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MilestonePayments', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusLtdAndFactorBioscienceMember', window );">Licensors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyNonRefundableOptionFee', window );">Non-refundable option fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_InitialLicenseFees', window );">Initial license fees</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AdditionalFeesObligatedToPay', window );">Amount require to pay of initial license fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AmountRequireToPayInitialLicenseFees', window );">Amount obligated to pay in license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AmountObligatedToPayInYearOne', window );">Additional fees obligated to pay in 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusLtdAndFactorBioscienceMember', window );">Licensors [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AmountObligatedToPayInYearTwo', window );">Additional fees obligated to pay in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NoveCiteMember', window );">NoveCite [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfRevenue', window );">Percentage of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=btx_UniversityOfSouthFloridaMember', window );">University of South Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LicensingAgreementsAbstract', window );"><strong>Licensing Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_LossContingencyPercentageOfRoyaltyPayable', window );">Percentage of royalty payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AdditionalFeesObligatedToPay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity is obligated to pay additional fees to Licensors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AdditionalFeesObligatedToPay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AmountObligatedToPayInYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity is obligated to pay additional fees to the Licensors in first year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AmountObligatedToPayInYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AmountObligatedToPayInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity is obligated to pay additional fees to the Licensors in second year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AmountObligatedToPayInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AmountRequireToPayInitialLicenseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount require to pay out of the total initial license fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AmountRequireToPayInitialLicenseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_InitialLicenseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial license fees required to pay including non-refundable fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_InitialLicenseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LicensingAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LicensingAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossContingencyNonRefundableOptionFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of Non-refundable option fee in licensing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossContingencyNonRefundableOptionFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_LossContingencyPercentageOfRoyaltyPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalty payable from one party to another in licensing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_LossContingencyPercentageOfRoyaltyPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_MilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of milestones upfront payment on licenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_MilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenue from receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd shall remit to NoveCite.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusTherapeuticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusLtdAndFactorBioscienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NovellusLtdAndFactorBioscienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NoveCiteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=btx_NoveCiteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=btx_UniversityOfSouthFloridaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=btx_UniversityOfSouthFloridaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227150746608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)<br></strong></div></th>
<th class="th"><div>Mar. 22, 2021</div></th>
<th class="th"><div>Jun. 22, 2018</div></th>
<th class="th"><div>May 01, 2012</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=btx_InvestorRoyaltyAgreementMember', window );">Investor Royalty Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_RoyaltyAgreementsAbstract', window );"><strong>Royalty Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness', window );">Percentage of royalty receive equal to revenues from sale of business</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales', window );">Percentage of payment of additional royalty on gross sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=btx_CollaboratorRoyaltyAgreementMember', window );">Collaborator Royalty Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_RoyaltyAgreementsAbstract', window );"><strong>Royalty Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness', window );">Percentage of royalty receive equal to revenues from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of additional royalty payable on gross sales by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalty receive equal to revenues generated from disposition of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_RoyaltyAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_RoyaltyAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=btx_InvestorRoyaltyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=btx_InvestorRoyaltyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=btx_CollaboratorRoyaltyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=btx_CollaboratorRoyaltyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227159988272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, Stock Option Activity (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="nump">723<span></span>
</td>
<td class="nump">3,366<span></span>
</td>
<td class="nump">1,981<span></span>
</td>
<td class="nump">3,366<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227154522032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Stock Options Granted (Details) - Stock Options [Member]<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Weightage-Average Assumptions Used for Stock Options Granted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted average risk-free rate</a></td>
<td class="nump">2.74%<span></span>
</td>
<td class="nump">1.06%<span></span>
</td>
<td class="nump">2.42%<span></span>
</td>
<td class="nump">1.06%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted average volatility</a></td>
<td class="nump">92.74%<span></span>
</td>
<td class="nump">134.30%<span></span>
</td>
<td class="nump">92.85%<span></span>
</td>
<td class="nump">134.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">4 years 1 month 24 days<span></span>
</td>
<td class="text">6 years 29 days<span></span>
</td>
<td class="text">4 years 9 months 14 days<span></span>
</td>
<td class="text">6 years 29 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227153247312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, Summary of Stock Options (Details)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>Installment </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>Installment </div>
<div>shares</div>
</th>
<th class="th">
<div>May 24, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 879,000<span></span>
</td>
<td class="nump">$ 1,154,000<span></span>
</td>
<td class="nump">$ 2,062,000<span></span>
</td>
<td class="nump">$ 1,573,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Dr. Federoffs's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of stock option awards outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,523,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock option awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">723,000<span></span>
</td>
<td class="nump">3,366,000<span></span>
</td>
<td class="nump">1,981,000<span></span>
</td>
<td class="nump">3,366,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Incremental fair value of stock options recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Stock options exercised, intrinsic value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of stock option awards outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod', window );">Exercise period of extended post-termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod', window );">Exercise period of extended post-termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Dr. Federoffs's [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock option awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,225,000<span></span>
</td>
<td class="nump">414,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares', window );">Number of monthly installments | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Number of accelerated vesting stock option (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_TimeBasedStockOptionGrantMember', window );">Time-Based Grant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock option awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,628,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares', window );">Number of monthly installments | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Number of accelerated vesting stock option (in shares)</a></td>
<td class="nump">657,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_TimeBasedStockOptionGrantMember', window );">Time-Based Grant [Member] | Vesting on one-year Anniversary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_PerformanceBasedStockOptionGrantMember', window );">Milestone Grant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock option awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">597,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Number of accelerated vesting stock option (in shares)</a></td>
<td class="nump">415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of extended post-termination exercise period under the share-based compensation arrangements, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of monthly installments for vesting of remaining shares in share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=btx_TimeBasedStockOptionGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=btx_TimeBasedStockOptionGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=btx_PerformanceBasedStockOptionGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=btx_PerformanceBasedStockOptionGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227157436464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, RSUs (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-Based Compensation Abstract [Member]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSUs Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">1,101<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227157436624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, Number of RSUs Vested and Settled (Details) - RSUs [Member] - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_NumberOfAwardsVestedAndSettledAbstract', window );"><strong>Number of RSUs Vested and Settled [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (in shares)</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_CommonStockWithheldToCoverTaxes', window );">Common stock withheld to cover taxes (in shares)</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued (in shares)</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_CommonStockWithheldToCoverTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares of common stock withheld to cover the withholding taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_CommonStockWithheldToCoverTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_NumberOfAwardsVestedAndSettledAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_NumberOfAwardsVestedAndSettledAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227154537616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, Summary of RSUs (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>Goals </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recognized | $</a></td>
<td class="nump">$ 879<span></span>
</td>
<td class="nump">$ 1,154<span></span>
</td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="nump">$ 1,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of RSUs granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">105,000<span></span>
</td>
<td class="nump">1,101,000<span></span>
</td>
<td class="nump">105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of stock units awards outstanding (in shares)</a></td>
<td class="nump">587,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">587,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_Two022PerformanceBasedRestrictedStockUnitsMember', window );">2022 PSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_NumberOfPerformanceGoalsAreSubjectToAchieve', window );">Number of performance goals are subject to achieve | Goals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Restricted stock units vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved', window );">Number of performance goals not achieved | Goals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of RSUs cancelled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_Two022PerformanceBasedRestrictedStockUnitsMember', window );">2022 PSUs [Member] | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of RSUs granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,101,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=btx_Two022PerformanceBasedRestrictedStockUnitsMember', window );">2022 PSUs [Member] | Dr. Federoff [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of RSUs granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of RSUs cancelled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForPostemploymentBenefits', window );">Lump sum cash severance paid | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_NumberOfPerformanceGoalsAreSubjectToAchieve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of performance goals are subject to achieve under 2022 performance based restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_NumberOfPerformanceGoalsAreSubjectToAchieve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of performance goals not achieved under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflows for payments of postemployment benefits (such as severance pay and health insurance benefits) recognized during the period. Postemployment benefits are benefits paid to employees after employment but before retirement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=btx_Two022PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=btx_Two022PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=btx_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=btx_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=btx_ChiefExecutiveOfficerAndPresidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=btx_ChiefExecutiveOfficerAndPresidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227150742368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, Restricted Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 879<span></span>
</td>
<td class="nump">$ 1,154<span></span>
</td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="nump">$ 1,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Common Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock replaced during the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock outstanding (in shares)</a></td>
<td class="nump">587,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">587,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Stock-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock replaced during the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Unvested restricted common stock forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227147639488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION, Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract', window );"><strong>Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 879<span></span>
</td>
<td class="nump">$ 1,154<span></span>
</td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="nump">$ 1,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract', window );"><strong>Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="nump">892<span></span>
</td>
<td class="nump">570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract', window );"><strong>Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 409<span></span>
</td>
<td class="nump">$ 986<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 1,003<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227153055904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY, Private Placement of Equity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Warrants fair value</a></td>
<td class="nump">12,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OverSubscriptionAmountReceived', window );">Over-subscription amount received</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember', window );">Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price (in dollars per share)</a></td>
<td class="nump">$ 1.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights', window );">Percentage of warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ClassOfWarrantOrRightsExercisableTerm', window );">Warrant exercisable term</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants outstanding weighted average contractual life</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">6,857,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights', window );">Percentage of warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">1,357,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember', window );">PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,857,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Aggregate gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_VariableRateTransactionsPeriod', window );">Variable rate transaction period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Warrants fair value</a></td>
<td class="nump">$ 12,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_OverSubscriptionAmountReceived', window );">Over-subscription amount received</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth', window );">Obligation to pay liquidated damages per month</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_TransactionFeesPayable', window );">Transaction fees</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ConsecutiveCalendarDays', window );">Consecutive calendar days</a></td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_AggregateCalendarDays', window );">Aggregate calendar days</a></td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimated contingent loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Liquidated damages payment</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember', window );">PIPE Investor [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ObligationToPayLiquidatedDamagesPercentage', window );">Obligated to pay liquidated damages percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember', window );">PIPE Investor [Member] | Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Warrant expiration term</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember', window );">PIPE Investor [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_PrivatePlacementOfEquityAbstract', window );"><strong>Private Placement of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,357,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_AggregateCalendarDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified aggregate calendar days (which need not be consecutive calendar days) during any 12-month period for resale, Updated definition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_AggregateCalendarDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of securities that would be issuable upon the exercise of warrants or rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ClassOfWarrantOrRightsExercisableTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ClassOfWarrantOrRightsExercisableTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ConsecutiveCalendarDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified consecutive calendar days for resale, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ConsecutiveCalendarDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ObligationToPayLiquidatedDamagesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ObligationToPayLiquidatedDamagesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_OverSubscriptionAmountReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_OverSubscriptionAmountReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_PrivatePlacementOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_PrivatePlacementOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_TransactionFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fees incurred related to PIPE transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_TransactionFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_VariableRateTransactionsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pursuant to the Purchase Agreement, the Company is prohibited from issuing equity in variable rate transactions for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_VariableRateTransactionsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227152857584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY, Merger (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesAcquisitions1', window );">Stock issued, shares, acquisition (in shares)</a></td>
<td class="nump">1,068,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">87,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">22,275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">2,515,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">1,676,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ClassOfWarrantOrRightIssued', window );">Number of rights options issued (in shares)</a></td>
<td class="nump">10,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of rights options converted (in shares)</a></td>
<td class="nump">11,828,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_MergerAbstract', window );"><strong>Merger [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Number of shares issued in merger agreement (in shares)</a></td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted to common stock (in shares)</a></td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_StockIssuedDuringPeriodSharesAcquisitions1', window );">Stock issued, shares, acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,514,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ClassOfWarrantOrRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued into which the class of warrant or right may be converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ClassOfWarrantOrRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_MergerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_MergerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_StockIssuedDuringPeriodSharesAcquisitions1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_StockIssuedDuringPeriodSharesAcquisitions1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227153921632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">11,244,000<span></span>
</td>
<td class="nump">3,513,000<span></span>
</td>
<td class="nump">11,244,000<span></span>
</td>
<td class="nump">3,513,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,366,000<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="nump">3,366,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">587,000<span></span>
</td>
<td class="nump">105,000<span></span>
</td>
<td class="nump">587,000<span></span>
</td>
<td class="nump">105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">6,857,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,857,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Preferred Stock Converted into Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potential common shares excluded from computation (in shares)</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">42,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Anti-dilutive Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to be outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,357,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140227154000368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENT (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 12, 2022</div></th>
<th class="th"><div>Jul. 14, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 09, 2022</div></th>
<th class="th"><div>Mar. 06, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,357,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,357,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember', window );">Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,857,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,857,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PIPE Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PIPE Investor [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_btx_ClassOfWarrantOrRightExercised', window );">Warrants exercised (in shares)</a></td>
<td class="nump">1,357,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate exercise price</a></td>
<td class="nump">$ 6,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PIPE Investor [Member] | Common Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,357,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_btx_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights exercised during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">btx_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>btx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=btx_CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=btx_PIPEInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>brhc10040603_10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:btx="http://brooklynitx.com/20220630"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="btx-20220630.xsd" xlink:type="simple"/>
    <context id="c20220101to20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-08-10</instant>
        </period>
    </context>
    <context id="c20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220401to20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20210630_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20210630_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20220630_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20220630_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">btx:CommonUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">btx:MembershipEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-16</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:ProFormaFairValueAdjustmentToAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">btx:PurchasePriceAllocationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">btx:NTNBuzztimeIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-26</startDate>
            <endDate>2021-03-26</endDate>
        </period>
    </context>
    <context id="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-26</instant>
        </period>
    </context>
    <context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-26</instant>
        </period>
    </context>
    <context id="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">btx:NTNBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-26</instant>
        </period>
    </context>
    <context id="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-16</instant>
        </period>
    </context>
    <context id="c20220101to20220630_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210716to20210716_AssetAcquisitionAxis_NovellusIncMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AssetAcquisitionAxis_NovellusIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210716to20210716_AssetAcquisitionAxis_NovellusIncMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">btx:CitiusPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-16</instant>
        </period>
    </context>
    <context id="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-16</startDate>
            <endDate>2021-07-16</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">btx:NoveCiteINCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-09</instant>
        </period>
    </context>
    <context id="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220101to20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2022-03-05</instant>
        </period>
    </context>
    <context id="c20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20220524to20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-24</startDate>
            <endDate>2022-05-24</endDate>
        </period>
    </context>
    <context id="c20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-24</instant>
        </period>
    </context>
    <context id="c20220524_AwardTypeAxis_MilestoneOptionsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:MilestoneOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-24</instant>
        </period>
    </context>
    <context id="c20220524to20220524_AwardTypeAxis_MilestoneOptionsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:MilestoneOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-24</startDate>
            <endDate>2022-05-24</endDate>
        </period>
    </context>
    <context id="c20220630_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_RestructuringCostAndReserveAxis_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:DheshGovenderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-15</startDate>
            <endDate>2021-12-15</endDate>
        </period>
    </context>
    <context id="c20211215to20211215_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:DheshGovenderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-15</startDate>
            <endDate>2021-12-15</endDate>
        </period>
    </context>
    <context id="c20210205to20210205_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="c20220805to20220805_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-05</startDate>
            <endDate>2022-08-05</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_LegalEntityAxis_UniversityOfSouthFloridaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">btx:UniversityOfSouthFloridaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-13</startDate>
            <endDate>2021-04-13</endDate>
        </period>
    </context>
    <context id="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c20210415to20210415_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-15</startDate>
            <endDate>2021-04-15</endDate>
        </period>
    </context>
    <context id="c20210426_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-26</instant>
        </period>
    </context>
    <context id="c20211031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember_StatementScenarioAxis_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusLtdAndFactorBioscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c20220101to20220630_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NovellusTherapeuticsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220630_RelatedPartyTransactionsByRelatedPartyAxis_NoveCiteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">btx:NoveCiteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:InvestorRoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-22</startDate>
            <endDate>2021-03-22</endDate>
        </period>
    </context>
    <context id="c20180622to20180622_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:CollaboratorRoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-22</startDate>
            <endDate>2018-06-22</endDate>
        </period>
    </context>
    <context id="c20120501to20120501_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">btx:InvestorRoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-05-01</startDate>
            <endDate>2012-05-01</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210301to20210331_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210401to20210430_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210430_AwardTypeAxis_TimeBasedStockOptionGrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedStockOptionGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210430_AwardTypeAxis_PerformanceBasedStockOptionGrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:PerformanceBasedStockOptionGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_AwardTypeAxis_TimeBasedStockOptionGrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedStockOptionGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_AwardTypeAxis_TimeBasedStockOptionGrantMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedStockOptionGrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220301to20220331_AwardTypeAxis_PerformanceBasedStockOptionGrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:PerformanceBasedStockOptionGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220301to20220331_AwardTypeAxis_TimeBasedStockOptionGrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:TimeBasedStockOptionGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220630_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20210101to20210630_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">btx:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_EmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">btx:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">btx:ChiefExecutiveOfficerAndPresidentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">btx:Two022PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220101to20220630_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220630_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20210401to20210630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220306_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-06</instant>
        </period>
    </context>
    <context id="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220630_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220630_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c20220331_InvestmentTypeAxis_PIPEInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210325_StatementClassOfStockAxis_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_StatementClassOfStockAxis_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325_StatementClassOfStockAxis_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210325to20210325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2021-03-25</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-12</startDate>
            <endDate>2022-07-12</endDate>
        </period>
    </context>
    <context id="c20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-12</instant>
        </period>
    </context>
    <context id="c20220714_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">btx:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-14</instant>
        </period>
    </context>
    <context id="c20220712_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">btx:PIPEInvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-12</instant>
        </period>
    </context>
    <unit id="U001">
        <measure>shares</measure>
    </unit>
    <unit id="U002">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U003">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U004">
        <measure>pure</measure>
    </unit>
    <unit id="U005">
        <measure>btx:BoardMember</measure>
    </unit>
    <unit id="U006">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U007">
        <measure>btx:Installment</measure>
    </unit>
    <unit id="U008">
        <measure>btx:Goals</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="c20220101to20220630"
      id="Fact_ddfc7c74924d4f309d4a59ace6576e34">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="c20220101to20220630"
      id="Fact_23826375958c4306acc8c76fc630b1b9">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="c20220101to20220630"
      id="Fact_38b6890574564b3db35d76aba54b2111">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="c20220101to20220630"
      id="Fact_ef1da885a61849f8b43548134172c53c">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="c20220101to20220630"
      id="Fact_6bf80679b32d4f7fa28276ba2126de6f">0000748592</dei:EntityCentralIndexKey>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_816a5bfe7554457abf9cb7a46a5bdc57">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <btx:AggregateCalendarDays
      contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_79f909b8446d493ba4844bbccec3c0e8">P15D</btx:AggregateCalendarDays>
    <dei:DocumentType
      contextRef="c20220101to20220630"
      id="Fact_65a5bd1dc56e4e9fa76fe4c159364cb1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="c20220101to20220630"
      id="Fact_f5695269fd9849b1ad3e287311e756db">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="c20220101to20220630"
      id="Fact_1a5e02a723a44803911ce76215333228">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="c20220101to20220630"
      id="Fact_8f0bb10d72d14a57a69b5a993fd689db">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="c20220101to20220630"
      id="Fact_90945eedff1d43ccb6b9f2cf10eb4255">001-11460</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="c20220101to20220630"
      id="Fact_667a4cb77c0e4f97a5f98867d5da68f7">Brooklyn ImmunoTherapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220101to20220630"
      id="Fact_365d4ddc9f38423e9711b8d4963edc92">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220101to20220630"
      id="Fact_97b5b2e4b47d404f9034ad5fbfd3ff25">31-1103425</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220101to20220630"
      id="Fact_24198666a6e1424db0ed06e7967ad2a3">10355 Science Center Drive, Suite 150</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20220101to20220630"
      id="Fact_7ddd7994e15149029c9b495d3f55e217">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220101to20220630"
      id="Fact_d6a7dfe18d2540d191c1187b4d1f1189">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220101to20220630"
      id="Fact_0e555dd5288741d7b9cd4cb57dbe1c83">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220101to20220630"
      id="Fact_aec6d7905fe745589eba585f16b05baa">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220101to20220630"
      id="Fact_3140b70708c34c3b9a68858bc300e443">582-1199</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="c20220101to20220630"
      id="Fact_784fd6f68af849e29a263038edce410e">Common stock, $0.005 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220101to20220630"
      id="Fact_e013b520c9f44ff789c9f63b9dd0b8af">BTX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220101to20220630"
      id="Fact_62cb464167ec4dbf90e91b7d4085fc8e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="c20220101to20220630"
      id="Fact_76afc7460ee64ea68778bff5cb3053c1">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="c20220101to20220630"
      id="Fact_bd444aff6e7b4585aa924e220d53ef0e">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="c20220101to20220630"
      id="Fact_6ad38af2f2c743f7a2915bc8443fc032">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="c20220101to20220630"
      id="Fact_ccf1d8e8266345448d6fdca3a5cd7b08">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220101to20220630"
      id="Fact_b9f91141568345a09bf6e35e6d05b327">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="c20220101to20220630"
      id="Fact_95af04fbd2c948c29a2cb7458163301a">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c20220810"
      decimals="INF"
      id="Fact_bc957f6268e2465a826577b07f033e50"
      unitRef="U001">58825739</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="c20220630"
      decimals="-3"
      id="Fact_95dda23c92d847678e06bd2488a77e2c"
      unitRef="U002">19407000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="c20211231"
      decimals="-3"
      id="Fact_00fbac43fe3841daa4f9f17da38d8a8c"
      unitRef="U002">16985000</us-gaap:Cash>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_eb3475879c984b229da0795b69991627"
      unitRef="U002">694000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ee182beb80e7427a8e44921a96eb5c21"
      unitRef="U002">684000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_924d072972a64dd2b93231a29a239d7a"
      unitRef="U002">1824000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_633ad162eaa44dc4a84145c32d193f57"
      unitRef="U002">1097000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_b1a7b6ef9531485da0a1aaaacd639959"
      unitRef="U002">21925000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_5ad64840ea984061bb9d10cc8681d789"
      unitRef="U002">18766000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20220630"
      decimals="-3"
      id="Fact_95132a85f15144539816df2bb02a1d59"
      unitRef="U002">424000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_616e4d8489d14af6aed2f9d5c53fce4f"
      unitRef="U002">670000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20220630"
      decimals="-3"
      id="Fact_2d6c8bfbafe64faeb5325d376d987e88"
      unitRef="U002">1943000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d3cbf3d126324979a3925bafe52a7e54"
      unitRef="U002">2567000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="c20220630"
      decimals="-3"
      id="Fact_8c5567a64f284563936e2406a212f5be"
      unitRef="U002">2044000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a91021e738a643ea81d1a3e80a79f3b8"
      unitRef="U002">2044000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20220630"
      decimals="-3"
      id="Fact_2563293303b0443184d81479b5fd26fe"
      unitRef="U002">0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20211231"
      decimals="-3"
      id="Fact_305c31e3e34e447498e6f4e82b5a4c36"
      unitRef="U002">5990000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="c20220630"
      decimals="-3"
      id="Fact_f765a194746c48209deb2d7ac37174bf"
      unitRef="U002">89000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e1f3e4ff044e4d9596113337af2cbe4a"
      unitRef="U002">1000000</us-gaap:EquityMethodInvestments>
    <us-gaap:DepositAssets
      contextRef="c20220630"
      decimals="-3"
      id="Fact_61ebf41ddf65449da4bbbaf14da5eec2"
      unitRef="U002">477000</us-gaap:DepositAssets>
    <us-gaap:DepositAssets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c031daa388624efd81b9d901e8502cfd"
      unitRef="U002">488000</us-gaap:DepositAssets>
    <us-gaap:Assets
      contextRef="c20220630"
      decimals="-3"
      id="Fact_c7903c4571694ce9b1482fe730890507"
      unitRef="U002">26902000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ee512d5e84194a08af027857dfe049d1"
      unitRef="U002">31525000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_ddf230f2796345b395bd34589bc38b79"
      unitRef="U002">1478000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_33a32138c0854027ad3522b61cc19cfa"
      unitRef="U002">1755000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_b61db524492d4b58bfb731f1120e6aff"
      unitRef="U002">3821000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d831c2cccf664f6d8fc457e89d5ba8c0"
      unitRef="U002">1249000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_b94f6793cab6457eb78f7e1832ba896a"
      unitRef="U002">390000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ef94ba6be7944a3c824a289d1e306ede"
      unitRef="U002">426000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_8dd64977a66549d6920b51ec5a568387"
      unitRef="U002">1429000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f9fd8dad044942f499343933f2acd4fb"
      unitRef="U002">247000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_6be829a26ca64ba286ba625da0ea7b54"
      unitRef="U002">7118000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9b27efcee29f42e691e5c5ab0193ece9"
      unitRef="U002">3677000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_81c39921f8f1494584e9b0e0df2f3e0d"
      unitRef="U002">2524000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3d35589e2cd049a4b429279cfc9bb764"
      unitRef="U002">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_abf2a7f4593748bdb9998514f383eb09"
      unitRef="U002">2433000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b71b9a9e7c01476da652aa1645264aa9"
      unitRef="U002">2297000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_993b24efd49d450d9d4bd629f60f4d81"
      unitRef="U002">48000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_12693b77fb904038aee287c909bdd16b"
      unitRef="U002">48000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="c20220630"
      decimals="-3"
      id="Fact_47d0c88d67d143fd882dbfd3c41ba003"
      unitRef="U002">12123000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c4685ad725a0456896a4daaea179f7cc"
      unitRef="U002">6022000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20220630"
      decimals="3"
      id="Fact_c0ea5613ea6d40f0b9dffe14abd1edc5"
      unitRef="U003">0.005</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="3"
      id="Fact_bcd8709d033f428e8173ed7775036d5c"
      unitRef="U003">0.005</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20220630"
      decimals="-3"
      id="Fact_4ac7253f1c734f6ea97099ac1ba020da"
      unitRef="U001">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4a03470ef4d44c388f86bc6c1a210cb6"
      unitRef="U001">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20220630"
      decimals="-3"
      id="Fact_f02586de8d224caaadf31d214af57aa9"
      unitRef="U001">156000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cf2c9722e4d248b3800a3c6265700290"
      unitRef="U001">156000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20220630"
      decimals="-3"
      id="Fact_9249699cab6b4d61b305f727f21d5fb3"
      unitRef="U001">156000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20211231"
      decimals="-3"
      id="Fact_62790db89ed1415c8007a230ba3678a0"
      unitRef="U001">156000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ebb9e8aebf25456688cf39b98102f735"
      unitRef="U002">156000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="c20220630"
      decimals="-3"
      id="Fact_6d87828446cb4966bfa8abfdc0b31371"
      unitRef="U002">156000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:PreferredStockValue
      contextRef="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="-3"
      id="Fact_bf15d0c11c1f4cf69948bff8bdbae6bb"
      unitRef="U002">1000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember"
      decimals="-3"
      id="Fact_45395650bc8540d6bb8258ab24654d4f"
      unitRef="U002">1000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20220630"
      decimals="3"
      id="Fact_bff4899c7a4c455b8db15fdbcecbf908"
      unitRef="U003">0.005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="3"
      id="Fact_257c1ec62cdd4252b18550449dd232ac"
      unitRef="U003">0.005</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7119e67f1a7d414fbf6f3bffc85e9a59"
      unitRef="U001">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20220630"
      decimals="-3"
      id="Fact_3e6a98d480254a9d85432242ebb4f684"
      unitRef="U001">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20220630"
      decimals="-3"
      id="Fact_f601d269d9c04248b625a64786b12601"
      unitRef="U001">57469000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20220630"
      decimals="-3"
      id="Fact_2e2aaa0c1032417d9bb0449e4aa7a77f"
      unitRef="U001">57469000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7915b2a904804cc7a5afe329e97d0616"
      unitRef="U001">52021000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20211231"
      decimals="-3"
      id="Fact_697836017c014cf592042b99e699dc22"
      unitRef="U001">52021000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="c20220630"
      decimals="-3"
      id="Fact_2b231a38168d4d269f9df29f7d542e8a"
      unitRef="U002">287000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ca85d9de920342b1b645849103698793"
      unitRef="U002">260000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20220630"
      decimals="-3"
      id="Fact_67dbf3fddadd48278c72fff99da58c09"
      unitRef="U002">167974000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0f4c94f4fa8e4d368768b6209f607800"
      unitRef="U002">165944000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20220630"
      decimals="-3"
      id="Fact_1e9c34acc7db4ab88c524eb84650e8ca"
      unitRef="U002">-153483000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20211231"
      decimals="-3"
      id="Fact_05e0332d63fc428795de517bc62f82c3"
      unitRef="U002">-140702000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="c20220630"
      decimals="-3"
      id="Fact_25a6999c8d124f7399563b7bb55bef01"
      unitRef="U002">14779000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7598124631174cfd8973ed650ad791d0"
      unitRef="U002">25503000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20220630"
      decimals="-3"
      id="Fact_cf6023ac81b54e04b6ab6b340a1e0533"
      unitRef="U002">26902000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9ffeeb1208514f12a9d7a2f5890fbd93"
      unitRef="U002">31525000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_fcb8f0cde1114c07b550fe04507d8d18"
      unitRef="U002">1685000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_4baba3fedfaa46a5b44db1c0124b5198"
      unitRef="U002">5432000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_840636f9220643929a58cb20b249e345"
      unitRef="U002">3467000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_efa411487c7443d29e55f55e87d5d015"
      unitRef="U002">6965000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_382a802f7726496388367cc0debdf509"
      unitRef="U002">6205000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_9b0a112c6c794a4e93e1d33ce49087b0"
      unitRef="U002">4581000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_9ad72ade040a4b049b70fbb4d86b37e5"
      unitRef="U002">10719000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_71bc332108c244b9b954c382194c95fd"
      unitRef="U002">6204000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_a52d436b986e479da3662e6dc4297aa6"
      unitRef="U002">5990000</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_f8204a263ca04f61a729589f0d936e76"
      unitRef="U002">0</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_fd15a7fd2684495fb7d50e75cdb9117d"
      unitRef="U002">5990000</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_7645bfe81afb45acad87078dec96eafc"
      unitRef="U002">0</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_14386ef69dd1497dbb51a88bb6d0c53d"
      unitRef="U002">0</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_f8a575a4b02e43fdbd4ba3d9b3546157"
      unitRef="U002">0</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_d881b244f47947a8b160e83a1efa1174"
      unitRef="U002">0</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_5f4f246c7004423686bd87e095dbd87c"
      unitRef="U002">5765000</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:OperatingExpenses
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_48719b92a24c4ac5b2752149e44e1201"
      unitRef="U002">13880000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_4a0f638652f34b16ba1639fb8bbc6055"
      unitRef="U002">10013000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_39c253dbb5124f45971363183669fe36"
      unitRef="U002">20176000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_24377a5b3c9b43b1848b682ef0a833b2"
      unitRef="U002">18934000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_2d897a233ebb4ad0be4ade512ee55fa6"
      unitRef="U002">-13880000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_f179c2fd71e547b0aa066aa61e5535d0"
      unitRef="U002">-10013000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_1418c70c8e0f435f865efb9432688699"
      unitRef="U002">-20176000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_6efb307c97c54042bf83014798879f7d"
      unitRef="U002">-18934000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_30173ad10791464cb91b3418ca4a142f"
      unitRef="U002">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_6a74ee0f9a064b45b437a3a4273a4417"
      unitRef="U002">-50000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_6855e694e42144c7b1e331b1e40854b9"
      unitRef="U002">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_3ce596e5f1b14ed8bb5ffe5706ac2a4c"
      unitRef="U002">-9648000</us-gaap:GainLossOnDispositionOfAssets1>
    <btx:WarrantLiabilitiesExpense
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_09993d5225204b7caa6ca7d4f40c6c92"
      unitRef="U002">-10792000</btx:WarrantLiabilitiesExpense>
    <btx:WarrantLiabilitiesExpense
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_e7b4de36b2c3466b8050a0a431426175"
      unitRef="U002">0</btx:WarrantLiabilitiesExpense>
    <btx:WarrantLiabilitiesExpense
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_950d79fa9d0449eea6c47ce7e73aa85e"
      unitRef="U002">-9470000</btx:WarrantLiabilitiesExpense>
    <btx:WarrantLiabilitiesExpense
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_457867c777044514a66cfe9c09fc092e"
      unitRef="U002">0</btx:WarrantLiabilitiesExpense>
    <btx:LossOnNonControllingInvestment
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_3f038166563149a4b083bd752f644e9c"
      unitRef="U002">296000</btx:LossOnNonControllingInvestment>
    <btx:LossOnNonControllingInvestment
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_ff416c1f37d94c02887a46fab3796636"
      unitRef="U002">0</btx:LossOnNonControllingInvestment>
    <btx:LossOnNonControllingInvestment
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_1e724508381b4cb58c9bf82a1a02ef1d"
      unitRef="U002">911000</btx:LossOnNonControllingInvestment>
    <btx:LossOnNonControllingInvestment
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_f739b0840a1947a89a84d0ff18a851e8"
      unitRef="U002">0</btx:LossOnNonControllingInvestment>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_ee661a9bed9d491b9df675ac429fb866"
      unitRef="U002">-14000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_199635d1118e4377867adddf06737e38"
      unitRef="U002">-22000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_ac6ed153c95941a09af234023c7d9448"
      unitRef="U002">-1156000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_dbe81c3a14c2421aabf1a11d26ed5c98"
      unitRef="U002">-25000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_a59c4e37d799493a8bb5aedd6001fd20"
      unitRef="U002">10482000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_7c0d2eab914c4a1487c58810e0911177"
      unitRef="U002">-72000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_8823257c2d30437c9572d21385e75ab6"
      unitRef="U002">7403000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_cf4114f4f3c84db8bb9c94125102779c"
      unitRef="U002">-9673000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_68213818e5ac47a097dfde7f03c1e393"
      unitRef="U002">-3398000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_438c5c00826b4c08836c403e9cade373"
      unitRef="U002">-10085000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_cd0915f19365455195d370c781cc246b"
      unitRef="U002">-12773000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_a97d3e8b54b34845b74ae6c11feb13f2"
      unitRef="U002">-28607000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_05c6e75ae7bb463ba96c2871b7032d49"
      unitRef="U002">8000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_0305675da2e5442589390b4539a1aafb"
      unitRef="U002">8000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_bd5dc0b6c5b54b8caa9510ca37735228"
      unitRef="U002">8000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_9a99306c5734409895f7d86828cfb424"
      unitRef="U002">8000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_4e1e088824dd44ad923a8e25ceb358b6"
      unitRef="U002">-3406000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_f2597401e7e44824a30433ffe906adfe"
      unitRef="U002">-10093000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_4b0ff00d58bd4918b7bb38e7b1fb271e"
      unitRef="U002">-12781000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_22922fe6a31b430cbd66cbf73ae129dc"
      unitRef="U002">-28615000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20220401to20220630"
      decimals="2"
      id="Fact_433df7f7277f4b94946da8bad192474e"
      unitRef="U003">-0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20220401to20220630"
      decimals="2"
      id="Fact_34e303eedf6d4022a679cd466dff4c2d"
      unitRef="U003">-0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20210401to20210630"
      decimals="2"
      id="Fact_1c308bf4448f4774b40f898bb89aae72"
      unitRef="U003">-0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20210401to20210630"
      decimals="2"
      id="Fact_0cef766e9b09437393e9a0d493fc9b6c"
      unitRef="U003">-0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20220101to20220630"
      decimals="2"
      id="Fact_e9f58143840a447f9b4067028d43e66e"
      unitRef="U003">-0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20220101to20220630"
      decimals="2"
      id="Fact_cc5a8df7b9b1487a9cfd802b3997d0c2"
      unitRef="U003">-0.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20210101to20210630"
      decimals="2"
      id="Fact_7d74759038d44725b24221fed9ba6b8f"
      unitRef="U003">-0.81</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20210101to20210630"
      decimals="2"
      id="Fact_18faedef211946f2b18e747aeb2aa275"
      unitRef="U003">-0.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_81ee7bb08d264453a916fcb311c108d6"
      unitRef="U001">58805000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_4f9541bb27cc4aa086bff8336f667a4d"
      unitRef="U001">58805000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_dbe8c3fc5a704a71977e6e252771729f"
      unitRef="U001">42448000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_453bc034a8e241cca5854de8eef0bfe3"
      unitRef="U001">42448000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_9c2e2607e7e3449bb03e99107b4c46e2"
      unitRef="U001">56230000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_0ee05e117a8e4df5a41747e7d6f2d59e"
      unitRef="U001">56230000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_c77751be56f0491fb9fe96fca6793fe4"
      unitRef="U001">35187000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_b198cc0dac9646a59e6c1831bdc2c158"
      unitRef="U001">35187000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2927047dbd66486b928aef2bc88a4f7c"
      unitRef="U001">57452000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4ed684404e144f029c5e555d8a6c896f"
      unitRef="U002">287000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_b7bf02e4a2ca4ce99a83cf5944517eb6"
      unitRef="U001">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_7f7790cc22fb4be28ceca3072560f3d7"
      unitRef="U002">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_a6a53515702e4892ab396f4944c39c74"
      unitRef="U002">167100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_26f44a86d6fa4ce0a539302374f9d95d"
      unitRef="U002">-150077000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220331"
      decimals="-3"
      id="Fact_71b76e2d64644c0d93b4bc506d8e7227"
      unitRef="U002">17311000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_eeac8b25cee44defb66cded41b7552ef"
      unitRef="U001">17000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b0b46c3263174a7b8663a3280b0a60b0"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_a4d56b1c7e7140f1ba512744f0861d20"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_5bb6c2541f3f41ac8edfc4847a0803af"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_b789a021df3f4b41948661867a548400"
      unitRef="U002">-5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_c10d0b63258b4938bf3c8843a6389df3"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_89f9751828694414bed3aaa6f1ceeb72"
      unitRef="U002">-5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_eeadcda726a2458a9d0c259a4d2b4b9c"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_2d9a9629dee44d539c83b6f2c87c0136"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_18ebf2c7324141ab9b3385efe5e37d2e"
      unitRef="U002">879000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_ba62822c15f742708f3f41b0ec4e9b2f"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_cd23086422654defb2bf9b91d2322b2f"
      unitRef="U002">879000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b2be19fe658a45b3aae7f51d8b882551"
      unitRef="U001">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_40e8ea7cc2944082aac409135d92018c"
      unitRef="U002">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_183dd9909ae444259868266a841e9e04"
      unitRef="U001">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_16d57614b47e4a3fa852da59648fc1f2"
      unitRef="U002">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_77ff6685be574eb6a3fccf4fc389eed0"
      unitRef="U002">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_a0db434726c34227a40cfc27b981b220"
      unitRef="U002">8000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_8f01dfdb28d546fab09680587e9f4da8"
      unitRef="U002">8000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:NetIncomeLoss
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b3a37c6aa1aa4412923407dc5e92d4aa"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220401to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_f245953ec5554fc19308bb23db07d173"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_599cca97ebd94dc9b6dbeafc52ffe2ef"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220401to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_e1b5d5991a874625a6ba5e790208a3f9"
      unitRef="U002">-3398000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_bae3ac3fb230434b8bfaf17b0feaea8a"
      unitRef="U002">-3398000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_81802789831f455581589c991284c342"
      unitRef="U001">57469000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5a089da664cf4998889c9ee38f5a56ec"
      unitRef="U002">287000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_27327000c0914b28a9333dbf579b46fe"
      unitRef="U001">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_45ea070f38a846208cfc46abdcd8209d"
      unitRef="U002">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_99803db7b17042c394e21f489f5d1609"
      unitRef="U002">167974000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_04ea6894f8fd476d90d9ef3bc4b0989f"
      unitRef="U002">-153483000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220630"
      decimals="-3"
      id="Fact_d53b7733c0784ef99d84ec0f9f18cf7f"
      unitRef="U002">14779000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_20d1759c466545e2a69833926142ed9a"
      unitRef="U001">52021000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_dc7eaea9d4ac4b41ad5cd57510ff240e"
      unitRef="U002">260000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_682c18f0b1d34c47964bd492338fd7bd"
      unitRef="U001">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_02146ade7f874076934a94f0ba89044a"
      unitRef="U002">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_7a08d647999b42dea61b9c1d739c7258"
      unitRef="U002">165944000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_859ec9af8ed24a46bb7b32cb692167ba"
      unitRef="U002">-140702000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b12cffe1962e4bcebed8951d7e63c86f"
      unitRef="U002">25503000</us-gaap:StockholdersEquity>
    <btx:StockIssuedDuringPeriodSharesPrivateOffering
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ccb3bc29200f40628fceb5a834529327"
      unitRef="U001">5500000</btx:StockIssuedDuringPeriodSharesPrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2d4073f4cc4146ff8a4efc6d18076222"
      unitRef="U002">27000</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodSharesPrivateOffering
      contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_24ba3d25af5c4c72986198ce9e36bba6"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesPrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_cd481066e8494d7d8db99da8bd4bcc86"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_bedbe0879a6d465aa7be11cdfe770277"
      unitRef="U002">-27000</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_528208fbeff142abac5e1504584aa34a"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:StockIssuedDuringPeriodValuePrivateOffering
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_239aa2b79d39452aaeb9f4c06f364144"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValuePrivateOffering>
    <btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4ce1b1b5ccc145fe80369c41d964b0f3"
      unitRef="U001">78000</btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a7e4033825c045b0ac97bdf9c1d0516e"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_cb8c7f010d5a4d3b830df07dac16f776"
      unitRef="U001">0</btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_2791c6b9bc1e4bccbe459976e855980e"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_1b1f53aafa6c46c5aec27af7774f41f5"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_3f9a416561f94d559f9dbbe8048c8437"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_42d78f8a4b5f412596ac52ccb3ccb074"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_97514c041ce547c4a675e0e9eaa9e761"
      unitRef="U001">26000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4f7f6ba2953f49fc883e1dcaaec0d19d"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_e511a048cec34c4cbdec4328cdb16703"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_b0b9a1d0d765455baca0edea120ae06e"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_e6218a3942e74af7b91b163bfadcfe4f"
      unitRef="U002">-5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_91e4f32b25c148eaa1e72aeb75a276e3"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_406d3c01c5ad4bcfaf9c12c6851052b6"
      unitRef="U002">-5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d82465f53d1e4381ab202c02c323ff99"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_d19d8f75261a4744805664ca458a67ea"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_a40235c78baf4546b554cc114ff3c593"
      unitRef="U002">2062000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_73bf769e6451493888db2757d587a08e"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_cee29d1609bd47c8a4bd97aacecb2446"
      unitRef="U002">2062000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_0979c7f5e6f64b019158ee17a5efc439"
      unitRef="U001">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_dc64e7e9126b4bdd95f4623b3273fc10"
      unitRef="U002">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:PreferredStockDividendsShares
      contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_92100f5c01a94d12975e7146fcb9e670"
      unitRef="U001">0</us-gaap:PreferredStockDividendsShares>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_ef9e69d6809d473381775ba8b46e505f"
      unitRef="U002">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_3806d8949b414f83b97cb1e6f53b14d1"
      unitRef="U002">0</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_6b575100798748f38b95b27cf7d912b3"
      unitRef="U002">8000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_f7e41e10705a4be28c4130b4ad6c9f68"
      unitRef="U002">8000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_e0d30a68239c4017ae0be6637ad1d61d"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_af6c1e883c86414ead8db7f45955191c"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_5f42513181414895b8c36a4eb8d29b36"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_8239d7fbf5cd402d85b4605c5096a60d"
      unitRef="U002">-12773000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_a80fa073fee44f90b63058a13dc2628e"
      unitRef="U002">-12773000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1fbfa1544418481ab3bfd8a17f7b8cfd"
      unitRef="U001">57469000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20220630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_3b2e7f0e82884ece82954f9043c5327c"
      unitRef="U002">287000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_9fe49c0267b4405fba2f690be6eb4f64"
      unitRef="U001">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20220630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_d1b3bcf315504f95b583211d43d22e65"
      unitRef="U002">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_3e33a3e246e24862919ff6a9c26b0468"
      unitRef="U002">167974000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_d3b95fe2b0034979b5ffa88359a95779"
      unitRef="U002">-153483000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20220630"
      decimals="-3"
      id="Fact_28d510b195f84ba8a56f04ab935d39f5"
      unitRef="U002">14779000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a38781f8641c4637897254358d5c2fa0"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_fc662eab0ce04070a86dfa6c05a27a0c"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_e035b0d742db43829615afac04e6a2e3"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_ce8838e139394033a0f8de4efc6d1e9a"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ac3efd219a854b7eae01cdf977458098"
      unitRef="U001">41506000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_56956a8fdf104af7bdc350e0fe877135"
      unitRef="U002">208000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_fd0ea072fb34497e9252051878bbc05f"
      unitRef="U001">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_62e3f3386c9a4554834f1826e0201dc8"
      unitRef="U002">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_c42f3a96d12147dbb4c95a21aaba70f9"
      unitRef="U002">50453000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_9b6aa464c6d242b7bf74af8b53428907"
      unitRef="U002">-36663000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210331"
      decimals="-3"
      id="Fact_fa2d43944326401d85536c2b4b58a6dd"
      unitRef="U002">13999000</us-gaap:StockholdersEquity>
    <btx:CommonStockToBeRetainedByNTNValueStockholders
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_0d506b9e6c8145f59d10285002450a5e"
      unitRef="U002">0</btx:CommonStockToBeRetainedByNTNValueStockholders>
    <btx:CommonStockToBeRetainedByNTNValueStockholders
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_705fe6aa6e7f48c3bff3a803a5adf99d"
      unitRef="U002">0</btx:CommonStockToBeRetainedByNTNValueStockholders>
    <btx:CommonStockToBeRetainedByNTNValueStockholders
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_88cfa77e5c0a4ba3bd63ac078fc6b2ed"
      unitRef="U002">0</btx:CommonStockToBeRetainedByNTNValueStockholders>
    <btx:CommonStockToBeRetainedByNTNValueStockholders
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_bcddca0c303747478ee38f1091ae4ce1"
      unitRef="U002">0</btx:CommonStockToBeRetainedByNTNValueStockholders>
    <btx:CommonStockToBeRetainedByNTNSharesStockholders
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c8be14a7cdbd4d3096a9a267c6f37da3"
      unitRef="U001">0</btx:CommonStockToBeRetainedByNTNSharesStockholders>
    <btx:CommonStockToBeRetainedByNTNValueStockholders
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_dc02cb479a36466fa23e59fde65f64ad"
      unitRef="U002">0</btx:CommonStockToBeRetainedByNTNValueStockholders>
    <btx:CommonStockToBeRetainedByNTNSharesStockholders
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_27bc4d74d0874195a6e90e5136c368cb"
      unitRef="U001">0</btx:CommonStockToBeRetainedByNTNSharesStockholders>
    <btx:CommonStockToBeRetainedByNTNValueStockholders
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_82d0a3cb74624359901ddf44d62acca3"
      unitRef="U002">0</btx:CommonStockToBeRetainedByNTNValueStockholders>
    <btx:CommonStockToBeRetainedByNTNValueStockholders
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_ec7b54084994457981cd29f9f22f3110"
      unitRef="U002">0</btx:CommonStockToBeRetainedByNTNValueStockholders>
    <btx:CommonStockToBeRetainedByNTNValueStockholders
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_c26ec4cc7a6f46159a5fcbf1731ac8c9"
      unitRef="U002">0</btx:CommonStockToBeRetainedByNTNValueStockholders>
    <btx:CommonStockToBeRetainedByNTNValueStockholders
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_397bf0fa09024ef5a0ad1d9f71aafcbc"
      unitRef="U002">0</btx:CommonStockToBeRetainedByNTNValueStockholders>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_32f8e8019cd74a8c88114273d63e362c"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_e520cccf475240739b0e02484fea5c7f"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_10ccef4696cb46349c6ae8d0a663f54c"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_382737801dd544d4815fdbf3527edbed"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_245bbf5e895c44c8b9608d5f7cfdf436"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ef4ef35cf2a74bfb982964ec50736c29"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_f89d7c9348ec4bd793ba1626aa5d65dc"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_7ffc73a29ccf49759b4b54edcf2199ec"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_2b7bc2f48dfb476c90553012f50aeeef"
      unitRef="U002">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_478a2ce0326c46be914a739cbe063a51"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_bea6db3c005544dfbc4119b994d2e012"
      unitRef="U002">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_c168d8d49dbb48f48f48c4f71584a6c2"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_dc3ec7d22ed245b6a5df7bd0d08843c8"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_d6e535fcbf8b496a88a798866e80b47c"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_8ab4c893fa6c40f39d1c02f23b66e803"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_616ed77ec7cb4da88ac54c03eae4e086"
      unitRef="U001">3212000</btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_faab698eecf34e18b3c2f35fb0b55253"
      unitRef="U002">16000</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_4d02d5f864f94eadbe0ce622425038d5"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_577e94e8336c41d494e58a805b66dc61"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_e480a6a005e3459fb6ca469bd2ce038b"
      unitRef="U002">48509000</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_8e03cdbc6f224f51b511facc206f2ae9"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_137f445205154b19b829382f9f1e2b3c"
      unitRef="U002">48525000</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_23297e50db564baf809a17b13a829fd1"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_8bb37397ff40435ba83fad1cb8c54099"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_c5e725329aef49629056a4eb9b06f180"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_b0960e52b9ef437db1aa1db8291b7a82"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodSharesInLieuOfDividends
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_85bbbccb62fc4ca9be1ac2ea030e8851"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_41970b1e94d74942afa458444fadb117"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodSharesInLieuOfDividends
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_56ac3737a2544d908fb07e16b8e6c1ae"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_253359f3a65b4fd0b1551db0c9cfb75c"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_058a4668a37b425ca341aa64b6ec6843"
      unitRef="U002">8000</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_855f8000150546a0b8162180f55a95f3"
      unitRef="U002">-8000</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_78d44e428f1a46c1b1b1b304ec0e191e"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_ade19aecd8fe45abb1fe8984f6e827cd"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_113b8c1236114647a0be751165a68092"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7bb49b0594264faa810b886be3313927"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_24e03e9642444125bb32c9d11adc8caa"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b7f3260987b94623b1904dbde2a35317"
      unitRef="U001">12000</btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_983cd797bff6409da63d75b6ebef30c3"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_cccc2822a1774a5093add1075ccd183a"
      unitRef="U001">0</btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_d28551077da44cc28b00c29f33759293"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_d388a5db1ad54ba5b5854f0f2bb659cf"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_122a811599014c6280cbf3cfff442965"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_61727658da324883a1844501c9667c1e"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_9b8be60598d34fda9a2c6b6db21938b5"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_f66fbfb6482e45b4a1b6ed096845a76c"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_675ae60c4ef648a69e1719ae089d6ad7"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_3be59dbef7d64dc5b214f5da34798ca2"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_532e5945aebf4e03970fefd69cd3b2e3"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_97d7200164d648089559ec74fd6d3825"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_aad34114114743faadbfbc5c3de893f4"
      unitRef="U002">1154000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_8e3ba9be246e48f7b1e85b1c4ad3c0fa"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_cbb8be64880d42e195e6b827577c5131"
      unitRef="U002">1154000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_c509871061884ede9ee4050eb013b24e"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_13d6493ee257425191f4d91bcacace1a"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_02e0f14b275341cbbb5a54dee9d3dde6"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210401to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_e1df1f5a91e54878a68fe01367dadea0"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_9c5a285d118446f9b5f3e5728b74fc3e"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210401to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_98a60516fc644d1e94c53fa6e001111c"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_86776e265cc54797a2485ed5d9f2ba8b"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210401to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_e53039cf0a1a4f28ba45797537c2163b"
      unitRef="U002">-10085000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_f16d3d8633f6492ba1c1b2c8153252fd"
      unitRef="U002">-10085000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_2e19747bd2a04a3893fe099ea9a4e14e"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_569301a6dabc45ba84f2662b470beda5"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_4ce622d6aa464810b9d2bf9581a1851f"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_092a4bc6f7974439b95e5f2b734e2773"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_7d93d75b38984883912d3a2c1045afb0"
      unitRef="U001">44707000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_375bc21550074535a00df4ba76d99597"
      unitRef="U002">224000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_adc2cd3894804f2f9578ed622295cc61"
      unitRef="U001">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_12d62ecd1bd8402c8ad200d55d5b8b2e"
      unitRef="U002">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_f49357a7547241a687659a1db161027b"
      unitRef="U002">100134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_e1e9caff6449489680c2411f5bcf5005"
      unitRef="U002">-46756000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630"
      decimals="-3"
      id="Fact_bed76d6ce1274b02aeacf26b18ac3306"
      unitRef="U002">53603000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_92065f596efd4002901e733675b73c58"
      unitRef="U002">23202000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_fc9be794287749618eaaba82c2a90969"
      unitRef="U002">1400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_65124b00db6749d29eff99734d19ae66"
      unitRef="U002">1000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_ceb4546f317c4933a1d96935f44663bb"
      unitRef="U002">198000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_bd4fe68c92c045fb9a9ae2b4838b3379"
      unitRef="U001">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5fe0c6acf14a402ca5bb9a28e03f89ad"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_599c95aa5f834b5fb158d0a1ef26f255"
      unitRef="U001">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_51d35c04137f4f1fa443682867464e9e"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_44c88183e07b400d98b60f729649cc59"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_613e3ef7b72d4993988610703705a016"
      unitRef="U002">-18141000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_99cb915e67c942448b8c8dcd5a7cf7b0"
      unitRef="U002">7659000</us-gaap:StockholdersEquity>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_0d719e63621e43eb9244ad9b5325af16"
      unitRef="U002">10500000</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_ee2314b0c660495595e9853774427721"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_03b8ce97ec344c99844f20ab920d7cff"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_59200f765e1c44bfa3557dcadd771553"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_2a08739825bb4307925d30fe7e70c295"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_1f1059783ff748dc86ca2c6f9a1b36c7"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_e510c8a8df9e451f87e24c16dea43857"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_d0f2b943e9c74ac2aa57167d2a1df760"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_789d7208e543428db81794652b0df319"
      unitRef="U002">10500000</btx:StockIssuedDuringPeriodValueRightsOfferingMembershipUnits>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_96ee3d34fa44430ab5985f52fed93bc6"
      unitRef="U002">-33702000</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_2e934b2248d0473792caf60f20124754"
      unitRef="U002">-1400000</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_ed6443e6e5e14a45ad554a254bf5244c"
      unitRef="U002">-1000000</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_887313fb354040f1b54b9a6a7bc36678"
      unitRef="U002">-198000</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a6db80f6ba9445368a3bfb54d85c535a"
      unitRef="U002">0</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_7638da1b206245848315ef0821f94a10"
      unitRef="U002">0</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_2c330382aefe4eb881a4f355888f387e"
      unitRef="U002">36300000</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_c885e8f3f768431abdf1158796c97a18"
      unitRef="U002">0</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_89398ad132b54fc085f764b56bfb4dee"
      unitRef="U002">0</btx:AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_f70c014f6ebf439ba1aea8b821f2beb8"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_bf8dc8d180a741268a141023cd147724"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_f9e0c560138947789db3cccd7d430581"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_3e6062c7a56843a4a9b0a74b1f621cd0"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodSharesAcquisitions1
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_7e69451602394ce9b0a347af17b3033b"
      unitRef="U001">1514000</btx:StockIssuedDuringPeriodSharesAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b92d36f40ab04de08dc0a1fdb749412f"
      unitRef="U002">8000</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodSharesAcquisitions1
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_00ab12d4e02f466b8dc2fdc3035274af"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_62ddd51867034e70b1b60eca13ea72c3"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_e7ba3bdb3b4940a1a3a8e661fe0be6b5"
      unitRef="U002">8170000</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_ae7a7a8b1563401d9832ba9122605234"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueAcquisitions1
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_f4a0b2ef123f4341b75ebab5ca51967e"
      unitRef="U002">8178000</btx:StockIssuedDuringPeriodValueAcquisitions1>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_d43fe073ecce4327bfadc3cabcb935db"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_46a18667e29440d0a75ff0f88d5f5356"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_1285dd92b97247b0a5baec8f2a932e30"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_99d3340edff7444182baf72b382df546"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_3b9e709f14a74441819908ae1bb3381d"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5699292090db43e5ad090c26158316d3"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_38e1b7cf700d47ce8416ada048fb5c9f"
      unitRef="U001">156000</btx:StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_cf17dcbb0d5c4a4b9e66302781a32607"
      unitRef="U002">1000</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_a809237b76f14202b2cb4133a0b0bc10"
      unitRef="U002">-1000</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_8b4aa62479634041a98760c5cac6b012"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_15f13f0b016646c8a8a3fc2ff79893c0"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_42f41f4535b14611be5e287b64ce5bad"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_92fb790948e24fcc82ce0586d7e47e93"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_13c613295a8e46dbb76d0a61900e1bb5"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_d078499d8199446dab50e8c09680fafa"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountUnitsAcquisitions
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_7766b03fe63f454fb40d38b5288e2f50"
      unitRef="U001">38924000</us-gaap:PartnersCapitalAccountUnitsAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a8e77e89498d4b5cad1d9ec151f20587"
      unitRef="U002">195000</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountUnitsAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_b6e73ace1ee6469f80a38a0d846e527f"
      unitRef="U001">0</us-gaap:PartnersCapitalAccountUnitsAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_2c299b215eda4503965ccadd832119f5"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_b2ed32593f2c4b428787062ef2bae704"
      unitRef="U002">-195000</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_bd6fe6ac3c6b4503b3a221f87cf188f8"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:PartnersCapitalAccountAcquisitions
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_f309ef64ee4b44ab9a06da488e22fcff"
      unitRef="U002">0</us-gaap:PartnersCapitalAccountAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a40da98b8a394b1eb6cdc58f5c61697e"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_76bfb07500c543d89c8b2b6d37b3781e"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_71d74f97e72c4813872bc035c08f0d45"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_bf0ff3f1c96245e597472f99c73a9740"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_b3c7f8f8fe634e49b07953bc7f944c2f"
      unitRef="U001">1068000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_fe4fcf721831464f8a18bfc2dbc74a7b"
      unitRef="U002">5000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_0ca48c39d8d246f4abbdf6f3e5f4a2bf"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_43661a9017134c80b1157275d3a26318"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_d2b18a1fcae04237bdfa20a49cbd0b98"
      unitRef="U002">5760000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_c78ad53c83694d6796029e1e9c0867e3"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_c0f9d99253894d4a8fed5342b2b9beed"
      unitRef="U002">5765000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_ea2a91666cd640dcb67fe088031e9835"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_6ffcc78911924490b27cb380d15bef78"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_e1582f6cfd6a45669de00ac03eff9ca3"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7be5ca5065d24044b3671aef5c72f5bc"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_8deded6f76a94b45bcd523b14bf6db55"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_0fee8f29731046b5a892b180fd83fbbf"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_a5f414c26ec3438494a6401af9598e1f"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_84150ce237c24b07b096840ebb9cb45d"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_174165280edc45ccba05be1b8e4907ac"
      unitRef="U002">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_cfa72e12d1284e3dbe7337afb22b0a95"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_f3fd016c1b70488fa5ea99e5980dd132"
      unitRef="U002">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_460242143a20455384559f60d5f02a9c"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_1e8cff897874422eabc482382f3ccebe"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_d14fabf39fbb4830b9afb4c3ceeb5f55"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_f04ebdd7638e4b319c927a0d2ad93ec7"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ccefeeb088704cce86bd471d9135b281"
      unitRef="U001">3212000</btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_47ddc6f227c443e2b7ab999728f59f93"
      unitRef="U002">16000</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_1ba4f2d179594d788b8da83350950ef5"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_d38acc474be8437d8f070d382bf85a5d"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_61fc80bec91346158a160defa49618ff"
      unitRef="U002">48509000</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_c380f23d47844b13843903ddeab8c182"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueStockPurchaseAgreement
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_3122c57c124743eca8e41dec83d36125"
      unitRef="U002">48525000</btx:StockIssuedDuringPeriodValueStockPurchaseAgreement>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_37fb7291e9934a42b9d483e4c26e5301"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7eca9abdf5b34bc5a37336c7bd1ae569"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_0278c90ab2bf40d0b49c96b85d5d197f"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_f933a458fa664a2287b229340d255920"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodSharesInLieuOfDividends
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_08b6bbbe18b044de9f5f1c06eff2eb61"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_603d0ab4c9474e788bcd2d30c8b187a0"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodSharesInLieuOfDividends
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_fabe86001039413fae2c9169110c428c"
      unitRef="U001">0</btx:StockIssuedDuringPeriodSharesInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_9285eaa544b74a4997ea629dd91f2a3d"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_6cfd51648b0743b7a5cbf5e57be6bb26"
      unitRef="U002">8000</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_ce35dfe5166a40edbd5ebf0ae5dda143"
      unitRef="U002">-8000</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueInLieuOfDividends
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_8767798641204b45b3a437beaf5a7037"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueInLieuOfDividends>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_4d6dad37538e48f39bb06d4aba3748f3"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_63854de944df4dad912a4be63c9a6d15"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_711edb9eb1cb4fa397430e9602b9c805"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_b2ade8e34a504673b0a4032c9432c259"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c8ac2b6fedce4852a4f28871f98f38b8"
      unitRef="U001">12000</btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_437b05c2259b47d8ae4c4f053c1e1096"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_09d3213a995d49df82fc3bf59fcb0119"
      unitRef="U001">0</btx:SharesIssuedSharesForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_d5e1177121a6498d978e5a139e7dbeec"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_30736d8f953b46078c2071d8e2a78264"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_397038a9bef34fd881f1c16905c1d54f"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_9eaaee313547428a83dec432e41e2ee6"
      unitRef="U002">0</btx:StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_d787739df4fe4c29b212387188718835"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_be3959f719c2401891917c20abb4ddcc"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_734ca259d2fe4517b1b216a5271c9f66"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_38023937562f40fa81aeb482d0e8c730"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_83875bf80c4d46208b25fb2c25bdcd79"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_eb7de405869445739622dbc315de6f6a"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_dfdd0c942ccc45ec99d93ff1e3023ffa"
      unitRef="U002">1573000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_4236253babe04c0b87f6ddb138631b59"
      unitRef="U002">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_5097ac416ac940abaed857d4d179a5c0"
      unitRef="U002">1573000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_54e71aed16cf4b9096a1f9e6f9e9d608"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_f0a99b7e3271497f99672a3b9af06015"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_3195539896b340aca8e2a0b81350dbf3"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_7cd00254abcf48d3b753ccf76f974fee"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d91b2cf5ac7e498fa30a5e68c6a2ab71"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_53e4a86fc91a4cebac132dbdf0e0a6ec"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_98cd330bb65a4694a81931bcb7752310"
      unitRef="U002">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_bdbfc4f04451465e9e23dff6bb021b0a"
      unitRef="U002">-28607000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_82e6500d91764a4584c81f86cf68f29f"
      unitRef="U002">-28607000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_cd289149c6dd4e398d76aa443c1223b6"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementClassOfStockAxis_CommonClassBMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_2acbfda4237c495abd4659a47245871d"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementClassOfStockAxis_CommonClassCMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_a1856189ed22433d9f2ef71a24545764"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementClassOfStockAxis_CommonUnitsMember_StatementEquityComponentsAxis_MembershipEquityMember"
      decimals="-3"
      id="Fact_bd3228d47d134bf18f6e5e57fcc19315"
      unitRef="U002">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_e512fa1307d9407d9ef4a64312a4a0cf"
      unitRef="U001">44707000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_79f62becc156412fafdc23c0f2cb1e19"
      unitRef="U002">224000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_7b8a50a145cf49f097d04df1ecf22420"
      unitRef="U001">156000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementClassOfStockAxis_SeriesAPreferredStockMember_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_b7b11b04f51d4be4bf23fa7901bb33ab"
      unitRef="U002">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_57a83bc89fd742deba87386b505798be"
      unitRef="U002">100134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_664993b436ec4faabba99d7ff13803f2"
      unitRef="U002">-46756000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20210630"
      decimals="-3"
      id="Fact_462114da01854e87bcb88af97a7f89bf"
      unitRef="U002">53603000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_6f4f0938e705409e94ac1b73bb1e3782"
      unitRef="U002">-12773000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_6f3b8843d08e4ee9a23065b21d921a11"
      unitRef="U002">-28607000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_52c3a375a4bc4ef3a35ebac43a7a055b"
      unitRef="U002">104000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_46233d7668a1445c909bce61aa877bfe"
      unitRef="U002">63000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_6fb1e37bcaff4d3ea366570481288ecb"
      unitRef="U002">2062000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_e9daee9d9c134e3ba876a7acdd3e7f0d"
      unitRef="U002">1573000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_e8a57958dfa64ad9af1fda481bbc817a"
      unitRef="U002">186000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_846320f5f364420baaedabc15565c637"
      unitRef="U002">149000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_7d6e1951ffab441fa30136c75211d561"
      unitRef="U002">772000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_c3f5998dca1f4449a63a37f0b621834e"
      unitRef="U002">0</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_a9cbbd3606314678adf463b4ed119cbd"
      unitRef="U002">5990000</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_4d4895a83d2a484bb975e46c5a9d5516"
      unitRef="U002">0</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_845d862a50614f16816355c3df31707e"
      unitRef="U002">0</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:NoncashMergerRelatedCosts
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_ea2dfa78201241efa117efa36c4e983e"
      unitRef="U002">5765000</us-gaap:NoncashMergerRelatedCosts>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_fd03224a48344f47b38694ef12fd9665"
      unitRef="U002">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_c92af19678294878b3796383c06fbc0d"
      unitRef="U002">-9648000</us-gaap:GainLossOnDispositionOfAssets1>
    <btx:GainLossOnDisposalOfFixedAssets
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_66db2d7e57854ec887f6e58344ea87ec"
      unitRef="U002">274000</btx:GainLossOnDisposalOfFixedAssets>
    <btx:GainLossOnDisposalOfFixedAssets
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_457e8979737d4828a06529ce29be430c"
      unitRef="U002">0</btx:GainLossOnDisposalOfFixedAssets>
    <btx:GainOnTerminationOfLease
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_d5112a306f0e42298775a537de0108f0"
      unitRef="U002">85000</btx:GainOnTerminationOfLease>
    <btx:GainOnTerminationOfLease
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_2aa8db5a59a44247bb110873cb5dfef2"
      unitRef="U002">0</btx:GainOnTerminationOfLease>
    <btx:WarrantLiabilitiesExpense
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_3b7eea33734148619b2f90453f98759e"
      unitRef="U002">-9470000</btx:WarrantLiabilitiesExpense>
    <btx:WarrantLiabilitiesExpense
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_c0a2ab30569d4c15b138ec2457bdbe58"
      unitRef="U002">0</btx:WarrantLiabilitiesExpense>
    <btx:LossOnNonControllingInvestment
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_4b1f3da2cc1944009396c13fa39c4ba3"
      unitRef="U002">911000</btx:LossOnNonControllingInvestment>
    <btx:LossOnNonControllingInvestment
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_68a861101a8c4077a800bd61258f50fa"
      unitRef="U002">0</btx:LossOnNonControllingInvestment>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_321c1973cc5047a891af6441bdf24fb0"
      unitRef="U002">5000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_c6ef839db990450f8b728fa2ddfbf06e"
      unitRef="U002">-5000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_520f5afb31b34c90ae1ef28e60bb64af"
      unitRef="U002">727000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_e64fdf9e0a804db3a0b4c84741503972"
      unitRef="U002">1508000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_bf8dd294cc0b412bb83aa8debd6020d3"
      unitRef="U002">-11000</btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets>
    <btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_cf7683086b6848e5a5e5b5a2bf36f095"
      unitRef="U002">27000</btx:IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_3d86258584294221bc4a8f1779bf05d1"
      unitRef="U002">2295000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_1017090743054a8b989bdcf7f1f92067"
      unitRef="U002">1862000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <btx:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_ab893a212ace4afd9248c9af7adde3b7"
      unitRef="U002">-153000</btx:IncreaseDecreaseInOperatingLeaseLiabilities>
    <btx:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_ec6073fc08e24ab08f7ec95a1eaa1167"
      unitRef="U002">-139000</btx:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_6388b59ba02b4c47b13572a9b8368eec"
      unitRef="U002">1183000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_6464b7360e484717bcde3755511ad950"
      unitRef="U002">982000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_6afe89da9d5e4371852a35cd6bcf978a"
      unitRef="U002">-9425000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_0d27849903f54936966c012f234980eb"
      unitRef="U002">-10234000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_907da751a9484053bd82995235768cfe"
      unitRef="U002">233000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_345be2badee34621acc0609312969b97"
      unitRef="U002">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_4e447ab2f13b4cb1b5a9e8876cd4c63c"
      unitRef="U002">100000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_80ce915fc2a0443bb431089b2edcb2e2"
      unitRef="U002">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSalesOfAssetsInvestingActivities
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_8738013835e34e668a0b8d2e26358450"
      unitRef="U002">0</us-gaap:ProceedsFromSalesOfAssetsInvestingActivities>
    <us-gaap:ProceedsFromSalesOfAssetsInvestingActivities
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_5c08b6ebac864f6aa134d216b4f43f95"
      unitRef="U002">147000</us-gaap:ProceedsFromSalesOfAssetsInvestingActivities>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_8481d30f6c17452cbc0f049374130a54"
      unitRef="U002">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_4d634b1023414ddbb6c7b5e13d186617"
      unitRef="U002">119000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_86c765326cbf4488a9d5ef8f728cac04"
      unitRef="U002">-133000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_dd20e0dd75b346f6a76968736b843588"
      unitRef="U002">266000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_8f7ade7b2c2d4d62b6a51617dbace42f"
      unitRef="U002">11993000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_f2fe506cce404ab4bf920a520b6a4b28"
      unitRef="U002">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_f1e98fc89dd24b2092775070c109ff70"
      unitRef="U002">5000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_8d18602ab28a439582665c4340208d05"
      unitRef="U002">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_2c5e2f636e9f480580f5a893f53b46ed"
      unitRef="U002">8000</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_d4181d37f2dd40838e89408f34444526"
      unitRef="U002">0</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <btx:ProceedsFromIssuanceOfCommonStockToLincolnPark
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_6ce04020486c479b8ad2e96bd5a000f3"
      unitRef="U002">0</btx:ProceedsFromIssuanceOfCommonStockToLincolnPark>
    <btx:ProceedsFromIssuanceOfCommonStockToLincolnPark
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_f73da412b2e04317aa4d6e064ebd4e72"
      unitRef="U002">50497000</btx:ProceedsFromIssuanceOfCommonStockToLincolnPark>
    <btx:FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_8e4cc7acdd7e4685808343e0ec186918"
      unitRef="U002">0</btx:FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark>
    <btx:FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_effb9da0837d42a3a1898e6569447588"
      unitRef="U002">1972000</btx:FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_81e0f700f7b24b9da524e4208f788c87"
      unitRef="U002">0</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_9ab7998575c94e0091fea177541ae6c4"
      unitRef="U002">10500000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_2b77964f2c20484facd57a4d73fa6684"
      unitRef="U002">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_5ad45aa45f484cadbf65e6ec4aed9d88"
      unitRef="U002">10000</us-gaap:ProceedsFromStockOptionsExercised>
    <btx:PaymentsOfPaycheckProtectionProgramLoan
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_bb728a9e854a4dfc85c9053211f0c4fe"
      unitRef="U002">0</btx:PaymentsOfPaycheckProtectionProgramLoan>
    <btx:PaymentsOfPaycheckProtectionProgramLoan
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_58b3dad94bc641a8b91d06894aa1f4bb"
      unitRef="U002">532000</btx:PaymentsOfPaycheckProtectionProgramLoan>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_7ee8c29eaf5d4137bd1dade481e9fe87"
      unitRef="U002">11980000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_a3c0168a36be4dc9b4e6aedd42e190c2"
      unitRef="U002">58503000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_a7ca9048f87f4fd2a35d9628a1157dbf"
      unitRef="U002">2422000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_d342d4143f6d43069d907c90637f390c"
      unitRef="U002">48535000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20211231"
      decimals="-3"
      id="Fact_68ddc76da6d24c3ca6d775ad07700aa7"
      unitRef="U002">16985000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20201231"
      decimals="-3"
      id="Fact_21e1369ba44b4e44af787746f2cb5a06"
      unitRef="U002">1630000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20220630"
      decimals="-3"
      id="Fact_4e6af96bfd13497f9ce3100a1be4038f"
      unitRef="U002">19407000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20210630"
      decimals="-3"
      id="Fact_f3250412451646d5979ec858937827e3"
      unitRef="U002">50165000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_bc7be38cf8dc49669a94ff5a0b1da0a8"
      unitRef="U002">14000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_ab19eca704eb470ca2f10673d71b420b"
      unitRef="U002">0</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_011a88eee4e94cf1b2cd0165df3665a9"
      unitRef="U002">8000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_ed12edf98566485f87fecac4405cebab"
      unitRef="U002">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:StockIssued1
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_b605189355444d24a4142fd3e8fad3c5"
      unitRef="U002">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_eefa35ba47fd41208551e33ee8ef2db6"
      unitRef="U002">8177000</us-gaap:StockIssued1>
    <btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_f4c255ac08514813bafeb28c359e9af5"
      unitRef="U002">0</btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger>
    <btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_6125f9343898419088c1928f1d5288aa"
      unitRef="U002">1000</btx:NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger>
    <btx:InitialMeasurementOfRightOfUseAssetsAndLiabilities
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_7d564310af0e485d8b60800f6518fbd1"
      unitRef="U002">1706000</btx:InitialMeasurementOfRightOfUseAssetsAndLiabilities>
    <btx:InitialMeasurementOfRightOfUseAssetsAndLiabilities
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_5add340712bc4e5bbaf034afc3e70e55"
      unitRef="U002">874000</btx:InitialMeasurementOfRightOfUseAssetsAndLiabilities>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="c20220101to20220630"
      id="Text_c159c89179e84bc69ae87d8760bbfc7e">
&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
         &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
                &lt;div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 700; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;"&gt;Description of Business&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Brooklyn ImmunoTherapeutics Inc., a Delaware corporation (&#x201c;Brooklyn&#x201d; or the &#x201c;Company&#x201d;), together with its subsidiaries including Brooklyn
              ImmunoTherapeutics LLC (&#x201c;Brooklyn LLC&#x201d;), Novellus, Inc. (&#x201c;Novellus&#x201d;) and Novellus Therapeutics, Ltd. (&#x201c;Novellus, Ltd.&#x201d;), is a biopharmaceutical company utilizing its mRNA technology platform, including mRNA-based cell reprogramming and gene
              editing technologies, to create next generation mRNA, gene editing and cell therapies, including iPSC therapies for multiple therapeutic indications. As used herein, the &#x201c;Company&#x201d; refers collectively to Brooklyn and its subsidiaries.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman';"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman';"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On August 12, 2020, Brooklyn (then known as &#x201c;NTN Buzztime, Inc.&#x201d;), Brooklyn LLC and BIT Merger Sub, Inc., a wholly owned subsidiary of
              Brooklyn (the &#x201c;Merger Sub&#x201d;), entered into an agreement and plan of merger and reorganization (the &#x201c;Merger Agreement&#x201d;) pursuant to which, among other matters, Merger Sub merged with and into Brooklyn LLC, with Brooklyn LLC continuing as a
              wholly owned subsidiary of Brooklyn and as the surviving company of the merger (the &#x201c;Merger&#x201d;). The Merger closed on March 25, 2021. After the Merger, Brooklyn changed its name from &#x201c;NTN Buzztime, Inc.&#x201d; to &#x201c;Brooklyn ImmunoTherapeutics, Inc.&#x201d;
              The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 26, 2021, Brooklyn sold (the &#x201c;Disposition&#x201d;) its rights, title and interest in and to the assets relating to the business operated
              under the name &#x201c;NTN Buzztime, Inc.&#x201d; prior to the Merger to eGames.com Holdings LLC (&#x201c;eGames.com&#x201d;) in accordance with the terms of an asset purchase agreement dated September 18, 2020, as amended, between Brooklyn and eGames.com (the &#x201c;Asset
              Purchase Agreement&#x201d;). &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On July 16, 2021, Brooklyn and its newly formed, wholly owned subsidiary Brooklyn Acquisition Sub, Inc. entered into an
          agreement and plan of acquisition (the &#x201c;Acquisition Agreement&#x201d;) with (a) Novellus LLC, (b) Novellus (the sole equity holder of Novellus, Ltd. and, prior to the closing under the Acquisition Agreement, a subsidiary of Novellus, LLC), and (c) a
          seller representative (the &#x201c;Acquisition&#x201d;), pursuant to which Brooklyn acquired Novellus and its subsidiary, Novellus, Ltd. As part of the Acquisition, Brooklyn also acquired 25.0% of the total outstanding equity interests of NoveCite, Inc. (&#x201c;NoveCite&#x201d;), a corporation focused on developing an allogeneic mesenchymal stem cell product for patients with acute
          respiratory distress syndrome, including from COVID-19. &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;"&gt;Basis of Presentation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The














          accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial statements and with the instructions to
          Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the unaudited financial statements include all the
          normal recurring adjustments that are necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;These
































          condensed consolidated financial statements should be read together with the audited consolidated financial statements and notes thereto contained in Brooklyn&#x2019;s Annual Report on Form 10-K/A for the year ended December 31, 2021 filed with the
          Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on June 30, 2022 (the &#x201c;10-K/A&#x201d;). The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements contained in the 10-K/A but does
          not include all of the information and footnotes required by GAAP for complete financial statements. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be anticipated for
          the entire year ending December 31, 2022, or any other period.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;
         &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;span style="font-style: italic;"&gt;Reclassifications&lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Certain reclassifications have been made
          to Brooklyn&#x2019;s prior years&#x2019; financial statements to conform to the current year presentation. These reclassifications had no effect on Brooklyn&#x2019;s previously reported results of operations or accumulated deficit.&lt;/div&gt;
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="3"
      id="Fact_f567853a4cee441eaed79f3734f9a8cd"
      unitRef="U004">0.250</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="c20220101to20220630"
      id="Text_981de089ea644818a2ff1997672bf5df">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;"&gt;Basis of Presentation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The














          accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial statements and with the instructions to
          Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the unaudited financial statements include all the
          normal recurring adjustments that are necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;These
































          condensed consolidated financial statements should be read together with the audited consolidated financial statements and notes thereto contained in Brooklyn&#x2019;s Annual Report on Form 10-K/A for the year ended December 31, 2021 filed with the
          Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on June 30, 2022 (the &#x201c;10-K/A&#x201d;). The accompanying condensed consolidated balance sheet as of December 31, 2021 has been derived from the audited financial statements contained in the 10-K/A but does
          not include all of the information and footnotes required by GAAP for complete financial statements. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be anticipated for
          the entire year ending December 31, 2022, or any other period.&lt;/div&gt;
</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="c20220101to20220630"
      id="Text_71c8f622b17c4c8e9d9a5535cd70cf24">
&lt;div&gt;
         &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;span style="font-style: italic;"&gt;Reclassifications&lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); text-indent: 36pt; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Certain reclassifications have been made
          to Brooklyn&#x2019;s prior years&#x2019; financial statements to conform to the current year presentation. These reclassifications had no effect on Brooklyn&#x2019;s previously reported results of operations or accumulated deficit.&lt;/div&gt;
</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <btx:LiquidityAndCapitalResourcesTextBlock
      contextRef="c20220101to20220630"
      id="Text_b6fb6892a9904282bc9f5185ebebb1c1">
&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
                &lt;div style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;LIQUIDITY AND CAPITAL RESOURCES&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company has incurred significant operating losses and has an accumulated deficit as a result of ongoing efforts to develop product candidates, including conducting clinical trials and providing general and
              administrative support for operations. As of June 30, 2022, the Company had a cash balance of approximately $19.4 million and an
              accumulated deficit of approximately $153.5 million. For the three and six months ended June 30, 2022, the Company incurred a net
              loss of $3.4 million and $12.8
              million, respectively, and the Company used cash in operating activities of $9.4&lt;/span&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; million.&lt;/span&gt;&lt;br/&gt;
            &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160; &lt;br/&gt;
              &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;In connection with preparing the accompanying condensed consolidated financial statements as of and for the three months ended June 30, 2022, the Company&#x2019;s management concluded that there is substantial doubt regarding the Company&#x2019;s
              ability to continue as a going concern because it does not expect to have sufficient cash or working capital resources to fund operations for the twelve-month period subsequent to the issuance date of these financial statements. The Company
              will need to raise additional capital, which could be through the remaining availability under an equity line purchase agreement with Lincoln Park Capital Fund, LLC (the &#x201c;Second Purchase Agreement&#x201d;) (to the extent the Company is permitted to
              use such agreement) (see Note 11), public or private equity offerings, debt financings, corporate collaborations or other means. The Company may also seek governmental grants to support its clinical trials and preclinical trials. The Company
              currently has no arrangements for such capital and no assurances can be given that it will be able to raise such capital when needed, on acceptable terms, or at all.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The accompanying condensed
                consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying condensed consolidated
                financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to the
                Company&#x2019;s ability to continue as a going concern&lt;/span&gt;.&lt;/div&gt;
</btx:LiquidityAndCapitalResourcesTextBlock>
    <us-gaap:Cash
      contextRef="c20220630"
      decimals="-5"
      id="Fact_621be4f751bf43a1b1d6bc5295adf4a9"
      unitRef="U002">19400000</us-gaap:Cash>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20220630"
      decimals="-5"
      id="Fact_086fa4a396e9443eae26a1ca9138a1ad"
      unitRef="U002">-153500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetIncomeLoss
      contextRef="c20220401to20220630"
      decimals="-5"
      id="Fact_22c0e4497b264a628decf3dbb3591584"
      unitRef="U002">-3400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220630"
      decimals="-5"
      id="Fact_4fa14d548fa6445ca77ea79f48506a31"
      unitRef="U002">-12800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20220101to20220630"
      decimals="-5"
      id="Fact_a808fc8258594a6383b7797381499e42"
      unitRef="U002">-9400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="c20220101to20220630"
      id="Text_fbcb17304ce04aa5b619ffb95c920909">
&lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="vertical-align: top; width: 36pt;"&gt;
                    &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;3)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                    &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
          &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 27pt; margin-left: 9pt; font-variant: normal; text-transform: none;"&gt;Merger&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On August 12, 2020, Brooklyn, Brooklyn LLC and the Merger Sub
          entered into the Merger Agreement, and the Merger closed on March 25, 2021. The Merger was accounted for as a reverse acquisition, in which Brooklyn LLC was deemed the acquiring company for accounting purposes. Brooklyn LLC, as the accounting
          acquirer, recorded the assets acquired and liabilities assumed of Brooklyn in the Merger at their fair values as of the acquisition date.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Brooklyn LLC was determined to be the accounting acquirer
          based upon the terms of the Merger and other factors including that (i) Brooklyn LLC members, received common stock in the Merger that represented 96.35%
          of Brooklyn&#x2019;s outstanding common stock on a fully diluted basis, (ii) all of the directors of Brooklyn immediately after the Merger were designated by Brooklyn LLC under the terms of the Merger Agreement and (iii) existing members of Brooklyn
          LLC&#x2019;s management became the management of Brooklyn immediately after the Merger.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;At the closing of the Merger, all the outstanding membership
          interests of Brooklyn LLC converted into the right to receive an aggregate of approximately 39,992,000 shares of common stock, of
          which 1,068,000 shares were issued as compensation to Maxim Group LLC, Brooklyn LLC&#x2019;s financial advisor (the &#x201c;Financial Advisor&#x201d;) for
          its services to Brooklyn LLC in connection with the Merger.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The purchase price of $8.2 million, which represents the consideration transferred in the Merger to stockholders of Brooklyn immediately before the Merger, was calculated
          based on the closing price of $5.40 per share for approximately 1,514,000 shares common stock that those stockholders owned on March 25, 2021 immediately prior to the Merger because that represented a more reliable measure of the fair value of
          consideration transferred in the Merger.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Under the acquisition method of accounting, the total
          purchase price has been allocated to the acquired tangible and intangible assets and assumed liabilities of Brooklyn based on their estimated fair values as of March 25, 2021, the Merger closing date. Because the consideration paid by Brooklyn
          LLC in the Merger is more than the estimated fair values of Brooklyn&#x2019;s net assets deemed to be acquired, goodwill is equal to the difference of approximately $8.6 million, which has been calculated using the fair values of the net assets of Brooklyn as of March 25, 2021.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The allocation of the purchase price to the tangible and
          intangible assets acquired and liabilities deemed to be assumed from Brooklyn, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Historical&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Balance&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Sheet of&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Brooklyn at&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;March 25, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Fair Value&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Adjustment&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;to Brooklyn&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Pre-Merger&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;
                  &lt;div&gt;&lt;span style="font-weight: bold;"&gt;Purchase&lt;/span&gt;&lt;/div&gt;
                &lt;/div&gt;
                &lt;div&gt;&lt;span style="font-weight: bold;"&gt;Price&lt;/span&gt;&lt;/div&gt;
                &lt;div&gt;&lt;span style="font-weight: bold;"&gt;Allocation&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash and cash equivalents&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;148&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;148&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts receivable&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Prepaid expense and other current assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;329&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;329&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Property and equipment, net&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;1,015&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;1,015&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Software development costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;1,296&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(368&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;928&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Customers&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Trade name&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts payable, accrued liabilities and other current&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(3,781&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(3,781&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(890&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;479&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(411&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Total consideration&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;8,178&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(411&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;8,589&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Brooklyn LLC was obligated under the Merger Agreement to have
          $10.0 million in cash and cash equivalents on its balance sheet at the effective time of the Merger. To ensure Brooklyn LLC had the
          required funds, certain beneficial holders of Brooklyn LLC&#x2019;s Class A membership interests entered into contractual commitments to invest $10.0
          million into Brooklyn LLC immediately prior to the closing of the Merger. During March 2021, Brooklyn offered its Class A unit holders an additional 5%
          rights offering for an additional $0.5 million to be raised by a rights offering. Brooklyn received funds from the rights offering
          between February 17, 2021 and April 5, 2021.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Disposition&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On March 26, 2021, Brooklyn sold its rights, title and
          interest in and to the assets relating to the business it operated (under the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of the
          Disposition are as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Proceeds from sale:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;Cash&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;132&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Escrow&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;50&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Assume advance/loans&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;1,700&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Interest on advance/loans&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;68&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Carrying value of assets sold:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash and cash equivalents&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(14&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts receivable&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(75&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Prepaids and other current assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(124&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Property and equipment, net&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(1,014&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Software development costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(927&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Customers&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Trade name&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(8,589&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Other assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Liabilities transferred upon sale:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts payable and accrued expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;113&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Obligations under finance leases&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;17&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Lease liability&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;26&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Deferred revenue&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;55&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Other current liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;149&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Transaction costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(265&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Total loss on sale of assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;(9,648&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; text-indent: 36pt; font-variant: normal; text-transform: none;"&gt;Acquisition&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On July 16, 2021, Brooklyn and Brooklyn Acquisition Sub, Inc.
          entered into the Acquisition Agreement. The Acquisition closed contemporaneously with the execution and delivery of the Acquisition Agreement. At the closing:&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
                  &lt;div style="text-align: left;"&gt;&#x2022;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
                  &lt;div style="text-align: justify;"&gt;Brooklyn acquired all of the outstanding equity interests of Novellus, Inc. as the result of the merger of Brooklyn Acquisition Sub, Inc. with and into Novellus, Inc., following which, Novellus, Inc., as
                    the surviving corporation, became Brooklyn&#x2019;s wholly owned subsidiary and Novellus Ltd. became Brooklyn&#x2019;s indirectly owned subsidiary; and&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
                  &lt;div style="text-align: left;"&gt;&#x2022;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
                  &lt;div style="text-align: justify;"&gt;Brooklyn acquired 25.0% of the total outstanding equity interests of NoveCite.&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;As consideration for the Acquisition, Brooklyn paid $22.9 million in cash and delivered approximately 7,022,000
          shares of common stock, which under the terms of the Acquisition Agreement, were valued at a total of $102.0 million based on an agreed
          upon price of $14.5253 per share. At the date of issuance, the fair value of the shares was approximately $58.6 million.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Acquisition Agreement contained customary
          representations, warranties and certain indemnification provisions. Approximately 741,000 of the shares issued as consideration were
          placed in escrow for a period of up to 12 months in order to secure indemnification obligations to Brooklyn under the Acquisition
          Agreement. The Acquisition Agreement also contains certain non-competition and non-solicitation provisions pursuant to which Novellus LLC agreed not to engage in certain competitive activities for a period of five years following the closing, including customary restrictions relating to employees. No employees of Novellus Ltd. or Novellus, Inc. prior to the
          Acquisition continued their employment, or were otherwise engaged by Brooklyn, following the Acquisition.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In connection with the Acquisition, the co-founders of
          Novellus, Inc. entered into lock-up agreements with respect to approximately 3,378,000 of the shares of common stock received in the
          Acquisition, and Brooklyn&#x2019;s Chairman of the Board of Directors (the &#x201c;Board&#x201d;) and its former Chief Executive Officer and President entered into identical lock-up agreements with respect to their current holdings of Brooklyn stock. Each lock-up
          agreement extends for a period of three years, provided that up to 75% of the shares of common stock subject to the lock-up agreement may be released from the lock-up restrictions earlier if the price of common stock on the Nasdaq exceeds specified
          thresholds. The lock-up agreements include customary exceptions for transfers during the applicable lock-up period. &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The Company expects the Acquisition will advance its
          evolution into a platform company with a pipeline of next generation mRNA cellular and gene editing programs. In addition, the acquisition of Novellus, Ltd. builds on the License Agreement. (See Note 9). The completion of the acquisition of
          Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor Bioscience
          Limited (&#x201c;Factor&#x201d;) under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene editing and cell therapy products, remained unchanged.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Although Brooklyn acquired all of the outstanding equity
          interests of Novellus, Inc., the Company accounted for the Acquisition as an asset acquisition (as the assets acquired did not constitute a business as defined in Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 805,&#160;&lt;span style="font-style: italic;"&gt;Business Combinations&lt;/span&gt;),&#160;and was measured by the amount of cash paid and by the fair value of the shares of common stock issued. As a result, substantially all of the value acquired was attributed to in-process research and
          development (IPR&amp;amp;D), with the exception of the cash paid for the investment in NoveCite, which is being accounted for as an investment in equity securities, as discussed further below.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Brooklyn paid $22.9 million in cash, net of cash acquired, as part of the consideration for the Acquisition, of which $1.0 million was paid in cash for the investment in NoveCite. Brooklyn also issued approximately 7,022,000 shares of the Company&#x2019;s common stock, of which approximately 3,644,000 shares are unrestricted and 3,378,000
          shares are subject to the three-year lockup. The unrestricted shares were valued at $10.05 per share, which was the closing price of Brooklyn&#x2019;s common stock on July 16, 2021. The fair value of the restricted shares was discounted by approximately 35% to $6.53 per restricted share,
          which was derived from the average discount rate between the Black Scholes and Finnerty valuation models. &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal;"&gt;The resulting fair value of the asset acquired is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; text-indent: -9pt; font-weight: bold;"&gt;Fair Value of&lt;/div&gt;
                &lt;div style="text-align: center; text-indent: -9pt; font-weight: bold;"&gt;Consideration&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash paid&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;22,882&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(28&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Unrestricted shares&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;36,628&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Restricted shares&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div&gt;22,056&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Total fair value of consideration paid&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;81,538&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Less amount of cash paid for NoveCite investment&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(1,000&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Fair value of IPR&amp;amp;D acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;80,538&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;IPR&amp;amp;D that is acquired through an asset purchase that has
          no alternative future uses and no separate economic values from its original intended purpose is expensed in the period the cost is incurred. Accordingly, the Company expensed the fair value of the IPR&amp;amp;D during the third quarter of 2021 in
          the amount of $80.5 million.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-decoration: underline;"&gt;Investment in NoveCite&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;As a result of the Acquisition,&#160; Brooklyn acquired and
          currently owns 25% of NoveCite and Citius Pharmaceuticals, Inc. (&#x201c;Citius&#x201d;) owns the remaining 75%. A member of the Company&#x2019;s management holds one of three
          board seats on NoveCite&#x2019;s board of directors. Citius&#x2019; s officers and directors hold the other two board seats. The Company is accounting for its interest in NoveCite under ASC Topic 323,&#160;&lt;span style="font-style: italic;"&gt;Investments&#160;&#x2013;&#160;Equity
            Method and Joint&#160;Ventures&lt;/span&gt;.&#160;The investment was recorded at cost, which was $1.0 million&#160;and is adjusted for the Company&#x2019;s share
          of&#160;NoveCite&#x2019;s earnings or losses, which are reflected in the accompanying condensed consolidated statement of operations. The investment may also reflect an equity loss in the event that circumstances indicate an other-than-temporary impairment.
          For the three and six months ended June 30, 2022, the Company recorded $0.3 million and $0.9 million, respectively, in losses from its investment in NoveCite, and of the $0.9
          million loss for the six months ended June 30, 2022, $0.5 million related to NoveCite&#x2019;s year ended December 31, 2021.&lt;/div&gt;
</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="4"
      id="Fact_473e5e62563b4a449402541d32e94007"
      unitRef="U004">0.9635</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="0"
      id="Fact_c078d6e413f444228084595d269b2b40"
      unitRef="U001">39992000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c20210325to20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="0"
      id="Fact_9f994df8ddb2422db68561292acae0d6"
      unitRef="U001">1068000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_9bac632d28684df99b4d7ccd3b861e5c"
      unitRef="U002">8200000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="2"
      id="Fact_b8cb777b335843f195a3706d195f8328"
      unitRef="U003">5.40</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="0"
      id="Fact_c03dc294afee4c7fbbfba83f045f302c"
      unitRef="U001">1514000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:Goodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_60d0c60bf5c04beebfbac6cc24d229e7"
      unitRef="U002">8600000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_c4998b5fcb854dbda6d5d8398d1e26e9">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The allocation of the purchase price to the tangible and
          intangible assets acquired and liabilities deemed to be assumed from Brooklyn, based on their estimated fair values as of March 25, 2021, is as follows (in thousands):&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Historical&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Balance&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Sheet of&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Brooklyn at&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;March 25, 2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Fair Value&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Adjustment&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;to Brooklyn&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Pre-Merger&lt;/div&gt;
                &lt;div style="text-align: center; font-weight: bold;"&gt;Assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;
                  &lt;div&gt;&lt;span style="font-weight: bold;"&gt;Purchase&lt;/span&gt;&lt;/div&gt;
                &lt;/div&gt;
                &lt;div&gt;&lt;span style="font-weight: bold;"&gt;Price&lt;/span&gt;&lt;/div&gt;
                &lt;div&gt;&lt;span style="font-weight: bold;"&gt;Allocation&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash and cash equivalents&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;148&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;148&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts receivable&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Prepaid expense and other current assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;329&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;329&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Property and equipment, net&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;1,015&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;1,015&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Software development costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;1,296&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(368&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;928&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Customers&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Trade name&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts payable, accrued liabilities and other current&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(3,781&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;(3,781&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(890&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;479&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(411&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Total consideration&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;8,178&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Net assets acquired, excluding goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(411&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;8,589&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_9cd5872f359548e2b420f2788bb923a0"
      unitRef="U002">148000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_46476bc58f464358b9d0b054c78e6ca7"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_cc8f1d409e2c40a4bde0302c7ea26bcb"
      unitRef="U002">148000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_707b862ef5b545a88b26d6594b92cb3d"
      unitRef="U002">103000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_d701ae65f2a04284aa46d1c67170aeac"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_1e4e5dfc37fc43768cc254a2a1d51fcf"
      unitRef="U002">103000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_273c0949aa7a49e08e24dcd4b8e821f4"
      unitRef="U002">329000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_b3ff1cb97a95486c9e02055f438fdc2a"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_9a58be55268240e18cf960871579f792"
      unitRef="U002">329000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_7b6a52dd71fc4d33bba85560c4260a82"
      unitRef="U002">1015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_d25c389ae84144f3a25ce222a1209b0e"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_7a7ef84cfd584bcb923e7b0ba4ceae93"
      unitRef="U002">1015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_9d199f0a33544fbd93e068c2624e0f82"
      unitRef="U002">1296000</btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts>
    <btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_dcf0044d9ad54f8a9fffd01e89e4727b"
      unitRef="U002">-368000</btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts>
    <btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_6a6e93053cab4ceca240bf184463d12c"
      unitRef="U002">928000</btx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember"
      decimals="-3"
      id="Fact_4307e51d59214de78a60893d6822a5a7"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_e672d0652a1949d397747dd78dc0ff62"
      unitRef="U002">548000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_1365b3ef20c749e58c1899380e07a56b"
      unitRef="U002">548000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember"
      decimals="-3"
      id="Fact_412e9bc8e670401d956b00aff1b38b62"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_f1549ecca9a5453cacf73ac1d7bb92b0"
      unitRef="U002">299000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_506c3cd91e9f4c708e87b83752254a05"
      unitRef="U002">299000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_98064196059548a1b6eca21c3efdfc50"
      unitRef="U002">3781000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_e65c44db68e041f395db01fc11730355"
      unitRef="U002">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_de533c9dc7a8438fa40e9caa89913f9f"
      unitRef="U002">3781000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_3ceb1fe3e9194f51aadcd89680163c71"
      unitRef="U002">-890000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_ProFormaFairValueAdjustmentToAssetsMember"
      decimals="-3"
      id="Fact_3b3d6310974b4b3c8968b3b66238aca8"
      unitRef="U002">479000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_2a0990040b434a88b974e718d8740617"
      unitRef="U002">-411000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_f3f30ae77cfb4d818676da5b898c91ca"
      unitRef="U002">8178000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember_NonrecurringAdjustmentAxis_PurchasePriceAllocationMember"
      decimals="-3"
      id="Fact_47cd18c8d2844cdd95595343af31bc44"
      unitRef="U002">-411000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-3"
      id="Fact_7e313a7e40dc45c98d991744da8fbd23"
      unitRef="U002">8589000</us-gaap:Goodwill>
    <btx:ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_8c65be17ff8a4c7ea9da364aa259abc7"
      unitRef="U002">10000000.0</btx:ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement>
    <btx:BeneficialHoldersContractualCommitmentsToInvest
      contextRef="c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_781feb6f148e44eb9a71041e1f81396e"
      unitRef="U002">10000000.0</btx:BeneficialHoldersContractualCommitmentsToInvest>
    <btx:PercentageOfAdditionalRightsOffering
      contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="2"
      id="Fact_64ae455798ea4194961d178f613a95e1"
      unitRef="U004">0.05</btx:PercentageOfAdditionalRightsOffering>
    <btx:ProceedsFromSaleOfRights
      contextRef="c20210301to20210331_BusinessAcquisitionAxis_NTNBuzztimeIncMember"
      decimals="-5"
      id="Fact_1574f1243d73418e9d0785568d71672d"
      unitRef="U002">500000</btx:ProceedsFromSaleOfRights>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="c20220101to20220630"
      id="Text_a08043633ac149379ad703bbb3529414">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;On March 26, 2021, Brooklyn sold its rights, title and
          interest in and to the assets relating to the business it operated (under the name NTN Buzztime, Inc.) prior to the Merger to eGames.com in exchange for a purchase price of $2.0 million and assumption of specified liabilities relating to that business. The sale was completed in accordance with the terms of the Asset Purchase Agreement. Details of the
          Disposition are as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Proceeds from sale:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;Cash&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;132&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Escrow&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;50&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Assume advance/loans&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;1,700&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Interest on advance/loans&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;68&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Carrying value of assets sold:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash and cash equivalents&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(14&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts receivable&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(75&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Prepaids and other current assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(124&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Property and equipment, net&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(1,014&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Software development costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(927&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Customers&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(548&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Trade name&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(299&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Goodwill&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(8,589&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Other assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;(103&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Liabilities transferred upon sale:&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Accounts payable and accrued expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;113&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Obligations under finance leases&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;17&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Lease liability&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;26&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Deferred revenue&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;
                &lt;div&gt;55&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Other current liabilities&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;149&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Transaction costs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(265&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-weight: bold;"&gt;Total loss on sale of assets&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;(9,648&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="font-weight: bold;"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-5"
      id="Fact_e5c11d3678774d8f834119ba17ceb45d"
      unitRef="U002">2000000.0</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromCash
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_76c17021385c473e9c6c9ae7fd4ec462"
      unitRef="U002">132000</btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromCash>
    <btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_2fccb37d6ff147299c5dc9514e53b00e"
      unitRef="U002">50000</btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow>
    <btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_ab2d0cde21f24ff595921deade35d3c6"
      unitRef="U002">1700000</btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans>
    <btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_f4c4e1b752ae41ff814510cf45bd4477"
      unitRef="U002">68000</btx:DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_ce5617a2b672423a8d2beff942423e16"
      unitRef="U002">14000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_0dd2545f78904def87dd7d8b194a5a7d"
      unitRef="U002">75000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_3ecd39e4fea140cc933f41e252b99e39"
      unitRef="U002">124000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_86df970d3c8e4316beb9891cadf3064d"
      unitRef="U002">1014000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <btx:DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_fafc3dfe87b242ada7a7d25ad333c226"
      unitRef="U002">927000</btx:DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_CustomerRelationshipsMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_4c9b0f9bb28340bc9c41f0658f16be35"
      unitRef="U002">548000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="c20210326_FiniteLivedIntangibleAssetsByMajorClassAxis_TradeNamesMember_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_ccda067df4864b6c838722ad175ef526"
      unitRef="U002">299000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_1574d315e1a24d33b1797f373595ba1d"
      unitRef="U002">8589000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwill1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_ecdd4316c4434fc39dd40789f57f6cfb"
      unitRef="U002">103000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_52bc316c630442f29925062d24c40acc"
      unitRef="U002">113000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <btx:DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_d7d23107488a4d7f9854ddceb546ff1a"
      unitRef="U002">17000</btx:DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases>
    <btx:DisposalGroupIncludingDiscontinuedOperationLeaseLiability
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_680a8b5844ff44e980590b7678833aa4"
      unitRef="U002">26000</btx:DisposalGroupIncludingDiscontinuedOperationLeaseLiability>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_c0b80053f0a546cea08367845906807d"
      unitRef="U002">55000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
      contextRef="c20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_d8e95392449d4aecb68a68efbece12bc"
      unitRef="U002">149000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <btx:DisposalGroupIncludingDiscontinuedOperationTransactionCosts
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_f09fa2b23a8a407a9b7a3cb94d3bf35c"
      unitRef="U002">-265000</btx:DisposalGroupIncludingDiscontinuedOperationTransactionCosts>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember"
      decimals="-3"
      id="Fact_4d153c5b252d42968661431f6ba52d2b"
      unitRef="U002">-9648000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="3"
      id="Fact_a5b136cbcd174f68a75241d2eed778a2"
      unitRef="U004">0.250</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_24ef348347ca4bf0a2b3906467380cda"
      unitRef="U002">22900000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_f7f3e49b34f94e6dacd71bfcc4fe9cd2"
      unitRef="U001">7022000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_52d8fc0526da4e3aa9c5bf541e3ce97c"
      unitRef="U002">102000000.0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <btx:AssetAcquisitionSharePrice
      contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="4"
      id="Fact_0e5db743fce948fdbfe6d4ae5d8e88d6"
      unitRef="U003">14.5253</btx:AssetAcquisitionSharePrice>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_80137ea0a902423990e42bcac63ca67c"
      unitRef="U002">58600000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <btx:EscrowShares
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_71609d787ba44f1a96605a60f67dbe27"
      unitRef="U001">741000</btx:EscrowShares>
    <btx:EscrowPeriod
      contextRef="c20220101to20220630_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember_RangeAxis_MaximumMember"
      id="Fact_1b01036813c1446688022a4898b389bb">P12M</btx:EscrowPeriod>
    <btx:AcquisitionAgreementNonCompetitivePeriod
      contextRef="c20220101to20220630_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      id="Fact_30c2a22ae4fb4448b5185b899a904cbf">P5Y</btx:AcquisitionAgreementNonCompetitivePeriod>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusIncMember_RelatedPartyTransactionsByRelatedPartyAxis_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember"
      decimals="0"
      id="Fact_7e805f2bddb547c1931d92618404e5e1"
      unitRef="U001">3378000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <btx:EachLockUpAgreementExtendsTerm
      contextRef="c20220101to20220630_AssetAcquisitionAxis_NovellusIncMember"
      id="Fact_691d8e990f064bd8bd12daff876ddc12">P3Y</btx:EachLockUpAgreementExtendsTerm>
    <btx:PercentageOfCommonStockSubjectToLockUpAgreement
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusIncMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_4d1ccd02e0e846d691efe4b10b49939d"
      unitRef="U004">0.75</btx:PercentageOfCommonStockSubjectToLockUpAgreement>
    <btx:PaymentsToAcquireProductiveAssetsNet
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_c7f8153cf5da49548ae0562a54b8de65"
      unitRef="U002">22900000</btx:PaymentsToAcquireProductiveAssetsNet>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_bf42a554f2ce408b9895e7eb9a4fcb2e"
      unitRef="U002">1000000.0</us-gaap:PaymentsToAcquireInvestments>
    <btx:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_918be23fd1c34f4a82edc895c58d3dbd"
      unitRef="U001">3644000</btx:StockIssuedDuringPeriodUnrestrictedSharesAcquisitions>
    <btx:StockIssuedDuringPeriodRestrictedSharesAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="0"
      id="Fact_0a5d9c7ffc2b44aa83d371f6bb030d11"
      unitRef="U001">3378000</btx:StockIssuedDuringPeriodRestrictedSharesAcquisitions>
    <btx:LockUpPeriodForRestrictedShares
      contextRef="c20220101to20220630_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      id="Fact_59d733d860824ddf9b8117fa67de0bba">P3Y</btx:LockUpPeriodForRestrictedShares>
    <btx:AssetAcquisitionUnrestrictedSharesSharePrice
      contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="2"
      id="Fact_5c15b3bb367846d0a35aee6463c8ab32"
      unitRef="U003">10.05</btx:AssetAcquisitionUnrestrictedSharesSharePrice>
    <btx:PercentageOfDiscountOnFairValueOfRestrictedShares
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="2"
      id="Fact_b311a6f2556445e8b6addeadc5a1fb38"
      unitRef="U004">0.35</btx:PercentageOfDiscountOnFairValueOfRestrictedShares>
    <btx:AssetAcquisitionRestrictedSharesSharePrice
      contextRef="c20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="2"
      id="Fact_00c7e5526f004330bb7fad536b1f1dd1"
      unitRef="U003">6.53</btx:AssetAcquisitionRestrictedSharesSharePrice>
    <us-gaap:AssetAcquisitionTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_3ac8744c64734e319bb6f2f33b766498">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal;"&gt;The resulting fair value of the asset acquired is as follows (in thousands):&lt;/span&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;&#160;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; text-indent: -9pt; font-weight: bold;"&gt;Fair Value of&lt;/div&gt;
                &lt;div style="text-align: center; text-indent: -9pt; font-weight: bold;"&gt;Consideration&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash paid&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;22,882&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Cash acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div&gt;(28&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Unrestricted shares&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;36,628&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Restricted shares&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div&gt;22,056&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Total fair value of consideration paid&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;81,538&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Less amount of cash paid for NoveCite investment&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div&gt;(1,000&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left;"&gt;Fair value of IPR&amp;amp;D acquired&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div&gt;80,538&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:AssetAcquisitionTableTextBlock>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_7198331b474647189e0f6ec357ed4a6f"
      unitRef="U002">22882000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_1a454a8e5c44448cb75e4abf70976a3c"
      unitRef="U002">28000</us-gaap:CashAcquiredFromAcquisition>
    <btx:StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_2519d12930fb49ccab2fa9cdd24a1a95"
      unitRef="U002">36628000</btx:StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions>
    <btx:StockIssuedDuringPeriodRestrictedSharesValueAcquisitions
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_60c1dae0529644f7b7429b12658e72d9"
      unitRef="U002">22056000</btx:StockIssuedDuringPeriodRestrictedSharesValueAcquisitions>
    <btx:AssetAcquisitionFairValueOfConsiderationPaid
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_b4c6cd3aa7d04bd9986d718def299eca"
      unitRef="U002">81538000</btx:AssetAcquisitionFairValueOfConsiderationPaid>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_d4073769b28c46dcb32f1e05af75a002"
      unitRef="U002">1000000</us-gaap:PaymentsToAcquireInvestments>
    <btx:ResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="-3"
      id="Fact_1534ad4545b1411c8bbf76ae06213e00"
      unitRef="U002">80538000</btx:ResearchAndDevelopmentInProcessAssetAcquisition>
    <btx:ResearchAndDevelopmentInProcessAssetAcquisition
      contextRef="c20210701to20210930_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember"
      decimals="1"
      id="Fact_2dcc688c6d224beba3a96db4b4fc14b7"
      unitRef="U002">80.5</btx:ResearchAndDevelopmentInProcessAssetAcquisition>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="2"
      id="Fact_b799c943a6244edb8739537efff37bc5"
      unitRef="U004">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c20210716_OwnershipAxis_CitiusPharmaceuticalsIncMember_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="2"
      id="Fact_13fb0dfeb4cb41c7b378ef632d6f6b0d"
      unitRef="U004">0.75</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <btx:NumberOfBoardSeats
      contextRef="c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="INF"
      id="Fact_47a2741b162a468a9455d28c49c0ed71"
      unitRef="U005">3</btx:NumberOfBoardSeats>
    <us-gaap:EquityMethodInvestments
      contextRef="c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_74641c58e631420cad665b6263d769c6"
      unitRef="U002">1000000.0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="c20220401to20220630_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_b415804e18544dbda288e301877d08b1"
      unitRef="U002">300000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="c20220101to20220630_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_796dc73b15e94e20afda85d0e77f7cfb"
      unitRef="U002">900000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="c20220101to20220630_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_e53013eb5c6842809755e36960307b9d"
      unitRef="U002">900000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="c20210101to20211231_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember"
      decimals="-5"
      id="Fact_6478090ecc51477c969b08131f025362"
      unitRef="U002">500000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="c20220101to20220630"
      id="Text_e7c69bb7250f40eca795c907e47ea32c">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold;"&gt;4)&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
                &lt;div style="font-weight: bold;"&gt;FAIR VALUE OF FINANCIAL INSTRUMENTS&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Fair












          value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. A fair value hierarchy has been established for valuation inputs that gives the highest
          priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:&lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="width: 36pt;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: top; width: 18pt;"&gt;
                        &lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                        &lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Level
                          1 Inputs &#x2013; Valued based on quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/div&gt;
                      &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
              &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="width: 36pt;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: top; width: 18pt;"&gt;
                        &lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                        &lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Level
                          2 Inputs &#x2013; Valued based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in
                          active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as interest rates, volatilities,
                          prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market data by correlation or other means.&lt;/div&gt;
                      &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
              &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="width: 36pt;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: top; width: 18pt;"&gt;
                        &lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#x2022;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                        &lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Level
                          3 Inputs &#x2013; Valued based on inputs for which there is little or no market value, which require the reporting entity to develop its own assumptions.&lt;/div&gt;
                      &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
              &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
        &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The following tables summarize the liabilities that are measured at fair value as of June 30, 2022 (in thousands).&#160; There were no liabilities measured at fair value as of Decem&lt;/span&gt;ber 31, 2021:&lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of June 30,
                      2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Description&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 1&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 2&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 3&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Liabilities:&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Warrant liabilities - Pre-Funded Warrants&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;702&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Warrant liabilities - Common Warrants&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,822&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;702&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,822&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
          &lt;/div&gt;

&lt;div style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;  &lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"&gt;On
          March 9, 2022, the Company issued pre-funded warrants exercisable for approximately 1,357,000 shares of common stock (the &#x201c;Pre-Funded
          Warrants&#x201d;) and warrants exercisable for approximately 6,857,000 shares of common stock (the &#x201c;Common Warrants&#x201d;) in connection with the
          PIPE Transaction (as defined below).&#160; See Note 11 for more information related to the PIPE Transaction. &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The Common Warrants and Pre-Funded Warrants were accounted for as liabilities under ASC
              815-40,&#160;Derivatives and Hedging, Contracts in Entity&#x2019;s Own Equity&#160;(&#x201c;ASC 815-40&#x201d;), as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40.&#160; These warrant
              liabilities were measured at fair value at inception and are then subsequently measured on a recurring basis, with changes in fair value presented within the Company&#x2019;s statement of operations.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The Company uses a Black-Scholes option pricing model to estimate the fair value of the Common
              Warrants, which is considered a Level 3 fair value measurement.&#160; Certain inputs used in this Black-Scholes pricing model may fluctuate in future periods based upon factors that are outside of the Company&#x2019;s control.&#160; A significant change in
              one or more of these inputs used in the calculation of the fair value may cause a significant change to the fair value of the Company&#x2019;s warrant liabilities, which could also result in material non-cash gains or losses being reported in the
              Company&#x2019;s consolidated statement of operations.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
              &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The estimated fair value of the Pre-Funded Warrants was deemed a Level 2 measurement as of June 30, 2022, as all significant inputs to the valuation model used to estimate the fair value of the Pre-Funded Warrants
                  were directly observable from the Company&#x2019;s publicly-traded common stock.&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more
            than the $12.0 million proceeds received in the PIPE Transaction.&#160; The excess $0.6 million represents an inducement to the purchaser to enter into the PIPE Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of
            operations.&#160; Given the Company&#x2019;s capital requirements and market conditions, the Company consummated this financing on market terms available at the time of the transaction. &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company remeasured the fair value of the warrant liabilities as of June 30, 2022, and the following table presents the changes in the
            warrant liabilities from the issuance date (in thousands): &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Pre-Funded &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                      &lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Warrants&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                      &lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(Level 2)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Common&lt;/div&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Warrants&lt;br/&gt;
                      &lt;/span&gt;(Level 3)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total Warrant&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                      &lt;/span&gt;Liabilities&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at January 1, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at March 9, 2022 (issuance date)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,646&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,943&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,589&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Change in fair value of warrant liabilities&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,944&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8,121&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10,065&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at June 30, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;702&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,822&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,524&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
            &lt;/div&gt;
</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_4d476c48d31d495f848d9bf273e04d58">
&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;
        &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The following tables summarize the liabilities that are measured at fair value as of June 30, 2022 (in thousands).&#160; There were no liabilities measured at fair value as of Decem&lt;/span&gt;ber 31, 2021:&lt;/div&gt;

&lt;div&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;As of June 30,
                      2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Description&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 1&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 2&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Level 3&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Liabilities:&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Warrant liabilities - Pre-Funded Warrants&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;702&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Warrant liabilities - Common Warrants&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,822&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;702&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,822&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
          &lt;/div&gt;
</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20211231"
      decimals="0"
      id="Fact_501cb0cfd94e42a8963661fd718f52b1"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_609ad91924bb456795b685924b336513"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_2d13b34a57884436a6604125e37c65f1"
      unitRef="U002">702000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_2ac917cdec6f4537a5cc31f7fa2416a6"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_24f22669017f40e8b44c094370d8c1dc"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_adbd83dc423d41678ee952017406046a"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByLiabilityClassAxis_DerivativeFinancialInstrumentsLiabilitiesMember"
      decimals="-3"
      id="Fact_848ffac4d850460fb1cd57e990c03f2e"
      unitRef="U002">1822000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact_76bdb1afa5664cc7926066f0aff0f4b7"
      unitRef="U002">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_80baf7ca33a546b6947400cab5a2bef8"
      unitRef="U002">702000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="c20220630_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_a6f41fe3bb5748e2829acbe49655f138"
      unitRef="U002">1822000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_6e10902d6cb14e89b08f292e04096575"
      unitRef="U001">1357000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20220309_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="0"
      id="Fact_aa04d20afe4f43c4817b4ab29eeb6877"
      unitRef="U001">6857000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20220630"
      decimals="-5"
      id="Fact_aa3003dcdfad459f92f8f86faeea3f70"
      unitRef="U002">12600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <btx:OverSubscriptionAmountReceived
      contextRef="c20220630"
      decimals="-5"
      id="Fact_d1d319dbf1484ec9953fe00a762116b4"
      unitRef="U002">600000</btx:OverSubscriptionAmountReceived>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c20220630"
      decimals="-5"
      id="Fact_3d1fb5cb97fc47b3bef1350c3a9ef2c6"
      unitRef="U002">12000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <btx:OverSubscriptionAmountReceived
      contextRef="c20220630"
      decimals="-5"
      id="Fact_39dfebd2c8ef460385f91d5c0fc4a54b"
      unitRef="U002">600000</btx:OverSubscriptionAmountReceived>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_55fe4c73466947d584f99fad7ef80692">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company remeasured the fair value of the warrant liabilities as of June 30, 2022, and the following table presents the changes in the
            warrant liabilities from the issuance date (in thousands): &lt;/div&gt;

&lt;div&gt;&#160;&lt;/div&gt;

&lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Pre-Funded &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                      &lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Warrants&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                      &lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(Level 2)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Common&lt;/div&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Warrants&lt;br/&gt;
                      &lt;/span&gt;(Level 3)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total Warrant&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;
                      &lt;/span&gt;Liabilities&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at January 1, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at March 9, 2022 (issuance date)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,646&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,943&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,589&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Change in fair value of warrant liabilities&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,944&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8,121&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10,065&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value at June 30, 2022&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;702&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,822&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                    &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,524&lt;/div&gt;
                  &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
            &lt;/div&gt;
</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20211231_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_d3184432696b42a9a3311fe132cec361"
      unitRef="U002">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20211231_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_3bb72ec5f2284be4a934cdfb1cb01cac"
      unitRef="U002">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e6c78bb63fed4235bc5efeec0644a200"
      unitRef="U002">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_2d9de2de7db44df68cdb0db6e61ac5cf"
      unitRef="U002">2646000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_ecc54ca567684fca96395092999f4972"
      unitRef="U002">9943000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_64b48933a0524840b86514d5ca061722"
      unitRef="U002">12589000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_29f2d7a567f4407eb6e189f0004b62fa"
      unitRef="U002">-1944000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_782617855baf44cfb11d5b48989866f4"
      unitRef="U002">-8121000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_09c0954b58ae42ff84c40f4a478beeed"
      unitRef="U002">-10065000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact_496ea452386446ccb643f4fdb25095c1"
      unitRef="U002">702000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact_88f1d3e86e7749cf8848ac3c3d37eab1"
      unitRef="U002">1822000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c20220630"
      decimals="-3"
      id="Fact_e94cad12047846d7ab9d9d3cf56d1906"
      unitRef="U002">2524000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="c20220101to20220630"
      id="Text_20195ec403ad458d849948633e03ae63">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold;"&gt;5)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: bold;"&gt;LEASES&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; The Company has operating leases for office and laboratory space in the borough of
        Manhattan in New York, New York and in Cambridge, Massachusetts, which expire in 2026 and 2028, respectively. On March 31, 2022, the Company entered into the Torrey Pines Science Center Lease in San Diego, California (the &#x201c;San Diego Lease&#x201d;) with&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt; Torrey Pines Science Center Limited Partnership for approximately 5,200
          square feet of lab and office space. The term of the San Diego Lease is 62 months and the lease commencement date was April 19, 2022.
          The San Diego Lease will expire in June&lt;/span&gt; 2027.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Base rent for the San Diego Lease is $6.35
          per square foot in the first year of the San Diego Lease, with a rent abatement for the second and third full months of the first year. The base rent will increase by approximately 3% on each anniversary of the lease commencement date. The Company is also required to pay its share of operating expenses and property taxes. The San Diego Lease provides for a one-time
          option to extend the lease term for an additional five years at the then fair rental value. &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;The Company recorded a $1.7 million right-of-use (&#x201c;ROU&#x201d;) asset and $1.7 million lease liabilities
            for the San Diego Lease.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;During the second quarter of 2022, the Company made the decision to consolidate its research and
            development efforts in Cambridge, Massachusetts, and the Company intends to sublease the San Diego lab and office space.&#160; As a result, the Company recognized an impairment charge of approximately $0.8 million on the San Diego Lease ROU asset.&lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On March 5, 2022, the Company entered into an Agreement to Assign Space Lease with Regen Lab USA LLC (&#x201c;Regen&#x201d;) pursuant to which the Company
          agreed to assign its Brooklyn, New York lease (the &#x201c;Brooklyn Lease&#x201d;) to Regen. The effective date of the assignment was contingent upon, among other things, a consent from BioBat, Inc. (the &#x201c;Landlord&#x201d;) to assign the Brooklyn Lease.&#160; Additionally,
          Regen agreed to purchase certain equipment from the Company for $50,000, partly reimburse the Company $50,000 toward certain existing unamortized leasehold improvements, and to reimburse the Company for the existing security deposit the Company had
          under the Brooklyn Lease of approximately $63,000.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 27pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On March 25, 2022, the Company entered into an Assignment and Assumption of Lease Agreement (the
              &#x201c;Assignment Agreement&#x201d;) with Regen, the consent of which was provided by the Landlord in the Assignment Agreement. The effective date of the assignment was March 28, 2022.&#160; Under the Assignment Agreement, Regen (i) accepts the assignment of
              the Brooklyn Lease; (ii) assumes all of the obligations, liabilities, covenants and conditions of the Company&#x2019;s as tenant under the Brooklyn Lease; (iii) assumes and agrees to perform and observe all of the obligations, terms, requirements,
              covenants and conditions to be performed or observed by the Company under the Brooklyn Lease; and (iv) makes all of the representations and warranties binding under the Brooklyn Lease with the same force and effect as if Regens had executed
              the Brooklyn Lease originally as the tenant.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;Notwithstanding the above assumptions by Regen, the Company shall be and remain liable and
              responsible for the due keeping, and full performance and observance, of all the provisions of the Brooklyn Lease on the part of the tenant to be kept, performed and observed.&#160; As a result of the Assignment Agreement, the Company wrote off
              the remaining ROU asset balance and the corresponding lease liability.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 27pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;The Company accounts for leases under ASC 842,&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; font-style: normal;"&gt;&#160;Leases&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;. Operating leases are included in
          &#x201c;Right-of use assets - operating leases&#x201d; within the Company&#x2019;s balance sheets and represent the Company&#x2019;s right to use an underlying asset for the lease term. The Company&#x2019;s related obligation to make lease payments are included in &#x201c;Operating lease
          liabilities, non-current&#x201d; and &#x201c;Operating lease liabilities, current&#x201d; within the Company&#x2019;s balance sheets. ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Because the
          rate implicit in the lease is not readily determinable, the Company uses its incremental borrowing rates based on the information available at the lease commencement date in determining the present value of lease payments. Lease expense for lease
          payments is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet and are recognized as lease expense on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;Some leasing arrangements require variable payments that are dependent on usage or may vary for other reasons, such as
        payments for insurance, tax payments and other miscellaneous costs. The variable portion of lease payments is not included in the ROU assets or lease liabilities. Rather, variable payments, other than those dependent upon an index or rate, are
        expensed when the obligation for those payments is incurred and are included in lease expenses. Accordingly, all expenses associated with a lease contract are accounted for as lease expenses.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;During the three and six months ended June 30, 2022 and 2021, the net operating lease expenses were as follows (in thousands):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;Three months ended June 30,&lt;/span&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;2021&lt;/span&gt; &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Operating lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;146&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;164&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Sublease income&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(21&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(21&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Variable lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;51&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;176&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;144&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom"&gt;2022&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;2021&lt;br/&gt;
                &lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Operating lease expense&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;333&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;315&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Sublease income&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(42&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(42&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Variable lease expense&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;53&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;10&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total lease expense&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;344&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;283&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt;The tables below show the beginning
          balances of the operating ROU assets and lease liabilities as of January 1, 2022 and the ending balances as of June 30, 2022, including the changes during the period (in thousands).&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 36pt; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating Lease&lt;/div&gt;
              &lt;span style="font-weight: bold;"&gt; &lt;/span&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;ROU Assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating lease ROU assets at
                January 1, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2,567&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Initial measurement of operating lease ROU assets&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1,706&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Amortization of operating lease
                ROU assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(186&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Impairment of ROU assets&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(772&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Write off of ROU asset due to lease termination&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(1,372&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating lease ROU assets at
                June 30, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,943&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="letter-spacing: normal; white-space: normal; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-weight: 400; text-align: left; text-indent: 0px; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating Lease&lt;/div&gt;
              &lt;span style="font-weight: bold;"&gt; &lt;/span&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating lease liabilities at
                January 1, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2,723&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Initial measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1,706&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Principal payments on operating
                lease liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(153&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Write off of operating lease liability due to lease termination&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(1,453&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating lease liabilities at
                June 30, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2,823&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Less non-current portion&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2,433&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Current portion at June 30, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;390&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 36pt;"&gt;As of June 30, 2022, the Company&#x2019;s operating leases had a weighted-average remaining
        life of 5.2 years with a weighted-average discount rate of 8.97%.&#160; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-weight: 400; font-variant: normal;"&gt;The maturities of the operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;June 30, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;span style="text-indent: 0pt;"&gt;2022&lt;/span&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;299&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;span style="text-indent: 0pt;"&gt;2023&lt;/span&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;673&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;span style="text-indent: 0pt;"&gt;2024&lt;/span&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;688&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;span style="text-indent: 0pt;"&gt;2025&lt;/span&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;703&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;span style="text-indent: 0pt;"&gt;2026&lt;/span&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;708&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Thereafter&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;470&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;Total payments&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt; &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,541&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;Less imputed interest&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;(718&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;Total operating lease liabilities&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2,823&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeasesTextBlock>
    <btx:OperatingLeaseArea
      contextRef="c20220630"
      decimals="0"
      id="Fact_5bc439b04d0c42f7b5532dde69a21b7b"
      unitRef="U006">5200</btx:OperatingLeaseArea>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="c20220630"
      id="Fact_921af385ba544713bcf0dafba021b788">P62M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <btx:BaseRentPerSquareFoot
      contextRef="c20220101to20220630"
      decimals="2"
      id="Fact_e874ba262af84d179a9c4577b276aa69"
      unitRef="U006">6.35</btx:BaseRentPerSquareFoot>
    <btx:PercentageBaseRentIncreaseOnEachAnniversary
      contextRef="c20220630"
      decimals="2"
      id="Fact_6a02786f56824702a0d20f9279867dd1"
      unitRef="U004">0.03</btx:PercentageBaseRentIncreaseOnEachAnniversary>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="c20220630"
      id="Fact_22a8780a1e234b809bdb5ce1ea54b1ec">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <btx:InitialMeasurementOfOperatingLeaseROUAssets
      contextRef="c20220101to20220630"
      decimals="-5"
      id="Fact_6304ca30afda4ff9881ccc1274408a0f"
      unitRef="U002">1700000</btx:InitialMeasurementOfOperatingLeaseROUAssets>
    <btx:InitialMeasurementOfOperatingLeaseLiabilities
      contextRef="c20220101to20220630"
      decimals="-5"
      id="Fact_33fea9ac140b403a95dc633a6a94b729"
      unitRef="U002">1700000</btx:InitialMeasurementOfOperatingLeaseLiabilities>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20220101to20220630"
      decimals="-5"
      id="Fact_60af938f2ca34ea696d12656dfe89e6c"
      unitRef="U002">800000</us-gaap:OperatingLeaseImpairmentLoss>
    <btx:LesseeCommitmentToPurchaseProperty
      contextRef="c20220305"
      decimals="0"
      id="Fact_5bc52a3de41847039c2e6d034b3a548f"
      unitRef="U002">50000</btx:LesseeCommitmentToPurchaseProperty>
    <btx:UnamortizedLeaseholdImprovements
      contextRef="c20220305"
      decimals="0"
      id="Fact_96f0ef2896344bcc8a5b874530bcc06d"
      unitRef="U002">50000</btx:UnamortizedLeaseholdImprovements>
    <us-gaap:DepositAssets
      contextRef="c20220305"
      decimals="0"
      id="Fact_bbce9293d85c43a1b9063e6b5930c764"
      unitRef="U002">63000</us-gaap:DepositAssets>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_61c9f6b734834163875eb001b9438a4f">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;During the three and six months ended June 30, 2022 and 2021, the net operating lease expenses were as follows (in thousands):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;Three months ended June 30,&lt;/span&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;2021&lt;/span&gt; &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Operating lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;146&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;164&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Sublease income&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(21&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;(21&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Variable lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;51&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total lease expense&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;176&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;144&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;
        &lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; font-weight: bold; white-space: nowrap;" valign="bottom"&gt;2022&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" rowspan="1" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-weight: bold;"&gt;2021&lt;br/&gt;
                &lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Operating lease expense&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;333&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;315&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Sublease income&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(42&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;(42&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Variable lease expense&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;53&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;10&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Total lease expense&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;344&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0);"&gt;283&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
         &lt;/div&gt;
</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_0a46fa5d1df74ee09c182630b3c47a3a"
      unitRef="U002">146000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_63be4e2bf72947afa38d04df9ecdfee8"
      unitRef="U002">164000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_3f1a9d67c94e4029ad5062b1a5111bfc"
      unitRef="U002">21000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_78f2864e78124f178fb4528937ceefba"
      unitRef="U002">21000</us-gaap:SubleaseIncome>
    <us-gaap:VariableLeaseCost
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_e3e935bb0ba5428ca347803255ba2270"
      unitRef="U002">51000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_219feced751b49a6adad91a9ac5a4b42"
      unitRef="U002">1000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_a729aeb6a19c4dac8fe578f66764409f"
      unitRef="U002">176000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_cf7b8b08d64e4386b3deb8be5f4b07ad"
      unitRef="U002">144000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_e7f7e8a2a70d46b7a889d4be7046964a"
      unitRef="U002">333000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_a256afee48d4471aa27b9ebc51dc9914"
      unitRef="U002">315000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_2e9aec5b776c495e942058373948137d"
      unitRef="U002">42000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_918695d03caa47389f9ad81687735341"
      unitRef="U002">42000</us-gaap:SubleaseIncome>
    <us-gaap:VariableLeaseCost
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_0ec678514c894531a376940348f645e2"
      unitRef="U002">53000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_24d8090bf7934291b8542e40505f54ec"
      unitRef="U002">10000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_87c061cca6494f1b9b7010f27b41f070"
      unitRef="U002">344000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_b61247b276f044fbac6770146eb8aec4"
      unitRef="U002">283000</us-gaap:LeaseCost>
    <btx:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_0117423f6c5d4e8889085a4954592f89">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 36pt; text-transform: none;"&gt;The tables below show the beginning
          balances of the operating ROU assets and lease liabilities as of January 1, 2022 and the ending balances as of June 30, 2022, including the changes during the period (in thousands).&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 36pt; text-transform: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;br/&gt;
          &lt;/span&gt;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating Lease&lt;/div&gt;
              &lt;span style="font-weight: bold;"&gt; &lt;/span&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;ROU Assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating lease ROU assets at
                January 1, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2,567&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Initial measurement of operating lease ROU assets&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1,706&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Amortization of operating lease
                ROU assets&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(186&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Impairment of ROU assets&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;(772&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Write off of ROU asset due to lease termination&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(1,372&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating lease ROU assets at
                June 30, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,943&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="letter-spacing: normal; white-space: normal; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-weight: 400; text-align: left; text-indent: 0px; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; text-transform: none; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating Lease&lt;/div&gt;
              &lt;span style="font-weight: bold;"&gt; &lt;/span&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating lease liabilities at
                January 1, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2,723&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; width: 88%; white-space: nowrap;" valign="bottom"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Initial measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;1,706&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Principal payments on operating
                lease liabilities&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(153&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: -9.6px; white-space: nowrap; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Write off of operating lease liability due to lease termination&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(1,453&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;)&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Operating lease liabilities at
                June 30, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2,823&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Less non-current portion&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2,433&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Current portion at June 30, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;390&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</btx:OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_af33c76e923e44a6a079cbcabc999bc6"
      unitRef="U002">2567000</us-gaap:OperatingLeaseRightOfUseAsset>
    <btx:InitialMeasurementOfOperatingLeaseROUAssets
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_39eacce730fb4c1da2352b814a4609a5"
      unitRef="U002">1706000</btx:InitialMeasurementOfOperatingLeaseROUAssets>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_003991c6f0ff4d919391035a8bf9cd78"
      unitRef="U002">186000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_56358d44a03e4690bc13ff1e3868c218"
      unitRef="U002">772000</us-gaap:OperatingLeaseImpairmentLoss>
    <btx:WriteOffOfOperatingLeaseRightOfUseAsset
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_c646e04a668d4fad83d81c4ebaa81a4c"
      unitRef="U002">1372000</btx:WriteOffOfOperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20220630"
      decimals="-3"
      id="Fact_e56329d893094854adfce357e4efd7f6"
      unitRef="U002">1943000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a12c1036abb0463bb9061375663172d6"
      unitRef="U002">2723000</us-gaap:OperatingLeaseLiability>
    <btx:InitialMeasurementOfOperatingLeaseLiabilities
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_cf2cb8d48d6e4b548838de220e75b117"
      unitRef="U002">1706000</btx:InitialMeasurementOfOperatingLeaseLiabilities>
    <btx:PrincipalPaymentsOnOperatingLeaseLiabilities
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_31d367b8e3934f5c81b3857f261bc1d7"
      unitRef="U002">153000</btx:PrincipalPaymentsOnOperatingLeaseLiabilities>
    <btx:WriteOffOfOperatingLeaseLiability
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_1aeb0087dee346f3893e7d04d2eaf805"
      unitRef="U002">1453000</btx:WriteOffOfOperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20220630"
      decimals="-3"
      id="Fact_64bf693a396f4d959d6531352ef217fa"
      unitRef="U002">2823000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_979b27d8b82047bda15e80881ea2ae52"
      unitRef="U002">2433000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_1b33db281ebb47abbd04f4a66844f874"
      unitRef="U002">390000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20220630"
      id="Fact_a9874613fea041d0a33110223f1e9099">P5Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20220630"
      decimals="4"
      id="Fact_ca437531d7594f29a104957ae64ca0d8"
      unitRef="U004">0.0897</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_e2b159b4095a42d88f56aa812e76c0ed">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-weight: 400; font-variant: normal;"&gt;The maturities of the operating lease liabilities are as follows (in thousands):&lt;/span&gt;
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;As of&lt;/div&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;June 30, 2022&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;span style="text-indent: 0pt;"&gt;2022&lt;/span&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;299&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;span style="text-indent: 0pt;"&gt;2023&lt;/span&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;673&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;span style="text-indent: 0pt;"&gt;2024&lt;/span&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;688&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;span style="text-indent: 0pt;"&gt;2025&lt;/span&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;703&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;&lt;span style="text-indent: 0pt;"&gt;2026&lt;/span&gt;&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;708&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Thereafter&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;470&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;Total payments&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt; &lt;br/&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,541&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;Less imputed interest&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;(718&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;)&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;Total operating lease liabilities&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;$&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;2,823&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="c20220630"
      decimals="-3"
      id="Fact_2ca15c1b294041f39ec1b7f601fd3263"
      unitRef="U002">299000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="c20220630"
      decimals="-3"
      id="Fact_df16cca7502f4b02978d976c11289b1b"
      unitRef="U002">673000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="c20220630"
      decimals="-3"
      id="Fact_74e4bf78f25544c9a11bfc66617bf753"
      unitRef="U002">688000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="c20220630"
      decimals="-3"
      id="Fact_a9c9134d115f4397a9b06548eb9928ab"
      unitRef="U002">703000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="c20220630"
      decimals="-3"
      id="Fact_26db5a8660934f8a84bcb0613a454f90"
      unitRef="U002">708000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <btx:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="c20220630"
      decimals="-3"
      id="Fact_5d82b9978a3e4fb4ae8930475d9f694a"
      unitRef="U002">470000</btx:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="c20220630"
      decimals="-3"
      id="Fact_cd046b47ad724898a1c182d9a2bfcbd9"
      unitRef="U002">3541000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="c20220630"
      decimals="-3"
      id="Fact_8460800d0965475d92dff2f395de585c"
      unitRef="U002">718000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20220630"
      decimals="-3"
      id="Fact_018fa72479764b13b5bf3bbbe3dde4c6"
      unitRef="U002">2823000</us-gaap:OperatingLeaseLiability>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="c20220101to20220630"
      id="Text_958859c10cee45918dfcea8c45a4d142">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;6)&lt;br/&gt;
              &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
                &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;IN-PROCESS RESEARCH &amp;amp; DEVELOPMENT AND GOODWILL&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In 2018, the Company acquired IRX Therapeutics (&#x201c;IRX&#x201d;), which was accounted for as a business combination. The Company recorded IPR&amp;amp;D in the
          amount of $6.0 million, which represents the fair value assigned to technologies that were acquired in connection with the IRX
          acquisition and which have not reached technological feasibility and have no alternative future use. IPR&amp;amp;D assets acquired in a business combination are considered to be indefinite lived until the completion or abandonment of the associated
          research and development projects. If and when development is complete, which generally occurs upon regulatory approval, and the Company is able to commercialize products associated with the IPR&amp;amp;D assets, these assets are then deemed
          definite-lived and are amortized based on their estimated useful lives beginning at that point in time. If development is terminated or abandoned, the Company may have a full or partial impairment charge related to the IPR&amp;amp;D assets,
          calculated as the excess of carrying value of the IPR&amp;amp;D assets over fair value&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company also recorded goodwill in the amount of $2.0
          million related to the IRX acquisition. Goodwill and indefinite-lived IPR&amp;amp;D assets are not amortized but are tested for impairment annually, or more frequently if the Company becomes aware of any events occurring or changes in circumstances
          that indicate that the fair value of the entity is less than its carrying values.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of June 30, 2022, the Company performed a qualitative assessment to determine whether it is more likely than not that the fair value of the
          entity is less than its carrying value. Such qualitative factors include macroeconomic conditions, industry and market considerations, cost factors, overall financial performance and other relevant events.&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;In June 2022, the Company received results from the INSPIRE phase 2 trial of IRX-2, a multi-cytokine biologic immunotherapy, in patients with newly diagnosed stage II, III or IVA squamous cell carcinoma of the oral
            cavity. The IRX-2 multi-cytokine biologic immunotherapy represents substantially all the fair value assigned to the technologies of IRX that the Company acquired. Despite outcomes that favored IRX-2 in certain predefined subgroups, the INSPIRE
            trial did not meet the primary endpoint of Event-Free Survival (at two years of follow up. Significant additional clinical development work would be required to advance IRX-2 in the form of additional Phase 2 and 3 studies to further evaluate
            the treatment effect of IRX-2 in patient subgroups and in combination with checkpoint inhibitor therapies.&#160; The INSPIRE trial is the only Company-sponsored study of IRX-2.&#160; IRX-2 has been studied externally in other clinical settings outside of
            head and neck cancer in the form of investigator sponsored trials, which have either ended or are not currently active. Based on the totality of available information, the Company currently does not have plans to further develop the IRX-2
            product candidate. As such, the Company determined that the carrying value of the IPR&amp;amp;D asset was impaired and recognized a non-cash impairment charge of approximately $6.0 million on the condensed consolidated statement of operations for the three and six months ended June 30, 2022, which reduced the value of the asset to zero.&lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;The Company also determined that there were qualitative indications of a goodwill impairment, namely the Company&#x2019;s stock price declined from $2.05 per share as of March 31, 2022 to $0.52 per share as of June 30,
            2022.&#160; Accordingly, the Company proceeded to the first step in the quantitative assessment of impairment and determined that the fair value of the reporting unit exceeded the carrying amount of the reporting unit, and therefore, the goodwill
            was not impaired as of June 30, 2022&lt;/span&gt;.&lt;/div&gt;
</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20181231"
      decimals="-5"
      id="Fact_9a8b565be318474480556f2abc655975"
      unitRef="U002">6000000.0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="c20220630"
      decimals="-5"
      id="Fact_325eaf3fabb44ad5bfb58384d3bbeeb3"
      unitRef="U002">2000000.0</us-gaap:Goodwill>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20220101to20220630"
      decimals="-5"
      id="Fact_6a72cf387e50467ab7d249b064cf05c0"
      unitRef="U002">6000000.0</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:ImpairmentOfOngoingProject
      contextRef="c20220401to20220630"
      decimals="-5"
      id="Fact_b7f1abd9333648408ed6422350e7a55b"
      unitRef="U002">6000000.0</us-gaap:ImpairmentOfOngoingProject>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c20220630"
      decimals="-3"
      id="Fact_091899da149849fda23af4d9c8d7f5c0"
      unitRef="U002">0</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:SharePrice
      contextRef="c20220331"
      decimals="2"
      id="Fact_dcad6a88818c49778f7a53af5b3e6b0a"
      unitRef="U003">2.05</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="c20220630"
      decimals="2"
      id="Fact_d972dc4a2c7246d98eca73659dd66a21"
      unitRef="U003">0.52</us-gaap:SharePrice>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_5fa9c00661f347db9e4abc34a65e2340"
      unitRef="U002">0</us-gaap:GoodwillImpairmentLoss>
    <btx:ChiefExecutiveOfficerSeparationAgreementTextBlock
      contextRef="c20220101to20220630"
      id="Text_6ceabdf972514268a0aae5473fc3ec3b">
&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="vertical-align: top; width: 36pt;"&gt;
                  &lt;div style="font-weight: bold;"&gt;7)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                  &lt;div style="font-weight: bold;"&gt;CEO SEPARATION AGREEMENT&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;On May 24, 2022, Dr. Howard J. Federoff resigned as the Company&#x2019;s Chief Executive
        Officer and President effective May 26, 2022.&#160; In connection with Dr. Federoff&#x2019;s resignation, the Company entered into a&#160;&lt;span style="color: rgb(0, 0, 0);"&gt;Separation Agreement and General Release with Dr. Federoff (the &#x201c;Separation Agreement&#x201d;),
          pursuant to which Dr. Federoff resigned from his positions as Chief Executive Officer and as an officer, director and employee of the Company and all subsidiaries.&#160; Dr. Federoff&#x2019;s resignation from the Board was not due to any disagreement with
          the Company on any matter relating to the Company&#x2019;s operations, policies or practices. In consideration for Dr. Federoff&#x2019;s execution of the Separation Agreement and non-revocation of a waiver and release of claims relating thereto, Dr. Federoff
          will receive following benefits under the Separation Agreement:&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt; font-size: 10pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;a lump sum cash severance benefit in the amount of $0.2 million, representing Dr. Federoff&#x2019;s
                target bonus for 2022;&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt; font-size: 10pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;payment of Dr. Federoff&#x2019;s annual base salary for a period of twelve months after the expiration of the applicable revocation period (the &#x201c;Separation Period&#x201d;), for a total gross amount equal to $0.5 million;&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt; font-size: 10pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;payment of Dr. Federoff&#x2019;s premiums for continued health benefits provided under COBRA for the Separation Period;&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt; font-size: 10pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;full acceleration of the vesting of all outstanding options (with the exception of the Milestone Grant (as defined below) options) that would have vested during the Separation Period, and such options,
                together with outstanding options that vested prior to the separation date, representing collectively approximately 1,523,000
                shares of common stock, may be exercised for a period of thirty-six months after the separation date.&#160; (See Note 10 for
                modification accounting impact);&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt; font-size: 10pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-size: 10pt;"&gt;acceleration and vesting of 25/36&lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;&lt;sup style="color: rgb(0, 0, 0); vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;th&lt;/sup&gt;&lt;span style="color: rgb(0, 0, 0);"&gt;&#160;of the Milestone Grant options, representing collectively approximately 415,000 shares of
                    common stock, may be exercised for a period of thirty-six months after the separation date.&#160; (See Note 10 for modification
                    accounting impact); and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="DSPFListTable" style="background-color: #FFFFFF; letter-spacing: normal; width: 100%; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-transform: none;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 18pt; font-size: 10pt;"&gt;&lt;br/&gt;
            &lt;/td&gt;

    &lt;td style="width: 18pt; vertical-align: top; font-size: 10pt;"&gt;&#x2022;&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;a lump sum cash severance benefit in the amount of $0.1 million, representing the value Dr.
                Federoff would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period, assuming the performance metrics were waived and
                assuming a per share value of $0.81.&lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;The Separation Agreement also includes certain other customary representations,
        warranties and covenants of Dr. Federoff, and provides for reimbursement of certain expenses incurred by Dr Federoff. The Separation Agreement supersedes all other agreements or arrangements between Dr. Federoff and the Company regarding the
        subject matter of the agreement, including those with respect to severance payments and benefits.&lt;/div&gt;
</btx:ChiefExecutiveOfficerSeparationAgreementTextBlock>
    <us-gaap:PaymentsForPostemploymentBenefits
      contextRef="c20220524to20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="-5"
      id="Fact_a78e5340a5724b008dfcf41894dfdf10"
      unitRef="U002">200000</us-gaap:PaymentsForPostemploymentBenefits>
    <btx:PaymentToOfficerBaseSalary
      contextRef="c20220524to20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="-5"
      id="Fact_ceadef75d8924c9d85668441b0d9b24f"
      unitRef="U002">500000</btx:PaymentToOfficerBaseSalary>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact_9c4531a411584c68ad46b4980616e9d6"
      unitRef="U001">1523000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="c20220524to20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      id="Fact_a216ec68b86945c98d676d850026a7aa">P36M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20220524_AwardTypeAxis_MilestoneOptionsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact_4d153ee6d5454a0f9ee5434b16670cf4"
      unitRef="U001">415000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="c20220524to20220524_AwardTypeAxis_MilestoneOptionsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      id="Fact_09d8226bc3c1427e8eb159bccb04a5da">P36M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <btx:SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits
      contextRef="c20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="-5"
      id="Fact_bfe791cc745f4b8eb6a9556ba085aafd"
      unitRef="U002">100000</btx:SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits>
    <us-gaap:SharePrice
      contextRef="c20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="2"
      id="Fact_2205ab382f7440c88ca0097ca61134c5"
      unitRef="U003">0.81</us-gaap:SharePrice>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="c20220101to20220630"
      id="Text_11b1ef32b2cd47caa90778a9d86a8757">
&lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;"&gt;


  &lt;tr style="vertical-align: top;"&gt;

    &lt;td style="vertical-align: top; width: 36pt;"&gt;
                  &lt;div style="text-align: left;"&gt;&lt;span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;8)&lt;/span&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="align: left; vertical-align: top; width: auto;"&gt;
                  &lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: bold;"&gt;ACCRUED EXPENSES&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
        &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;June 30,&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2022&lt;/span&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2021&lt;/span&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued compensation&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,613&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;656&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued research and development expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;388&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;222&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued general and administrative expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,820&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;371&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Total accrued expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;3,821&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,249&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
          &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt; text-align: justify;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued compensation includes $1.0 million of severance, of which, approximately $0.5
                million relates to severance for Dr. Federoff pursuant to the Separation Agreement discussed above.&lt;/span&gt; &lt;/span&gt;Accrued general and administration expenses includes $1.2 million for legal-related matters.&lt;/span&gt;&lt;br/&gt;
        &lt;/div&gt;
</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_be17dfdfa79a4b779d61a265c3966534">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued expenses consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;June 30,&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2022&lt;/span&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;December 31,&lt;/div&gt;
                &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2021&lt;/span&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
                    &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued compensation&lt;br/&gt;
                &lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,613&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp;amp; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;656&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="font-family: &amp;amp; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued research and development expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;388&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;222&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Accrued general and administrative expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,820&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;371&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: top; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); text-indent: -9pt; margin-left: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Total accrued expenses&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;3,821&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;$&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;
                &lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;1,249&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_d27fee4487544377a923b8025bb91517"
      unitRef="U002">1613000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3e7742ed41af424ca35b49aa0587cc72"
      unitRef="U002">656000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <btx:AccruedResearchAndDevelopmentExpenses
      contextRef="c20220630"
      decimals="-3"
      id="Fact_7dd0dbc7e70d4574ac9a92a5b2313e89"
      unitRef="U002">388000</btx:AccruedResearchAndDevelopmentExpenses>
    <btx:AccruedResearchAndDevelopmentExpenses
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9d548722ca3947dda8811e8936375b42"
      unitRef="U002">222000</btx:AccruedResearchAndDevelopmentExpenses>
    <btx:AccruedGeneralAndAdministrativeExpenses
      contextRef="c20220630"
      decimals="-3"
      id="Fact_ec0a50ba10c24509962d906fce4ac28a"
      unitRef="U002">1820000</btx:AccruedGeneralAndAdministrativeExpenses>
    <btx:AccruedGeneralAndAdministrativeExpenses
      contextRef="c20211231"
      decimals="-3"
      id="Fact_71ca1d797b3e4243bbc016d59437f3d1"
      unitRef="U002">371000</btx:AccruedGeneralAndAdministrativeExpenses>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20220630"
      decimals="-3"
      id="Fact_b9b5f25b1033458c8405888a6c2e3b1a"
      unitRef="U002">3821000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_8b0e06feeb9641aa9b38c71137230a6f"
      unitRef="U002">1249000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20220630_RestructuringCostAndReserveAxis_EmployeeSeveranceMember"
      decimals="-5"
      id="Fact_a6d72e6bdfdc4ceea06915cd6e6ae505"
      unitRef="U002">1000000.0</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20220630_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="-5"
      id="Fact_a0750be0bea24cbca5e1e0beb441b200"
      unitRef="U002">500000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="c20220630"
      decimals="-5"
      id="Fact_4193ceb1e676424f8287f91cebaf1ac2"
      unitRef="U002">1200000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="c20220101to20220630"
      id="Text_4cf1c0a45d11426480401321d6af121c">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;9)&lt;br/&gt;
                &lt;/span&gt; &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;COMMITMENTS AND CONTINGENCIES&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Legal Matters&lt;br/&gt;
        &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;The Company is involved in litigation and arbitrations from time to time in the ordinary course of business. Legal fees and other costs
            associated with such actions are expensed as incurred. In addition, the Company assesses the need to record a liability for litigation and contingencies. The Company reserves for costs relating to these matters when a loss is probable, and the
            amount can be reasonably estimated.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="font-style: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"&gt;Dhesh Govender v. Brooklyn
                Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;On or about February 5, 2021, Dhesh Govender, a former short-term consultant of Brooklyn LLC, filed a complaint against Brooklyn LLC and certain individuals that plaintiff alleges were directors of Brooklyn LLC. The complaint is
              captioned, Dhesh Govender v. Brooklyn Immunotherapeutics, LLC, et al., Index No. 650847/2021 (N.Y. Sup. Ct. N.Y. Cty. 2021). Plaintiff alleges that Brooklyn LLC and certain of its officers and directors (&#x201c;defendants&#x201d;) engaged in unlawful and
              discriminatory conduct based on race, national origin and hostile work environment. Plaintiff also asserts various breach of contract, fraud and quantum meruit claims based on an alleged oral agreement pursuant to which he alleges Brooklyn
              LLC agreed to hire him as an executive once the Merger was completed. In particular, plaintiff alleges that, in exchange for transferring an opportunity to obtain an agreement to acquire a license from Novellus for its mRNA-based gene editing
              and cell reprogramming technology to Brooklyn LLC, he was promised a $0.5 million salary and 7% of the equity of Brooklyn LLC. Based on these and other allegations, plaintiff seeks damages of not less than $10 million&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;. By Order dated November 10,&#160;2021, the Court granted defendants&#x2019; motion to compel Govender to arbitrate all of his claims against them, based on the arbitration clause
                of his consulting agreement with Brooklyn LLC.&#160; Govender thereafter filed his Statement of Claim (the &#x201c;Demand&#x201d;) with the American Arbitration Association (&#x201c;AAA&#x201d;), Case No. 01-21-0017-9417, on December 15,&#160;2021 against the same defendants,
                and served it on defendants&#x2019; counsel on February 3,&#160;2022. In his Demand, Govender continues to assert statutory discrimination claims against all defendants, claims against Brooklyn LLC premised on the breach of an alleged oral promise to
                issue Govender 7% of the equity of Brooklyn LLC and to employ Govender at a $0.5 million annual salary in exchange for allegedly arranging and negotiating the Novellus license, common law fraud claims against Brooklyn LLC and Cherington based on
                the breach of these same promises and a claim for quantum meruit against the Brooklyn LLC. In his Demand, Govender now claims that the fair and reasonable value of his services on the quantum meruit claim exceeded $100 million and is seeking damages in an amount to be determined at the hearing. Defendants filed an answering statement to the Demand on
                February 28,&#160;2022 and the parties have selected a three&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;-member arbitration panel. The
                  arbitration is scheduled to begin December 5, 2022. Defendants intend to vigorously defend themselv&lt;/span&gt;es against these claims.&lt;/span&gt; At this stage in the litigation, the Company is not able to predict the probability of a favorable
              or unfavorable outcome. &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Emerald Private Equity Fund, LLC Matter&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;br/&gt;
                          &lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;By a letter dated July 7, 2021, Emerald Private Equity Fund, LLC (&#x201c;Emerald&#x201d;), a stockholder of Brooklyn, made a demand pursuant
                            to 8 Del. C. 220 to inspect certain books and records of Brooklyn. The stated purpose of the demand was to investigate possible wrongdoing by persons responsible for the implementation of the Merger and the issuance of paper
                            stock certificates, including investigating whether: (i) Brooklyn&#x2019;s stock certificates were issued in accordance with the Merger Agreement; (ii)&#160;certain restrictions on the sale of Brooklyn common stock following the Merger were
                            proper and applied without favor; (iii) anyone received priority in post-Merger issuances of Brooklyn&#x2019;s stock certificates that allowed them to benefit from an increase in the trading price of Brooklyn&#x2019;s common stock; and (iv)
                            it&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; should pursue
                              remedial measures and/or report alleged misconduct to the SEC. Brooklyn responded to the demand letter and produced certain information to Emerald in connection with the demand, which is subject to the terms of a
                              confidentiality agreement entered into among the parties, including certain additional stockholders who subsequently joined as parties to such agreement. In October 2021, Emerald requested that Brooklyn produce additional
                              information related to the authority, purpose and justification for the restriction imposed on the sale of Brooklyn common stock following the Merger and the timing of share delivery to Brooklyn stockholders, following which
                              request Brooklyn agreed to produce certain additional information and emails relating to these topics.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
                            &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;On March 30,&#160;2022, counsel to Emerald advised the Company that it was prepared to file suit against the Company, certain current and former directors of the
                                Company, and the Company&#x2019;s financial advisor in connection with the Merger, on behalf of Emerald and a class of similarly situated stockholders with respect to some or all of the foregoing matters, alleging claims for breach
                                of fiduciary duty, conversion and aiding and abetting breach of fiduciary duty. Emerald&#x2019;s counsel expressed a willingness to engage in private pre-suit early resolution discussions with the Company and its financial advisor
                                on behalf of individual stockholders whom counsel represents in addition to Emerald (collectively, the &#x201c;Emerald Plaintiffs&#x201d;); and the Company engaged in such discussions in lieu of incurring the legal costs anticipated in
                                respect of litigating &lt;/span&gt;the Emerald Plaintiffs&#x2019; claims, all of which the Company disputes.&#160; Following such discussions, with no admission of wrongdoing, the Company and the Emerald Plaintiffs entered into a
                              confidential settlement agreement, pursuant to which the Company agreed to pay $1.2 million in full settlement of
                              all of the Emerald Plaintiffs&#x2019; purported claims, including a release by the Emerald Plaintiffs in favor of the Company in respect of any and all such claims&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;. The Company
                                  subsequently made such payment.&lt;/span&gt;&lt;br/&gt;
                              &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;John Westman v. Novellus, Inc., Christopher Rohde, and Matthew Angel, Civil Action No. 2181CV01949
                                (Middlesex County (Massachusetts) Superior Court)&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
                            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;On&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; or about September 7, 2021, John Westman, a former employee of Novellus, Inc. filed a Complaint in Middlesex
                                County (Massachusetts) Superior Court against Novellus, Inc. and the company&#x2019;s founders and former executives, Dr. Christopher Rohde and Dr. Matthew Angel (collectively, &#x201c;Defendants&#x201d;). The case includes allegations that
                                Novellus, Inc. violated the Massachusetts Wage Act.. Brooklyn acquired Novellus, Inc. on July 16,&#160;2021. Mr. Westman&#x2019;s claims relate to alleged conduct that took place before Brooklyn acquired Novellus, Inc. Defense and
                                liability in association with any Wage Act claims have been assumed by Dr. Rohde and Dr. Angel. On December 24,&#160;2021, Westman dismissed the case without prejudice so the parties could mediate the matter. The parties&#x2019;
                                February 2022 mediation was unsuccessful and the dispute is currently pending in arbitration.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-style: italic;"&gt;&lt;br/&gt;
                              &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-size: 13.3333px; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-left: 36pt; font-family: 'Times New Roman';"&gt;&lt;span style="text-decoration: underline;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; font-style: normal;"&gt;Novellus, Inc&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;"&gt;. &lt;span style="font-style: normal;"&gt;v. Sowyrda et al&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; font-style: normal;"&gt;., C.A. No.
                                    2184CV02436-BLS2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-style: normal;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; background-color: rgb(255, 255, 255);"&gt;&lt;br/&gt;
                              &lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);"&gt;On October 25, 2021 Novellus, Inc. filed a complaint in the Superior Court of
                                Massachusetts, Suffolk County, against former Novellus, Inc. employees Paul Sowyrda and John Westman and certain other former investors in Novellus LLC (Novellus, Inc.&#x2019;s former parent company prior to the Company&#x2019;s
                                acquisition of Novellus, Inc.), alleging breach of fiduciary duty, breach of contract and civil conspiracy. Brooklyn acquired Novellus, Inc. on July 16, 2021. On May 27, 2022 Novellus, Inc. amended the complaint to withdraw
                                all claims against all defendants except Paul Sowyrda and John Westman. On July 1, 2022, Westman filed a motion to compel arbitration or in the alternative, to stay the litigation pending the disposition of certain
                                litigations in the Court of Chancery for the State of Delaware filed by Mr. Sowyrda against Novellus LLC, Dr. Christopher Rohde, Dr. Matthew Angel, Leonard Mazur and Factor Bioscience, Inc. captioned&#160;&lt;span style="font-style: italic;"&gt;Zelickson et al., v. Angel et al.,&lt;/span&gt;&#160;C.A. 2021-1014-JRS and by Westman against Novellus LLC captioned&#160;&lt;span style="font-style: italic;"&gt;Westman v. Novellus LLC&lt;/span&gt;, C.A. No. 2021-0882-NAC (the &#x201c;Delaware
                                Actions&#x201d;). On July 1, 2022, Sowyrda answered the complaint and asserted counterclaims against Novellus, Inc, and third-party defendants Dr. Matthew Angel and Dr. Christopher Rohde alleging violations of the Massachusetts
                                Wage Act, Massachusetts Minimum Fair Wage Law, the Fair Labor Standards Act, breach of contract, unjust enrichment and quantum meruit. Sowyrda also joined in Westman&#x2019;s motion to stay the case pending the Delaware Actions.
                                Novellus, Inc.&#x2019;s claims and Mr. Sowyrda&#x2019;s counterclaims relate to alleged conduct that took place before Brooklyn acquired Novellus, Inc. Defense and liability in association with any Wage Act claims have been assumed by Dr.
                                Rohde and Dr. Angel. The Company believes that the plaintiffs&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#x2019; claims in the foregoing matters are without merit, and the Company intends to defend against them vigorously&lt;/span&gt;.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255);"&gt; &lt;br/&gt;
                              &lt;/div&gt;

&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Under applicable Delaware law and Novellus Inc.&#x2019;s organizational documents, the Company may be required to advance or reimburse certain legal
                                  expenses incurred by former officers and directors of Novellus, Inc. in connection with the foregoing Westman and Sowyrda matters.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Licensing Agreements&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;USF&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;Brooklyn LLC has license agreements with University
                  of South Florida Research Association, Inc. (&#x201c;USF&#x201d;), granting Brooklyn LLC the right to sell, market, and distribute IRX-2, subject to a 7%
                  royalty payable to USF based on a percentage of gross product sales. Under the license agreement with USF, Brooklyn LLC is obligated to repay patent prosecution expenses incurred by USF. To date, Brooklyn LLC has not recorded any product
                  sales, or obligations related to USF patent prosecution expenses. The license agreement terminates upon the expiration of the IRX-2 patents.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Novellus, Ltd. and Factor &lt;br/&gt;
                  &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;In December 2020, Brooklyn LLC entered into option agreements (the
                    &#x201c;Option Agreements&#x201d;) with Novellus, Ltd. and Factor (together, the &#x201c;Licensors&#x201d;) to obtain the right to exclusively license the Licensors&#x2019; intellectual property and mRNA cell reprogramming and gene editing technology for use in the
                    development of certain cell-based therapies to be evaluated and developed for treating human diseases, including certain types of cancer, sickle cell disease, and beta thalassemia (the &#x201c;Licensed Technology&#x201d;). The option was exercisable
                    before February 28, 2021 (or April 30, 2021 if the Merger had not closed by that date) and required Brooklyn LLC to pay a non-refundable option fee of $0.5 million and then an initial license fee of $4.0 million &lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;(including the non-refundable fee of $0.5 million) in order to exercise the option.&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt; &lt;br/&gt;
                  &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt; In April 2021, Brooklyn LLC and the Licensors amended the Option Agreements to extend the exercise period to May 21, 2021 and to require Brooklyn, LLC to pay a
                    total $1.0 million of the $4.0
                    million initial license fees to the Licensors by April 15, 2021.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;In April 2021, Brooklyn LLC and the Licensors entered into an exclusive license agreement (the &#x201c;License Agreement&#x201d;) pursuant to which Brooklyn LLC acquired an exclusive worldwide license to the Licensed Technology &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;for
                        use in the development of certain mRNA, gene-editing, and cellular therapies to be evaluated and developed for treating human diseases, including certain types of cancer, sickle cell disease, and beta thalassemia. &lt;/span&gt;Under the
                      terms of the License Agreement, Brooklyn LLC is obligated to pay the Licensors a total of $4.0 million in connection with
                      the execution of the License Agreement, all of which was paid as of June 2021.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&lt;span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;The completion of the acquisition of Novellus, Ltd. relieved Brooklyn LLC from potential obligations to pay Novellus, Ltd. certain upfront fees, clinical
                        development milestone fees and post-registration royalties under the License Agreement. The agreement with Factor under the License Agreement, which grants Brooklyn LLC exclusive rights to develop certain next-generation mRNA gene
                        editing and cell therapy products, remained unchanged. Accordingly, Brooklyn LLC is obligated to pay to Factor a fee&lt;/span&gt; of $3.5
                      million in October 2022, which will be in addition to a fee of $2.5 million paid to Factor in October 2021.&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;&lt;br/&gt;
                  &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Brooklyn



                      LLC is also required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization milestones. In general, upon its
                      achievement of these milestones, Brooklyn LLC will be obligated to pay, in the case of development and regulatory milestones, milestone payments to the Licensors in specified amounts and, in the case of commercialization milestones,
                      specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers. In the event Brooklyn LLC fails to timely achieve certain delineated milestones, the Licensors will have the right to terminate
                      Brooklyn LLC&#x2019;s rights under provisions of the License Agreement relating to those milestones.&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;Novellus, Ltd. also has a license agreement with Factor, which was entered into in February 2015, amended in June 2018 and March 2020, and then amended and restated
                    in November 2020. This license agreement provides for Novellus, Ltd. &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;to use certain technology owned by Factor for the development of certain cellular therapies to be evaluation and developed for treating diseases.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: normal; white-space: normal; word-spacing: 0px; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;Novellus, Ltd. is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory
                    milestones and specified commercialization milestones. In general, upon its achievement of these milestones, Novellus, Ltd. will be obligated, in the case of development and regulatory milestones, to make milestone payments of up to $51.0 million in aggregate to Factor and, in the case of commercialization milestones, specified royalties with respect to product sales,
                    sublicense fees or sales of pediatric review vouchers. In the event Novellus, Ltd. fails to timely achieve certain delineated milestones, Factor may have the right to terminate Novellus, Ltd.&#x2019;s rights under provisions of the License
                    Agreement relating to those milestones.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;NoveCite&lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
                            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt; &lt;/span&gt;In October 2020, Novellus, Ltd. (as
                            sublicensor) and NoveCite (as sublicensee) entered into an exclusive license agreement (the &#x201c;Sublicense&#x201d;) to license novel cellular therapy for acute respiratory distress syndrome, which NoveCite is licensing from Factor. Under
                            the sublicense agreement, NoveCite is required to use commercially reasonably efforts to achieve certain delineated milestones, including specified clinical development and regulatory milestones and specified commercialization
                            milestones. In general, upon its achievement of these milestones, NoveCite will be obligated, in the case of development and regulatory milestones, to make milestone payments to the Novellus, Ltd. in specified amounts and, in
                            the case of commercialization milestones, specified royalties with respect to product sales, sublicense fees or sales of pediatric review vouchers.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify;"&gt;&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
                            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;Under the terms of the Sublicense, in the
                            event that Novellus, Ltd. receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd. shall remit to NoveCite 50% of such revenue.&lt;span style="text-decoration: underline;"&gt;&lt;br/&gt;
                            &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-style: italic; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Royalty Agreements&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Collaborator Royalty Agreement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;Effective June 22, 2018, IRX terminated its Research,
          Development and Option Facilitation Agreement and its Options Agreement (the &#x201c;RDO and Options Agreements&#x201d;) with a collaborative partner (the &#x201c;Collaborator&#x201d;), pursuant to a termination agreement (the &#x201c;Termination Agreement&#x201d;). &lt;span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;The Termination Agreement was assigned to Brooklyn, LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. &lt;/span&gt;In
          connection with the Termination Agreement, all of the rights granted to the Collaborator under the RDO and Options Agreements were terminated, and Brooklyn LLC has no obligation to refund any payments received from the Collaborator. As
          consideration for entering into the Termination Agreement, the Collaborator will receive a royalty equal to 6% of revenues from the
          sale of IRX-2, for the period of time beginning with the first sale of IRX-2 through the later of (i) the twelfth anniversary of the first sale of IRX-2 or (ii) the expiration of the last IRX patent, or other exclusivity of IRX-2.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt; &lt;span style="text-decoration: underline;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Royalty Agreement with certain former IRX Therapeutics Investors&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt; &lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;On May 1, 2012, IRX Therapeutics entered into a royalty agreement (the &#x201c;IRX Investor Royalty Agreement&lt;span style="color: rgb(0, 0, 0); font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;&#x201d;&lt;/span&gt;)
              with certain investors who participated in a financing transaction. The IRX Investor Royalty Agreement was assigned to Brooklyn LLC in November 2018 when Brooklyn LLC acquired the assets of IRX. Pursuant to the IRX Investor Royalty Agreement,
              when Brooklyn LLC becomes obligated to pay royalties to USF under the agreement described above under &#x201c;Licensing Agreements-USF,&#x201d; it will pay an additional royalty of 1% of gross sales to an entity organized by the investors who participated in such financing transaction. There are no termination provisions in the IRX Investor Royalty
              Agreement. Brooklyn LLC has not recognized any revenues to date, and no royalties are due pursuant to any of the above-mentioned royalty agreements.&lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="text-decoration: underline;"&gt; &lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Investor Royalty Agreement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-indent: 36pt;"&gt;On




            March 22, 2021, Brooklyn LLC restated its royalty agreement with certain beneficial holders of Brooklyn ImmunoTherapeutics Investors GP LLC and Brooklyn ImmunoTherapeutics Investors LP, whereby such beneficial holders will continue to receive,
            on an annual basis, royalties in an aggregate amount equal to 4% of the net revenues of IRX-2, a cytokine-based therapy being
            developed by Brooklyn LLC to treat patients with cancer.&lt;/div&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <btx:LossContingencyDamagesSoughtExpectedSalary
      contextRef="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_b7fbef9f035f48579990240c9cd4ab53"
      unitRef="U002">500000</btx:LossContingencyDamagesSoughtExpectedSalary>
    <btx:LossContingencyDamagesSoughtExpectedEquityPercentage
      contextRef="c20210205to20210205_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"
      decimals="2"
      id="Fact_cdd41b3e8ea6480b94ec8418b77864bc"
      unitRef="U004">0.07</btx:LossContingencyDamagesSoughtExpectedEquityPercentage>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="c20210205to20210205_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"
      decimals="-6"
      id="Fact_15baee9e0525492b8a38605a6ee8c637"
      unitRef="U002">10000000</us-gaap:LossContingencyDamagesSoughtValue>
    <btx:LossContingencyDamagesSoughtExpectedEquityPercentage
      contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"
      decimals="2"
      id="Fact_c23a6c006e3541238b77066c0cd2deef"
      unitRef="U004">0.07</btx:LossContingencyDamagesSoughtExpectedEquityPercentage>
    <btx:LossContingencyDamagesSoughtExpectedSalary
      contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"
      decimals="-5"
      id="Fact_82f5579ffcd84240a9840f4b7f699392"
      unitRef="U002">500000</btx:LossContingencyDamagesSoughtExpectedSalary>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="c20211215to20211215_RangeAxis_MinimumMember_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"
      decimals="-6"
      id="Fact_0e61b4edf3604ddcade881b64824b3f6"
      unitRef="U002">100000000</us-gaap:LossContingencyDamagesSoughtValue>
    <btx:LossContingencyNumberOfArbitrationPanel
      contextRef="c20211215to20211215_RelatedPartyTransactionsByRelatedPartyAxis_DheshGovenderMember"
      decimals="INF"
      id="Fact_5d22711d052f49e7a7c54dfab3b3a24a"
      unitRef="U005">3</btx:LossContingencyNumberOfArbitrationPanel>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="c20220805to20220805_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-5"
      id="Fact_f53e1eac4eb84eca8bc18b2e3002c816"
      unitRef="U002">1200000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <btx:LossContingencyPercentageOfRoyaltyPayable
      contextRef="c20220101to20220630_LegalEntityAxis_UniversityOfSouthFloridaMember"
      decimals="2"
      id="Fact_add3e0fa9ab84ee29723690c14284c4a"
      unitRef="U004">0.07</btx:LossContingencyPercentageOfRoyaltyPayable>
    <btx:LossContingencyNonRefundableOptionFee
      contextRef="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_a92731ee50e841d09d34000385026567"
      unitRef="U002">500000</btx:LossContingencyNonRefundableOptionFee>
    <btx:InitialLicenseFees
      contextRef="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_3ae9e333b02645c68f652e4c9aeac1ec"
      unitRef="U002">4000000.0</btx:InitialLicenseFees>
    <btx:LossContingencyNonRefundableOptionFee
      contextRef="c20210413to20210413_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_8764dacfc6ab443c95c4f2fea53d6fed"
      unitRef="U002">500000</btx:LossContingencyNonRefundableOptionFee>
    <btx:AdditionalFeesObligatedToPay
      contextRef="c20210415to20210415_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_4535bfdcd81745d8b41264c588a382ef"
      unitRef="U002">1000000.0</btx:AdditionalFeesObligatedToPay>
    <btx:InitialLicenseFees
      contextRef="c20210430to20210430_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_0e4da9725f9945f3875cbe5f3751d763"
      unitRef="U002">4000000.0</btx:InitialLicenseFees>
    <btx:AmountRequireToPayInitialLicenseFees
      contextRef="c20210426_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_b79e180459734a338224bad1b0f97002"
      unitRef="U002">4000000.0</btx:AmountRequireToPayInitialLicenseFees>
    <btx:AmountObligatedToPayInYearTwo
      contextRef="c20221031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember_StatementScenarioAxis_ScenarioForecastMember"
      decimals="-5"
      id="Fact_b86821fecc404d949c7b0da6d4916019"
      unitRef="U002">3500000</btx:AmountObligatedToPayInYearTwo>
    <btx:AmountObligatedToPayInYearOne
      contextRef="c20211031_RelatedPartyTransactionsByRelatedPartyAxis_NovellusLtdAndFactorBioscienceMember"
      decimals="-5"
      id="Fact_cf4243431dc241d58a0206d62a76f05e"
      unitRef="U002">2500000</btx:AmountObligatedToPayInYearOne>
    <btx:MilestonePayments
      contextRef="c20220101to20220630_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember"
      decimals="-5"
      id="Fact_021890fa77444f8db2a2f15ed5404403"
      unitRef="U002">51000000.0</btx:MilestonePayments>
    <btx:PercentageOfRevenue
      contextRef="c20220630_RelatedPartyTransactionsByRelatedPartyAxis_NoveCiteMember"
      decimals="2"
      id="Fact_e25da5b0eeb443ecb15b1574a47afb85"
      unitRef="U004">0.50</btx:PercentageOfRevenue>
    <btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness
      contextRef="c20180622to20180622_TypeOfArrangementAxis_CollaboratorRoyaltyAgreementMember"
      decimals="2"
      id="Fact_9d3aa5977dd641fc84aaeecebc993109"
      unitRef="U004">0.06</btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness>
    <btx:PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales
      contextRef="c20120501to20120501_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"
      decimals="2"
      id="Fact_8969005e0e8a4c24926ff931f9f51b1d"
      unitRef="U004">0.01</btx:PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales>
    <btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness
      contextRef="c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember"
      decimals="2"
      id="Fact_93c877398e7442ccad48fa6caba9543f"
      unitRef="U004">0.04</btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="c20220101to20220630"
      id="Text_70a2bde5640b4c6fbfb4f07f8c2ae6f1">
&lt;div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"&gt;
      &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;10)&lt;br/&gt;
              &lt;/span&gt; &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
              &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;
                &lt;div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;"&gt;STOCK-BASED COMPENSATION&lt;/div&gt;
              &lt;/div&gt;
            &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
    &lt;/div&gt;

&lt;div&gt;&lt;span style="font-family: 'Times New Roman';"&gt;&#160; &lt;span style="color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/span&gt;
     &lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;During the three and six months ended June 30, 2022 and 2021, the Company granted the
        following stock options (in thousands):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three months ended June 30,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Six months ended June 30,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; 2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Stock options granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;723&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,366&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,981&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,366&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt; &lt;br/&gt;
      &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;The following weighted-average assumptions were used for stock options granted during the three and six months ended June
        30, 2022 and 2021:&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; font-size: 10pt; font-weight: bold; text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;Three months ended June 30,&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: right; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: bold; text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Weighted average risk-free rate&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;2.74%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;1.06%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Weighted average volatility&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;92.74%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;134.30%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Dividend yield&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;0%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt; &lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;0%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Expected term&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;4.15 years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;6.08 years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Six months ended June 30,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Weighted average risk-free rate&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;2.42%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;1.06%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Weighted average volatility&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;92.85%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;134.30%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Dividend yield&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;0%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;0%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Expected term&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;4.79 years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;6.08 years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;  &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;Of the 1,981,000 stock options granted during the six months ended June 30, 2022, approximately 414,000 stock
      options were granted in March 2022 to Dr. Howard J. Federoff, who served as the Company&#x2019;s Chief Executive Officer and President until May 26, 2022 (the &#x201c;March 2022 Stock Option Grant&#x201d;).&#160; The March 2022 Stock Option Grant vests in 36 substantially equal monthly installments from the grant date and had an exercise price equal to the closing price of the Company&#x2019;s common stock on the
      grant date.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;Of the 3,366,000 stock options granted during the six months ended June 30, 2021, approximately 3,225,000 stock
      options were granted to Dr. Federoff upon his appointment as Chief Executive Officer and President in April 2021. 2,628,000 stock options
      were under a time-based grant (the &#x201c;Time-Based Grant&#x201d;) and 597,000 were under a performance-based grant (the &#x201c;Milestone Grant&#x201d;).&#160; The
      Time-Based Grant vests over four years, with 25%
      vesting on the one-year anniversary of the grant date and the remaining options vesting in 36 substantially equal monthly installments
      thereafter.&#160; The Milestone Grant vests upon the first concurrence by the U.S. Food and Drug Administration that a proposed investigation may proceed following review of a Company filed investigational new drug application in connection with that the
      License Agreement. Both the Time-Based Grant and the Milestone Grant had an exercise price equal to the closing price of the Company&#x2019;s common stock on the grant date.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;Vesting of all stock options grants is subject to continuous service with the Company
      through such vesting dates.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;As discussed above, pursuant to the Separation Agreement that the Company entered into
      with Dr. Federoff, the Company&#160;&lt;span style="color: rgb(0, 0, 0);"&gt;accelerated the vesting of approximately 138,000 stock options under the
        March 2022 Stock Option Grant and approximately 657,000 stock options under the Time-Based Grant.&#160; The Company also waived the
        performance condition under the Milestone Grant and accelerated the vesting of approximately 415,000 stock options under the Milestone
        Grant.&#160; Lastly, the Company extended the post-termination exercise period from 90 days to 36 months immediately following the Separation Date for all options that were vested after such accelerations.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="color: rgb(0, 0, 0); font-size: 10pt;"&gt;The above modifications to Dr. Federoff&#x2019;s stock options grants resulted in modification accounting under ASC 718,&#160;&lt;/span&gt;&lt;span style="font-style: italic; color: rgb(0, 0, 0); font-size: 10pt;"&gt;Compensation &#x2013; Stock Compensation.&#160;&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-size: 10pt;"&gt;As a result, the Company immediately recognized approximately $0.1 million for the incremental fair value of stock options that were vested prior to the modification by calculating the difference&#160;&lt;/span&gt;&lt;span style="font-size: 10pt;"&gt;between
        the fair value of the modified award and the fair value of the original award immediately before it was modified.&#160; For stock options that were not vested prior to the modification but then vested as a result of the acceleration, the Company
        reversed any stock compensation expense previously recognized, remeasured the fair value of the modified award and immediately recognized approximately $0.1
        million of stock compensation expense in full since there was no future service period required to be provided.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;During the three and six months ended June 30, 2021, there were 1,300 options exercised for total cash proceeds of $10,202.&#160;























      The options exercised had a total intrinsic value of $57,212.&#160; There were no options exercised during the three and six months ended June 30, 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;As of June 30, 2022, there were approximately 3,750,000 stock options outstanding.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;During the three and six months ended June 30, 2022 and 2021, the Company granted the
      following restricted stock units (&#x201c;RSUs&#x201d;) (in thousands):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three months ended June 30,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Six months ended June 30,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; 2022&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;RSUs Granted&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;105&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;1,101&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;105&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;The Company recognizes the fair value of RSUs granted as expense on
      a straight-line basis over the requisite service period. For performance based RSUs, the Company begins recognizing the expense once the achievement of the related performance goal is determined to be probable.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;Outstanding RSUs are settled in an equal number of shares of common
      stock on the vesting date of the award. An RSU award is settled only to the extent vested. Vesting generally requires the continued employment or service by the award recipient through the respective vesting date. Because RSUs are settled in an equal
      number of shares of common stock without any offsetting payment by the recipient, the measurement of cost is based on the quoted market price of the stock at the measurement date, which is the grant date.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;In lieu of paying cash to satisfy withholding taxes due upon the
      settlement of vested RSUs, at the Company&#x2019;s discretion, an employee may elect to have shares of common stock withheld that would otherwise be issued at settlement, the value of which is equal to the amount of withholding taxes payable.&#160; &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The following table shows the number of RSUs that vested and were settled during the three and six months ended
        June 30, 2022, as well as the number of shares of common stock withheld to cover the withholding taxes and the net shares issued upon settlement (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Three months ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Six months ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;June 30, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;June 30, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;RSUs vested&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;26&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;35&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Common stock withheld to cover
              taxes&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(9&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(9&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Common stock issued&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;17&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;26&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;The 1,101,000 RSUs granted during the six months ended June 30, 2022 are performance-based RSUs (the &#x201c;2022 PSUs&#x201d;), of which approximately 414,000 were awarded to Dr. Federoff.&#160; The 2022 PSUs are subject to the achievement of four performance goals, which are weighted equally.&#160; Once a performance goal is achieved, the tranche of shares allocated to that performance goal will be earned and will begin to vest over a three-year annual basis beginning on the date the performance goal was achieved.&#160; If a performance goal is not achieved, the tranche of shares allocated
      to that performance goal will be unearned and forfeited.&#160; As of June 30, 2022, one of the performance goals was not achieved by its due
      date, and as a result, approximately 275,000 2022 PSUs were cancelled and any previously recognized stock compensation expense was
      reversed.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;Pursuant to Dr. Federoff&#x2019;s Separation Agreement, Dr. Federoff&#x2019;s 414,000 2022 PSUs were canceled in full (a portion of which included the PSUs allocated to the performance goal that was not achieved timely), and&#160;&lt;span style="color: rgb(0, 0, 0);"&gt;a lump sum cash severance benefit in the amount of $0.1 million was paid to Dr. Federoff, which represents
        the value Dr. Federoff would have received if he were entitled to receive a settlement of a pro rata portion of his 2022 PSUs through the expiration of the Separation Period, assuming the performance metrics were waived and assuming a per share
        value of $0.81. Any stock compensation expense previously recognized on Dr. Federoff&#x2019;s 2022 PSUs was reversed and approximately $0.1 million was recognized as compensation expense.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;As of June 30, 2022, there were approximately 587,000 RSUs outstanding.&lt;br/&gt;
      &lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;Pursuant to the Merger, Brooklyn LLC&#x2019;s approximately 3,000 outstanding restricted common units were exchanged for approximately 630,000 shares of Brooklyn&#x2019;s restricted common stock. There were no changes to any conditions and requirements of the restricted common stock. The shares vested quarterly beginning on March
      31, 2021 and were to continue through December 31, 2022, contingent on continued service. Due to the modification of the restricted common units, the fair value of the restricted common stock immediately after the Merger was compared to the fair
      value of the restricted common units immediately prior to the Merger, and the change in fair value of $0.3 million was recognized in the
      statement of operations during the six months ended June 30, 2021. The Company recognizes the fair value of restricted common stock as an expense on a straight-line basis over the requisite service period.&#160; During the six months ended June 30, 2022,
      approximately 78,000 shares of unvested restricted common stock were forfeited due to the holders of such shares no longer providing
      services to the Company.&#160; As of June 30, 2022, there were no shares of unvested restricted stock outstanding.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; font-style: italic;"&gt;Stock-Based Compensation Expense&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 36pt; margin-right: 0.5pt;"&gt;For the three and six months ended June 30, 2022 and 2021, the
      Company recognized stock-based compensation expense as follows, which includes the expense related to Dr. Federoff&#x2019;s modified awards discussed above (in thousands):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three months ended June 30,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Six months ended June 30,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; 2022&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;Research and development&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;470&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;168&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;892&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;570&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;General and administrative&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;409&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;986&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;1,170&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;1,003&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;Total&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;879&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;1,154&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;2,062&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;1,573&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <btx:ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_a42af0f817d24c2ebcb0d6af991c7f03">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;During the three and six months ended June 30, 2022 and 2021, the Company granted the
        following stock options (in thousands):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
      &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three months ended June 30,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Six months ended June 30,&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; 2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
              &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
              &lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0);"&gt;Stock options granted&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;723&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,366&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;1,981&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
              &lt;div style="color: rgb(0, 0, 0);"&gt;3,366&lt;/div&gt;
            &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</btx:ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_0bcc0bfdad094afc8b258e8de5817223"
      unitRef="U001">723000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_b889dd1fb7c14c5e92f0d01aad7186b2"
      unitRef="U001">3366000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_146d5f9a492443298cd07ecbcf83a69c"
      unitRef="U001">1981000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_4cf2e7062c8849999f1a63a28a0f7d01"
      unitRef="U001">3366000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_5cceeba9c96e484bac4dec338d0cbe9f">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;The following weighted-average assumptions were used for stock options granted during the three and six months ended June
        30, 2022 and 2021:&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt; &lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
        &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td rowspan="1" style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" rowspan="1" style="vertical-align: bottom; font-size: 10pt; font-weight: bold; text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;Three months ended June 30,&lt;/td&gt;

    &lt;td colspan="1" rowspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; text-align: right; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: bold; text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Weighted average risk-free rate&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;2.74%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;1.06%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Weighted average volatility&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;92.74%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;134.30%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Dividend yield&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;0%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt; &lt;br/&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;0%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Expected term&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;4.15 years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;6.08 years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;br/&gt;
      &lt;/span&gt; &lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Six months ended June 30,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;2021&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Weighted average risk-free rate&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;2.42%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;1.06%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Weighted average volatility&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;92.85%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;134.30%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Dividend yield&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;0%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: center; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: center;"&gt;0%&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Expected term&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;4.79 years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;6.08 years&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_751e130eb76f412ebe759cf4879853f0"
      unitRef="U004">0.0274</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_2479f84f934a46cbbe2720ac3e38492d"
      unitRef="U004">0.0106</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_e7b950bc09dd414c88b8237764699cd6"
      unitRef="U004">0.9274</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_e19f7fbb0862459093bb7c01cbd3e83c"
      unitRef="U004">1.3430</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_b0c0b225e5434a948277dced0d22ecee"
      unitRef="U004">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_4e05088d9de348c0bf5fa1c4a57d9c5f"
      unitRef="U004">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_cf4670b12e4a45919280648cdcb93657">P4Y1M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_80440035599f40ef93ca34bf269a56fd">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_41b67031538e438a8aa140eeabddffac"
      unitRef="U004">0.0242</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_07eeab3e830c4a7689f740735edbd5ae"
      unitRef="U004">0.0106</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_3da0567a3ba94276ac1e949f50882a78"
      unitRef="U004">0.9285</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_b7bcf66763a44cbaaa6779dae08136a2"
      unitRef="U004">1.3430</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_6c23acf616464e739d08960c35aa4994"
      unitRef="U004">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_2da000f2171941ed87c618be4eeb2761"
      unitRef="U004">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_0189abd6b87f48e8abe725b33e51ec3a">P4Y9M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_4b82022aabba47009918edd2f48471f1">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_9534622bddd2465d90d48be3adf5fd7c"
      unitRef="U001">1981000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20210301to20210331_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact_46e26e2a076b45de8720acc4a96527fa"
      unitRef="U001">414000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <btx:ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact_dd22790d33a04e4aa3added2ca1acff8"
      unitRef="U007">36</btx:ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_4706c2db18d7476b864fd43eba70e1ec"
      unitRef="U001">3366000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20210401to20210430_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact_e829e2b453cd41ccbe762fa0e1cfb88e"
      unitRef="U001">3225000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20210401to20210430_AwardTypeAxis_TimeBasedStockOptionGrantMember"
      decimals="0"
      id="Fact_45d5edb624f945298a7415ce66c51610"
      unitRef="U001">2628000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20210401to20210430_AwardTypeAxis_PerformanceBasedStockOptionGrantMember"
      decimals="0"
      id="Fact_09ad4eb411ff4096b1ce60c1bb52328e"
      unitRef="U001">597000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="c20210101to20210630_AwardTypeAxis_TimeBasedStockOptionGrantMember"
      id="Fact_60e137675ca34d6e936f611f0203a883">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c20210101to20210630_AwardTypeAxis_TimeBasedStockOptionGrantMember_VestingAxis_ShareBasedCompensationAwardTrancheOneMember"
      decimals="2"
      id="Fact_51a4099125024d61abd0831290a3be92"
      unitRef="U004">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <btx:ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares
      contextRef="c20210101to20210630_AwardTypeAxis_TimeBasedStockOptionGrantMember"
      decimals="0"
      id="Fact_29b52e2246c74a6d85853c379eddbe4a"
      unitRef="U007">36</btx:ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_TitleOfIndividualAxis_ChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact_3cba46c2b5124000b362160cc8cb5cfe"
      unitRef="U001">138000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="c20220301to20220331_AwardTypeAxis_TimeBasedStockOptionGrantMember"
      decimals="0"
      id="Fact_056ee95d2b4642d0aee4f68fd887bf3e"
      unitRef="U001">657000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="c20220301to20220331_AwardTypeAxis_PerformanceBasedStockOptionGrantMember"
      decimals="0"
      id="Fact_2377f5a8d22546b1a5c0644a6d22fe91"
      unitRef="U001">415000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember"
      id="Fact_888bbb0e306143cbbfe0dc7ef367e931">P90D</btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod>
    <btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember"
      id="Fact_19cdd0622f55494b85bddcb832939a84">P36M</btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-5"
      id="Fact_8afcb4b4321c4948bb38f60818d757d7"
      unitRef="U002">100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-5"
      id="Fact_46b54861a8294ae4acc0b83257a1ddd2"
      unitRef="U002">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_d19e65488b19475abd1459c83969a7ad"
      unitRef="U001">1300</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_39d6f9861d0c4bc3862d567f4b161eae"
      unitRef="U001">1300</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_6fae267c83444352b88784f66c30bfda"
      unitRef="U002">10202</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_261258ee708942898c6ff4d32ff241d8"
      unitRef="U002">10202</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="c20210401to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_f77b6ed7ca5644448faccbc25805a6bf"
      unitRef="U002">57212</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="c20210101to20210630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_6bdb4fb05c7144359545788308d00aa9"
      unitRef="U002">57212</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact_f1d88ebdf2f04e0a8bf84677f967ef36"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact_beec668f577443feb7bb844bd42827ae"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20220630_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_2a2217d98f3948bf90e732047714f903"
      unitRef="U001">3750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <btx:ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_82480ccdbaf14aaa93f1747e868977fa">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt;"&gt;During the three and six months ended June 30, 2022 and 2021, the Company granted the
      following restricted stock units (&#x201c;RSUs&#x201d;) (in thousands):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three months ended June 30,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Six months ended June 30,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; 2022&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;RSUs Granted&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;-&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;105&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;1,101&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;105&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</btx:ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_182acec271964550987182c00ad56b3a"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20210401to20210630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_ab8b9d704290425ca6ee913e0a0522f3"
      unitRef="U001">105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_59fd560094104505b8d5f91cf39d08bf"
      unitRef="U001">1101000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20210101to20210630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_2c1a2283d48441ba9ef38c7f88f66288"
      unitRef="U001">105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <btx:ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock
      contextRef="c20220101to20220630"
      id="Text_c47d53b3e1244a578725da6cdb8320a8">&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: 400;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;The following table shows the number of RSUs that vested and were settled during the three and six months ended
        June 30, 2022, as well as the number of shares of common stock withheld to cover the withholding taxes and the net shares issued upon settlement (in thousands):&lt;/span&gt;&lt;/span&gt;
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-align: justify; text-indent: 36pt; margin-right: 0.5pt;"&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
      &lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Three months ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Six months ended&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;June 30, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; padding-bottom: 2px; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;June 30, 2022&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;RSUs vested&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;26&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;35&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-size: 10pt; width: 76%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Common stock withheld to cover
              taxes&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(9&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;(9&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;)&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 76%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-indent: -7.2pt; margin-left: 7.2pt; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Common stock issued&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;17&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: right; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;26&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="font-size: 10pt; text-align: left; vertical-align: bottom; width: 1%; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</btx:ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_7547b422eb9947ed83d93599301da56f"
      unitRef="U001">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_ca91031349c742fa8fabd43c23b48346"
      unitRef="U001">35000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <btx:CommonStockWithheldToCoverTaxes
      contextRef="c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_136a5d54a4f148c48d7d63019cef3243"
      unitRef="U001">9000</btx:CommonStockWithheldToCoverTaxes>
    <btx:CommonStockWithheldToCoverTaxes
      contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_ef427f3492e34c81976e09cdb2a773fd"
      unitRef="U001">9000</btx:CommonStockWithheldToCoverTaxes>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_2bede683e73a4b648362ac183bcddd0c"
      unitRef="U001">17000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_94a92edd9a804a0c9e3fd98ae0bf97f3"
      unitRef="U001">26000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_EmployeeMember"
      decimals="0"
      id="Fact_c965246ca8514beda0c3ab1f07473c3b"
      unitRef="U001">1101000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember"
      decimals="0"
      id="Fact_a6e85e41cf474a1b83b71f9646f394ef"
      unitRef="U001">414000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <btx:NumberOfPerformanceGoalsAreSubjectToAchieve
      contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember"
      decimals="INF"
      id="Fact_691961d3f68c42898741d9c01116296f"
      unitRef="U008">4</btx:NumberOfPerformanceGoalsAreSubjectToAchieve>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember"
      id="Fact_c41b0f27a43a4c80bb75ff2d652a3a3a">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved
      contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember"
      decimals="INF"
      id="Fact_05559d5f8bf84c7fbfcb76e927aa9f58"
      unitRef="U008">1</btx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember"
      decimals="0"
      id="Fact_f5480683618f4c0a8602f48527ec286e"
      unitRef="U001">275000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember"
      decimals="0"
      id="Fact_9b2073c6d6d64de0920d0082c302b845"
      unitRef="U001">414000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:PaymentsForPostemploymentBenefits
      contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember"
      decimals="-5"
      id="Fact_6495558c81a145de8ed0ac261e72cecf"
      unitRef="U002">100000</us-gaap:PaymentsForPostemploymentBenefits>
    <us-gaap:SharePrice
      contextRef="c20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember_TitleOfIndividualAxis_ChiefExecutiveOfficerAndPresidentMember"
      decimals="2"
      id="Fact_8404665076be42489483f2c300d63e26"
      unitRef="U003">0.81</us-gaap:SharePrice>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember"
      decimals="-5"
      id="Fact_901b359098614bd79242cb6e27b5650f"
      unitRef="U002">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_2c36d23f81a941789efdf2e6e8fced53"
      unitRef="U001">587000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_fb95cebbd68e4e0595316736227ed15c"
      unitRef="U001">3000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_2cabf15d180c4b8ab3b346ed1bcd90ea"
      unitRef="U001">630000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20210630_AwardTypeAxis_RestrictedStockMember"
      decimals="-5"
      id="Fact_c2451470d5e2426499fc48dc3e458fa4"
      unitRef="U002">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20220101to20220630_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_32fedd72dd3c4d8a877600f557c5bc87"
      unitRef="U001">78000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c20220630_AwardTypeAxis_RestrictedStockMember"
      decimals="INF"
      id="Fact_0618f1c28632459795c7370e23aa730a"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="c20220101to20220630"
      id="Text_2a62e4701a9043609da3bdda0440e3d0">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; text-indent: 36pt; margin-right: 0.5pt;"&gt;For the three and six months ended June 30, 2022 and 2021, the
      Company recognized stock-based compensation expense as follows, which includes the expense related to Dr. Federoff&#x2019;s modified awards discussed above (in thousands):&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"&gt;&lt;br/&gt;
    &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Three months ended June 30,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;Six months ended June 30,&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;&#160;&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt; 2022&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2022&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
            &lt;div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"&gt;2021&lt;br/&gt;
            &lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;Research and development&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;470&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;168&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;892&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;570&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;General and administrative&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;409&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;986&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;1,170&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;1,003&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;Total&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;879&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;1,154&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;2,062&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;$&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;
            &lt;div style="color: rgb(0, 0, 0);"&gt;1,573&lt;/div&gt;
          &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220401to20220630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_a92b70cce8294496a56eda599c8623ec"
      unitRef="U002">470000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210401to20210630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_b11ae5ae0d534106b1d31b466c0cfd45"
      unitRef="U002">168000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20220630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_b0c70ee3797a4f9bba3683982f4d6325"
      unitRef="U002">892000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20210630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_3ae33328de4544f6bec092888e7a7424"
      unitRef="U002">570000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220401to20220630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_629c6551f2494d2f8186623865fcc072"
      unitRef="U002">409000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210401to20210630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_5ce584deef304462a35e08f5781eb3b2"
      unitRef="U002">986000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20220630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_a288bbd0c71f4ec0a3b33da689c892b4"
      unitRef="U002">1170000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20210630_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_33f379dc923440e1b45b1b257775540e"
      unitRef="U002">1003000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_f15b81da1e16424399815dba5729fabd"
      unitRef="U002">879000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_fbad970780414e0399b8dc6d7e4503e5"
      unitRef="U002">1154000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_fa40a3d2efdc4d16b63a5e16dc48be3d"
      unitRef="U002">2062000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_27942ad712814bea926ceab9c01ee1b0"
      unitRef="U002">1573000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="c20220101to20220630"
      id="Text_b2be21af16d24bb093b1de68f296d004">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;"&gt;11)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
                &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"&gt;STOCKHOLDERS&#x2019; EQUITY&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="font-weight: normal;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;Private Placement of
            Equity&lt;/div&gt;

&lt;div&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;br/&gt;
              &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 6, 2022, the Company entered into a Securities Purchase Agreement (the &#x201c;Purchase Agreement&#x201d;) with an investor (the &#x201c;PIPE Investor&#x201d;)
                providing for the private placement (the &#x201c;PIPE Transaction&#x201d;) to the PIPE Investor of approximately 6,857,000 units
                (collectively, the &#x201c;Units&#x201d;), each Unit consisting of (i) one share of the Company&#x2019;s common stock (or, in lieu thereof, one
                Pre-Funded Warrant to purchase one share of common stock) and (ii) one warrant (the &#x201c;Common Warrants&#x201d;) to purchase one share of
                common stock, for an aggregate gross purchase price of approximately $12.0 million (the &#x201c;Subscription Amount&#x201d;). The PIPE
                Transaction closed on March 9, 2022. &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"&gt;Pursuant to the Purchase Agreement, the Company is prohibited from issuing equity in variable rate transactions for a period of one-year following consummation of the PIPE Transaction, including issuing equity under the Second Purchase Agreement.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt;
              &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;Each Pre-Funded Warrant has an exercise price of $0.005 per share of common stock, was immediately exercisable, may be
              exercised at any time, has no expiration date and is subject to customary adjustments. The Pre-Funded Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 9.99% immediately after exercise thereof. Upon the closing of the PIPE Transaction, the Company issued 5,500,000 shares of common stock and issued Pre-Funded Warrants representing approximately 1,357,000 shares of common stock.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 36pt;"&gt; &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt;
              &lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt; &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;Each Common Warrant has an exercise price of $1.91 per share, becomes exercisable six months following the closing of the PIPE Transaction, expires &lt;span style="-sec-ix-hidden:Fact_816a5bfe7554457abf9cb7a46a5bdc57"&gt;five-and-one-half &lt;/span&gt; years from the date of issuance and is subject to customary adjustments. The Common Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof would exceed 4.99% immediately after exercise thereof, subject to increase to 9.99% at the option of the holder.&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of June 30, 2022, the Company had 6,857,000
              Common Warrants outstanding with a weighted average exercise price of $1.91 per share and a weighted average contractual life of 5.2 years. As of June 30, 2022, the Company had 1,357,000
              Pre-Funded Warrants outstanding with a weighted average exercise price of $0.005 per share. The Pre-Funded Warrants do not expire.&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;The

































            Common Warrants and Pre-Funded Warrants were accounted for as liabilities under ASC 815-40, as these warrants provide for a cashless settlement provision that does not meet the requirements of the indexation guidance under ASC 815-40. These
            warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the statement of operations.&lt;/div&gt;

&lt;div&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The fair values of the Common Warrants and the Pre-Funded Warrants at the issuance date totaled $12.6 million in the aggregate, which was $0.6 million more
              than the Subscription Amount. The excess $0.6 million represents an inducement to the PIPE Investor to enter into the PIPE
              Transaction and was recorded in warrant liabilities expense in the accompanying consolidated statement of operations. Given the Company&#x2019;s capital requirements and market conditions, the Company consummated this financing on market terms
              available at the time of the transaction.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; margin-right: 2pt;"&gt;The Company incurred fees of approximately $1.0 million through June 30, 2022 related to the PIPE Transaction, which were allocated to the fair value of the Common Warrants and the Pre-Funded Warrants and recorded in other expense, net on the
              accompanying condensed consolidated statement of operations.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In connection with the PIPE Transaction, the Company and the PIPE Investor also entered into a registration rights agreement, dated March 6,
              2022, pursuant to which the Company agreed to prepare and file a registration statement with the SEC no later than 15 days following the filing date of the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021 (the &#x201c;2021
              Annual Report&#x201d;) to register the resale of the shares of common stock included in the Units and the shares of common stock issuable upon exercise of the Pre-Funded Warrants and the Common Warrants. The Company agreed to use its best efforts to
              have such registration statement declared effective as promptly as possible after the filing thereof, subject to certain specified penalties if timely effectiveness is not achieved. The Company filed the 2021 Annual Report on April 15, 2022
              and the registration statement on April 29, 2022. The resale registration statement became effective on May 11, 2022.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Pursuant to the registration rights agreement, the Company is obligated to pay the PIPE Investor liquidated damages equal to 2% of the Subscription Amount per month, with a maximum aggregate payment of 12% of the Subscription Amount, in the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered for resale
              thereunder for more than 10 consecutive calendar days or more than an aggregate of &lt;span style="-sec-ix-hidden:Fact_79f909b8446d493ba4844bbccec3c0e8"&gt;fifteen&lt;/span&gt; calendar days (which need not be consecutive calendar days) during any 12-month period.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On May 24, 2022, the Company provided the PIPE Investor with notice that it was not able to resell the securities registered for resale under
              the registration agreement because the Company had not timely filed its Quarterly Report on Form 10-Q (the &#x201c;Q1 2022 10-Q&#x201d;) with the SEC, and that the PIPE Investor could not use the registration statement to resell the related securities
              until the Company filed the Q1 2022 10-Q.&#160; Because the PIPE Investor was unable to use the registration statement for at least 10
              consecutive calendar days, the Company accrued $0.2 million during the first quarter of 2022 for the contingent loss the Company
              incurred as liquidated damages as a result of the late Q1 2022 10Q filing, which is recorded in other expense, net for the six months ended June 30, 2022 in the accompanying condensed consolidated statements of operations.&#160; The Company paid
              such $0.2 million liquidated damages payment in June 2022.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;br/&gt;
            &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt; On June 30, 2022, the Company filed its Q1 2022 10-Q along with the 10-K/A, and on July 1, 2022, the Company provided its notice to the PIPE
              Investor that it may resume use of the resale registration statement.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify; text-indent: 36pt;"&gt;&lt;span style="font-weight: normal;"&gt; &lt;span style="font-style: italic;"&gt;Merger&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-indent: 0px; text-transform: none; background-color: rgb(255, 255, 255);"&gt;&lt;span style="font-weight: normal;"&gt; &lt;br/&gt;
            &lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); font-weight: normal; text-align: justify; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt;Under the terms of the Merger
              Agreement &lt;/span&gt;&lt;/span&gt;(see Note 3)&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt;, on March 25, 2021, Brooklyn issued shares of common stock to the equity holders of Brooklyn LLC. The 87,000
              Class A units of Brooklyn LLC were converted into &lt;/span&gt;&lt;/span&gt;approximately&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; 22,275,000 shares of common stock; the 15,000,000 Class B units were converted into &lt;/span&gt;&lt;/span&gt;approximately&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; 2,515,000
              shares of common stock; the 10,000,000 Class C units were converted into &lt;/span&gt;&lt;/span&gt;approximately 1,676,000&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; shares of common stock; &lt;/span&gt;&lt;/span&gt;approximately 630,000&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; shares of common units were
              converted into &lt;/span&gt;&lt;/span&gt;approximately&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; 630,000 shares of common stock, and 10,500,000 rights options were converted into &lt;/span&gt;&lt;/span&gt;approximately 11,828,000&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; shares of common stock.
              Brooklyn also issued &lt;/span&gt;&lt;/span&gt;approximately&lt;span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&lt;span style="font-weight: normal;"&gt; 1,068,000 shares of common stock to the Financial Advisor pursuant to the Merger Agreement&lt;/span&gt;&lt;/span&gt;.&lt;/div&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_563d12bc7ff9412eabbeb67318c857f4"
      unitRef="U001">6857000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_7689de62376a48ceb4c4f6a6620f2a4f"
      unitRef="U001">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="INF"
      id="Fact_cf4b01859f4b4182b542f5da2b84524a"
      unitRef="U001">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c20220306_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_187e55a9d8f7417f87dc8a4a7d6a0841"
      unitRef="U002">12000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <btx:VariableRateTransactionsPeriod
      contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_f61cf46e05df4d7daa3dbc9f44cc8b35">P1Y</btx:VariableRateTransactionsPeriod>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="3"
      id="Fact_894c3e49dd2a40b385c514545d21ff3c"
      unitRef="U003">0.005</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="4"
      id="Fact_6e05b7bafecc4b93ae70cbd4bb4dfc3f"
      unitRef="U004">0.0999</btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_22bfe9902c324d63a5b3cb285743869a"
      unitRef="U001">5500000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="0"
      id="Fact_d0b8ff26d23a46cebc9f622bd7b96616"
      unitRef="U001">1357000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="2"
      id="Fact_5206f805bb76478387b6a7d9c5b0c53c"
      unitRef="U003">1.91</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <btx:ClassOfWarrantOrRightsExercisableTerm
      contextRef="c20220101to20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      id="Fact_0bc84526e5aa4ef5847278993fb0e8f1">P6M</btx:ClassOfWarrantOrRightsExercisableTerm>
    <btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights
      contextRef="c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="4"
      id="Fact_f3d9590fa358412fbc88ceb630a8997f"
      unitRef="U004">0.0499</btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights>
    <btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights
      contextRef="c20220306_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="4"
      id="Fact_6c16e567491547269b9a0c2cf6354f22"
      unitRef="U004">0.0999</btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="0"
      id="Fact_b7b3bd305ad94e548e03b21a9666296b"
      unitRef="U001">6857000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      decimals="2"
      id="Fact_e5040636d3a1415e95e1576e2c069e91"
      unitRef="U003">1.91</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20220630_ClassOfWarrantOrRightAxis_CommonWarrantsMember"
      id="Fact_acfee63cb60740df820cf6ce09a2bea1">P5Y2M12D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_79843868e1e04805ab95e2d8c6c13797"
      unitRef="U001">1357000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="3"
      id="Fact_6f257dab2ee04a7e860d66c967c23e70"
      unitRef="U003">0.005</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_86d82cc410f44288bada4a6ceb1ce790"
      unitRef="U002">12600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <btx:OverSubscriptionAmountReceived
      contextRef="c20220630_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_f00431ac99f54bd4aa172267b7a3baaf"
      unitRef="U002">600000</btx:OverSubscriptionAmountReceived>
    <btx:OverSubscriptionAmountReceived
      contextRef="c20220630_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_a9a49ea0cbfb4f4e8c703254b9ae4f2e"
      unitRef="U002">600000</btx:OverSubscriptionAmountReceived>
    <btx:TransactionFeesPayable
      contextRef="c20220630_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_5f8ec3211de64c488e365e9b6d6a24c7"
      unitRef="U002">1000000.0</btx:TransactionFeesPayable>
    <btx:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth
      contextRef="c20220630_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="2"
      id="Fact_9a4681fca163463aa18d94aa150d7096"
      unitRef="U004">0.02</btx:ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth>
    <btx:ObligationToPayLiquidatedDamagesPercentage
      contextRef="c20220630_InvestmentTypeAxis_PIPEInvestorMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_e2f45a0b3910437999cb50cc5f0eead0"
      unitRef="U004">0.12</btx:ObligationToPayLiquidatedDamagesPercentage>
    <btx:ConsecutiveCalendarDays
      contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_93ff62bc87de4227a9160a4b6eb81818">P10D</btx:ConsecutiveCalendarDays>
    <btx:ConsecutiveCalendarDays
      contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember"
      id="Fact_060d3ab9430f43059992b8f5b69b2855">P10D</btx:ConsecutiveCalendarDays>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="c20220331_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_a110b29d6d904ef4838f9207c33083a7"
      unitRef="U002">200000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="c20220101to20220630_InvestmentTypeAxis_PIPEInvestorMember"
      decimals="-5"
      id="Fact_aa6d71005eb3481893bb3d37ba3d96c1"
      unitRef="U002">200000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassAMember"
      decimals="0"
      id="Fact_de9b7152851d46fd815ef2254520b1dd"
      unitRef="U001">87000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassAMember"
      decimals="0"
      id="Fact_56c4ee6e359f426fbbca4cf416148eac"
      unitRef="U001">22275000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassBMember"
      decimals="0"
      id="Fact_799a095890f344cc936ac132902330a0"
      unitRef="U001">15000000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassBMember"
      decimals="0"
      id="Fact_98b0665cffe64a8393d6427acebc0b6a"
      unitRef="U001">2515000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_7dbb6103dabd45edbd695d7a0893cbd0"
      unitRef="U001">10000000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_27c326e192164d4a906f780b08217c89"
      unitRef="U001">1676000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharesIssued
      contextRef="c20210325_StatementEquityComponentsAxis_CommonStockMember"
      decimals="0"
      id="Fact_061ab6481df44792af6d2fb1005d2abf"
      unitRef="U001">630000</us-gaap:SharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c20210325to20210325_StatementEquityComponentsAxis_CommonStockMember"
      decimals="0"
      id="Fact_3fd80be6463c4b52a05872c2ce86f643"
      unitRef="U001">630000</us-gaap:ConversionOfStockSharesConverted1>
    <btx:ClassOfWarrantOrRightIssued
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_07a9a4d931e64523a66db33102729e92"
      unitRef="U001">10500000</btx:ClassOfWarrantOrRightIssued>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20210325_StatementClassOfStockAxis_CommonClassCMember"
      decimals="0"
      id="Fact_fc7fdd873cb342e09633f0563fbfc574"
      unitRef="U001">11828000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <btx:StockIssuedDuringPeriodSharesAcquisitions1
      contextRef="c20210325to20210325"
      decimals="0"
      id="Fact_0eea871e9e204f5ea743aa3b8b2efeb5"
      unitRef="U001">1068000</btx:StockIssuedDuringPeriodSharesAcquisitions1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="c20220101to20220630"
      id="Text_8268f62872184c44b547e4e59daca28d">
&lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; background-color: rgb(255, 255, 255); text-align: justify;"&gt;12)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top;"&gt;
                    &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;"&gt;&lt;span style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"&gt;EARNINGS PER SHARE&lt;/span&gt; &lt;/div&gt;
                  &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
          &lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"&gt;Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period
          including the weighted average effect of the Pre-Funded Warrants the Company issued in connection with the PIPE Transaction, the exercise of which requires little or no consideration for the delivery of shares of common stock. The Company
          determined that the exercise of the Pre-Funded Warrants requires nominal consideration for the delivery of shares of common stock, and as such, has considered the 1,357,000 shares underlying the Pre-Funded Warrants to be outstanding effective on March 9, 2022 for the purposes of calculating basic EPS. Diluted net loss per share is calculated by dividing net loss by the
          weighted-average number of common shares outstanding (including the weighted average effect of the Pre-Funded Warrants) plus dilutive securities. Stock options, RSUs, warrants and other convertible securities are considered potential common
          shares and are included in the calculation of diluted net loss per share using the treasury method when their effect is dilutive. Diluted net loss per share is the same as basic net loss per share in periods where the effect of potentially
          dilutive shares of common stock are antidilutive. &lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;"&gt;The following table presents the amount of stock options, RSUs, warrants and convertible preferred stock that were excluded from the computation of diluted net loss per common share for three
          and six months ended June 30, 2022 and 2021, as their effect was anti-dilutive:&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;Three and Six months ended June 30,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; text-align: center;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Stock options&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;3,750&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;3,366&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;RSUs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;587&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;105&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Warrants&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;6,857&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Preferred stock converted into common stock&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;50&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;42&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Total potential common shares excluded from computation&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;11,244&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;3,513&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20220309_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember"
      decimals="0"
      id="Fact_dcb02023e81e4f1ab27c414ba894958b"
      unitRef="U001">1357000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="c20220101to20220630"
      id="Text_f95b70294eaa41198c37dcff691de5a5">&lt;span style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000;"&gt;The following table presents the amount of stock options, RSUs, warrants and convertible preferred stock that were excluded from the computation of diluted net loss per common share for three
          and six months ended June 30, 2022 and 2021, as their effect was anti-dilutive:&lt;/span&gt;
&lt;div&gt;&lt;br/&gt;
        &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;


  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="6" style="vertical-align: bottom;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;Three and Six months ended June 30,&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;2022&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: center; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; text-align: center;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold;"&gt;2021&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Stock options&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;3,750&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;3,366&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;RSUs&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;587&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;105&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Warrants&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;6,857&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;-&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Preferred stock converted into common stock&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;50&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;42&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;Total potential common shares excluded from computation&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;11,244&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal;" valign="bottom"&gt;&#160;&lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;
                &lt;div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"&gt;3,513&lt;/div&gt;
              &lt;/td&gt;

    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255); font-family: 'Times New Roman'; font-style: normal; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_aee4d37683474486ad5eb3f271d964ee"
      unitRef="U001">3750000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_7c6ae32900fa4ac6a715749d4216a8f6"
      unitRef="U001">3750000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_7b4ab9f3bc0b4c0391ef72c81d635ec0"
      unitRef="U001">3366000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_2436aefabc6b4045af5dfa770ceed0de"
      unitRef="U001">3366000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_a276db7e2e6d4aa0ac2d2846ebf612aa"
      unitRef="U001">587000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_73469461f5624046821d7ab60c9aa79d"
      unitRef="U001">587000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_a8634324148f4162a0723d8646dddb72"
      unitRef="U001">105000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_5fcbb4fa4ccf45afa4c78815a58d601c"
      unitRef="U001">105000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_90c053ecb16e43f38d65d470bd780079"
      unitRef="U001">6857000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_7132c9659fe04df0a69390bff4dac542"
      unitRef="U001">6857000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_e95216e9378f47cab62fa0566a135499"
      unitRef="U001">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_c70b33d4483245e2b68502d3f325efa4"
      unitRef="U001">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact_e2ac0556ff474f149df36d8bbf7005c0"
      unitRef="U001">50000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220401to20220630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact_61cfa18a2f094f62be68253209b8bdf9"
      unitRef="U001">50000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210401to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact_c470d7205864468f82ad3d14185dfde4"
      unitRef="U001">42000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210630_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ConvertiblePreferredStockMember"
      decimals="-3"
      id="Fact_80c3e269abe1432fb437e7f7d6afb6f1"
      unitRef="U001">42000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220401to20220630"
      decimals="-3"
      id="Fact_bccaa20c2ab84780a6f8d5b65cdb91ee"
      unitRef="U001">11244000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220630"
      decimals="-3"
      id="Fact_8f486badf8ac43aa89d3226ead8b7d6d"
      unitRef="U001">11244000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210401to20210630"
      decimals="-3"
      id="Fact_55eac250830142f8b3ca8c9a132f831b"
      unitRef="U001">3513000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210630"
      decimals="-3"
      id="Fact_0ff1ab0ce261434b80a121a6c3b707ab"
      unitRef="U001">3513000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="c20220101to20220630"
      id="Text_71749bfdf5ce4d45be3204a3fb4fa9d8">
&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"&gt;13)&lt;br/&gt;
          &lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
            &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/div&gt;
          &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/span&gt;
     &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In June 2022, the Financial Accounting Standard Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update
        (&#x201c;ASU&#x201d;) No. 2022-03,&#160;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities&#160;Subject to Contractual Sale Restrictions&#160;(&#x201c;ASU 2022-03&#x201d;). The FASB issued ASU 2022-03 to (1) clarify the&#160;guidance in Topic 820, Fair Value
        Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new disclosure requirements for
        equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered part of the
        unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years with early adoption
        permitted. The Company is evaluating when to adopt the amendments in ASU 2022-02. The Company does not expect a material impact as a result of adopting this amendment.&lt;/span&gt;  &lt;/div&gt;
</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="c20220101to20220630"
      id="Text_ded1775e458c4616b485ea8de8a75a66">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-align: justify; text-transform: none; text-indent: 36pt;"&gt;&lt;span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;In June 2022, the Financial Accounting Standard Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update
        (&#x201c;ASU&#x201d;) No. 2022-03,&#160;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities&#160;Subject to Contractual Sale Restrictions&#160;(&#x201c;ASU 2022-03&#x201d;). The FASB issued ASU 2022-03 to (1) clarify the&#160;guidance in Topic 820, Fair Value
        Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new disclosure requirements for
        equity related securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. ASU 2022-03 clarifies that a contractual restriction on the sale of an equity security is not considered part of the
        unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years with early adoption
        permitted. The Company is evaluating when to adopt the amendments in ASU 2022-02. The Company does not expect a material impact as a result of adopting this amendment.&lt;/span&gt;  &lt;/div&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="c20220101to20220630"
      id="Text_677b4506c14f4d87b7c706a033b5aa24">
&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt; &lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 36pt; vertical-align: top; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;14)&lt;/td&gt;

    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;
                &lt;div style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;SUBSEQUENT EVENT&lt;/div&gt;
              &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt; &lt;/span&gt;&lt;/div&gt;

&lt;div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"&gt;On












            July 12, 2022, &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt;the PIPE Investor exercised its&lt;/span&gt; 1,357,000
            &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt;Pre-Funded Warrants at an exercise price of&lt;/span&gt; $0.005
            &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt;per share for an aggregate exercise price of&lt;/span&gt; $6,786,
            in cash.&#160; The Company issued 1,357,000 &lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt;shares of common stock to
              the PIPE Investor on July 14, 2022 upon receipt of the cash proceeds. Subsequent to the exercise,&#160;&lt;/span&gt; no Pre-Funded Warrants
            remained outstanding.&lt;/div&gt;
</us-gaap:SubsequentEventsTextBlock>
    <btx:ClassOfWarrantOrRightExercised
      contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="0"
      id="Fact_afc86420b785424ea670cd09aa7418ef"
      unitRef="U001">1357000</btx:ClassOfWarrantOrRightExercised>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="3"
      id="Fact_0df87ba6057a427380cb54ccde9c5697"
      unitRef="U003">0.005</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c20220712to20220712_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-3"
      id="Fact_fb0d8c6ed2174a6dabdf382a94db2109"
      unitRef="U002">6786000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20220714_ClassOfWarrantOrRightAxis_CommonWarrantsMember_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="0"
      id="Fact_abb73b5d85464758a2169c685a730af4"
      unitRef="U001">1357000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c20220712_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="INF"
      id="Fact_dffe688a897a49c9a1693ad0e48427fa"
      unitRef="U001">0</us-gaap:ClassOfWarrantOrRightOutstanding>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>75
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M15*F)[8M@@AB+(Y8"HF:F3,>8ZFZ?&&+E ,.C2BFMN<X73O&)+'\@1F;<G_
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MCE\>HJ^LDDN!/E<9S0['#\"+G2MXZ\HG[)WPSW7U 47!;P@'&%OPW)P^//3
MB7:1C>KY(E=DB5BB!6P3@=:"9BI:L/DXD7GUW&1O+G,J/MHBU\P<VV=6._NC
M6)&47O9@ZPK*-[1W]>]_A</@/S:WSS3901#B71!BW^Q7#U"("B:LZ=&,'-8C
M5;797/5#/!I%%X/-/GR+&1X/@]'.[ !8L@.6>%?G.OLO;"ZH1U(@R: @I:Q*
M\X*BJD6L/E77J5K&=R]@<LX%/--D!W$:[N(T]"[@+85)TYPT-;?*$"D9E_G_
MZ@]LGC?3)7O+%09Q9TE-FV%D7\[1#N;("W,F6?JCK^IYAE)6 LD))\*1\>LX
M&.(.1-,H3$8.D.,=R+$7Y/5>Z!!;(*XHIL\6?4@O1(2@T@9W;"(9#SMH+3;Q
MQ YVL@,[\8*]+U<DYVJ#G YU8L 8C;J!-6T".] PT!06O -J7O57G*44MK#:
M#H2GRSIQ,[H!T;)29E:R"@Q@R602=-!;K%SP]Q@X],)_X@2RM5$U*1-0D/I(
M+ F 5S7H+J\(5"92H.MLDPO&K>!##ZP6N6F2C(:) SS6X+$7_!=5*@&X(% [
M(?H/3P]-?M@5 3Z.TS29#..Q Z<FX]!+<SN<62Y6#, JK(O\%<J%!VUD5HI1
MMY99C%P9H4DS]+/F[T1Q384*"@4-2<I!^#G+63O7/H#^..FB-(U<*#6#AE[B
MV:%\(1PR&%@S)_.\J#G1BC,Q<4[BD;'^IID+J>:PT$]BV\6O6-4'GI><%84B
M\;S:T$8$6 &;-#4)PRY<T\@%5W-9./(KQR6IGF'W'PJ..DWK2K87:*OX"+U<
M^5[U<:[9#H.A.3/TD^:C7%*N]!G--V1>4*O#)O_UC1U@VKB*GZ;(T,^14TZ!
M>3)$7Y7@H,WJL!IPNN9<$9*GNIA,V!_A41>VQ2I, D<]Q)HSL9\S9Q00YO(-
M:!'J82[WL=?;Y"A^;%*AL3LL-GWL4.Y8$R;V$^9UFK*U$NXK\J92HM&E:<K7
M5*^%%;+)@1A/NIEBL0+%A1VH-5-B/U,^[K9R4]:WN_C-BM1D05CV;FMDM8H<
MP@]KKL1^KFRVW)%RCDW>"\.Q@="TFHQ=H=3\B(]WE4?[,BMH"U=.8FQD@,4L
M#' 4.X!KRL3^KG/O3."7%ONO"-3J)L_@9O[6,M()#28^:X=YKMD.PZ+Y&?OY
M>;H&D:[V!(@RB 8L)A0FM:GI/^O<J=BQ2;U]'!D9>#)!8TW0V-]M3E5_03.!
M%IR5"'9++7_%*9H26QK+H*N!+$8NS)I'L9]']V,,(OVW^G #KNM]1%((-.^>
MPK6(3>(T\-KZ3U>9U^R*C[&K+<J'3<:A&XVX=[CA:SQ;-TR3,'14TT@S;>1G
MVEVQ.GW'6X\$+50:&MENL<+#H<,%3;A1>&K9VH>^:%K3$XXSO7S^[O/,,\UV
M& S-XY&?QP_3,A=B#4&HTS)E9:E:874659>OMC.JE3ST'57[Z.(EETL().A9
MJ<8M*(<86N-F\CLDY,18=%]7?>CEWN&U7P-,R9OJDI DKR"^RUQ*6'/50D$V
MUX<3"+:?+.CVU$55:E6TP67[PX#(5 *&1K?8N!S16B'R:X7;7.5KE2FU"%)=
M,C2#>$.QOH8EH!![*'O-DBU9D5%N!V_KL;O@3VZQ(ZT7(G^+?6*N@5-?\BIE
M186FA/^P>N!KJUL'3),DB">..AYI=H_\['Y'ZUZV[B@RVU90I?W '^4HS4YR
MR\?NK5L6F1!.1@X1&FD1$+U'!&RIJ:3E')+HYW9#6#'[V+W%;%,)2>#*)RT"
MHB,BP*!4^DIYFC>RH D^6ZF5L6^#XU+ 8A*Z8&LE$/F5P#=HL]^VE0;(_V>!
MIM,I*ABQGHA%QZG>8M)/(D=.Q)KKXQ.Y_AA-6I^'V1KJR;@+W6*6C)/ \6PB
MUB0?^[MJA1UV&Z^;4[5+:V$(+%9?J'3>0(Y7=ED;6SKK&'?/_BU6\3B)'.<P
ML:;DV$_)-RZHB$@TI\]Y5:GPJ^X":C^SZL/8PK7#B7&0:C6+'!D>:[J-_73K
M]8"JDQDO=DLO/HF#[EF2Q2P)0M<S@'CO&6]\7![6[)JME92I"TN#%BT8MTK"
MV,O:[Y6$YYKM, ":IF,_3=]7DL*\UBXU-EDU[#Y#L-BX,DJS;NQGW7L@SI(J
M_>:H-B8M=A6-Q<0%2[-F[#_;GJU7JT8UDD+U:VG!Q)K7]%,?.ZI4VFN)(/-/
M[C+BLQY[GVNVPSAIIH[]3'WOTGJPH=!\+<!<"/7-W/-H*#[.UQ:3<3AR:+Y8
M,W;L9VR7QH9>0A*PK77@R6X<YW.+26CW(=%DGAQYK%Q!KD&6EL"(D*);_?'M
M\;OC88SU19#F-_9?7PE'0??YO<5J/.J>-@[VWO(J*7^N7WY3P5M7LGE+:O?I
M[@6[Z_JULL[GG\*/-\UK<GJ:YJV]KX0#60I4T 5,&7P804!Y\R)<<R/9JGZ7
M;,ZD9&5]N:0$VB9E -\O&)/;&_4#N]<1K_X/4$L#!!0    (  *""U7BWP9C
MY @  !P7   8    >&PO=V]R:W-H965T<R]S:&5E=#<N>&ULO5AM;QLW$OZN
M7T&HN"(!%,F2DS27V ;DE[9.$\=G);T##O>!VAUI>=DEMR37BO+K[QERWV3)
M"0H4]\76DISWF6>&/-D8^]EE1%Y\*7+M3H>9]^7KR<0E&172C4U)&CLK8POI
M\6G7$U=:DFD@*O+)[.CHY:202@_/3L+:K3T[,97/E:9;*UQ5%-)NSRDWF]/A
M=-@LW*EUYGEA<G92RC4MR'\J;RV^)BV75!6DG3):6%J=#N?3U^?/^7PX\+NB
MC>O]%FS)TIC/_'&=G@Z/6"'**?',0>+?/5U0GC,CJ/%'S7/8BF3"_N^&^\_!
M=MBRE(XN3/Y/E?KL=/AJ*%):R2KW=V;S*]7VO&!^B<E=^"LV\>Q+2$PJYTU1
M$^.[4#K^EU]J/_0(7AT]0C"K"69![R@H:'DIO3P[L68C+)\&-_X13 W44$YI
M#LK"6^PJT/FSRZO%Q=WU[<?K#S?BP\_B_-/B^N9JL1#SFTMQ/E]<+WCU]NYJ
M<77S<<ZG3B8>8IEXDM0BSJ.(V2,B7HKW1OO,B2N=4KI+/X&ZK<ZS1N?SV3<9
MOJWT6!P?C<3L:#;[!K_CU@?'@=_Q7^4#\>_YTGF+C/K/(7=$:<\/2^,J>^U*
MF=#I$&7DR-[3\.S''Z8OC]Y\PY;GK2W/O\7]KXGGMT5,GP[^O,<NR256E:$2
MS4J<5PY<G1/G%@6;;[6X+HI*FX\965E2Y57BQ+5.QB,A09O+C;0D$F-+8V5@
M\N3''U[-9D=O&@;A<_I&&"M\1J+>O3!%*?6VWGPZ$MZL"?L69>8SH;P#'"V=
M2I6TBIQ0.LFK5.EUJ]C@@&+OWEWLR>?%3LR-N0?05&X4C&@/-\O-02%UVIX5
M?1DC\<ZG^X1QN9.C'/RS5*;,)" J";0RAZ."V0*?N?K*YK"EQ=W-7'A*,FUR
ML]Z*,I>>87W4,YO//&.82T4"B<#=TIJUE47!NZSNFC0-*%6>%UIN<!X[5R3H
M#)Z$IB\^G*RCQ6Q'84$TI,PKB/#![,"@TT/=+BZZ'0$U10&@565.]7*P%10I
M+&89;BSF3E2L.?9)Z='CB<#MA*R#G_+0'N#<+6O?!I.5>Y@<8_%!BWFU!BB+
MZ2R@#S"H)7D":5I\UF8#<M?(O?EX@V3_^M6CD\5DZ(+73YT@\?SZHWA/=HWT
M7%3+45L FPQZ;@4XP[A6)2RL!COB&Z$=CTX8:0^OP"H-.R547%LB=%<?)",5
M0ET6D9*7+*'52ZV^UO6VSW_>L&C3N:RLJR1X0L8F4TD&[0N#<)I0<VBB4 )Q
M[A2,$M-8CL'KNA\'>&84]W:<E:"A*%V%-$(%#!YWT&Y(<9C-<)6]5_=,W10*
M#O)&;?Z^K8V%8R[21OTD-YQM<,Y[:9-,S%Z$I)@B$5>P,W",1WNQ3C*IV6#.
M+BT+$BMKBN]F"SOT(>#L ],.R:"GZ8:]E"2F0A*DH9AX 2&^1S@(6W]4RBF.
M,]=@#-VNQYE#RM%.@UF!PO8]&)A&$;R,3"CAG5@TM7M>1O?TG.%,GNYX^U(Y
MD 5-VJ1B3UD>KAAAE < U'F"?$8IJAA:."@HYASQ>;2,"%!Q>=GT&TRS@"1*
M!Q6&D1BB$(7O!J"TBEN+Z465O^@74+LQO"!^A3$0N=L>NOW.'AT<95.I$XK)
MS3QA3N$X$;DXV0KV(;*%X]/6:LJZBP65GHHE-)B^:G"( XHCF+!&8DE^0P"C
MG=SO:=KW^)Q%#6X;47LU'0+XMD)U3??CU\"DIDT>4J!@\8]58TLV[_*M [J'
M"#4XC%"]7-VUH[>^#TS!RT_DTZ[9!F1YLNRM!&[(2+0HL/); 3,X1R!TM_VR
M/J/=A& HX'3KLNJ@/@SFN_#4X_SN C#-ICY),!@,<'/)P8L;,*9$[26WJ<=,
M[G!^#X)[T0I%2[V)8Z_-;4</;45/+:7U#4+.^U#1<<Z=Z=C/7HR/_M80>.,Q
MD. ZZ#RDL8]J[S8%[!HW7"A/!^8E7N[,DSM#X,HD50W!*; L-V6<+* 09A),
M&Y@0"O9>DFT+J.%0-G'HP%235HD/L%6"&1SLZB:45)X&T*Q4D&(0IE1AV&?P
M<%N= JVI/Z@$^+[X\/OUY;/IW\?B7#H5++IMHP;E ,4#KOD E3%/),@]U3BF
M"FYI*>ZZ/'=AEC&YBJ6^4AHPH8+N6"B"GIE$)BRYPI$;B$Y@LP<J?30&5"<\
M.[EZ*./ZQ#[C2*#E2'W20:$%RW%M"'Z9SV_;,F)O-0H?U(P3JD4TI>&W*MR^
MT7?-@*_18GKT[!_AV-RB9:'87K&W[FA=Y=%7BV?_0M8%6Z!ZO@UC'()@A#:^
M=CQQ@)L,4SJ^381+ON;V9CR.$G>!.B.76\%V!/TY"CEA1CUDP!CY%YAR)M5W
ME4)JN:[+E[>ZV!UT05]#'!]H5HX'Z:2RH6/*]+\8(>-AGTG F^6!.4&&,2B$
M1BI64EE1]G.HMK:3V33*$7@[S,8A[6)_"QX/ [9TF5CE9A-':&:  \JDKF%.
M:9AI' W^3 :ZS%1HW4L2_!+TX%85^G#MHN^S8C5CN)@#\1T"TYU4.F9F_WXW
M_>F-$W.M*W"X(Z" Y\IOTNJWR;PU<DO2BM -<7M,8J\\GL;^!35RZM)TL.#(
MP),4=;GZ$D<T@2M#H9Q[V&@65^T]CZ6_K7"G:1XC=@Y&E78GQQT0>,3A2YF'
M(HZ/<C*$==\(=.L( 6@X: QI!**^ZP]Z>\>W?+IVW++"<&'(#?XO1<:N.)RT
M30!]AI89)#GU113Q 2D&=-?CH7B@<U- *M^VET*@9*U^(PS9M62V@!Y5RGH8
M'O )* 8KVL3A^#QT.NY\7)M\70C)'BMI/+BC),?$IE;-351<D&4O<]$_V.F@
MNY I#7IWG3;!XV#!BKAZ[7 H8Z5P6-HI! C#\U(PH@\>=8D?U(>K3]!JA7LP
MY_,!=>A>F<K!KS;4'*6/Q"[> *J"D1R'4H(8Y<>'7K4FO1?+<.GB=UG.3C2L
M^'C9KK9/O_/XXMD=C^_&N%RLT6E$3BN0'HU_>C&,UX7FPYLRO'\NC?>F"#\S
M@!99/H!]3N7F@P6T#^)G_P-02P,$%     @  H(+52U[_DCT!0  S@T  !@
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M6>*#BQP?P'YA(27M P=8?\*=_@]02P,$%     @  H(+5;E<<X'C$   J"X
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MZLI4X,>9KR5)^4.LZC1]%(E.:R(#R318.-'@3J9I(U0"L:T4'?UGL(B&+D%
MKBIFJ_5!.#8T:O0ZETSYL2MN#> LGU2?#P!6)-@!/^J'-FP'IZF0EP@DO<"9
MS)%Z>?="+65F#1G\^K-"#,2<G8JCCD[N,!FSANA[J&''W$9O(\W1;:JNUDCX
M99$C%*LP\DO*M.1WSOP07,@UU+ &;T1 ;K=E\4-GEM6+Z_CZ>AP/AT-A-A*G
MT)+0NC%^B&QDC^+A=!8N9=MH1!0%FN&81D4B.3; P6>)8\1O95%O;12'O'LM
MKW0N\Z66J9#)@S; @Q.2@YZ/AR\_^*=S^Y1_'[T\)>2(-'1":4(OP0U.["@'
MG@[]Y*["V>EJTS$)X1S@9KE!$(IM"1(D^O%L,$8ID:8,:E9N'Q\6A$#4:#B=
MD[.4N5FITL)O)[8*J\%-D2;J&9=?*(BB.@Y!*+*4Z;).R><=3CB4:'RH97DR
MN!R*+4YDLUA([1AY%$]&EZ'A.N'+&%!M +L]?G?YH0S1X1U,%"QI(#?%2FW4
M/K9(D9&@I2) 3A%)2IJZ5$TTM'A++O>36AZ(/SP A-"<*4C$,-\";VQAHJAD
M&O4LCX_@6^44BL62@<8)Y3,) G.MB6U"$H2;_^HR3I[XY!(FG-#JH1TA*T*:
M+90<2#5=G<?]U$T.X+*/UW;?,[=2=^ R<D$1D-+&F@2FLK\?9NE0-LC1$SG1
MFP3/N:[15RS619'L$$ETBOI>(X2=2A.]@BE5OCR 1XB_:3_^O'':D!"UL1E0
M]1FEGP+>0O4?TJS% 6=UTIHCT?,/QWGH ]$!'WBJZNAJR'G)JBRRH,;[?SB'
MY@>K E+L#+(<T2AJ R[,Z8OH[TAW!:2  =[*5)+:[[FE[>BFZE&-/M"Q?W(X
MSI-_H#+EE!>"[%VISIH\RPJ([AJMW;'6YEZMT8TT&U;+DC[ '30D(DB-CJ/1
MY0Q_S]RGN8U7XQ(8(44T&E[@.?W%F>S7Z@>E&A741\L:Z) WAH\NQM?80G_O
M2G3I9?7(:^GDK:V(X2414MIH0J3Y__MB5>TDUQL/Z,AY'8(*F1<+QM?3Z.1B
M.HM.H^OQ++KA]A,XB=T3L$W_OI4R@?>A4L"/X^MK_N?EV<I'$B8F1"KK'DSL
MR1$%3W%N?#4;X>2S]N-MZ^1MS*D?37'81!^T>C*['F+#<71Y=4U?+T>T_QOA
M8!<R\' 6CZYF/TW;D?JM/6L63V;7^R5QL4CUV@:NA^N]$@V^M9$/*CH>#0?#
M!@0XC3_E/!0N5 ,LG%_;48VMX(4"RO!80R"25+?F0M@7 @Y$Z:?#[$9R'Q&5
MRH7R"@RCDEW"@R186:A<K307)(?R>EC8W*10H9@'E9QH*[E.QP8C<,M<LT&R
M3'.L<46C4>"A*6251*U*]FJ=IW+RP8IS(-[5W(6YD&<0\?0*1N>$%=O(4.>Z
M\@)319DDG&?!,+H%KCF-W4ADN0+I+#H>#B;>HA8&2ZF-K>>EZ!$(>BK?Q+ =
M+&;Z,K?=$2U4M:,4\4$MREJ6J'FN7+E"?C.'3L!I _GOM$&7:0N%+[Z^F<9]
M31@(S&JPIR$+ZZH%?[8DN2>WUD78?J+$D=QBN)\7E*X4- DM$AAQ))RTH4"0
M(6Z_W8JW]3__2=X:BX_Y<G!ZL+["-_4;-I@!?(7.1V B?Z]=Y7>HJ!T'\>0+
ME6V3[\Q6+?5*]Q"I*P-BJA'"IDR#"+1U*JK^5-D>A(NM,N%8] 5WIR_C1"%\
MGO#!#Z,H!%C:+(Q"&Q$D/Y/@ /!+I1KO(,9>V'QS+$87X^B]69;%+IH,HSEG
M7NHSB,/SM$!1"62_&@ZCCXT]Z;C.<R#^C2S+1U)%4YTV=B8'>?%,;CL970(>
M#V6TDZL)GKAL=@#^FS1V,AI?\L*G<]@))2]:]$SZ.KD>7V%%F[1.*%^=AAGK
MA))5@.4G#.7XY0OSY?E!$CZ-/@6.$M;F/,NP%NCG/>MX+O6Y] WMCRZB+S8Y
MP-+&I0?;$RJ1HD.@15?1)_KD_?,Q&D^C=\H=2O.HO%;19.)X;708IM#1Y35)
MB_;4]H-.+^/IQ.="0"5G%'9M;V3*F-?QE-0EYD&' >#XO:;F:A\W2%+_)=QS
M7R]L9.]/[,)E051\ZSUR<SO*&"K;%A!((1# A@\W]4,MZZJ)] 3-UH,"'C;Q
M=_B8[GSB1<1=]O1EU(KD2]MVFA..*\@GX9Z=4<5M 3=,:V-%;F9X>%RG54,C
MLY@6YM"#"K/RN=:KZ)&.'300(]PRQ'L+I(GH."3\!_U@)U@EJ<\.+]UX9Z_)
MV2'E0;>V$S;U J62IN1"?#0GB$]5,GB2@L[MS.L E9><2)[6]'@R&/[2Z(F[
MUI_2^(VFMG!N>MT@Y8:> P0>RS7U\7@\N#Y8=SDO(O-WNK6K>#CFX5'TU/#(
M=G!/#.D..F-LQTH,M0G5<K(1?D5E4)C*?,O$,R[L3R(&H#;QC2X'D_'DHIV.
M>%=/W#B,QE>$-?'^#()_:49=-/GN=JJ3H%7=#]2VK*58E3P-ME=6,'WDQR(6
M]FCB4R*6?2O0E)MP'Y7E2,ZN.P4##YKN_)"%YUU37(YXPM-E.QS.A=Y *HZV
MJ5S:M*TX13;U RHJ.SJIMY3\1V.1V4LJK*1)NQUM 65H^M=CL BP/"Q26P\(
ME!0] W3!Y#8U1:-$XS63%_D9#QPK[<&.?D-*1GE>]=5%51$9FKL,ZY1M -.E
M"KL/*/ "E:_E6G$(N./\4311I:["YKZ^QE;T_%')T@20%"!K'(SOO3<0)%9P
M6:NUL.X"Q*?%HZ+[D-O@6PBN%G[ 1@]MP\HQZF20@H9AM;TOH4$#4[615[AY
M.Y<B.]3G3A.=.5+<$RT@/L#9!X>N'=2QHZJS5<%.0=)$/>8[V3$%D)S!%67C
M$<;2A=90N+*]>C/M^.)J=B 8>N#4]A9V*!9UF QS>-O2;8 /F?13HK>%+-GN
M[_S%1CB\YL=^8,W)JV*?0=8#+:U6XKW-UO":+RL$D;OQ05U(P0IO[6B"?^)!
MSD_HQ%JW*86H=X/!NMTJJV$@WDM$@Z,8>8HH)"K%/5?/QZL-5E@GCVV$V<LW
M0+4%C*O)+_]"\TB"_VC9W)=&9/*1>T3%%6#2]GW-TD[(@)54TSC3S>X:^._?
M4M'#6VD2^9UZ)FX9?.\3D5B&U.0:G ,JMK&K@L@E,EO+!"=85PH;D=@&FWO"
M[1:0Q"5P0],JTYYSXVY"J21>NBN&,%YYA.I:$O*?2#T4J2WPV"E@&@ &.96_
M5+6UDMCJK:(K:E)%#FN*M<J;!)!]O9T#W!!SJ;0^1P^%HHZ=+Q>*=2DSPP'=
M]/'QWI2]4^39.JC6T&"C[$\P1-YM\T[NX3RW!9+O]:E5@&L@@^%K]XBH=P3=
M'R@*V\X$A#UD"[J($"H6NGD(/4B?TP;9ZRVVPN56 -88.*USCK"PAT*2A[L5
MT \M8FVA-ZW.2K76]+(#,UH6CS+EI-#FN@/R\[C9^SE;Z@/?[(JWNC!+36-Q
MM%>9YA%!<PO&*SR2/'- 4W&MJ9HP717Q ,\0UKCI"13CQ&S3*OSDK.\G'=>P
MY8F]L2SEEN9-15(O*[YQSFRA4^=V(@$USU-JU=?!>P$_UTI$S[02UA&;P.F^
MH= /'VGG53QV"/WJI'FEH#>Z3[2M JA>0KZOX:BRG=_P[?Z*9=34J?@[_7OB
M'FB/'%$D;3G4&'!^?^.M]ZW8ZJ68#2>HOQNZD&6!GM?ZZT]4Y=SY,\1QB>YG
MM)+:[=)W5S_1 F"E]9CC45!9[YB03GP7T.RU\TCV73QJ^XW6NE2M-67GX68A
MR J!'7V2[=\^._[Z.7YZV;G2I+E'G3=IP=W!^$H@"E;UD@^GLS-*9PS/]=;&
M:(=6>-_=-B8\E)VTO443>SOG6GLWM7OU1#]!=08*EH_]CN0 7^26VC1A0"/5
MKK*0D"'M\73@6J$^B3AJ.8>[V(%KDW(E.C^JAIL3!(TO13-PY3((C<1?XGZ)
M[.G@\8-&#4CS*N+<(4F!+M+E5CL#X%'QGGA!J'+A\^S=5G!)A>TWG<L,'LN1
M$T?'$1QO-AN[29TC'9V,:03VQ[ZAHXMI/,7#KWL/R($G4S<OZO*^?_D:S4;Q
MY&(6?6+DR%AW3<AR<*U<V4XA%$063_2&=&7SH7/"Q[NOO\IL^_)=*\)Q-!O2
M&<$S+L1T@&AP< 9@#X-^0,Q+\2G*44:D@%M"(*2'55U1;U<;9\V<VCW@"ME=
M0<XB X"Y&TEV$RIK"R053;-^ FYZF[%YF8OO?^V\SU_>NVK28I1A?E%<4:U*
M*8.'R/".]+&+])[*X5:]U4%0?54;C1+]>PU4M',F^PY#SN.@UBC'L^"&@JJ>
M0S!'4Q79&V =GJ>$-\&1J\'M",B(L2V//5'2,#YH]')W\+(,37G-57[3#35)
MQ"[R>82)64"@M$L"H_(>^!NGI_ U>(&)RUU1Y,K7]=&"6QJCI+U=:[CTNQ=-
MR^/?Y1J(EC$L$7PK0ZV,=9[VG2\ZS69[GM)6NT($IW6K86W"-^8H4#07X.VM
MB]>?K8:085UFO1A?Q($!#7=CH]%+\=X6%I_MJR'$V^\%*(H_L0K^;@Z]8WH>
MO#W,LTIZ1YJ &YS9%XG]K_XU[+E]^[A=;M_A_BS+-4TP4K7"UN'@:G)D"['F
M2U5L^5WD15&AO>"/&R4A'"W \U6!\M9]H0/\R^EO_@]02P,$%     @  H(+
M55*B<V/<"   =A<  !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&ULK5AK
M;]NX$OVN7T%XBT4".(GM.&F:%Y"FR6X6?01-V_UP<3_0$FT3D425I.+D_OI[
M9BC)DJNDO8N+(K4>P^&9UYFA3E?&WKNE4EX\9FGNS@9+[XOCO3T7+U4FW:XI
M5(XW<V,SZ7%K%WNNL$HFO"A+]R:CT>%>)G4^.#_E9[?V_-24/M6YNK7"E5DF
M[=-;E9K5V6 \J!]\UHNEIP=[YZ>%7*@[Y;\6MQ9W>XV61&<J=]KDPJKYV>!B
M?/QV2O(L\$VKE6M="[)D9LP]W=PD9X,1 5*IBCUID/AY4)<J34D18'RO= Z:
M+6EA^[K6?LVVPY:9=.K2I'_KQ"_/!D<#D:BY+%/_V:S^5)4]!Z0O-JGC_\4J
MR$Y?#T1<.F^R:C$09#H/O_*Q\D-KP='HF063:L&$<8>-&.4[Z>7YJ34K84D:
MVNB"3>75 *=S"LJ=MWBKL<Z?7U_<?!;?+MY_O1*?KL7US<>+CY<W%^_%S<>[
M+Y^_?KCZ^.7N=,]C(Q+?BRNE;X/2R3-*#\4'D_NE$U=YHI+N^CT ;%!.:I1O
M)R\J_*O,=\7^:"@FH\GD!7W[C=7[K&__GULM_G4Q<]XB:_[=YX"@?]JOGRKI
MV!4R5F<#E(I3]D$-SG__;7PX.GD!_;1!/WU)^S^-V8M*^R%/MZ-?<=6UU#9Z
MD&FIA'94$]"=".F$7RI16!TK7$F/ BW31,P4JCE6*,9$>"-0H:F0J$_GE!\*
M8T4A-;^!]W,W5U9(D6HYTZGV3T.A<Y(V-E$V?0HR,E3X3/F54CG*P]Z#S@II
MO8YU(7/0EK@0<Z 4 >52*RMMO'P22Z"<T2+EO)RE&I64"' ="TI6J_.B]"Y8
ML #J8-82Y8XU$<PS%L (\/?2>"QGBQT#9<ZI #G6JQ.5 Y9,@\&.#*ZMTU@E
M\X3U@RVA7K35E[F946" 4U6H=L47R/9:ADA(VC*%)G<<_?[;T61R>!*]5P\J
MC<;B)EA%C\?C$_&-5B=,<(F T?\/4]AC9(M5A4$L\H6@!3YXG5Y4027C9(R-
M #FLR)1TI55@?R\2Z=7N!O[)S_!703-09@G(CQ;%:0ER(M-8I1@'O-(JT7(S
MV<E(R<*V@<A$I5E[HI'.'KE(+LGK.XZ,@R74%NKM-D"0<J<SG4K[C MU'G4=
M/^Q1L8[#+^AK(MA8FQM?17?X4[?];RX26ZZ,EY2&.O?*4CY;!!-&/)@4Q15
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M!/!^;C#;5C>T0?.I_?R_4$L#!!0    (  *""U7Y:W="J0L  !8@   9
M>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;)5:6V_;1A9^YZ\8N&[A (JLNY2;
M =MML2F<-HB3%HO%/HS$D30(R6%G2,O:7[_?.3.D2-V2/M21J#FW[]R'?;LQ
M]JM;*U6(YS3)W+N+=5'DKZ^OW6*M4NFZ)E<9?ED:F\H"7^WJVN56R9B)TN1Z
MT.M-KE.ILXN;M_SLH[UY:\HBT9GZ:(4KTU3:[9U*S.;=1?^B>O!)K]8%/;B^
M>9O+E7I4Q9?\H\6WZYI+K%.5.6TR8=7RW<5M__7=B,[S@3^UVKC&9T&6S(WY
M2E_>Q^\N>J202M2B( X2_SRI>Y4DQ AJ_!UX7M0BB;#YN>+^*]L.6^;2J7N3
M_*7C8OWN8G8A8K6495)\,IM_J6#/F/@M3.+XK]CXLWT<7I2N,&D@A@:ISOR_
M\CG@T""8]4X0# +!@/7V@EC+GV4A;]Y:LQ&63H,;?6!3F1K*Z8R<\EA8_*I!
M5]P\_'+[^,OCV^L"O.C)]2+0W7FZP0FZB?A@LF+MQ"]9K.(V_35TJ!495(K<
M#<XR_*W,NF+8ZXA!;S XPV]8&S9D?L.SAHG_W,Y=8>'[_QZST;,8'6=!^?#:
MY7*AWET@X)VR3^KBYJ<?^I/>FS,*CFH%1^>XGT'^+-UQK<8OHF#PY[42]R;-
M9;85:^D$TM?*0F<KD2A$KQ-(9&&62[U00F:Q2.3<X("Q6\%<A<Y$ 1YX:LK5
M&D>C#S);RZ*0&?WV.Q+MWTBT3OV)V>"7>YG.K8Y7JB,^2.?D8ETZ512N(S9K
MO5@+]9QKR_SAX@E3X<.L@]QVN>+L3+9=\4<&<HOSP[X/A@[K4]FDLD)910(+
MPS]\-M:JK?@(F)QX7&B5P8A[/B8>R&22^ CE?]9J93I0,]' (--27!']3S_,
M!H/>F_J$)^*G_3<OD([%^KP,G>H""GV4MLB4=6N=,\8RSZUYUB@<,$N,.RB3
MD?N[E(!@2=76+ E[AB&X@_'OL@?!.*43I.">9D([,1F(U*<?D=,A=JY8F#0E
MW?"G$#$DBPU"X#:W.A']5Q[.;O3Y"-.-3I*&AY"-2MS1#Y98D3TG5+F<=(?C
M"$$F*N.,*:H@6FKK"K%5TIXPIN/QE5Z,G$/EM"G0J86!A=Y*;6.Q+*%GL#VP
MW GQV,UKM=DHG2TL*SO?[OED^*- 7U (5 C($'[6H2]5;$\@VFUE& "0B3,0
M]W>I*2P1E+G$\\()MR8XP&V7@@ 8_4QYMT$5_%!L12&?E?-\]P'&F2<=AZR5
M4%>]+- 3(Y-S3X,T]5RH5@QPZ/!Q]+PXUG10)D#I23%($%[P<?R7B:74EL'"
MD2>9E'OV6>!O4> A^[+?G:(#)0FW8VIV+\WR)5)<7(44^O3'ESIM4  0XV1F
MB\ZKF&@YUPDT4RXZ$5I=\7-I";)&%%!\4<8!TL.ZD,J834)+7F@7P &9,XGF
M3""74+WDV@+%HEBAX)B</:N6T ,'SI:Q*M=JYV<$O2-!KIP']%NF'$_P6\<!
M[S XM&T@M%>9_A_AC6*+A]JR>@N$THICJ1W!E[WNK,;69$=S%%[QWFB4UO$W
M*RN8W*ZL\G&/[[?.Z17J*+>(JF0@<S^I%:+H 79^>;P5#P_WNVB@7^IXR$OK
M2NEY^7;0$!U)$L7)([T<<M:=Q2R7;+-&I_$8-\MV=6BO:H,3R_?1#._Z_N)K
M8DAP+XH-I"J)6*$<I:]E;B!5HLRLA,%1BE#\1"' (<45RII4W&ES)^'$]]FB
MVU+K 5Y/D#E-A8)I=*JM-2*BSM-DVXD\ICM,@!T"@(H1R@7F;$'%QL<M:]%T
M(J73Y;C7Z?4P2N7(EX3"2J=SX*]:)\,I"-A(%-::][-V7*O*# #8@J.1<5^;
M)*:@1$GBL*@RPIP04&5VS1%IC)Q&P8M5;IPN6J?7,HY*S)+V"$!' G\R).4;
M(3WXOIC>^9QTQ]<R]:44(KRL7=B30Z/@T 9A?: ]([#7O/0J1L#3QSK%5RCE
M,?4A.E2%2-4KCTGX!^$;4)B%)B^^U%@>8]P)B7NE4:H7"Y4CW_:88O [],0;
M4&BN[F5*;0S]-:ACYHE>28(2<=$H\!V@\:0RI+[O>E3).=;K_AU\16CVIV]P
M"JHP@3@5#ZQ%4PT:$<@TKL5HJK2L^L([YP'YI*+4+%VG:M\^JJ.3"H/Y7%7\
MX4F:I+V VJM5X)U6G7A>Z:<7Z%A?VQ!:Q0,]>K$71R>1FQ:J $@QUU"$$_-$
MEG 8<K^4*<UA-HSX/GX(5[WT?G>4;DA,)"1&UR-^AFEZI;D>L3]X)"5,NN)W
M4Y @AWT@KAHT=H@GY=V1>]T!1R,A*E0P$L'<N5<+>%/!H5A)^$E$BP"(-7VO
MJD=<*O%5J1RB?+WA"3#X0&;!1.\&^MKA8H$C1,PYYYK!MF^FSSTJE-6)$'O>
MUU^1&9V&QQLQ%;<:>45]/-F:&&RLX23VZ>5!(!SK/HT!-JD-\^7$>F3B>HVK
M,VS;GM>0RZ:DR"7XPL+GX^7V\5[,1BB/#_XI2N?^9BAY]E\D9<P5LRI]G\*L
M)VC68PV=>'FP5X9BR$$8*MI^8E=V\6V%"S$00OXH 4^9Y F6G'E+DBT)]4A5
M0;*;?%MP[!BI1-*.MLM]XDH)&$@QLW/R[V-0]?,]K*)6@<M,]A*=S>Y: MMV
MG'2O-K;)OAN\[BY</) -KFQ#<Y0LCNR%M"3%=?@''_ "P(MI&Q0D]R'.=VHA
M2]_R(\L#=IHG>J'KY2^I5L0,"R%=&.J$6C]1H[(@Q]MY45((:I[!%[X48R69
M(_3-AL C$:ZMML[\I23?[CU)G?A"4IQ=B*%<I4-5O;YA?C?4BK"\[5(KJ@'2
MK@DXJ2/HUHD3A^YO2&]] L>0CWX/IBL6.!&65S< _7K59['.N]=#&G:S $<K
M0GQ/W L$%P17EOPS11]-ZA]P_E%;6OF.6;5/ &A],:^!*=9P!ZF!D0^[$L\5
MR&,G:9NQR, M$?E9T4_:M*MS:W8E[6EN!S*=T9DKK2_SV)H;:4MUF>E3[18J
M 1+*E#34NR*LUCOE:*KU$]]>G(=8;>8_@=!(M<KUS7Q#+DH2W3FTOU.O#Y)8
M&=<$@K8,[_%8/1-G"O$.H14%!Z']TX[>GEI"T3-[BD-IJB5Q[?BF%2VW0^';
M!84._(AU@YOE[F+".;/07"S#S4R52!E?HS+KT&5PAN\9W '_QNY>K-$%62FG
MGZM0)@1B?\E47?E6]X%]7Q4RNB';JYRUDAM%2E!$)(G9.(Q3C"[""NOXB]?1
M9Y9Y5%;$LDA.M%^8 _OH,NJ/)O1W,HH>J[T>:"+\HRO0O0A__ZR\W28?]Z-^
M]-E0]3K@.V6^(_ ]A<5WZ3<<#NEO?WRHWVA ^O'?4_H-HW[OA()#J'89#69#
M?PE)U*BY].8&505_N,PH#(94.Z-0<.K9:N>O_>:TGS+D/!#])K.2LK_?" '>
M&/VD4_,/IYOAT@GQ7849%F24(X=QL8X\:*--O!<<W0:LN_N16];U /&F&46T
MIRT!U1E/IM'[4+%3T)2^<[5O_0Z8]3O3WB2Z]>NUK(K1'D&T(XBN^K,)//I^
M=R.$\PV&5]/I0+R(_L)VS:-EZV<>H3'N[&HYVB\)!=O.<$JA\@W#F\!3 '=>
MC88'.#XT+O7.S#RGD)P.AM^+9).;A_(CG+[0.4AW,TNVHXL.KQVO^LB#/<1.
MR=F>17#$C+YE<0O"06<&:Q^HF3=FQZHQX><1$OR^_93FFGU'#%_U: <YS(UC
M ^3!BR!: 25J*35_%;^4Z/G4ENN-!$/NDL>A<7<0;HY#2SB@B=%TJ2-P"R.2
M6??5]$??=S&@T:V//E8GCF!UOK(?L3:J0NC5*_HXC";3(7T819/9C#Z,HVF/
MGTSP849O/S!C+.'%:#2M"F$5-M&P,Q[UO6LPS])VS->\F! +9%E_ABSS%.>,
MN!3L87'L+>%UXUUMJNR*WTC3H +X_&O;^FG]TOO6O^O='?=OS#](BU),W7<)
MTEYW.K[P*U/UI3 YO_F=FZ(P*7]<8PY7E@[@=WI54WTA ?7_"G#S?U!+ P04
M    "  "@@M52#DNBW@(   ?%   &0   'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6RM6-MNVT@2?==7-#2#8 :P)5F.,T%\ >S8,^-%+H:=S2RPV(<669)Z
M378SW4TIRM?OJ6J2HFS'"!;S$$>4JNMRZM2E>;)V_CXLB:+Z6A8VG Z7,59O
MQN.0+:G48>0JLOAE[GRI(Q[]8APJ3SJ70V4QGDXFK\:E-G9X=B+?W?BS$U?'
MPEBZ\2K49:G]YH(*MSX='@S;+V[-8AGYB_'92:47=$?QG]6-Q].XTY*;DFPP
MSBI/\]/A^<&;BY<L+P*?#:U#[[/B2&;.W?/#=7XZG+!#5% 668/&?RMZ2T7!
MBN#&ET;GL#/)!_N?6^V_2^R(9:8#O77%7R:/R]/AZZ'*::[K(MZZ]9_4Q'/$
M^C)7!/FKUDGV",)9':(KF\/PH#0V_:^_-CCT#KR>?.? M#DP%;^3(?'R4D=]
M=N+=6GF6AC;^(*'*:3AG+"?E+GK\:G NGEU_V+^Y_?CVZNY.W5[=79W?OOU3
MO=!E=:PNKSY?O?MX\_[JPR=U_N%2_?'QX^5?U^_>G8PC[/+I<=;8N$@VIM^Q
M\4J]=S8N@[JR.>6[Y\?PMW-ZVCI],7U6X3]J.U*'DSTUG4RGS^@[[$ X%'V'
M?QL(ZM_GLQ ]./6?I_!(YEX^;8[K[$VH=$:G0Q12(+^BX=F+GPY>38Z?">9E
M%\S+Y[3_31E]WL:K7P?_!V;7%@D[>+VGXI+46U=6VFY0EE]JXRE7U[?_4I^6
MY'5%=3194+^\^.GU=#HYQ@_RZ>#XUSVU7IILJ=8ZX&#F:AMQ$JU)\1=J5@<X
M&H+*7#DS5G/=CUAI9\U3YGS.UFYNQ=M+92S[,] E:U-NKGY^-9J@U(H"IUN#
MGB13-@9Q?JZ-5RM=U 3#P2PL-$:G(F5+ZPJW,,1R.JHU>=J&"%.9L[9I2&L3
MEZ(- 0Y$)IC4J6S>F%WJ%2GK(NQKM..\9R'3A9J3#F9F"A,W<J@15[J(Y#E\
M/,[K6,.'.M"H%S2\IAAV/'L:/J5Q&$X'DY-/4<X(XFA\QII(JH"17 $Z4T@P
M.%L5)$<Y+3/XY2RZN$#+ C#M,J.1N %#JCWB9.=S6F%$5"):>?=?H!3@\KR!
M@^R.A FM)6ISM" +]A3%1KDLJWU0=26#8U$7.CH/B"KH1=;V1&6?A-"F9P5Q
M=-!:DH>#A?E&[$A>9XQ4YW4O;P_@%&('ZL %<C'Y326B;2';3Y"Q#RP"XOD(
M6[E,EUPYX2/X12&:4BPB>?.Z$*@#X%\8:XU=*/!+2%8YPXC@',:E0/8 *;"A
MY'RR]BXGE.\68JDWB4 :G"D*EJPT/ //#"2,%VW94OL% =5"U#'IGT)B 'IF
M=9+1J6;H:\;< @LR[?V& T@5U/#B$3G=BGR_TOIUK(O@ML6\<"Y?HV";6E:]
M6IZ.)H.FEA\YC8;3*[N1^J-5PZG94KS)U^/B\:DV>PFL8\HZ4M?TI1YTVMJ:
MZ;G'T.(,:M/3EQH_@;)FOI.,&4(KD6R]9GV.BV"CD%1N0,)NS_A!#_)A%Q#D
MUF)\5I<A:@N@!\(,!(%&$2GQY$'G:G"'3NX?H$G!^8&D509F=K.$4CR7Y&'V
M4C=[=QE4D><MD5.NOB!4$U,+8KQ"$ P ?4Z)CL1%C>/ 2$@JB!3FGH"&.,'8
M?M_OP8_Y/5)W-7I#WYTYIK;S#%E6U#F!^)EWP-NZTF3<ZW+A \H9\&$#\ZFY
M8F>]QY+<]D+=R&0NQ%;EGG 6.59@#M+ M=. PDD1-4Y"!A5II0%(RNF(9Z,@
M^QA5L)R$@.B66#4#6./*1. /=S?7MU>J6J)QJ*F*G@T"'C!['UJT*G' [&>;
MZ.X9\)E)HP.L+&LKGNAJPW&BU*,1=DEWL[1&%G*C%]9Q3P*I4/37UWOX=\VT
MN_Y\C@6ZYD(#XMBI&?;, $+=\LH!"+2!%9*49K!X]6,N]>=MJ&?,:6Y$!1=^
M\>P$7M+N%$YH;'GT<.T8J4L*%0\RW%A2S8GL7*]<LY7 ::XN\E$S4/B6&P.C
M4L\6WM55:OQM.@8I#;G)A<$EWZSXY\H;OO:@WO+4L.':%6=__W=/!)KZE4%
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MK42IO*BM5PSF6<07@HE-P?!9&F'3FY'(E8,R-GVCJM9V383/SQ2(^[1&AUU
M;"6=(C_^ORHF<HQS83GD*Y@V-HB\(7:+@7/E9:\AZS78-,O-%7_0(A$ (&O
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MQ ))E_C'MH-Q[AA4T^(1#KO0&UUTLJ3#E*UP$_5B 2U+M<1I;!4<I- XWM;
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M(=-0F9-Y>/^8G;R ER$M/L'B6#W8%IJVR%ZN$/2Q"N13 _CTR.4$6)BR--L
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M^ZX89MH&3WOD6QW[V%<I5X8,+GCH,@ >7S1RFQ%9N;/QQSV>=7OW(;$@3K3
M'L/Q!7<ZZ">G#15'V)BTEP@K:DAND,F(5+5RY_)L?PD90B/$CNG/QSM*UH^V
M8>7@M0!UJDF;7>3^W#:F)R\!>UOBZ4YH8 QA9%1Z+[^X:X&C:6)TF"-&XJT"
M-6\H-_^S<R7":TDT5[S0QN9:U72KQ,<6K]_$_Z!@R&\LE MW:AL/<_&+(^2
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MNW<98+Q+OBW$1.HYW4F)R/+XQ^LH&>,&KW]IZ]Y+2ZDU.3M==1#\H";<#=[
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M*+QO[G],1O QROPO5-Q+V7-I-94S$>C#CSM"(O'O!R/)2W[UZ"*^%EZK-@!
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MOJ2/>77/LX.8!.7#/:&_NW*KZOUOWU[[@)V&JY"4(UDO_77WYDK/UI$%:]"
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MRN/Y48@,6R3*-UU&)P;%RFJX[;?F>HKMRK7!CRPDCSE:BDKN3[#MG&GDPR,
M<+6BVR<W50,=O).F<I1<&QJ?,M=<0)RA-*T*/D[(B*Z<E&K?F*3NWD6P0+L.
MUUUN$3HUXYVP_EK?J"?Q(OEH'J_C'X5=TW$'"E>TM==Y3\FR\8H;7[PIP[5R
M:3Q=4L-C3I,3+1O0.O?3[H4=U/]GC/\&4$L#!!0    (  *""U4?6H4K0 0
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M?275VWB:C9-_D 20!2U!:/9,-;R] [T$71VI-ZV]-G5>&S=N]:ZY63FWQ-0
M]!,B0H'&._+"WA"_;ZO6.(Y5@1/(MC'@*O2O%P9=G*<OZLRY2!A\PXI@RM!2
MZ#&-/*4U65B>A=>-1KB%OE.-U4/;%[>6-.>$Q&<96"_T@[!/HMW_DUK8-=>
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M*XLI[)HK?-R"I@4XOU#*UAU2T#R7+_\#4$L#!!0    (  *""U68*[[BC@,
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M;A,Q$'W?K[ 6A*A4=6]I&D*R4I(& 5)1U+2 A'AP=F<OJM=>;&]3_IZQ]]*
MTHB7V#.><WQFG3.SO9 /J@#0Y*EB7,W=0NMZZGDJ*:"BZD+4P/$D$[*B&D.9
M>ZJ60%,+JI@7^O[8JVC)W7AF<QL9ST2C6<EA(XEJJHK*WTM@8C]W [=/W)9Y
MH4W"BV<US6$+^K[>2(R\@24M*^"J%)Q(R.;N(I@N1Z;>%GPM8:\.]L1TLA/B
MP02?TKGK&T' (-&&@>+R""M@S!"AC%\=ISM<:8"'^Y[]@^T=>]E1!2O!OI6I
M+N;NQ"4I9+1A^E;L/T+7SZ7A2P13]I?LV]H0BY-&:5%U8%10E;Q=Z5/W'0X
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M77QV>QX^V[CR"1+\/8FL/ NP#>#FGFKZ&=)R>J37-=<;%P7=JN,TR51H%AF
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M+@K4JIF*KQI$Y03Q?$D(WW:D0/N=%/P!4$L#!!0    (  *""U7L#O %4 0
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M B-A 1(FMC!_7^"1URWP>"?PF!3X5LEU&,^8_**-FDY*Y2&=%4NI]*VZ4OJ
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M7<SF^GAQ@F;IG]M,9%68/\14)EDN?D&GZ.LB1A_^\LO%0*IF:?@@;9HPKYN
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M>/U3 _4'R3;5N_0/3$I65(=KFBPIUR>HOZ\8DZ\?= 7M#SY,_PM02P,$%
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M6_&5ZW7[CJ/<E8L$U*@F4K\4J6\4:1J'H9SEO,NF1E);<2!A! BF*3@H%1P
MV70 J1\DC #!-/TN2OTNP&UJ)+95\F+/IKU!G4V!&M5$<ATU'7;,DPZV90%R
MC08U(]KJ DHC4#1=ODJ:<(%<6H"@1(2D$2B:+J+*#:YQ6GWDQ+> UL\O"Y5
MLP$435=)I0.W(1Z\<2KZ#YDFQ/)R<4Z+LT:?@V8)4!J!HNGBJ^3A=J!\#IHZ
M0&D$BJ:+J(*':YR7'^OS[MZ#=,_GH.$"BJ:KI.*%:\X7-3X_-)L^QN.@4024
M1J!HNO JLKA]*(^#1A90&H&BZ2*JU.(:)_7'>GS0[''09 )%TU52V<0UAY/<
MX]CL5- T DHC4#3]>V856K #]4TS:'0!I1$HFBZBBB[8.*L_TJD%M.K4OH/W
M4NW4W'AKJ4X14'!E8:,AH+RQ*_S4V]R!UN,4=DWD%+D'J]R#/2BS@^874!J!
MHNDBJOR"S4LG1YJ]\TZS@Z84*)HNE4HIN"&E[)L=</YM;KSU& 4-/E T77@5
M?' /RNB@(0:41J!HNH@JQ&#SPLN11N\WSK_-[;96Z10I!:N4@AM22N9QS^Q4
MT'454!J!HNGRJ?B"+Z"<"AIB0&D$BJ9O]E AQFM8>3ENNX>SO_H[P#7/9'/K
MK?=RG"*K>"JK> U9Y8U?X2?@Y@ZTWD<#FGZ@:+KX*OUX4/NZ/- 4 THC4#1=
MQ,K>KI-L[O(:G\OF=ENK=(J8XJF8XC7$E'V? \Z]S8VW'IZ@H0>*I@NO0H\'
MM2G, PTPH#0"1=-%5 '&:UBY.<[CO;UU[ -/=-"< D7+M;(K.[+3_?,WE#_[
M48("MI1XY[PO?S,\WY*>'XAXG6W2GL5"Q&'V=L7H@O'T _+Z,H[%ZT&Z[[O\
MQX#Q_U!+ P04    "  "@@M5Z!JQ ^P#   Z#P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6R]5U%OXC@0_BM6;G5JI;9)# 3H 1*EY8Y3VZV@[3ZL
M]L$D [$VL5G;@3WI?OS924CH$2*6KO8%8L?SS3>VOYE,;\/%5QD"*/0]CICL
M6Z%2JVO;EGX(,9%7? 5,OUEP$1.EAV)IRY4 $J1&<61CQ_'LF%!F#7KIW),8
M]'BB(LK@22"9Q#$1_]Q Q#=]R[6V$U.Z#)69L >]%5G"#-3+ZDGHD5V@!#0&
M)BEG2,"B;PW=ZQN<&J0K7BELY,XS,J',.?]J!I.@;SF&$43@*P-!]-\:1A!%
M!DGS^):#6H5/8[C[O$4?I\'K8.9$PHA'GVB@PK[5L5  "Y)$:LHW?T$>4,O@
M^3R2Z2_:Y&L="_F)5#S.C36#F++LGWS/-V+' .,#!C@WP"GOS%'*\I8H,N@)
MOD'"K-9HYB$--;76Y"@SIS)30K^EVDX-QL/)%+T.[U_NT,<Q&D\>AX^CR? >
M31YGS].7A[O'Y]D%&H6$+4$BRM G(@1A"MU3,J<1551/G]V"(C22Y^B#6?(<
M\D02%LB>K31#X\?V<S8W&1M\@(V''CA3H41W+(#@K;VM(RO"P]OP;G MX-\)
MNT(-YP)A!V/T,KM%9Q_.:W ;Q;8U4MS& =R='1D3*M KB1) ?%&Y/Y^G/(J0
MOD0;(H(O5;N2.6M6.S/"O)8KXD/?TLJ3(-9@#7[_S?6</VI":1:A-.O0!Q_7
M("YE,I>^H*M,*3%/= @"?-"*":H(9Y!>"FF$OQYXCM.SUQ4\6@6/5BV//P67
M$JT$]P$"6>L] VKM>'=U%CK@WRO\>[7^TW-<FW.\0'-84L8H6YHC78&@O)*'
MM\?C (=VP:%]) =$%'H@P@]1-[^\9U3*A# ?4$ 4G%?Q:5?L2ZO3K>;4*3AU
M:CEE5]W<]$7)3F_+)K_I47G3JSAU]CA=NKIBM*I)=0M2W:,/"UA0?TS=/0JX
MA9O5!%RG3)Q.+85[6$.$,/K\ /$<Q!?T+WH2<+E(3.K:Y@%9O*Y,AK4>3M2]
MNY/ZW5^9Q')O/SD:7$:#?[9^<\0C!.R6A<&M3=;OE7"._N:R>DWO *LRQ[OU
M2?Z=(L[1WZJXVSRDH3+EN_4Y_X=D[.ZG_;:##U HL[Y;G_8S&3=V93SB<<S9
MD1*N13_UTI?UPFW_4@G7EJ=3HRDKC5M?:DZ1\'Y].23ALK:XQQ:7TR2\7V^Z
MW6:CFA4NZPVNKS?OE'"._D;"'1>[!VB51037IO4?DW".M?O=Z';P_S5L[[0S
M,8AEVK1)Y)NOTJRS*6:+QG"8M4/E\JRKU(>GKY%$$2RTJ7/5UO&+K%'+!HJO
MTN9HSI5NM=+'4#>W(,P"_7[!N=H.C(.B71[\!U!+ P04    "  "@@M5][&
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MUD5?E(-6(T^UX&2EONESPL6$H"Y3,24B*@'B_H(0OEW( ,W<&?P%4$L#!!0
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M?*\Q/Q$TR7;?-E0(&F>'!P2WB*D'Y/T=I>)TH@8H=WQG_P-02P,$%     @
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M8:\FU!_6?>Q=>)-I-'/W?5?6]Y[I*NQ<A=8Y_]\_ /99'K[F+'\ELB>!C+M
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M;\!V?CAWC_-[Y^$[&#_88/;X:/^\O;L#%S9B,(SH);@&3TL;7'R^!)^!"F@
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M9$:QO&W/)X*F6>>[I$+VT=DPD)\ZP-0">7]%J7B<J&:Z_'AR_P-02P,$%
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M*J/PXE%&L2/9/O]Q?\VD9$F^N0.BUK4^0'V_84P^[>CG!=4#I=E_4$L#!!0
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MT>J6VD4)MCE+^)KR#9,95\6Z[Z-8JR7Q8R%Y1,TU%KD,/H;27"C-@])\*"V
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MOQ3D$KG6!7(LQVFP9WP\W&YRY_^T!_^L?2\8;GU*7,W7?NN4[)P%CAXFD"V
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M-*%HNF0KJ\DZP&MZ'[XKBV#?R VUFJ T!TIC)6US_*P-VO4FEET?L?>"W(-
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M[/F0[2$)BE6AC7*&>E\HFB[GRONBAWA?#45(FT4,YARM-0VUPJ T!J5Q*$U
M:2Z4)E$T7>6584<'1RE&H%8=E.9 :0Q*XU":@-)<*$VB:+JN*^./FHT_R$\0
MS3E:JWQ8MQ,H'=3L!*>A8=^JKTUET.YQ*$U :2Z4)E$T79J5 4@/-0"+2FK^
M1OSJT@E)5F!L7$FA4950WP]*<Z T!J5Q*$W0!G-PN.4+0C-*%$V7;>4+TD.7
MBGF3B9JKV,N/H,\J27.O6CO*[CNL0DU"*,V!TAB4QJ$T01O69=FG=7,;FE6B
M:+J(*_N/FA>-??4#=7)=5+LBKP',)V]0TP]*<Z T!J5Q*$U :2Z4)E$T_;)&
ME>EG'V7]F WU^J T!TIC4!J'T@24YD)I$D73=5WY?_;_8?V8.4=KE==72M$A
MK0^7#C0M@](XE":@-!=*DRB:+N#*XK/-Z]5^*ZOBE1/2J$ZHFP>E.5 :@](X
ME":@-'>/*/KD37EQXU414?W0Y;IQ?42SJ?.C,Q)F?&LQ8Z^5B+U8(O9JB=C+
M)6*OEVCOG=^0J(RZ;"N'SC8[=+@9B3+1YLX.!Z/:X'YC[E!K:4(-."B-0VD"
M2G.A-(FBZ2*N##C;O&)NYXQ$=MA]+R,R 4>A.LF'#W(5AOZSBI/\:M.FR0MS
MVM;'9*A#!Z4Q*(U#:0)*<Z$TB:+IPJ\<.GMXE,D+J"<'I3E0&H/2.)0FH#07
M2I,HFJ[KRMZSS?;>QKG?)+]BR:-JE#'4Q(/2'"B-06D<2A-0FEO2QAM59.\3
M'6P7S<>P\>S*QK/--MZM/\\$FI43!Q@@9E1KD4*-.BB-06D<2A-0F@NE211-
M%W-EY]E'6<UG0XT]*,V!TAB4QJ$T :6Y4)I$T?0[/%3&7M^\T MB@)ASM%5Y
M2=N<(AF,ZU,D#C0K@](XE":@-!=*DRB:KM_*P.L?:N#]Z,Q<O^Z[]:WZ;R9O
MS!UJ>Q"&TAB4QJ$T :6Y4)I$T58B[F[<]RU0\6-QT\"$3*)EF.9)-K:N;TQX
M5=R.;VO[M77F6 W;F77&F[8+Z\Q=W8ZP2KNZ.^*M%S_Z84+F:I9UH?=IE,D\
M7MUP</4DC1;%W>@>HC2-@N+AD_*F*LX;9*_/HBA]?Y(G6-_V\?(O4$L#!!0
M   (  *""U786UK%O@(  %T)   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q
M+GAM;*U66V^;,!3^*Q:3IE9JRR6DG3*"E 2V=E/:J&FWAVD/#IP$5+"9;9+N
MW\\VA"4=R:J-%WP[WW=N^!Q[&\J>> (@T'.>$3XT$B&*@6GR*($<\PM: )$G
M2\IR+.22K4Q>,,"Q!N69Z5C6I9GCE!B^I_=FS/=H*;*4P(PA7N8Y9C_'D-'-
MT+"-[<9]NDJ$VC!]K\ KF(-X+&9,KLR&)4YS(#RE!#%8#HV1/0C[2EX+?$EA
MPW?F2'FRH/1)+6[BH6$I@R"#2"@&+(<U3"#+%)$TXT?-:30J%7!WOF7_H'V7
MOBPPAPG-OJ:Q2(;&.P/%L,1E)N[IYAIJ?[2!$<VX_J)-)7ME&2@JN:!Y#986
MY"FI1OQ<QV$'('G: 4X-<%X"W . 7@WHO5:#6P/<UVKHUP#MNEGYK@,78(%]
MC]$-8DI:LJF)CKY&RWBE1/TG<\'D:2IQPI\_W$T^GX]'\S! D[OI++R=CQYN
M[F[/T/W\D:.3  1.,WZ*SA%/, .^'5*"'A):<DQB[IE"FJ((S:A6.Z[4.@?4
M]M"4$I%P%)(8XA9\<!Q_>01ORA T<7"V<1@[1PD_E>0"]:PSY%B.TV+/Y/5P
MN\V=_],>_K/VO6#TFI^BI_G< WPZ]=^FD"^ ?6]+[E&X*FT#7N (AH:L71S8
M&@S_[1O[TGK?%MDNR8(NR<*.R/9RX#8Y<#5[[]#%5-?L?"QK8(PF-)=]@6-=
M6D<++IBLKT<3Y':9H"[)@B[)PH[(]A+4;Q+4__LE^<@P$3)#)[(<5H7QM"T=
M%5-?,ZG.O?8MSUSOQOA/"=OJ[\L$+3*V9>\+A<>)*D_-G7Z1 UOI1LU11$LB
MJBK1[#9O@9%N@2_VQ_9@8K?L!_+M4+7ZW_35PV.*V2HE'&6PE*JLBRMI*:N:
M>;40M-#=:D&%['UZFLCW#S E(,^7E(KM0BEH7E3^+U!+ P04    "  "@@M5
M0T'FC[L"  !U!P  &0   'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6RM55%/
MVS 0_BM6)DT@ 4D3&K8NC=0&IK&I4%%@#X@'-[DV$8G=V4[+_OW.3IJU-!0T
M[27VV?=]_NXN/@<K+IYD"J#(<Y$SV;=2I18]VY9Q"@65)WP!#'=F7!14H2GF
MMEP(H(D!%;GM.HYO%S1C5AB8M;$( UZJ/&,P%D2614'%[R'D?-6W.M9ZX2:;
MITHOV&&PH'.8@+I;C 5:=L.29 4PF7%&!,SZUJ#3BWSM;QSN,UC)C3G1D4PY
M?]+&9=*W'"T(<HB59J X+"&"/-=$*.-7S6DU1VK@YGS-_M7$CK%,J82(YS^S
M1*5]ZY-%$IC1,E<W?/4-ZGBZFB_FN31?LJI]'8O$I52\J,&HH,A8-=+G.@\;
M .1I![@UP'TOP*L!G@FT4F;".J>*AH'@*R*T-[+IB<F-06,T&=-5G"B!NQGB
M5#BYO8Y^' \'DXMS$EV/QA=7D\'MY?75$;DJBRD(PF?D9G(GR3U(!0FA+"%8
M6I7C_. <%,UR>4B.*Y^'$6C,(]HRI0+D>L@8N4UY*1$M UNA;GVZ'=<:AY5&
M]Q6-'AEQIE))+E@"20L^VH_W]^!MS%>3-'>=M*&[E_![R4Z(YQP1UW'=-CW_
M#-^2XS4U] R?]PK?VY5Z&$RE$GAE'MNR7[&?MK/K-M*3"QI#W\(^(4$LP0H_
M?NCXSI>VT/\3V58B3IM$G.YC#TWXRRK\ _SGJK_OL"WFBJAKB'2G6X:N']C+
MS4AV7;QNX[*EK]OHZ^[5%_&BP-:%ESI^PGNNTA3RA"A.8K[$ BKZC'?E#>'=
M'57'GU\(W^NR)=QOA/OO%YY)6;Z=8']'1.?LA<Y=EXT:5#KMC<Y6@)B;AB\Q
M7R5359-K5ILW96!:J?W7O7J01E3,,R9)#C.$.B=G>+"HFGQE*+XP?7+*%79=
M,TWQ702A'7!_QKE:&_J YJ4-_P!02P,$%     @  H(+5=")1#(Y!@  (R\
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M&2J6WE'9VT@$2LXX?GHKH<=VUA"2YA:TNH;VZ'#;X8%F]:%H32$K'\?2&SD
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MUN5(%#A:=+3%A).]:MDVA(L&4 UCP!%0:2">;PGA3Q/IH/I?8?X/4$L#!!0
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M>FGQN%)QP--5_@#/-.4\C?.W2X)GA,HOB/_/TY0_'<@*JH?&1O\!4$L#!!0
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M ]<WJ-\7C,F[$SU L2/O_P]02P,$%     @  H(+52)V:1NZ!   E2,  !D
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
M1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2
M?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;
MZ/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  "@@M5,%CMWNP$  "$
M)P  #P   'AL+W=O<FMB;V]K+GAM;,6:6V_;-A2 _PKAAZT#G-G6)6FSNH B
M,8E06])$.5N?!L6F8R*Z&!2==/WU.Y)KE$KC@[TP?K)$"?2G0_)\%*F/S[5\
MO*_K1_*U+*IF.M@HM;T<C9KEAI=Y\WN]Y15<6=>RS!6<RH=1LY4\7S4;SE59
MC*SQ^'Q4YJ(:?/IXJ"N1(_VD5GRI1%U!85MP)_AS\^-Z>TJ>1"/N12'4O]-!
M=USP 2E%)4KQC:^F@_& -)OZ^;:6XEM=J;Q@2UD7Q70PV5^XXU*)Y4_%K(7,
M\ONF*U'Y?9H#R'1P/H8*UT(VJKNCJS\'QB<.-^_/=JJ^%H7B,L@5OY'U;BNJ
MA[8:>(J1]AA=' Z_^R!>RO\3QGJ]%DL>U,M=R2NUCZ/D10M8-1NQ;0:DRDL^
M'1QN(7FU(K12$"025ONJX-[V2>&OP]7^J17@:C&4EP(NR'#5@9N#].,HH!&C
M 8$C%L_"P,O@Y,J;>9%/B09I(9#6"2'_L31(&X&T3P+),OB9TTB#=!!(YX20
MO4BZ"*1[2DA;@SQ'(,_-0@:4^6F89&$<D?B:7"U8&%'&B!>U'9-ID!<(Y(59
MR%GXYR(,PNQ+A^5[29AY,Y)2%B]2G^J0[Q'(]V8AYS2]H>F0!"%+8A9V$6UQ
M/1_@6:A!?D @/YB%O/;"E-QYLP5M6_LZC"#SA!#+,&)9NICKR7R,9?.QX0:G
M'NNUZP1UBV&YA-%9DL9^.RR@SU$O]6_)+WFY_8,$]([.XF1.=53,,!/3BJ$Q
M833Q4F_?_VY2VF;M3.?#Y#(Q;!?/]],%)$'Z=]*FQEX38SZ9&!?*?!YF;:3V
MJ0\R=A9&-Q1&1Q\2\\G$L%!8%ON?SR K=TJ9MQ'LFEGGPU0R,>R2CN\VG@4T
M9;\2"FDO^Z*S80:9&%8(C-H(&I21A*:$W7II;\ABVI@8]D9*?>AVH D_7G2=
MCD"RB>#8_VGD8N*8&#8'6UPQ:-(6%9)>C\O"5&$95@4Z@>E-!2W,(99AAZ"M
MW,=$WU ,^P.=Q/0Q,8U8AC6"3F/ZF)A5+,-6V4]CR#MXJR]X\YN.A7G$,NR1
MEQ)^%1 3B?46(GE%=-]!=4S,*=:;.^752&)RL0S+!<^.^CNHA<G%,BP7] 6O
MOS*"N<8V[!H\.^K1M#'7V(9=@V,Z.B;F&ONDKG%U3'0]S+!K<,QS'1-SC6W8
M-3CFA8Z)N<<V[![<W+TAA!G(-FP@'+,WA# #V:87QKH)QI#$6R[A:O5 9CQO
M.'D7<)6+0L?$+&0;MM !,X+Z7Z+2KUL=$[.0;=I"1Z*9BH>-.JOUI6_,0LZ;
M+(X-R3Q7.RF4X VIUS^@=4S,0LZI5\UZ7G<P$SDG6C7[/HYT3,Q$SALOGAV&
M>6^ZZ:#;,J=<1AOJVW .)B''^,X,@MGOEIB$',,2PC%U5SJ8A!S#$CKVMC8D
M3-7+1QT3DY!C6$+',?_BD.!U3$Q"CNEUMN/1W)5EKF]M8A)R#4OH.&;*%HT^
MTEU,0JYA"1W'C';EO;Z2X&("<@T+"&WT_GXV)B#7L("01N>-DCHF9B'7L(70
MA-2/)OIYP%MLY[S8+AF21(HG "*)CHE9R#W!K@Y,/KE\X!)F(#HF9B'W!(MQ
MKTR/7$Q!KFD%O=A#>9T0LX_;V6=T^.IKQ=>BXJL(:F^@?)D7RT22]F>_$^VX
M[9[1>E<4/I3%U:S.5X>/R X?P'WZ#U!+ P04    "  "@@M5678!^/4!   X
M(P  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=J[3NM %(7A5XG\
M $SV+< 1H:*A1;R %287D<26/0AX>Z)0A&51G ;-JJRQY>V_^F2-??>4]VW9
M=<=QN^O'V<=A?QR7S;:4_E]*XVJ;#^UXU?7Y>+JR[H9#6T[+89/Z=O7:;G+2
M^7R1AI\SFON[GS-GSY]]_I^)W7J]6^6';O5VR,?RR^#TW@VOXS;GTLR>VV&3
MR[))'_O+Z3&=#W)UFMS,'E^6S?#X(DVJ':00I/6##(*L?I!#D-</"@B*^D$+
M"%K4#[J&H.OZ03<0=%,_Z!:";NL'R1QEG!,D3; FT%J0:R'P6A!L(1!;D&PA
M,%L0;2%06Y!M(7!;$&XAD%N0;B&P6Q!O(=!;46\ET%M1;R706R<OVP1Z*^JM
M!'HKZJT$>BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'H;ZFT$>AOJ;01Z&^IM
M!'K;9+.$0&]#O8U ;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]'O9U ;T>]
MG4!O1[V=0&]'O9U ;Y]L=A/H[:BW$^CMJ+<3Z.VHMQ/H[:BW$^CMJ+<3Z!VH
M=Q#H':AW$.@=J'<0Z!VH=Q#H':AW$.@=DX^5!'H'ZAT$>@?J'01Z!^H=!'H'
MZAU_J?=8/O=YO/1\K_$[]U]274[WYLOCS\OODXCSXHQS@A]E[K\ 4$L#!!0
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M?\KZ9.WZKW^RZ.]Y:^KN/9\-?[)<O0)02P$"% ,4    "  "@@M5!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    (  *""U46VTL*[P   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  *""U697)PC$ 8  )PG   3
M          "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M H(+55/20D'J!0  _AX  !@              ("!#@@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  *""U5:G*,4. 8  #H;   8
M          " @2X.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M    "  "@@M55Y:N#!\#   1"P  &               @(&<%   >&PO=V]R
M:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @  H(+5;T6+D8&!@  ?QH
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M965T."YX;6Q02P$"% ,4    "  "@@M5N5QS@>,0  "H+@  &
M    @($81P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @
M H(+55*B<V/<"   =A<  !D              ("!,5@  'AL+W=O<FMS:&5E
M=',O<VAE970Q,"YX;6Q02P$"% ,4    "  "@@M5^6MW0JD+   6(   &0
M            @(%$80  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4
M Q0    (  *""U5(.2Z+> @  !\4   9              " @21M  !X;"]W
M;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @  H(+5<_G@[5K!@
M,Q   !D              ("!TW4  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6Q02P$"% ,4    "  "@@M5!;=E/_8"  !D!@  &0              @(%U
M?   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (  *""U4C
M$R5K*!4  -@\   9              " @:)_  !X;"]W;W)K<VAE971S+W-H
M965T,34N>&UL4$L! A0#%     @  H(+5:G([;92#0  [RD  !D
M     ("! 94  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  *""U5YB<[?_00  ',,   9              "
M@4.Y  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @  H(+
M51]:A2M !   P@D  !D              ("!=[X  'AL+W=O<FMS:&5E=',O
M<VAE970R,BYX;6Q02P$"% ,4    "  "@@M51^47D&4&   Z#P  &0
M        @('NP@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0
M   (  *""U68*[[BC@,  . (   9              " @8K)  !X;"]W;W)K
M<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @  H(+55$O9T)\!   > P
M !D              ("!3\T  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q0
M2P$"% ,4    "  "@@M5K+!VEI@"  "U!0  &0              @($"T@
M>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (  *""U6&.MAS
M]00  +(.   9              " @='4  !X;"]W;W)K<VAE971S+W-H965T
M,C<N>&UL4$L! A0#%     @  H(+57N&S\H2 P  N 8  !D
M ("!_=D  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    "  "
M@@M5I94 .T8"  #I!   &0              @(%&W0  >&PO=V]R:W-H965T
M<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (  *""U47JT1)9P,  #,-   9
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M970S-"YX;6Q02P$"% ,4    "  "@@M5Z"G[+_L#  !8%0  &0
M    @(';_@  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (
M  *""U77)U"X304  "0P   9              " @0T# 0!X;"]W;W)K<VAE
M971S+W-H965T,S8N>&UL4$L! A0#%     @  H(+5>@:L0/L P  .@\  !D
M             ("!D0@! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"
M% ,4    "  "@@M5][& $%0$   F%@  &0              @(&T# $ >&PO
M=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (  *""U5T?"I5!0,
M (,*   9              " @3\1 0!X;"]W;W)K<VAE971S+W-H965T,SDN
M>&UL4$L! A0#%     @  H(+57*O+*I7!   _14  !D              ("!
M>Q0! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    "  "@@M5
M)9UG=I(#   M#@  &0              @($)&0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0Q+GAM;%!+ 0(4 Q0    (  *""U4#E/X-X ,  $L3   9
M      " @=(< 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%
M  @  H(+50L4& H7!   WQ0  !D              ("!Z2 ! 'AL+W=O<FMS
M:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    "  "@@M5Y%7@QD,#  !(#0
M&0              @($W)0$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+
M 0(4 Q0    (  *""U5EMFKQ7 0  %P:   9              " @;$H 0!X
M;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @  H(+55I,TC&\
M!0  C#0  !D              ("!1"T! 'AL+W=O<FMS:&5E=',O<VAE970T
M-BYX;6Q02P$"% ,4    "  "@@M5O15X P$#  #-#   &0
M@($W,P$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    (  *"
M"U4%X9]MSP(  'T)   9              " @6\V 0!X;"]W;W)K<VAE971S
M+W-H965T-#@N>&UL4$L! A0#%     @  H(+5;L@D?U+ P  >PL  !D
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M=#4S+GAM;%!+ 0(4 Q0    (  *""U4'G^M/& 0  !@7   9
M  " @1A3 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @
M H(+56 R,9R' P  8Q   !D              ("!9U<! 'AL+W=O<FMS:&5E
M=',O<VAE970U-2YX;6Q02P$"% ,4    "  "@@M5>\WW=%@'  ! -@  &0
M            @($E6P$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4
M Q0    (  *""U4>Q1&F& 0  )T7   9              " @;1B 0!X;"]W
M;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @  H(+52)V:1NZ!
ME2,  !D              ("! V<! 'AL+W=O<FMS:&5E=',O<VAE970U."YX
M;6Q02P$"% ,4    "  "@@M5^/N_?>H$   =*P  &0              @('T
M:P$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    (  *""U4R
M4M6V20,  / 4   -              "  15Q 0!X;"]S='EL97,N>&UL4$L!
M A0#%     @  H(+59>*NQS     $P(   L              ( !B70! %]R
M96QS+RYR96QS4$L! A0#%     @  H(+53!8[=[L!   A"<   \
M     ( !<G4! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  *""U59=@'X
M]0$  #@C   :              "  8MZ 0!X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    (  *""U47R,P;VP$  -$B   3
M  "  ;A\ 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !# $, 3!(  ,1^
$ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>222</ContextCount>
  <ElementCount>343</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>57</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>060100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>060200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LiquidityAndCapitalResources</Role>
      <ShortName>LIQUIDITY AND CAPITAL RESOURCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>060300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>060400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/FairValueOfFinancialInstruments</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>060500 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>060600 - Disclosure - IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwill</Role>
      <ShortName>IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>060700 - Disclosure - CEO SEPARATION AGREEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CeoSeparationAgreement</Role>
      <ShortName>CEO SEPARATION AGREEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>060800 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/AccruedExpenses</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>060900 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>061000 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensation</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>061100 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockholdersEquity</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>061200 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/EarningsPerShare</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>061300 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/RecentAccountingPronouncements</Role>
      <ShortName>RECENT ACCOUNTING PRONOUNCEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>061400 - Disclosure - SUBSEQUENT EVENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/SubsequentEvent</Role>
      <ShortName>SUBSEQUENT EVENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>070100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>071300 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies</Role>
      <ShortName>RECENT ACCOUNTING PRONOUNCEMENTS (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>080300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>080400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/FairValueOfFinancialInstruments</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>080500 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/Leases</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>080800 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/AccruedExpensesTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/AccruedExpenses</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>081000 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/StockbasedCompensation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>081200 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/EarningsPerShareTables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/EarningsPerShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>090100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>090200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails</Role>
      <ShortName>LIQUIDITY AND CAPITAL RESOURCES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/LiquidityAndCapitalResources</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>090300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>090302 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>090304 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>090306 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>090308 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails</Role>
      <ShortName>MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>090400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>090402 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>090500 - Disclosure - LEASES, Operating Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LeasesOperatingLeaseDetails</Role>
      <ShortName>LEASES, Operating Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>090502 - Disclosure - LEASES, Net Operating Lease Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails</Role>
      <ShortName>LEASES, Net Operating Lease Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>090504 - Disclosure - LEASES, Operating Lease Right-of-use Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails</Role>
      <ShortName>LEASES, Operating Lease Right-of-use Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>090506 - Disclosure - LEASES, Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>LEASES, Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>090600 - Disclosure - IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails</Role>
      <ShortName>IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwill</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>090700 - Disclosure - CEO SEPARATION AGREEMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CeoSeparationAgreementDetails</Role>
      <ShortName>CEO SEPARATION AGREEMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/CeoSeparationAgreement</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>090800 - Disclosure - ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/AccruedExpensesDetails</Role>
      <ShortName>ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/AccruedExpensesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>090900 - Disclosure - COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>090902 - Disclosure - COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>090904 - Disclosure - COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>091000 - Disclosure - STOCK-BASED COMPENSATION, Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>091002 - Disclosure - STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Stock Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Stock Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>091004 - Disclosure - STOCK-BASED COMPENSATION, Summary of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, Summary of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>091006 - Disclosure - STOCK-BASED COMPENSATION, RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationRsusDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/StockbasedCompensationTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>091008 - Disclosure - STOCK-BASED COMPENSATION, Number of RSUs Vested and Settled (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, Number of RSUs Vested and Settled (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>091010 - Disclosure - STOCK-BASED COMPENSATION, Summary of RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, Summary of RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>091012 - Disclosure - STOCK-BASED COMPENSATION, Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>091014 - Disclosure - STOCK-BASED COMPENSATION, Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION, Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>091100 - Disclosure - STOCKHOLDERS' EQUITY, Private Placement of Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY, Private Placement of Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>091104 - Disclosure - STOCKHOLDERS' EQUITY, Merger (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/StockholdersEquityMergerDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY, Merger (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>091200 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/EarningsPerShareDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/EarningsPerShareTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="brhc10040603_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>091400 - Disclosure - SUBSEQUENT EVENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/SubsequentEventDetails</Role>
      <ShortName>SUBSEQUENT EVENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://brooklynitx.com/role/SubsequentEvent</ParentRole>
      <Position>59</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="brhc10040603_10q.htm">brhc10040603_10q.htm</File>
    <File>brhc10040603_ex10-3.htm</File>
    <File>brhc10040603_ex31-1.htm</File>
    <File>brhc10040603_ex31-2.htm</File>
    <File>brhc10040603_ex32-1.htm</File>
    <File>brhc10040603_ex32-2.htm</File>
    <File>btx-20220630.xsd</File>
    <File>btx-20220630_cal.xml</File>
    <File>btx-20220630_def.xml</File>
    <File>btx-20220630_lab.xml</File>
    <File>btx-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>logo01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="705">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>81
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10040603_10q.htm": {
   "axisCustom": 0,
   "axisStandard": 25,
   "contextCount": 222,
   "dts": {
    "calculationLink": {
     "local": [
      "btx-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "btx-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "brhc10040603_10q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "btx-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "btx-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "btx-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 537,
   "entityCount": 1,
   "hidden": {
    "http://brooklynitx.com/20220630": 1,
    "http://fasb.org/us-gaap/2022": 1,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 7
   },
   "keyCustom": 109,
   "keyStandard": 234,
   "memberCustom": 26,
   "memberStandard": 28,
   "nsprefix": "btx",
   "nsuri": "http://brooklynitx.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://brooklynitx.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS",
     "role": "http://brooklynitx.com/role/FairValueOfFinancialInstruments",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060500 - Disclosure - LEASES",
     "role": "http://brooklynitx.com/role/Leases",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060600 - Disclosure - IN-PROCESS RESEARCH & DEVELOPMENT AND GOODWILL",
     "role": "http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwill",
     "shortName": "IN-PROCESS RESEARCH & DEVELOPMENT AND GOODWILL",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "btx:ChiefExecutiveOfficerSeparationAgreementTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060700 - Disclosure - CEO SEPARATION AGREEMENT",
     "role": "http://brooklynitx.com/role/CeoSeparationAgreement",
     "shortName": "CEO SEPARATION AGREEMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "btx:ChiefExecutiveOfficerSeparationAgreementTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060800 - Disclosure - ACCRUED EXPENSES",
     "role": "http://brooklynitx.com/role/AccruedExpenses",
     "shortName": "ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060900 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://brooklynitx.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061000 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://brooklynitx.com/role/StockbasedCompensation",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061100 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://brooklynitx.com/role/StockholdersEquity",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061200 - Disclosure - EARNINGS PER SHARE",
     "role": "http://brooklynitx.com/role/EarningsPerShare",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061300 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS",
     "role": "http://brooklynitx.com/role/RecentAccountingPronouncements",
     "shortName": "RECENT ACCOUNTING PRONOUNCEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061400 - Disclosure - SUBSEQUENT EVENT",
     "role": "http://brooklynitx.com/role/SubsequentEvent",
     "shortName": "SUBSEQUENT EVENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "070100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)",
     "role": "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "071300 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS (Policies)",
     "role": "http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies",
     "shortName": "RECENT ACCOUNTING PRONOUNCEMENTS (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080500 - Disclosure - LEASES (Tables)",
     "role": "http://brooklynitx.com/role/LeasesTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080800 - Disclosure - ACCRUED EXPENSES (Tables)",
     "role": "http://brooklynitx.com/role/AccruedExpensesTables",
     "shortName": "ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "btx:ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081000 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "btx:ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081200 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://brooklynitx.com/role/EarningsPerShareTables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)",
     "role": "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U003",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U003",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES (Details)",
     "role": "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails",
     "shortName": "LIQUIDITY AND CAPITAL RESOURCES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Merger (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember",
      "decimals": "4",
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090302 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Fair Value of Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210325_BusinessAcquisitionAxis_NTNBuzztimeIncMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090304 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Disposition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210326to20210326_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_NTNBusinessMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210101to20210630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueAcquisitions",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090306 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210716to20210716_AssetAcquisitionAxis_NovellusTherapeuticsLimitedMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireOtherProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090308 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS, Investment in NoveCite (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210716to20210716_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_NoveCiteINCMember",
      "decimals": "INF",
      "lang": null,
      "name": "btx:NumberOfBoardSeats",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090400 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details)",
     "role": "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS, Liabilities Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "btx:OverSubscriptionAmountReceived",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090402 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)",
     "role": "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
     "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS, Changes in Warrant Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "btx:OperatingLeaseArea",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U006",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090500 - Disclosure - LEASES, Operating Lease (Details)",
     "role": "http://brooklynitx.com/role/LeasesOperatingLeaseDetails",
     "shortName": "LEASES, Operating Lease (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "btx:OperatingLeaseArea",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U006",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090502 - Disclosure - LEASES, Net Operating Lease Expenses (Details)",
     "role": "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails",
     "shortName": "LEASES, Net Operating Lease Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090504 - Disclosure - LEASES, Operating Lease Right-of-use Assets and Liabilities (Details)",
     "role": "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails",
     "shortName": "LEASES, Operating Lease Right-of-use Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": "-3",
      "lang": null,
      "name": "btx:WriteOffOfOperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090506 - Disclosure - LEASES, Maturities of Operating Lease Liabilities (Details)",
     "role": "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails",
     "shortName": "LEASES, Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090600 - Disclosure - IN-PROCESS RESEARCH & DEVELOPMENT AND GOODWILL (Details)",
     "role": "http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails",
     "shortName": "IN-PROCESS RESEARCH & DEVELOPMENT AND GOODWILL (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20181231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "U003",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090700 - Disclosure - CEO SEPARATION AGREEMENT (Details)",
     "role": "http://brooklynitx.com/role/CeoSeparationAgreementDetails",
     "shortName": "CEO SEPARATION AGREEMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220524to20220524_TitleOfIndividualAxis_ChiefExecutiveOfficerMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:PaymentsForPostemploymentBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090800 - Disclosure - ACCRUED EXPENSES (Details)",
     "role": "http://brooklynitx.com/role/AccruedExpensesDetails",
     "shortName": "ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220805to20220805_SubsequentEventTypeAxis_SubsequentEventMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090900 - Disclosure - COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)",
     "role": "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES, Legal Matters (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220805to20220805_SubsequentEventTypeAxis_SubsequentEventMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "btx:MilestonePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090902 - Disclosure - COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details)",
     "role": "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES, Licensing Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630_RangeAxis_MaximumMember_RelatedPartyTransactionsByRelatedPartyAxis_NovellusTherapeuticsLimitedMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "btx:MilestonePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090904 - Disclosure - COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)",
     "role": "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES, Royalty Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210322to20210322_TypeOfArrangementAxis_InvestorRoyaltyAgreementMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "btx:PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091000 - Disclosure - STOCK-BASED COMPENSATION, Stock Option Activity (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION, Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091002 - Disclosure - STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Stock Options Granted (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails",
     "shortName": "STOCK-BASED COMPENSATION, Weighted-Average Assumptions Used for Stock Options Granted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY",
     "role": "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20201231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_MembershipEquityMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091004 - Disclosure - STOCK-BASED COMPENSATION, Summary of Stock Options (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
     "shortName": "STOCK-BASED COMPENSATION, Summary of Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091006 - Disclosure - STOCK-BASED COMPENSATION, RSUs (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
     "shortName": "STOCK-BASED COMPENSATION, RSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091008 - Disclosure - STOCK-BASED COMPENSATION, Number of RSUs Vested and Settled (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
     "shortName": "STOCK-BASED COMPENSATION, Number of RSUs Vested and Settled (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "U003",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091010 - Disclosure - STOCK-BASED COMPENSATION, Summary of RSUs (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails",
     "shortName": "STOCK-BASED COMPENSATION, Summary of RSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630_AwardTypeAxis_Two022PerformanceBasedRestrictedStockUnitsMember",
      "decimals": "INF",
      "lang": null,
      "name": "btx:NumberOfPerformanceGoalsAreSubjectToAchieve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U008",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091012 - Disclosure - STOCK-BASED COMPENSATION, Restricted Stock (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails",
     "shortName": "STOCK-BASED COMPENSATION, Restricted Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630_AwardTypeAxis_RestrictedStockUnitsRSUMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091014 - Disclosure - STOCK-BASED COMPENSATION, Stock-Based Compensation Expense (Details)",
     "role": "http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
     "shortName": "STOCK-BASED COMPENSATION, Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091100 - Disclosure - STOCKHOLDERS' EQUITY, Private Placement of Equity (Details)",
     "role": "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails",
     "shortName": "STOCKHOLDERS' EQUITY, Private Placement of Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220306_ClassOfWarrantOrRightAxis_CommonWarrantsMember",
      "decimals": "4",
      "lang": null,
      "name": "btx:ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210325to20210325",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "btx:StockIssuedDuringPeriodSharesAcquisitions1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091104 - Disclosure - STOCKHOLDERS' EQUITY, Merger (Details)",
     "role": "http://brooklynitx.com/role/StockholdersEquityMergerDetails",
     "shortName": "STOCKHOLDERS' EQUITY, Merger (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20210325to20210325",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "btx:StockIssuedDuringPeriodSharesAcquisitions1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091200 - Disclosure - EARNINGS PER SHARE (Details)",
     "role": "http://brooklynitx.com/role/EarningsPerShareDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220401to20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220630_ClassOfWarrantOrRightAxis_PreFundedWarrantsMember",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unitRef": "U003",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091400 - Disclosure - SUBSEQUENT EVENT (Details)",
     "role": "http://brooklynitx.com/role/SubsequentEventDetails",
     "shortName": "SUBSEQUENT EVENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220712_InvestmentTypeAxis_PIPEInvestorMember_SubsequentEventTypeAxis_SubsequentEventMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060100 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "role": "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "btx:LiquidityAndCapitalResourcesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060200 - Disclosure - LIQUIDITY AND CAPITAL RESOURCES",
     "role": "http://brooklynitx.com/role/LiquidityAndCapitalResources",
     "shortName": "LIQUIDITY AND CAPITAL RESOURCES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "btx:LiquidityAndCapitalResourcesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060300 - Disclosure - MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS",
     "role": "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions",
     "shortName": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10040603_10q.htm",
      "contextRef": "c20220101to20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 57,
   "tag": {
    "btx_AccruedGeneralAndAdministrativeExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/AccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued general and administrative expenses.",
        "label": "Accrued General and Administrative Expenses",
        "terseLabel": "Accrued general and administrative expenses"
       }
      }
     },
     "localname": "AccruedGeneralAndAdministrativeExpenses",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AccruedResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/AccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued research and development expenses.",
        "label": "Accrued Research and Development Expenses",
        "terseLabel": "Accrued research and development expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpenses",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AcquisitionAgreementNonCompetitivePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Acquisition Agreement contains non-competition and non-solicitation provisions pursuant to which the Seller has agreed not to engage in certain competitive activities for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquisition Agreement, Non Competitive Period",
        "terseLabel": "Non-compete period"
       }
      }
     },
     "localname": "AcquisitionAgreementNonCompetitivePeriod",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_AdditionalFeesObligatedToPay": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entity is obligated to pay additional fees to Licensors.",
        "label": "Additional Fees Obligated to Pay",
        "terseLabel": "Amount require to pay of initial license fees"
       }
      }
     },
     "localname": "AdditionalFeesObligatedToPay",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease (increase) in additional paid in capital (APIC) for the increase in redemption of temporary equity as the result of a triggering event associated with the temporary equity.",
        "label": "Adjustments to Additional Paid in Capital, Elimination Historical Member Equity",
        "terseLabel": "Elimination of Brooklyn's historical members' equity"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEliminationHistoricalMemberEquity",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AggregateCalendarDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified aggregate calendar days (which need not be consecutive calendar days) during any 12-month period for resale, Updated definition.",
        "label": "Aggregate Calendar Days",
        "terseLabel": "Aggregate calendar days"
       }
      }
     },
     "localname": "AggregateCalendarDays",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_AmountObligatedToPayInYearOne": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entity is obligated to pay additional fees to the Licensors in first year.",
        "label": "Amount Obligated to Pay in Year One",
        "terseLabel": "Additional fees obligated to pay in 2021"
       }
      }
     },
     "localname": "AmountObligatedToPayInYearOne",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AmountObligatedToPayInYearTwo": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entity is obligated to pay additional fees to the Licensors in second year.",
        "label": "Amount Obligated to Pay in Year Two",
        "terseLabel": "Additional fees obligated to pay in 2022"
       }
      }
     },
     "localname": "AmountObligatedToPayInYearTwo",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AmountRequireToPayInitialLicenseFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount require to pay out of the total initial license fees.",
        "label": "Amount Require to Pay Initial License Fees",
        "terseLabel": "Amount obligated to pay in license agreement"
       }
      }
     },
     "localname": "AmountRequireToPayInitialLicenseFees",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AssetAcquisitionFairValueOfConsiderationPaid": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fair value of consideration paid in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition, Fair Value of Consideration Paid",
        "totalLabel": "Total fair value of consideration paid"
       }
      }
     },
     "localname": "AssetAcquisitionFairValueOfConsiderationPaid",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_AssetAcquisitionRestrictedSharesSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered with restrictions to be paid in asset acquisition.",
        "label": "Asset Acquisition, Restricted Shares, Share Price",
        "terseLabel": "Restricted shares, fair value per share (in dollars per share)"
       }
      }
     },
     "localname": "AssetAcquisitionRestrictedSharesSharePrice",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "btx_AssetAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in asset acquisition.",
        "label": "Asset Acquisition, Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "AssetAcquisitionSharePrice",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "btx_AssetAcquisitionUnrestrictedSharesSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered without any restrictions to be paid in asset acquisition.",
        "label": "Asset Acquisition, Unrestricted Shares, Share Price",
        "terseLabel": "Unrestricted shares, fair value per share (in dollars per share)"
       }
      }
     },
     "localname": "AssetAcquisitionUnrestrictedSharesSharePrice",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "btx_BaseRentPerSquareFoot": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of base rent expense per square foot for leased asset.",
        "label": "Base Rent per Square Foot",
        "terseLabel": "Base rent (per square foot)"
       }
      }
     },
     "localname": "BaseRentPerSquareFoot",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "btx_BeneficialHoldersContractualCommitmentsToInvest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual commitment made by beneficial holders to invest in the entity.",
        "label": "Beneficial Holders Contractual Commitments To Invest",
        "terseLabel": "Beneficial holders contractual commitments to invest"
       }
      }
     },
     "localname": "BeneficialHoldersContractualCommitmentsToInvest",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of software development costs recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Software Development Costs",
        "terseLabel": "Software development costs"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedSoftwareDevelopmentCosts",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_CEOSEPARATIONAGREEMENTAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CEO SEPARATION AGREEMENT [Abstract]"
       }
      }
     },
     "localname": "CEOSEPARATIONAGREEMENTAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "xbrltype": "stringItemType"
    },
    "btx_CashPaidDuringThePeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid During the Period for [Abstract]",
        "terseLabel": "Cash paid during the period for:"
       }
      }
     },
     "localname": "CashPaidDuringThePeriodForAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of chair of the board of directors, former chief executive officer and president.",
        "label": "Chair of the Board of Directors, Former Chief Executive Officer and President [Member]",
        "terseLabel": "Chair of the Board of Directors, Former Chief Executive Officer and President [Member]"
       }
      }
     },
     "localname": "ChairOfTheBoardOfDirectorsFormerChiefExecutiveOfficerAndPresidentMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_ChiefExecutiveOfficerAndPresidentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of chief executive officer and president.",
        "label": "Chief Executive Officer and President [Member]",
        "terseLabel": "Dr. Federoff [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerAndPresidentMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_ChiefExecutiveOfficerSeparationAgreementTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure pertaining to chief executive officer separation agreement.",
        "label": "Chief Executive Officer Separation Agreement [Text Block]",
        "terseLabel": "CEO SEPARATION AGREEMENT"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerSeparationAgreementTextBlock",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "btx_CitiusPharmaceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents Citius Pharmaceuticals, Inc. Ownership interest.",
        "label": "Citius Pharmaceuticals, Inc. [Member]"
       }
      }
     },
     "localname": "CitiusPharmaceuticalsIncMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_ClassOfWarrantOrRightExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights exercised during the period.",
        "label": "Class of Warrant or Right Exercised",
        "verboseLabel": "Warrants exercised (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercised",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_ClassOfWarrantOrRightIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued into which the class of warrant or right may be converted.",
        "label": "Class of Warrant or Right, Issued",
        "terseLabel": "Number of rights options issued (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightIssued",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of securities that would be issuable upon the exercise of warrants or rights.",
        "label": "Class of Warrant or Right Percent of Securities that Would be Issuable Upon Exercise of Warrants or Rights",
        "terseLabel": "Percentage of warrants exercisable"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightPercentOfSecuritiesThatWouldBeIssuableUponExerciseOfWarrantsOrRights",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_ClassOfWarrantOrRightsExercisableTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants or rights exercisable term, , in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Class of Warrant or Rights Exercisable Term",
        "terseLabel": "Warrant exercisable term"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightsExercisableTerm",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_CollaboratorRoyaltyAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative royalty arrangement in licensing deal with the company.",
        "label": "Collaborator Royalty Agreement [Member]",
        "terseLabel": "Collaborator Royalty Agreement [Member]"
       }
      }
     },
     "localname": "CollaboratorRoyaltyAgreementMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_CommonStockToBeRetainedByNTNSharesStockholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock to be retained by NTN stockholders during the period pursuant to acquisitions.",
        "label": "Common Stock to be Retained by NTN, Shares, Stockholders",
        "terseLabel": "Common stock to be retained by NTN stockholders (in shares)"
       }
      }
     },
     "localname": "CommonStockToBeRetainedByNTNSharesStockholders",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_CommonStockToBeRetainedByNTNValueStockholders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of common stock to be retained by NTN stockholders during the period.",
        "label": "Common Stock to be Retained by NTN, Value, Stockholders",
        "terseLabel": "Common stock to be retained by NTN stockholders"
       }
      }
     },
     "localname": "CommonStockToBeRetainedByNTNValueStockholders",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_CommonStockWithheldToCoverTaxes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares of common stock withheld to cover the withholding taxes.",
        "label": "Common Stock Withheld to Cover Taxes",
        "negatedLabel": "Common stock withheld to cover taxes (in shares)"
       }
      }
     },
     "localname": "CommonStockWithheldToCoverTaxes",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_CommonUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to common units, representing ownership interest in a corporation.",
        "label": "Common Units [Member]",
        "verboseLabel": "Common [Member]"
       }
      }
     },
     "localname": "CommonUnitsMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_CommonWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A common warrant represents the right to purchase a company's stock at a specific price and at a specific date.",
        "label": "Common Warrants [Member]",
        "terseLabel": "Common Warrants [Member]"
       }
      }
     },
     "localname": "CommonWarrantsMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_ConsecutiveCalendarDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In the event the PIPE Investor is not permitted to use the registration statement to resell the securities registered in specified consecutive calendar days for resale, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Consecutive Calendar Days",
        "terseLabel": "Consecutive calendar days"
       }
      }
     },
     "localname": "ConsecutiveCalendarDays",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_DetailedInformationAboutLiquidityAndCapitalResourcesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Detailed information about Liquidity and Capital Resources [Abstract]",
        "verboseLabel": "Liquidity and Capital Resources [Abstract]"
       }
      }
     },
     "localname": "DetailedInformationAboutLiquidityAndCapitalResourcesAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_DheshGovenderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dhesh Govender, a former short-term consultant of the entity",
        "label": "Dhesh Govender [Member]",
        "terseLabel": "Govender [Member]"
       }
      }
     },
     "localname": "DheshGovenderMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as Lease liability attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Lease liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLeaseLiability",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as Obligations under finance leases attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Obligations under finance leases",
        "terseLabel": "Obligations under finance leases"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationObligationsUnderFinanceLeases",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate proceeds received from assume advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Assume Advance/Loans",
        "terseLabel": "Assume advance/loans"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromAssumeAdvanceLoans",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromCash",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate proceeds received from escrow deposits in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Escrow",
        "terseLabel": "Escrow"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromEscrow",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate proceeds received from interest on advance/loans in a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Disposal Group, Including Discontinued Operation, Proceeds from Interest on Advance/Loans",
        "terseLabel": "Interest on advance/loans"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationProceedsFromInterestOnAdvanceLoans",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as software development cost attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Software development costs",
        "negatedLabel": "Software development costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCosts",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DisposalGroupIncludingDiscontinuedOperationTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs of the business disposal including legal, accounting, and other costs incurred to consummate the business disposition.",
        "label": "Disposal Group, Including Discontinued Operation, Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationTransactionCosts",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_DispositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposition [Abstract]"
       }
      }
     },
     "localname": "DispositionAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_EachLockUpAgreementExtendsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of lock-up agreement extend term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Each Lock-up Agreement Extends Term",
        "terseLabel": "Each lock-up agreement extend term"
       }
      }
     },
     "localname": "EachLockUpAgreementExtendsTerm",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of the employee of the entity, appointed to the position.",
        "label": "Employee [Member]",
        "terseLabel": "Employees [Member]"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_EscrowPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of secure indemnification obligations to acquisition agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Escrow Period",
        "terseLabel": "Period of escrow"
       }
      }
     },
     "localname": "EscrowPeriod",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_EscrowShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares have been placed in escrow shares.",
        "label": "Escrow Shares",
        "terseLabel": "Escrow shares (in shares)"
       }
      }
     },
     "localname": "EscrowShares",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the fees incurred in connection with the common stock issued to Lincoln Park to the entity.",
        "label": "Fees Incurred in Connection With the Common Stock Issued to Lincoln Park",
        "negatedLabel": "Fees incurred in connection with the common stock issued to Lincoln Park"
       }
      }
     },
     "localname": "FeesIncurredInConnectionWithTheCommonStockIssuedToLincolnPark",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_GainLossOnDisposalOfFixedAssets": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of fixed assets.",
        "label": "Gain (Loss) on Disposal of Fixed Assets",
        "terseLabel": "Loss on disposal of fixed assets"
       }
      }
     },
     "localname": "GainLossOnDisposalOfFixedAssets",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_GainOnTerminationOfLease": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain on termination of lease before expiration of lease term.",
        "label": "Gain on Termination of Lease",
        "negatedLabel": "Gain on lease termination"
       }
      }
     },
     "localname": "GainOnTerminationOfLease",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security deposits and also includes any other non-current assets which are not separately reported in during the period.",
        "label": "Increase (Decrease) in Deposit Assets and Other Non-current Assets",
        "negatedLabel": "Security deposits and other non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInDepositAssetsAndOtherNonCurrentAssets",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the operating lease liabilities.",
        "label": "Increase (Decrease) in Operating Lease Liabilities",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_InitialLicenseFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial license fees required to pay including non-refundable fee.",
        "label": "Initial License Fees",
        "terseLabel": "Initial license fees"
       }
      }
     },
     "localname": "InitialLicenseFees",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_InitialMeasurementOfOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of initial measurement of operating lease liabilities in noncash financing activities.",
        "label": "Initial Measurement of Operating Lease Liabilities",
        "terseLabel": "Initial measurement of operating lease liabilities"
       }
      }
     },
     "localname": "InitialMeasurementOfOperatingLeaseLiabilities",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_InitialMeasurementOfOperatingLeaseROUAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of initial measurement of operating lease ROU assets.",
        "label": "Initial Measurement of Operating Lease ROU Assets",
        "terseLabel": "Initial measurement of operating lease ROU assets"
       }
      }
     },
     "localname": "InitialMeasurementOfOperatingLeaseROUAssets",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_InitialMeasurementOfRightOfUseAssetsAndLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of Initial measurement of ROU assets and liabilities in noncash financing activities.",
        "label": "Initial Measurement of Right-of-Use Assets and Liabilities",
        "terseLabel": "Initial measurement of ROU assets and liabilities"
       }
      }
     },
     "localname": "InitialMeasurementOfRightOfUseAssetsAndLiabilities",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_InvestorRoyaltyAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement other than collaborative applicable to investor royalty.",
        "label": "Investor Royalty Agreement [Member]",
        "terseLabel": "Investor Royalty Agreement [Member]"
       }
      }
     },
     "localname": "InvestorRoyaltyAgreementMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_LIQUIDITYANDCAPITALRESOURCESAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIQUIDITY AND CAPITAL RESOURCES [Abstract]"
       }
      }
     },
     "localname": "LIQUIDITYANDCAPITALRESOURCESAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "xbrltype": "stringItemType"
    },
    "btx_LegalMattersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Matters [Abstract]",
        "terseLabel": "Legal Matters [Abstract]"
       }
      }
     },
     "localname": "LegalMattersAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_LesseeCommitmentToPurchaseProperty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property for which lessee committed to purchase.",
        "label": "Lessee, Commitment to Purchase Property",
        "terseLabel": "Commitment to purchase equipment"
       }
      }
     },
     "localname": "LesseeCommitmentToPurchaseProperty",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fourth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments Due after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Lessee Operating Lease Weighted Average Remaining Lease Term And Discount Rate Abstract [Abstract]",
        "terseLabel": "Weighted Average Remaining Lease Term and Discount Rate [Abstract]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseWeightedAverageRemainingLeaseTermAndDiscountRateAbstractAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_LicensingAgreementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licensing Agreements [Abstract]",
        "terseLabel": "Licensing Agreements [Abstract]"
       }
      }
     },
     "localname": "LicensingAgreementsAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_LiquidityAndCapitalResourcesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of liquidity and resource matters when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). going concern.",
        "label": "Liquidity And Capital Resources [Text Block]",
        "terseLabel": "LIQUIDITY AND CAPITAL RESOURCES"
       }
      }
     },
     "localname": "LiquidityAndCapitalResourcesTextBlock",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LiquidityAndCapitalResources"
     ],
     "xbrltype": "textBlockItemType"
    },
    "btx_LockUpPeriodForRestrictedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period in which shares are locked-up, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Lock-up Period for Restricted Shares",
        "terseLabel": "Lock-up period"
       }
      }
     },
     "localname": "LockUpPeriodForRestrictedShares",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_LossContingencyDamagesSoughtExpectedEquityPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of equity promised to the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Expected Equity Percentage",
        "terseLabel": "Percentage of equity promised against plaintiff"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtExpectedEquityPercentage",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_LossContingencyDamagesSoughtExpectedSalary": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The monetary amount of salary promised to the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Expected Salary",
        "terseLabel": "Defendants salary promised against plaintiff"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtExpectedSalary",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_LossContingencyNonRefundableOptionFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of Non-refundable option fee in licensing agreement.",
        "label": "Loss Contingency, Non-refundable Option Fee",
        "terseLabel": "Non-refundable option fee"
       }
      }
     },
     "localname": "LossContingencyNonRefundableOptionFee",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_LossContingencyNumberOfArbitrationPanel": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number member in arbitration panel pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, Number of Arbitration Panel Member",
        "terseLabel": "Number of member arbitration panel"
       }
      }
     },
     "localname": "LossContingencyNumberOfArbitrationPanel",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_LossContingencyPercentageOfRoyaltyPayable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of royalty payable from one party to another in licensing agreement.",
        "label": "Loss contingency, Percentage of Royalty Payable",
        "terseLabel": "Percentage of royalty payable"
       }
      }
     },
     "localname": "LossContingencyPercentageOfRoyaltyPayable",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_LossOnNonControllingInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss on non-controlling investment.",
        "label": "Loss on Non-controlling Investment",
        "negatedLabel": "Loss on non-controlling investment",
        "terseLabel": "Loss on non-controlling investment"
       }
      }
     },
     "localname": "LossOnNonControllingInvestment",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_MembershipEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity membership interest in entity.",
        "label": "Membership Equity [Member]",
        "terseLabel": "Membership Equity [Member]"
       }
      }
     },
     "localname": "MembershipEquityMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_MergerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merger [Abstract]"
       }
      }
     },
     "localname": "MergerAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_MilestoneOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions based on milestones.",
        "label": "Milestone Options [Member]",
        "terseLabel": "Milestone Options [Member]"
       }
      }
     },
     "localname": "MilestoneOptionsMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_MilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of milestones upfront payment on licenses.",
        "label": "Milestone Payments",
        "terseLabel": "Milestone payments"
       }
      }
     },
     "localname": "MilestonePayments",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_NTNBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the disposal group.",
        "label": "NTN Business [Member]",
        "terseLabel": "NTN Business [Member]"
       }
      }
     },
     "localname": "NTNBusinessMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NTNBuzztimeIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of acquiree entity.",
        "label": "NTN Buzztime, Inc [Member]",
        "terseLabel": "NTN Buzztime, Inc [Member]"
       }
      }
     },
     "localname": "NTNBuzztimeIncMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of preferred stock issued in a reverse merger transaction in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Preferred Shares Issued in Connection with Reverse Merger",
        "terseLabel": "Series A preferred stock retained in business combination"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionPreferredSharesIssuedInConnectionWithReverseMerger",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_NoveCiteINCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of company involved in licensing agreement.",
        "label": "NoveCite, INC. [Member]",
        "terseLabel": "NoveCite, INC. [Member]"
       }
      }
     },
     "localname": "NoveCiteINCMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NoveCiteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of company involved in licensing agreement.",
        "label": "NoveCite [Member]",
        "terseLabel": "NoveCite [Member]"
       }
      }
     },
     "localname": "NoveCiteMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NovellusIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of company involved in licensing agreement.",
        "label": "Novellus, Inc. [Member]"
       }
      }
     },
     "localname": "NovellusIncMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NovellusLtdAndFactorBioscienceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of companies involved in licensing agreement.",
        "label": "Novellus Ltd. and Factor Bioscience [Member]",
        "terseLabel": "Licensors [Member]"
       }
      }
     },
     "localname": "NovellusLtdAndFactorBioscienceMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NovellusTherapeuticsLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of company involved in licensing agreement.",
        "label": "Novellus Therapeutics Limited [Member]",
        "terseLabel": "Novellus, Ltd. [Member]"
       }
      }
     },
     "localname": "NovellusTherapeuticsLimitedMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_NumberOfAwardsVestedAndSettledAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Awards Vested and Settled [Abstract]",
        "terseLabel": "Number of RSUs Vested and Settled [Abstract]"
       }
      }
     },
     "localname": "NumberOfAwardsVestedAndSettledAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_NumberOfBoardSeats": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of members of the company's management holds board seats on board of directors.",
        "label": "Number of Board Seats",
        "terseLabel": "Number of board seats"
       }
      }
     },
     "localname": "NumberOfBoardSeats",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_NumberOfPerformanceGoalsAreSubjectToAchieve": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of performance goals are subject to achieve under 2022 performance based restricted stock units.",
        "label": "Number of Performance Goals are Subject to Achieve",
        "terseLabel": "Number of performance goals are subject to achieve"
       }
      }
     },
     "localname": "NumberOfPerformanceGoalsAreSubjectToAchieve",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents obligated to maintain under merger agreement on balance sheet at the effective time of the merger.",
        "label": "Obligated to Maintain Cash and Cash Equivalents Under Merger Agreement",
        "terseLabel": "Cash and cash equivalents obligated to have under merger agreement"
       }
      }
     },
     "localname": "ObligatedToMaintainCashAndCashEquivalentsUnderMergerAgreement",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_ObligationToPayLiquidatedDamagesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages percentage of aggregate payment on Subscription Amount.",
        "label": "Obligation to Pay Liquidated Damages Percentage",
        "terseLabel": "Obligated to pay liquidated damages percentage"
       }
      }
     },
     "localname": "ObligationToPayLiquidatedDamagesPercentage",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuant to the registration rights agreement, obligation to pay the PIPE Investor liquidated damages equal to the Subscription Amount per month.",
        "label": "Obligation to Pay Liquidated Damages Percentage on Subscription Amount per Month",
        "terseLabel": "Obligation to pay liquidated damages per month"
       }
      }
     },
     "localname": "ObligationToPayLiquidatedDamagesPercentageOnSubscriptionAmountPerMonth",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_OperatingLeaseArea": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of leased property under operating lease.",
        "label": "Operating Lease Area",
        "terseLabel": "Operating lease area"
       }
      }
     },
     "localname": "OperatingLeaseArea",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "btx_OperatingLeaseAssestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Asset [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseAssestAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for lessee's operating lease right-of-use assets and liabilities.",
        "label": "Operating Lease Right-of-use Assets and Liabilities [Table Text Block]",
        "terseLabel": "Operating Lease Right-of-use Assets and Liabilities"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "btx_OverSubscriptionAmountReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Over-subscription amount received in PIPE (Private Investment in Public Equity) transaction.",
        "label": "Over-Subscription Amount Received",
        "terseLabel": "Over-subscription amount received"
       }
      }
     },
     "localname": "OverSubscriptionAmountReceived",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PIPEInvestorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private investment in public equity, often called a PIPE deal, involves the selling of publicly traded common shares or some form of preferred stock or convertible security to private investors. It is an allocation of shares in a public company not through a public offering in a stock exchange. PIPE deals are part of the primary market. In the U.S., a PIPE offering may be registered with the Securities and Exchange Commission on a registration statement or may be completed as an unregistered private placement.",
        "label": "PIPE Investor [Member]",
        "terseLabel": "PIPE Investor [Member]"
       }
      }
     },
     "localname": "PIPEInvestorMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_PaymentToOfficerBaseSalary": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflows for payment of annual base salary for a period of twelve months after the expiration of the applicable revocation period.",
        "label": "Payment to Officer Base Salary",
        "terseLabel": "Payment of annual base salary"
       }
      }
     },
     "localname": "PaymentToOfficerBaseSalary",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PaymentsOfPaycheckProtectionProgramLoan": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash outflow for payment of paycheck protection program loans.",
        "label": "Payments of Paycheck Protection Program Loan",
        "negatedLabel": "Repayment of NTN's PPP loan"
       }
      }
     },
     "localname": "PaymentsOfPaycheckProtectionProgramLoan",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PaymentsToAcquireProductiveAssetsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets excluding cash acquired.",
        "label": "Cash paid, net",
        "terseLabel": "Cash paid, net"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssetsNet",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PercentageBaseRentIncreaseOnEachAnniversary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of base rent increase on each anniversary.",
        "label": "Percentage, Base Rent Increase on each Anniversary",
        "terseLabel": "Percentage of increase in base rent on each year"
       }
      }
     },
     "localname": "PercentageBaseRentIncreaseOnEachAnniversary",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfAdditionalRightsOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of additional right offering made by the entity for unit holders.",
        "label": "Percentage of Additional Rights Offering",
        "terseLabel": "Percentage of additional rights offering"
       }
      }
     },
     "localname": "PercentageOfAdditionalRightsOffering",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfCommonStockSubjectToLockUpAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of shares of common stock subject to the lock-up agreement",
        "label": "Percentage of Common Stock Subject to Lock-up Agreement",
        "terseLabel": "Percentage of common stock subject to the lock-up agreement"
       }
      }
     },
     "localname": "PercentageOfCommonStockSubjectToLockUpAgreement",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfDiscountOnFairValueOfRestrictedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of discount on restricted shares, which was derived from the average discount rate between the Black Scholes and Finnerty valuation models.",
        "label": "Percentage of Discount on Fair Value of Restricted Shares",
        "terseLabel": "Percentage of discount on fair value restricted shares"
       }
      }
     },
     "localname": "PercentageOfDiscountOnFairValueOfRestrictedShares",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of additional royalty payable on gross sales by the entity.",
        "label": "Percentage of Payment Of Additional Royalty On Gross Sales",
        "terseLabel": "Percentage of payment of additional royalty on gross sales"
       }
      }
     },
     "localname": "PercentageOfPaymentOfAdditionalRoyaltyOnGrossSales",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenue from receives any revenue involving the original cell line included in the licensed technology, then Novellus, Ltd shall remit to NoveCite.",
        "label": "Percentage of Revenue",
        "terseLabel": "Percentage of revenue"
       }
      }
     },
     "localname": "PercentageOfRevenue",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of royalty receive equal to revenues generated from disposition of business.",
        "label": "Percentage of Royalty Receive Equal to Revenues from Sale of Business",
        "terseLabel": "Percentage of royalty receive equal to revenues from sale of business"
       }
      }
     },
     "localname": "PercentageOfRoyaltyReceiveEqualToRevenuesFromSaleOfBusiness",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "btx_PerformanceBasedStockOptionGrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on performance basis.",
        "label": "Performance-Based Stock Option Grant [Member]",
        "terseLabel": "Milestone Grant [Member]"
       }
      }
     },
     "localname": "PerformanceBasedStockOptionGrantMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_PreFundedWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A pre-funded warrant that allows the warrant holder to purchase a specified number of a company's securities at a nominal exercise price.",
        "label": "Pre-funded Warrants [Member]",
        "terseLabel": "Pre-funded Warrants [Member]"
       }
      }
     },
     "localname": "PreFundedWarrantsMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_PrincipalPaymentsOnOperatingLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal payments on operating lease liabilities.",
        "label": "Principal payments on operating lease liabilities",
        "negatedLabel": "Principal payments on operating lease liabilities"
       }
      }
     },
     "localname": "PrincipalPaymentsOnOperatingLeaseLiabilities",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PrivatePlacementOfEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement of Equity [Abstract]",
        "terseLabel": "Private Placement of Equity [Abstract]"
       }
      }
     },
     "localname": "PrivatePlacementOfEquityAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_ProFormaFairValueAdjustmentToAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value adjustment to acquisition-date assets reported in proforma information.",
        "label": "Pro Forma Fair Value Adjustment to Assets [Member]",
        "terseLabel": "Fair Value Adjustment to Assets [Member]"
       }
      }
     },
     "localname": "ProFormaFairValueAdjustmentToAssetsMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_ProceedsFromDispositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Disposition [Abstract]",
        "terseLabel": "Proceeds from sale [Abstract]"
       }
      }
     },
     "localname": "ProceedsFromDispositionAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_ProceedsFromIssuanceOfCommonStockToLincolnPark": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the proceeds from issuance of common stock to Lincoln Park to the entity.",
        "label": "Proceeds From Issuance of Common Stock to Lincoln Park",
        "terseLabel": "Proceeds from issuance of common stock to Lincoln Park"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockToLincolnPark",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_ProceedsFromSaleOfRights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of rights during the period.",
        "label": "Proceeds From Sale Of Rights",
        "terseLabel": "Proceeds from right offering"
       }
      }
     },
     "localname": "ProceedsFromSaleOfRights",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_PurchasePriceAllocationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price allocation of acquisition-date assets and liability assumed.",
        "label": "Purchase Price Allocation [Member]"
       }
      }
     },
     "localname": "PurchasePriceAllocationMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_ResearchAndDevelopmentInProcessAssetAcquisition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a asset acquisition have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process, Asset Acquisition",
        "terseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcessAssetAcquisition",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_RoyaltyAgreementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Agreements [Abstract]",
        "terseLabel": "Royalty Agreements [Abstract]"
       }
      }
     },
     "localname": "RoyaltyAgreementsAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number RSUs vested and settled.",
        "label": "Schedule of Restricted Stock Units Vested and Settled [Table Text Block]",
        "terseLabel": "RSUs Vested and Settled"
       }
      }
     },
     "localname": "ScheduleOfRestrictedStockUnitsVestedAndSettledTableTextBlock",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "btx_SeparationAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Separation Agreement [Abstract]",
        "terseLabel": "Separation Agreement [Abstract]"
       }
      }
     },
     "localname": "SeparationAgreementAbstract",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "btx_SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of severance benefit, would have received if he was entitled to receive a settlement of a pro rata portion of his performance restricted stock units through the expiration of the Separation Period.",
        "label": "Severance Benefit Receivable Based on Performance Restricted Stock Units",
        "terseLabel": "Severance benefit receivable based on performance restricted stock"
       }
      }
     },
     "localname": "SeveranceBenefitReceivableBasedOnPerformanceRestrictedStockUnits",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of extended post-termination exercise period under the share-based compensation arrangements, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Extended Post-Termination, Exercise Period",
        "terseLabel": "Exercise period of extended post-termination"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExtendedPostTerminationExercisePeriod",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of performance goals not achieved under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Performance Goal not Achieved",
        "terseLabel": "Number of performance goals not achieved"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPerformanceGoalNotAchieved",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of monthly installments for vesting of remaining shares in share-based compensation arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment, Number of Monthly Installments for Vesting of Remaining Shares",
        "terseLabel": "Number of monthly installments"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentNumberOfMonthlyInstallmentsForVestingOfRemainingShares",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "btx_ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option granted during the year.",
        "label": "Share-Based Payment Arrangement, Option, Grants in Period [Table Text Block]",
        "terseLabel": "Stock Option Granted"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementOptionGrantsInPeriodTableTextBlock",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "btx_ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the equity options or other equity instruments granted during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Grant in Period [Table Text Block]",
        "terseLabel": "RSU Granted"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementRestrictedStockUnitGrantInPeriodTableTextBlock",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "btx_SharesIssuedSharesForfeitureOfUnvestedRestrictedStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares Forfeiture of unvested restricted stock during the period.",
        "label": "Shares Issued, Shares, Forfeiture of unvested restricted stock",
        "negatedLabel": "Forfeiture of unvested restricted stock (in shares)"
       }
      }
     },
     "localname": "SharesIssuedSharesForfeitureOfUnvestedRestrictedStock",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodRestrictedSharesAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued with restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Restricted Shares, Acquisitions",
        "terseLabel": "Restricted shares, issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodRestrictedSharesAcquisitions",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodRestrictedSharesValueAcquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "btx_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued with restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Restricted Shares, Value, Acquisitions",
        "terseLabel": "Restricted shares, value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodRestrictedSharesValueAcquisitions",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodSharesAcquisitions1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions1",
        "terseLabel": "Issuance of common stock for business combination (in shares)",
        "verboseLabel": "Stock issued, shares, acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions1",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodSharesInLieuOfDividends": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period in lieu of dividends to be paid.",
        "label": "Stock Issued During Period, Shares, in Lieu of Dividends",
        "terseLabel": "Issuance of common stock in lieu of cash dividend to Series A preferred stockholders (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesInLieuOfDividends",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the shares of new stock issued of preferred stock during the period.",
        "label": "Stock Issued During Period, Shares, New Issues of Preferred Stock, Retained by Stockholders",
        "terseLabel": "Series A preferred stock retained in business combination (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssuesOfPreferredStockRetainedByStockholders",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodSharesPrivateOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been issued in private offering during the period.",
        "label": "Stock Issued During Period, Shares, Private Offering",
        "terseLabel": "Issuance of common stock in connection with private offering (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPrivateOffering",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodSharesStockPurchaseAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been issued in a stock purchase agreement during the period.",
        "label": "Stock Issued During Period, Shares, Stock Purchase Agreement",
        "terseLabel": "Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockPurchaseAgreement",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodUnrestrictedSharesAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued without any restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Unrestricted Shares, Acquisitions",
        "terseLabel": "Unrestricted shares, issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodUnrestrictedSharesAcquisitions",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "btx_StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "btx_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued without any restrictions during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Unrestricted Shares, Value, Acquisitions",
        "terseLabel": "Unrestricted shares, value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodUnrestrictedSharesValueAcquisitions",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValueAcquisitions1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions1",
        "terseLabel": "Issuance of common stock for business combination"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions1",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Forfeiture of unvested restricted stock during the period.",
        "label": "Stock Issued During Period, Value, Forfeiture of Unvested Restricted Stock",
        "terseLabel": "Forfeiture of unvested restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueForfeitureOfUnvestedRestrictedStock",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValueInLieuOfDividends": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued during the period in Lieu of Dividends to be paid.",
        "label": "Stock Issued During Period, Value, in Lieu of Dividends",
        "terseLabel": "Issuance of common stock in lieu of cash dividend to Series A preferred stockholders"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueInLieuOfDividends",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued of preferred stock during the period.",
        "label": "Stock Issued During Period, Value, New Issues of Preferred Stock, Retained by Stockholders",
        "terseLabel": "Series A preferred stock retained in business combination"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesOfPreferredStockRetainedByStockholders",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValuePrivateOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been issued in private offering during the period.",
        "label": "Stock Issued During Period, Value, Private Offering",
        "terseLabel": "Issuance of common stock in connection with private offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValuePrivateOffering",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValueRightsOfferingMembershipUnits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to rights offering membership units during the period.",
        "label": "Stock Issued During Period, Value, Rights Offering Membership Units",
        "terseLabel": "Brooklyn rights offerings membership units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRightsOfferingMembershipUnits",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_StockIssuedDuringPeriodValueStockPurchaseAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been issued in a stock purchase agreement during the period.",
        "label": "Stock Issued During Period, Value, Stock Purchase Agreement",
        "terseLabel": "Issuance of common stock related to stock purchase agreement with Lincoln Park Capital Fund, LLC, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockPurchaseAgreement",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_TimeBasedStockOptionGrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares on time basis.",
        "label": "Time-Based Stock Option Grant [Member]",
        "terseLabel": "Time-Based Grant [Member]"
       }
      }
     },
     "localname": "TimeBasedStockOptionGrantMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_TransactionFeesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fees incurred related to PIPE transaction.",
        "label": "Transaction Fees Payable",
        "terseLabel": "Transaction fees"
       }
      }
     },
     "localname": "TransactionFeesPayable",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_Two022PerformanceBasedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of awards.",
        "label": "2022 Performance-Based Restricted Stock Units [Member]",
        "terseLabel": "2022 PSUs [Member]"
       }
      }
     },
     "localname": "Two022PerformanceBasedRestrictedStockUnitsMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_UnamortizedLeaseholdImprovements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of unamortized leasehold improvements.",
        "label": "Unamortized Leasehold Improvements",
        "terseLabel": "Unamortized leasehold improvements"
       }
      }
     },
     "localname": "UnamortizedLeaseholdImprovements",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_UniversityOfSouthFloridaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal entity involved in litigation.",
        "label": "University of South Florida [Member]",
        "terseLabel": "University of South Florida [Member]"
       }
      }
     },
     "localname": "UniversityOfSouthFloridaMember",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "btx_VariableRateTransactionsPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuant to the Purchase Agreement, the Company is prohibited from issuing equity in variable rate transactions for a period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Variable Rate Transactions Period",
        "terseLabel": "Variable rate transaction period"
       }
      }
     },
     "localname": "VariableRateTransactionsPeriod",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "btx_WarrantLiabilitiesExpense": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to warrant liabilities.",
        "label": "Warrant Liabilities Expense",
        "negatedLabel": "Change in fair value of warrant liabilities",
        "terseLabel": "Gain on warrant liabilities"
       }
      }
     },
     "localname": "WarrantLiabilitiesExpense",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_WriteOffOfOperatingLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of operating lease liability due to lease termination.",
        "label": "Write- off of Operating Lease Liability",
        "negatedLabel": "Write off of operating lease liability due to lease termination"
       }
      }
     },
     "localname": "WriteOffOfOperatingLeaseLiability",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "btx_WriteOffOfOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of operating lease right-of-use asset due to lease termination.",
        "label": "Write-off of Operating Lease Right-of-use Asset",
        "negatedLabel": "Write off of ROU asset due to lease termination"
       }
      }
     },
     "localname": "WriteOffOfOperatingLeaseRightOfUseAsset",
     "nsuri": "http://brooklynitx.com/20220630",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Dr. Federoffs's [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails",
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r178",
      "r180",
      "r181",
      "r182",
      "r197",
      "r206",
      "r244",
      "r247",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r425",
      "r426",
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r178",
      "r180",
      "r181",
      "r182",
      "r197",
      "r206",
      "r244",
      "r247",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r425",
      "r426",
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r164",
      "r178",
      "r180",
      "r181",
      "r182",
      "r197",
      "r206",
      "r233",
      "r244",
      "r247",
      "r276",
      "r277",
      "r278",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r425",
      "r426",
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r164",
      "r178",
      "r180",
      "r181",
      "r182",
      "r197",
      "r206",
      "r233",
      "r244",
      "r247",
      "r276",
      "r277",
      "r278",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r425",
      "r426",
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r91",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r91",
      "r96",
      "r176",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r91",
      "r96",
      "r176",
      "r245",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r131",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails",
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails",
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r34",
      "r378"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://brooklynitx.com/role/AccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails",
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued Expenses [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Legal expenses"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r28",
      "r378"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r79",
      "r80",
      "r81",
      "r287",
      "r288",
      "r289",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r249",
      "r290",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Stock-based compensation expense",
        "terseLabel": "Stock-based compensation expense recognized",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Total potential common shares excluded from computation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionTableTextBlock": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of asset acquisition.",
        "label": "Fair Value of Asset Acquired"
       }
      }
     },
     "localname": "AssetAcquisitionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r24",
      "r78",
      "r122",
      "r125",
      "r129",
      "r137",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r320",
      "r322",
      "r342",
      "r376",
      "r378",
      "r413",
      "r419"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and Liabilities, Lessee [Abstract]"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r18",
      "r33",
      "r78",
      "r137",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r320",
      "r322",
      "r342",
      "r376",
      "r378"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying value of assets sold [Abstract]"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails",
      "http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r243",
      "r246",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r243",
      "r246",
      "r301",
      "r302",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Purchase price",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Number of common stock issued in exchange of membership interests (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of outstanding common stock received by members and financial adviser"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Closing price of common stock (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Merger Agreement [Abstract]",
        "terseLabel": "Description of Business [Abstract]",
        "verboseLabel": "Acquisitions [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Prepaid expense and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedLabel": "Accounts payable, accrued liabilities and other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r303",
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Net assets acquired, excluding goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r303",
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Price allocation of Assets Acquired and Liabilities Assumed [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r20",
      "r378",
      "r435",
      "r436"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "btx_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "negatedLabel": "Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r63",
      "r70",
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r63",
      "r346"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r76",
      "r78",
      "r102",
      "r103",
      "r104",
      "r107",
      "r109",
      "r118",
      "r119",
      "r120",
      "r137",
      "r186",
      "r190",
      "r191",
      "r192",
      "r195",
      "r196",
      "r204",
      "r205",
      "r209",
      "r213",
      "r220",
      "r342",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r229",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Warrants exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Number of common stock (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Number of rights options converted (in shares)",
        "terseLabel": "Warrants to be outstanding (in shares)",
        "verboseLabel": "Warrants exercisable (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r183",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A [Member]",
        "verboseLabel": "Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Common Class B [Member]",
        "verboseLabel": "Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation.",
        "label": "Common Class C [Member]",
        "terseLabel": "Common Class C [Member]",
        "verboseLabel": "Class C [Member]"
       }
      }
     },
     "localname": "CommonClassCMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r79",
      "r80",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r27",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding (in shares)",
        "terseLabel": "Number of shares of common stock owned by Brooklyn stockholders immediately before the Merger (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r27",
      "r378"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.005 par value, 100,000 shares authorized at June 30, 2022 and December 31, 2021; 57,469 and 52,021 issued and outstanding at June 30, 2022 and December 31, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r72",
      "r73",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Number of shares converted to common stock (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r204",
      "r205",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Preferred Stock Converted into Common Stock [Member]"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customers [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepositAssets": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.",
        "label": "Security deposit",
        "terseLabel": "Security deposits and other assets"
       }
      }
     },
     "localname": "DepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r68",
      "r121"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date. Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect.",
        "label": "Warrant Liabilities [Member]"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Warrant liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r252",
      "r253",
      "r282",
      "r283",
      "r284",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCK-BASED COMPENSATION [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r161"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "negatedLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r161"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of.",
        "label": "Deferred revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill",
        "negatedLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "negatedLabel": "Intangible assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r157",
      "r161"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Other current liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets",
        "negatedLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r3",
      "r4",
      "r11",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r68",
      "r156",
      "r159"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Total loss on sale of assets"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r243",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPreferredStockCash": {
     "auth_ref": [
      "r228",
      "r418"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Preferred Stock, Cash",
        "negatedLabel": "Cash dividends to Series A preferred stockholders"
       }
      }
     },
     "localname": "DividendsPreferredStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EARNINGS PER SHARE [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r48",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r99",
      "r102",
      "r107",
      "r108",
      "r109",
      "r114",
      "r115",
      "r328",
      "r329",
      "r416",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per common share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r48",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r102",
      "r107",
      "r108",
      "r109",
      "r114",
      "r115",
      "r328",
      "r329",
      "r416",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Net loss per common share - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Anti-dilutive Securities [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://brooklynitx.com/role/AccruedExpensesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Stock Options [Member]",
        "terseLabel": "Stock Options [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r44",
      "r45",
      "r46",
      "r79",
      "r80",
      "r81",
      "r85",
      "r93",
      "r95",
      "r117",
      "r138",
      "r220",
      "r228",
      "r287",
      "r288",
      "r289",
      "r294",
      "r295",
      "r327",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r370",
      "r427",
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Ownership percentage",
        "terseLabel": "Percentage of total outstanding equity interests"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r50",
      "r51",
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Losses on investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r21",
      "r123",
      "r135"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Investment in non-controlling interest",
        "terseLabel": "Investment"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r333",
      "r334",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r333",
      "r334",
      "r335",
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r242",
      "r334",
      "r383",
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r339",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE OF FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r198",
      "r234",
      "r235",
      "r240",
      "r242",
      "r334",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r234",
      "r235",
      "r240",
      "r242",
      "r334",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r242",
      "r334",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Changes in Fair Value of Warrant Liabilities [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair value at March 9, 2022 (issuance date)",
        "terseLabel": "Warrants fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value, end of period",
        "periodStartLabel": "Fair value, beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r242",
      "r383",
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetAssetLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosure [Abstract]"
       }
      }
     },
     "localname": "FairValueNetAssetLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r148",
      "r149",
      "r151",
      "r153",
      "r395",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r148",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Loss on sale of NTN assets",
        "negatedLabel": "Loss on sale of NTN assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r22",
      "r141",
      "r143",
      "r145",
      "r147",
      "r378",
      "r412"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "IN-PROCESS RESEARCH &amp; DEVELOPMENT AND GOODWILL"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r68",
      "r142",
      "r144",
      "r146",
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Impairment of goodwill"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfOngoingProject": {
     "auth_ref": [
      "r68",
      "r155"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as an operating expense or loss during the period to reduce the carrying amount of a project that has been impaired but not abandoned.",
        "label": "Impairment of in-process research and development",
        "terseLabel": "Impairment of in-process research and development",
        "verboseLabel": "Non-cash impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfOngoingProject",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r243",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r12",
      "r13",
      "r14",
      "r15",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r160",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Other receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r62",
      "r64",
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r365",
      "r367"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease expense"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Operating Lease Expense [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Net Operating Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Maturities of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Extended lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r36",
      "r78",
      "r126",
      "r137",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r321",
      "r322",
      "r323",
      "r342",
      "r376",
      "r377"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r78",
      "r137",
      "r342",
      "r378",
      "r414",
      "r421"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r38",
      "r78",
      "r137",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r321",
      "r322",
      "r323",
      "r342",
      "r376",
      "r377",
      "r378"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.",
        "label": "Change in fair value of warrant liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities, fair value disclosure"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsLiabilitiesMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities transferred upon sale [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation settlement, amount"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r175",
      "r177",
      "r178",
      "r179",
      "r180",
      "r184",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r175",
      "r177",
      "r179"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Liquidated damages payment"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r175",
      "r177",
      "r179"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss contingency, damages sought, value"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r178",
      "r180",
      "r184"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Estimated contingent loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r16",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "MERGER, DISPOSITION AND ACQUISITION TRANSACTIONS"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Ownership percentage by Citius"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows provided by financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows (used in) provided by investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r63",
      "r66",
      "r69"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net cash used in operating activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows used in operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r15",
      "r42",
      "r43",
      "r46",
      "r47",
      "r69",
      "r78",
      "r84",
      "r88",
      "r89",
      "r90",
      "r91",
      "r94",
      "r95",
      "r105",
      "r122",
      "r124",
      "r127",
      "r128",
      "r130",
      "r137",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r329",
      "r342",
      "r415",
      "r423"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r88",
      "r89",
      "r90",
      "r91",
      "r99",
      "r100",
      "r106",
      "r109",
      "r122",
      "r124",
      "r127",
      "r128",
      "r130"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r1",
      "r82",
      "r83",
      "r86",
      "r87",
      "r96",
      "r97",
      "r98",
      "r133",
      "r134",
      "r139",
      "r140",
      "r296",
      "r297",
      "r298",
      "r326",
      "r330",
      "r331",
      "r332",
      "r343",
      "r344",
      "r345",
      "r354",
      "r355",
      "r369",
      "r371",
      "r396",
      "r397",
      "r398",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "RECENT ACCOUNTING PRONOUNCEMENTS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/RecentAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/RecentAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashMergerRelatedCosts": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.",
        "label": "Noncash Merger Related Costs",
        "terseLabel": "Transaction costs - shares to Financial Advisor",
        "verboseLabel": "Transaction costs"
       }
      }
     },
     "localname": "NoncashMergerRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonrecurringAdjustmentAxis": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Axis]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonrecurringAdjustmentDomain": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Domain]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r122",
      "r124",
      "r127",
      "r128",
      "r130"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r360",
      "r367"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r356"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Impairment of right-of-use asset",
        "negatedLabel": "Impairment of ROU assets"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/LeasesOperatingLeaseDetails",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Operating Lease Liabilities [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r358"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetailsCalc2": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Total operating lease liabilities",
        "periodEndLabel": "Operating lease liabilities, Ending",
        "periodStartLabel": "Operating lease liabilities, Beginning"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r358"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "periodEndLabel": "Current portion",
        "terseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r358"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Less non-current portion",
        "terseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right-of-use assets - operating leases",
        "periodEndLabel": "Operating lease ROU assets, Ending",
        "periodStartLabel": "Operating lease ROU assets, Beginning"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "negatedLabel": "Amortization of operating lease ROU assets",
        "terseLabel": "Amortization of right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/LeasesOperatingLeaseRightofuseAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r364",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r363",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r17",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses [Abstract]",
        "terseLabel": "Other income (expense), net:"
       }
      }
     },
     "localname": "OtherExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r37",
      "r378"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other receivable"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PartnersCapitalAccountAcquisitions": {
     "auth_ref": [
      "r227",
      "r228"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the different classes of partners' capital accounts during the year due to acquisitions. Partners include general, limited and preferred partners.",
        "label": "Partners' Capital Account, Acquisitions",
        "terseLabel": "Issuance of common stock to Brooklyn members"
       }
      }
     },
     "localname": "PartnersCapitalAccountAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PartnersCapitalAccountUnitsAcquisitions": {
     "auth_ref": [
      "r228",
      "r310",
      "r315",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in the number of units for each class of partners' capital accounts during the year due to acquisitions. Partners include general, limited and preferred partners.",
        "label": "Partners' Capital Account, Units, Acquisitions",
        "terseLabel": "Issuance of common stock to Brooklyn members (in shares)"
       }
      }
     },
     "localname": "PartnersCapitalAccountUnitsAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCRUED EXPENSES [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForPostemploymentBenefits": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflows for payments of postemployment benefits (such as severance pay and health insurance benefits) recognized during the period. Postemployment benefits are benefits paid to employees after employment but before retirement.",
        "label": "Payments for Postemployment Benefits",
        "terseLabel": "Severance benefit",
        "verboseLabel": "Lump sum cash severance paid"
       }
      }
     },
     "localname": "PaymentsForPostemploymentBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock",
        "negatedLabel": "Dividends paid to Series A preferred stockholders"
       }
      }
     },
     "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Payroll tax remitted on net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Less amount of cash paid for NoveCite investment"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherProductiveAssets": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.",
        "label": "Payments to Acquire Other Productive Assets",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r58",
      "r312",
      "r313",
      "r314"
     ],
     "calculation": {
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails": {
       "order": 0.0,
       "parentTag": "btx_AssetAcquisitionFairValueOfConsiderationPaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Cash paid"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendsAndOtherAdjustments": {
     "auth_ref": [
      "r100",
      "r110"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.",
        "label": "Preferred Stock Dividends and Other Adjustments",
        "negatedLabel": "Series A preferred stock dividend"
       }
      }
     },
     "localname": "PreferredStockDividendsAndOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendsShares": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.",
        "label": "Cash dividends to Series A preferred stockholders (in shares)"
       }
      }
     },
     "localname": "PreferredStockDividendsShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "auth_ref": [
      "r76",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.",
        "label": "Preferred stock, liquidation preference"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r26",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r26",
      "r378"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.005 par value, 1,000 shares authorized, 156 designated, issued and outstanding of Series A convertible preferred stock at June 30, 2022 and December 31, 2021, $156 liquidation preference"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from the sale of NTN assets, net of cash disposed"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "verboseLabel": "Proceeds from issuance of common stock and warrants in connection with private offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Aggregate exercise price"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "terseLabel": "Proceeds from sale of members' equity"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from the sales of fixed assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfAssetsInvestingActivities": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions that are classified as investing activities in which assets, which may include one or more investments, are sold to third-party buyers. This element can be used by entities to aggregate proceeds from all asset sales that are classified as investing activities.",
        "label": "Proceeds from Sales of Assets, Investing Activities",
        "verboseLabel": "Purchase of NTN, net of cash acquired"
       }
      }
     },
     "localname": "ProceedsFromSalesOfAssetsInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Sale of rights, title and interest in and to the assets relating to the business"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r60",
      "r286"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from the exercise of stock options",
        "terseLabel": "Proceeds from stock options exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r158",
      "r378",
      "r417",
      "r422"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r241",
      "r372",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r241",
      "r372",
      "r375",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLicensingAgreementsDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r293",
      "r393",
      "r455"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Common Shares [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "RSU [Member]",
        "terseLabel": "Restricted Common Units [Member]",
        "verboseLabel": "RSUs [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails",
      "http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r165",
      "r166",
      "r169",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r228",
      "r378",
      "r420",
      "r430",
      "r434"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/LiquidityAndCapitalResourcesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r79",
      "r80",
      "r81",
      "r85",
      "r93",
      "r95",
      "r138",
      "r287",
      "r288",
      "r289",
      "r294",
      "r295",
      "r327",
      "r427",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Computation of Diluted Net Loss per Common Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r301",
      "r302",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/DescriptionOfBusinessAndBasisOfPresentationDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsInvestmentInNoveciteDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": {
     "auth_ref": [
      "r231",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative liabilities at fair value.",
        "label": "Changes in Warrant Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r12",
      "r13",
      "r14",
      "r15",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposition Details"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Tangible and Intangible Assets Acquired and Liabilities Assumed, Based on Estimated Fair Values"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r248",
      "r250",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Weighted-Average Assumptions Used for Stock Options Granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r76",
      "r118",
      "r119",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r213",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [
      "r25",
      "r26",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A preferred stock.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]",
        "terseLabel": "Stock-based Compensation [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Restricted stock units vesting period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Unvested restricted common stock forfeited (in shares)",
        "terseLabel": "Number of RSUs cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "RSUs Granted (in shares)",
        "verboseLabel": "Number of RSUs granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r264",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Unvested restricted stock outstanding (in shares)",
        "terseLabel": "Number of stock units awards outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-Based Compensation Abstract [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "RSUs vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weightage-Average Assumptions Used for Stock Options Granted [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Weighted average volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Weighted average risk-free rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r271"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Stock options exercised, intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Number of stock option awards granted (in shares)",
        "terseLabel": "Stock options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Stock option outstanding (in shares)",
        "terseLabel": "Number of stock option awards outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails",
      "http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails",
      "http://brooklynitx.com/role/StockbasedCompensationRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationStockOptionActivityDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails",
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Vesting on one-year Anniversary [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Abstract]",
        "terseLabel": "Stock-Based Compensation Expense [Abstract]"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementExpensedAndCapitalizedAmountAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share price (in dollars per share)",
        "terseLabel": "Stock price (in dollars per share)",
        "verboseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails",
      "http://brooklynitx.com/role/InprocessResearchDevelopmentAndGoodwillDetails",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfRsusDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number",
        "terseLabel": "Number of accelerated vesting stock option (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Warrant expiration term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationWeightedaverageAssumptionsUsedForStockOptionsGrantedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Options exercisable period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CeoSeparationAgreementDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r271"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Incremental fair value of stock options recognized"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "terseLabel": "Number of shares issued in merger agreement (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r76",
      "r78",
      "r102",
      "r103",
      "r104",
      "r107",
      "r109",
      "r118",
      "r119",
      "r120",
      "r137",
      "r186",
      "r190",
      "r191",
      "r192",
      "r195",
      "r196",
      "r204",
      "r205",
      "r209",
      "r213",
      "r220",
      "r342",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r40",
      "r44",
      "r45",
      "r46",
      "r79",
      "r80",
      "r81",
      "r85",
      "r93",
      "r95",
      "r117",
      "r138",
      "r220",
      "r228",
      "r287",
      "r288",
      "r289",
      "r294",
      "r295",
      "r327",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r370",
      "r427",
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockholdersEquityMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' AND MEMBERS' EQUITY [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r79",
      "r80",
      "r81",
      "r117",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r72",
      "r73",
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Issuance of common stock for business combination"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r26",
      "r27",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Acquisition of common stock (in shares)",
        "verboseLabel": "Issuance of common stock to Financial Advisor upon consummation of merger (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Number of common stock issued as compensation for services (in shares)",
        "terseLabel": "Lock-up agreements shares received in acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsMergerDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r220",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Restricted stock replaced during the period (in shares)",
        "terseLabel": "Issuance of common stock from vested restricted stock units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockbasedCompensationRestrictedStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r26",
      "r27",
      "r220",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Common stock issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationNumberOfRsusVestedAndSettledDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r26",
      "r27",
      "r220",
      "r228",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Issuance of common stock from the exercise of stock options (in shares)",
        "verboseLabel": "Stock option exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r40",
      "r220",
      "r228"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock to Financial Advisor upon consummation of merger",
        "verboseLabel": "Acquisition agreement"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r26",
      "r27",
      "r220",
      "r228"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Fair value of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r26",
      "r27",
      "r220",
      "r228"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Issuance of common stock from vested restricted stock units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r40",
      "r220",
      "r228"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Issuance of common stock from the exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Gross proceeds received",
        "terseLabel": "Aggregate gross purchase price"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/FairValueOfFinancialInstrumentsChangesInWarrantLiabilitiesDetails",
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Private placement (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r27",
      "r30",
      "r31",
      "r78",
      "r132",
      "r137",
      "r342",
      "r378"
     ],
     "calculation": {
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedBalanceSheets",
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfStockholdersAndMembersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCKHOLDERS' EQUITY [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r77",
      "r205",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r219",
      "r228",
      "r230",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r362",
      "r367"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r353",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r353",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r353",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r353",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesLegalMattersDetails",
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENT [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r379",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENT"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsDispositionDetails",
      "http://brooklynitx.com/role/MergerDispositionAndAcquisitionTransactionsFairValueOfAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CommitmentsAndContingenciesRoyaltyAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r165",
      "r166",
      "r169",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r361",
      "r367"
     ],
     "calculation": {
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable lease expense"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/LeasesNetOperatingLeaseExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockbasedCompensationSummaryOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Note Disclosure [Abstract]",
        "terseLabel": "Warrant [Abstract]"
       }
      }
     },
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants outstanding weighted average contractual life"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/StockholdersEquityPrivatePlacementOfEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r101",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted average shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r99",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://brooklynitx.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.F)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=66006417&loc=d3e8580-128490"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=66023778&loc=d3e9298-128500"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=66023778&loc=d3e9334-128500"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=66023778&loc=d3e9337-128500"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r456": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r457": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r458": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r459": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r460": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r461": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r462": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>82
<FILENAME>0001140361-22-029251-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-029251-xbrl.zip
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MRU9K?GQ&2S,.CPTRF;'>]H-DQF/= D)-'"4RME"[--?-V$)I*TYOK<*)>^T
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M3ZDMS272+ICIDPN4X:LM'\EMQ=(S58;3<$6+N&)[;A=LN*+-7+&EI-<#K
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M65\OXZUI9WV?N:Z5>^$M8KG)<$"#>@;UVAVHN"B_&K!\L6#9$DXU>&JVEEZ
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MI]#18%=V*2[3*63;R5+/(?QH5+NQ*XL@'%9-AY^U]^Y2'NM(X;L<PW-J%6F
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MV<FGZ_/;<_7Q^.+4.ON_D]^/+WX[LTXN/WX\O[DYO[QX$R23_:AP7EW?JMV
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MO/ [W\>)E=T+Z\\!5UN%46 )[2)Z&I*O\M9GA2^Q(@N .L*&U(.(8NS;B #
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M[R7[/"UVJXO85:SWA/^_L#>A_]G"<1S.'>C['@;<"PCCRNYQ/!X(P/Q%9(Q
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M'T5Q]%Y'U^I0G8@^J+;]]/".TMZ19I.#W NHXS _$X=S"A$CD/O8<SU?V&[
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MK(J%'K$1PXX'7(*9( ' /I3"0[9/;,=>9[(KZ':(#=L/AWA7TD@8D38BG:?
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MS'@",P!T%6IXG@R(C6WD4R&@[S%BDX!SX*XSKL)@1G4L6U?4UA]?T7H5;">
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M &CG188 I(1[%$K')[8,^%ICG!#H.+#N*,6>"7NMQC3Z_->_J)M4\4CEOF:
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M75_*L"M&W'6M("'[47W^$?SXXX^'AV\G?EC]5OV<?Z],[A*S5DCQ3&H,V&-
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M :;<#H3ZKU#ZDM#)2IH\6Y'F<WZX'QZ5I]&O61K_;)#!(,-FD4$"3YE/DGM
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M5#>F63D+!YJK;BX_G)\>WRK&NKE5_WS4$&1=OE??+D_^^?OEAU/%7__XP8?
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MP27G=-+YJ$.-@@Y!AZ#CJ>AP%8S35D?=P!&3HYBM1V"*Q22RZYS@W8N(H=!
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M1K95@;#YG:Q0H="9.I=OKZ;-7?F)I^>3\@>)7RU,^KMK6R^WD6QJY*ATRB4
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MC9@S!"".8$.)50757C14HT.I-NB#>0N&AO&<!$-/QI#7M3O'@7/2%KQV$=N
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M1@(C@=$J, I:<Z'$I#-!19L"6,7)*T,I1R7]V05& ]2PP&B0,"*#A2-;0*?
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MV&;L&@XHBMHZ56AKIX[T+'55^"1\$CX-@4\AEZ9Y!TAM?1>+I>!LSC6T!5Z
MRGR4";>")\&3X&F_>'HFLA/9B>R&X164I,GDZC 'AA0K6H6.?<P>#5+00\B7
M%MH(;80V,LF+[$1V1RZ[)X9V+0-&7W/2")G;76EK"I6J6*$_\B[-@BG!E&!J
M")A*,1=K%9%W"#XU9.ED-64*P1FKUVD)T(O&S4*>G><$'Q9'VTO[[ ^CMI>
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M:!%?)EFJUP"FSX-$_%ZHO_CU'X)XH6 A"4+%L$%VR!4+) M\.XJT"#9I9*]
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MB\O3]\09@"N*$V#70"+"/,L'5AFNL^#K(/X7K@X7?O?]_!@V4=P. ;UO'BU
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M:+1TFMRMQ26$[[QBMZ@ SCPR#Z/:Q!\0AD* L##93Z"TX 5  '.P 7Z:'(A
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M7*Z^NQHBN@DGV;:C-"Z.)ZXY'M0@L4^2+,?V<(5Y?0H SQ^O\6W% /CSC-8
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M3L[,4'7?!B-:1;XFE"E*513R@-B4**(9<4-?=1I5ZILUQ1J V,S.QG=W2L9
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MXARY&%;FDG\P;S)E8!D9>ZG0/P_ *,^!KX-B6>?6E56,5C_JG*6)5IX22]4
M=@S,A/)R5.KF,*Z5&&0%=??'J1\&<=\"1=VJ-/4#"S#YZ..L_5=Z:^";^BL\
MD!T!KN/[U1_BE@]O5&&46*/R# 8^+(Q 6F*:5+0V;YZ 03<Q)K2.!VB+ O7
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M!5]]8$5*@/$^F1<B# E^SN -\#*0+0]# $<VCK)8QAR$#4ZN>JWU+9='2T<
M*0^P%'G#*#_C,$]"RA6NW>GG5>;5EC@R:<61G3<BWS:3<,\"H-,*@&XOTGJ1
MUHNT=2!:)=)6^VQ/C63[5>6WB3P;WH-P0^OA OAVBCVJ+U4JX#N_J9^MY%Y$
M7%]$0I* :I_QP',HD8Y2,@@8=YJ\M 'Q_W$E;I4<#]2%;G[KXE5E.F(6'E>0
M/2=QKL[.3YH\KK3N<9TZ7 ^=U8E'WI&]X&?]H9+>N0F!;:('X,2.WJ1<<UNQ
M95K)M4_6+^AA[;QX0V#C1#]M9,F5]VS#,'9I*P![[\7[<IPA>$ ]+,,K2*WS
M7HV:1V;$8VG]>35+N^2/R$VRZ^2XX('F9-MEFL@QW'Z_V-[7H4J[E+DT$)Q&
MVN9.Y(:V3_W 9;:0C=71@)^542?D;&;(VHPG' NUY6MX.Q^I,4B:[%M\!ZQ"
MKH\9>1,6YJ_F8,[1X@$U"S9P8-!T: F>W=;=1FCDC$9I\@<\GRO0T5<#\RI/
MQ.]G60;8^V6< @\$B1 G\NJ6 P.LK7@FJS70KJ)AY%(=4N5++F1 (BT$U2H4
M<IE\V#(\21V>]@2<]DIP!@>VXQR GK< TSHWR<SJD?F+Y.X.TR,02@>%=586
MY30"1*5WV4HW'3P#6X)1.JR5S7.+5U)'KT/S)3OS=QQJR<9XCF1:V)X#>T*5
MRWDHO$A[E"A7J#!H3#?N"J(3VVF0U1-,CSCZ4(V'U.((75G?,-._8I3&0JT
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M(O5-K%9VCL?@)L,NH(]K"X<#PBBJ(THIBSS"@,.&(6@ 5$1Z5^C3B"8/@ /
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M3%K:).INU@]H7;W#0 &_3.!@_8C731C-_MG\;#Z3GS\6F0>Y$>P *LO RIH
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MA%EK%(_4(!X:1!G"7*P;-:S\G7??SX]-DN!XP O=%7^T%!X!!4$'NM--RN]
M=H+1QLN#H85UQFO3G,GT+?)>QS&(W$I0?P,A/LQ4W:GWXQ5H;.=)KJSP8R&9
M<=8#58VW^(IF ]"\#72+6*%1,%&-T7%G%(U1@H018[1XUA4Y K5D;IC*HS<>
MP:.@N6BEX"<!L#-*NX17#))1H=3$ ]!:8"/-309PHR3+#U-U$X,V4P W31[Y
MP#@#I^[.!E#@XJ?JDMDT5"A!\?@<)YF(%6Q^??&E2\[ZL313BILG=LJ*=U71
M]QN,)V2ST *=!R"!EHPY.FU@5*YXZEE%3)['GAF$*0(4@+2Y\2$^(@9A2@G
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M>R]!K5,(\'UM_!5*\%4IRTW^08/R0-<]-^3<(DYD>;[%W5 GH<EIY.G':H5
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M01MS?=<A@6$%=A!901!P*PPY88<<:;ZJ\V&_&FCLEY(:>&'^TSXZ:*PH6E$
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M/F/?)I8F0%B39!PSO+90$#XH&@ \ &8J-< Q3;_S6:&P4?4=EF2S?,F!D)M
MS!JP"* W%.4*/DA]8IE$G!YX#G\$ U 1[^5QL=/M@IU>#[%S*5_DL'#SNL#-
M[R'<]MM#[5C-?)MA0+P7TO)JF_FMGR:2YR[S6]#2N% \P*R;CX#?16DREHK+
ME[NOG[[=:-,A1D]-;98B_P'&"1K-!:Q"M3$\$%^PYUGR'=\?Q-+<A6V,YQ/!
MF.CT&=D>&"*S6&@5P@R;\"?@SV%,'R8)6DR@3(!)\NG3 /[_)U0W/OWM2LN
MQX*BF G'.')A@"\@2]$+#_ABU4_(Z",P<.D_$5MLM[^R[R";!ZC8('A'J,6.
MUGH3AKSJ49"@68B;NLOH4OO LZD8I#N?2<5+?#>BCXGR*,&F4<7B<(D(-?@4
MM4,$T3Q A)I*<S6_FRH Y 6%<2BDWIASN8UI"OHK"!T^":6A"?N\03%Q\3'E
M'.19^AC#Z;2WN.VG1+7$A"_)7H)@D(/0@U/'$6AVJ&"&4J#!(PSP3K@WRO8J
MT,-W^,]\%*+_ 77/6+DC:/@HY%9Q4 %=(".A>BZ6_:HP#N6;!=@Q#X7#)@&[
M-A7BCN-M@)99.S]>2,KI3&R#1Q%GLP)?2UBX *92P2M>%(&A;,C9]]PL'\9!
M#.)8DP@#6\E[8]Z7J$0"/Y;V<3(!]%'7#ZP!!+NX8#S)<[&C?!6Y/3@R@(M/
MU'%#L+&%9P@1$78HQ7P!;[ ,,$R<(2:A^@"+5F$QY%1Z*"9P$" - 'M:AW@\
M>407Q0/Z6;3%+L5)LD'9K\5C"?9)J#P0RB91 Y>05ACJ0I?:^Y(+!&X,.RO/
MQ)'I(XU'PET33Z21)=QW93I9K!8F/!,O$&\')C>I7+_"MMR\NC"K9U?N'SPU
M$ .@R:5VA;3-AM7W%4IDN*#95OX,X<^5)I?R Z&M"Q3R+Z&VBGEM-!LVN%T0
M$.C/^B$<0W#231[;8H7;Z';R  CY\%5ZV<K3$*EKLLCR7&[KQ'%IX(8FP<)#
MPB+=9HTU-:TG!K>UCO=PCL"-#!J$OF59#O&([O'0(:9IV3IWJ6TW%D^2?9^C
MR=N\TOV<(SHJ^7R"F(_J/";)"0\ R)(9SQVJ*AT)_BXL=D$?6#TJ\">+?X#M
M@MU#%)'5+*3<RPUXS:43M(*?$BN!0@[F_]=]P_/]D!J@CQ(_"JEI41R]R;S0
MC5;@6,>\$]&T&6X%]2H0RV]^^Q=/DZ4KN%15D =6T?U.87Y]-S?!>>;"AID+
MY#QSX3QS87&>SC,7=LH+T/=KB'=+L*HU_C\;XCTWQ)>B) U**"C7(BY==C(J
MO[I0'U")+ 55"M5J(,2]\'PN3WK(9@D8 F +@OT%1QF)-PI;?X,*>@>:*_^*
MSY4;FS$:.M3S/,-CQ'==+P(-#30".["X$^B-18M6/1W *JL#9J$-Z)NB,/:R
M/@:ZE98-50]\@,_O(D!M&5)_0LVHTRE]UPP9H29S3>*$OL<9=2W']L/0<:AI
MM%)Z.IU2O[3-S:?,E<0J0\1MY+;E%<,8'- #QH,J;O8T89R'"T]&%*<96,8S
M/LW-1$ _=(DON=_1<BR'F\)&0VHY[)-R,8<4;"L$CX@ARPV4S:Y%;'#YD2(#
M ,0%6*KR0#D=5&& !EJ[V.+",OF<9.7>?79$?:;KCF-$%G'#P.>$!B 'J&-S
MTR*[656M==_)LN8[*YF>R]$4I1FU"IZM4#G[F*K6EQ3I6LFERN)>TH9K484F
M;;6:]/S?U63(Q@QHK#:_'L8\NOG!V1S)\C:*@&.E=WQ*I6BZ>DBYL#B;$J =
MQL&\CH"IV08Q'8_JE'*;N%;$+,ZL1OMZRP3H"&C%#ZS <XV(V!9'":&#!6][
M0#B&IQ<C JN6R%89T17->NM818M\YWK&<Y'SO*K,9%5*[U)B<&,6=#E/NFF5
M3:G!;WYSWS4GTZ[(5V[8V-IBC/(N14YSMUU>W]QJ=S=?K[Y=W7^Z_:)=_?G;
MS0UF"V^U]\9DX/H$AD5"\&*M$C=L2!!N/WQM,X9W((L3CJ!IQ:S/TV?66P#M
MI\_LCF"-Z=6;'NJ>7OT:$*S?R-/"%%:RX78"ALVS9I+<+?PAO=3^DCS1--3^
M>JE]!'4Z3:((0[DR2JG2->NVH% BM$*+6+!)I4\(/?LKKA(N(FEH!8BW.X.*
MB?%I.6D:MY5OIGBIW%1#V$>X&V5?@42C2NW;Y,=X\]M"Z=$*K4=L_,\RHUC[
MQF7=[]*6M+?X>I6MW[1,D;Y?%BO3>9JA180&DW3'5]8L8"YLZF&<:=-$9OQA
M&G(=Y!5(8RW !!1Y\<E "T&UQ_0?\3<^GHZ29UX8487O )\#ZQ\CUG$8 Y4L
MPI*;P+\(\;]/$'706,)@6S@7N=0B-!9GM  J K":Z+?8A\B!Q]QC)#^9^HCF
MFC(J5XR;%(E.TV04,Q$V3\$:1=N&<4P=GU13HD2PI/%$7 (3HS 2-BLQ @-R
M*7],I -%^D^>:/RHX)\J1,%TYA&-QUGI'&ALSI)!90=E6 @7C,JA4 %S?"X
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M@B2;957A!LI:PF)A>8GF^V+(NK32X,FTR,6&32VF#5QJGV"CH%O.Q/R@\B0
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MLWXGAL"SUTG8RZ;;W*>ZZ%2!Y_85>+VZ6$DB70BKK[T[7J+IF+LP\]1?=/+
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M83Z1X$TY++*IZ]N18&XL!+,IM:4K[)4F[ M+@@TRPHA^/I$FDD]<+PD\)MV
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MT92%1GS-([N)P#,]*7=HL3L0]7<H@^]PLNWT62":N9P7JBL&@9JEZE2.7CZ
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M<5V;&1(<-H#)F]VU.U'P,,-$<]6;DJMZ+MH+%T5A;/N^QY-$^I2%;N0*GY*
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M,;*Q.9<;MJK'GDJCKD_2I[6O1;MH[E>E;=4;B[8BY=T0[O+H\):A'MU>LME
M2$HJW, /71I0&OI,8"NAA 2.B'PJC3,]:*N!T)8K>O-H?H"*-U\_C ;9HY2*
MF6\4+Z^,.)]/A\:Z2T/.AP5TP'TFL9#'3AAE\ OX]P&-!"6.S\+$V C6>1Z
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M$-IV8&BM=$@WHN3?4U7,@>,2'OE>E$B;BL1F?N1&=IPD5##N48,5=$B'>.?
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M@3*EWG$Y @!^F&Z5-[::-W:IFZ*/\NP^C=-QV6=_L."!9]9+\@J?!G(()P7
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M+/$%YB4G20SE=3GU\2 3 3KWG9C.O+G1A]\1/W_*R@H4X[_X/^#7H@.(=?X
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M*^/2>ELH]M!<I<^,:UK1=^CA)$/.EW:;FC[L:+VNN:?)<S%M;G)#\&5,6^^
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M6)#*.>H<'?VMQ"+9;BMGMOK5/"9^#H#W3\FT70J(RE)_#X!ZG:.>>:EMP&6
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M;Y]N'2_@HPQQ<=_HQ<I(W8\G&&+&OV/@(AG,0\TH64-G;OLFVT2%DXJ[T"!
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MPD9#%_,)N,R_#03>,2]N"*>C(/&W\=Y0/AG8]5BB'<TZKUG%1NE[]/7JVM+
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M5CIX6,A_0?GM"]$C1.QA7H(18# 0I9DY<Y?% )*AV]3-"5VOQLSCSPU.4@)
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MV;I:\NNWCIIIOA73!C#3@/@N81,@, '+%_:OWU_UL3%M*/_N8;^'HG'#O7T
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MPAPV JR-]V9\\;P,9N%-=:6,QMF@]A#Q"+$Y;%%XU!+00 #MU:UW7^CZK9V
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MT P'"N=UM]/+T86[]>NCSG[^0:CHE\<T*:<X!76<>Z3OH^?B>60B'0OAU)5
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M>JV%39-I>UF0?H$JO>G'Z/>?@G]EJA&$S\;LIG9S;>T"W,1LPF?D-NQV&[>
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M4;HJ%@AM >\?R$U!M>CZS"(F5Q\_Z!V\%:C%O$P(75;\.&+A5 0$CC/=1*R
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M:VX[H)]&_:F\[!ZVY"GV^V+^?_:E)[C7W?[3T!HB@Q_>$N[4M/'(3B]DN+4
MF%/Z3C45J104^D:[!TZ R4-0"EI&OA@R<@DS#'SR ]Z-L.U)<HN"+'XF8&]R
M"9-O+WRC^NWS[S.BS8NE\HV;LU+[1[!+B?Y00L\ GG)<(R4_1W^UH#YP\WN(
M@'Z@% )R2H%<%0AQ'[P@B]@),U+!4'KUP^:K0QNIX6RZ!ZO% LV MHS50(NY
MU(?S,OX8T:80MQ&BDSM8[C6ZX^P[KC\^*.,?2!4')?VLM7R (5,1@;G$%F;H
MK/NLR?NK( ^X<H[KB[V"3O0T@8O&6G[5QXA5P_#;!)LAQ^@6-B,[*BP.E'ZF
M?D(49-=!<NF3HS..-!Z"<I\@9QS[/)2A+70]\YLI;2;HZ0.U",ONDY^6!@7;
M(4LBFKX23@Z?QU..NKS04M3O2M(V)@>G4(\72"PT3Z'H8,YLK)L>2;K)+ %]
M.8Y1^5&F#)HQV$T-1P?]C>,%D=%GS CEB90-A^6&7%QAFIJ@"MD+"O8=C-,(
M?H/V@.:LG^4MZ7"HD'G4ELZP++21(SGCQV#]8(<V_8*)$0,U=60NQ7GT44F'
M;'2";;%U=*90H\51M9 QZ7LVY@LK!D(;J>4L$X2&+C*(*.*,K#<5P2:8P)%?
M.^5S*1T'(F^QHA>\(,GHOD*]SU ?#5#HL0D<KAQ(E ^<P5XNAGD 6EX;8@,F
M@M4K[^.\V5<HH4W:,XLT)!0Q:'/3#/_L::7X9[%)@U6LLW9H7X71*%B<)'&2
MAY,K>9-;X,J^_I($-P%J$PS(DMK!3Z4;7T:4\[# 3D]FS!3<PW6%3[HZ-BVW
M<PXF!#,U0B4A>BA >X)VGQQ,J@PU4E^GSA1:<G:'HAU&SIKX.)-\40%&K6?5
M_Y(D$:'8\XWP#S*AP#FE/$ 2J1\ZGT[3]!=7YR(SS3$/+>@#QG$49;E.1K2=
MP1%%!;\?QNV"R7$T$]VG4%F24-2LX,-]J__($=51RURGJCR#KEMPX(I/4O4Z
M_65Y4>&_Y?PK'&3N5WD:UQ67BSK+MZ'L&(@B#?I41^@P:*<F6]MQR0 GMI&D
M)H(!0H8^4D%*L?!D+@T70QN2]1(,,GFPB)67;\Y.S4T]%-[<,J/-L$I/4R/1
M!*"<TI%IS/U GJ?PZ%PL7T[2_*OQ#7H2;C'#T@&M2!L&2L.IW!+T:'2&44%<
MW7!3)=]5]L%Z]$K8]H#/"MWMV]"=#=T](73W4AS^]S3[+EU36EN7[_>C@,PP
MHY]LI3F.&3).1&)O.'^*(Y;AHQQ23VE4[O<<2-1I(:-FTN@K0R>K>NP?Q\>7
MI<.8XY'OH<)1>C>*Q]2J.5 9+I\9=K F6^?M>N)_%MI-@;;J2*Q=TKGY0;T\
M%0@C3(4-TCC/I9LUF@!C">8@1:73L'D(+GE]R;G$9ZSIJJ.OE"AU<ANC99.8
MF%\\6,BTE:?MK=G).X4W:X%I9T7CA8M&X28U%'^:L"!2V*K:!-XB&->456&A
MTQ3H8$:I\L>2#< B$RS,OPT$GK71!:#=(V[N$$%MAI= $TQ;)9V;7SFDE^7[
M.8:U>'0#-K0\*P[X318YQ=@M2NY1J:L82Z9D5A0O<VM"KW5,/N#R\1GF?QO
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M3B"*^ >%5+3YUW&^F-$>(\9#8H,O#B+I3E<6I)GWH 4TA'^KN"-EQP3B^_9
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M#$U_+@4RZDP.. G91, S^J_:T'38Z6+[BT4=,A[6KN[QOC6UZ ]:Z\7$]Y=
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M,IV3B@WS'IGHO+F&#8G$@QMM@8IM]R1E51MV!75VF!TN_]_^=+J_=_*B MK
M(Q5UW"UT#'8YC(HK27-Z#8YV'\/6U+@K>1&96QQM7J8%;?LY_)39]Z^HJWSI
MZ[KA?E\M]SOX:KG?Y<=Y*J'M+\_[7DV]>=KERU%UDV09761GA$\2 C0D<,4S
MDT^2DO65&+^2"[^\CU(8:9*RO3\OS=B0D8Y_K=*/]?WSRB"OC+:.]_.):#S
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M-/D-O8Z=]5-34U6E 19!^C/N#C;%1'8>4QUY5T)<X[OQE@)QT!8A;)"G!6L
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MU6CUCGS>]5A*4:[,>U<3&?X)KZ=PQ?M6%(SSB4>VRXE237PE SF\%^V,^VF
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MO/]\Y6]@72Q'+-V^34K)%"YG%!DG,<4YVK[YDV47'*N-8<\GU\*V,BJ_&TO
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M_2!7+Q/E[O@;'4E"!>&*\H[ Q@EIN!8GU#RU14++"&RI+*6JF+Z]0(!^X^B
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M/R_QF3T(JU66S=RZ&GZI3!^N20.>>R2"A[.3!FD[':#I.E)VF,V*<@%JI[G
M1IN/&/ZI,C)+["DYG(NB[KVSG2,B;BELC:]4];6G39DCU5%J5I9@/QC[F<NL
M$DU-B7NPF,W\!I4R4EG1\-"X:\?9M@FB9VWY20KGW]@^,D@"(!AL&_%_X#4E
M=Z3%95(HE\C-SM=-$G]0@SE3LAB/DXI,OKB_DP#L,7FAJ2HGE^J@&+ASN3"L
M,IU1"QKY0'P*F+;SP6"+BO$'JHYI+29JTA#59=%0)OP(-]'VH\7+:<8X>66=
MQ=A9.(Y\HV >9]J8S#95\L9&Z?0M:\$[F\M,*:+MKRDA\=V$@2^I64X25, Q
M_\;=\=CKO-CD@IVCA I-@&MFZ#Y8K7[ZGN6@@IVX@T>J C3KDB<SMKE_B=1;
M\;A.Z5S"P&?:#)F]Z"Y8=>B%^-,\*52.%O GCPIW-"&W#:> ]PV;Y=B293FP
MC+HAS!\H_S:)OZ3>RTTYLG43'=-M!-<58DH##89;/",DWE6$0&8_3Z@X"6?P
M#]S=E2YM2^/+"328UI[N^_%C4OSB1\Y5P[28#H CY$>^H<PX+<?-S+;^I!M,
MO5DBO)ETHWYMJ"B6RFF0JZ[^1+\!Z5B[ I47U7G!HAV7=F"2-^.KI@2HOBGN
M\&C5O6]*KL5C41E\Z]M):/2I"P*@_=/'#&6#\8@]=*A4:D6K.81#Z]F,HN/E
MB/M5%*I-&'T31G_*,/KI)HR^":/_,X;1G4&PI(SF6N7[0'.ZU]65HY<^*>V5
M3PSK,Q!0Q26]"'/[,C.Y[E@+B/4**Q2[3$DJE(Y.%)5]YETX,)'25>4V/,FY
MFJ3(-:=?:@M9-=M^BSVIQYC(06&)BAN:6_UD_^AP=W]G;]=YK ,4*?>U5B,S
M>#2$]T7KE+N3S58;_$[!Y-JY[RVCM6^SV69O%:I[B=&0_S:ESR6XN#'C#V"5
MUV3/*]V7*THMFM1Z]?RZ8P44%*Q/2LOWV9B8M%QSXKG-6O9)HQ0/#R&*"Q,0
MEJW0F[MZ9]MSP^*/BJH_$-"BE=&!RI7+Z6AGYBZE8'$G)*@#)N-[3AGFW A*
MI>'OVWU8N-.QK1#9MW;U/;2$7%B.DWI(!YU3XR?< E7:(?"=.RS+"@M#'G"+
MD4<&ZDI(8]K49 OKUWW+U6+;([BBE^FV*P+04Z$M+UQ3Q'OESK%FNRG+@G-7
M"[!V.)5Z\ JH39*RI9-6F%1\XC?I**W[DH2KN'5QL2*<Y'Z1C-:IN5QAK@C*
M'OQ_]MZUN8TCVQ;\/A'S'Q">VV,R M(1*5(D6S,G@I9D-V=L22/*Q_=\+  %
MLBP Q:X"2*-__>1^[\S* D")MGS;C'NN6R2!JGSG?JR]5J=1TO=HHK=X'!O?
M)O4_953Z$S.*=K:8\S/T)$^+B-572\>@$45IG3\6UC1]"5'.9&%)#2L)U9S#
M6L!R\3*8X>D,TJF'J6XB?YPZAKE_R8MN/AUV&F'?"'GOYXSC]@VKR]I 1Q%'
M13E>=<NYY(1SI;ERTDF0#KY]?OGDXG(#:T!O$-JM'DV76*1" $Z[G19Z&@LS
M3=>X<.WPP*-M\]AKD_ AP >2GP]?%^],DF0TN5,$ZH'0#-LU4+4]L9#0EG64
M+[4?2J$]1R@IBYB,F=8=W.>JYF'F4?NY]79?AX4GWL5[Y_M"MV#)UY51OF2?
MR722>]_M;[(7^W0M6%E= VY4:]IYGXR$O?;W/(KP@U]V &5[$37_XR92A!</
M7/CYA]:%J3=S],#I#1[0GSA+&Q;0)<2N4PZ8G9V8V,:(!<4X'SJ,,AP($PM'
M!]T.5ZO"& 8D"V'@/V[:8!XF $/"8I$!#\*T6N:BM/0SAM,[_6C;%1;J8-Z*
MT^UD$[GZ&E=((]8OP"R UO6*CDLE<QEZT1@XQFZ#P5-*E5V)6T/\)XVA:O:#
M5OG8Q7BGO0?CX%-9WL#_3FJPU"!!P1A4&JHP0E1;!PBR+N ;SVPB?4G9N.RZ
M(G)@Y;ZF%*K$.T_[TZ<DO<-";_7=PJBK6>M _Z 3RACGG9G0DFM%UNS@$I^3
M4J0GZ /31=&H,NM5IY5>X)0(^)?;;G6.5 <6K8R^!B558G /M'CMNK?V?M=R
M70AM759""IS1QTK&4]::@86IMHLHB 1$/LR8[+LU#&^?WZU5'>(H1SRIUDRM
MBPJ."2[-@Z=O;OPNL)M[<+++<>$722P88*N%D,]S(8;?TLX'+N@O3HY.GXW&
MHY/1\Z.CP_&+L[(X>#$JB^/GIV=G)\]/_@(%_<_.=BSH/_DJ!?T?WKP_O_CP
M!U;P[V)XG.Q6UG]_P^,#)N2],%%,$*(95#,8+)>ZL^*HIA^CVPBNT!@=9Y$S
M+8="L0P/#8A*C PWP;SN*HT)7M*LKI$&%?_1<44@LD,(I^AJ!D(DQF\CHN&J
MKB<$^Q'X0GPQQS7'>0H#O.<G@@#H'1ZU._PH0060Q0?;U0U89:T<9([2;*D\
M<U[WPL'_%ZIE0%S!!B1'*0,<'U3?0Y&/*D;M#U6.@'P.AACBB4V#@BP/61TC
MYN "P ?E[9,O@*YJ4W\J%[H (#I9-XMXLD.W@G^$4N]E&Y7H\WM-+XDL!V#N
M@0HK\D<+7 NC<EUK!%U' ,W&VMT'3KLM,E$ZV7P57%!(MD@OQ+7Z]0U-?I\@
M T(U/QEREP2?$"WCQT]8SA:3^ +MK0Q2Z];V5%R%0L5+TY*@4=52-$()%&54
MHWV-":X\"7(M()$Q]\ Z1\)K$5D6HN%ZAIE?B-+Y61COV;Y;<4BC3'CEX!_,
M^+F ;KZOX.0R$8[8"%<46_OPA/2,&!K"4Q4-"P![EVQA@)_@CBS$^4W$BD_W
MAD;$I/,"/:(_Q-6&4E>B!C6CE#HH0$(M$F(G6'S&S@%M:3?GO)!7-.(M(:Q8
M6SWIX8?&\/\*Q3TF1#P]*<=-6:;^G@LK2]S"*XWXTC1V*)DG>M0*2@=^-LC.
M\T/\,/^B#;\Y.L#?A'\<JNJ/I=A>5;?5C/)J$+Y7Z$U;!8NJ %C9'=;] 5:)
MW&0\1X@/\PZY[T)/"!2F3%-? #KAV_T1=/((.GE(T,G9(^CD$73R%P:=G.R&
M0M_)3]*K<HNGE-:T1N56':LQ0\#98U]U%%&=J0"Q(B*6#L]$BYA_IJ D&?R+
M2<W2;0A^#G9)/7750VJ8E8M@=-4W&$P)<^UB)>$+'HF./\_+^:@I%E#_M@*.
M>W#,9@5Y8F2>AM<N0@]7RW:_FR2W8G$!BZIE9!]"?V?9K,;!!8 B7&,L\[FT
M'N<.$TR[LX$-+OE%I2,!P\@V.'$&W6&2IF EE'?@$TR:HEH@M-U3.TW!^++0
M]5 +*8>#&=0.M<6T!$SZ)@ZW)U%=B(3H[MTM^IYTBB.-5T0%K/'F[BCLS*;F
MA\<XX;*HB+3>2EVX3.@S=CD:,U$5>+Y2/W-17HG8'NR%X"!,5[-!,*^9%2/G
MU:61YVK:?>5GO:(+]X:WA&<@\V'';XBB(^KSPT*IILC,FFB6?^MUB\.V6(Q3
M^9!Z@6SQ"8ET00C_"0D$P9D30[71383U\-03&^[H$'VA"\8!%.>.&W\;>GY=
M#]$7@/U._MB?TQ&3 ?@C_+$_I2,F W /?^P+0_:GSYZ].'DVFD+0_FA:ALY.
M#XOI]&@ZG8[&TY-G?X60_>F.(?O3KQ*R/W_]^N+CQ;NW1,(;W(U@RN//?ZX@
M_FDNB']_]GH7OGO%0B+AM#BWXRZ''(#S!8YC/"AAI\5!]>BPM,,1#I)K*&++
MGI/P&".QU-BM$EF&CV"AL>,L@Z@=6S(W!#URM"]&A_8YI*31 "@W+:.7IEB]
M#0J]%I_?JLE"9;[A3CGWHT,I _FXF//2>3C RS:64D#^+B1_H/+J1" C@L61
MB"Z;_AJ[1>L]\UZ^8$'A3*M^H<O!VN@&[SE5L^P W]S%"XZ([SX^+(POQH7'
MMMJ0>U]'13I/32PF*"@'B0(\C]M^0YYS&KPB /6C-VP&<ERU \A\8#L%$:DN
M3P>;M\4A2]//I*?&YA+N$C?KCMA:17.DDDX-4B>B8X:)S0"81;(<W1:FV>>A
M[?(;B2GL&P/X[DE-?$TXPHD-;\.9L^L1;@WF+7Q_Y_$<$J:9<@JVF/]'N*6&
MX7YX^NR9JX@&JB/5 AO\6H^0LJUN/@DZ^E8[P 9/^,9(?2R<"?8A6;!J7F&5
M(+3HMIBM.AI^PUSU+@'2L/JT645DO.%I)%SDS<+T%-*E0596F=/]T>+37T+O
M%/!MJF^2Z>F@XB(8S]> LIW>IU+_'K?33T2?$;KZR@U\GD >+B5BD1L2!CD"
M]&:.'+%2_6YPH9,,^JP8A?WFPP6V8MA=</4CWB"'8A^4#-*ST=BVL>%HSZ-Y
M3VKL6T@;*>&H+Z.MC=Z-.PSX]MB405<?$2$L9?=TR$B.NJPJNC$@T-<%5L89
MZU1(A::R^SHLTR:,=.S8(ID*)L_Q]@K[(]B[L^I3R0PK0_9 %5W-I) VRXX,
M?UH"J^6,?((28'ZK!3DZ2(%0W0!Y)A8R(,<^!]&R;-\^X5? :5)-TK,G-*UM
M5[;AB;_0HP7TM*E:]07W%"?I&I[WT/:3\87% L4D>^KR\@V"YW+B4HYQEN#V
MN=J/\8Y2.3VDX29FM%%MI(\F^Q3=M938KI*EJ O_UQ6![^&QH'W)5?M,PG!=
M-/-ZL;9@$KP[3"J%2D+C)L#(M[B"/#^R0EA5/<O3XL5 #S.6LI;85F@#=TR!
M-)3$XJM<A%2I*JQT/+H^[<383^R G)[NM *:Q%D5[GWTEQM6*A"99QO]U<C]
MC&M-QGM>(C.&4XW!K0(]C[ A$8EOMT#,W1MG.?CGJC,&MO#7L16;T*;4A)T(
M&^*MZ/[!^,J#*,,/,@+-Q*(>K.7 A\<'^JM:#J]XBTX'E\%0>%T%PRLG/BLQ
MA.?/SI[K5UUT@'YSN60!!A=#X-,LC"3$5.K&X@6&CE X13J]/FH360BL$HD%
M,4SN2P"1&R4HV.Z+@"1R6*U+#;M.FN(.04I2O^)/4$<29\*^0R<0:[#B27!@
MZ*ZR$ZJK08GT(A'+6$S)D+3@,8']F,#^4R6P#Y\])K ?$]A_X03VZ0.R)KPO
MUDKO?>'\W8YXJU<]O:$OM7SSH\"?MTV\H2-%RSG[@N[=/0P<S&\X.I461L?6
M9N21(76:&6!:"$?I;++&,IQ#VLX;UWFPMIB.RHPVKM;>9_LGTT&, @)S?0XV
M:1^#3N1<CP3[VW\I)WYMALS;5(X6K $ Q=* W 0L+G(K3>L5\E:-D=7[Z&^:
MB8U8JRT4(YR!S /OK%X7"(SF!UC+EBMPQ8)=_J2>/KF!TJ<E%1[ZHHR6/S@#
M2P0K]B<;>F_V\%>)A=RCK.\>6\]'0,(RX'QMM/$2XS^)$J1YUX-G.;,_8E7V
M=53$_9!W@X8;XLZR3C8LQZQF<PF_ \O>-V)<-"C=NB-HH82==!Y>\:%J/ZG]
MK,EN="'"_\W!NV 3.2'YQZPY1WS=<HN"@-WN%4)W1X:VO3#-TKI0.\\4:JP3
M.AG]M'8I40]TKYB!@F5(.P$4#3/B*Z/$@0]5;%D%@RK,WZ0B1#[X@;YF3;PX
MT9O.5",D9SJ7%OA?.>"2Y:AA<M=XOK\RBGH6C1S\J P7%[M/WS N8L.)Z</2
M1V'TB L_PA+?L)_'?Z)8HRD@\+BWN[1-/3&LA,FXL[D-;/.6[ER]?>#D@[L,
M9BL<GLQXHJ/&6M]TXW$FOJFOY&.#:7%+(7M=J4_32Y:P&1S5],*!$H'G-0<T
MX"/D!"CHSJ5B%UU$(ZB> &>[GI>4-L0*38S_0<.TUA E<7'MQ)4)T2@[?:3P
MF7+!19DEOOK)-.R>)*:3C3\NBKFO:\#YM?7_! ,IY5<I&#_M9YA_$%3BMT@_
MC2L_NE;.4V,B7T,U=$% +OJ/BFPXXLG@%"ZN)'$/!"A.?) N'V7O4# /[21A
M7AZKZ8Q+O.USB$,!K?E!5+GM%SQ7=1))%[5.GF\*HY;%^PR^@2T9Q?R& Y0-
M9Y@M*2C'>\2'LIATP_ (?0'^ZX5KNX3P-[8VW=<]203D\<$\0F+!RW*(,F3\
MNVRYL.: NYI'4MZLU7/K385B&N:U:B[.*U#)+DUT6+XL&X894. ^ZU$<Q3"_
M!OC5<E^RE-"<CWE7S]<:<W8B7&.$ZD")0W%3YKU*"K>TK?]!4]SMNW6/[@PM
M2/[2F>C((_T!(V;PAR[[>'*%1L84LB=SJ'S-RD:=VC7;,BF C2&V*'HV#3L(
M&1I8FYX[#N@%9\%!M@+3UTIIHCQ<1)XRC*KR>*,@$&965'C%X:W(1924RK+>
M*Z?*H%N-KI#NH<TV>;>+,0.R.9Y]O<O9+6O S_MP4"=)$SN(Z2CW204[;86M
M_C/(6"SIG>-D^8Q[])OM*+.SI\HP<;^[U?]WZUM>O?NO-V_/WWX<G/]P?O'V
M\N/@QXLW;R\'_.IHY%PE,P-!4;-%A:W+TJ^WDK+6P5-:(8A^[*BXF(%'\FB*
MJ9+$T=#E\+CXF>YC/['J;V,E[ !K)T,[IQZE;!<L;R+90[:%UKJ!^O</^#@%
MK'/L&^X1(((RHJ&AI@\)3H9A@KTM!%-=P&^Q#(;DHERWWT+ 0[A16B@N2(8.
M-6\Z5-0.WQS-7"PNP5=T 1"7 @Z@5-%MH\^LNQ<C375R"D/:$?_J7 ^TBXI6
M#"Q#!T?UD E9'XK\%,!#[^8%\W$HO[9:5&0:W83A$0Y$2MWA3R9TP=W%@P!4
MI!(*GKT8B^22VDG-[*+3PF20G8F!(X G:+P#4": 70MUL%*;(H5>>94]GKJ.
MMU8EAQQ<W(RN!M[^Z#;"(FJX(<DYB<IN/-PBTWY;QQ0(2*M[JL5M&:;CBN\'
MPC%5$Z>^\*CW_9ARB]_\AZ;<#AY3;H\IMW^?E)L]\AZ5'L].P#4Z+0^/#J9'
M9\]/3D>GA\>'D^=%49Z.GA?C/TNE1WQT=0^N+Z_W.-FQWN/@66_!QY>5?&PO
M^@@F^<\?SL.^SNV\;OE)O.MLAR4[+N^S?&;T+XS.3K1-.PIAL6,[MC+17S @
MG&-LBFTWBS5TR.'"+FW;K?6-*2.I8VZT00UV^">P)2VXXW5J5*,&G)F6W!2&
MK&4]5O.8*#5K D>66DG8+X<8W ;H^:)D1)[\( 6H52-I;C#\"<&&>6"FD@3T
M89&22C*O+5%D]F4:*-< *P"8PW'47?8D*6G9G@Q3P_0]<4]:34N/JAESU#=E
MPAKKR&*[')M#'Y$J*TQ]Z0QAF-?-8(:0&FAG;0#"W*^(&EKDQ"#DP$\'H?.P
M60J)")D>U4B4IV1AH!M)=C(I"R71'Y6&)S?5/%=U9=5Q57\5 ZO)F'9I=-6!
MK=M6XD'4_B$O8(L)A>]8UXW-W57*=UU;KLNT9+D#/B0N[KY/F^=4E<3O3?;)
MYB@0=A8C9L8L#Y6T;O]'4F'DU?)ZT'D9K8?6=2?_1#!5"3%8%4D,N=BTU82R
M=<A\K0/D31_#@)=MW#9U)ZEUPYZ>:Q$O?![L(XB"33-5&1PWYUT@GOZ0*=VP
M.^1JNKSR( J4=</WIJXK(@11\8C3XZ7%K#+B6-R#XI%])SG\<K?#V^=)G@XN
MKQ'$K7L!X@X%0)*Q H-V4D%19!IA2&[C#"\EUF.]Y]G8O$ Y,&/ 9M51Z%3Q
M;.0THX*0#LS$;Q-<#]!DSW>6BS A?3#B4U#AC$3FP@\87*(P381*@K!)40'-
M^;=NZ4/V=[58PBK^ELZ0> ]3!1(N@E9"KBDO-A@)1HR](0C;UO5B4\J'QMV!
MN"PB1[M(3BB9E\RL86[I5K0U4-_-8EXP+/F%'[7JZ1;+*3*2!OGHQD.:8 _'
M!:,K^)7)-O_BT0HN'=N#]TEJ.2K+>&O>*TLAJ6%6TN43RD.;#JFA'WQ#9?QM
M\ SU\C8DP4T=3M,UD#Q@,6FPIN!N=A@47OP8 9/T;4L?GH=-6PDY?KWP<)D<
M8?6P YW9*,>K^:*G@W.-D,Z(R)JBF[+DU=RSWK.JA_12.X859D[4 <:%:+F#
M!7#]SQ4#I#"1 D0R$[%6<#-;H/:Z^%?10'H)R@(09(_S$([*<*65DC\?@#PK
MU"35#9E&<(25I?]8&\$UH$E@II14O(89I;I90JT,RVT"+@4^V(1%SO'&#KAI
M0(J/91M7+Z<Z\EPV0VZYWM8SU,N<805%AT5G*/>FI H50K1#@9I#? YTK?/T
MP%):QT"9;CVXD]<QM?8+NTBL_WK1-;DOT:5)/!=A,32$EUHPEB!\9C4G/LEX
M$>%6J=#'*!=I0#L+F%2+1-[R='/V78KKXG%"&.F0N#M0*==TOM (MS&++&\L
MZIB7P$#DP(:#\S"QXXK.Z3W,(36L!/:VX,7]70WIW?"([P$O\#.L"L LA+?O
M$]!6;@9AYQC5DW5BC!>SMNZB @LGB:T>)YUYS5Z[[Z"?7KXDEJ/*32CN3G5<
MG"F:X@EP\M:,VR,\1.;6PX6@A%M0>JK#)_REJ:)!,<%KQ]*V),"1MB!S%_ZG
MCZ]F_NRB=9]S<X8+[_D@HI88?,X-E[^]HBF?LV8%6[("3Y&S5Q6K''*%;I5T
M4.YURS^$;<!:KS!464J.';&,&(1A0ZGDQ3*/X*>*Z93;6\RQ*>RA"J'1Y%22
M#X-H1 R3,&Z1KF^^DYQG*>J\SMW>=V9IG^%]$^-=Q2U;(;[>M&$<_7;T&9E:
MSJSIIZA.;BD&  %BG$!#Z[XY15-TSHQ"9I3"8,(H4#DM(@V+MN+<I*<<V&-,
M6K@JYN'@UF?E?'';QYQA)51BA0X9>:U(1CQR!G4P=^<%SP#PD[7M?T"2KYS-
M"GO>_M__B%7[90DT?-C__0VEB=+<U1F$G-/0_'T#V!PV/SP].#PI#I\7H^+@
MZ.AD=%H4TV(\.2TFX^?C\>GQYV3=XM8>'?\MEU-HKD9[A\^.AH/#YZ?A/\?'
M^_?*-F&4_9O__(YVXH5M/+7A7]/&T\V_<Y+G#^_$_S@&&@[X_P.*<.BI=-]<
M5_>!Q6*QPK+2*[B9ESU/W"75=9_Y_F;0U'>2>?W/+TA*?O;#OJCYO]M,OY>;
M@A?L_PJ+\_E#+\[GO\/BO%<>=E=L1I*9[,U2?K;]DHEN9&(09I5 K0:5HF#Q
M/F+(B!A(4368*@'>!H<3YX\[=2! M3U1+/0X+,)%N>32,D W(E (XNQL<(!%
M=0V?;DL-MW.M#=$5N1O<ZO<T_9"@J0R+/EH/*9,!#MA2XF:$VC2XFXK,;L^\
ML)$;UTJB 3S\ACP*> W$9*J.0+%C V(:H*$Z*]Q9#^,E4Z;\K6J7KC9NT'%B
MHLCR*P\[>PTXKCW4GE"/*>)DW=^5,O9=4UUAI66FX]_L.UU;/W-])')1_*3K
M%5'XR:RSE$5MH*!YLK%W8%S@H)<QW8(I=[UN(=&<!,W(LC31*!1I]I3+"#XF
MGJD])[#BN8",1Y6=FOW!(EA*$FKFOX-V,(9Q;II2G'!-B1"W:Z4 ;K\ ^*&T
MUN9ER?#*^HD+HLPHJL'/TVA%Y+X:RE.B8!H:<[HI2ER#XV0IABE3EVIVKIH-
MMM <W0)8?%:U<P9U0Z/J58O9B.NJG"(1TA2H9 #&J@V(R%K"^E_?>$:E01N,
M\L6G&;2P+#ZA'P'AER6'M=IE?7/#S[FI;B1$&8Z!T*$=(M*['+8[G^F/Z+M'
M]-V]T7>'C^B[1_3=OP_Z[O-,V0SG13!CV"B]6&#]WP7LNF9UHW<KI%SV#O8'
M:]#WNIF%J^;-;\%X#?\E&S"J'/>Y+>1=JJ)@OM1V@25)$:])N $IKQ :3/^6
MT%MXWP(IG8KELJG"74C,Y;7EF61<@T$P8R/Q_UK]Y\ E?H/YCJG?8A1NY2^@
M8>)1_-*B53\9$2,"&K18F?_*%RC#)?N&L!OP-XN1JLT@&0.75?'T>S')'W+[
MX4,A!C@3/J\,I<9',7C6B77C:J1E]+>52A,6P$%0?G0JYCG %\*B&%;VY=19
M#U1H'.9L)PZ+G;( WW,Q]WNV*>,<0!C[3O"UQ_Q4J@ #[HB4H:(69 )!KYJ@
M!_A4K@+7%:7SV?.<'I\"W%V MR33#4SVU:0J&BD3+()_.X.BF)9!A.FD[U5H
MH^XG[APLA'4,+FMK55"D''BQR- -("1#4\3T.=T*>;4^&0%L$D;GK] 3IY:]
M)!\7DOB.&BZ3=;TN;BFTWQ22P(HC[.=_O_B?,"'?E6V4"AK\L*J(L)_\ULJK
M@A9CP)W*&1AE !F_I:(&<J2SSYSA]GM)',&C4J+QTO6(EH-/$,ZI8!K$= LD
M%TG<&PN?"R!&DI@TI&HYV$^N6(L%49C[@*-=4$3)@[K+.S2<VETM*!LD:198
MUP[LD!^ME^1DWX9IC)K?%M6D.P(1#G0,O^+2?'7QB+M]$O8*3V[,//YM0H'.
M)51.UW)4AE]3_7DZJ1ZK4$:X@SU^':%&L%VL;%.U7.L,.%*I.A.*)DR]8#(^
MK1^3K@M](PR''/]P%NO1$[H.UCA"I,O6EP]KXPBM-"H!>;<QID)H+JD#E,HS
M+#ASWW8@J(E_)W*L&"E/M@*-V.C+!'8P9+T1[:P#7?7T-!5@$>5W9DF)WJ./
MD. '0]C2TM!.#;81I</H^R'EZKPIH-;VCO=]41YW8NU(#R#U&:PN'JG0BC_3
M%;H36<=.5^BE61UY_%=A"JZ"J0=$.XS4K*X_B1PZQ%0PB%.6G["*$X<3-7X
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M?,!ZUK6<E/QCXDP_Z537\Z.@5@,5E.GV4[@A0M)4[A3BJ5>-"RQ8N7LZ*C(
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M1#\6=YZ?U1_;TISM8WD'#=M8>8SHU_7?/P?BDBHXA578[]5BGL[-&ZFL%YY
MM(DN%G"LKK#X&N&?>E,H%YJD1E)*TG^NBEF&43N!W]ZK:_G!Z-=VS(U,[P[M
MC S6F.*B% JK:"_$K&)&SPKCT<^7]W+GPH#?H>_/8[QQ9BUP^JI(\C!0G+>F
MXCR!KM#DLL'UP+VZOVH9]"ZC@97I(>HW,"(9^23T3#"[ZRYX,-=B^D;6*BM2
M(6R'$88$XG.&6J6^#DX^Y=LR5GQT,/+YB>X7'R=:D-@:=2C44W^M\<T(I$B9
M2'K<(<LAH7.*P6U5FP]5+)AA&4]=%/3 S:1T+0:GHJ=<$=!0XC$NUTR)T,(
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M2FGW'-^Z0A(=[3HZRYYZP7V7+!*(S52A.;?U&",E$JEU:W<_L4<P::)FR/U
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MZ5I4L]9V*Z*4("L=;DKB@4F6_-95V)MRLES$(A+TQKV\],+:4:UYQBY*V0:
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M?#EX]\O;-Q\N_W'Q'CG_PZ_?_=?YC_"1CQ_.7[\9?'_Q/S_^_.%-9E]^50F
MXVT2 #OY6)<BC0@FCK@RB:\%M"?DWJ,L.QAHWD)G%YDB9F"%,4>\=\#S<D^=
M4(>A*&(F7!=,B=Y,,K&N!Y%#QMXRFH)8YH)A*:8'&F-@.QPN(OOL:=3]6Z0:
MT'C%/Y5K%1?SWM_]1B0OT&4%B7V]@N>Q3F^_%K&%:*R2B=I=-!$ZWL/VG78#
MI<TB'YLCACP,:0S6\R,1?'BY:A::NJ97+U-R8&1A\Q!\RY\O$522!,DMK$*B
MDK.UBY;31$5)6 K;)&.ISU2_SD9+Y,+3!8X"&!@$F*^6JV(6C;RD.YT^<-U\
M@L]RHI#"R*YV)K,0*%FLX6 D4O9N2[2^*"@A3FO+/LVR1+A.V;(LL6PXOW2L
M[@7=FH8?!#3]\+3@UW4?]U5"2,?;.(EW.MX^H)KHS,5BWHL:J<Y^=-K]W(\M
M]S)UH*TAP>A@A,RJLMFT&2.0B6WQ;2DC'[8Y)K\?"(XXX22+NE\%.UHT%1;1
M7M50N=%0<L6A_I#!^]JTOI=U_<D_&9=P&]754!5_O%68>U2VE=OJ=V&8?+G]
MDG^&A *$ AP3;71"$S_ =<)5NHYVD,5=2>86SH*?B0(O/-+/9#1+.? /I"98
M$3:&YZ$N+0::J$"7T@/TVXG0S[FA)R#;J*DHV="L1J.JO=;)+UC7=5 M2ZJN
MT%+VJ,9]VI3EDX$>PN-B%$YK.F @P4Y*N5B;9(D-YH2CE4/<7ATM7@@8^5HM
MYL@M,"")"?IB''T .:E;'9ML=1:=(U6P88OX_1I"UP@2*\T@J1MTC*9/UDT1
M,S=B0 G>CD1JDZH=A^L%)U!SCWXV(IXQR6#!(I-. /^7= 3G"0G6.E<Z/$7I
MG\/R6\T(^JBX1-(JGGVE\_'AF&G>+&ZKIA;6Y'/<]/.4N?VBF[[$*>DS5!)D
MF[ ;^CVED;\.W@Z+YI.*)+>/36Y&+_.]6@GZK<!RL<OAC(6$= (ZF"Z<?172
M*RO5>2J2C,7$P?+)#U[G,(8DNA>HATK$WP"% CB$2?P<2XR1N@'SF>._<0U6
M,:@8=$3;*4HQ)8EC'SPLC&>0,H/=TYM#Y60Z>*;%<;'0/#!TJV_-[(OL#P /
M2HBZ(U!&97UM=S4E%3V"&T\7#.BV.@= ;B8(Y(N,"?K\<J3\H_A7T4SJ53OX
M"1A6JV+6#O94Z1R@86&YAG:!-3C5:PD ,0<G+[U>K0#U1$@DM#L\=;;&LV:&
M?'YN4/=?.F0;(0E;3*9B/#<W[>DJ,94*IFH P8/I:G&U:LT\N*D;.5CI1)_7
M58NEBX;5YS\OGK05$'!?AW>&:Q/R!U:6US=3T. 2AHSE? D=QM?D*YB4)ZL;
M8?'&X+6!,N)G$A=B;KL7T7/#I0*6.RB6,SS=$"$36_(](V4PX9&S!F9$,D/5
MOXR6]>^$;TEG<*\CD@QO3-!(:F9KRP[%@D;'0D&%Q75?Z9!_.$Z55Z:GD2@;
MP!#I<D6[2:,"Z0T@T#8YDZGND!>($T3*&Z^9PLTDF?I0-K:[EOJO=.,!5GP;
M'TI85U$5PJJ:X_[$1^$?M9;AEO0]X*M2I,^T6<G!T\D?1777:1$ 'V4>/^\8
MM(9LVP1KL, @![1ZV.D!PH^79;N4"1>L*E65^A:9KQ15'[OY/.FR_R;L!CJJ
M^4660MYTMD2NPTY_)I,7NF_LU]J*'OKIPH^E[GU4DL4N.;VBFHGLH#TKS>1&
M73?P^<*9 ZG1PM/;(<$82O!+B/JBKSF+&*J@HT.T6PXQ5B: 1;VP.>X  9.(
M#!J[D[2>@\Y+3R7"KHWLAF2,R OCN\!FB,G&9;]U;&]/<M^4U7R$JDG28(__
MTE@$M0P?S*/9>:H%#5UHD0?10QKJQAN<A)T9PR$SQUJVH2"\HMF/2XI*.P\'
M%YZ[CKR.,("@IH/H<:67UJ/O16:O[*B6LT,<_<73Z![(_0__\(]W/[Z^>/O#
MX-U_O?G )_J&+\7?-<PE=+0EH+QI+VX*E:#AFCF\M49 5U9X2H/&&(86\ C-
MZLJR%;Y C5.K[ E.F2PEQ'<_6=8,]*X7L[4O,DI#K@#.*Z&N@P&'!-4V?JLI
MAW.53R%TX^F7C<ET^YB(TNY]AL5B*\GH6,$FTH[+WY&L$C#H!%/\?<9I(66;
M8SQ$/Y1^"PNC)82&E0L/XJ 0 X$PJ\;&@%!RP&R2\"OY\ >'HG-$?.Y00 *1
MALQ)HRY)IJ2+<503OQ X"L0(M%D'Q\_^YM\2/++P&EIQ_L3S]T69Q*)ZK9K8
M$(*6'#X+K[/H&R%U>Q:\3"]&NS(SG3\'4SX0O#<HY4'Q)!O<)39+\+,4&]12
M2X/<$<L0HO6N6?HL >/9*>E8CFK4:D+0CB[U"&9<>^"LZ*KA_G,1?6B4?H4W
M$5Y B/5IXVM5PDC&&GGO\*IGXXCD#?)T)8UCWLD:M$]%HR@-"O.82?]UZ&(<
M(+!"0<DH"TC;)HZQQ&P%DEA*;>S[47A5^\6T477#E/O^%%0ZHQ[+6T<AZG'3
M.2B] 1RY&YT8HE305NE,,/28M@M<#&F195,OD0!J4DY+J.<$MVN^ /(V6#4H
MC><4)IHYIA$)"Q:^#H()0S91G*B&,ZQ,NI(E*.&Q5O";"R7"\)'X1D_M+W=(
M.G\5SN(F$JISQ4I(&D-R&1@^Y_*-\"(0N"1.'YHTP%64$S'AK!WQ1!9,^AIZ
MOA2=B&C(K4<ZYO<DG/&X#9]2AQ\',8XH 7ILHFEXA*\]PM?N"U\[>X2O/<+7
M_DW@:UN/W>T>YLG3R%O\O/]N?<V;RX_OWK]_\V-8FA\^7GQ_\>K\XYO+;4%/
M:M<O3-E0+@9[!\_V+:J/B20G5*N\*7F<3V(D,/V+)6P-*83W8899!MVA-MP@
M-^5,J%;&6(O Y-!%RW'Q90JX\<:WJ[OEA!;%)Z:[Y?)^NZY&P>Y[[4*W**9-
M(E:L&;$G!1-D .(+(#9._#Y."MY3FH2;G_@U;DNM[<:,^,VJ&5\'F\WE $T.
M$[\9"]3MH\D%8Z,F0\5Q7DS>H+W+M644S(&&E;]5+>LWPG_"!>B]5:F" @_#
MF;8;Q.Z[M2:UE_$SY\KW-#<$5"U,@2N;=1M,=-K1Q&)#;+>!E+HC-W[Q\#[-
MKMAH==Z%H2K1WN?1$!E<-]?1H%1,'VZ16:BC8#:.T%&"<"%N*P_I$\$"HSRI
M(;AP@P& 6; GBV:PAAR>).HR9;&%, ^!,=N4^@,"DY YH:O-G'E,$G7W,I\R
MS?K'B'UJ<#Y;*G6'#H449.P/(W!"QGEDARDM?AI0T?DREN8EWB;*<G9_K_2[
M0!RS=[B/8\?Y<:UVV_!8^#B7];IG.N)?3L95"+(,;;64 ;L8,SL#!!S'K%$P
M\J$AX94W,\JM('4QP5K(PU[ Y@./"Q0*QZXFSAUY2&MS7[JJIX/OV5-QQ;NU
M$.C*X=U[:A,P*'-6FV?N]HIN!B$9SD-3T_  N4VN#7,.96BQ,12CV:QP+EFI
MC[/M0_QFL^)L>-TT)!V@T"4^/W>-,7^I>7#ZAY@'ES]_]^[#ZXNWYQ\OWKW=
M+2-*K?J8H=&6^!;3-BB- U&I#[B\G>L',=].!APF),$?GJUAY0OT<NK=<G\B
MJ>+P0E&QX2903C1C1PG3"13')1>9X^HC4I.&6$;"\D&IX8C3FHJ8N5HY/0WE
MW7)_%,W2PLNL[RD-8ZTC".VV0XOGMD.F\"/6EC;ANVD]F"^<(H 7XZR(I__A
MYQ>36^H**9_XOE!0&G^O,2*N/#3.9QDLPK#J>+5#7Q(-@1OF'(N_Y(>XS8_Q
M4$KFX6EU(W5]^!R>?JTTM46@H2A<"P9'<Q8F9T(-= P+$,/06CZO][@Q$FA(
MM8U!36P]<!B'0#0CY#1:JN8F!(( M,*'HW)HR' 0K0\=,V%!KF3"E($9V.M\
ME^$L5Y3U/O)?4(1+C6-/ZJ#:3X0C+I=/ZNFT14NDK<$6&?K=0'.6V#Y*_#'F
MR1!;4/$ %*MR'15"I=Z.\3NU8_#@?;JO:F<. K='#;\2(:^H65&+-13G'ZFK
MWJA.MCPF_KZ$YOFG;EI"@['XV U#&#]66*J9IH1N+;\NA2EK@ABCD2,X( %[
MX+@SPB"UB?@FHVOW!CPNRA+S <J,&8RKHDQK:XG[8;+D>TE(Z9!0_@WW- ]2
M?>K,=ZL39O>"[5VF"L& O1XSA3-K.=1L(QN;V4*%Y7)MY'>BNXG@(S(S(_].
M;'-:MYP@\]8XSGQ8R71*)OA7;Z1#?-_!VC!)0R"[@3&HT"&J=QN'VN7<T:"Q
M'][.,1&?FL/H2&C=\N]<B3I>K.W;!;=C?)J-UKJ16Q8L(33:FA7M91#U)<P$
MC %J PDU8(/6'OY*\,G*\@])!2%BB92 Y>!'A>=P(X6[HD06V"D1@49[ 8LU
M8E0,_"HF C#@>1=ZNH[.)SNTQ8G9R4*[1_WAR>EX,CZ8G!7CP\.C@^G!V?1L
M/#XZ.9T>3,;C@]._1/WA\UWK#\^^2OWAZS??G__\X\?+EU!D^.;UQ1]94YA"
M"\^VE0_>!S]^*YYJCDKMHB>/-^A\32H_TA0JD3S5$6D;LS*0P:,([8Z#IA14
M?.#)4"858(,]$'E'/#?3YVT/6<I6USZS'X1T>_M_WWTVN@+?9X_ZWH^YKM\_
MU_7\V6.NZS'7]=?(=<4 ^Y-#O05S]R &] 4*$:G)"GG/AS(EAPN>5W,5,_T@
MP*WJT@4.\W$9LG7EM<Q$A<2,PF,[!8-W[SA-<E$@A;7(9%@9.(L0DYBBL84V
ML6;D7<&TR? [+ "=K,J4'<SHFZ\1YJ3E,:I&"YP >P?&U$LO;Y.WNXR!A\C=
MP&,(EF(LO0//THN^@493.D!NF13JDP6ENC.Q03G;.H\X[TR=?L+C)+%D9+),
MA0\Q@#-(;80,(AJM&@ML;%QTS6Z+3B'EN;6G_7P9GK23C<)[Y4MK6OR6RY1V
M#]Y0.N@.=@/0.G 1,#GEO Q C5 ].(/H6VU7\/LY+H 1^<2*K*2<0(H42H]W
M$B"X#;U7 //-L-2%F)<RY+GU%0QD8^S"W@OM8,]T<Y@#G5UND^.@%$_: 3#)
M\??5/7V!$WMD5-Q+@QX!P$1*L>6X8E80(7_D2-@M.7ID;[SLGBZ8*BJ6'+%,
MN6DS=3KC8@$[TL5%1F5\5!9IFY6G/,?/%@&D'7%M!;QO@TD5%G98,;.UBM9R
MJ^"5/@@JJX47"@<2)-3MGL/Q@)9#A4L!'UJ!!S?A8;9I]K+MW9Z9RN+!^2@T
MKU8*O=MBK*!-)<ATX(5NRMK*(649)!W[2F=1IL(.H;<[;TU,F[IBD3C69;4@
M[8#+X,*OF(43CH:#$V'LA=^?=LM%U%B(&7$U\O4+D(W\6"Z]="]N:#SPP*^E
MTGY$?F_8XTZDY!K"Q'O/H[V>LR>^YAW2JZ=E5X$[W#&*O8Z7XMU&Y)#5<M L
MO/)RU2CH^P IUFS9Y[D:%%)BI >F1ZOTZ+V&L<$UY.G1,1LB*3DX\F)L]=#;
M,$FUKS[WX,7!H(2:P'\^E07XJI[@@?VJNJUFD',,9AR"F%UJD,/N<O\HP0@'
M3$GJEC2L"7F"'V6L@(Q"AV3S:Q3CGFUCI-DQF4VT- 2SQVK;;B0I1TC3#7]I
ML%EN*U?^D!$&Z$?4*^Q?D1ZW8>>D$F4,^F>P#:P2N%VYPI7L*BT?L,JC"DI.
M :+0 M)$Y!+&J_EJANI3K!#/O$A@A@%A =,3+<I4^\-B??JNO2UR6>QUT(A5
MM)KGH#A3-]5JKME(3'Q;*1$OR#"D<>%O:"\>J0774VK?K8!%^\;;;5'^%AK8
M5C %$?T];;A:A*5<CO3ASQ8[.@^S'N_'C"!ZQV+NK>OL*?J(V3Y(^2*M%\%T
M:PRILF$*KN&O86K'96:]*IGVTI\U6#,+QXBOVP$VFF"$-8@@J!;H2 U)%$Y<
MKV"H@73#AFH?(>R8<:%,[9-/$V^B$R'QW74MIQ_=/CD^KDP4@+L^*C&E5A5"
M<0"H058JE&]BD8?+Q1&1#>?+PW=>QF50E$H<8ZD4WN.F>F ;JQ.X_IRE%\6N
M*<B=6XU[U7[O+9XI1'76V1TZ?NP2H&\&AR((8<B\K1;H_Z+/3 L%@A=('A=6
M F: XV^G]"[!3PF[MJ_;._;P]QR[_L'K-XUV&CJ.#8W66K*>&\Z[>C6;.$H^
M&56RFUR5EY#YI6\#L!JZ0/9*G@8+X6#5)E1<1:$?K,$&T&;< J^R"?SLY>3/
M/X>[3>(#39Q A$;%S",6'7S7K-Y=Y\I/DH(B_BWGZO8>^PTCR%PX2\,583:0
M!FK1PG4;$;^+FMBD7#85>AIA^'ZKYG3+(CV#B]O$+HXXI-M$">#RX)O34"S7
MCJT_3%73"K\6H,QHIX\ L?6I)&4BJOCS)981:Y^510H>'"TR#+$, ;'VJ83+
M&,,I5=LJ]1*B,I:DI,8,;8B+!?,"833\*R+YJ2$$VW>IQB4'-+IA$NZX]M&[
MRE(#8?$E_/"D@HIIF(25%(0C2@8Z2M1$XY+;3BR%$!^@^@/W(KR#O]!NZV:(
M3SH9XJ/#QQ3Q8XKXP5/$!X\IXL<4\;]?BGC72_\^=W[WO^>1?+B@$H>^](ZL
M@S:-S5"0A>-V<7V_*]0S@1LBH&7\*OYO)W+QN\4K/U[O+,K<(*LH"S)O$CHZ
MHRQ9'X4-8:Q1_HA(HX@$C/A*.).T.?\;B^I$XIL=S4Z5NXLYWF&:X/=0%V==
ML5X@CSZ/\8HC+\'CQ7Y!#\(OP8ES)(,4"_NFW]#_QO.DS&]64C<E03$%/?.7
M,>#61^-V>.R3#1$R;HAV6X72?<@2<P42HJ6("6/@-IBEJWGJ#&@#;&F.UL05
MDAVC@0Q+)0/CQF'K<NH?J$3U.QDOH/64"K9(VHPZPP^43]$H\C;\OIQ 5=S@
M Q')#+XK%I_@;Y=A7+X'^#9\*>^D@7LSB.2M#OZV__M&^J*(=;]:+(73)F4[
M;JH13=&K\(ZP:!95P>%]#/;;K!T?/#T:['%U 1Q'DDR2HI&%RA2@2TG<\N$4
MA*M(XJ<NIUBP/.PMAO?@%R ,"^1]]=P"TXC/J*;\-(SH+#V1#RE[,9H^C-%0
MJ[V W8H<%Z5IL2!QNQ^6I^3Q@ 6K\M(5PCV(YW<,*?=>U4+*$R4^WT%_Y.+S
M&.[LG-X:!O3G$L93B'A0CR95LZ10-/A^S.9# \HQ\BX"R=-+1DQ(- 5<%)9,
M XS_;KF7!T_X'6:STJD@[I(\:/0&8O;$9$#V^H/V6/R*:Y1OZ"A?06'LE D5
M"3HSK[%$BC(#RN5@UA<=@?Y:H+T;70SLUG(")L&"Q!?6OH^?5Y9>J#6)RZ77
MA>/VA5O$S 6B"PW[J2P_<577>%9@S@39V']=+:A\W8KI(!^$W\6"=\XU1D$!
M6:N9VP8CZNVR*2H6\ONU1C?ZMJIG6K_")T>="L22A_^[F3=A,AZ.:OW2-#LD
M%1*E^WZ)95N,P0S.GO:!#I\BYC>U(%!"VWM&*W";R'@B*B*9,94G&8:3=HQQ
MFV$4--&U0\7W+3#K%4T#JO94%)6D<="OQ=MI67ME GA?K^")R <X.SQ5$9#^
M,S^6(95\%9D@>W;IE>]$0HQ;3W,> :OV;GR[%FC=MP4I-7*AQ4Q,HY_ MQ*%
M)2J55]<%9S]8A5+$IHL /19KKI8!1K-<3817@:"CE&/6,JJOE-??0K*]6PW,
M%+83[M /8;26J8964SX);R59HJ:T52W\S6U*X'P-$P@$[\I%(2%2Y7X'M5*4
M,1W"V1U.S*4J: LTUXLH,.]=KDBR]1+M$<*T4$7SFB.UT0+)TS8"$8XL[82Z
M,7]\.?RF+B@_1N1M<=7J!LVO(3!." 5],5>WCM65!EV)5\QPUU1P&/Z-N5@O
M^[I9Z%OKSX6FE1&1FMMW;M$"AP/PC!E&2RE@%9QU>$'X1!6Z>5N/,4O"U92N
MSM%J&1,K0PP%DU,+QR;4C>+:0S!8-/X[$Q+GXC'=_9#=9OU[B#A":"<>WX--
M JXJ'<((.M,?_GE @S2KO[?34?$#$:M$)T1W0SD4:B>#X]T3!5)$6.%I)PUD
MM:HQ)2T^42:V W)CEHS[ H-Y&3-$/B:+3+8(F8AK)>3G][P<7-=W1!<@G#+:
M@JW@7_SX\V=//.P7 AJF9J(P7B95=S: O:CW:9N O0A?8GY=K7? %)30J;-V
MT88R S?W-FU('*!HD!3J\30&T'>!J&[Y7#6%@7D*M?_X#(,T&^.5.#(P9*)6
MYM -.\&,+_V('I3IMR/"I<],6>JNL#2BC$#DCHCO 9> %!"X@H"7BHA%,FIU
M0JQQQM(*-YYK$GJ%H#K",0 UQ[B3G18FA, NY'5X]O0 I46^0+O[Y#';]YCM
M>_ALW^%CMN\QV_?OE^V[GUV7JT[;Q:X['PGK7KAN/Y1=_3P+ WB 5$4EE;"/
M.8\'=0A7%$#3X/-*:!"V 5T*TB)KF?1@K]K7[ :6$';$@D@%5@D/H_HP0^\J
M:"@R/+G^DKXRW%XSP=%1BSG&:;:*PAL1 VIX(J!P6L_I^"VFDKK.7V@D23:X
MTCIS@H26D0L,@#QL*03R-6G_MEUAYR1(ZB4'6=B"HC(E#O>X:L:K.57;M&F@
MC<4^0<*"6VIY/\Q1 E'@@AWH[=DO6V\8[).4USZ;EC%5#=DGR)BC,Y@XJ<GS
M%+&=^V/B!FAA,H;R *0,.+],/8TSM3!"<:,!2U8UPA;M[9;^>Q-VM.C!OD?#
M/!T#E]G]#J;L _9+%]'E=4&E!:\K*,(+)O0-Q],*U1N*7'^IQL7(9-%\ O-^
M+RH@H,T*Z^I?'JJW[XI&1R2Y!;[X9#4N>W2):+RZ.C+=3E/5C!:INK-%^FZ3
M1>NLK7<\<A05QT2>4&;*0BPZ.C+-F>,I/9R&$AD$'5K]D^2J 4>*\@GA^I+>
M]I41[GJ :N(P.D='2*+*\[:L ;Z:?;N\SDI6A\XM?8 #O>CM(.$5G5X-3"UX
M+[_A*=6_&-@UM<@/'/5(U=KS)B8: 'V8:EP)"2Z$"%SA(^5RPZ[&&EA:!."U
MZ1Y?$LU:6N;AA-LR7XJD=.-FJMR:7]J[[PE+&#OI-9N?[@;(=! !%=D^PCOU
M/(G/BKXC17<2Q &;I*QDQY,F/4*2P6D?:M?'.QE47MRRYT$,VQF*6BH.2?8M
M+AY_5Q1-#Z>!"XML+&5FO SXJ1-;!Z.BI<K!70^.*);3?6*W)/F>IX'C+A;]
M*LM&J1(X)E>Z@T4CD6_)T\''Z"H!)NKDV@UKUU#@$&;GR_BV9/O$U1O_[_\;
M_#^Q^@\.?)WQ\VZ=<60V^$ \KC9*YFC'K^"-"S&)G XC]L\G$;NOQ?O.DLU#
MY=O+G&916,Q+4 EU*E);)TW5K6F6[RX[5#NG'\5,(=5]96):A(_0"<J51Y(F
M6CJ+&JO+B4;%V"@N&5]T)+28U=*%B\,4A.W-P3& QN6J,2J,S^$"PI4:%C \
M%[?C9%4.^E-QOP^!].&SI_+<+Z"1WOJ:5^_^Z\W;\[<?!^^^'_Q_/U^\^3AX
M\_;_>???/[T)O^(WN]BP4)*Z@1O" <2#)>?7D.E76E^V3 <ZXS.*=<0?SG/&
M&F1T58?'?BK+&SR'B5U U%+9J\(?N2S$-,,\=>HP$H1V45]E$:9T.K_>UI"<
MJ9#SBFC4P14)ZW/8P[@ZE%1R5@( )#6+<4FE/6:!A0U10H"<2I%19 MWUN+7
M.JG+=P)T>K1\9G>A.I>A,.I)+L:JB$65FBWLV^D*W$TLJ&1A$+ROD5M9O182
M93,DKC*P5*V'ZW:DRO1S737'/VJ?'=R?J'U[T./RS:N?/UQ\_._!ZS?OWUU>
MZ%YZ52^8WU6T8UUV0&M8^_6;!Q/(D%?$P.,*T(VQES\@ [RCPW@I7W]-7U=W
M48QY!H!&3KN<QJ=R75^NYO,"<%">0EC9MXO0Y+"8(AXB,P^$+J6;G^MP'#AQ
M/4X&=;(0/K+3E^V)).5RU5A)JBC5ON5#3&):0T&,UK<%]@,LLA)R@'*+4XB)
M2K1$NYUR-7U5WEW%9&AG+_$6F %K9IV)1H#/,9RC9*9U?EQW\CQN[6KN\V]F
M.L3\SYMI0R3'R<@[2=(-$>56<WZNT\;0-UP5P9RI%@"&HM68(3B0;G\VS\$&
M@@.2LUDMT-KJFLV=5JL)$HR/%=J$;B*1$3V"G!#3@Y' @SHKDW*745PA(O!F
MM$7,O=U6OT'N^87DGN/$]JQ@>0&B6*M-._:S5%@EMFC J47L5B(E$M__"E!I
MD[!%[>^2#!%5Z52[829U$.HHF)5.PD[ D0FF1Q=A([77[+8)5H^PJQ 8692@
M[CADL:,E@U5--(+? Y(4UP5]3E2JB,9;2!B&*8',V?&SIR=*'9.#EP\E$#AF
MTGIA!.=F*IHG1K_B@8>(U9Q0!CGV6T_!#L.2L8_#L@E3$ :3!DZ1_=.FH$(;
M^EP1OB/'VPHUAZ>K1>[6$I@.0>6Q>_\ARXO] 38^_2--*YYH'PBEU'TX(=T1
MDHQU,0XG$=4@*^J?[Q8)S=D!2309^%$\TND4]PZH"(D2/@N2.BS@P2;<C7FV
MC!<P09Y(Y0)[NU=0Z)[FO6[6;IA;KTI%UPR<-@1VZXQ!T;#,1FBH.:EB?0F;
M(*1^8KII+8TYT,@\-')OM ]%(-=2 $/!%%X^B1R4FYSL<0DTF3%,=MXZ<,7F
M1NEUY]IVR,]C7& QVSSMO:7GKDTSA-X-',PD4WJ>,&OO:&V@=<</%1\:'$_2
M?HF/8#I^7:66._ZL#.5PXYER3QW:1T#%(Z#B(0$5SQ\!%8^ BK\&H&*7*,3A
M[Q&%>/4.E@UHQEZ\>WLY.'_[>A!^]?YG6)4_7KQ]HV)P9(+ )8T8:'#F$ =1
M5 3#!PVSH5![@?I22Q4M@!9=+40(C>AVL9@T.'K!*37:/*@4@Z76#B20%UG_
M>V'29I)EVK7&]4=P+EU>.R;/C7P(9A]QSA;5?XDWRB*70^X8TJDT%03$*!;W
MSQ7<H&!Z0(P0-!O!+KA!!I])KVRNB_$AO)4C/ASFL+!E;*\K*>H)OOHT-B,2
MYP@)L%'9HR5#U4E]HF\-;W0@:HZPNN+0(1D8'9[N2$AS1[_0)4QJ"4QD8NWH
M^,:I!&B_\L@M6EMLL,IPH@>0$5O2:$M0.5U&7]+FAU8=.GMV>#HZ.SD8'Y]-
MCIZ=G8V>CY^='8P.3L]>%&>GQ<E?077H<$?5H</G7T5UZ/+BA[=_H-#0+C57
M822VJ _M!+C[?A7.A.]G==VT$=3NTA((O6<A'6O%;$BX+.<O1;6!E/B0(Q?]
MM= ]$EZL-'5#)YZ+S^!)N@QG?/#DP^<I)@1]D2-1Q3KA+RJ7+0='E62HX5QM
M*CZT"3\PA6ZG3\,C!SK3<]JXJT\=3>;QAF86J)*[I@H"#@<83$0+Q@7X,BMO
M(;@8CJS12,289  L5Q[?5X25PR'$& F'O>!BP,H&<9LA2HGSE?3P:U0(AM6Z
MA?EWI]7Z4W"6JR=\[V16[<54\WN4?F3.:CB#2\G5\;0O',&?!_+P[>$@;CS-
M7%\3W'!80"@S*%,>(P1[V*:C**ZJ9E>+:DE4:"U$;\!4HK+%J(HU_]JN(.\N
MVY5VDK94L:I;K]K]H94RI2WPYDO1"" %UZM$/:)0"2<*JG!M%0U-B8;/HHTM
M>F1F%;D. MKBB<@@ZM< .CH!MA!I9.CW55/,O]+"[ZU\WVG)AX/MNAIA[.=2
MSY?)X!V.WP6 8:,=8*B(G,I'!B !#30Q#3Q6AD(:/@R;X:J& Z@:0V :_H)Q
M1)<T8K9!3AAS%!?//CPC2T'3%4NI>UX2>Z606<_69A_[5<+\3&3=3=)$E_^D
MJ%K FN6E:ED0-8/A><3;3H>W=E?.!3LOFT%3AP<HM$B%H#%$%CR96O,G$+]J
M*=W#8W<75D!]1W@BH'[$^/YH%GX;O!? &LG5A"R),%1BKX[*ZXH3@-*W)SHT
MZ6,U&R?+?G_HA-<1)+WU1O! 4[O_<H<*)3@K]64*2R1,W0''=D#"#O"5]MV6
MDO1[[,$?\78FK%/=K+-5I]OL!B;\YL6G!RWLI\ZY-Y$W>5<&\W'0$%QM>MYF
M+@LR)NPA7^>V@)+])>Q:/(XYK4H0+%Y0Y"$W:P>G2=2&5,V\@U?5NL,XO:@B
M4+MXGG$2/IV2BLLG]"J?6IZN.U-NV\2YVOS8_$&(E:/[QXKN$3%Z_^/%.40O
M?[GX^(_!C^>_Q ^( D:6H)W4M@X0>PL$L='2 *8ZH/@B][T8A5,_>G)Z<KDS
M6E8%LVM7N.-P/=P1O=9T%FXR#JY0A?_04J3$WLOE/,R2OP)P)<UR11Q"F$1O
MRJO5C$$#5ZL*271+2L9@+,/C(PCG.2>*9TQ.(S J^G78GHOQFC XNZJGQIB#
M-A%/E:& ?&Z%(/"QHRW&#+.F>#%I7HRYI"(L^/EJ=@7G3CAJ-AYJ<80I?.^&
M!9ZB$!8:C%%WYV$'@CT1_,QK)$;FE"69;3B,,K[=A#0@-><W-2.:/9L@-P>R
MJFJ1 T_#<#!ERCETM<;A'U%S1O5DS4#$B?JAEJ^>8\#/-8E =SBD,M$D\4[)
MPV%H;#$+3X'U74S+I?6-KNTRC$^]+H&PA/^)MA;WA!:U /4<H)@3O=MN&LOQ
M\43HQ&#7R'S7]D2#W29!0[2_VAM@G2&4\987AW7UB8C4/.4*'_>)OVZU847"
M-.G7#WPQFBO8D:V?#?Q!-YVW3:V3$2U?G! ^(D#BKZO)E=^T0.!-U6B0ZT6X
MSZ^KIFHGE9*Y(-AM(HPN!O[D$P=%-\"S*YCV)S0Y-&;&I2="B*GKMX*B0\!?
MK069/8SBTT#41UQ>Y40(*E"&T@^/=%TVF+N6@-Z( =AX$18@(#)&5V%4+N]*
MSZ1@B*VG@^]K%HQGQBU+'#\_W9@V=DE]AM2 23BK6V^N^#(Q^9@'. RM1D%#
M//F%!-Z%'7H,$+FBBP3!?LRD$YH('@O&Z,^I7O&2Z,@K\,!?G5_>["/3IB]9
M])W>*_?OV6\\A'"I$[RJ_?O@F_,=F@$T'=+Z+":$RDY*,G),14^X5G/?Z,DO
MN+H IB'"#C]!*",L.&RB5!;8SB(8#K'A$$7I#/RTJVO[G=7%\(C"%(3N^7GA
M5J2M';*=.)^7#>XE14K6=POF\U#Z3#_Y-^PUD]5,3)=ZJI)#1)D>7$:[-D=]
M+CKMX<9&>C4D)H+;Q7X]S;X9PY(P"N%N,4Q-^BDZD> H,!VH^6JY0G,4[P!Q
M63U'F71?VD@%38N)Z(/)DHV[.DP!2Q@A*ZUJL?-YP:CB^1^^$(Y\P4PR#5<*
MEFFP1D1Y"%LZ5N^QR 0NBDXHHZ&^@6IP9E!C(0X/;5* ^3!WJNE)@X/I]Z7@
MI](5$4U:>D=RL5LYV2E?16<0/-_G!8O)K>"<31I0@%.>:=ENKO#JT&@+>1=J
M_\(E#2\>PJWB;G 2*>Q.F!M@C[/\\JG#+@CRD2Q\M.VI-L!$9R5RL"(FL\Y&
MLL*&:Z)5I8-$VA\34.O]L!=<!^#+BQZQ_S ]BRTSX07,PG2YQEV8>KBFCEJ^
M=;TPX=A\A((BIEP(CBY!HP%$K^$H0[ 1TERV,3XV(M^>^NH8WZ9'N-<CW"M^
M\Q\*]SIZA'L]PKT>X5X2PCO^W!#>O8H[?SS_&);E/\X__/#F\O->(0&_BRD7
M76"@VY<]=6N$ +3L1123<B5D7XV30N;<NWN6  *ED@TJDTJNK,AJLXT[):%3
M3$37,><.CC;7$E4M<>AW[G_$6$5JKUA PY$EJ&<.UW+X.[9/!0R._Z;N)#CR
M,";\(A0[(#--<!6:=@LG:[,HU^VW8*R;OE<T6"/Y9A3>]MR!Q5KI%_[#2(:Y
M(O<.^A<7-*-CXON4:HLD]H<5M!DY/EENON@IU=0EK]0;4DNE28Z @LH1'S$\
M<A&YY2UX047TNK,JM&."!IZ#TN,?Y@30BVAV^#T<VB&/"OFH8@[[>' LZJ2U
M!E8M%TO74,F5=</RJ.C-PNJ+Z[:T="X1VIX0+6VYQB_#[,DP%XY<.F98T(DF
ME4E\&Q;.(-_O#8;G%V&[Z@)6IS4J"8,/A;]_@W(>[T%[;_!C72R^H<>,*Y?'
M2A5 +J$ KT7C :F?(:?S?C6:";+FAZ<'S_>.#H[WM7KC9D6E1%J!/0V6:["E
M@Y,&'*,@9$,<E;,2[/7!/)Q-U\$A:+QPD ,K0/KP-YC_G+<H3H?)+:+?B#:X
MD#M1)XF7GM5RI(G[M).G]:H9[!WMR]9'9 (P3C-7DI;&78>%#K,DPZ\B,&KE
MWU^4Z!YXQ.GT67EX7#PO7HQ&1V&BSJ8GS\=GX^?C:7%0GIX<_Q7PB >[XA%?
M?!4\XH_G;U__^.[#ZV\O!Q\N?OC'Q\''=X-7/W]X,WC]YOOSGW_\^'+P_AR9
M&2X'W_WWX"/R-OS)X(LO'@2^Z [I5^%2BS+SYX@;$B**A-G &!HPA.<)^WC3
M]Q/HYC[M_'A-/V3=>?BW5S!' C,).I+/SM(B4;&Q58\:KL<JWC1'3?P4ONZ=
M6@V7?H?@VHB2NMHV"O02<T%P6*Q0U*'1HG C543+"*2"+<#&<I"(LC#Y>V%D
MP_@DJ2^,<$Q+PT)82^-Z^$[5._>22^<H/R54>1KV;**!P;\5*'AD9A-6QLO$
M03VP4%NQ9@U1+,&5X.OI78&?D]J0QQ"//CS(,Q_%<]-NX)/Y(W T+[8!-^^Q
M6W4P/TA :YY2?!I^C?%?D?R- 6$3!$FR)C99Y<8^@+SK,EM&OQ[FBDG7UWF)
M <R\+9F.R.C#_XZ6$-6BBJ6$NSY8B)"+\P8$BMTB=XV;Z*P1'U=J:$Z4*H^3
M0I+(SM>BY$2F+RDBL=T9<UW! 0TS\Y+LDKA;5N ZI(*2H;)^5_ [,:G=P0?=
MGY8-IWAC%;V#9UTJK9=B$V5?'HWK/0>3ZH<(?A+\J')^PUP=EC:?S23C)N8Z
MG'>8\<]]T23$1%FB]1Y,5C[:SPK"4+H,%1$U162!@OE]%48#?;]"R9+$FVAE
MX95*D?!M+U.*7P!N\KUV9+MJ;BM6+(J+9=JZ7FSC??BCP$XGN4C)(/J?7<^J
M8#E]^&\PG<30^MQHR(9R*E%:<Y-*HFLPG^A:N+\(J2N6@A./8K$8')W*E%V#
MWC@C^"2*X20#%&U.^CFH_D3>ZHC83=!=++*)H'UW\.VQ:<(?0;)5!$P,PG'4
M((9IG_:#^*,^G03'H\MFS^5HN:[O.I\-AQ3EWFZQ>CUXU"WB99@E@2'?%@[R
MGY_7S?(JG#]P$E'L#Z&!L.1G>&12SI@HI!: D\!_1UQ<R*FRO"MG$$HZ.-PG
M![+MKNYAVEI&[KSDL^NF;@6TC-]>U M-R%%**2&_=9GXY.1>I#0S+]T [%6W
M^X2Z&0(\JN'Z2Z:=R&'F#/'+J3C*?:W ,7?P'5578L8M>++:T!&N)WDN9+36
M+2*1\1[XYZJZF2-U7X3QCDTR6* 5,U7#$8B!A9047$UD2WR9E=AA ^R2*F3/
M5\\@D<J]=MD$*;$># MH/6?/=+>&3M_$K->DO 30BZJE"YR-64'64##)[:,=
M-.-6)CJ#4:FR6# +2#3 *%M$P FD\KDA4N?!1&HNBH4:5$:C"8CVY+0PML_X
M2H6_,<B _(\1F$,^_A59Y+$,,2(3,3>->Y1HY-R;24L+0"Z $(: TS!?)$4T
MD<%L7Q'.SY*YMZ6Q.9DAKK9V'Y/HO6QG3E8V=(T<G3P].78Y3-+(/GYZ=OPH
M.?*8,GWPE.GQ8\KT,67ZF#(51^#T<_EPMSL&%$H=O#__\/]>O/UA:\%#]LXF
MFT8UWY69/$>8>9809H+3 'KRP:C43)!9YUS[2OKR0%XF9 ]@^9BT6T+:O)_G
MH*6(:;@?WR&,B8U=ON[K13@E2(L$$X?3*?Z<EV&0'D[#W4$6+QB<]$,%[V?5
M$DP%.:1O D8O1@#E&JT]C9TSNA 8SFE!Q8:[1!K8=FR.=+3"#=C9H)/ 8I>"
M]7="*9V^.*TX_M--@<Q?OK+/Z">YTJ$:?Z)D)=?K)87D:#8[PKPXBN'80CB>
M@UA7MF%NRVL,JK#E3X:J*=4 &OV6!%N4K2[J$LS(,"J]%>5/X,HN2UHI'K>F
M-0SX+8@M+<&R+&9MC.4G,SDW32Y*$8G24.%E.N:=:NL.B*ZIVD\^@;>1,B]G
M9R]J)V-W%S[5UD#=[V0#Q6+FX79BU$,,"T># GM$QD7=K5I0@2WFRT&"C[1M
M%>3,;Z*U.5TJKZS;^F3H0GC0EZ[(B'$L"L4*C?!<<!@6+$R:_&W:YF\W;($J
M8RI_80:R.!R?'$Y>E&<'H_'187E\=O)L.CH<GYV69X?32?F7R$ ^VS4#>?95
M,I _75R^>O/CC^=OW[S[^7+P_L.[_[JX!.JH/UF6\6Q;EG%'?!0F+YIY^W+P
MJL#K,*ZZ!UC,'99N[4!&Q<>-\%'A>;3]:[15[4MX4NH]$$D9\'U/FW5&\9QP
M$Y:SF5S/D',*9R\#>@RN#RP)\X)P&%)9[&,8&*M)<@BBF8:,T@QU)H3U32T5
M8"3 L@S^>WM=W7#@+4QH-0G..LAVEW@JW=7A'UT;@EM@-=1$9 50"^D_7 )M
MNYH3N(<K4+Q0Z8#(Z3G$4S(-_9@G,V+3@OE@^XMN\2D=LK?E HF^B!VV R^R
ML :&E8:*-P(=JBD3"&!<C0(F98'%)ZH<EGO]5\GXG3T(5<MW%15]O\&^]W$+
M(=9KV:4V\X$[G$.^>[(*!D8PE%/JI4G"X.HDXGN?*&J_;[V-*@H=5PL&S,''
MF-\9IQU7@L_T8"[&# '(1J,91,VO&B&>AY@4_ S<&F( !(,-L@0+B$C>8NF>
ML#@S-HT))AP;$$C9S(!6UBU% @P1%RU^!2.GBE2P)!>G3ONR@IJ<.^HFY[[2
MNNQE4KG'NGQ;#\[#/'Q RRA:EN$O;"\Q<?AM5=YQPF%&<O%A%H"6_Y8%XL50
M&VK)'53D+*XX*^A+DPWX2O,]Q)-%##-;EE;"G,@8%#2E7-6U9CZ0-HU:XF,A
M-1G.WJ8"I>E@K94+JNS&Q(;T!'M'N6MPAP!I,:* :9E 1UVET##* '0T,)&]
MFOFMI'8_KMU<"O&)&N\=.GXQNR,D;3]J!J3#YV&'QN'=_GSGUUS #T=)\E,]
M,7]1>)[C4]8JZRU=EL^3(1T!)<JXG#(EEX%/B#MF59SSN!'FE*:"I-$'D98!
M]>P*)M$,!@NL-B3-;)>LE(YH*8>Y: 1]2]OH#E-'P&=#99'@U $748OJ<VB[
M6.2E[< #+ _@I!$PQP:?%,7Z\M:)749.H[M@!*BB>YAZR\Q'\J6:95M*="?1
MF9S4XQ5ETJ@"7M$A9G(QM$12-(Q+L5WD]\AF40T3=BBDF%$?CS0/A"JA/_@K
MC0^O_L4R3&Z6;H\+R/$V&-Z:&RDYU2X_0(=\R[5+7V>#'S\<5BI<#>V4$-8.
MY7C!$.[8_<A$.>+0QG7AD0=PY<OC20,F38152R<>4D6Z&8X.*RK$3]*M/OKB
M]DVD^%D[V5II4"?O"3XK^R0S9@2;T6%!&3R (NF=T4':9)H1;O.Z_H2!HME:
M91/E_:[TV<L/V>GFZQ)R*+T4C \7M ZVH"K=V](2BM @#$&1PZ)>S0+XP;"G
M7,9+;,71B>;ZS1#TO!"U12-IZZ@*Q&+=$5N(R(GC>"S6H&0&\'Z9T^Y.>DRF
M/B93HS?_H<G4%X_)U,=DZE\CF=IGQ;QX,"OFO<M-G5\54!4Z^%".D6GMJ@?X
M[0%<GJ@TN$\YQ=V%Q!S][\1H+4&];3$![;9B.JTFQ:T)'FH*1BCY8V5 X6!R
M3%C0[JCJ Y@]4083."T*0A6SX*5H=Q'5\*@,3YDZ5M*O8YZ>/!PEIEE!'T%M
M+<N)"0R]\$?DMD)=)-B(7OJYX3RXZ)3BIQUWZUL6[>WHKG)4;WY3WVE1KPNC
M$,L@%G&0!SHN%C*5Q!8T*!=C///C%ZNTW->9H-,'F)H/)6=5KZL;Z-)[(A)*
M8EVI&')DOG>,4L/3&6V1$!311K&]@(45$Z$RJP?@VR^=ND/)>4QKX4T3+-+J
MALE&@0MQ.?0)@^'@5ZB3'(#3 &A=<5B"<5R/*XHJ;.(P^SIS>?9@FXUAO^*<
MO6=-Y.R>ZT6>4()&])2MO-X7X,> 8SM/8^JZM-"-ZN^U>;ZTJD5X= O5O=-U
MI[(I&X21V M>L[0@N*S!5>?V40T3/W\)Y1M?:=8/GGV9VP_QW3 N;]H6<DVQ
MFP]_JS3D6])'4D';C.L*[G:3:#.ZS5XI%3Z_W'\;CFZ9Z"G*V7RM@>W-Y.YF
MB<!I%4Z8B\5M>.$D>+BI<@ >722^;0/56)YI\V$YE*R!U&LBL0&^BY#-7"-4
M()&FBZ<T)031)\+09IM.*";CS4^^]J9F4IEG*S)+51/N.:"MP@*$%"&6+AY:
M"!7+<?<U/TI\4G93HI6C-<5^,&N'_\"U9[+K5L*OS8>/6?MSZ3O0M\"V%$:]
M:B(#%"R!4!774-S4+?&=^>IYY"?\2FLWDU'=-5OU"Y+\I<MU(2K@''WC0"H9
MH)U"2 C_$0$CRA$S1[9/.)) [59]5UNT_JN80:T37".RP ",C957H&DI/8@L
M<?T2_)1^2'3%KZ[@&EHR'LI'-T-_IZMF4;77$M.B%!,H/XTIY!?)@@RY]FHH
MY!'X\5E8J3.VU_67HZ*MI+A >W_'4R)VB!:#1H%SWDHT\H;N-! 6_)=8H^=0
M+B''^F_H,0$UW#+L(89M+>N'**/K79\/D5G5C@=7;C4C,N0.2L9"M4F. <&G
M\C.;K"[](_*J4E#M\9"Y\LJ"5YPQIK@J6I$[0\Q)(BFBR$\P)8 VG]B?N5!;
MBJ'@?Q?UK=9F2K54G.J=0Y5HTY&#3P0E$FY#C/+2IN,0-571,GDOA:RATH4V
MC:ZR/G:68M^;WB:&/>W4\/AD'[!.XFK\YPHF2[]FJQNSBVAFIE^O$GVF.T#(
MBKLE_D-P$9Z0BS I1TR:+'VR\FE88VOC2CI]9F1)X3Y8=;6@]HJ6KDCZ<^6,
M5&;)C6+A'3' "EB@.#TAQ:_A:;9L%4A".[^8E59'B 93>-ZX+"?.PHX)K/(K
MO:?,N\MYC(E8*=)ZR[$/,XLE\I&H)*2O<TX"9GX$@^*R[YQ(RQ$T6Z%<+(Q.
M[#=D_W>?&(5!P@%7SJ8<%9BIP8+*SU35/I1(BA9OFJ++=>EJ]TB[7%_CK;0H
M(QW'D@Z>NP+G+, G3KP)DU4ZE-\.^";$3[" N_BNH@8?G-0&"^/K:?@!_R#*
M$> A->%X+IFLNRFOPXF*'T%'F(LGC2:>&Q)CB>R%A"I2B+1!B'"H"4/T=/ S
MCB=4$D3F(2=V$-I"G0(L0-2GZ.#8JZ;1+5QXKYT$:;AS&![0L5C'WY3\8^8-
M^%!\1GB<KE>;[<_*U770(#FI$D-(F:%*=[?%'+69B[Y][<YTM%<Y10B/CT:>
MQ$4$ :X0\R&=+>'H@LR:>'M.FTQRXCZI-S(T36K" 6D#15SJL,1;^T7#W/G"
MM08GX*IT']#D>WT#>>+5 K7YY*]7=3U!7 <P<O/O5E1U:QC,,('U'2(?@-^W
M::3V&+^ I!!P[)*8RKCBB@BLG"^:\77T2Y)=Y0B#KV)?5'- E#H? X!"L+6
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M_A2%JO(5($Y8:7^2:M3?VX]2@TGV_M1%30WV0),$JC^W^<5?U!-WM<]")SV
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M!*ST &9 ^<,Q$U)/")Q'MY*^2Z $SZ&8V0 T!L-[( I^1'#RG-6)8D*4!I9
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M8\,Y(F!?A_FB.0"[H#V1F_PZN\GJ:K).0J19"D"6 K##%(!"E@*0I0"<3@K
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M(1L%+HDZ1JB<B3W5GB^F8S9&0'8/J8 ^P*:Z4P?VBOO#\T?]'9;=G6]]#N?
MX@C:B%BC(01V'UDA!"L7H+&S,TPD$I .IH0 6%U?1=+"+(W+6BN7K$;U+ )4
MOO!C87QMA&F1A!S:TU]\S!2B#=710W23DY -"\^P$9\\VXC*-U)QQ513H+%
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ML\<FEN[XKLH:G@(*1=:A 3D\1;<)_BLK%GF8UE2KR3.^<H':C?62)!Z>Q9^
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M_-BLU_K*6T[*@XV-F0*FE!+.,0%Y4B!- C-ZZ,?JA/"3\5[$%M=?1<HW58S
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M@+?&$T>UW"%W"+U?0O[K!+?O3H'A9LHM+%1+L[ JT(S)#P^;8-=:0C82N))
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M8Y +&&M9F+YN@&/NJG0R"G]KSZ!]N.=6^]/)R<G@0ZKUQ!V<XG?5Q5JM[G2
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MMLN ER8V0P<1Q\?!\90BU1BBXP@/X!Z"<%K9)$@'Y3UK#ADW:)CVD/Q74YW
M(+U6)]]M='69AL,%]_?LMM>Z**'+^LYVHF6)H^J&;;@V+!A_AQ_(13[/P629
MJK\8+C0S>58GP+T3\/%,H$W5Y;XO[;[3#)P8 W]:_*(^.9R/0&>Z^#BL%PP3
MOA;+ZGX@_]F8FT;P.PU?>N\YACR&O:@FN.?@LH^H3^ ;& >,S^&_3PT'!O@=
M&H/='M- A@P\=\>E+0"!9&FOT3,'PGFV'>,_<AZPS-QR.?GT,*17Z$"S1S"?
M%]4P:9?V[MW/6Z81\OB  FF) Q\KJU:PVOX]HV2QS@B3<D?>4VG%P#R1B*I+
M?B4YG<897O5%#R_*A/CC'VZNR^7E0URRD+L(+&_B$'KODB\5\^(&R[_R_&Q_
M0?!D,XHQZ)#3NX;[C7T"TV7,BN]N#=M5AWSRREK\A9L710;?2!D9;QIFA)H1
MZD$)M;1 J*6,4#-"30NAAFQ;]UW7,V[7)LL-PY-R% MV78RK?7R^YKH&793'
M&4E:-/KOTLT?V*8>9V"6+O-KT/).7,79H,CB2,%=GOYV5_OO6K?1>>RQ+[5>
M7V%GQB6_S+&N\NFQ5>LK#5:_4^Z;]5I+_'[^YW?3)5&V?9#E9L>(L^_*Z+<0
M:;2=O_PVX\E&-UX#%^\,_$5TX\Y#_O9WU9T &9\-^#D#OXT[X'_K?Q5#B?LW
MD]*:?>7NDE_;]I)0YOZ6(X:LP(O_JO1R\*LU,:PI%_XKNO,6,";[?<I=E%.7
MZ.Z#VYUC[C=C#+\;+G/E$35ZT4\V!A>\;\J7^4@/=:O9_9PR:9THV%JVS))(
MV!HBK_ V(H_X5K(MT-^K%X(:VACF 5H(L?*9)]_./:[V&3H'CUFZB7] 8[KA
MCFV,,4%C9]^?.701Q,6(RBF(Q/5S!C1.J1TBF/;ZUR.1EUG$9F\IMT<9QHG_
MD'B6F8]R.CY*R_A]:J3?5<ZH-J/:$-4^.+;&73!'S:G^Q#/JS:CWJ*BW?KL^
MR1XHM>\HS:$WOG]P2NQZ7*RXE,UZV,AA=$-&@!D!+A+@/9^H9D: &0&^%0%2
M[.L[II%EP:HLWIL@^EJZ*,9E/NX[NHLK3 %7/'S U$>*MOX^5:V)S/ ;SI_5
M,$/G\.O0X#I>G_N'/+=@I8N"O#]W4F2?77;;VD?91+:7#Z!Z#^@X%PX!\;#7
M^?@D4_1))B5QFR0G]E%7>Z).\<7!??_K@[(3 W(E-Z5^VT^'+;<,Y3CV]W5$
MYLC0=9-ODIHLR3/1[L0/*G*GY@:UB\W:_<@C1>51C+R:#?S0M)* ]=(Y\D/Q
MY\JX0;+I[#\.O@.!N0O?[2W%YB:)AS$6T5WMOT4F8I"3L_1NZ29]"%OID])6
MNIC=N!N#Z2V%_P[7IM=Y[-9W8T.^I7#>X8ITZ]W:SDG0--P)WG@<<IBA:BZA
M\9]OP=NV=;'S!=_++I[581F&NQ^L[5B&NO-6.^W65TQB=+CVJIE\-S3WIH;,
M#A>G]O#0[?SSDMUWVOT[6*=_/-;:_6;_Z\YW@9*GIY8QV<U)3_K,L<UN(32:
MO8=.K]EO=MKL7_SRZ3+'[.'P H',-M\"D+.JI0\-T\PQP](,RNDU;"O'AE-N
M;M/NP.061EJ9JSGJF(WPZ&XI3,JJ!H.S%V;QZ01T@KSJS<YL:]M5L!U_,<__
MY]"I)&LZ06N$;#=.%UG3NWF;D]-]1"..<B919DTVD3>EK4-$AP\RDQ3Q>XH!
M_+8P$7:4TG?D^_1F)VN'G5)Z!%Q<I'!UBM&ISRA%LONHSMPS(9X)\4R('Z7(
M.[T994(\;5/*A/AQ[%,FQ(]4Y)W>C#(AGK8I94+\./8I$^)'*O).;T:9$$_;
ME#(A?AS[E GQ(Q5YIS>C3(BG;4I[NUB9M!CG]B4)H[)L-KZZ21LA2M?\IU@M
MZ8.R/B@5J]7R=:E2U?.EJTI9K59*VO F7]S\QO/\?<]#%L^J_+J:S*,(O?PK
M742.+>(9_5:ABJ]]H6O!VK/JJ!H63Y$95X/7]QLTYH%,?;/L[R;7GSA;)8CB
MVU(>:LQ4!TRU5//5-=R-FBI>8U.W0.@K7X^QF1;(=Z-*3'.%C!+ 2T=SWV;7
MH+/;_TDUQOJW_V/K'D6UO\O;_P^B>(\AR]U:ZHCG_"(_.<(%&'-G9$R81>7A
MV!FFE#)DJV:#M>U+65+742UW;#N8=4F%<@G>5379$.C)-":O;*[P46TR4;5G
MYO*QBNBP#(N,40D>BR/OJ\YKDN)( B>9O?()"0L8\'<'"_;^\0_58C'_H7_;
MN*0_"Q]65K0[/"[!3N'A%Q5=AE'P5M[D*K/^2"_&W_D@(*3MDZ91)VV^'XB0
M=PU/?'STQ$<;!--NTOSWN#N)EGO]ZYB[7.<8*O'7N25%_XZN\EVBZ72*S!"B
M5G;6/V?V$J2GS7KP>>"L<>[SP6ZV)6.!B&$_"#-'5,$]09300VFW=(=#?I(I
M)9&\1SBKX]ZH3$8<QS[])%/*9$0*IY3)B./8IY]D2IF,2.&4WOI(+SLQ2,&)
M0>6M3@RP&MS8-LTIG?!A*4,'%!#"H8QLRYC8#H(Y\-'8M%\%/+ LWD9'>A,;
M_N0OX)O3"X9EC&#?Z1&'BZ,(>^B5CC,L>!Q_XM:+X=C6"%[[:X)3@7:GK[QG
M?2R;J-M(:YT^&W'58L/IB+-GV];=#XS_4&&,U(LX^E -!S$HI@-P_]U<] +@
M/PCY8EO<S3%-=0:P!#"1.SP/&1KF!%YEZH0-IH9)H!;\Q[,Z=2=LJ%KP@LMU
M R<A#D<GJO4-OAS?S>-4N*\P_9%+!RL!FD6.\8EVF<)SC&1%,I/1V1:G'72B
M7R@.\T6MFA]4*\5R85A12U6]H-(?UZ7J=7710MK%R<>^3_0+^0V/]*_PO025
M64/%5'T"6Z.;:CEA/U%U6=_B('VF8NM5B63[[-EZDC63E687BL]&*82MRM#N
MFDOT<GF@WI2+5VJQ7"[HU>I5L9@?7JFJIFHZ+Q>/ETLV\TYB;<3HUKPROF.A
ML!"![IW.07<8 [Y>OLMU\=>DAF*<3I9:.4&@?$U.6V<C5@"<;+$I2UJ.WZ M
M6UYK5U8Y']N(,19;2#Y&Q&V8_X,"" 4#&M /ZA._=;CZ#>P\U5^9L'1D4GH2
M$+<PV.4WWF+%L/M"/Q]M&PR;2&D31>[KB[U#I>]%"[)E'+1*F)5*OT85]UFP
MX<62STRA.IXDX8%(-Z?\:^1!7/)NX^WFA&+*?U3YYUWSMMEG2IQ_)9]-TE;\
MS_(!H>_#M"G. 7_Y[:)TL=+F3C*2=7<"]W_-U8TZ!O5J0MTIM5;_[D&I_9TU
MV_7+1,NVK+U"OE2IL%Z]J;3K"JLK[;[298WNUNW>=CN=O[>^MEGS_OX1'+<[
MI5M[4![[S7IOX_6-57"1;E*T'([L.UIP^JR,.6T7 _SJ0AT"&X$?;GY77]UH
MX?;L,,MVGU4=WI1_S*=P2=K(X[E\A$1^S\J@I>C7&</MF?N1JD71-E"U;T^.
M/;7TB_FX2K2UFH6#O'!09#PE<;Y!^3+_-A&<9?B6?Y[^1CS'NLJGQQ9B>C.!
M\7UF7/++7.CKVV:GU?F$L.+BB1QS^) [#M<QR*.Z7@[F/==QQ")G3"9C8E2(
M '\)GO?\S^^F1QC0F/$AB2 2N8WEB\+EHL\XXS]^,4R3G=D.T^US]FI/V1,G
MO%7.1G(Q*2KTU^7-1#0<<O,W?K=M,_!_VIT<<[\98]SK'M<H;%6YS"\+3VV[
M[IMZP9'20/C!0UW5BUKQJECAPW(1/A6N;XK#\HU6T0=75R'Y.R.!]NCW>OU%
M\7DL2T=+I_6<WDC!$@Y.+W<_HS2ZS !.Q!+%U7'-Y1H^V4Q(B.YS)O5GKGVC
MD/7D=2Q*YXF">9-G=0*C +X><)^=]1P8!"8]]&QHSVR(GT 1<X>:""0DFQ&B
MK*9-WF^S7ON]H[+W&GQ96GOL8>*!RGYODQ]Z2A5KO7=W76+M[:K:)IO1DM/!
M.G /\):%XHV!$^.,7<]V-(9T6NC_2OC]8!%6\Y4/K&NXW]@G\$/&K,BP"JEC
MJ*:[F\H*&3G'/G:<E+LED2Y7537+&(&JU51' \.1'Z:,^,](@IE$3211']3)
M,[3[]"I-2;KHB$D'[M0=@^LE'&XP*Q,*US&V!R;H!L(U5<F)![)UW@B#X\CY
M^+AX="G_=8&;!NH3&QCV?!ET:=@D,60HF0?]3\U47X!L#Z)5,MK=1<V+MR#3
MS<V7NRFXL:@>+-NZ>*8/8\= 0F0#T[;U')L8KCO%_#613Y;L:EUT9V>BOI1F
M&A;%)U A88;;@0SWC+Y_/OKN.ZK&6?V9C^S),W?4,9_"4&5D3+7T=T#Z#^!W
MCN"QZ22(EF]'Z)A"2OU]-UQ,57V:FF1FJ2[#>HA,@_$DZ6L?AQE1^2$[RC.+
MGL;V@?=\?G@SR%]7"OD2+U\7!@.M<%6LWER7M()>K.KE_07>EV1J;!)\7Q)^
M7Y&2L$U60])<@BVB^G*498*#VO=85L3EY5B^8 S]A5LZID7+4/K4!28<AJKR
MA6TL3QR$"Q;^-6U9!.G("+W2RL5J5;VN5/E56<L7J]?J]759+1>N\X5B11MF
M&:'OV4U^C;3 >/8^U+',^L![\SG0<U/8NL%M#WYF2;::KU:TJCX<EE6M7"[=
M5 O7U]5"\6I8XM7BH'*P5/]=Q4-$KO[V=XDH%[^\WOV@4C4NKU'*WH9-B0C/
MZ@M(V+GC2 F<03!@>.<&Q? 2,;L>/NK<W83DJU .O]NV<P04YO#?IX;#];BU
MV6F :_,-]=LL;M] .,]Y9CT&TPDH2 ^4C3(X/*WJ3@>PHV#?[M9<W00*-!96
M-,M"VTD66B6E66B/[8;2_=3MP']9K]_IUCXIK%]K_[W'SAY[_=XY^Z,Z@EYK
MMYW/2O1C-7SLB%++?D[J3<^5VLI%X2VOU%+>CTC$A9YL1WWBXH8H$;Q[GF/J
MP'[AT4_4Q!,88G9=6S,H-C$VQMP$Q\<-O"1,*_)>M8=LS/'N+I^.\'ZN/M4F
M>*E51C)<:LXT0&'JWH7<L<-=NKIKD9)G9^("E,,M_IV"W/"&IV*IO[&I6A;7
MX[PM>RR],I@"- %T::G6Q#W_*^AZO"%X%'P;DS3V[ZD[,8:O'BO.7%%FB_</
M$Z67@5S$N\THU-YC%B::9*2SR2Z#3^ '?[>8;L VF8R/@*"XI;VRL?V=.U[:
MF>WDD ZLN;?!M\;=Q,WE#.CIO]B_Q#UJZ$>E+/'I>'')_3:9RYT70P,B&4W-
MB3$&429W4_:&I ?4H,.\="#(J6J:K] S? 'OT!5Q,B/=R__9(H<T<F&WV+O$
M?<REQ+HR)?;J,G_)YJX+>C<%F::BG)^\YNCDEM-2 6/F*'<0V1-7!7D?V0HY
M/(?AQN^@$,!N>PUS.C3\#=J=B%[?N6/<57G/'H<Q@HZGP+N7\QLHT7]5 <:+
M:@:?!\M>P/$:PQ <[]LG_OVTP+8C0P<VV0-JSP[T;!24RMQX#PCQ&8TBN9D5
M"JRW!JQG5 O M#OQ@V\N;VY.=IGK4@RRLR?0"?:NS@Z+"1AI9UE76RU!C+U8
METIA)ZMQ?<H4])6K6[%ITW+!+C,QW+$+PBL>.>$)E=U'(^2L-^'<S+&/8*\X
M3^@2BJR!';'H?E?J+4FR%AAG+33.&IYQQMYM0ZD]LNP> LON7EIV__>X<_GV
M"31XW%AO:Y@#QSVI2'U]W%.*4;K'/:E(H9U-*6UPD)DD3]LV99+\>*>42?)L
M2IDDSR1Y_(PR27X<4\HD>3:EMY+DNSB*3@[1/G^V:5@ZMV Q+D3BA3S%E"M4
M+EU6*Z&OQ>K>W,2G:/S?F</H_C-G0]LT[>^4=^WP %_;'LZ=3[)W+/:$\CV"
M?O,G!\\#)MR=0&LY^ H?LYU7YG#-MK 2FBQ/.MOP_'H+'.T<LX&.AMBAUZTM
M7T!$;FA05Z%INCUK$,8X(GM/GFW=T$+/OM7Y9Y;PL[^$G^(;5]T%ZGHQ=+RY
M/38D6I"#>9<"&WZ.%8#XW:DY<;U;#2&T?=W6ICZN/ %MJ"^J85*EW>/)HEF\
MU+#5]:-0XL"!>"ARE6.H8 4P[$(F\9I\(W=I'<31<HS"39295,%[0BMN-*W"
ME8\:5"7.4T@TJJ;KY="\J_7Z>&T/)!O'Y+2@KK4/EH!/JF-@R;&#!S?>)3]4
M.RJF40&'KHVX%_[W9@M0BK6#5B+Y;P'QE_/*:A_+?:C-:U#$I7.%4[:\_"@4
MU*]>9I:?Z"CHZ,P]3U*QO,>Y#YAX?5'PLS+11G'1%O.)36#&T5UM+S<N%U J
M_Z'Q,;5"P[%=M+^<Q:5?E0OH2NPY--D"AAB\BGP]&V]YU R'_6.J4GG@!C"0
M8V@3=G:KOC*$")_Y^5ZU8/BHBH(G_\)N:[5_W#<^8!I;3[7@%_YDTVL/?AF9
MNB@C$WXK].A#O7&^3VA)_]T-4,YC@-,CE5D&?A[\EH&?+WLT+>#GY0S\/ ,_
M7P)^+B>S@'3N 9U'H*-'R;9EV.?+L<UGTX3R&X.=S]]]S9#/Q??I=^++;^7$
M-X?BONL_IABHLBU+!7,0##8VX.B4:S;&OR;R)HS*9N[*Y,@#04?=>@VG^J.?
MXHH+&1C;0HA@:8.Z$W4B"N6YTP%\L#2_9)Y.5RP('%P%,Y09(R!%[%C"\[BV
M 1W*(G*J.WY6S8G,XQ-OJIJXA#.!'BTQ--4TXX2-PZDG$P,28WB-4UD_; >!
M%C#(>+"@0\2]T/E+ZR=TRV!! L><%FYV*KBK\[X8X(1EL?R=!^ CR2E;KFRY
M]K5<LT(I0E#MYECG",V-Y&2UK:&1F&(V,#)BT33V9&+LP, @(R*P*0:<6ZBZ
M[1=\P;%'I+$?'+R#.WF-Q>LX% -LCPY#H#"E4E7+%Z[TBJH/R]?%TDW^JGA=
M&);R*GY9K1PJ*K*-B5V(C;,DC".LB["R9H'8)<A&*TJZ+G9?7+/_575C-\B@
M6EZ[,E'J0AS<REP8V3ON$S;_T-#0B-9,&T^^@7LG5#V:KM"/;4<<](&Q/\8/
M"Z=\GFVO6JKY*F .PX>$.<]*IV=%@\%O9/JOA8&3]/PO&19AIMA2H]BNWD*Q
M?00B;\U 1^3H  (!-@5[$-8%\L* F_9W)E$O D0+#X&"D"W0^W14RQUR)X"O
M8%[Q=/<@NFUK]97II2WU4F257*_C="JFC0(<0<1^Z<"\2>_$K+H95+3*\*8Z
MX.5*N5HH#BI75_FKX:"H7_&K8CDCW_FT!4*?0S$7@K41,LX0EXTE[(TM37R"
M_)B!SB%(% &?$\+)^6LLE6\!J[>+-HOK<NP>++E#[K=O\I6B3#Y42=Q =<9^
ME\X;UKP4\(A>N<2+JP5,F!W;9%EX- M@9?&^;+G>?+D26="+PNFG=A.+ES>5
M[?$]KV+Q/??HX"V#L/CS]+=:[U;I]3L]5N^T^[5FN]G^Q&X?FZT&_G%?ZRO=
M9JW56P;=>;BHY#+\V:70<;/W*ZXOBPNW*Y8% F2"^ "\8?W%("<7LP$1K]<=
M@$%A@QTQ=5[X*S3Y*D*]%. %0Q&,QQ%FN$YF KP$0R<#4,&ALL-?##10Z>P6
M7Q3Q(I%YB">YQE!D(O+9=<7$0-^ %07)_'')BQ08L?+*'Z$OCMB14QK8D@<O
M60TO:'#'M<'P-<5)="@GUYT.\"U'U2AUT7VVIZ:.JV39-%3=.TL72)6:!Z,'
M4_5+,<FC=TNN$R:Z@K6F _].G<'\PS @ZW5V[GA8_D))^;1*UHMMOD@(0]D(
MG<U3'&]DOZAFQ!C8",A$9MW"Z'7$7!R\2CAF;[;F*X8U#'0 # O(S="GJODN
MF'_$*?MJ>LYD[$R>V?8"]CIM I;2QAB(V:[RZ;%5ZW>Z7]F#TKUO]GOONLH_
M'IM=Y5YI]],N7W\B*DQ10/@Z'@1YGP'AABTEJ!_I$#HMP!-&V0A2<(KIX5Z9
M)<IHDEGK4H9KSZ!A49G)C"21P=Y6):RI2#A717JZ?%8Q#2J:B9WVZ,8@.VL_
M-)3>^5\3Y//_2Q'W'/$*)#CWA*;/,:D>E'%HD'C@&AV*8 PG.*:<>4P"('T(
M+3GVE$I[/L,?3WCW8'S'+#X%V6\:_Q&C%?<;L;P;QHLBY^]">Q.\WHA8SNJ
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M,5$/O1$;7N1/[1)OSQ;ZBZUA^>Z:,S FCCJQ'?=T>.. ]\5VQQHFF#I4+>'
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M?Z1WQ;=GE!\&[ Q&%-7_J(YN3UUV#]OD&*IY0KY)X8!U#G?',H)#V%>N.L?
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M7V5X,S$M,BYH=&WE65UOVS@6?5]@_P/7Q<XD@.W83M).G0_ S218+XJDDWB
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M&H[UQ+KC0;)MJ35J27_'5^'1G_95N GA_(B^H?M!_:>"_P-02P,$%     @
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M5<$V=$G2&   TQ8! !    !B='@M,C R,C V,S N>'-D[3W9<N,XDN\;L?_
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MOSOQJ",>VV'FUL+:""L=^E,VLPL02GEZ47^*S^;PS[TY!GY:MX8U,:?]^1
M.FXVY>;,I_;O*^HZX*7! GJ/UX_PR_PC@(6O)G]+JRCE^*>V')_-K<'_?K%&
M-^9T]E]&?WQCW)OWU_(/\Z\/P_G?.T%H*@@#Q%>W+GVN.ZMW\*4L_KXMBP?]
MV1?C=F1][29UQB3&W&9D(QJT%M<!)Q[F8N9=(TZ ,Y/8"(06<@.$4F[^&!G,
MA-LNY0'#X@]S-I@.)T(!"\9=/\R&8W,VD]/RNC\;2G9.IN8,6"O5=,?0%$-'
M!)2E ^H2>#) &^(C=XHY#9B-P^E8"E'!LHLLRT9#T)(WH"<EDP;]R7#>'QG
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M N$V@4Q:6!3):]U:I;3LHO0(!Y42(]Y-8U+5D1=(68EI=S<']#'M\UBR\03
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M5/G:/Z>-85]_%P":./6#!3GG5P! 2[-T/WR0%UH L),S(M\V.[5"2XO=3TX
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M7-5ACO--6&6IHY%UR)!S-$Q'V#.7ZM59:;'JL[EUS^K.J8"@EG/H"+0W2X<
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M+C+X36^BET?NCH/^&HW'[PL@T3GZ2[YA?^[X;*\F].Q:";M='DZCC,3,WFT
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MH'HX<2=#U42:-WT85>1ZW&Z5T8)7;EXA&#L2< O0+<AJ?X&\A$KWV24@N_K
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M^C;&QZ=N8BQ\BX69"& >!L9BQ7OI0(U#DVM8@H)40X11WGO*95I TPEN_4-
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M9J.A=("HVI-IU76Z[HR/,<<GF-,"Z2I-6(?*U":AJX8ZWT8'RE3TIN6]J4K
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M20&A0%2)5E+I,+K$+:GD5IN<U<R$S^ L+<'E]1F]9B;K>U<S<_K=DU,O.0U
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MN>XJR6>RCOB2$&TIE141=S$4"<E9\ 7NORIN-A':1G&=81!ES,!_.> N5$(
M[&G58]D-5&2/*KQ>2(, E^=(A5ZYIXLTC_(XC;++O"A151_,7J710YKASD#Q
M!41%A4!R4N[:>(Q3V-'0E.D\R1,*J:O\%L05(N70,, US%'WYVE4I,7D7*G5
M;B>X6VVQC-O'\>6.A6M0UEQT'+PR(BGD&XP'B=/ TZSA1C>@QB#UYQVK5)%9
M2X8:WW$>/1;W,U):D,-6S"Y#%]4:=:\^2#8Z-IW4&BRG>BE+D>_0$3Z=2CJI
MI(MO30?#T3U'V8$J=<*SJ"A6Z]\CA**\7*';]'%3=J$5=X2OFO:S*,M <OK:
MPA4MX-@)LH2MVP.88CLVM;8[O$[UWIA4WZ$\-D:$=A%O':_%/8*/JWOWOK'E
M@3Z,"VU.=#\XRD\X@8ZUG;[N_OG?*4!8;3:O5Z1 +.6<7:W1V$X$C;R>S-O7
M7:@Y7+:U?7?(+TN-[PWCCKB6P?J$:THQ]1Q:J^U83^7:^KMC4%0K:#8L5'WD
M]CQ0-KD>WXS.32X5PM0ZVKV)8[7C7K<X4CQGY3%T5.\R?ZK*HF;F _4Z1P)R
MK%0T2-][-*4Y"*JP3=48F>X&BD/K)ICYJ4?<1VDE^2BM)!^/24GH;%M7DH\C
M)0EJ)OE)6DE^DE:2GXY)2>AL6U>2GT9*$M;Q(V6K)X3C'1D>ZX9.=E"<[>$X
M!/B>?:BD41UF"4B><OG?@(G5@*4KPAT6$S53^J%LH:S(?[()"$$#:)LA4Q7@
M[G9TE<!5T-D- A<5"5CJ+@VH3H4 JGO#C07ER9F0,5,HRYQ0B'LG@8G0187@
M,[C=PIPK/1Y(9XM4D+#E)L&6@M#HV'ROO+W#D5W\3\T(_P2?#3L]N*?!'I][
MIS(XASBFIQ'A>_^P(X_/8LW3UQP^%  ]$];JO1#^#/,8MZK?*ATSR#]===W?
M6.G=]1?$S0%'P>'A1YUQUCLE<F A[HCS[4P?G96Q[SUF;V>"NQ+/AB9[K>+)
MU$*X@?D$4/H<D5*5PMP*BN.LV;J5AG)KWV>NSA<$:#JD5 5W138Q$F5RPTXF
M.MN0^O7%9;?/Z3&P9!*]Z4PB<R,ZB[*XRNI_WL(LNX#H6X02=\X(OS_[K@BK
M/]^SMK-0SP.)Z# AH.Z8<7&HMWH&Z*YZ*&*4/M6ZM(45J:@6 [P2C6U*#KC+
MUA8 'YLV*PV.4U444>+;5;XK8?S'+7BJ4+R)"G"#X".*MB=5N8&(U/%KZ/TP
M4C[%5EV9,=E6QZ:.>L/E5"^E20KF>+(7K/%[6FXF\W8QG+B+VQ'SK:M?XY((
M^+36!R<LU$(?QV8JAQ#%87P/NPP$D\NER!:#J\NBJ !SU^:B#T,S%/2QF*&Z
M*((T0P$#OLMETW*A3Y)_5TW!OI$]R0%S\MO[P,>FX4J#<_#\]CXEOLMF6[^9
M7])XES1>#VF\'JN"+VF\H88%R0_7DL9[J)1*"9?=?T+EDL9[5#JWI/%*C\P;
M3N-=,C1I6N0_0]/__+1D: :?H1E6(MV2H;ED: :1H2>C7/Y]ZR5#<\G07#(T
MEPS-)4,S>+GYR= \:,#U%?8A0+'"_E!48H>A_K,+I>[H<=7K-2B''9^_/.%I
M<Q_+[9J 8>^UN."Z*JC.UJ%H^A*5;3G<U7I(7^#$D/C2CPXIPOLA!&-0%+>@
M &33](ELC> 3V5%A47V&,/F69IG[H3D#\ X\1:B^93]Y1*#>U'G,/_@$U@#A
M?0">8(C]-'216>9Q%RQPF2?I<YI447;^$F=5@L5XMXD0P!L$D-Q$K_6V%(_B
M#2Q*!,JTV:B>@AP/7,E,3CA\Q[O4I,-U;&L9I>@,XX4)"<@N#I4'Z6EM]: 4
M4&7,^BOVX6BM(U5Y-/K>@76L7$!$6 ';IPR^]ED9.^RR\)WK+H9_4PJK.G[^
MU%:"4B?[QJ;;>[A:K],8($+Y791%Z)6NB1S H0I2 =^B[HE'S+O244GT'<B_
MYXDQ%J>O$[9/2++5JDZ<*59569113H:G>01CO/Z[PM]Y#?;QORGS<2T?CQZ*
M?<Y\A_O7]#Z(67I@L'3^ E"<%N0.Y7= 3@A <O*,=\*/X!80O<2LGL&\=N*P
M!.X!VDY2S/Q1T#?X0U/P]J8$KS+V/&D<FG?#] 7&#IUTF\>@9;/);25TU:.R
MRF\ 6D.T)2"W (]+&F-:Z_S#K_ETAV0+W6ZO;XKN;5FDW='W>6I@RHCOM(N:
M\QM,USAO8OJAOV"U']Z6UK)&Q//TWI+4SS_PHDGQ!B15!E9KYV-P^GI/1GZU
MWJ/!L/A7S!Z]>UIFT'P([BQO!@0?-)?)TSPP S&$,C_-8*C:>?,?_O*V"E3V
M)EC\UWYRQ7_\:\K7-*B3"].J 0/&:S#G'!1D;_DRH]PWMO"Y(T;*X,K)I9>J
MJI.!N05-9:QBDS[=P_,<#S0]%4>S-<L\1*W]A:GR]9"FJ$HCT5=A:E=4K1%U
M<?3Z-(G\#%6C:&&OME6*&P9K2ZF<)7 )U.ILDX+U^0N(*U*]M;T%HP=?BB&[
M&$P>I*=]MNXT E48YRH&O\,Z<I/7D>_ C?HHE2S!%)>-^JT=D]&WQ463=M%X
MHSH_UVS$C>],(.$59,&Z@]PS@D<IB_+K: NH:Z[++F2OV+6Z\.<-TE5>YB[<
M?"S[)C6@0^K&6JM_WW/Z3(U@XI#-V@QH+NQ![8#KWQ[$$ESEA'U),U"4, ?M
M%3#5K^4#M4/" O+DS3J=#J'DF Q\$ <$$6UC$>+Y_8B3.$852,:)1!ZF\/HJ
MMHI)_@R)7RA(C@K)7$'/8'+BWRJ\2I-6U')-O&Q+&DGT\H3.*NR#,I,>I.&[
M[8L8WM,<H"1&J,YYW[QE^JJ=?'$?OGV>\SJN'(!Z*TXC=:0PTO#ML$G ST1A
M5#G741B)/EPX!JV>=BE^F+A>EE\WJ]-G#KDVP]E#U&8F"J$S @:SB*@?P_A\
MGF)\!CE ]=G&2;+%])/)BYS)\55#MM50.<2MYJ4>BJ-@H"#BGGQ'A3/70UFO
M1-8;F9N2.%E,.+A]ER%O2;M!< T*LN^/L@L@T 8!\% EF,#ST@LYG@V4@]F!
M]^C5W2G^@*.:F]HW(KQ1RX)KM)Q$X4FT/&@XG*KZZ(^!CBXI]3:K8MJ<$:#<
M^TE"BP\1@KH;E-<@J#H$]&L[88=$YX0=^=Y8-W>  S+IH2@BN"[DA WG[X)*
M5MQ0GD_)"6@75\)&.WL-F(8=>=<!VNV,#27@7KJ8J$$(E:"[4YU=3A'UXD4
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MA$;'-C4Y5B1F^SOYST-4@/_\_U!+ P04    "  #@@M5%"83&V#8   B  T
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M8@4PG5@U3G$K5$'XZ)Y8T*<@ ;EDF6%D[%!]C/ 7G*[#C+W3\XU4>F#QF54
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MXJ&CH+1+LB#Z+4WVN\NX7.^CWX8=*;_'FYL=3ME7^2U)-I_#*.J^WC!&Q2$
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M^INO37[C_0A\'C/Q_:^?%D'V3-RG_Z&5WTL0T:W?PRLFN3[S&DFD;[J RO?
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M8,,@)>,9,\ L^$M.H]Q0T&^HXEG5$NV*IL6Y#45CA(NW3]US=PST$D@@]&+
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M*5LBHLSQ!6F# 25DLEDGR\BMUB0FO*X7WL6 .TQ/;JT>WN-T>VH2 R3B.C&
M*VXS!G ,3A8#Q+8'QP"1RGX,2*N6**)-44[:>AP*9+C2#06*OC8(!1Q-VJ%
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MZ<@Q?AC&"VW-,RI 0T4:/CW34,&\9J/9,";?B8"9_,'^3>!/1F;EL!:E]&:
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M:1!G 5M/S\Y?FT_F7\+N9*VY( ?_*D% 7LA-V>*+EE5='FDHZ_*+/O"(79I
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M8=<YP8A>UD@0T<'&]#RUX)O$I69,B-,<VS>Y4@'#EV&]M$<E1%$/['GM97P
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MAWF&7KZQ=3R\CI.N?A4P;(*(?!4R!+Z),7]\:2XI+S_XDG:"&,_65,6#Q/:
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M9:Y:IVL3HSYH$T<B1&FBI=<>;D8/Y31M# 0-&:JQ%JAN@LHV;PX]@@'8>/A
M#K(4 97W^@/=9<K='*'7N/PU5(U',$2N&J(&TK8B8HF&\*SXG.[(.F&;FCW9
M;J'9RXEI7[19(I>KB**C?2JJ? B^A-O]EEMM<)^57[CS; 3N6YJ@8,Y3*D)U
MO^VL_,B3X,[OAT3Q\[61V6I6 9$C.QGNPEB,.]ZS"G?M9V-PU]0$ACN.4B'N
M>FUGY4>^X([;#XGBY^O@KMFLQEU?=BK<W7R.R;#C.=QQ:P'!T_(K]9Z.0%]'
M%Q3^^&I%".2UGM4?>I*Y17V2*'_(-A([#2LL<N4G1R-GXSCW61>)HS:/]SP
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M9#P^BM@^?F(OUD=Y3I8Q#X7RPQ(FT%0T,7&$=2L2"-7U>1!$O9HC ?LZAWD
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M/+Z-M'D[!67"O(N]<7 +<Y7)S1X 8MGU)8[+LCFZKN"RE)C)TA(>GZ:;2L$
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MNF=A-ZU.P()N1OUN8[\XK;$W56IS'/O0 9<;RG7HK'J]/DSG]YNH^(,5UOJ
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MGCI@; ,#XC9<C1A,AU09@NG5'!!E,+%B"R-#\?6^%M/CI1>:(>/3 9$I2 R
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M$PU'LJ9^LC.XS 64K53I2B@[]&%LEP(OBN]D&=296H7Q/U:\J5Z&;F9Y/=,
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M'\!+C 5)B_M@WW?B>"2=SNV3N-K!7%&D.KG/H>[H7YWOZ$LD6H:/WB+P]O^
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M\Y].J5M235@*"LO8S_,&IIR"IK6:'&C.G\A4V6 B*;<@+LH,K+=?R(.8('I
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M?:TV@I" FPRFZ)\AL!;%= ^^LIJ#%XLD:UQ^F[9I8K1T?$TX3X 9XWA,S6J
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M:QO"$=+:J^+44!230C_";?$5P?4*'$ "B;B\^^%S5#F!*6!7N5B"23K/:T/
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M-:]D>8_0.%8[)M:]DO4VN'3E>*,WJ/H-EC:*XH(,D\@KZ!$$M?5ARASR*FQ
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M&01YB81:%<<R%D,P3FV(\S"!N&6L?109TAHE?%(;[L>Q1=4UO54:4;IDG3Z
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MD?(7!:3\6B$E!2]! >AG$?KFIYIQ\=6=F)R-/L'-*=H/25+T?6?Y AVOAE_
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ME%GMGS DDB]02RE38**0)%0)T[V7(:6'*?5([3O]9&BLMU_JH<$5E$%+E71
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M<O0X1UXY>R-5HHN& 8_2*N@-9W9EE,A'7B5N[17W0S9A^@"V91KAME;/1-\
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M1P^NE=CO/WZ[JJDQ[YV?.:=<6&:P/PZW)D,\=E%NW=V<M74U5*:GY'ZO+JD
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M_P!02P$"% ,4    "  "@@M5+6&>R#,@ @!R\!P %               @ $
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M,BYH=&U02P$"% ,4    "  #@@M5?&/7-,,$  !R#@  %P
M@ %8BP, 8G)H8S$P,#0P-C S7V5X,S(M,2YH=&U02P$"% ,4    "  #@@M5
MO6W2+Z@$   T#@  %P              @ %0D , 8G)H8S$P,#0P-C S7V5X
M,S(M,BYH=&U02P$"% ,4    "  #@@M5P39T2=(8  #3%@$ $
M    @ $ME0, 8G1X+3(P,C(P-C,P+GAS9%!+ 0(4 Q0    (  .""U4P[Q*"
MO0\  +S6   4              "  2VN P!B='@M,C R,C V,S!?8V%L+GAM
M;%!+ 0(4 Q0    (  .""U7:SBAPBDL  "9]!0 4              "  1R^
M P!B='@M,C R,C V,S!?9&5F+GAM;%!+ 0(4 Q0    (  .""U44)A,;8-@
M "( #0 4              "  =@)! !B='@M,C R,C V,S!?;&%B+GAM;%!+
M 0(4 Q0    (  .""U7)1#E\T6L  'S)!P 4              "  6KB! !B
M='@M,C R,C V,S!?<')E+GAM;%!+ 0(4 Q0    (  .""U5"$8[(/A<  -47
M   *              "  6U.!0!L;V=O,#$N:G!G4$L%!@     ,  P &0,
' --E!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
